Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
WASHC1	"FAM39E, FLJ00038, WASH1"	ENSG00000181404	"WASH complex subunit 1"	A8K0Z3	9	14521-73865	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 57.6;Cytotrophoblasts: 30.8;Distal tubular cells: 43.1;Proximal tubular cells: 37.7;Syncytiotrophoblasts: 35.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002689	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA002689: AB_1078803"	"unprognostic (9.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (5.00e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.37e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.02e-1)"	1.7	1.5		0.8		2.4	0.4		0.5	0.4	1.1			1.9	4.1	5.4	3.3	3.3	1.2	2.5			1.5	0.0	1.4	2.1			2.5	0.8	0.0		0.6		3.2	0.0		1.2	5.0	4.2	3.7	1.3	3.8		2.1	1.3	0.3			0.3		0.3	0.2		3.5	5.7	4.9	8.7	5.0	5.0	3.4	11.5	7.0	4.3	9.0	7.5	5.1	10.7	10.8	9.6	5.9	5.0	6.7	7.1	4.7	5.8	4.1	5.6	14.2	6.3	4.9	2.3	4.9	11.6	4.6	5.0	7.0	4.2	9.3	8.5	3.8	3.7	3.0	4.1	15.3	1.8	4.3	10.3	18.1	1.8	3.4	9.5	7.7	7.9	7.6	14.8	6.5	5.8	6.0	4.3	8.1	4.8	13.1	5.8	13.1	6.9	5.6	7.4	8.9	7.1	8.0	8.3	3.5	9.1	8.2	6.4	3.7	7.5	10.1	7.4	2.4	5.9	4.9	5.0	6.2	3.9	3.5	4.0	4.1	5.7	3.3	4.2	3.4	3.6	5.0	8.7	5.1	4.2	3.4											20.8	22.7	0.0	0.0	0.0	0.0	0.0	0.0	14.7	13.6	57.6	0.0	30.8	43.1	11.8	0.0	0.0	0.0	0.0	13.6	21.5	0.0	0.0	15.1	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	8.2	0.0	0.0	11.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0
FOXD4	"FKHL9, FOXD4a, FREAC5"	ENSG00000170122	"Forkhead box D4"	Q12950	9	116231-118204	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.7;testis: 3.1"	"Cell type enriched"	"Detected in single"	7	"monocytes: 4.6"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"THP-1: 8.9"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.46e-2)"	"unprognostic (2.52e-4)"	"unprognostic (3.66e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-3)"	0.6	0.6	1.2	0.5	1.4	0.1	0.1	5.7	1.5	0.4	0.2			0.4	0.7	0.1	0.1	0.3	0.1	0.2	1.3	1.5	1.6	0.2	0.6	0.7	0.8		0.3	0.5	0.2	0.7	0.6		0.7	0.3		0.3	0.5	1.4	0.3	0.6	0.4	0.4	1.0	0.6	3.1			0.2		0.2	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.6	0.5	0.0	0.4	0.8	0.4	3.7	0.2	0.4	0.0	0.3	1.0	0.2	3.7	0.6	0.0	0.1	0.0	0.9	0.2	0.3	3.6	3.0	0.0	0.5	0.3	0.2	2.6	1.9	0.5	0.0	0.0	0.1	0.6	0.0	0.2	1.2	1.6	0.1	1.4	0.3	2.1	0.1	0.5	1.8	0.3	0.8	0.5	0.9	1.9	1.8	1.4	1.0	0.6	0.0	0.3	0.9	8.9	0.5	1.1	1.1	0.7	1.3	0.1	0.4	0.8	0.8	2.0	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 54.7"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	6.3	14.1	5.5	5.3	6.7	3.8	7.2	5.5	4.5	4.9	5.5			4.6	4.5	8.3	10.4	5.0	3.5	7.0	4.9	6.9	16.3	10.1	5.7	4.1	5.9		5.5	10.5	7.5	7.6	8.3		7.2	5.7		8.6	4.5	7.5	7.1	4.1	4.2	4.8	5.6	6.1	6.3			10.0		7.3	6.9	5.1	8.2	28.0	7.0	28.2	4.5	7.6	15.6	12.7	4.8	7.0	3.7	9.2	8.4	15.6	6.7	4.4	9.4	7.2	7.0	4.9	11.7	8.8	2.4	5.7	2.2	3.4	6.4	10.2	20.0	11.9	0.1	11.4	21.5	10.0	33.8	5.3	7.4	3.1	2.2	18.5	6.1	10.0	6.0	3.9	25.9	7.7	15.3	7.3	54.7	7.0	11.2	10.5	14.1	10.7	22.3	12.2	36.3	12.7	7.7	13.8	5.1	5.1	18.1	10.9	32.4	10.4	5.0	7.1	6.4	5.8	3.1	4.2	13.4	12.4	18.1	5.8	1.2	25.3	7.0	4.2	28.2	6.8	8.2	7.6	6.7	28.0	5.6	6.7	7.3	3.8	4.5	21.3	7.4	6.6	15.6											50.6	47.9	33.7	27.4	42.4	48.0	46.0	25.5	38.8	59.1	33.2	102.1	83.3	29.9	60.1	37.4	22.4	21.9	0.0	103.4	31.0	20.3	19.4	30.2	16.0	28.7	36.5	30.0	18.4	26.3	13.0	16.7	36.5	30.4	85.6	35.3	24.9	55.6	28.1	12.4	58.7	53.6	32.3	38.2	33.7	19.8	44.3	104.4	16.0	55.5	21.8
C9orf66	FLJ31158	ENSG00000183784	"Chromosome 9 open reading frame 66"	Q5T8R8	9	212824-215741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 20.9;kidney: 17.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 60.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 20.9;monocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;MCF7: 3.7;RT4: 3.6;THP-1: 7.8"									HPA035652	Uncertain					NA	NA					"HPA035652: AB_10601151"	"unprognostic (1.24e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.65e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.10e-3)"	0.5	3.1	0.3	0.3	0.9	1.7	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.5	0.1	0.3	0.3	0.3	0.1	17.8	0.5	0.3	0.3	0.3	0.3	0.5	1.3	1.9	0.3	0.3	0.3	0.7	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	1.4	0.2	0.7	0.8	0.3	1.3	0.3	0.3	0.4	0.3	2.0	3.0	20.9	6.0	1.6	0.6	0.6	0.1	0.4	0.3	0.4	0.1	0.1	3.6	0.1	0.0	0.2	0.1	0.7	2.1	0.4	1.0	0.3	0.4	0.6	0.1	0.0	0.0	0.3	1.1	0.3	0.5	0.3	0.1	0.9	1.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	1.9	0.8	0.0	3.7	0.2	2.4	0.4	0.1	0.8	0.4	0.3	2.1	0.1	3.6	0.6	0.4	0.0	0.2	0.5	0.3	1.6	7.8	1.1	0.3	0.8	0.5	0.2	0.9	0.4	0.1	0.2	1.3	0.7	7.0	4.9	8.0	0.3	3.3	0.1	1.8	0.6	0.4	3.0	2.0	0.1	0.2	20.9	1.6	6.0	0.7	0.1	0.6	0.3	0.9	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.8	0.0	0.3	2.0	1.5	1.0	0.6	1.1	2.5	1.4	0.0	10.4	13.7	8.5	10.0	1.1	0.0	0.3	0.0	0.0	4.7	1.7	0.7	1.5	0.0	0.4	4.9	0.0	3.4	0.0	3.1	0.0	0.9	3.8	0.0	6.4	2.6	0.8	1.1	0.0	0.4	60.2	3.2	6.5	1.0	2.2	5.5	0.1	3.9	2.1	0.2	1.4
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.4	17.3	1.2	0.0	0.0	0.7	0.2	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	17.2	2.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	3.7	8.7	0.0	1.0	16.1	27.2	0.1	0.0	0.2	20.2	0.0	6.7	0.0	17.9	0.0	0.0	0.0	0.2	1.2	0.3	0.4	51.7	3.4	0.0	0.1	0.2	0.0	3.5	0.0	0.0	0.0	10.9	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9	8.9	31.0	83.1	1.5	5.7	0.2	2.0	22.9	1.4	3.4	7.0	72.6	44.4	1.7	0.8	24.2	4.8	0.5	0.0	5.9	3.1	2.9	1.1	23.2	2.5	50.8	0.0	8.1	3.1	113.9	11.5	2.8	79.1	8.5	79.4	8.9	1.0	1.4	17.5	0.4	8.7	3.8	12.9	14.4	15.4	4.1	3.3	35.7	76.2	1.0	3.0
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: AB_2683034"	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	28.9	5.3	23.9	8.7	23.2	1.4	15.5	17.7	18.2	18.2	17.4	28.5	7.6	8.8	26.5	10.3	33.7	12.7	13.2	46.5	21.9	10.4	19.8	39.4	10.0	6.9	21.4	14.8	16.9	17.0	9.5	14.7	18.2	16.5	23.4	11.2	14.8	17.9	24.4	24.2	20.0	9.2	27.6	21.3	3.9	10.7	12.1	23.5	2.8	16.2	8.2	8.8	28.9	26.3	1.5	7.1	0.0	0.2	0.2	4.4	1.0	2.1	4.4	1.5	27.2	22.6	8.6	7.5	13.9	9.7	1.1	1.4	11.1	0.9	16.9	3.4	17.1	2.6	4.5	5.8	11.3	2.0	8.1	3.1	0.0	6.4	35.0	3.2	4.0	0.0	4.9	15.9	1.2	13.7	5.0	11.7	0.5	0.8	21.3	8.7	5.2	1.6	17.1	1.9	3.2	3.4	0.6	3.0	3.1	9.2	13.4	0.6	0.0	1.3	4.1	18.4	13.2	2.7	3.2	17.2	3.2	1.2	4.0	6.3	3.7	21.9	0.0	2.1	7.7	5.9	0.0	0.2	0.0	0.2	0.2	0.0	1.5	2.3	0.8	0.7	1.2	4.4	1.4	0.0	0.2	0.0	7.1	3.0	1.0	23.9	23.2	17.7	17.6	21.9	10.4	21.4	14.8	16.5	23.5	11.9	32.2	2.2	72.1	20.5	22.8	86.0	25.5	6.7	6.8	17.4	39.3	71.9	6.6	10.2	85.1	17.5	9.5	23.3	6.9	5.7	13.2	37.8	1.1	61.8	11.9	0.0	17.2	17.2	4.7	178.6	30.0	3.3	21.9	0.0	11.2	7.5	11.3	10.2	19.4	12.6	20.9	25.8	23.4	16.2	23.9	22.5	55.4	3.2	20.9	53.1
DMRT1	"CT154, DMT1"	ENSG00000137090	"Doublesex and mab-3 related transcription factor 1"	Q9Y5R6	9	841690-969090	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	81	"testis: 44.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 31.6;Spermatogonia: 103.9"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 8.5;SuSa: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027850	Enhanced					NA	NA					"HPA027850: AB_10600868"	"unprognostic (3.23e-1)"	"unprognostic (1.91e-1)"		"unprognostic (9.75e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.50e-1)"		"unprognostic (3.08e-1)"		"unprognostic (1.45e-1)"			"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.02e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.2	103.9	0.0	0.0	0.0	0.0	0.0
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976964-991731	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 34.2;testis: 11.7;thyroid gland: 11.5"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 3.0;Spermatocytes: 14.4;Spermatogonia: 5.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.6"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;HEK 293: 3.8;hTERT-RPE1: 5.7;SCLC-21H: 2.3;SuSa: 2.2;THP-1: 6.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	HPA077685	Approved					NA	NA					"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	4.0	0.0	0.4	0.0	0.2	0.0	6.4	0.0	1.1	0.2	0.0	1.8	0.0	0.0	0.1	1.0	0.6	0.7	0.0	1.4	8.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.5	0.7	0.0	0.2	0.4	0.0	0.0	11.7	0.0	0.2	11.5	0.6	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.7	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	6.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.4	5.1	0.0	0.0	0.0	0.0	0.0
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9"	"Cell type enriched"	"Detected in some"	23	"Distal tubular cells: 97.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.9;RH-30: 5.3;RPMI-8226: 19.8;SCLC-21H: 3.1;SK-MEL-30: 5.4;THP-1: 3.8;WM-115: 3.8"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	HPA029297	Uncertain					NA	NA					"HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	3.8	0.5	1.9	0.5	6.5	0.4	4.5	0.5	4.5	0.5	1.6	11.0	2.6	0.4	0.5	1.3	0.6	0.6	0.4	0.5	3.2	1.3	27.3	0.4	2.4	0.6	7.0	2.5	0.4	0.4	52.9	0.7	0.6	3.6	0.6	1.1	0.0	1.4	1.5	9.0	0.6	0.4	0.5	3.0	0.4	0.4	0.9	6.2	18.4	0.4	6.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.9	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.3	19.8	0.0	0.9	3.1	0.0	0.0	0.0	5.4	0.3	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.5	0.5	4.5	3.2	1.3	7.0	2.5	3.6	6.2	0.0	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	97.8	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.3	0.0	0.7	0.3	0.0	2.3	0.0	0.0	1.7	0.0	0.0	4.2	1.5	0.1	0.1	0.0	1.5	0.1
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 180.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA			"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	23.6	29.6	38.8	21.3	43.6	40.7	30.1	41.6	44.0	23.8	17.3	20.0	38.4	10.3	26.4	30.1	20.4	29.4	22.8	21.2	30.2	30.8	23.4	28.9	20.2	29.5	25.9	32.4	85.0	18.5	104.1	35.0	23.2	24.7	23.2	15.9	22.8	26.1	44.8	41.3	27.0	18.3	26.6	19.7	23.9	15.8	26.5	23.4	20.6	28.0	24.8	27.1	23.7	22.0	9.9	11.3	20.4	8.3	8.6	12.5	4.2	5.4	4.0	3.0	4.3	6.2	7.3	9.0	6.8	5.5	3.1	2.4	0.0	2.2	9.3	2.8	6.2	1.7	2.3	1.6	5.7	2.2	180.9	2.5	25.2	11.1	1.9	2.4	10.5	14.8	4.8	2.2	3.1	5.9	5.7	5.0	4.4	0.8	32.1	5.3	2.2	2.6	8.8	3.0	3.3	1.5	11.8	3.8	8.4	7.3	4.9	1.9	1.7	4.4	1.0	1.9	4.5	2.0	6.8	6.0	5.1	2.5	3.2	3.3	2.9	3.7	4.2	5.6	4.0	1.4	20.4	4.6	13.1	10.3	6.2	9.9	9.9	9.9	10.5	5.6	8.0	12.5	10.0	13.5	8.6	8.3	11.3	10.4	4.2	38.8	43.6	41.6	44.0	30.2	30.8	25.9	32.4	24.7	23.4	68.5	60.6	20.6	16.9	52.1	54.6	85.9	25.5	107.1	55.7	101.2	35.3	80.6	26.6	21.1	24.7	47.7	25.6	0.0	19.4	19.6	52.6	19.1	45.2	54.3	27.1	33.4	35.7	35.0	45.5	17.2	71.1	37.2	47.2	35.1	32.1	44.7	15.3	7.0	81.7	15.9	34.9	12.9	28.8	18.6	13.6	46.0	74.1	47.1	24.0	12.4
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621834-2660053	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 72.2;Cone photoreceptor cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 14.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 27.2;JURKAT: 21.2;THP-1: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Uncertain	"Vesicles,Cytokinetic bridge,Centriolar satellite"		NA	NA		180000	Vesicles	"Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	11.3	13.7	7.2	3.7	9.6	1.3	11.2	8.7	7.3	6.9	3.9	12.8	6.5	1.2	12.1	4.3	11.6	15.1	5.5	38.0	7.6	4.5	8.8	2.5	6.9	0.9	13.2	5.3	50.5	20.8	43.6	5.9	9.4	7.7	5.7	2.9	12.3	7.5	4.4	21.2	3.4	1.6	15.7	10.1	5.5	5.8	5.6	10.3	0.0	8.8	12.5	3.9	11.9	6.1	0.1	0.8	14.1	0.1	0.1	1.1	0.0	0.0	2.9	18.8	0.8	2.8	0.2	27.2	8.5	2.8	2.2	6.5	4.7	0.3	0.0	9.2	5.2	1.4	0.2	5.2	5.7	7.3	9.9	1.9	0.1	2.5	2.2	3.0	11.8	2.1	1.2	4.2	0.8	0.4	9.7	1.1	21.2	0.0	16.7	1.3	0.8	2.1	1.6	9.5	1.5	1.1	0.2	0.6	0.0	10.9	1.1	4.2	3.0	0.6	0.9	11.8	14.2	0.4	28.0	0.3	3.1	5.8	0.0	5.6	12.7	5.1	3.0	20.2	9.9	1.1	0.1	0.1	14.1	0.2	0.0	1.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	2.0	0.1	0.0	0.8	0.0	0.0	7.2	9.6	8.7	7.3	7.6	4.5	13.2	5.3	7.7	10.3	14.9	9.1	0.0	1.0	2.4	17.9	72.2	2.5	8.1	2.3	5.2	98.2	11.4	1.7	10.1	4.5	2.7	0.9	0.0	8.9	18.7	14.0	5.0	0.0	1.3	2.1	11.1	10.5	1.3	0.3	1.9	7.2	0.6	10.1	1.8	0.3	2.7	11.2	2.6	10.3	4.4	30.4	0.0	10.3	1.5	7.0	1.8	2.9	1.8	0.6	3.0
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717502-2730037	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 82.3"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 485.0;Rod photoreceptor cells: 393.2"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HDLM-2: 2.9;HEK 293: 1.4;HeLa: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA					"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	82.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.6	0.0	0.2	0.7	0.2	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	1.4	0.8	2.3	0.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.7	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.1	0.1	0.6	0.0	0.0	0.7	0.4	0.6	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.2	0.0	0.0	0.0	0.0	485.0	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	19.8	0.6	0.0	0.0	0.0	0.0	36.6	0.0	0.0	1.1	0.0	393.2	12.9	0.0	5.9	11.4	0.0	0.0	0.0	0.0	0.0
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844241	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 73.4;HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.4	17.0	11.5	19.0	15.2	14.8	22.1	15.6	17.7	18.9	16.9	8.3	9.8	11.2	17.1	10.6	29.3	15.7	10.5	15.1	16.7	5.9	23.2	18.4	18.6	18.9	14.0	14.3	24.4	17.8	11.5	23.1	15.9	15.8	18.0	17.3	6.1	20.7	10.3	21.0	16.4	13.2	19.5	18.2	17.8	14.2	13.8	14.9	15.4	15.1	14.5	18.9	20.1	21.6	15.3	13.7	3.8	12.8	15.9	18.4	7.8	17.0	12.6	10.6	10.8	8.9	9.5	12.1	15.9	8.4	16.4	15.4	9.5	8.0	18.9	3.7	10.9	9.8	8.6	19.2	13.7	21.5	73.4	6.8	71.5	12.7	11.4	11.9	31.5	13.4	7.7	6.1	13.3	19.1	7.5	12.1	12.4	7.4	8.6	14.3	7.7	15.9	25.7	27.2	13.1	5.6	18.8	8.3	8.1	11.1	11.5	11.0	10.6	9.6	8.9	8.6	12.4	5.6	17.1	11.5	11.1	9.1	10.6	21.2	4.0	6.5	26.6	8.4	11.5	8.0	3.8	9.2	2.7	13.2	12.8	18.4	15.3	13.7	13.2	12.1	13.5	15.3	14.8	1.3	15.9	10.4	13.7	10.0	7.8	11.5	15.2	15.6	17.7	16.7	5.9	14.0	14.3	15.8	14.9	44.7	39.5	24.8	31.5	0.0	23.8	0.0	20.4	58.9	76.2	22.7	9.8	29.4	39.7	30.6	3.5	15.7	3.1	0.0	22.9	37.0	25.8	19.6	16.3	15.7	19.1	25.4	8.2	20.3	14.3	2.2	43.7	23.0	0.0	35.1	10.7	18.3	24.5	7.0	21.5	99.1	25.6	0.0	0.0	32.5	43.2	0.0	29.3	8.7	16.7	27.1
RFX3		ENSG00000080298	"Regulatory factor X3"	P48380	9	3218297-3526004	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1;testis: 36.5"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 140.5;Early spermatids: 159.1;Intestinal endocrine cells: 135.5;Late spermatids: 86.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 22.4;HDLM-2: 13.2;SCLC-21H: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035689	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035689: AB_10671224"	"prognostic favorable (1.47e-4)"	"unprognostic (8.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.52e-1)"	"unprognostic (8.89e-3)"	5.2	4.6	17.9	7.6	14.9	11.4	6.7	35.1	19.5	6.9	4.7	6.9	5.0	5.0	6.8	6.3	3.8	22.0	5.2	4.0	12.8	7.5	5.0	4.1	7.2	6.7	6.0	11.9	7.0	5.4	9.0	21.7	5.8	9.9	6.1	5.6	4.2	4.7	4.6	5.7	4.4	5.0	4.0	12.5	5.7	6.6	36.5	11.0	12.7	5.7	2.9	7.5	4.5	7.8	8.3	4.6	8.9	4.8	5.3	9.3	3.2	2.0	2.7	22.4	5.4	0.9	1.0	2.2	0.8	2.4	1.9	1.4	0.8	2.6	3.2	0.9	1.1	1.6	1.1	5.5	2.3	3.4	13.2	1.5	6.0	3.0	1.8	1.1	1.2	0.8	1.4	1.1	2.3	3.8	3.8	3.3	4.2	1.1	3.3	2.0	1.6	3.8	4.4	5.9	1.7	1.2	4.0	1.5	0.8	3.1	1.6	12.0	5.3	1.3	0.6	2.0	4.6	1.1	3.2	2.0	1.4	3.3	0.7	1.3	1.1	0.5	6.4	1.6	1.4	1.5	3.5	3.2	6.2	8.8	4.8	5.4	6.3	8.1	7.2	3.1	8.3	5.7	7.0	8.9	5.3	1.4	4.6	9.3	3.2	17.9	14.9	35.1	19.5	12.8	7.5	6.0	11.9	9.9	11.0	6.0	7.7	6.2	7.4	4.4	22.0	4.9	0.0	140.5	34.2	3.5	23.6	1.6	0.0	3.1	159.1	13.5	2.5	0.0	2.2	2.1	4.3	9.6	5.8	0.9	2.7	36.5	135.5	11.6	6.9	86.4	6.6	6.2	1.7	1.0	9.2	13.8	3.2	5.8	7.1	1.7	25.2	0.0	10.3	10.2	2.5	5.5	1.1	6.7	5.5	3.3
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 57.8"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 45.9;Collecting duct cells: 66.3;Ductal cells: 42.5;Intestinal endocrine cells: 42.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.4;HSkMC: 23.4;RPTEC TERT1: 14.5;U-251 MG: 12.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	5.6	2.8	5.6	4.4	7.4	1.0	2.9	3.5	9.5	13.4	2.9	10.7	33.5	1.6	6.1	6.5	1.5	15.0	14.7	4.7	8.9	4.5	11.4	5.1	5.7	2.6	7.7	3.8	10.4	17.3	6.4	8.8	2.8	16.3	5.3	4.0	4.6	5.2	57.8	2.1	1.4	2.2	5.1	26.7	3.8	3.2	4.6	10.2	0.0	29.3	1.4	1.7	5.6	8.8	0.0	0.0	1.8	0.9	0.3	0.7	0.0	0.6	6.7	2.0	0.0	2.7	7.4	0.2	5.1	15.4	2.3	3.4	1.1	2.4	0.0	4.0	3.7	7.7	0.0	1.3	0.0	4.8	1.5	1.0	0.0	0.3	0.0	8.1	0.7	0.0	23.4	0.0	7.1	0.7	4.2	0.4	0.0	0.0	0.1	1.9	0.2	0.0	0.9	0.1	0.0	0.9	0.0	4.6	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	5.1	2.6	0.6	2.7	12.1	0.0	0.0	0.0	7.1	0.0	3.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	1.1	0.3	0.9	0.0	0.1	0.0	5.6	7.4	3.5	9.5	8.9	4.5	7.7	3.8	16.3	10.2	8.9	20.0	0.9	6.4	1.6	0.2	1.1	45.9	29.4	30.7	66.3	0.0	2.0	0.0	42.5	3.6	5.8	2.0	0.0	20.0	2.7	6.6	10.3	1.1	6.6	2.1	0.0	42.0	6.2	1.0	1.8	12.7	2.7	3.3	3.6	1.1	22.1	34.5	2.9	10.6	17.0	0.2	0.0	10.3	0.7	4.3	1.1	3.5	1.0	3.5	3.9
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490444-4587469	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;kidney: 31.2"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	30	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA					"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	3.3	1.4	8.6	3.4	10.2	0.3	2.9	4.7	12.4	4.0	17.9	2.7	0.5	21.0	4.0	28.8	1.7	1.9	16.3	2.0	10.0	10.2	31.2	29.1	12.8	1.8	8.6	5.8	0.7	1.8	0.4	5.2	5.1	6.7	4.3	6.6	1.9	3.1	2.4	2.2	1.2	40.4	5.6	5.3	0.5	3.4	0.8	4.4	0.0	25.0	1.8	5.0	3.5	1.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.7	4.4	11.5	13.9	3.9	4.7	9.8	1.5	1.4	7.8	0.2	6.1	0.3	2.4	1.8	0.0	1.6	2.6	1.3	31.6	2.1	0.0	6.6	0.0	0.4	0.4	0.0	0.9	0.1	5.6	0.0	0.7	14.9	0.1	0.0	0.0	1.0	0.1	0.0	0.1	1.9	4.7	0.8	0.0	0.0	0.0	31.0	2.7	1.0	0.9	0.3	1.7	0.0	3.7	0.6	0.2	8.0	2.3	0.1	4.4	1.3	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	8.6	10.2	4.7	11.7	10.0	10.2	8.6	5.8	6.7	4.4	151.8	2.7	0.8	1.0	0.0	0.7	0.8	35.7	4.0	9.1	0.0	0.0	0.0	3.3	5.5	3.5	7.0	37.3	0.0	0.7	0.0	0.9	1.7	0.0	62.7	0.1	0.0	0.0	3.1	2.1	6.1	0.3	0.1	0.0	0.0	6.5	0.8	5.8	8.6	0.0	37.2	0.9	0.0	1.1	0.0	0.2	0.5	0.1	0.8	4.8	0.2
SPATA6L	"C9orf68, FLJ10058"	ENSG00000106686	"Spermatogenesis associated 6 like"	Q8N4H0	9	4553386-4666674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 23.0"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 96.7;Late spermatids: 69.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;CAPAN-2: 5.8;HDLM-2: 3.2;RPTEC TERT1: 4.4;SCLC-21H: 3.8"					"Low region specificity"	"Detected in all"			HPA039585	Enhanced					NA	NA					"HPA039585: AB_10674984"	"unprognostic (8.18e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.03e-3)"	"unprognostic (4.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-3)"	1.7	1.1	4.9	0.6	7.3	0.2	3.0	15.3	5.3	1.5	1.6	1.7	4.1	2.6	1.7	5.4	2.3	9.4	4.0	1.4	3.2	1.7	2.5	7.6	4.0	1.7	1.2	2.5	1.7	5.3	3.9	23.0	1.3	3.8	1.9	1.2	0.0	1.3	1.6	0.9	1.6	3.6	0.5	1.3	1.0	3.4	13.2	1.5	0.0	2.9	0.8	0.9	1.6	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.4	1.2	0.4	0.6	0.0	0.0	0.1	3.4	0.1	0.3	0.0	0.1	0.1	5.8	0.0	0.2	0.2	0.1	0.3	0.6	0.0	0.0	3.2	0.1	0.9	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	1.4	0.0	0.3	0.0	0.0	0.0	0.2	1.7	0.9	0.0	0.0	0.0	0.4	4.4	0.0	3.8	2.1	0.0	1.5	0.0	0.4	0.6	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	1.0	0.9	0.0	0.0	1.7	1.8	0.0	0.0	0.0	0.0	0.9	0.4	4.9	7.3	15.3	5.3	3.2	1.7	1.2	2.5	3.8	1.5	8.9	13.0	0.0	2.3	0.6	1.7	1.6	12.7	21.4	10.3	3.5	11.8	2.1	3.3	4.3	96.7	5.8	1.7	0.0	4.6	0.3	1.1	2.3	1.1	10.5	0.5	0.0	0.0	3.1	0.0	69.3	1.7	0.6	0.0	0.0	4.4	1.4	4.3	3.2	2.5	2.2	0.7	0.0	0.5	6.0	2.9	1.0	1.7	0.5	2.0	2.2
PLPP6	"FLJ46512, FLJ90191, PDP1, PPAPDC2"	ENSG00000205808	"Phospholipid phosphatase 6"	Q8IY26	9	4662315-4665258	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 74.5;Late spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018096	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA018096: AB_1855609"	"unprognostic (2.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.99e-4)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.88e-2)"	4.0	8.3	4.4	7.2	6.8	1.1	7.3	11.9	9.7	5.7	9.4	6.2	4.2	10.2	4.9	13.2	9.2	4.1	9.7	3.0	4.9	4.8	6.3	20.0	4.7	8.3	8.6	6.3	4.2	19.2	8.7	5.5	13.1	9.4	16.9	10.0	4.7	10.4	8.5	2.2	8.6	15.4	3.3	4.9	7.1	10.7	8.4	3.4	16.2	7.2	6.9	9.6	7.4	5.5	4.3	5.1	8.5	5.1	4.7	13.0	5.1	3.9	4.1	4.4	5.4	3.6	4.0	4.4	2.7	3.5	2.2	2.5	1.0	2.6	3.8	1.1	2.6	5.5	4.9	3.1	3.8	2.3	47.7	2.9	7.6	3.9	5.4	3.2	2.7	5.7	4.4	3.1	1.7	3.8	2.9	3.3	4.3	1.3	4.0	2.8	4.2	2.5	7.2	4.0	4.0	1.4	2.5	0.0	2.9	3.8	4.5	11.1	5.6	3.2	2.9	1.6	5.7	4.1	6.1	3.8	2.0	1.7	2.6	1.7	0.8	3.0	1.0	3.1	1.9	1.8	8.5	5.1	4.1	4.2	4.4	4.6	3.5	7.4	6.3	5.1	4.3	13.0	9.2	2.1	4.7	4.9	3.9	10.0	5.1	4.4	6.8	11.9	9.7	4.9	4.8	8.6	6.3	9.4	3.4	6.0	2.4	3.4	2.0	0.0	6.8	0.0	5.1	0.0	2.3	1.8	2.0	14.4	1.7	10.9	74.5	1.4	8.5	0.0	12.1	2.1	0.0	7.1	0.0	13.2	5.4	3.2	10.5	4.3	5.3	33.5	2.6	2.2	0.0	1.8	8.4	3.8	8.7	7.4	4.6	2.6	4.3	0.0	0.0	0.6	1.0	0.0	8.7	1.5	6.4	2.6
CDC37L1	"CDC37B, FLJ20639, HARC"	ENSG00000106993	"Cell division cycle 37 like 1"	Q7L3B6	9	4679559-4708398	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HDLM-2: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021175	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA021175: AB_10959752"	"unprognostic (1.18e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.71e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.78e-2)"	"unprognostic (7.97e-2)"	"prognostic favorable (2.66e-7)"	"unprognostic (8.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-2)"	14.9	12.6	10.4	7.1	15.4	5.6	10.5	12.4	14.9	12.2	10.0	7.1	11.2	7.8	10.9	12.0	15.8	10.1	11.6	28.6	11.2	12.6	13.4	42.0	8.4	9.0	10.0	9.9	12.4	15.1	9.3	13.7	7.5	17.3	13.0	6.5	6.2	9.4	11.1	58.8	8.1	8.0	17.9	8.8	6.3	9.5	10.8	8.9	7.0	12.2	14.0	7.2	18.0	16.1	10.7	6.2	14.8	6.8	8.1	20.7	7.9	7.2	6.6	3.5	5.6	12.7	9.4	5.4	8.6	5.9	5.2	6.0	2.1	4.5	4.6	2.4	6.2	3.5	3.2	3.9	5.2	5.1	54.0	3.3	12.3	7.2	5.7	7.6	4.9	5.1	6.0	6.8	3.9	6.2	5.8	3.7	4.2	1.4	7.2	5.8	3.5	3.8	10.2	8.9	4.8	2.3	3.1	4.3	2.6	7.4	3.0	10.1	5.0	6.3	5.2	4.2	4.7	4.2	4.7	4.0	7.9	3.7	4.4	5.6	5.6	8.8	3.4	7.0	3.5	2.5	14.8	5.7	11.0	13.3	5.3	13.1	10.7	13.4	14.0	5.4	10.5	20.7	18.5	6.8	8.1	6.8	6.2	12.1	7.9	10.4	15.4	12.4	14.9	11.2	12.6	10.0	9.9	17.3	8.9	26.8	16.5	11.2	38.4	58.5	28.6	62.3	20.4	17.4	17.0	15.7	31.4	15.6	41.4	28.4	8.6	17.6	12.9	0.0	36.2	13.7	33.8	56.3	23.1	91.2	10.4	19.1	17.1	15.4	11.2	3.9	33.4	16.0	38.8	13.6	14.9	28.6	23.9	11.5	34.3	49.1	21.9	32.3	48.6	69.4	49.7	50.2	28.3	26.1	10.7	43.1
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709559-4742043	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 86.8;HEL: 55.6"	"Low region specificity"	"Detected in all"							HPA063324	Enhanced		Supported	Mitochondria		NA	NA		68000	Mitochondria		"HPA063324: AB_2684985"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favorable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	24.6	25.1	20.9	9.8	22.4	6.8	24.0	14.6	17.5	17.7	23.7	15.3	16.0	24.4	18.9	17.5	28.3	14.0	16.1	90.0	22.4	16.4	37.7	75.1	16.4	13.1	25.2	15.2	22.4	15.7	16.9	14.1	13.0	22.9	19.0	23.0	17.4	14.5	19.1	72.0	18.1	22.0	21.2	24.1	12.1	22.5	9.3	24.9	15.2	20.8	32.8	14.9	20.1	17.1	7.0	14.4	17.0	5.6	14.7	17.1	10.2	8.8	7.5	12.8	5.2	17.9	13.2	0.9	11.3	26.5	7.1	10.6	1.3	9.9	8.3	3.8	14.3	3.9	5.8	9.3	10.8	12.0	86.8	7.0	55.6	13.3	22.5	14.1	5.8	2.9	20.8	9.7	6.0	8.4	16.5	20.8	8.5	4.2	11.3	21.1	5.3	5.6	16.9	11.4	17.4	2.8	7.6	4.6	4.1	20.6	12.5	21.1	13.3	13.2	4.3	7.5	13.0	6.0	11.7	12.8	5.9	6.0	15.5	8.8	2.9	1.8	10.2	10.9	4.4	4.2	6.8	5.6	17.0	16.2	4.4	14.7	7.0	12.5	14.8	10.5	6.9	16.6	17.1	1.9	14.7	3.4	14.4	16.7	10.2	20.9	22.4	14.6	17.5	22.4	16.4	25.2	15.2	22.9	24.9	53.6	88.6	32.0	59.7	65.9	11.9	155.8	66.2	45.5	68.2	62.8	21.6	83.2	218.8	74.1	2.6	56.6	104.3	0.0	61.0	10.9	79.1	116.1	44.0	282.7	40.3	14.3	105.2	74.3	36.8	1.9	100.7	36.7	70.9	53.3	103.3	22.3	61.2	57.5	140.7	148.4	8.8	103.5	59.8	6.6	15.3	91.2	179.0	38.5	135.0	92.5
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792869-4885917	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"liver: 108.1;pancreas: 37.5"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 35.1;HEL: 90.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	15.9	6.8	4.2	6.7	5.9	17.2	12.9	5.5	6.3	5.6	3.8	6.2	6.3	2.4	5.5	5.4	5.5	5.6	3.8	3.7	4.1	3.6	5.7	108.1	6.9	9.1	5.8	4.2	9.0	37.5	3.8	5.1	6.8	5.6	3.6	4.2	4.5	4.8	9.1	10.9	10.5	4.1	5.2	7.1	5.0	5.2	6.8	5.6	5.7	4.5	8.1	7.2	5.3	6.8	10.4	6.8	12.9	2.3	10.8	9.1	3.5	5.6	6.7	2.6	4.1	3.9	2.6	6.8	2.6	2.9	5.0	4.2	3.4	3.3	10.9	1.9	2.4	5.6	3.6	11.9	8.0	5.8	35.1	6.1	90.1	8.1	6.7	5.6	8.1	7.3	5.8	4.6	4.8	7.4	2.7	4.9	8.0	9.2	7.1	3.0	7.3	6.6	14.0	8.9	6.8	2.7	8.2	3.4	5.7	6.1	6.4	7.4	6.1	3.4	5.0	3.9	5.3	4.7	9.6	3.4	3.0	3.3	4.1	8.2	2.9	8.2	11.7	5.4	5.0	1.9	12.9	1.5	3.8	5.6	2.3	6.8	8.0	6.6	7.6	4.0	10.4	8.9	9.1	0.6	10.8	1.2	6.8	5.5	3.5	4.2	5.9	5.5	6.3	4.1	3.6	5.8	4.2	5.6	5.6	6.0	5.0	10.0	14.8	22.7	4.8	10.1	5.1	16.0	6.8	3.5	0.0	33.2	21.6	11.0	59.1	7.7	2.2	0.0	9.9	10.9	10.3	6.4	13.9	135.7	15.5	4.8	2.9	16.0	8.8	39.4	21.3	5.8	3.3	15.4	6.4	7.8	9.2	2.9	35.3	12.1	6.5	12.9	14.6	17.7	19.5	18.4	29.6	10.1	7.2	12.6
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Group enriched"	"Detected in many"	5	"ASC diff: 19.4;HDLM-2: 27.4;HEL: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.5	1.5	2.5	19.4	5.0	0.4	3.5	3.0	2.7	1.8	0.1	0.8	0.1	0.8	2.1	2.2	0.9	1.6	2.1	2.0	27.4	0.5	56.1	3.0	0.7	4.0	3.8	2.9	4.1	0.9	1.1	1.8	3.3	2.5	2.0	4.0	6.5	4.8	0.9	0.9	5.4	1.3	1.3	1.7	1.9	2.8	0.8	2.0	1.3	1.7	0.9	1.0	1.5	1.1	1.6	0.8	6.7	5.1	4.1	1.4	4.2	2.4	1.2	2.3	0.5	5.3	1.9	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0	14.9	6.4	6.9	2.8	8.7	7.4	22.0	0.0	5.3	7.9	7.0	7.9	1.8	1.7	3.0	7.4	8.7	3.9	23.3	3.4	0.8	7.0	1.7	13.9	1.6	11.9	7.9	2.9	4.9	36.0	5.3	21.9	27.7	5.0	16.2	4.2	12.2	5.4	14.4	31.5	2.5	11.1	0.0	5.0	14.9	5.7	7.3	2.9	5.0	3.3	4.1
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5131979-5185668	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 22.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 106.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;HL-60: 1.6"					"Low region specificity"	"Detected in single"			HPA021364	Enhanced				"Secreted to blood"	NA	NA					"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	106.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.5	0.0	20.6	9.0	0.0	0.2	0.0	0.0	0.0
INSL4	EPIL	ENSG00000120211	"Insulin like 4"	Q14641	9	5231419-5235304	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"placenta: 88.0"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 2990.3"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"A549: 23.6"									HPA065145			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA065145: "		"unprognostic (9.77e-2)"						"unprognostic (2.02e-1)"		"unprognostic (4.66e-1)"				"unprognostic (7.74e-2)"				0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	88.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	23.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	269.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2990.3	0.0	0.0	0.0
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299868-5304969	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 44.0"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 8.6;Spermatocytes: 10.5;Syncytiotrophoblasts: 11.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.7"	"Region enriched"	"Detected in single"	64	"basal ganglia: 44.0"	"Group enriched"	"Detected in many"	39	"gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0"	"Group enriched"	"Detected in many"	47	"B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;HEL: 20.2;T-47d: 5.8;U-266/84: 9.2"														"Secreted to blood"	NA	NA	24400					"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.6	0.0	0.6	1.6	44.0	0.0	3.2	0.6	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	7.5	0.6	0.6	0.6	0.6	2.0	0.6	0.7	3.5	0.6	0.6	0.6	0.9	5.2	5.8	0.7	0.6	6.2	0.3	0.6	0.6	0.7	0.6	0.4	0.8	0.6	0.6	1.4	0.4	4.2	0.6	0.6	0.9	0.6	3.0	0.6	0.6	2.8	0.0	0.0	0.0	4.9	6.5	1.4	2.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.3	1.5	5.2	0.4	0.0	0.0	0.9	0.0	2.7	0.7	4.1	1.9	20.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.5	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.6	2.7	2.9	0.0	0.6	0.1	0.2	5.8	0.1	0.2	0.0	0.5	0.0	0.1	1.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.5	2.8	4.3	3.5	0.0	2.1	6.2	4.6	0.0	4.9	0.0	0.0	2.0	1.4	0.6	44.0	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	3.0	1.1	0.5	2.3	0.5	1.5	1.6	0.0	4.0	1.2	1.8	0.0	6.0	6.6	2.5	7.4	0.3	0.0	0.0	1.4	1.7	0.2	1.3	0.0	0.0	0.5	3.2	3.5	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.2	8.6	0.7	0.0	0.4	0.8	1.8	0.0	0.1	10.5	2.8	1.1	11.3	2.9	1.0	0.3
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334969-5339873	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"prostate: 25.4"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 6.8;Intestinal endocrine cells: 4.6;Spermatocytes: 2.3;Spermatogonia: 2.0"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;HEL: 4.8;SK-BR-3: 1.1"														"Secreted to blood"	NA	NA						"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	1.2	0.0	0.0	0.0	0.4	0.2	0.0	6.8	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.3	2.0	0.1	0.9	0.5	0.2	0.0
PLGRKT	"AD025, C9orf46, FLJ14688, MDS030, Plg-RKT"	ENSG00000107020	"Plasminogen receptor with a C-terminal lysine"	Q9HBL7	9	5357973-5437878	"Predicted intracellular proteins"	"Chemotaxis, Inflammatory response, Plasminogen activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 74.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008214, HPA011144"	Supported		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA008214: AB_1078363, HPA011144: AB_1078364"	"prognostic favorable (5.56e-4)"	"unprognostic (5.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.45e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.09e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	11.3	15.6	10.6	12.9	12.1	6.8	15.5	8.7	17.6	11.4	24.0	12.6	11.8	25.6	9.6	17.3	16.4	11.9	9.3	34.5	8.9	7.5	23.1	13.9	13.3	36.5	9.9	9.8	9.2	10.9	7.8	10.1	16.7	14.1	10.6	28.4	13.1	10.7	10.5	30.5	12.1	20.6	15.6	13.3	12.0	11.9	7.4	10.1	18.2	15.2	26.3	14.8	10.7	9.9	14.1	12.9	59.3	7.2	14.1	21.4	13.5	16.3	4.7	9.9	7.1	6.4	9.0	0.0	8.0	9.0	7.0	8.1	0.0	7.4	3.8	4.3	6.0	10.3	3.8	6.8	22.2	14.7	74.5	4.3	29.4	4.0	5.2	14.0	8.8	7.0	9.8	8.1	6.5	13.4	6.0	10.0	12.7	1.6	26.8	16.9	3.6	9.4	10.0	6.4	13.4	2.8	6.0	4.9	11.9	15.8	3.5	7.9	10.3	7.9	12.7	15.1	7.4	10.2	12.5	7.1	8.9	10.9	7.7	15.5	5.1	7.4	7.7	15.4	5.6	5.0	59.3	5.7	10.7	13.6	7.2	16.9	14.1	17.3	17.9	8.1	11.8	16.7	16.5	6.7	14.1	4.8	12.9	21.4	13.5	10.6	12.1	8.7	17.6	8.9	7.5	9.9	9.8	14.1	10.1	11.9	26.7	19.3	18.6	23.5	10.6	52.9	22.9	46.8	23.9	21.0	0.0	76.9	92.9	68.8	0.6	17.9	129.2	23.3	44.8	96.5	28.0	25.8	88.9	24.3	72.3	9.5	25.5	17.2	19.0	1.5	15.3	35.1	32.1	139.7	115.7	18.3	64.0	135.5	18.7	58.8	11.6	0.0	20.9	11.9	8.5	26.5	55.0	34.1	97.8	17.5
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 23.9;placenta: 56.0"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 8.4;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, HPA003528: "	"prognostic favorable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	3.4	2.1	1.7	10.8	3.2	1.4	2.2	2.5	3.3	2.0	2.3	2.5	2.8	2.6	1.7	2.4	3.0	1.9	4.3	9.5	1.4	3.7	3.0	3.6	23.9	6.4	2.3	0.7	1.7	2.7	3.8	7.4	56.0	3.2	2.9	2.2	3.3	1.7	1.6	4.3	1.3	2.7	2.3	2.4	12.8	1.9	1.2	1.0	11.6	3.7	2.1	5.8	3.1	1.9	0.9	0.0	8.4	0.1	0.4	2.4	0.7	5.9	0.1	0.0	0.2	0.0	0.0	0.0	11.9	10.1	3.0	4.2	0.0	1.9	0.0	0.2	0.3	1.5	0.2	0.0	5.2	9.9	34.2	0.0	3.4	0.1	0.0	22.8	0.0	0.0	0.2	0.0	6.3	9.3	3.1	5.9	0.3	0.0	1.1	9.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.3	0.6	0.1	0.0	0.1	0.1	0.9	0.7	0.9	0.0	0.1	10.9	6.5	2.0	0.2	37.9	0.2	0.1	0.1	2.1	0.1	0.0	8.4	0.1	0.3	1.2	0.1	2.1	0.9	2.4	1.8	0.0	0.2	1.3	0.7	5.7	0.4	0.0	0.0	1.1	0.7	1.7	3.2	2.5	3.3	1.4	3.7	2.3	0.7	3.2	1.0	11.9	10.7	0.5	1.2	4.0	1.4	6.5	0.0	4.0	3.4	0.0	0.0	4.9	0.0	6.4	0.2	6.3	0.8	0.0	3.7	20.2	1.9	0.9	26.7	1.0	4.9	0.0	0.0	10.4	1.9	0.0	0.3	7.7	3.3	73.9	0.1	0.6	12.0	0.0	0.4	0.4	0.1	0.0	0.9	0.5	0.7	2.3	37.2	1.3	0.2	2.2
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510570-5571254	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 15.1;monocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 25.9;BJ hTERT+: 40.8;HDLM-2: 31.1;TIME: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		34000000	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	15.2	1.8	1.2	7.7	1.4	0.2	9.5	0.7	1.2	7.0	1.9	2.3	0.0	0.8	2.9	7.2	3.9	3.8	4.0	5.8	1.2	1.3	2.5	6.4	13.3	10.8	1.6	0.5	4.1	1.8	0.5	1.1	12.9	1.9	5.0	2.5	2.4	2.9	1.7	5.5	3.6	2.5	4.6	3.7	19.5	1.9	4.2	1.2	8.1	3.5	3.5	8.1	6.0	5.4	0.5	0.9	4.1	3.6	0.0	3.0	0.7	2.1	0.0	0.0	0.0	1.8	2.1	0.0	25.9	40.8	12.5	15.2	0.0	0.1	0.0	0.1	10.5	1.8	0.2	0.0	3.5	12.5	31.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	1.9	0.0	5.8	6.9	3.6	8.2	0.0	0.0	3.1	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	18.0	9.0	0.5	4.3	7.1	0.4	0.0	0.0	5.1	0.0	1.1	4.1	0.9	0.0	1.4	3.6	1.9	0.5	2.2	0.9	0.9	0.3	0.0	1.0	2.0	0.0	0.5	0.0	3.0	0.7	1.2	1.4	0.7	1.2	1.2	1.3	1.6	0.5	1.9	1.2	6.0	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.2	15.1	2.1	0.1	3.5	0.0	2.8	0.0	0.0	6.7	4.3	0.0	5.5	2.2	1.7	45.9	0.0	0.0	2.1	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.7	0.0	0.0	0.0
RIC1	"bA207C16.1, KIAA1432"	ENSG00000107036	"RIC1 homolog, RAB6A GEF complex partner 1"	Q4ADV7	9	5629025-5776557	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 31.0;HEL: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051578	Supported					NA	NA					"HPA051578: AB_2681541"	"unprognostic (1.78e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.16e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	16.3	11.7	7.4	24.7	9.0	13.1	21.6	16.0	8.2	15.5	15.3	8.1	24.9	11.5	18.7	16.7	16.2	13.8	14.0	11.5	7.3	5.8	10.1	11.4	15.9	23.4	9.1	6.8	16.6	16.9	13.9	8.6	20.2	9.3	12.4	11.2	11.2	20.8	21.5	38.6	18.2	18.7	18.0	8.6	20.1	12.4	12.7	10.1	32.1	14.8	16.8	21.4	17.3	22.2	3.0	3.1	1.9	4.0	3.5	2.0	1.6	7.8	4.6	8.1	5.5	9.4	11.0	6.7	11.3	10.5	7.8	10.2	4.2	1.7	17.8	1.4	11.6	3.1	3.8	6.1	6.2	10.9	31.0	4.0	38.9	9.6	4.5	7.8	6.0	7.1	10.3	4.3	5.3	8.4	9.0	9.2	5.6	2.3	21.3	6.4	1.9	5.0	11.0	4.1	3.0	2.3	9.7	5.3	7.1	4.1	3.0	2.2	5.5	6.1	3.9	3.1	13.5	3.4	10.3	8.9	6.3	8.0	3.5	5.3	5.9	7.4	22.4	2.6	2.3	2.1	0.8	2.4	1.9	1.4	4.0	1.8	3.0	1.7	2.0	2.2	1.3	1.1	1.6	1.3	3.5	1.9	3.1	2.0	1.6	7.4	9.0	16.0	8.2	7.3	5.8	9.1	6.8	9.3	10.1	8.9	3.7	18.0	4.9	0.0	8.2	4.0	12.7	1.4	0.0	0.0	3.9	6.1	1.7	3.9	7.6	6.3	3.9	0.0	4.6	3.7	5.1	4.8	4.7	7.4	6.7	20.6	3.5	10.4	25.6	6.4	8.1	6.8	0.0	9.0	3.1	2.9	4.9	3.5	6.0	2.2	5.6	12.9	5.1	7.0	2.7	0.0	6.1	4.3	3.2	8.2
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 57.6"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 69.8;Urothelial cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.5;RT4: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA					"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	4.0	12.0	5.3	3.6	13.8	1.6	4.8	7.3	12.3	8.5	8.2	20.5	1.5	3.4	4.9	2.9	12.7	4.9	8.8	7.1	6.8	5.8	18.8	3.5	4.7	2.7	18.3	7.0	5.6	4.4	57.6	3.3	5.7	17.0	4.8	8.4	6.9	12.8	3.4	5.2	6.8	4.8	3.2	15.9	2.5	9.1	5.9	11.5	4.6	19.1	4.6	7.2	18.7	8.1	0.2	0.3	0.9	0.5	4.7	2.0	0.3	15.3	15.0	0.6	1.8	7.8	7.5	8.0	1.7	3.9	0.8	0.7	3.6	9.4	3.6	6.8	2.9	9.2	11.0	3.2	10.2	1.2	18.9	2.6	19.1	7.9	7.0	1.7	5.4	7.5	3.8	4.5	0.7	4.5	10.3	10.6	1.6	2.3	3.4	0.9	7.0	0.2	2.1	2.3	9.6	2.9	0.5	1.9	4.8	27.5	53.7	3.5	1.1	2.5	18.1	2.8	9.0	12.0	6.9	6.3	0.5	1.8	1.1	5.5	3.2	4.5	1.8	2.3	4.5	1.4	0.6	0.3	0.9	1.3	0.5	2.0	0.2	0.6	0.3	0.0	0.0	0.5	0.5	0.0	4.7	0.2	0.3	0.5	0.3	5.3	13.8	7.3	12.3	6.8	5.8	18.3	7.0	17.0	11.5	6.0	0.6	0.0	11.5	2.6	3.5	12.6	20.4	5.3	4.5	69.8	9.8	5.8	0.0	3.6	19.1	5.0	9.1	0.0	2.6	5.6	2.6	6.9	9.2	5.1	5.4	3.2	10.9	3.1	1.3	31.7	2.8	3.3	1.7	1.0	10.0	3.5	3.4	27.9	4.6	2.8	2.1	6.5	1.9	7.2	4.1	4.0	3.4	4.4	10.3	55.0
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6007901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	7.0	6.3	10.3	13.7	11.1	6.6	6.7	21.4	12.4	10.2	7.5	8.6	5.7	5.5	9.7	7.0	7.2	6.7	7.4	6.2	11.7	9.0	7.5	5.4	6.4	7.0	16.7	7.1	13.0	6.0	13.9	14.5	8.1	9.9	8.0	5.9	5.9	12.8	15.6	15.3	9.4	6.7	7.7	11.2	9.1	7.8	13.3	12.9	11.0	10.3	3.7	7.5	8.0	17.8	7.0	4.1	9.4	5.9	7.0	7.5	1.2	5.9	2.9	6.0	3.9	4.6	7.4	2.9	4.1	5.7	3.7	3.5	1.9	3.3	7.5	1.5	4.9	4.6	3.0	3.5	3.1	5.6	17.2	2.9	22.4	6.5	2.9	3.6	7.9	10.4	4.5	4.2	3.2	5.4	7.0	5.8	4.7	2.4	13.4	4.7	1.7	4.2	13.6	3.4	3.3	2.5	4.7	3.9	3.8	4.0	3.8	8.3	4.9	3.8	3.3	3.1	4.3	3.4	10.1	6.8	7.1	4.3	3.6	4.4	10.4	8.2	7.5	3.6	3.7	2.0	5.2	3.4	9.4	6.4	2.6	7.3	7.0	6.2	5.7	1.3	6.1	6.8	7.5	8.8	7.0	5.9	4.1	3.6	1.2	10.3	11.1	21.4	12.4	11.7	9.0	16.7	7.1	9.9	12.9	41.7	31.3	33.5	27.5	39.6	86.1	47.2	25.5	16.0	17.0	36.6	74.6	12.9	6.6	15.8	25.2	35.7	26.7	23.3	11.7	8.8	23.6	29.1	18.6	14.5	14.8	42.9	37.0	29.4	26.4	11.5	65.3	26.1	21.9	29.7	28.8	49.5	15.0	30.8	71.8	8.6	74.2	45.3	32.0	129.1	110.7	45.8	25.1	37.4	25.6	35.9
MLANA	MART1	ENSG00000120215	Melan-A	Q16655	9	5890802-5910606	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 191.5"	"Cell type enriched"	"Detected in some"	25	"Melanocytes: 1629.7"	"Cancer enriched"	"Detected in single"	556	"melanoma: 277.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in single"	385	"SK-MEL-30: 123.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000057, HPA048662"	Enhanced					NA	NA					"CAB000057: AB_442107, HPA048662: AB_2680485"	"unprognostic (2.52e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.43e-2)"	0.1	0.1	0.1	0.2	0.1	0.6	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	191.5	1.2	0.1	0.2	31.5	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.3	2.1	1.6	3.5	1.2	1.8	1.5	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.5	1.2	0.8	1.4	0.8	1.1	1.4	1.3	1.2	0.4	2.1	1.4	1.5	2.9	1.8	1.1	1.6	0.6	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	65.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1629.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	12.7	0.0	0.0	0.0	0.0
RANBP6		ENSG00000137040	"RAN binding protein 6"	O60518	9	6011043-6015625	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043748, HPA052684"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA043748: AB_10796796, HPA052684: AB_2681913"	"unprognostic (1.47e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.61e-1)"	10.6	14.6	11.8	12.6	18.1	27.0	11.7	23.7	27.1	8.6	7.2	8.1	8.6	7.5	9.3	7.5	9.8	8.2	7.8	13.6	12.8	15.8	14.2	15.3	8.4	15.8	19.7	17.3	10.4	10.9	16.1	16.2	15.6	32.0	10.4	7.4	5.4	10.1	9.3	15.1	10.0	11.6	10.5	16.0	14.3	10.9	6.1	15.0	22.3	12.6	9.2	16.0	9.3	7.6	4.2	5.2	7.2	11.1	4.8	8.1	4.4	10.9	6.0	12.4	10.5	10.9	8.7	6.7	14.1	9.8	12.1	9.9	3.2	3.4	14.9	3.9	10.8	6.0	6.4	10.8	12.5	13.7	35.1	6.3	38.7	22.7	6.7	6.4	14.6	8.3	9.4	6.9	7.6	7.5	9.7	14.0	13.4	2.9	12.5	11.6	3.6	10.4	23.7	5.5	3.9	5.1	11.2	7.7	7.0	12.8	7.7	6.1	9.0	6.6	5.0	3.7	10.6	7.9	10.0	16.6	11.5	6.9	5.6	13.0	7.4	11.9	14.3	6.5	8.8	4.2	7.2	7.2	6.4	4.6	11.1	4.5	4.2	6.7	4.7	4.5	3.7	7.9	7.5	2.3	4.8	7.7	5.2	8.1	4.4	11.8	18.1	23.7	27.1	12.8	15.8	19.7	17.3	32.0	15.0	8.9	7.2	4.2	5.8	9.2	17.3	22.0	2.5	5.3	19.4	10.4	2.0	7.3	6.6	7.6	1.0	9.3	2.1	0.0	9.3	3.9	5.4	4.5	10.4	11.3	3.8	11.1	9.1	12.3	12.0	0.9	6.1	6.6	1.7	1.8	2.7	14.1	6.0	3.6	6.3	10.9	21.0	0.0	5.1	6.2	7.9	8.3	5.5	7.5	4.5	5.0
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 112.4;Club cells: 135.4;Endothelial cells: 153.6;Ito cells: 400.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 19.9;U-2197: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	19.7	8.6	13.7	17.7	13.2	0.0	14.8	7.4	6.7	33.0	16.7	4.6	9.1	3.4	29.2	14.8	32.3	13.5	13.8	29.6	12.7	5.6	3.9	22.3	22.0	57.7	5.8	7.9	18.6	2.5	1.9	6.0	25.2	5.9	39.8	8.3	16.6	9.5	13.9	6.6	18.1	9.6	42.0	6.3	7.9	21.6	9.2	6.0	1.3	13.9	11.6	17.4	53.2	15.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.1	0.1	19.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	13.2	7.4	6.7	12.7	5.6	5.8	7.9	5.9	6.0	6.0	11.1	0.0	10.2	21.5	0.0	5.6	7.6	112.4	135.4	0.0	0.0	0.0	0.0	2.2	0.6	153.6	0.0	23.3	6.7	0.0	9.7	1.7	1.1	2.6	0.1	0.0	10.3	400.8	26.5	0.7	19.0	1.5	1.7	0.0	0.0	9.6	7.1	0.0	11.7	0.0	0.0	0.0	12.4	0.0	0.4	42.3	0.1	1.5	0.1	1.7
TPD52L3	NYD-SP25	ENSG00000170777	"Tumor protein D52 like 3"	Q96J77	9	6328375-6331900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	111	"testis: 107.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 503.6;Late spermatids: 841.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"BEWO: 5.4"															NA	NA															"unprognostic (4.33e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	503.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	841.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	112.9	5.4	0.0	0.0	0.0	0.0	0.0
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.7	7.7	11.1	4.7	9.1	13.2	8.1	15.6	9.6	9.8	17.2	4.9	4.9	10.3	3.4	7.7	9.1	4.4	10.2	9.1	15.0	18.7	4.7	18.0	15.0	7.8	7.5	8.4	6.1	5.9	5.9	7.6	18.8	18.8	38.2	10.6	1.7	10.1	23.1	2.3	14.1	32.7	4.3	9.9	5.7	16.0	5.1	3.6	7.3	4.6	10.0	3.9	6.7	4.5	9.7	14.1	5.6	16.9	32.2	10.5	3.8	4.3	13.0	2.7	8.0	12.1	5.1	7.4	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8	6.0	11.8	25.0	9.7	19.2	22.6	42.0	5.1	5.3	9.1	12.2	29.5	10.8	1.7	5.1	16.0	20.4	8.1	23.3	3.4	8.5	12.4	13.9	17.3	11.3	9.2	27.0	6.8	15.4	11.7	5.9	17.8	11.0	20.3	6.4	12.4	6.7	6.0	12.9	13.8	5.1	34.9	12.9	13.7	37.2	17.2	16.7	4.9	13.8	11.3	7.1
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.6	7.2	0.0	0.1	66.8	0.0	0.0	0.0	0.0	15.9	0.1	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.3	3.8	0.0	0.0	10.6	0.0	0.0	14.5	0.0	0.0	0.5	0.0	0.2	2.7	1.2	0.0	0.1	0.3	0.3	0.2	0.0	7.8	1.2	1.2	0.3	0.0	0.1	27.7	0.3	6.4	3.3	0.0	6.2	0.0	4.1	1.4	0.0	0.9	0.1	0.2	0.8	0.3	0.3	9.2	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8	0.0	0.0	4.3	0.0	0.0	0.3	0.6	7.6	0.0	0.0	29.6	0.0	59.4	5.0	0.0	8.8	0.0	0.0	0.0	0.2	35.6	0.0	0.0	0.0	126.2	6.1	0.0	0.0	3.1	2.1	9.0	0.3	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	29.3	0.2	0.0	0.3	4.4	5.0	0.0	38.4	0.5	0.0	0.0
KDM4C	"GASC1, JMJD2C, KIAA0780, TDRD14C"	ENSG00000107077	"Lysine demethylase 4C"	Q9H3R0	9	6720863-7175648	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 73.8;Late spermatids: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069357			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069357: AB_2686128"	"unprognostic (1.56e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.64e-3)"	12.1	12.1	13.3	21.5	15.0	27.5	12.7	51.2	14.3	12.4	14.9	18.0	14.6	14.2	14.7	13.9	12.5	12.0	11.9	10.0	11.1	11.9	9.9	12.2	16.1	21.1	15.1	10.5	13.5	18.9	26.0	24.0	10.6	13.7	11.5	18.5	15.3	15.1	13.9	9.7	16.9	16.6	15.4	13.8	15.2	16.2	10.4	16.0	29.0	14.9	7.9	25.7	13.5	14.2	13.8	8.4	13.0	11.1	10.8	11.8	6.9	9.4	5.6	2.4	3.5	8.2	9.2	6.8	4.3	5.9	5.2	5.0	6.6	5.4	11.1	2.7	6.0	5.1	2.9	5.2	7.5	6.7	32.0	3.8	15.5	8.0	8.9	7.8	5.9	10.7	7.9	5.2	4.1	8.8	13.1	6.2	9.7	2.4	7.6	5.4	4.9	9.7	23.1	4.0	10.4	2.1	5.8	2.1	6.8	7.6	5.6	8.2	4.9	4.0	7.8	3.8	6.9	3.8	10.2	6.6	5.1	2.4	5.8	4.1	5.7	4.1	11.2	5.0	5.7	1.9	7.2	6.4	13.0	9.8	6.9	10.8	11.9	10.9	10.7	8.4	13.8	11.8	8.8	1.5	10.8	11.1	3.4	9.2	6.9	13.3	15.0	51.2	14.3	11.1	11.9	15.1	10.5	13.7	16.0	6.0	11.8	5.3	5.9	17.6	22.2	7.0	12.7	8.1	6.8	7.0	43.2	4.3	3.3	5.7	73.8	7.9	11.1	0.0	5.5	4.6	6.2	5.5	8.1	9.0	5.8	11.1	9.4	8.0	9.1	64.8	8.9	15.0	6.8	8.2	13.0	5.6	6.5	12.4	8.9	3.1	30.6	12.9	7.6	5.4	3.7	20.8	4.9	17.3	9.3	6.5
DMAC1	"C9orf123, MGC4730, TMEM261"	ENSG00000137038	"Distal membrane arm assembly complex 1"	Q96GE9	9	7796490-7888380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Distal tubular cells: 424.4;Hofbauer cells: 180.4;Proximal tubular cells: 165.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014585	Approved					NA	NA					"HPA014585: AB_1845803"	"unprognostic (1.48e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.23e-3)"	"prognostic favorable (4.15e-4)"	"unprognostic (2.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.96e-11)"	"unprognostic (1.75e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.41e-2)"	13.7	16.0	17.8	14.1	20.1	7.9	17.1	17.9	20.9	13.6	15.1	14.4	12.4	13.5	12.5	16.9	15.9	15.6	16.5	30.7	16.8	16.2	18.8	17.1	9.5	13.2	17.7	14.1	18.8	17.1	15.6	14.9	11.3	15.4	16.8	13.9	14.4	19.9	17.1	49.4	10.2	11.7	14.1	17.5	13.0	12.4	11.9	12.0	35.6	18.6	26.5	12.7	13.0	10.0	16.0	8.6	2.8	7.6	12.7	14.7	11.5	9.8	11.9	11.0	6.9	8.9	11.1	7.5	6.0	4.3	6.4	5.9	5.3	6.3	14.7	3.1	5.4	8.4	5.4	11.8	10.3	6.6	8.8	13.5	26.6	18.8	17.0	9.0	9.2	3.7	13.9	7.4	5.1	7.9	6.0	6.1	13.4	4.8	3.1	6.8	8.4	13.3	21.2	9.8	8.4	5.8	10.2	6.2	8.7	7.4	9.6	17.8	9.9	6.6	4.4	7.3	7.9	5.8	5.7	7.7	5.0	8.0	6.5	4.1	3.9	6.3	7.8	4.2	7.7	4.9	0.8	6.8	2.8	8.1	7.6	12.1	16.0	11.0	8.5	8.2	13.8	14.7	11.6	1.1	12.7	5.9	8.6	12.3	11.5	17.8	20.1	17.9	20.9	16.8	16.2	17.7	14.1	15.4	12.0	65.5	40.3	0.0	0.0	0.0	0.0	0.0	0.0	129.8	44.3	96.0	0.0	97.3	424.4	77.8	0.0	0.0	0.0	0.0	78.5	76.3	0.0	0.0	25.6	0.0	180.4	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	45.1	0.0	0.0	59.8	0.0	0.0	165.4	0.0	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2500000	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.5	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.6	4.8	0.6	0.0	0.0	0.0	0.2	8.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.7	0.0	1.5	2.9	8.7	0.0	2.1	0.0	4.0	0.3	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5	0.0	2.7	0.0	0.2	0.5	110.1	4.6	25.5	0.0	2.3	5.2	15.7	0.3	0.0	2.5	13.0	0.4	10.1	0.0	0.0	0.1	7.6	1.7	0.0	12.8	1.0	4.8	34.0	1.3	0.6	3.7	14.7	0.0	0.0	0.0	14.3	44.7	0.3	3.5	0.0	22.3	7.4	0.0	3.7	1.1	1.1	0.6	0.2	0.0	5.2	0.0
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710290	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 277.3"	"Cell type enriched"	"Detected in some"	19	"Melanocytes: 2358.5"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Region enriched"	"Detected in some"	5	"pons and medulla: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	52	"SK-MEL-30: 177.7"	"Group enriched"	"Detected in some"	5	"olfactory region: 5.6;thalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		16000	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.2	0.0	0.2	0.2	0.3	0.0	1.7	0.2	1.0	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	5.0	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	177.7	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.0	0.9	0.1	0.2	0.3	5.0	0.2	0.0	0.0	0.0	0.0	82.0	0.6	39.7	0.0	0.0	0.0	3.5	2.0	0.0	122.7	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.3	0.3	0.0	2358.5	0.0	0.0	15.4	0.0	0.0	0.0	0.8	1.3	0.0	3.1	0.5	0.7	14.6	0.0	0.0	0.0	0.1
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775021-12822131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 48.7"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	10.6	7.2	2.9	7.9	9.2	0.1	13.0	23.4	5.5	11.5	13.7	7.1	2.9	4.0	5.0	7.9	8.5	4.1	14.7	3.5	3.5	3.3	4.1	48.7	17.8	5.3	7.7	4.0	4.5	19.9	0.2	7.3	21.0	5.9	8.0	9.6	4.7	21.6	7.3	2.4	8.8	6.6	13.2	8.1	11.0	9.9	3.7	7.9	0.9	8.6	2.8	5.3	10.3	9.4	0.0	0.1	1.2	0.0	0.0	0.0	1.6	0.9	3.2	0.0	1.0	4.9	6.8	0.0	1.7	9.1	2.2	2.5	0.0	1.1	0.0	0.6	8.7	10.8	1.3	0.0	0.1	1.7	0.0	0.4	0.4	3.0	1.7	45.3	0.0	0.0	2.6	4.3	8.1	36.3	3.8	1.5	0.0	0.0	11.9	1.2	0.7	0.0	0.0	0.0	4.1	3.5	0.0	0.6	0.0	8.9	0.5	6.9	0.6	1.9	1.2	1.5	0.8	52.1	0.1	0.5	2.0	0.3	5.0	1.2	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	9.2	23.4	5.5	3.5	3.3	7.7	4.0	5.9	7.9	8.9	17.3	0.0	29.2	80.1	4.1	5.3	15.3	5.3	17.0	1.8	2.0	0.4	6.6	56.6	2.6	6.3	32.8	0.0	10.3	1.2	27.7	116.6	10.4	28.7	0.5	17.5	25.6	1.8	0.0	0.8	8.6	0.6	25.3	0.0	8.9	3.6	22.9	77.2	2.8	4.1	9.3	38.8	40.0	0.1	0.3	56.2	0.9	0.0	13.4	93.3
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105704-13279590	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 94.2;Hepatocytes: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.2;HUVEC TERT2: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Enhanced					NA	NA					"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	17.6	9.2	16.7	5.1	14.4	1.0	18.7	20.4	18.8	13.4	12.5	12.8	8.0	3.1	15.1	13.3	6.9	15.4	10.2	23.6	14.7	12.8	16.0	68.7	9.5	3.5	14.5	12.4	22.3	4.5	11.4	21.7	20.0	14.8	16.9	5.2	9.6	5.4	20.3	14.7	3.2	5.3	21.0	18.6	9.2	7.3	9.5	17.0	0.0	10.2	6.5	2.3	12.1	24.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	6.9	9.3	26.2	11.5	17.9	16.5	5.3	7.0	7.3	6.2	5.9	0.0	0.0	0.0	2.0	17.3	6.4	0.1	7.6	3.8	10.1	0.0	4.5	4.6	9.5	1.6	9.3	0.0	2.5	12.0	1.6	4.4	2.9	15.9	23.7	0.0	0.1	0.0	5.4	1.8	0.0	0.1	11.1	0.0	3.8	0.0	6.4	0.0	6.2	3.8	3.2	12.1	5.5	1.2	6.7	18.5	3.5	0.0	18.9	6.4	1.2	2.1	5.4	0.0	0.0	0.0	3.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	16.7	14.4	20.4	15.1	14.7	12.8	14.5	12.4	14.8	17.0	29.8	6.4	0.0	8.1	4.5	26.0	94.2	0.0	45.5	22.7	7.0	37.3	11.0	1.7	3.9	3.5	46.7	0.0	0.0	1.7	19.9	22.4	13.4	1.1	66.0	4.6	25.4	1.7	39.9	0.6	2.7	22.5	1.6	16.9	1.0	0.0	42.9	2.8	0.0	31.8	14.4	26.0	38.8	27.8	4.8	8.9	3.4	9.0	0.0	0.0	3.2
NFIB	"NFI-RED, NFIB2, NFIB3"	ENSG00000147862	"Nuclear factor I B"	O00712	9	14081843-14398983	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 55.0;HBEC3-KT: 22.3;HUVEC TERT2: 22.2;TIME: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003956	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA003956: AB_1854424"	"unprognostic (1.93e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.72e-3)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.53e-4)"	"unprognostic (4.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.62e-1)"	29.3	9.5	22.6	9.2	12.9	1.0	39.7	30.0	22.9	14.8	17.0	13.6	34.1	11.3	16.8	22.3	11.5	17.0	18.0	24.1	22.0	9.3	18.8	22.3	16.3	9.8	10.8	15.5	18.7	17.5	8.2	6.0	14.7	13.7	21.3	10.4	9.2	40.0	41.3	20.8	23.6	16.8	24.2	14.9	10.4	14.2	7.6	15.6	2.7	18.8	13.9	7.7	27.4	23.4	0.3	0.3	2.4	0.4	0.5	1.0	1.3	6.4	4.6	2.9	55.0	13.9	8.1	0.1	0.1	0.0	1.3	4.8	0.0	2.6	0.1	4.3	0.4	4.2	1.4	2.7	22.3	2.4	0.9	2.6	19.8	10.4	0.6	4.6	0.5	0.1	7.0	3.1	5.0	18.5	5.2	22.2	0.0	0.6	0.1	1.8	3.0	0.0	0.1	1.0	2.9	5.4	0.0	2.6	0.0	4.1	2.4	4.6	17.2	4.7	5.8	1.9	0.1	11.7	0.0	21.7	4.3	6.4	3.3	4.0	0.5	0.4	1.6	3.8	0.1	5.4	1.3	0.1	0.2	0.3	0.2	1.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	2.4	0.5	0.4	0.3	0.5	1.3	22.6	12.9	30.0	18.8	22.0	9.3	10.8	15.5	13.7	15.6	47.6	31.8	8.5	155.7	238.9	30.8	173.3	203.8	49.5	63.7	43.6	0.0	4.1	33.2	58.5	2.9	193.3	44.6	0.0	108.3	1.6	65.3	158.3	3.5	91.3	1.9	0.0	21.9	176.8	10.2	2.3	124.0	9.2	89.4	2.8	28.6	261.1	66.5	55.8	45.6	159.0	8.8	84.1	186.4	0.7	0.9	147.9	1.4	2.2	68.3	55.3
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type containing 21"	Q8IVQ6	9	14611071-14693471	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	6.5	10.8	15.9	7.9	16.8	4.2	11.6	29.0	22.6	7.8	8.5	9.3	3.8	12.2	9.8	11.7	14.4	7.5	6.7	9.0	13.8	10.4	9.4	4.8	9.2	11.1	9.4	16.5	10.0	8.4	11.5	22.2	7.8	14.8	10.0	9.9	6.6	8.3	7.4	7.7	15.7	12.6	7.7	9.9	9.5	7.9	7.3	9.7	4.7	11.3	9.9	10.7	7.7	11.3	5.2	1.4	0.5	0.8	2.8	1.7	0.6	5.4	2.8	5.6	3.6	0.9	1.0	4.3	7.0	2.2	2.5	2.9	1.4	2.6	5.4	1.7	4.9	3.1	3.6	3.8	2.3	3.6	10.8	2.9	23.0	6.1	2.7	3.0	4.0	7.7	1.9	5.3	2.9	1.9	4.6	14.6	2.2	1.9	0.6	4.4	3.0	0.9	3.9	3.9	2.3	5.3	0.0	2.6	2.7	7.7	6.1	3.4	9.1	3.2	4.0	2.1	4.4	5.0	6.6	10.3	1.8	2.7	1.8	6.4	2.3	4.2	0.0	3.8	0.2	1.8	0.5	0.4	0.1	1.2	0.8	1.3	5.2	1.2	1.1	0.2	3.5	0.8	1.2	0.0	2.8	0.6	1.4	1.7	0.6	15.9	16.8	29.0	22.6	13.8	10.4	9.4	16.5	14.8	9.7	20.8	17.9	23.9	7.6	8.5	42.8	16.2	20.4	10.7	22.7	41.8	41.2	7.1	5.0	13.7	4.0	14.8	33.7	0.0	15.6	5.4	9.4	16.4	10.4	6.8	9.6	35.0	15.0	30.7	15.1	4.5	17.8	11.7	1.7	12.6	13.4	75.7	25.7	10.5	29.4	7.9	50.3	6.5	11.3	14.6	16.1	17.6	6.4	10.2	10.2	13.2
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722717	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;epididymis: 5.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Group enriched"	"Detected in many"	8	"basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 6.4;NTERA-2: 11.8;SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019917	Uncertain				"Secreted - unknown location"	NA	NA					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.1	0.0	0.1	0.1	2.5	0.1	0.2	2.2	1.1	0.1	0.2	0.1	0.1	0.7	0.7	5.5	0.1	0.0	0.4	0.2	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.2	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.2	1.1	0.1	0.2	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FREM1	"C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR"	ENSG00000164946	"FRAS1 related extracellular matrix 1"	Q5H8C1	9	14734666-14910995	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 33.3;epididymis: 30.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 69.1;Late spermatids: 99.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 22.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEL: 63.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.13e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.95e-13)"	"unprognostic (2.28e-3)"	"unprognostic (8.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.86e-1)"	4.4	2.5	1.5	3.2	1.4	0.2	4.0	22.2	2.5	10.9	7.5	5.0	22.9	1.8	33.3	30.8	0.9	4.5	3.1	7.3	1.8	2.0	10.4	0.8	2.6	0.1	1.1	1.0	2.3	14.2	6.0	1.2	4.6	4.0	3.1	1.5	5.0	1.0	11.4	0.7	2.6	9.3	12.8	2.7	0.4	1.3	3.5	0.6	1.7	0.8	3.4	1.1	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	22.2	2.5	1.8	2.0	1.1	1.0	4.0	0.6	0.0	1.1	0.0	0.2	1.1	0.7	2.0	5.1	0.0	0.0	1.8	0.0	0.4	0.0	0.2	69.1	0.0	0.7	0.0	0.0	0.2	11.3	0.1	4.7	0.0	0.4	0.0	0.0	6.2	1.2	99.8	0.6	0.0	0.0	1.0	0.1	4.0	0.3	0.0	1.4	1.0	0.0	0.0	1.0	0.7	0.6	1.0	0.2	0.0	0.2	0.0
TTC39B	"C9orf52, FLJ33868"	ENSG00000155158	"Tetratricopeptide repeat domain 39B"	Q5VTQ0	9	15163622-15307360	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"HEL: 27.2;RT4: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063162			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA063162: AB_2684952"	"unprognostic (1.64e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (9.64e-6)"	"unprognostic (5.99e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.89e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (3.31e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.48e-1)"	7.3	4.9	3.6	7.2	7.9	2.3	7.7	35.9	12.9	8.2	10.5	1.7	1.8	9.0	10.0	4.4	14.2	6.1	11.2	3.0	3.6	5.6	14.6	8.5	8.6	8.9	5.3	6.4	6.6	6.3	3.7	13.5	2.2	20.8	4.6	9.3	3.8	6.3	3.4	3.7	15.1	15.2	6.9	5.9	6.8	8.8	8.5	2.9	1.3	4.7	4.7	9.3	6.2	8.1	1.0	0.6	2.0	0.9	7.6	6.7	3.4	2.6	0.5	0.8	3.9	3.8	7.0	0.8	3.4	6.2	2.7	6.5	0.5	1.1	0.0	0.4	4.2	3.2	2.3	0.6	4.2	2.3	2.9	0.5	27.2	1.2	4.9	6.2	0.0	0.6	6.8	3.3	5.6	6.3	1.9	3.8	2.3	0.1	6.2	6.8	0.8	1.4	0.1	1.0	8.2	0.8	0.3	2.1	1.2	5.8	15.5	2.0	0.4	0.8	2.0	0.6	1.3	8.7	1.7	2.8	1.5	1.3	2.1	0.9	0.1	0.0	0.0	1.4	0.3	0.7	2.0	0.9	1.2	4.1	0.7	5.4	0.3	5.6	6.3	0.6	1.0	6.7	4.1	0.7	7.6	0.9	0.1	4.9	3.4	3.6	7.9	35.9	12.9	3.6	5.6	5.3	6.4	20.8	2.9	11.9	17.5	2.7	6.0	15.3	23.4	2.7	7.6	16.0	9.1	7.0	0.0	2.7	14.9	5.3	30.6	6.3	28.8	0.0	19.0	0.9	8.9	7.4	27.8	10.4	4.2	12.7	12.2	6.2	3.7	25.3	6.6	5.6	6.8	2.8	14.3	16.0	10.1	44.2	12.0	32.1	3.9	0.0	10.3	2.3	1.9	18.7	3.4	20.1	12.6	13.2
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 98.3;Late spermatids: 162.5;Spermatocytes: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: AB_2682055, HPA066031: AB_2685600"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	9.8	18.5	18.7	10.3	21.1	4.6	10.4	26.3	21.2	17.9	13.2	10.4	10.3	11.6	16.5	15.5	12.6	10.8	10.8	17.5	18.0	14.0	12.3	8.6	10.0	11.2	15.2	16.3	17.4	11.1	12.8	18.4	16.7	21.8	13.3	14.6	9.6	10.5	11.3	19.3	13.7	14.2	12.8	15.2	12.8	10.5	14.7	15.9	11.9	11.3	6.8	10.8	12.9	15.1	12.2	7.7	5.0	21.2	5.0	8.2	5.5	3.9	5.1	10.8	4.1	8.7	9.1	6.3	6.2	2.8	3.7	4.4	2.4	1.7	2.8	2.4	3.9	5.2	2.4	5.7	2.9	4.6	13.1	6.7	10.1	10.8	3.3	4.3	2.2	7.8	5.9	5.9	2.6	3.0	15.7	6.8	6.7	2.8	4.6	8.4	1.2	2.7	7.2	3.4	3.0	13.5	5.5	1.3	1.5	6.4	2.4	11.6	8.2	2.1	1.9	1.4	9.9	4.6	4.6	5.6	6.2	2.5	2.6	7.9	6.1	7.3	3.5	4.0	3.0	2.8	3.4	10.1	5.0	5.7	16.7	5.5	9.9	5.7	5.1	7.7	12.2	8.2	7.9	1.2	5.0	21.2	6.3	7.9	5.5	18.7	21.1	26.3	21.2	18.0	14.0	15.2	16.3	21.8	15.9	17.9	11.0	17.8	12.4	8.5	19.2	37.1	5.1	13.4	5.7	19.2	29.5	10.6	11.6	16.6	98.3	16.4	21.6	0.0	8.2	10.8	16.4	10.3	17.3	12.4	13.8	33.4	14.5	19.0	22.1	162.5	31.4	10.0	18.6	17.2	14.1	15.1	11.3	27.7	28.7	24.2	17.8	12.9	21.7	125.8	27.9	10.5	8.1	17.1	16.2	10.2
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15511019	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 273.8;Spermatogonia: 282.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	15.1	20.3	42.7	20.8	48.8	24.9	12.2	65.3	49.4	22.6	16.1	19.0	11.5	10.8	27.9	18.2	12.9	20.0	14.9	16.0	38.7	42.7	16.1	10.5	15.6	35.4	34.1	30.2	43.6	8.1	18.8	24.9	18.7	32.4	18.3	15.3	12.3	9.0	21.1	16.3	12.3	14.2	21.3	37.7	24.6	12.5	37.2	29.3	70.4	18.1	6.5	31.9	17.0	16.1	11.4	2.6	8.5	4.3	8.0	16.4	1.9	17.9	11.9	40.7	29.8	8.8	10.7	9.1	21.7	15.5	19.5	23.3	5.0	9.3	38.3	5.0	11.4	10.9	5.0	25.3	11.7	28.3	25.1	15.3	132.4	31.3	9.3	10.7	15.4	14.7	8.9	3.4	16.3	12.0	19.5	17.0	18.1	21.8	21.3	12.6	6.5	31.9	38.4	63.1	0.4	18.6	29.8	22.2	7.7	10.9	6.3	25.9	28.5	19.4	8.6	10.1	26.5	8.6	20.8	12.0	14.2	14.4	10.6	20.5	9.1	12.8	34.5	11.4	15.6	8.1	8.5	2.1	4.2	5.5	1.6	6.7	8.4	11.0	7.6	2.4	11.4	16.4	10.1	7.2	8.0	4.3	2.6	9.8	1.9	42.7	48.8	65.3	46.6	38.7	42.7	34.1	30.2	32.4	29.3	50.6	32.2	51.9	42.9	28.3	223.7	37.1	20.4	58.9	36.4	45.4	62.8	99.5	53.0	8.4	62.0	69.9	10.7	46.7	7.5	66.4	50.7	20.2	15.0	16.3	26.7	130.3	36.5	55.3	27.7	44.5	116.5	31.1	38.8	43.3	27.2	149.7	3.6	23.2	126.2	41.8	252.4	122.9	61.2	273.8	282.5	18.4	34.6	73.4	41.7	15.4
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553086-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 152.4;Late spermatids: 134.7;Rod photoreceptor cells: 44.6;Spermatocytes: 149.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.5;HEL: 14.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	2.5	2.5	5.8	5.5	7.5	4.0	3.6	8.2	7.8	4.1	2.4	1.1	6.9	1.9	11.6	5.8	2.4	4.6	3.4	2.6	4.9	4.1	2.8	1.3	2.5	2.4	3.4	7.6	6.3	3.4	4.2	7.8	7.3	6.6	3.4	2.5	2.0	1.9	7.4	2.4	4.9	2.2	7.1	6.1	1.5	3.1	20.4	3.3	20.2	4.3	1.4	2.2	2.5	2.8	1.6	0.7	5.1	0.6	0.4	1.8	0.2	1.7	0.9	2.2	2.1	1.2	2.6	1.4	1.4	1.1	1.4	1.5	0.6	0.8	9.5	0.7	0.8	2.5	0.4	0.9	1.3	1.5	2.0	0.9	14.8	1.5	1.3	1.8	2.1	1.9	1.5	2.6	1.1	2.1	1.0	0.6	5.4	0.4	2.6	1.6	0.7	4.1	1.9	1.7	0.8	2.1	4.9	1.6	0.3	1.0	1.4	3.1	1.5	2.8	1.0	3.6	1.9	1.1	1.5	1.1	2.9	1.6	0.8	0.9	1.4	1.7	6.2	1.2	1.2	2.0	5.1	0.6	0.0	0.8	0.6	1.8	0.7	0.7	0.7	0.7	1.6	0.5	0.9	0.5	0.4	0.4	0.7	0.6	0.2	5.8	7.5	8.2	7.8	4.9	4.1	3.4	7.6	6.6	3.3	0.0	6.9	0.0	5.3	2.5	24.3	7.0	0.0	17.4	9.1	3.5	15.7	4.8	5.0	2.0	152.4	2.6	2.7	0.0	3.1	3.6	1.9	0.5	1.1	0.8	1.6	9.5	1.2	2.5	0.3	134.7	5.5	1.1	0.0	1.8	2.6	11.2	2.0	0.0	5.6	1.4	44.6	12.9	2.1	149.3	27.2	2.9	4.7	0.7	3.6	2.6
C9orf92	Em:AL513424.1	ENSG00000205549	"Chromosome 9 open reading frame 92"	A6NGG3	9	16203935-16276313	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"kidney: 3.3"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 4.3;Glandular cells: 2.1;Proximal tubular cells: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.7;BJ hTERT+: 4.4;HBF TERT88: 2.6;PC-3: 1.4;SH-SY5Y: 1.3;U-2197: 4.8"															NA	NA						"unprognostic (1.06e-1)"				"unprognostic (4.77e-2)"					"unprognostic (3.74e-2)"		"unprognostic (5.47e-2)"	"unprognostic (1.20e-1)"		"unprognostic (5.04e-1)"	"unprognostic (5.09e-2)"		0.6	0.0	0.3	0.5	0.3	0.0	0.6	0.0	0.5	0.5	0.6			0.5	1.7	1.2	0.0	1.2	1.4	0.0	0.6	0.5	3.3	0.4	0.0	0.1	1.3		1.2	0.0	0.0	0.0	0.0		2.5	0.0		0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.0	0.0	1.7			2.8		0.0	1.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.2	0.6	4.8	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.8;ovary: 37.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 21.9;Leydig cells: 83.4;Peritubular cells: 63.6;Proximal tubular cells: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"gdT-cell: 5.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"HSkMC: 18.5;Karpas-707: 22.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	4.3	1.0	0.5	5.1	0.7	0.3	4.3	0.5	0.7	19.8	7.6	1.8	2.9	0.8	35.8	5.5	3.8	14.3	9.3	3.8	1.2	0.5	7.6	0.4	2.6	0.9	0.9	0.5	37.0	0.5	2.7	1.5	2.2	2.3	6.4	2.1	11.0	1.3	4.8	7.6	2.9	2.8	23.1	2.0	0.5	3.0	4.7	1.0	0.9	1.7	3.6	1.3	8.5	9.0	0.1	0.0	0.0	0.0	1.0	5.8	3.2	0.1	0.9	0.7	0.0	10.1	12.5	1.6	6.2	10.9	4.5	3.7	0.0	0.0	0.0	2.1	4.2	3.3	0.0	2.9	0.0	4.6	0.1	1.2	0.1	2.9	0.0	7.8	0.0	0.2	18.5	0.0	9.5	0.0	7.8	10.0	0.0	0.0	22.5	6.3	0.0	0.0	1.5	3.7	0.0	5.7	0.0	7.1	15.0	3.4	0.2	0.1	0.5	0.0	0.0	10.6	4.9	0.0	0.0	9.8	10.5	7.8	8.5	11.4	0.1	0.0	0.1	4.3	1.4	1.4	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	1.0	0.0	0.0	0.0	3.2	0.5	0.7	0.5	0.7	1.2	0.5	0.9	0.5	2.3	1.0	0.0	2.1	0.0	0.6	9.0	2.1	4.3	0.0	1.4	1.2	0.0	0.0	2.4	0.0	0.5	5.0	6.8	0.3	0.0	0.3	1.6	11.6	0.1	21.9	0.0	6.1	0.0	0.0	11.6	2.1	1.8	83.4	2.2	10.1	0.0	0.0	2.3	0.1	0.0	63.6	31.8	0.2	6.5	7.4	0.7	5.1	4.8	1.0	1.5	0.0	0.0
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 58.9;Spermatogonia: 51.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.9"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEL: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	13.2	5.6	4.3	5.2	5.1	12.5	7.4	15.5	4.5	16.6	8.6	4.2	6.7	2.2	22.6	6.0	6.0	8.0	7.4	4.9	4.2	3.8	5.0	20.0	5.4	4.8	4.9	2.6	15.2	3.6	10.0	13.2	6.1	6.3	9.8	4.0	7.0	3.8	6.3	5.9	3.5	4.4	11.9	8.1	8.6	4.4	8.2	6.8	4.4	5.5	5.8	2.8	11.7	13.5	0.3	1.5	0.8	6.9	1.2	0.2	0.5	5.9	4.1	9.0	5.1	4.5	10.5	0.3	7.0	4.7	5.2	7.2	0.3	2.0	4.3	1.1	4.8	5.7	0.3	10.4	2.9	8.2	0.2	3.7	25.5	8.7	1.5	4.9	3.5	5.6	6.6	1.5	4.4	4.3	4.9	7.4	1.6	0.9	1.0	8.3	0.5	2.8	5.6	7.0	1.0	7.7	4.2	8.3	2.1	3.0	1.5	5.7	5.9	8.5	0.2	2.2	3.7	1.7	8.9	5.4	7.2	2.8	7.8	6.0	3.6	4.3	0.1	3.4	4.4	3.2	0.6	2.7	0.1	0.1	3.3	0.0	0.3	0.2	0.1	1.5	0.3	0.1	0.1	0.8	1.2	6.9	1.5	0.2	0.5	4.3	5.1	15.5	4.5	4.2	3.8	4.9	2.6	6.3	6.8	6.0	14.5	0.8	12.1	7.8	9.1	10.6	5.1	2.7	2.3	8.7	0.0	1.5	5.0	7.5	13.2	20.3	1.3	23.3	10.4	4.0	13.6	3.2	7.0	35.9	15.7	19.1	2.4	19.6	34.5	6.5	42.3	18.3	8.5	26.2	2.6	25.0	4.2	0.0	29.0	6.3	8.4	12.9	15.0	58.9	51.1	4.8	0.8	3.2	3.0	3.5
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579082-17797129	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 83.0"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 74.6;Cone photoreceptor cells: 21.6;Late spermatids: 36.0;Rod photoreceptor cells: 24.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HeLa: 13.8;JURKAT: 12.1;RT4: 26.7;SCLC-21H: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	1.1	1.2	16.7	1.1	17.3	1.0	1.1	68.4	83.0	3.1	1.5	1.6	0.0	1.2	2.8	2.1	1.4	2.6	1.1	4.1	17.1	11.3	13.7	1.1	1.9	1.0	9.1	22.2	2.5	3.4	1.2	6.6	1.0	12.8	2.5	1.6	1.6	1.0	1.1	1.1	1.1	1.5	2.4	6.3	1.1	4.5	5.8	2.2	0.0	2.2	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	4.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	13.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.5	0.0	0.0	0.0	0.0	26.7	17.3	0.0	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.2	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	17.3	68.4	41.1	17.1	11.3	9.1	22.2	12.8	2.2	0.0	0.0	0.0	0.3	0.1	74.6	1.6	0.0	0.0	0.0	7.0	21.6	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	12.7	5.1	0.0	0.0	36.0	1.1	0.0	0.0	0.0	0.7	6.5	0.3	0.0	0.4	18.3	24.1	0.0	0.1	2.1	2.5	0.0	0.1	0.0	0.2	0.4
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 50.7;retina: 39.3"	"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 4.5;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 35.1;HSkMC: 17.8;hTEC/SVTERT24-B: 18.4;LHCN-M2: 18.1;TIME: 57.9;U-138 MG: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA		74000000	Vesicles		"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	6.3	7.6	0.5	5.9	0.8	0.0	4.4	3.9	1.5	14.3	5.2	0.6	6.5	1.6	50.7	12.0	9.0	5.2	4.4	2.9	1.6	1.0	3.4	1.0	1.9	2.2	0.4	1.2	4.9	1.3	0.1	3.9	0.8	0.9	8.4	4.6	39.3	3.1	5.6	0.5	2.0	2.7	13.3	0.7	0.9	5.0	2.3	0.0	0.0	2.0	1.7	1.5	2.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.3	0.0	5.1	35.1	0.0	1.0	4.5	4.1	9.5	0.0	0.0	0.0	0.0	12.3	1.5	0.0	1.8	0.2	12.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	17.8	0.0	18.4	0.0	15.9	7.7	0.0	0.0	0.0	18.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.9	28.2	0.7	0.7	4.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.9	1.5	1.6	1.0	0.4	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.5	0.8	1.3	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.1	0.0	0.0	1.3	0.0	1.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.4	1.9	0.9	0.1	0.1	0.0	0.8	0.0
SAXO1	"C9orf138, FAM154A, MGC35182"	ENSG00000155875	"Stabilizer of axonemal microtubules 1"	Q8IYX7	9	18927658-19049354	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 47.2"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 471.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.8;T-47d: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023899	Enhanced					NA	NA					"HPA023899: AB_1845813"	"unprognostic (4.23e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.28e-3)"	"unprognostic (8.64e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.38e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.40e-2)"	0.2	0.2	0.2	0.5	0.5	0.1	0.2	0.2	0.8	0.2	0.2	1.5	0.0	0.2	0.3	3.1	0.2	0.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.2	0.0	0.2	0.3	0.2	1.7	0.1	0.8	0.5	0.1	1.3	0.6	1.0	0.2	0.3	0.2	0.1	0.6	0.2	0.2	47.2	0.3	0.5	0.2	0.0	0.5	0.2	0.2	0.2	0.4	0.1	0.1	0.2	2.1	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	1.8	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.9	1.0	0.6	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.6	0.0	1.1	0.2	0.5	0.8	0.2	0.2	1.1	2.1	0.0	0.2	0.0	0.4	0.3	0.1	0.2	0.5	0.2	0.8	0.3	0.2	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	471.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	1.5	33.4	4.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.5	0.5	0.0	0.0	0.0	6.1	2.3	0.0	0.1	0.0	0.0	0.1
RRAGA	"FIP-1, RAGA"	ENSG00000155876	"Ras related GTP binding A"	Q7L523	9	19049395-19050983	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003734	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA003734: AB_1079851"	"unprognostic (6.30e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (6.74e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.05e-1)"	39.0	39.0	38.0	21.5	44.9	14.6	33.8	40.1	67.7	36.9	30.4	39.0	39.8	21.8	45.9	46.6	33.7	43.6	28.6	48.3	39.5	46.5	39.0	38.3	27.7	28.4	38.0	41.7	50.2	26.9	38.4	33.3	40.1	43.4	35.7	26.9	25.1	29.5	45.3	57.1	31.6	24.9	47.9	34.3	25.5	27.1	26.1	31.6	27.0	34.3	32.6	26.2	37.3	28.1	20.9	30.9	54.1	38.5	29.5	36.6	35.1	26.4	21.9	18.1	18.7	65.3	41.7	12.5	26.7	32.1	23.3	28.8	8.3	8.2	5.2	14.8	44.9	21.1	10.1	15.4	25.2	24.8	22.5	17.3	33.7	31.4	32.1	42.9	4.6	12.8	36.8	24.5	19.9	13.6	32.3	27.7	8.7	7.6	7.7	48.3	16.7	12.7	27.4	10.0	13.8	16.9	9.9	11.8	7.5	35.4	23.2	14.9	18.6	14.6	13.3	13.7	17.1	17.1	12.6	21.5	28.4	10.9	20.1	19.8	5.4	8.8	11.9	31.2	7.1	10.2	48.3	32.5	54.1	30.5	35.9	29.7	19.6	31.6	30.1	30.9	20.9	29.4	28.8	22.8	29.5	38.5	22.3	36.6	35.1	38.0	44.9	40.1	67.7	39.5	46.5	38.0	41.7	43.4	31.6	23.8	23.0	18.6	97.4	54.3	46.9	41.1	33.1	32.1	29.6	50.6	17.7	116.6	89.5	84.2	48.5	65.8	37.1	23.3	54.0	84.8	68.5	44.0	32.4	61.0	57.2	46.1	16.8	74.9	33.1	18.5	86.9	36.2	54.0	56.9	29.0	87.9	46.5	37.4	96.9	104.9	34.2	32.3	57.3	91.9	17.2	51.8	101.5	38.3	32.9	74.5
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053143-19103119	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 91.7;Spermatocytes: 55.3;Spermatogonia: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Supported	"Nuclear speckles,Centriolar satellite,Cytosol"		No	No			"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	8.7	9.6	10.9	9.2	13.1	17.5	11.1	10.8	10.3	7.7	7.0	9.9	5.6	4.9	8.9	8.0	7.0	7.4	6.4	7.1	10.5	7.3	5.2	11.0	7.1	12.8	15.0	8.9	11.1	6.3	5.8	8.5	8.4	12.4	7.6	7.9	5.6	7.1	7.4	7.2	9.8	7.2	8.9	13.5	10.0	5.8	27.1	13.6	27.3	6.6	3.8	12.7	7.0	7.1	3.6	2.6	10.9	2.2	7.2	6.1	2.5	11.1	7.6	15.6	12.1	6.0	7.3	8.4	11.9	8.5	11.1	17.0	3.9	5.1	13.0	4.4	6.9	8.5	4.6	14.3	7.0	17.2	11.8	6.8	69.2	13.8	8.9	4.0	9.1	15.8	4.5	7.2	10.5	22.8	5.7	8.0	13.4	9.4	8.6	12.7	3.6	17.8	15.5	16.7	6.3	7.6	13.9	10.6	5.3	5.9	6.4	9.1	12.6	5.3	5.0	7.6	10.4	3.9	11.5	7.9	9.9	6.0	8.5	13.6	3.4	7.5	12.8	9.3	7.8	4.3	10.9	2.2	2.2	4.5	2.2	6.1	3.5	4.3	5.6	2.2	3.6	5.2	4.6	3.5	7.2	2.0	2.6	5.4	2.5	10.9	13.1	10.8	10.3	10.5	7.3	15.0	8.9	12.4	13.6	17.9	12.2	10.4	10.2	8.7	11.6	7.4	5.1	1.4	6.8	8.7	9.8	8.4	0.0	8.9	91.7	7.8	4.2	23.3	5.2	13.1	7.6	7.3	10.5	5.7	7.2	11.1	2.4	4.3	3.2	21.2	10.9	13.1	8.5	3.6	4.4	13.1	7.4	3.5	7.8	3.3	9.3	6.5	5.4	55.3	51.9	7.0	4.1	10.0	7.4	8.8
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Cell type enhanced"	"Detected in many"	12	"Syncytiotrophoblasts: 1518.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Group enriched"	"Detected in many"	5	"ASC diff: 201.9;HHSteC: 174.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.3	2.4	201.9	27.5	36.6	9.3	7.2	5.7	6.5	4.4	0.6	0.0	0.1	19.0	36.6	0.3	3.2	0.0	9.8	11.8	0.0	15.5	0.4	16.5	174.9	1.8	28.4	29.1	3.3	13.9	0.0	4.6	7.0	0.0	2.8	3.4	22.0	0.8	4.2	6.3	4.4	0.0	5.7	10.2	1.5	0.1	0.0	10.8	0.2	5.4	4.3	1.1	9.1	4.4	2.2	4.1	11.0	0.0	1.7	8.8	0.0	2.0	2.0	6.2	0.0	3.1	0.9	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4	17.9	63.4	41.2	370.9	183.2	2.2	58.6	89.2	24.1	69.4	12.2	0.0	148.6	23.2	64.2	3.3	59.0	94.5	116.8	13.9	494.8	114.6	78.6	397.7	505.9	405.3	11.1	14.3	96.3	188.8	7.8	36.8	170.1	82.7	39.7	15.4	42.6	57.0	23.0	65.0	211.8	4.8	12.9	104.0	7.7	23.3	94.9	1518.0	59.8	29.9	214.1
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19373545	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	31.5	14.0	7.4	11.2	9.4	5.8	17.8	17.7	10.4	18.8	17.9	7.3	17.5	17.4	15.0	12.7	15.8	12.5	9.9	13.7	8.0	5.7	10.2	10.1	16.3	7.2	9.1	6.7	16.3	16.0	16.9	18.2	14.6	8.4	14.9	14.5	10.4	16.9	12.2	11.5	20.5	18.4	19.1	8.9	9.8	13.8	9.0	9.6	14.3	12.9	8.3	11.0	22.3	17.7	3.0	4.0	8.5	2.1	8.1	10.2	3.4	11.7	11.1	8.0	10.4	17.6	21.3	14.6	6.7	10.2	7.2	9.6	5.5	7.8	5.0	5.7	8.9	8.3	6.3	9.3	5.6	8.8	32.9	5.3	22.9	12.8	6.4	8.7	5.3	13.1	8.3	12.9	6.3	10.8	14.6	13.4	6.6	6.1	5.8	9.2	4.5	9.3	11.8	6.0	15.5	5.5	8.4	4.6	7.2	18.9	22.7	8.1	5.9	6.0	13.7	4.8	7.6	8.4	7.2	12.5	6.4	3.6	6.9	7.0	3.9	9.5	2.7	5.3	5.2	3.5	8.5	2.1	2.5	7.8	1.1	10.2	2.5	6.7	7.8	4.0	3.0	6.1	7.3	1.1	8.1	1.1	4.0	4.8	3.4	7.4	9.4	17.7	10.4	8.0	5.7	9.1	6.7	8.4	9.6	8.9	8.6	1.4	14.5	45.4	21.5	10.4	15.3	14.7	15.9	15.7	56.9	22.1	1.7	8.0	6.3	18.3	23.8	0.0	10.6	11.1	15.5	14.1	25.5	9.6	17.4	22.3	19.0	46.1	20.6	4.0	17.3	19.5	20.3	3.6	23.6	16.7	9.8	17.3	19.1	3.7	17.8	0.0	11.1	2.4	6.4	43.2	13.5	12.2	23.9	17.1
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 584.2"	"Low region specificity"	"Detected in all"							"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		100000	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favorable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	90.0	65.3	64.1	110.2	70.2	166.3	152.8	37.0	50.4	125.4	149.9	38.8	57.4	73.0	91.6	97.7	166.8	87.7	81.5	70.0	51.5	44.4	88.5	91.3	104.0	243.5	66.0	36.2	206.6	441.2	26.1	64.0	67.9	64.7	152.5	83.9	53.3	109.1	72.1	129.5	139.9	96.3	157.8	84.5	137.8	87.5	67.2	53.2	127.9	147.0	119.7	125.8	207.4	143.4	237.2	135.7	30.1	75.5	129.7	274.9	399.9	108.2	71.2	72.4	84.8	122.8	189.6	87.0	73.2	95.6	88.0	73.7	59.2	50.2	249.0	72.5	69.9	31.2	53.3	81.1	112.7	95.7	129.7	77.6	164.1	92.2	107.3	150.0	86.9	82.0	157.2	206.1	58.6	172.9	126.7	105.8	112.5	68.9	101.6	94.9	65.2	184.0	584.2	135.8	86.0	48.5	144.1	73.3	118.4	121.8	93.2	72.4	97.4	27.7	118.0	151.3	60.7	76.8	317.7	77.5	50.7	54.3	52.4	114.4	48.1	93.1	169.0	34.3	130.7	29.6	30.1	75.5	23.3	111.6	67.1	193.2	237.2	205.0	150.5	135.7	196.8	274.9	215.8	12.8	129.7	60.6	126.1	152.7	399.9	64.1	70.2	37.0	50.4	51.5	44.4	66.0	36.2	64.7	53.2	1536.5	2830.0	6502.2	11967.4	8648.0	283.0	709.9	2662.4	2307.4	4835.2	1210.9	119.8	4727.3	4907.4	2480.2	2006.9	4335.8	1389.0	2149.2	5906.0	7578.1	3573.8	7361.0	3033.7	1998.6	3545.0	71.5	1975.3	3407.3	3797.3	4913.1	4288.0	4784.3	4367.8	4093.0	4198.5	516.9	4659.6	3594.7	2278.1	5890.0	305.7	1461.7	5142.7	1143.2	654.9	10561.7	4523.6	5315.7	7244.9	10415.6
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409059-19452020	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Ito cells: 1.8;Late spermatids: 1.8;Syncytiotrophoblasts: 3.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"BEWO: 16.7;RT4: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	17.4	1.7	3.1	0.7	5.9	0.4	20.7	2.3	6.8	1.4	3.5	0.9	5.3	3.0	1.3	3.0	1.8	2.8	1.3	3.2	3.0	1.9	1.6	2.6	1.5	0.6	4.4	0.3	1.3	4.7	2.7	1.6	20.0	4.5	9.4	3.1	1.4	1.8	6.8	2.1	4.0	1.7	2.1	2.9	1.2	41.0	1.3	4.7	0.4	1.8	1.0	0.8	31.3	40.6	1.0	1.2	0.0	3.1	0.0	1.0	0.5	0.6	1.3	2.1	1.1	3.5	0.2	16.7	1.1	0.8	0.5	0.5	0.3	1.0	0.7	0.4	0.1	0.2	2.5	0.5	3.3	0.9	1.4	0.6	1.1	1.0	1.5	0.7	0.2	1.1	1.1	3.1	1.3	1.4	0.3	3.5	1.2	1.7	2.1	1.2	1.0	1.9	0.9	1.6	6.0	0.5	1.7	0.6	0.4	0.3	41.0	3.9	0.9	0.2	1.1	0.2	5.6	1.4	1.4	1.7	0.3	0.8	0.3	0.5	0.7	0.9	0.8	0.3	0.8	0.7	0.0	0.1	0.0	0.8	3.1	0.2	1.0	0.3	0.3	0.3	0.4	1.0	0.2	0.0	0.0	0.0	1.2	0.3	0.5	3.1	5.9	2.3	6.8	3.0	1.9	4.4	0.3	4.5	4.7	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.5	0.0	3.3	0.0	0.0	0.5
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.8"	"Group enriched"	"Detected in some"	18	"Bipolar cells: 68.2;Cone photoreceptor cells: 257.2;Horizontal cells: 92.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"K-562: 5.7;NTERA-2: 2.0;SCLC-21H: 5.2;U-87 MG: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.2	6.1	4.0	0.2	11.2	0.3	0.1	2.4	31.8	0.2	0.2			0.2	0.5	0.2	0.2	0.2	0.3	0.2	8.9	4.0	0.3	0.2	0.1	0.2	8.2		0.2	0.2	0.2	0.0	0.3		0.2	0.2		0.2	0.2	0.2	0.3	0.2	0.2	10.7	0.2	0.2	0.4			0.2		0.1	0.2	0.0	1.2	1.0	2.6	1.3	1.7	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.2	0.1	0.3	0.0	0.1	2.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.0	6.8	0.0	0.1	2.6	0.8	0.9	0.7	0.8	1.0	0.9	0.8	0.6	0.5	1.2	1.1	1.0	2.0	1.7	1.3	1.0	0.8	0.4											0.0	0.0	0.0	0.0	0.0	68.2	1.7	0.0	0.0	0.0	0.0	257.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	92.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	7.7	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3, super elongation complex subunit"	P42568	9	20341665-20622543	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Mucus-secreting cells: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 3.8;T-cells: 14.4"	"Cell line enhanced"	"Detected in many"		"HEL: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	8.6	17.3	18.0	10.4	25.8	19.7	11.4	34.6	20.3	12.3	20.9	7.2	10.6	7.2	13.6	7.9	10.2	11.5	12.7	8.6	18.0	12.8	10.1	2.1	10.7	9.1	14.8	13.8	10.5	4.6	18.3	24.7	10.3	13.2	11.7	22.8	7.4	21.3	12.1	9.1	7.9	12.3	13.5	12.0	5.9	15.3	3.6	21.4	22.1	22.5	6.1	6.5	12.9	10.4	1.4	0.7	1.6	0.3	3.8	14.4	2.8	2.6	7.2	2.6	2.9	6.0	3.7	1.6	6.8	11.5	3.1	3.5	7.0	2.5	10.0	3.7	3.2	0.9	1.3	2.4	11.8	2.8	20.6	6.3	73.6	22.3	3.3	4.3	1.3	6.2	2.8	4.5	1.1	7.4	10.4	3.0	4.2	0.0	12.9	6.4	2.0	7.2	4.3	1.6	14.4	2.1	0.0	4.7	2.7	14.1	3.9	8.3	2.9	5.5	2.8	3.0	2.6	2.9	1.9	2.0	0.0	1.7	1.7	2.4	5.8	5.3	4.1	0.0	3.2	1.4	1.6	0.3	0.5	3.9	0.2	3.6	0.5	7.0	5.3	0.7	1.4	14.4	8.3	0.1	3.8	0.3	0.4	7.3	2.8	18.0	25.8	34.6	20.3	18.0	12.8	14.8	13.8	13.2	21.4	26.8	23.0	7.3	15.3	7.3	5.5	12.1	7.6	9.4	38.7	21.0	31.4	0.9	11.6	23.0	2.7	8.6	13.6	0.0	7.3	5.3	16.7	15.6	11.5	1.7	2.0	4.8	31.7	6.7	2.6	4.2	12.7	3.2	21.9	1.0	101.9	37.2	18.7	17.3	8.9	7.0	1.0	0.0	16.5	0.1	5.6	7.3	1.4	25.4	28.6	13.2
FOCAD	"FLJ20375, KIAA1797"	ENSG00000188352	Focadhesin	Q5VW36	9	20658309-20995955	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 62.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 62.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055015	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA055015: AB_2682673"	"unprognostic (3.05e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.25e-4)"	"unprognostic (3.69e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.64e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.09e-8)"	"unprognostic (1.90e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-2)"	3.6	9.0	4.5	3.6	7.2	1.9	3.9	8.7	9.0	4.9	4.8	15.0	3.6	1.8	3.9	6.3	3.6	7.4	3.6	5.3	7.1	7.3	3.8	3.6	3.7	3.6	4.4	3.6	3.6	5.5	10.4	11.8	4.1	62.1	5.6	5.6	6.8	5.8	3.7	5.1	4.2	3.6	4.7	3.6	3.6	4.2	3.6	3.6	3.6	11.8	3.6	3.6	3.6	3.6	3.4	6.9	8.9	5.7	4.5	7.1	3.1	16.3	11.3	12.3	9.2	11.6	13.3	6.5	9.7	15.5	6.9	8.0	7.5	5.6	6.7	5.2	13.9	5.8	5.7	10.7	19.3	12.1	29.8	7.9	5.2	13.9	9.2	6.0	8.7	6.8	12.2	13.3	6.9	11.4	9.7	26.4	5.7	0.1	9.9	11.5	6.3	6.5	16.4	9.7	8.7	11.4	0.0	5.6	4.5	10.8	7.0	8.2	4.1	6.4	11.0	2.6	17.3	6.9	5.1	16.1	0.0	4.5	7.6	8.8	2.4	13.7	7.6	0.0	12.3	4.1	8.9	2.8	8.0	5.3	5.7	7.1	2.7	4.7	5.1	6.9	3.4	4.2	5.0	2.2	4.5	3.1	2.8	4.3	3.1	4.5	7.2	8.7	9.0	7.1	7.3	4.4	3.6	62.1	3.6	8.9	14.3	3.9	2.7	2.6	5.7	10.0	7.6	13.4	7.9	15.7	3.9	4.1	1.7	7.4	11.0	4.4	4.1	0.0	7.4	5.7	6.2	6.5	4.7	3.4	4.6	11.1	16.8	12.3	5.4	3.7	4.6	4.3	8.5	1.0	10.9	7.3	8.1	0.0	3.5	2.8	3.8	6.5	5.7	14.9	7.8	3.1	2.7	3.5	8.9	2.6
HACD4	"Em:AL662879.1, PTPLAD2"	ENSG00000188921	"3-hydroxyacyl-CoA dehydratase 4"	Q5VWC8	9	20999515-21031636	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 44.7;Ciliated cells: 89.7;Hofbauer cells: 50.9;Kupffer cells: 90.6;Macrophages: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.8;HDLM-2: 9.6;TIME: 7.9;U-937: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058666	Uncertain					NA	NA					"HPA058666: AB_2683793"	"unprognostic (1.71e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-4)"	"prognostic favorable (3.14e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.89e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-3)"	4.3	7.9	4.9	9.2	7.1	16.3	10.3	3.3	3.1	8.9	10.1	2.6	1.2	3.2	6.9	5.6	10.7	6.5	7.6	7.5	4.1	3.2	3.3	1.8	24.1	18.2	5.2	1.8	6.5	1.9	4.0	2.3	9.9	3.7	5.9	5.0	6.3	3.6	3.8	1.5	4.7	7.5	11.5	9.6	10.1	5.4	1.8	5.5	19.9	4.1	6.2	7.9	5.1	5.6	1.2	8.4	13.6	8.8	3.0	3.0	3.9	3.7	1.1	0.4	0.1	0.0	0.1	0.1	3.4	15.8	2.8	3.2	0.0	0.0	3.4	1.9	6.7	0.0	1.0	0.2	1.4	3.5	9.6	0.1	0.0	1.2	0.0	2.2	2.8	3.0	6.4	6.2	2.5	0.0	0.0	0.9	3.9	0.0	2.0	0.5	0.1	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.8	0.3	0.0	2.3	2.8	5.3	7.9	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	12.1	0.1	13.6	7.1	11.4	2.2	8.8	2.0	1.2	2.4	2.5	8.4	1.2	1.7	2.4	10.2	3.0	8.5	0.9	3.0	3.9	4.9	7.1	3.3	3.1	4.1	3.2	5.2	1.8	3.7	5.5	44.7	6.7	16.7	9.5	0.0	1.4	1.6	0.0	89.7	20.5	12.2	0.0	10.0	5.0	0.5	0.4	3.3	0.0	0.0	0.4	30.5	7.8	3.2	3.5	1.3	50.9	0.0	0.0	9.8	90.6	0.0	3.4	52.2	0.0	14.4	0.0	6.7	0.1	0.0	1.1	5.1	1.5	12.9	7.3	0.3	1.3	0.0	4.2	28.8	0.1	3.8
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077105-21077963	"Cancer-related genes, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 1.8;bone marrow: 3.7;breast: 5.9"	"Cell type enriched"	"Detected in single"	21	"Hofbauer cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;GAMG: 1.2;NB-4: 1.2"					"Low region specificity"	"Detected in many"			HPA073843	Supported				"Secreted to blood"	NA	NA	3750				"HPA073843: "	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.1	0.3	0.0	0.0	0.0	3.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.8	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IFNW1		ENSG00000177047	"Interferon omega 1"	P05000	9	21140214-21142145	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.2;NK-cell: 1.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.2;NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.0;U-266/70: 1.1;U-937: 1.1"														"Secreted to blood"	NA	NA																							0.1	0.4	0.5	0.1	0.6	1.3	0.1	0.6	1.0	0.1	0.0			0.3	0.0	0.1	0.3	0.2	0.2	0.1	0.5	0.9	0.0	0.2	0.1	0.8	0.6		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.7	1.4	0.5	0.1	0.3	0.4	0.2	0.8			0.4		0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.4	0.0	0.5	0.5	0.2	0.0	0.3	0.5	0.9	0.0	1.1	0.3	0.0	0.1	1.1	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA21	IFN-alphaI	ENSG00000137080	"Interferon alpha 21"	P01568	9	21165637-21166660	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.2;brain: 2.1;lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.4	0.3	0.3	0.9	0.0	0.0	2.1	0.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.3	1.3	0.0	0.0	0.1	1.4	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.3	0.0	0.2	0.2	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA4	"IFN-alpha4a, MGC142200"	ENSG00000236637	"Interferon alpha 4"	P05014	9	21186694-21187671	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA7	"IFN-alphaJ, IFNA-J"	ENSG00000214042	"Interferon alpha 7"	P01567	9	21201469-21202205	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"THP-1: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA10	IFN-alphaC	ENSG00000186803	"Interferon alpha 10"	P01566	9	21206181-21207143	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA16	IFN-alphaO	ENSG00000147885	"Interferon alpha 16"	P05015	9	21216373-21217311	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA17	"IFN-alphaI, LEIF2C1"	ENSG00000234829	"Interferon alpha 17"	P01571	9	21227243-21228222	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21239991	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;kidney: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"HMC-1: 1.0"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA5	IFN-alphaG	ENSG00000147873	"Interferon alpha 5"	P01569	9	21304326-21305312	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ: 1.5"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.3	0.3	0.0	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.5			0.6	0.4	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0		0.0	0.1	0.0	0.3	0.2		0.2	0.1		0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.3	0.1	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329671-21335380	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	17.8	15.1	16.4	12.4	15.6	9.3	20.8	18.0	19.5	19.7	14.4	19.4	12.7	8.7	19.5	18.7	14.8	16.8	12.6	13.6	15.8	19.9	17.8	15.1	13.6	13.2	16.9	11.9	25.3	20.4	18.1	16.9	22.6	15.7	20.0	15.1	15.3	16.2	14.8	9.3	10.1	15.6	17.6	16.9	17.3	16.1	9.9	13.2	23.0	19.9	11.6	13.5	15.7	16.5	3.4	5.0	16.7	7.2	6.0	8.3	4.5	6.0	7.3	16.7	9.0	21.6	21.5	3.6	11.3	11.5	8.6	9.7	2.7	4.8	2.7	7.3	16.5	8.6	3.3	9.7	11.0	10.7	15.0	7.0	0.0	13.8	7.1	15.1	4.7	3.3	21.1	11.9	6.7	10.9	14.1	13.0	0.0	0.0	3.6	19.6	3.8	9.8	16.6	6.8	6.2	6.3	0.0	7.3	3.2	10.6	7.5	5.3	10.1	6.5	5.9	6.9	16.1	10.7	0.0	15.6	0.0	6.1	4.8	6.5	3.9	5.3	2.9	0.0	5.0	5.8	7.5	6.2	16.7	5.5	6.9	6.2	3.4	6.7	5.0	5.0	2.6	8.3	5.6	2.0	6.0	7.2	3.7	4.6	4.5	16.4	15.6	18.0	19.5	15.8	19.9	16.9	11.9	15.7	13.2	23.8	15.6	6.9	27.6	9.2	23.8	16.3	17.8	16.0	29.6	15.7	17.7	13.6	10.0	13.1	0.6	16.1	14.7	0.0	13.1	6.3	14.6	21.4	11.5	19.5	12.9	17.5	26.5	43.6	22.7	0.9	19.8	10.3	16.9	6.4	23.0	18.7	11.5	17.5	22.6	20.3	16.7	12.9	10.3	12.5	9.5	9.2	8.4	14.9	14.5	18.0
IFNA6	IFN-alphaK	ENSG00000120235	"Interferon alpha 6"	P05013	9	21349835-21351378	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	1.2	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.9		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.1;epididymis: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HeLa: 1.6;hTERT-RPE1: 1.2;NB-4: 3.5;TIME: 1.5"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	1.1	0.0	2.1	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.1	3.7	0.0	0.1	0.0	0.0	1.5	0.6	0.4	0.0	0.2	0.2	0.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384254-21385388	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.6;brain: 1.3;lymphoid tissue: 1.1"	"Cell type enriched"	"Detected in single"	20	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in single"		"SuSa: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	253000				"HPA047557: AB_2680087"																		0.1	0.0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	1.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.3	0.4	1.0	0.4	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA8	IFN-alphaB	ENSG00000120242	"Interferon alpha 8"	P32881	9	21409147-21410185	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"HeLa: 3.2"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 5.7;hTERT-RPE1: 5.9;NB-4: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	10000				"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNE	IFNE1	ENSG00000184995	"Interferon epsilon"	Q86WN2	9	21480839-21482313	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 3.9;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"	21	"Basal glandular cells: 3.6;Glandular cells: 1.1;Urothelial cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	10	"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;HeLa: 10.6;hTERT-RPE1: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (1.52e-3)"	"unprognostic (8.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.56e-5)"	"unprognostic (2.70e-1)"	"unprognostic (2.25e-1)"		"unprognostic (5.14e-3)"	"unprognostic (6.32e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.34e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.6	2.6	0.2	1.3	0.0			1.4	0.3	3.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.2	0.0		1.4	0.0		0.1	0.8	0.0	0.0	2.4	0.0	0.0	0.1	1.5	0.0			0.6		0.7	4.1	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	2.5	0.0	0.0	1.2	1.2	0.2	4.1	0.2	0.2	0.3	0.1	2.7	0.0	0.8	0.8	0.4	1.4	0.0	2.6	0.4	0.0	0.0	0.0	10.6	0.0	0.7	0.0	0.0	1.1	0.5	1.6	2.3	13.1	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Supported	Nucleoplasm,Cytosol		NA	NA		3100000	Cytosol	Nucleoplasm	"HPA046915: AB_2679862"	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.4	2.2	11.7	9.9	9.7	10.0	13.2	21.2	10.4	10.7	12.4	9.9	6.8	7.2	6.6	10.0	8.8	6.7	12.0	29.9	18.3	0.1	9.8	0.1	27.4	13.1	9.4	11.5	12.9	12.0	0.0	19.8	21.7	12.4	11.1	0.2	0.1	9.7	11.2	2.0	13.2	0.3	13.7	6.7	17.7	0.2	8.9	12.7	9.3	0.1	6.7	7.6	6.9	8.1	10.5	8.9	5.2	0.2	12.1	0.1	7.6	0.1	16.8	6.5	11.4	15.1	0.1	11.5	6.2	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1	20.8	16.6	17.1	39.8	12.6	0.0	21.0	25.5	16.0	28.4	14.0	0.0	42.6	13.3	34.0	42.8	11.2	6.9	0.0	24.4	68.9	13.3	17.2	10.4	19.8	23.3	0.0	9.2	16.5	21.0	8.8	13.8	17.0	10.1	12.6	13.2	0.0	37.3	0.0	13.8	15.3	0.0	12.9	13.2	0.9	16.0	11.4	18.9	13.4	18.8	44.6
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 178.1;Late spermatids: 275.2;Pancreatic endocrine cells: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.2;HEK 293: 56.9;HeLa: 53.2;SK-MEL-30: 53.1"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA			Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.7	35.1	3.5	50.2	7.2	32.3	1.6	0.0	6.0	5.9	36.5	15.9	31.0	56.9	0.0	53.2	2.3	1.5	3.6	3.0	3.8	0.0	19.8	11.0	42.3	2.0	0.0	0.0	33.0	18.0	0.1	0.3	0.0	0.4	4.0	29.3	0.0	13.4	26.5	4.0	0.0	33.1	2.3	38.2	6.3	53.1	1.7	7.5	0.1	6.6	0.1	0.4	0.0	0.1	14.7	8.3	29.5	0.0	9.5	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9	0.0	0.0	1.5	0.7	1.5	0.2	4.0	0.0	14.7	1.2	10.4	0.0	20.9	0.0	32.4	178.1	2.2	6.9	0.0	22.9	52.3	3.6	10.0	4.6	0.0	6.6	0.0	68.2	0.6	8.2	275.2	2.8	1.8	8.5	26.2	6.2	0.8	259.8	10.5	1.8	0.0	0.0	0.0	1.0	5.7	4.1	0.4	7.7	12.5	2.3	34.0
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009363	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 140.1;Pancreatic endocrine cells: 107.4;Urothelial cells: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9"	"Lineage enriched"	"Detected in single"	16	"monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7;HaCaT: 16.2;HeLa: 15.3;hTERT-RPE1: 28.4;SiHa: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	22.4	1.4	1.4	7.3	1.1	0.0	25.1	0.8	1.2	6.6	35.4	1.4	1.5	14.1	2.6	0.8	27.0	1.2	1.4	1.4	1.6	0.8	0.5	0.6	9.9	2.3	2.0	0.8	0.8	1.0	3.9	7.8	3.7	3.4	3.1	13.4	0.7	5.1	3.2	6.5	8.6	47.0	3.2	1.0	4.4	3.9	3.3	1.3	1.1	0.8	9.8	12.5	2.8	16.6	0.0	0.6	0.0	10.9	0.0	0.4	1.3	0.0	0.0	0.1	0.9	13.6	18.7	0.3	0.6	0.0	2.1	5.9	1.5	4.1	0.0	1.7	1.0	0.0	16.2	0.3	3.2	2.6	1.1	5.0	0.0	15.3	0.7	6.9	0.4	2.7	3.9	0.0	2.7	12.0	28.4	2.0	0.0	0.0	7.2	3.4	1.2	0.0	0.0	0.7	0.8	9.4	0.0	0.9	0.3	4.6	0.0	2.6	0.0	20.5	5.3	14.7	12.6	1.1	0.0	5.3	0.0	0.3	0.0	0.0	6.9	3.9	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.1	3.9	0.0	0.0	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.1	1.3	1.4	1.1	0.8	1.2	1.6	0.8	2.0	0.8	3.4	1.3	62.5	7.9	0.9	16.4	4.7	1.2	2.4	2.5	4.0	3.4	5.2	0.0	0.8	0.0	50.3	4.4	2.5	140.1	0.0	34.0	0.4	7.2	41.1	0.0	0.0	1.2	0.0	7.5	2.5	14.8	1.7	0.6	4.0	3.3	1.8	21.9	3.7	107.4	49.1	1.1	0.0	6.7	0.0	6.3	13.8	3.3	21.1	2.6	0.0	11.2	219.8
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446841-22455740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.2;salivary gland: 16.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 13.3;Hepatocytes: 25.3;Proximal tubular cells: 21.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.0;hTERT-RPE1: 11.0;LHCN-M2: 4.2;RPTEC TERT1: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 2.5"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	2.1	0.2	0.7	1.4	0.7	0.0	5.6	0.8	0.7	2.4	1.0	0.7	1.1	0.7	1.2	1.8	5.5	0.3	1.2	0.6	0.6	0.5	5.5	12.2	1.1	1.4	0.8	0.4	0.6	2.7	6.1	2.9	0.0	0.9	2.4	0.4	1.9	16.3	0.5	0.9	0.5	0.8	0.7	0.7	0.4	2.8	0.6	0.0	1.1	5.0	0.6	2.0	0.9	1.7	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.4	0.1	0.2	0.0	9.0	0.3	0.3	0.1	0.1	0.0	2.0	0.0	0.2	0.3	1.8	2.4	0.3	0.0	0.6	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.7	11.0	0.6	0.0	0.0	3.3	4.2	0.9	0.0	0.0	1.8	0.4	3.0	0.0	0.2	1.2	4.3	0.0	0.1	0.0	1.1	0.7	2.0	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.9	0.0	0.0	2.4	0.0	4.7	0.0	0.5	1.1	2.5	4.0	4.5	5.2	0.0	0.0	13.3	5.4	0.0	0.0	2.6	0.0	6.0	0.0	1.3	5.6	0.0	25.3	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	4.8	5.6	0.0	0.0	21.4	0.0	0.0	0.4	0.0	0.6	0.4	0.1	0.0	1.9	6.2
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 30.7;testis: 45.3"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 154.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	1.0	2.4	8.7	1.0	13.4	1.4	1.1	18.3	27.5	1.0	1.3	0.7	0.0	1.0	1.5	1.4	1.1	1.0	1.1	1.0	8.1	19.2	1.4	0.8	1.1	1.0	16.3	18.9	2.1	0.8	1.2	2.5	0.9	30.7	1.2	1.5	0.5	1.0	1.0	1.0	1.5	1.1	1.1	5.0	1.0	1.0	45.3	1.1	0.0	1.2	0.0	1.0	1.6	0.3	1.8	1.1	5.1	0.9	1.4	1.3	0.1	10.1	0.1	15.6	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.2	6.5	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	4.0	0.0	4.7	0.0	0.1	0.0	0.3	0.5	2.2	0.0	0.0	0.0	4.1	0.0	4.9	0.0	5.6	0.1	0.0	0.0	52.1	4.9	0.1	0.1	0.1	4.2	0.2	0.7	0.0	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	2.7	0.9	1.6	0.5	0.6	0.6	1.0	0.5	0.4	0.4	1.8	1.1	1.3	5.1	1.4	0.5	1.1	0.6	0.1	8.7	13.4	18.3	27.5	8.1	19.2	16.3	18.9	30.7	1.1	0.0	0.0	0.0	0.3	0.9	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	34.9	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	15.9	4.1	0.0	0.0	30.7	2.8	0.0	0.0	0.0	0.7	2.7	0.0	0.0	1.4	0.0	9.6	0.0	0.3	12.2	154.0	0.6	0.0	0.0	0.8	0.8
IZUMO3	"bA20A20.1, C9orf134"	ENSG00000205442	"IZUMO family member 3"	Q5VZ72	9	24542952-24545946	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	169	"testis: 16.9"	"Group enriched"	"Detected in some"	89	"Early spermatids: 185.3;Late spermatids: 58.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	19.8	13.1	10.9	6.2	12.2	3.6	13.8	9.9	17.4	15.3	13.2	10.7	9.7	11.3	17.6	14.0	9.3	15.0	11.0	11.0	10.4	10.5	13.8	12.2	9.3	4.3	12.3	11.3	16.5	10.3	9.6	9.1	17.9	10.4	15.8	8.4	10.2	14.9	14.2	15.6	14.8	11.9	12.1	8.6	7.5	11.8	32.0	11.9	2.9	20.0	11.4	6.7	11.0	14.9	0.6	1.8	0.0	0.8	0.0	0.1	0.0	6.6	1.4	1.5	0.0	4.9	4.1	0.0	5.1	0.0	2.0	2.4	0.1	2.4	0.0	1.6	6.0	5.3	0.0	3.6	6.4	1.2	0.0	7.1	25.9	7.7	0.0	2.4	0.0	0.0	5.0	9.0	2.2	5.1	0.0	2.1	0.0	0.0	0.0	2.3	3.3	0.0	0.1	1.3	5.3	6.6	0.0	1.0	0.1	2.7	3.1	0.5	11.7	6.3	5.3	5.2	3.0	4.6	7.3	4.5	0.0	9.5	0.1	0.0	0.0	0.0	0.0	6.2	1.7	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.8	1.8	0.0	0.0	10.9	12.2	9.9	17.4	10.4	10.5	12.3	11.3	10.4	11.9	11.9	5.4	0.0	35.5	54.0	25.2	9.7	17.8	2.7	5.7	15.7	3.9	24.7	56.3	6.4	50.7	21.8	8.0	0.0	10.7	12.0	22.0	30.2	0.0	16.4	8.1	20.6	12.6	15.4	2.2	5.0	28.4	5.3	27.0	1.0	12.7	29.9	6.4	10.5	20.5	18.1	13.4	32.3	39.6	89.6	11.5	33.1	24.3	0.0	12.8	15.6
CAAP1	"C9orf82, CAAP, FLJ13657"	ENSG00000120159	"Caspase activity and apoptosis inhibitor 1"	Q9H8G2	9	26840685-26892804	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020404, HPA024029, HPA024100"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-2)"	"prognostic favorable (1.27e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (7.94e-9)"	"unprognostic (2.74e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-2)"	9.5	26.3	10.5	14.3	11.7	10.0	11.6	12.9	12.9	10.1	16.9	9.1	16.4	14.9	13.6	19.5	14.3	9.1	12.3	9.1	10.2	10.6	25.6	30.1	7.9	12.7	9.7	7.2	8.1	20.7	17.7	20.0	9.1	10.7	10.8	19.1	14.2	17.5	15.5	9.9	10.6	17.6	10.0	8.8	14.1	10.8	19.4	9.6	25.6	27.1	10.6	16.7	10.1	9.8	16.2	15.0	12.7	14.5	15.1	17.6	12.7	13.0	8.2	14.0	14.6	9.4	8.0	10.2	9.0	9.8	9.5	11.7	2.5	8.6	16.4	9.0	8.7	5.5	6.7	14.3	9.7	13.4	19.6	7.2	27.6	13.7	15.4	16.0	11.4	13.0	8.0	12.5	7.2	18.0	10.7	15.8	10.4	7.3	12.1	10.8	7.2	18.1	4.9	18.3	13.0	5.3	12.7	6.5	10.1	24.6	9.9	10.8	22.4	8.6	10.3	8.7	13.3	8.8	14.4	8.6	0.0	14.3	5.8	9.2	5.3	9.9	17.9	4.7	12.4	5.8	12.7	9.4	6.4	14.1	14.5	17.6	16.2	15.6	16.3	15.0	14.1	13.0	13.6	1.2	15.1	12.1	13.8	15.1	12.7	10.5	11.7	12.9	12.9	10.2	10.6	9.7	7.2	10.7	9.6	20.8	16.3	15.2	9.8	8.9	10.2	6.7	15.3	24.1	33.0	29.6	7.9	15.8	49.7	17.2	7.9	10.4	15.3	0.0	17.2	12.3	9.8	13.5	17.4	27.2	10.8	7.9	14.9	11.6	10.7	2.7	7.8	10.6	8.5	16.2	22.0	20.7	17.9	21.0	6.0	19.9	11.6	12.9	9.1	39.5	18.8	12.8	9.0	8.7	26.8	10.5
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26904083-26947463	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5300	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	13.6	20.1	9.4	12.4	13.1	29.6	11.9	12.9	18.0	13.4	12.3	11.1	13.5	10.5	15.6	12.8	16.2	10.8	13.6	26.2	10.1	10.2	15.0	19.6	14.4	16.4	9.6	10.9	12.3	12.9	15.0	10.0	17.4	13.4	12.1	13.1	9.5	13.4	11.6	52.6	13.5	12.3	16.1	10.0	16.1	12.0	15.7	7.9	27.0	13.0	18.2	14.6	14.9	12.7	13.2	12.2	19.2	17.9	13.5	16.5	8.6	27.8	16.5	20.9	21.1	14.2	18.1	15.8	26.2	15.0	20.1	19.7	5.8	13.4	25.2	21.9	20.0	14.0	11.2	20.7	20.7	22.2	33.1	8.7	15.6	27.2	11.1	14.5	12.5	21.4	16.1	12.5	24.5	17.9	15.2	20.0	18.9	9.5	25.6	21.6	11.6	24.2	12.2	30.3	14.4	14.4	17.3	13.1	14.9	15.6	16.7	13.4	23.0	14.0	16.6	8.2	21.4	11.5	9.7	24.2	0.0	24.9	13.0	21.2	8.4	18.3	26.2	14.2	17.9	10.4	19.2	11.9	18.7	11.2	16.8	12.5	13.2	11.6	11.3	12.2	11.5	10.7	12.2	11.2	13.5	17.9	6.3	16.5	8.6	9.4	13.1	12.9	18.0	10.1	10.2	9.6	10.9	13.4	7.9	14.9	9.1	11.2	9.4	9.7	8.3	21.0	2.5	12.0	13.6	8.7	0.0	21.0	8.3	14.9	21.7	15.3	9.5	0.0	14.0	21.7	10.4	9.6	40.3	9.0	18.5	4.8	9.2	12.9	13.3	3.6	8.1	9.9	1.7	10.8	7.3	8.5	12.8	8.7	7.8	7.9	6.1	19.4	17.8	24.7	22.0	8.3	41.2	13.8	11.4	10.2
IFT74	"CCDC2, CMG-1, CMG1, FLJ22621"	ENSG00000096872	"Intraflagellar transport 74"	Q96LB3	9	26947039-27062930	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 137.9;Spermatocytes: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020247, HPA026684"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA020247: AB_1846140, HPA026684: AB_1846141"	"unprognostic (3.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.43e-1)"	7.7	14.4	11.1	7.9	11.2	6.1	11.9	14.5	11.2	13.7	11.5	6.8	13.7	6.2	11.2	22.1	9.8	16.1	8.2	8.3	9.8	8.4	17.7	10.3	8.3	6.4	6.7	9.9	14.0	8.9	17.4	37.8	7.7	11.0	12.8	11.6	9.5	9.1	16.6	9.6	7.5	6.7	17.6	7.5	8.2	7.4	35.9	8.1	12.3	20.3	6.1	5.9	11.7	9.1	11.3	7.2	2.0	5.5	11.0	10.0	3.4	9.9	13.0	13.3	11.3	9.6	16.0	4.2	9.1	13.9	10.9	10.2	1.6	6.5	3.1	7.1	8.5	10.2	6.8	10.0	11.5	13.4	7.9	5.5	9.3	6.2	6.5	15.9	5.3	8.7	11.5	17.1	12.7	22.5	14.0	6.8	0.3	6.0	12.2	14.9	3.9	7.6	18.1	9.4	5.3	7.0	3.1	5.6	9.8	17.8	5.6	10.9	11.4	6.9	8.5	6.1	8.3	11.8	8.5	6.7	0.0	11.7	3.7	8.1	4.6	10.7	2.3	6.2	8.2	5.4	2.0	5.4	0.4	5.8	5.5	4.3	11.3	5.8	5.3	7.2	10.8	10.0	7.2	0.4	11.0	4.2	7.1	4.6	3.4	11.1	11.2	14.5	11.2	9.8	8.4	6.7	9.9	11.0	8.1	29.8	20.6	2.2	13.3	6.9	22.5	24.6	5.1	137.9	38.7	15.7	21.6	19.9	18.3	22.1	45.4	11.9	11.5	0.0	20.0	8.5	11.4	7.2	16.1	8.5	13.1	27.0	12.7	8.0	35.1	19.3	18.7	6.7	5.0	7.2	11.9	27.3	10.8	10.5	17.0	26.1	44.9	19.4	8.1	132.3	27.7	7.3	9.2	4.3	15.4	5.9
LRRC19	FLJ21302	ENSG00000184434	"Leucine rich repeat containing 19"	Q9H756	9	26993136-27005693	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 61.3;kidney: 50.0"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 22.7;Enterocytes: 78.3;Paneth cells: 39.5;Proximal tubular cells: 50.0;Undifferentiated cells: 24.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;RPTEC TERT1: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		96000				"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.21e-5)"	"unprognostic (1.87e-2)"	"unprognostic (4.48e-2)"	"prognostic favorable (7.08e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	0.2	0.2	0.2	5.9	0.2	0.0	0.2	0.2	0.2	0.2	23.4	0.1	0.1	11.9	0.2	1.3	0.2	0.2	2.9	0.1	0.2	0.2	50.0	0.8	0.2	0.1	0.2	0.1	0.2	0.6	0.0	0.2	0.1	0.1	0.2	17.0	0.1	0.2	0.1	0.1	0.2	61.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	2.0	0.9	1.1	0.7	0.4	0.8	0.0	2.4	0.6	0.3	0.4	0.0	0.4	0.9	0.7	0.0	0.0	0.0	0.6	0.3	0.3	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.3	0.6	1.0	0.5	0.0	0.6	0.8	0.1	0.5	0.0	0.3	1.0	0.0	0.2	0.3	1.0	0.0	0.3	0.5	1.5	1.7	0.3	1.1	0.5	0.5	0.6	4.2	0.4	0.6	0.3	1.7	0.3	0.1	0.6	0.3	0.5	1.2	0.8	0.4	1.6	0.5	0.3	0.3	0.1	0.2	0.6	0.2	1.0	0.7	0.6	0.5	0.6	0.4	0.6	0.8	0.4	0.5	2.0	0.8	0.7	1.1	0.4	0.6	0.9	0.6	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.4	20.4	0.0	0.0	22.7	0.0	0.0	8.3	0.1	0.0	0.0	78.3	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.1	39.5	0.4	50.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
EQTN	"AFAF, C9orf11, equatorin, SPACA8"	ENSG00000120160	Equatorin	Q9NQ60	9	27284659-27297139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 39.9"	"Cell type enriched"	"Detected in some"	26	"Early spermatids: 558.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1"									"HPA015089, HPA015504"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA015089: AB_1845795, HPA015504: AB_2067598"	"unprognostic (7.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-3)"	"unprognostic (4.41e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.67e-2)"		"unprognostic (1.14e-1)"	"unprognostic (4.59e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.1	39.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	1.3	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	1.1	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	558.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.1	1.9	0.3	0.1	0.0	0.2	0.1
MOB3B	"C9orf35, FLJ13204, MOB1D, MOBKL2B"	ENSG00000120162	"MOB kinase activator 3B"	Q86TA1	9	27325209-27529781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;ovary: 29.9"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 47.8;Muller glia cells: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.1;HAP1: 10.4;K-562: 29.7;SK-BR-3: 12.5"	"Low region specificity"	"Detected in many"							HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (6.96e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (2.33e-10)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (7.99e-2)"	6.0	2.3	6.2	4.2	18.0	1.0	7.0	5.0	13.9	7.8	13.2	32.6	2.8	19.0	10.9	6.1	4.3	9.4	5.8	2.0	9.8	6.4	8.6	1.9	7.5	4.2	19.7	6.2	29.9	4.5	0.9	1.8	5.3	17.2	2.8	14.9	5.7	3.9	3.8	8.5	7.1	16.6	7.5	33.2	8.6	6.2	3.7	17.5	0.6	7.0	2.9	6.2	4.0	5.2	5.9	4.6	0.0	1.4	0.0	0.1	0.5	2.0	1.5	4.8	0.0	1.2	0.1	10.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	2.1	0.0	0.0	6.8	10.4	8.2	0.0	4.6	1.6	3.0	6.3	0.0	0.0	0.0	0.6	2.2	8.7	0.0	1.6	0.0	0.0	0.0	29.7	0.1	0.0	0.0	0.0	0.0	6.1	3.8	0.5	2.0	0.5	0.0	2.9	3.9	0.0	1.5	1.7	12.5	2.9	6.6	0.8	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.9	0.0	0.0	1.4	0.0	4.8	0.0	0.0	4.6	5.9	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.5	6.2	18.0	5.0	12.0	9.8	6.4	19.7	6.2	17.2	17.5	3.0	5.5	18.6	6.8	20.1	1.2	1.2	30.6	1.4	4.5	10.4	0.0	18.9	8.3	13.5	0.7	4.3	47.8	0.0	18.5	45.9	11.2	4.0	1.1	2.6	4.6	1.6	2.4	6.2	11.6	1.7	14.7	22.9	15.1	8.2	27.2	68.7	10.1	17.5	15.2	9.1	1.3	0.0	12.2	1.4	1.7	8.3	9.8	1.0	31.1	6.2
IFNK		ENSG00000147896	"Interferon kappa"	Q9P0W0	9	27524314-27526498	"Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.9;skin 1: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.8"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA							"unprognostic (5.58e-3)"				"unprognostic (4.64e-3)"								"unprognostic (1.06e-1)"				0.1	0.0	0.1	0.1	0.5	0.7	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.8	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.3	0.1	0.1	1.7	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C9orf72	"DENNL72, MGC23980"	ENSG00000147894	"Chromosome 9 open reading frame 72"	Q96LT7	9	27546545-27573866	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Secreted - unknown location"	NA	NA			"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	10.0	11.2	9.7	14.2	17.6	19.1	8.0	31.2	21.3	7.4	6.0	10.9	6.7	5.8	10.7	10.6	5.8	14.6	8.9	7.4	9.4	14.6	4.2	14.0	13.0	10.7	11.0	10.7	19.5	8.4	6.7	15.3	10.3	20.0	13.3	7.1	9.4	5.3	5.9	11.0	6.2	6.1	7.6	11.5	13.7	6.5	14.8	6.7	8.0	11.0	3.2	7.3	9.7	6.3	1.7	11.7	15.6	21.8	2.9	2.5	4.4	2.8	2.5	21.1	3.2	4.3	5.3	3.2	4.1	3.5	2.6	1.3	0.3	1.0	7.2	2.7	3.6	5.4	2.2	6.0	5.2	1.9	13.1	2.5	3.4	7.5	2.1	6.6	2.3	3.7	5.6	6.4	0.6	11.9	2.5	5.5	7.4	6.5	13.1	3.1	0.5	4.4	3.5	10.2	4.7	11.6	1.7	6.3	3.2	2.0	2.5	7.2	17.7	2.7	3.1	2.6	8.3	2.6	2.0	4.7	0.0	10.6	6.2	2.7	3.4	10.2	4.7	8.0	7.6	2.6	8.0	15.5	1.0	0.9	21.8	1.7	1.7	1.4	1.2	11.7	1.2	2.5	1.5	15.6	2.9	16.5	1.8	1.8	4.4	9.7	17.6	31.2	21.3	9.4	14.6	11.0	10.7	20.0	6.7	14.9	17.1	6.9	37.1	31.9	22.0	12.8	5.1	77.6	12.5	7.0	19.6	18.4	1.7	6.9	1.7	10.8	3.9	0.0	8.3	6.2	12.4	25.8	16.1	7.8	23.9	11.1	10.9	6.7	86.3	3.3	5.8	73.0	18.6	19.8	9.9	46.1	6.4	8.6	3.5	4.1	28.5	0.0	20.6	30.7	19.3	25.5	28.9	10.9	5.2	35.5
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 10.5;smooth muscle: 11.4"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 7.3;Early spermatids: 12.0;Late spermatids: 11.5"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;hTERT-HME1: 2.3;SH-SY5Y: 13.7;U-87 MG: 2.4;WM-115: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA016633, CAB025361"	Approved					NA	NA					"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.3	1.8	0.0	1.7	0.0	0.0	1.0	3.4	0.3	0.0			0.0	10.5	1.0	0.0	0.4	1.0	0.0	1.4	4.1	0.6	0.0	0.0	0.0	0.6		0.0	0.0	2.7	0.6	1.8		0.6	0.0		0.0	1.9	0.0	0.0	0.0	11.4	0.3	0.0	0.4	1.8			3.7		0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.4	0.4	1.7	0.0	0.5	0.3	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	13.7	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	0.0	6.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.7											0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	1.7	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.2	0.6	0.0	0.0	1.2	0.9	0.0	0.2	0.0	0.0	0.0
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 174.5;Proximal tubular cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.5	8.7	6.8	10.7	53.1	28.8	3.1	18.1	44.5	8.3	6.6	9.2	3.0	1.9	5.8	18.9	22.8	1.3	13.5	17.3	16.8	6.0	3.6	14.0	9.5	10.0	26.7	1.3	5.6	25.0	5.3	21.4	15.1	25.7	21.5	7.4	5.0	4.1	23.7	2.5	7.4	6.7	7.1	6.0	9.4	5.8	10.1	1.9	31.7	8.8	0.9	2.8	18.8	0.7	1.9	7.6	4.4	3.4	23.2	30.4	10.3	10.1	4.7	2.1	3.9	3.8	21.2	4.7	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9	3.0	25.5	7.5	6.9	3.9	18.8	39.8	45.9	8.1	9.1	22.7	21.6	39.8	16.6	14.3	6.3	18.2	29.7	0.0	35.8	17.8	21.6	11.2	2.3	174.5	13.3	31.8	4.7	14.1	12.7	5.1	21.9	7.2	6.8	2.8	32.4	30.7	23.2	21.0	21.9	160.8	13.9	19.4	22.3	6.1	16.2	4.6	44.7	8.7	26.9	7.1
DDX58	"DKFZp434J1111, FLJ13599, RIG-I"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455705-32526324	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 47.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012643, HPA047193"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane"	Cytosol	"CAB012643: , HPA047193: AB_2679978"	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	27.7	8.2	5.7	14.5	7.9	5.6	11.3	4.2	5.7	9.9	9.5	5.2	9.1	7.2	12.7	11.7	10.8	7.6	10.3	7.1	6.0	5.1	14.7	8.5	13.7	14.3	6.3	4.5	9.2	7.7	6.6	10.2	14.8	7.5	12.1	8.1	5.5	12.4	5.8	8.3	10.7	16.1	10.8	7.7	13.8	8.0	4.5	6.4	35.4	13.0	7.4	9.7	9.9	9.4	4.9	2.0	24.8	5.7	6.1	6.5	3.0	2.9	1.1	1.6	0.9	3.9	4.1	2.5	1.8	8.9	45.5	47.6	1.2	2.6	0.8	3.2	1.6	14.7	2.4	1.8	2.0	6.4	7.3	0.6	2.8	2.5	2.0	3.2	1.8	2.2	2.8	0.7	5.2	1.6	3.5	8.3	2.2	0.6	0.6	6.0	0.4	2.6	4.7	1.3	0.6	1.3	2.4	1.2	0.3	6.9	1.6	1.2	0.8	2.6	1.1	5.0	1.1	1.9	1.6	9.4	1.4	1.3	1.1	0.9	0.1	0.5	0.6	2.0	0.8	0.9	8.5	3.8	10.3	6.2	5.7	5.5	4.8	5.6	5.6	2.0	4.9	5.1	5.6	24.8	6.1	3.9	0.1	6.5	3.0	5.7	7.9	4.2	5.7	6.0	5.1	6.3	4.5	7.5	6.4	20.8	9.1	5.4	4.4	3.8	3.7	4.4	2.5	8.1	6.8	1.8	2.0	4.5	0.0	17.2	2.0	14.5	14.6	0.0	10.6	6.7	5.1	4.6	4.7	6.4	5.0	6.4	2.9	8.6	6.9	0.0	6.1	6.7	0.0	2.8	2.9	9.4	12.8	5.8	5.6	6.5	2.7	6.5	6.6	0.5	1.5	4.6	2.1	9.2	1.9	4.3
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Cell line enhanced"	"Detected in all"		"HEL: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.2	7.6	10.5	9.2	12.9	11.7	6.7	10.5	9.9	8.7	10.2	4.7	4.2	13.4	6.1	10.5	7.7	5.5	12.4	11.9	12.3	11.1	6.8	45.2	13.3	5.9	8.0	12.8	12.5	9.4	13.4	12.6	8.9	10.9	10.6	10.2	7.8	7.0	14.2	4.4	11.4	23.6	14.0	6.1	7.8	11.8	9.4	6.0	11.7	8.7	5.2	8.4	10.5	5.7	6.8	12.4	5.8	7.3	11.1	9.6	9.8	5.0	7.7	4.9	7.8	14.5	8.9	7.4	4.3	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0	50.6	20.6	26.5	37.9	41.9	48.4	16.8	28.1	18.7	38.7	24.4	35.3	25.9	16.6	21.0	148.7	37.9	22.0	0.0	16.2	14.5	27.8	32.6	40.5	20.2	15.7	52.4	44.0	22.1	16.6	13.0	30.8	27.2	18.6	27.9	18.4	48.5	18.7	22.9	30.8	19.1	38.4	19.4	37.1	51.9	49.7	41.7	42.4	34.1	19.0	41.6
SMIM27	"C9orf133, TOPORS-AS1"	ENSG00000235453	"Small integral membrane protein 27"		9	32551144-32568621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in many"	6	"blood: 102.4"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 54.9;Distal tubular cells: 101.2;Proximal tubular cells: 50.5"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 102.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 102.4"	"Low cell line specificity"	"Detected in all"																	NA	NA						"prognostic favorable (4.18e-5)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.74e-3)"	"unprognostic (8.58e-2)"	"prognostic favorable (8.39e-4)"	"prognostic favorable (7.33e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (7.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-3)"	4.0	6.9	5.0	4.3	12.2	7.9	5.6	4.8	11.0	4.0	4.0	2.4	4.4	4.8	2.2	7.8	2.3	4.0	2.1	8.6	5.1		6.2	3.9	5.6	8.8	5.7	5.8	3.7	11.5	3.7	5.5	2.1	8.9	4.4	1.6	4.0	5.9	4.6	13.8	2.1	3.9	4.5	11.4	6.6	5.1	16.2	6.1	4.5	2.8	4.7	4.1	2.6	0.0	18.4	8.4	102.4	7.6	13.3	22.0	9.9	7.1	4.1	7.5	6.7	3.3	10.0	4.1	3.8	5.6	2.9	5.9	1.0	2.0	5.5	5.5	5.4	5.3	2.9	5.1	3.3	4.2	10.7	11.4	27.2	12.4	9.1	7.6	6.7	4.7	7.3	5.3	2.8	6.7	8.4	6.6	18.1	3.8	14.0	5.2	5.5	11.8	27.5	9.2	7.3	7.8	6.2	3.5	9.8	6.8	3.8	5.6	6.9	9.0	3.5	4.6	9.5	2.8	5.9	3.8	2.1	5.6	2.7	3.7	15.7	12.0	19.5	12.5	4.1	1.8	13.6	7.3	47.4	12.7	7.2	16.9	17.6	18.3	14.7	6.1	18.4	22.0	19.0	102.4	13.3	7.6	8.4	18.3	9.9											26.8	29.6	0.0	0.0	0.0	0.0	0.0	0.0	54.9	17.0	27.9	0.0	21.4	101.2	16.2	0.0	0.0	0.0	0.0	28.2	10.1	0.0	0.0	23.3	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	10.8	0.0	0.0	21.1	0.0	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32552999-32573184	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 591.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	21.9	26.8	33.9	17.7	31.8	16.0	18.7	22.6	28.3	13.7	21.9	15.5	17.3	26.5	16.8	17.4	18.6	15.4	15.9	58.6	27.6	27.9	32.8	36.6	13.9	15.4	28.4	27.2	14.1	19.5	15.4	17.8	15.5	22.9	15.1	18.2	14.6	22.7	16.1	87.2	14.6	25.5	16.4	25.9	13.5	20.0	28.9	17.1	19.2	22.2	34.4	14.5	14.1	13.5	26.0	38.8	77.4	27.3	22.2	27.5	26.5	30.2	18.6	20.7	23.7	14.1	13.2	13.3	20.3	16.6	18.8	20.8	18.2	13.7	22.6	21.2	13.9	19.5	17.2	19.5	22.4	14.1	31.0	31.3	53.7	28.6	18.8	13.8	26.7	13.9	13.6	10.9	16.9	12.9	14.2	16.9	34.7	17.1	25.5	20.9	17.5	36.0	63.1	21.9	26.0	41.4	24.8	17.4	20.9	21.0	11.4	20.9	23.6	23.5	27.0	13.6	16.2	25.5	20.8	15.0	20.5	31.1	22.6	29.7	11.4	21.2	36.6	34.3	18.9	9.6	25.0	25.8	33.3	21.0	23.1	20.2	26.0	22.4	21.6	27.6	21.8	23.0	24.3	77.4	22.2	27.3	38.8	27.5	26.5	33.9	31.8	22.6	28.3	27.6	27.9	28.4	27.2	22.9	17.1	116.1	94.0	77.4	80.5	83.7	39.2	514.3	107.0	155.2	108.1	102.9	5.9	175.9	452.6	143.9	591.4	96.3	138.7	93.5	145.0	113.2	93.0	79.2	86.8	170.4	141.7	17.5	62.0	71.8	59.8	88.6	84.8	89.6	151.8	111.8	116.6	72.0	133.2	118.5	84.5	440.9	40.8	103.5	124.6	143.8	114.3	84.6	87.1	65.4	146.3	88.4
TAF1L		ENSG00000122728	"TATA-box binding protein associated factor 1 like"	Q8IZX4	9	32629454-32635669	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 6.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.8;Early spermatids: 3.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	11	"U-87 MG: 4.5"									HPA056605	Uncertain					NA	NA					"HPA056605: AB_2683186"	"unprognostic (7.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.79e-2)"		"unprognostic (4.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.13e-2)"		"unprognostic (1.60e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.86e-2)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.3	1.2	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.3	0.2	0.0	4.5	0.1	0.0	1.0	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.3	0.2	0.4	1.2	0.4	0.1	0.3	0.1	0.1											0.0	0.0	0.0	0.1	0.0	13.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	1.7	0.9	0.0	0.0	0.0	0.0	0.0
TMEM215		ENSG00000188133	"Transmembrane protein 215"	Q68D42	9	32783499-32787399	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.0;retina: 6.5;testis: 17.9"	"Cell type enhanced"	"Detected in some"	32	"Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4"	"Cancer enriched"	"Detected in single"	14	"thyroid cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 6.6;SH-SY5Y: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052804, HPA063207"			Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA052804: AB_2681957, HPA063207: AB_2732697"	"unprognostic (1.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.38e-3)"		"unprognostic (2.17e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"		"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-2)"		0.1	0.0	1.8	0.4	1.5	0.0	0.1	0.1	0.9	1.9	0.0	0.0	0.0	0.0	8.0	0.9	0.1	0.1	0.0	0.9	0.9	1.5	0.0	0.0	0.1	0.0	1.7	0.2	0.7	0.0	0.0	0.1	0.0	0.6	0.1	0.0	6.5	0.1	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	17.9	0.0	0.0	3.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.1	0.8	0.9	1.5	1.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	564.3	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	188.4	2.6	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.7	0.0	21.9	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.6	16.4	12.5	10.8	12.8	11.2	16.6	14.5	15.1	17.7	19.6	21.8	7.7	16.9	8.7	12.1	11.0	11.5	20.3	19.4	22.0	22.8	8.3	10.0	23.5	22.2	14.8	16.1	9.6	15.0	23.8	20.3	26.4	11.3	16.9	13.1	15.1	16.9	16.5	9.3	14.4	23.7	19.1	14.2	17.7	13.1	8.7	12.0	14.5	13.2	8.7	7.3	13.3	11.9	9.7	12.1	13.5	6.6	10.4	9.9	13.2	17.1	14.9	7.3	12.0	16.9	14.7	13.2	7.9	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5	17.9	31.9	15.7	18.7	14.8	13.6	12.9	28.1	25.4	19.4	8.7	9.8	23.7	24.9	20.4	49.1	11.9	11.6	0.0	24.6	22.8	12.6	16.4	16.1	17.4	16.5	12.7	16.1	6.7	15.2	35.4	12.4	14.5	13.5	20.8	12.6	17.8	24.5	3.5	9.9	24.1	16.2	12.9	12.2	35.9	27.0	18.4	23.3	14.1	15.1	20.4
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025211-33039907	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 189.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001306, CAB033665"	Approved		Supported	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"CAB033665: AB_2094242, HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	29.0	46.7	46.5	26.1	47.2	42.7	57.2	31.6	53.3	30.4	18.7	20.7	25.5	14.4	27.6	27.9	17.1	34.8	28.2	22.2	42.5	51.7	36.0	71.9	30.7	23.8	56.5	30.8	30.7	19.5	47.3	40.2	35.0	49.6	29.8	21.7	9.0	18.9	23.0	14.5	13.1	15.9	29.0	42.4	22.3	20.8	42.2	51.5	24.1	47.0	15.3	28.1	27.9	189.5	36.6	60.0	50.0	69.0	31.6	37.2	49.5	38.7	69.6	56.4	19.5	39.2	25.5	32.3	40.1	32.4	72.2	56.2	46.1	18.0	39.8	30.8	27.2	40.9	17.7	81.1	24.1	62.3	56.0	23.6	31.9	85.7	58.4	18.8	36.6	37.5	15.6	24.9	27.1	8.7	35.1	43.0	17.4	49.6	17.4	41.3	31.7	61.1	80.7	54.8	39.1	48.6	45.0	20.2	20.4	40.4	23.0	35.8	39.1	53.9	34.9	17.9	44.0	16.3	35.6	36.8	25.8	44.1	29.3	53.2	11.2	34.7	42.1	33.8	32.0	22.1	33.3	40.1	43.3	28.5	56.0	33.3	36.6	35.6	31.4	35.7	32.7	37.2	34.7	50.0	31.6	69.0	60.0	30.1	49.5	46.5	47.2	31.6	53.3	42.5	51.7	56.5	30.8	49.6	51.5	199.5	144.3	123.6	875.9	235.0	170.2	172.5	48.4	514.0	273.0	78.5	196.3	237.2	145.9	218.2	352.5	305.0	136.1	70.0	158.2	280.3	289.7	362.1	422.8	118.0	203.3	114.4	374.9	98.8	133.8	169.3	91.7	282.9	269.9	316.6	116.6	133.1	170.5	185.9	89.1	138.6	144.4	103.5	321.4	400.4	214.4	232.0	388.8	169.6	115.9	335.9
SMU1	"BWD, FLJ10805, fSAP57, SMU-1"	ENSG00000122692	"SMU1, DNA replication regulator and spliceosomal factor"	Q2TAY7	9	33041764-33076659	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019708	Supported		Approved	Vesicles		NA	NA		16000	Vesicles		"HPA019708: AB_1857300"	"unprognostic (2.20e-2)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (4.98e-3)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.67e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.96e-2)"	25.0	20.0	21.7	17.0	22.2	23.3	20.7	29.6	24.5	22.2	18.0	28.3	17.4	14.5	28.3	21.2	18.1	20.6	15.0	17.1	21.3	21.2	19.5	21.9	17.0	19.7	22.1	18.1	26.3	18.7	30.3	26.6	18.2	24.2	21.1	19.1	20.2	20.5	21.0	22.9	21.9	19.6	23.6	23.5	21.0	16.9	16.0	19.5	31.1	24.1	16.5	24.6	20.8	17.7	14.4	21.2	20.7	17.5	12.9	16.5	10.4	16.0	12.7	15.3	13.3	16.7	12.8	12.0	12.6	11.4	17.3	17.2	12.9	6.8	20.4	9.3	15.6	9.4	9.9	19.6	15.1	19.3	23.3	9.4	15.3	22.0	15.0	14.5	26.4	14.5	13.3	17.3	15.9	11.4	13.0	14.4	14.3	14.1	13.1	14.4	7.4	20.6	28.3	21.1	12.1	13.6	17.7	12.7	11.0	13.1	12.1	13.1	11.4	17.0	12.3	7.9	12.5	11.9	9.7	15.4	11.1	12.4	16.1	14.6	5.9	10.8	24.1	12.4	12.5	7.9	20.7	14.9	11.6	14.1	16.0	15.0	14.4	16.0	13.2	16.6	13.7	16.3	16.5	8.7	12.9	17.5	21.2	13.2	10.4	21.7	22.2	29.6	24.5	21.3	21.2	22.1	18.1	24.2	19.5	23.8	28.9	28.1	39.6	47.7	26.6	25.4	28.1	54.9	39.8	19.2	35.3	29.5	18.3	29.2	19.4	33.7	15.9	0.0	21.2	30.4	26.9	27.7	37.1	26.6	27.4	22.3	27.0	23.4	26.4	4.7	30.0	32.1	21.9	31.5	18.7	36.8	23.2	18.4	24.4	25.3	37.1	19.4	32.4	27.7	31.8	50.3	48.3	29.4	20.4	33.1
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor, Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3"	"Cell type enriched"	"Detected in some"	24	"Mucus-secreting cells: 2251.6"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 38.2;OE19: 100.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Not detected"	"Not detected"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	0.2	0.4	0.2	24.3	0.3	0.0	0.2	0.2	0.2	0.2	69.3	0.2	0.2	28.8	0.2	0.2	0.3	0.2	35.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.4	0.2	0.2	0.3	110.5	2.5	0.2	0.2	0.3	0.2	120.9	4.6	0.2	0.3	0.5	0.3	0.2	0.2	0.2	0.2	0.2	3.4	0.2	0.0	0.0	5.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	6.2	0.2	0.0	0.0	38.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.4	0.0	100.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	3.2	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	20.7	0.0	0.0	0.0	0.0	5.2	11.8	0.0	0.0	0.1	0.7	0.0	94.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	84.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2251.6	15.3	0.1	40.3	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.1
BAG1		ENSG00000107262	"BCL2 associated athanogene 1"	Q99933	9	33247820-33264720	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 1003.4;Late spermatids: 2167.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 82.4;NB-4: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002486, HPA018121"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002486: AB_563422, HPA018121: AB_1845255"	"unprognostic (4.49e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.22e-16)"	"unprognostic (4.45e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-2)"	21.5	22.1	30.0	14.6	34.3	25.2	28.6	21.2	25.0	21.4	32.0	18.3	19.5	20.8	15.5	20.4	26.9	17.4	34.8	48.6	25.0	24.3	41.9	34.5	21.2	14.1	33.8	20.1	14.4	43.2	40.9	24.9	16.6	20.0	24.7	27.7	18.2	38.5	26.4	93.2	26.7	27.2	22.2	27.7	21.4	32.5	46.0	20.5	14.9	29.7	41.9	21.2	30.8	27.3	10.2	18.8	29.4	11.6	8.2	9.0	5.1	10.6	10.6	9.0	19.8	13.8	8.1	12.6	8.6	12.3	13.3	13.6	7.4	10.3	35.2	6.5	8.7	4.7	13.4	10.4	7.1	8.8	17.8	9.9	17.5	82.4	11.5	11.7	40.0	21.4	8.2	39.9	6.2	15.0	6.2	15.7	9.1	20.2	17.7	11.0	16.6	27.3	78.8	17.5	13.8	15.5	14.4	12.9	22.6	16.8	31.0	28.9	17.4	38.5	33.9	8.7	3.7	15.4	48.9	8.3	5.9	7.6	17.4	15.0	14.1	21.8	19.1	5.0	21.7	3.3	12.2	11.5	29.4	5.8	11.6	5.2	6.8	6.6	6.9	14.0	10.2	9.0	5.4	7.0	8.2	11.2	18.8	7.8	5.1	30.0	34.3	21.2	25.0	25.0	24.3	33.8	20.1	20.0	20.5	83.4	68.2	64.1	244.9	381.9	70.1	123.1	117.2	45.5	85.3	207.6	55.0	122.0	336.5	113.1	1003.4	65.4	200.5	23.3	167.5	46.5	81.3	398.0	41.5	69.3	91.7	36.5	190.1	49.7	67.4	2167.8	79.4	97.7	155.3	55.1	184.6	65.3	112.7	159.6	83.4	221.7	93.8	97.0	133.9	99.2	59.6	490.8	205.6	67.3	143.0	386.9
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282069	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol		Yes	No			"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	29.7	37.5	48.0	24.3	48.6	18.8	36.2	39.9	49.4	28.3	39.0	28.1	28.4	38.1	28.2	36.3	39.2	31.4	30.6	35.1	45.1	45.2	55.6	39.2	35.6	26.1	44.1	47.5	26.5	19.9	36.4	34.8	55.7	47.4	40.8	40.9	19.8	26.0	30.2	27.1	25.6	51.9	27.5	49.2	33.0	37.3	21.2	37.0	24.9	42.0	26.1	26.0	33.7	33.5	12.4	27.8	51.2	24.6	18.1	16.6	18.1	31.3	23.4	23.8	15.4	36.4	33.2	22.2	31.4	35.5	50.0	55.6	17.7	19.9	16.9	34.7	29.5	34.3	13.6	24.9	25.6	40.6	35.0	17.5	14.2	47.2	19.3	31.7	18.0	28.0	35.3	47.4	33.6	31.4	41.2	26.0	23.9	15.2	22.4	39.4	14.3	18.6	55.7	21.9	24.1	28.8	11.5	21.1	11.2	41.1	17.1	11.7	30.0	31.8	18.8	28.7	29.1	19.2	28.4	25.9	25.1	26.2	21.4	27.7	14.9	29.6	19.5	36.1	12.4	16.0	31.5	20.1	40.2	10.7	21.6	11.5	12.4	14.3	14.0	18.3	10.6	13.2	12.5	51.2	18.1	24.6	27.8	16.6	18.1	48.0	48.6	39.9	49.4	45.1	45.2	44.1	47.5	47.4	37.0	83.4	48.3	59.3	129.0	167.0	61.8	57.1	91.7	144.6	67.1	104.7	25.5	150.8	242.1	116.7	177.9	132.6	173.1	93.5	75.7	146.8	116.0	157.2	58.7	60.2	136.7	25.4	77.0	73.1	86.4	27.4	86.3	96.9	111.3	216.4	117.4	120.4	122.7	207.0	98.3	256.7	46.8	84.1	128.8	87.4	65.0	206.5	216.6	61.2	74.2	224.1
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.3	12.5	11.5	10.9	17.2	19.4	11.6	14.5	14.5	16.5	16.5	11.4	6.3	23.8	9.3	16.7	11.1	8.7	20.5	15.7	15.5	17.4	10.3	12.5	30.6	12.7	21.0	22.2	13.9	18.1	26.3	14.0	35.5	14.8	10.0	13.6	19.0	20.8	17.2	10.8	14.3	20.9	18.7	11.3	14.2	15.4	12.6	13.0	11.1	14.7	16.0	11.2	14.5	15.7	8.3	14.2	9.1	22.2	12.5	13.5	11.3	9.7	15.7	11.2	10.1	23.7	14.8	11.3	7.7	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0	56.6	43.9	35.8	19.9	7.4	27.8	34.3	28.1	53.5	48.9	26.2	51.1	10.2	6.6	13.9	65.8	11.3	19.0	23.3	11.5	10.2	12.0	21.1	17.4	26.0	12.8	20.6	8.7	16.5	16.7	13.3	17.0	11.5	3.3	13.6	22.8	15.1	11.3	17.6	21.5	6.4	32.6	12.9	11.2	12.1	13.1	9.8	15.1	13.1	16.7	16.1
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 81.4;Early spermatids: 99.6;Enterocytes: 64.2;Proximal tubular cells: 60.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Cell line enriched"	"Detected in some"	52	"ASC diff: 79.4"															NA	NA						"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	72.7	1.2	0.6	1.3	0.8	0.0	25.6	2.4	0.9	0.6	3.9	0.6	0.6	3.9	0.6	1.1	1.2	1.2	2.3	21.5	0.6	0.0	5.3	5.9	0.6	0.6	0.6	0.6	1.0	3.0	10.2	0.6	0.9	1.2	1.2	0.8	0.8	2.7	0.6	8.8	0.9	5.7	0.6	1.0	0.6	0.3	5.5	0.6	0.8	1.0	3.0	1.6	1.7	0.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.5	0.0	0.0	79.4	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.6	0.8	2.4	0.9	0.6	0.0	0.6	0.6	1.2	0.6	6.0	8.2	0.0	0.2	1.3	0.0	81.4	15.3	4.0	1.2	33.2	0.0	0.0	5.0	1.1	99.6	0.8	64.2	0.0	0.2	0.3	0.2	0.4	0.0	16.8	0.1	0.0	0.0	1.8	0.0	14.4	2.0	0.1	0.0	0.0	3.8	0.0	0.3	28.1	1.8	60.8	0.0	6.5	2.1	1.1	0.7	2.3	0.0	0.0	2.1	1.4
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.6	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	0.1	28.1	1.3	0.1	0.0	13.4	1.3	0.9	51.2	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.0	0.1	28.8	14.3	13.0	1.5	6.2	12.8	5.0	1.1	19.2	0.1	0.2	21.3	2.3	0.2	47.6	0.4	1.1	7.1	32.9	0.0	1.9	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.1	44.2	3.2	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0	35.7	265.4	2.2	608.6	1708.5	1.4	2.1	104.4	136.5	215.0	1526.7	2.0	0.6	0.0	27.2	1.3	40.5	4.2	93.5	41.7	1.3	46.3	959.6	19.7	111.7	2.2	0.0	7.9	16.0	3.8	0.0	30.8	32.1	150.1	1.0	63.7	0.3	32.0	2.9	1.1	28.8	0.4	0.0	42.2	0.0	1.0	2172.4	42.0	43.3	3.5	2008.6
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.6	22.6	8.6	19.5	13.5	9.3	14.8	17.5	13.1	20.5	17.2	24.9	5.8	27.3	8.0	19.6	9.0	11.0	25.0	25.1	21.7	17.3	10.4	14.0	26.3	13.8	13.3	31.9	20.6	10.3	20.8	27.1	26.2	8.5	13.4	10.1	22.8	10.5	16.2	13.8	17.8	32.1	31.2	17.5	20.6	15.4	8.5	14.2	15.8	18.8	10.2	14.1	14.6	18.9	6.2	9.6	7.6	18.6	14.9	12.6	17.0	15.8	30.4	10.0	14.0	23.1	11.2	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8	3.0	14.6	4.5	5.1	17.7	4.5	5.5	7.6	4.0	11.4	3.5	5.9	3.4	3.3	6.7	17.3	6.0	2.3	0.0	3.4	4.8	4.1	6.5	3.5	6.7	4.4	3.2	9.8	3.7	1.2	17.9	5.5	2.7	5.0	1.8	4.1	4.2	4.9	0.0	5.6	2.1	3.5	0.0	5.1	2.3	6.1	22.6	2.5	5.0	6.8	7.4
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.9;testis: 26.9"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	1.5	0.9	4.3	0.1	0.4	0.2	1.3	12.9	3.9	0.3	0.2	0.2	0.1	0.0	0.5	1.0	2.1	1.0	0.9	0.3	2.1	1.3	0.1	0.4	0.7	0.1	1.0	1.4	0.1	0.1	0.1	1.6	1.3	2.6	2.0	0.3	0.2	0.2	0.1	1.4	5.5	0.2	0.1	1.0	0.9	0.0	26.9	0.1	0.1	0.9	1.6	0.7	1.2	1.1	0.5	0.8	0.1	0.2	0.0	0.8	0.1	7.5	8.5	0.7	0.2	0.3	1.4	0.7	1.6	1.7	2.1	2.3	1.6	0.2	0.2	0.4	0.2	2.3	1.7	4.6	1.6	2.9	0.1	4.6	8.2	9.9	3.1	0.0	2.7	0.6	1.1	4.5	2.9	7.6	0.9	3.9	0.0	4.5	2.1	2.6	1.3	0.2	20.8	7.3	0.3	3.7	0.0	10.5	1.5	1.2	1.8	0.2	7.3	3.5	0.4	0.6	6.8	6.0	10.1	3.9	1.7	7.6	3.5	3.0	1.2	0.8	0.1	0.8	0.1	1.2	0.0	0.1	0.1	0.3	0.1	0.7	0.4	0.2	0.6	0.0	0.5	0.4	0.8	0.1	0.0	0.2	0.8	0.1	0.1	4.3	0.4	12.9	3.9	2.1	1.3	1.0	1.4	2.6	0.1	0.0	0.0	0.0	4.4	1.8	2.6	2.4	2.5	16.0	3.4	1.8	0.0	0.0	0.0	0.6	23.8	0.0	0.3	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.6	0.6	0.1	0.0	0.0	1.6	23.4	0.3	1.4	0.7	0.0	4.3	0.0	0.0	37.6	1.7	2.9	0.0	0.0	1.0	3.5
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell type enhanced"	"Detected in many"	19	"Enterocytes: 998.3;Exocrine glandular cells: 1691.4;Pancreatic endocrine cells: 545.2;Paneth cells: 388.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"	"Group enriched"	"Detected in some"	5	"OE19: 46.2;PC-3: 121.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		490000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	1.9	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	0.0	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.2	121.2	0.0	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0	0.0	0.0	2.2	0.2	50.7	0.2	0.9	48.4	0.0	0.0	1.8	0.0	0.0	3.3	13.8	29.4	1.1	998.3	0.0	1691.4	0.0	0.4	7.0	9.2	1.0	0.0	0.0	184.8	1.3	0.3	56.5	1.4	1.2	6.8	10.0	156.0	0.0	545.2	388.3	0.7	6.7	0.0	0.0	3.1	0.5	0.4	117.2	0.1	0.0	282.9	19.5
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 295.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061000, HPA074334"			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA061000: AB_2684408, HPA074334: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.5	18.1	35.0	15.2	19.3	31.5	10.8	14.7	20.5	17.3	17.3	14.5	12.4	14.1	6.0	20.5	12.6	7.4	18.3	16.8	19.0	23.2	9.7	12.2	20.0	18.4	27.5	14.4	13.3	26.7	25.0	14.1	26.8	27.7	29.0	17.0	11.4	15.2	17.1	9.6	27.1	38.0	19.9	14.2	15.1	25.3	10.6	7.3	18.3	12.5	16.4	19.7	17.2	15.4	11.0	23.2	13.5	17.6	21.7	16.7	15.2	11.5	13.6	9.7	9.1	19.8	15.9	8.4	35.9	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6	20.8	30.7	29.5	39.6	93.8	61.0	106.8	56.0	22.7	25.0	21.0	13.7	52.6	13.3	43.8	295.7	77.1	60.6	23.3	59.7	65.2	54.0	68.4	12.7	72.1	68.5	57.2	69.2	77.3	105.2	195.4	62.2	81.9	33.7	49.5	57.3	87.1	69.4	38.6	71.5	49.6	30.1	58.2	41.9	90.2	66.2	105.3	69.2	30.5	49.0	79.7
UBAP2	"bA176F3.5, FLJ22435, KIAA1491"	ENSG00000137073	"Ubiquitin associated protein 2"	Q5T6F2	9	33921693-34048949	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021684	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA021684: AB_2211887"	"unprognostic (2.71e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.21e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (1.75e-1)"	"unprognostic (9.76e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (8.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.77e-2)"	13.0	23.8	11.8	13.9	12.8	17.0	11.6	15.1	14.5	11.6	11.9	12.8	9.4	10.0	18.6	10.8	16.8	10.7	10.5	11.5	10.4	8.6	12.7	9.5	11.6	11.0	8.4	10.7	15.2	13.5	13.4	18.2	18.3	11.5	12.7	14.4	12.3	17.6	11.7	38.1	18.4	9.7	12.2	10.6	10.4	12.0	27.5	11.5	24.7	15.4	21.0	19.2	11.6	13.6	4.7	6.8	4.7	10.5	7.5	8.2	3.3	18.2	16.9	12.2	15.4	12.1	10.7	14.7	14.7	9.2	15.2	14.8	22.8	9.7	21.3	4.7	12.2	11.7	10.7	20.5	16.1	17.0	15.6	10.0	11.8	21.5	24.9	9.9	26.7	19.1	9.9	13.7	19.3	13.5	8.0	12.2	13.1	16.2	17.6	13.7	12.2	19.8	45.4	13.0	10.3	13.3	15.4	7.6	13.5	14.7	13.8	12.6	8.7	17.4	14.2	4.3	12.8	12.6	12.0	14.3	9.1	12.3	10.7	16.3	6.8	14.2	22.9	10.0	10.3	22.5	2.6	4.3	4.7	3.9	5.2	8.2	4.7	4.8	5.4	5.0	2.5	4.3	5.8	2.6	7.5	10.5	6.8	5.3	3.3	11.8	12.8	15.1	14.5	10.4	8.6	8.4	10.7	11.5	11.5	50.6	20.2	9.0	24.4	25.0	26.2	52.5	10.2	21.4	35.2	12.2	56.9	37.2	3.3	18.9	83.6	26.8	12.7	23.3	17.1	31.0	14.7	20.0	13.9	11.6	14.4	15.9	24.1	12.9	14.3	60.5	28.1	14.3	25.3	17.2	25.5	15.1	23.5	28.1	23.0	14.0	28.1	25.8	15.5	69.4	62.7	27.1	61.0	10.2	24.8	20.2
DCAF12	"CT102, DKFZP434O125, KIAA1892, MGC1058, TCC52, WDR40A"	ENSG00000198876	"DDB1 and CUL4 associated factor 12"	Q5T6F0	9	34086387-34127399	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062279	Uncertain					NA	NA					"HPA062279: AB_2684734"	"unprognostic (9.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (2.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	14.4	32.9	9.7	22.3	9.3	17.3	25.9	9.6	22.9	13.6	16.4	11.5	11.3	10.3	12.8	15.9	28.6	11.6	14.4	13.5	8.7	8.6	11.9	16.0	22.0	22.4	8.6	6.6	15.3	21.0	13.5	11.1	30.6	9.3	11.7	16.3	11.7	15.7	17.9	28.2	13.4	10.8	10.8	11.0	15.5	10.9	49.7	10.1	29.2	13.5	13.1	24.9	13.4	16.3	0.8	15.5	19.3	17.1	9.7	13.7	11.5	15.9	10.7	21.5	9.5	9.4	8.2	12.2	8.9	11.7	16.3	14.1	9.1	7.8	31.6	7.7	10.1	5.7	7.1	23.7	10.4	14.2	14.2	12.7	24.9	22.9	12.7	13.8	30.3	15.6	8.2	20.3	10.5	19.9	12.6	13.0	17.8	24.5	11.1	10.4	6.5	19.2	30.3	11.0	10.5	10.3	18.4	11.7	13.9	17.0	11.8	21.1	18.2	18.0	15.4	7.2	11.9	8.6	48.0	9.2	7.8	9.5	6.6	11.9	7.3	13.4	24.5	7.4	23.3	18.7	19.3	17.1	16.7	8.1	14.7	11.9	0.8	8.1	9.1	15.5	0.3	6.6	7.6	17.2	9.7	12.0	12.6	13.7	11.5	9.7	9.3	9.6	22.9	8.7	8.6	8.6	6.6	9.3	10.1	6.0	21.9	6.7	13.2	34.2	6.0	6.3	7.6	12.0	7.9	5.2	5.9	18.8	21.6	13.8	131.8	16.9	13.4	70.0	15.9	21.0	13.1	21.1	17.3	19.1	26.4	9.5	24.2	14.1	53.3	37.6	18.7	14.7	16.9	1.0	21.8	8.1	16.1	17.5	19.8	17.0	6.7	12.9	10.8	32.4	27.9	33.8	18.8	16.6	19.1	30.1
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	26.4	34.6	25.7	17.5	25.0	81.9	28.6	29.1	29.5	24.2	26.0	26.5	14.5	16.6	25.3	20.0	40.5	20.4	22.9	34.4	24.0	23.6	25.6	38.6	27.7	17.3	27.0	20.0	26.8	20.7	26.7	19.2	26.8	25.5	20.4	19.0	21.5	19.4	24.3	62.3	22.6	24.6	26.4	26.3	21.4	20.9	33.5	26.0	17.2	23.6	22.1	25.4	29.2	29.5	10.5	17.8	45.9	19.6	17.4	26.5	19.2	20.9	11.8	13.6	14.8	25.3	15.7	11.5	16.8	23.7	18.9	25.8	12.8	8.8	14.7	7.6	25.1	16.1	10.8	18.9	26.5	18.3	21.1	8.5	13.1	26.5	13.3	23.1	14.5	17.5	19.4	44.0	22.4	29.5	28.8	20.9	14.5	10.0	14.7	17.6	8.8	13.4	20.4	14.8	14.5	17.7	12.1	9.7	8.5	40.5	14.0	7.8	10.9	18.7	19.5	8.6	12.7	9.5	14.5	14.8	9.7	15.0	14.5	15.6	7.3	9.1	15.5	19.5	11.8	28.5	9.0	19.6	24.1	15.4	17.1	26.5	10.5	15.5	16.1	17.8	8.8	15.1	12.3	45.9	17.4	14.5	9.9	19.1	19.2	25.7	25.0	29.1	29.5	24.0	23.6	27.0	20.0	25.5	26.0	62.5	24.2	13.9	57.1	41.7	12.9	11.4	12.7	25.4	38.7	7.0	23.6	29.1	16.6	29.7	56.8	17.9	20.6	23.3	35.1	29.2	28.2	45.4	24.4	20.8	19.3	6.4	15.4	12.9	17.1	45.7	27.0	22.9	23.6	20.8	15.4	23.6	35.8	23.0	40.0	15.8	11.4	19.4	28.6	21.7	20.6	51.6	74.9	25.4	16.8	59.0
KIF24	"bA571F15.4, C9orf48, FLJ10933, FLJ43884"	ENSG00000186638	"Kinesin family member 24"	Q5T7B8	9	34252381-34311371	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 5.4;testis: 12.1"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 12.0;Early spermatids: 15.7;Late spermatids: 24.8;Spermatocytes: 13.6;Spermatogonia: 7.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	14	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA020643	Uncertain					NA	NA					"HPA020643: AB_2131749"	"unprognostic (2.68e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (9.44e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	0.1	0.5	0.4	0.5	0.8	1.8	0.4	0.1	0.2	0.4	0.6			0.2	0.4	1.3	1.0	3.5	0.1	0.1	0.5	0.5	0.7	0.1	0.6	1.0	0.1		0.5	0.2	1.9	1.0	0.2		0.3	0.8		0.3	0.2	0.1	0.6	0.3	0.4	0.1	0.2	0.4	12.1			1.0		1.4	0.3	0.4	0.1	0.0	5.4	0.1	0.0	0.3	0.0	10.1	6.8	8.1	6.7	0.7	1.1	3.1	5.7	3.7	7.6	9.2	3.3	3.2	7.9	1.7	2.6	5.0	4.8	8.1	4.8	8.0	5.1	3.6	3.7	11.2	2.0	0.2	7.4	5.8	0.5	1.0	9.9	4.2	1.5	3.4	5.6	3.7	6.5	4.2	4.1	8.9	7.0	3.2	4.7	4.1	8.4	5.0	2.2	3.2	2.7	3.8	3.7	6.9	3.6	1.0	3.3	3.9	3.7	2.7	7.2	7.9	5.5	6.8	1.8	3.0	4.4	4.9	3.7	9.2	5.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0											0.0	0.6	0.5	0.1	0.3	0.1	0.8	2.5	12.0	2.3	1.8	0.0	0.2	0.0	0.2	15.7	0.0	0.3	0.0	0.2	1.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	24.8	0.9	0.0	0.0	0.0	0.6	0.2	0.2	0.0	1.8	0.3	0.4	0.0	0.0	13.6	7.5	0.6	0.2	0.0	0.3	0.1
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343713	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	12.0	18.0	21.6	9.6	21.9	10.2	20.6	14.0	25.5	14.9	14.9	26.0	15.4	12.8	15.7	30.2	14.5	20.5	12.3	16.0	17.3	18.6	10.7	17.5	11.2	12.2	19.5	19.0	28.3	20.9	12.0	19.0	14.1	20.5	16.5	15.3	15.7	16.1	13.0	30.8	13.9	10.1	14.7	20.7	11.3	13.0	8.6	19.1	18.6	3.8	13.2	13.8	14.4	12.1	16.6	15.8	14.3	12.2	14.3	22.2	11.2	23.8	9.8	12.8	4.5	8.8	16.3	9.2	11.5	26.1	13.3	14.0	6.7	11.3	6.6	9.6	14.3	5.1	10.5	11.5	28.4	13.6	24.8	10.3	14.3	18.5	12.6	25.6	11.0	5.9	16.5	18.4	17.2	32.4	18.2	27.5	23.2	4.0	27.1	19.5	14.8	11.4	10.3	7.9	10.6	28.3	14.8	8.0	16.7	13.1	7.8	2.6	10.4	18.7	7.1	10.8	12.0	5.7	11.9	17.7	11.5	10.4	7.5	11.9	6.1	9.9	11.7	14.4	10.6	14.3	14.3	12.2	9.7	11.7	10.3	16.7	16.6	19.2	15.2	15.8	15.0	22.2	19.6	4.5	14.3	10.7	14.7	19.7	11.2	21.6	21.9	14.0	25.5	17.3	18.6	19.5	19.0	20.5	19.1	3.0	5.5	15.9	17.8	25.0	13.1	18.6	43.3	17.4	11.4	15.7	5.9	33.9	74.6	22.6	9.7	21.5	18.6	0.0	34.7	35.6	23.1	17.1	12.7	31.0	32.5	7.9	21.4	30.1	38.4	21.8	25.3	23.9	21.9	32.5	29.1	16.2	26.1	26.9	18.0	39.6	12.8	25.8	23.6	35.8	17.5	27.6	15.8	25.3	31.4	15.7
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366670-34376853	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.1"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 41.5;Exocrine glandular cells: 10.3;Syncytiotrophoblasts: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 17.6;SK-BR-3: 29.4;T-47d: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	6.3	5.6	16.7	4.7	20.5	2.1	3.5	6.9	16.0	2.0	19.9	9.8	1.3	20.9	2.2	2.8	4.8	3.6	11.6	2.9	11.1	8.7	11.7	31.8	3.1	1.7	11.2	12.6	1.6	16.6	2.0	4.0	15.4	10.7	3.2	13.1	0.5	4.7	4.9	56.1	3.6	26.7	4.8	7.0	1.7	9.9	1.7	6.9	0.0	2.2	6.4	2.1	3.5	1.9	1.1	0.8	1.9	0.8	1.9	3.3	0.6	4.1	2.9	4.9	2.9	2.0	0.7	10.4	0.8	0.6	0.4	0.7	7.1	4.3	2.3	8.4	0.7	2.1	8.4	3.4	7.8	0.6	0.7	1.9	0.4	13.0	17.6	0.3	0.4	1.4	1.0	3.8	1.3	1.6	2.3	1.9	1.7	0.5	2.4	1.1	6.8	1.3	0.7	2.9	13.7	2.3	2.1	2.5	0.7	2.6	1.5	0.7	6.8	5.8	29.4	0.5	4.3	27.3	0.7	1.7	1.1	6.0	0.9	1.8	1.5	3.2	0.9	0.9	1.6	0.9	1.9	0.6	1.2	3.3	0.6	2.6	0.8	2.0	1.9	0.3	1.1	1.3	1.6	1.6	1.9	0.8	0.8	2.6	0.6	16.7	20.5	6.9	16.0	11.1	8.7	11.2	12.6	10.7	6.9	8.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	3.5	0.0	41.5	1.7	5.6	0.0	0.0	0.0	0.0	10.3	1.9	0.0	0.0	1.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	9.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397832	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 47.6;fallopian tube: 76.2;testis: 23.7"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.5	1.2	12.7	1.0	20.0	0.8	1.0	1.5	10.8	3.3	1.6	12.2	0.0	2.1	1.3	7.2	1.1	76.2	1.0	4.8	11.2	11.0	1.9	1.0	10.3	0.9	5.3	6.4	6.2	1.5	0.8	3.1	0.9	47.6	1.5	1.3	0.0	2.0	1.1	1.6	1.2	4.3	1.2	2.0	0.9	1.4	23.7	3.0	0.0	1.2	0.1	1.0	0.9	0.0	0.6	0.4	0.1	0.1	0.9	3.6	0.5	0.8	0.0	1.6	0.6	0.3	0.0	1.3	0.6	0.6	0.3	1.4	1.4	0.0	0.3	0.6	0.0	0.7	1.2	0.5	0.2	0.0	2.3	1.3	0.0	1.6	4.1	0.0	0.1	2.0	0.3	0.2	0.4	0.0	0.5	0.6	1.0	0.0	0.6	0.2	0.0	1.3	0.9	0.6	1.2	0.9	0.6	0.1	0.1	0.5	0.1	1.6	0.6	0.0	0.4	0.1	0.1	1.1	0.0	0.0	1.3	1.0	0.5	0.9	2.5	1.4	0.4	1.4	0.2	2.5	0.0	0.0	0.0	1.1	0.1	0.0	0.6	1.3	0.4	0.4	0.0	3.6	1.1	0.1	0.9	0.0	0.0	1.7	0.5	12.7	20.0	1.5	10.8	11.2	11.0	5.3	6.4	47.6	3.0	6.0	13.7	0.0	2.6	1.9	1.0	34.3	2.5	1197.9	128.5	7.0	0.0	0.5	61.3	0.5	656.4	1.0	15.5	0.0	1.3	0.2	0.5	2.8	8.1	2.9	0.4	0.0	11.6	1.8	0.3	2140.7	9.8	2.5	0.0	0.0	9.8	1.2	0.3	6.2	6.7	5.7	0.8	32.3	0.3	10.8	3.8	0.9	0.5	0.0	16.4	1.7
FAM219A	"bA573M23.5, C9orf25, FLJ39031"	ENSG00000164970	"Family with sequence similarity 219 member A"	Q8IW50	9	34398184-34458570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.9"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019338, HPA052909"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA019338: AB_1845819, HPA052909: AB_2681986"	"unprognostic (9.96e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (2.46e-4)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.76e-1)"	13.6	10.3	27.8	10.9	27.0	4.9	7.1	26.3	56.9	7.5	6.3	23.3	3.7	7.2	13.2	8.6	6.3	6.5	7.6	17.5	25.4	27.6	6.1	5.0	11.0	7.8	30.8	31.0	10.7	8.4	9.4	10.6	16.3	34.0	9.2	6.6	5.4	7.1	9.7	28.6	12.3	6.7	15.0	25.2	9.8	7.2	6.9	25.6	2.9	7.2	4.0	6.6	6.5	6.4	0.5	0.6	3.8	0.7	0.7	1.5	0.3	12.6	4.9	11.6	6.6	10.8	4.1	11.3	7.7	5.8	6.7	8.5	3.4	2.9	2.8	8.0	7.4	13.3	5.3	9.2	4.9	6.7	43.6	5.2	1.1	6.3	3.6	6.1	2.7	6.5	4.3	5.0	10.0	5.6	8.3	11.0	5.0	2.7	14.0	5.2	2.5	4.2	3.8	7.5	1.7	7.3	5.5	1.9	2.4	4.8	2.7	3.7	11.8	6.6	4.8	3.8	11.1	2.4	2.8	13.0	7.4	5.8	15.3	10.6	3.7	5.3	2.4	21.2	6.4	13.0	2.3	0.6	3.8	1.5	0.4	0.8	0.5	0.8	0.4	0.5	0.4	0.6	0.8	2.0	0.7	0.7	0.6	1.4	0.3	27.8	27.0	26.3	40.8	25.4	27.6	30.8	31.0	34.0	25.6	6.0	3.5	2.2	2.9	5.6	18.4	10.5	0.0	1.4	1.2	3.5	3.9	8.2	0.0	5.2	12.0	14.3	0.9	0.0	4.2	12.1	5.6	5.6	2.3	2.4	5.2	50.9	10.4	5.5	4.6	25.8	3.4	2.3	8.5	3.6	1.6	8.5	5.6	1.4	5.3	2.1	10.5	6.5	8.2	10.3	2.4	5.6	17.3	4.4	0.8	2.6
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520989	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;fallopian tube: 32.2;pituitary gland: 36.4;testis: 47.0"	"Cell type enhanced"	"Detected in some"	25	"Ciliated cells: 109.7;Late spermatids: 23.8;Spermatocytes: 48.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 5.8;HDLM-2: 4.1;RPTEC TERT1: 2.2;SK-BR-3: 3.0;T-47d: 1.9"	"Low region specificity"	"Detected in many"							"HPA021649, HPA021843"	Enhanced					NA	NA					"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.4	0.4	2.3	0.4	8.0	0.4	0.9	0.3	3.1	2.2	0.4	3.6	0.0	0.4	1.3	6.8	0.4	32.2	0.5	0.4	2.7	3.3	0.9	0.5	4.3	0.4	1.0	0.2	3.5	1.2	1.9	36.4	0.4	14.6	0.5	0.4	1.3	0.4	0.5	0.4	0.4	0.4	0.4	0.6	0.4	0.6	47.0	1.5	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	1.8	0.7	0.2	0.0	5.8	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.4	0.3	0.0	3.0	0.8	1.2	1.9	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	8.0	0.3	3.1	2.7	3.3	1.0	0.2	14.6	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	109.7	13.6	0.0	3.9	0.1	1.7	0.0	16.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.0	48.1	2.7	0.0	0.2	0.0	0.0	0.0
ENHO	"C9orf165, UNQ470"	ENSG00000168913	"Energy homeostasis associated"	Q6UWT2	9	34521040-34523041	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 79.6"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 53.5"	"Cancer enhanced"	"Detected in many"		"glioma: 44.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"myeloid DC: 19.4"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 19.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042575	Approved				"Secreted to blood"	NA	NA	4240000				"HPA042575: AB_10794914"	"unprognostic (2.63e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.76e-2)"	1.5	1.9	58.0	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0.0	3.0	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12.0	2.0	1.4	52.0	27.1	1.5	2.6	1.2	1.0	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0.0	1.4	0.0	1.4	1.5	0.0	0.0	19.4	0.0	2.5	2.7	0.0	0.4	0.1	1.0	5.3	13.4	0.1	0.0	0.3	0.0	0.0	2.1	2.2	0.5	0.2	2.2	3.7	0.0	4.3	0.2	6.1	0.4	0.4	0.3	5.9	0.0	0.1	1.2	0.2	0.0	3.0	0.0	0.1	0.0	0.2	0.0	0.0	4.3	0.0	1.9	0.5	0.3	0.0	0.0	18.5	1.0	3.7	0.1	0.0	0.3	0.5	0.0	9.4	8.9	0.7	4.1	0.4	0.7	0.3	1.7	0.0	0.4	2.1	0.1	0.1	1.1	1.3	0.1	0.5	0.0	3.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	2.7	0.7	1.0	0.0	0.4	58.0	59.3	15.5	37.0	36.3	37.5	52.0	27.1	13.7	13.4	0.0	0.3	0.0	2.5	2.5	4.3	0.4	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.2	1.0	10.2	0.0	2.6	2.6	4.8	1.7	1.3	0.3	2.7	0.3	3.2	1.7	1.0	0.0	53.5	0.0	0.0	0.4	0.3	2.8	0.0	0.1	0.5	5.9	2.8	0.0	0.0	0.0	0.5
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 44.7;skeletal muscle: 33.6"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 23.9;Muller glia cells: 80.1;Paneth cells: 23.0"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 47.9;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved					NA	NA		36000000			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	44.7	9.4	17.0	2.2	27.9	0.7	17.3	30.6	28.7	11.1	5.8	8.2	1.1	3.4	2.6	2.9	3.9	5.6	5.7	10.1	18.6	11.7	1.9	6.5	2.2	1.5	15.5	9.8	4.5	2.4	0.8	2.5	4.8	12.0	5.3	2.5	7.5	9.0	7.6	33.6	4.4	6.0	1.8	6.3	16.1	3.0	4.9	10.9	0.2	3.2	3.8	1.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	23.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	27.9	30.6	22.0	18.6	11.7	15.5	9.8	12.0	10.9	0.0	0.0	0.0	1.1	3.2	8.3	0.7	2.5	0.0	0.0	0.0	5.9	0.5	1.7	0.0	3.9	0.2	6.5	0.0	0.0	0.4	23.9	0.2	0.0	0.9	1.2	3.2	0.0	4.3	0.0	1.7	9.2	0.0	3.3	0.0	0.3	80.1	0.0	23.0	2.1	0.0	2.8	0.0	2.3	1.6	15.8	2.0	1.9	0.0	0.2	0.3
RPP25L	"bA296L22.5, C9orf23, MGC29635"	ENSG00000164967	"Ribonuclease P/MRP subunit p25 like"	Q8N5L8	9	34610486-34612104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052187, HPA059698"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052187: AB_2681755, HPA059698: AB_2684106"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (3.01e-9)"	"unprognostic (4.63e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (8.21e-4)"	7.4	10.1	11.1	7.9	13.8	4.9	9.3	8.6	14.0	8.2	18.0	7.2	14.0	15.4	9.9	11.4	13.3	11.8	10.9	19.9	9.8	8.8	11.1	19.9	9.3	10.1	10.1	9.1	11.7	20.4	6.3	7.6	11.0	7.5	14.4	8.2	6.4	15.7	9.5	56.0	9.7	18.4	9.3	7.1	11.4	8.6	10.9	6.1	14.4	14.8	21.9	11.3	11.0	10.4	40.7	30.1	41.5	35.4	32.5	41.7	24.8	18.8	24.6	10.0	9.8	10.3	9.5	10.0	8.1	8.5	13.5	15.5	10.8	12.8	14.6	12.7	4.9	6.3	12.7	15.1	20.4	4.8	29.5	20.3	8.7	18.3	15.8	22.0	8.9	13.3	16.9	19.7	11.2	26.2	11.7	14.1	20.4	13.9	15.7	10.3	20.2	18.6	33.7	9.2	19.3	22.4	16.5	10.6	14.6	14.5	9.9	6.7	3.9	14.9	16.8	9.5	5.2	15.3	15.8	6.4	4.2	12.4	10.2	6.7	7.6	13.3	16.6	12.9	18.7	20.3	41.5	35.4	33.3	25.6	28.8	31.6	34.9	30.2	26.9	30.1	40.7	35.5	33.5	32.9	32.5	33.6	24.5	41.7	24.8	11.1	13.8	8.6	14.0	9.8	8.8	10.1	9.1	7.5	6.1	0.0	13.7	24.8	44.7	9.8	7.9	31.3	28.1	13.4	13.6	19.2	2.0	52.4	84.6	22.9	2.2	12.0	59.6	46.7	17.3	31.1	14.9	29.7	10.3	68.6	28.4	0.0	32.3	26.4	34.1	4.5	20.8	12.1	11.8	25.2	40.0	19.0	18.3	51.8	14.5	51.9	9.3	6.5	17.4	49.2	25.4	12.9	35.0	22.7	46.6	41.5
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favorable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.2	28.8	26.8	28.0	23.8	33.3	11.0	29.3	27.4	40.9	32.2	18.4	12.9	15.8	18.4	38.5	14.3	13.7	24.3	30.7	26.2	49.5	30.5	10.5	51.0	15.8	25.8	27.6	32.1	29.3	26.6	28.2	18.5	20.0	26.9	29.8	12.5	32.8	35.6	28.2	34.7	74.5	8.1	14.4	46.5	17.5	14.5	21.7	19.7	12.2	8.9	22.9	21.7	20.0	11.2	8.2	26.8	31.7	24.4	25.8	20.9	29.2	28.4	22.2	28.7	10.5	40.5	16.1	52.4	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0	29.8	31.8	49.9	82.5	90.2	76.0	72.8	63.7	57.6	43.3	76.8	23.6	100.4	175.8	103.7	8.3	78.7	68.5	210.2	135.3	93.0	101.4	62.7	86.5	74.9	115.9	69.9	71.7	73.1	79.5	15.7	95.8	80.9	141.7	86.6	53.8	145.8	101.0	66.0	115.2	170.3	63.4	58.2	101.0	73.5	71.3	124.6	83.4	96.6	55.1	72.9
ARID3C		ENSG00000205143	"AT-rich interaction domain 3C"	A6NKF2	9	34621379-34628107	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	12	"liver: 16.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;ovarian cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.6;Karpas-707: 6.1;T-47d: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.05e-3)"	"unprognostic (4.42e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.28e-14)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.91e-2)"	"unprognostic (4.26e-3)"	0.0	0.0	0.2	0.0	0.5	0.0	0.2	1.4	0.8	0.0	0.0			0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	16.8	0.0	0.0	0.2		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.1	0.4	2.2	0.3	0.8	0.0	0.6	0.1	0.2	0.6	0.1	0.3	0.1	0.2	0.7	0.2	0.0	0.4	0.0	0.1	4.6	0.6	0.1	0.6	0.0	1.5	0.1	0.2	0.3	1.1	0.1	0.1	0.6	0.1	1.0	0.0	6.1	0.1	0.0	0.1	2.0	0.0	0.3	0.2	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.2	1.5	0.5	0.0	6.1	0.3	0.0	0.1	0.3	1.3	0.0	1.1	0.9	0.0	0.5	1.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637809	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Receptor	"Amyotrophic lateral sclerosis, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 82.3;Hepatocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Enhanced					NA	NA					"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.42e-4)"	15.3	19.7	9.2	9.8	14.5	8.5	13.0	9.4	16.1	17.0	18.2	13.4	13.3	23.0	18.6	13.4	18.6	17.4	17.1	12.1	9.4	12.0	14.2	89.1	9.6	14.5	10.7	10.7	20.1	22.9	15.0	8.3	17.8	14.0	18.9	13.2	15.7	12.0	19.6	7.7	16.8	24.9	15.1	9.2	9.8	14.6	9.4	9.3	9.6	11.8	15.0	15.8	16.4	15.2	14.0	23.8	12.4	19.3	13.1	32.6	20.1	41.1	36.5	12.7	41.4	47.0	32.6	16.4	30.0	20.3	26.5	24.5	22.9	18.0	20.2	17.8	32.5	16.8	25.8	16.2	34.0	5.8	35.1	43.7	19.3	54.4	25.0	30.9	33.1	16.8	32.9	36.4	29.1	36.2	14.0	20.0	26.7	7.2	37.4	28.3	0.2	20.1	48.0	15.9	21.8	47.5	23.5	14.2	56.8	24.1	8.2	14.9	16.8	29.8	21.3	15.7	5.2	25.2	22.6	16.8	22.0	17.6	23.2	4.4	10.4	16.4	0.5	22.8	28.8	45.5	10.5	19.1	12.4	22.2	18.4	24.2	14.0	32.6	26.7	23.8	10.8	27.8	22.6	5.4	13.1	19.3	17.5	29.9	20.1	9.2	14.5	9.4	16.1	9.4	12.0	10.7	10.7	14.0	9.3	3.0	9.9	15.9	14.7	16.4	7.7	7.3	15.3	8.1	6.8	7.0	0.0	35.2	0.0	30.9	0.6	12.4	34.1	23.3	29.3	82.3	26.6	19.8	6.9	84.9	34.7	4.8	9.9	14.7	11.0	1.1	25.3	7.9	18.6	11.8	22.5	12.7	25.2	28.5	24.1	11.0	6.2	19.4	20.6	5.7	10.0	18.7	30.6	11.7	37.5	11.6
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		NA	NA		120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favorable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	5.0	6.7	6.1	2.5	8.4	8.5	7.1	3.7	10.7	3.9	4.5	8.3	4.7	5.6	3.9	4.5	1.5	2.7	1.1	10.4	0.7	8.4	4.5	2.3	13.4	8.4	8.2	1.3	3.0	12.3	6.6	2.5	3.1	8.3	9.5	7.4	1.9	6.2	6.3	4.4	4.8	9.5	2.1	5.8	1.2	7.4	5.6	3.0	10.8	7.0	1.4	5.4	4.7	9.4	5.1	4.6	8.4	7.3	1.4	1.8	3.3	3.3	0.0	3.5	2.0	1.2	4.1	4.0	9.9	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1	6.0	23.4	12.3	13.7	19.3	40.6	20.7	15.3	6.7	10.3	15.7	45.2	59.8	24.9	16.7	6.9	12.0	18.0	0.0	6.5	29.6	13.1	4.5	19.7	52.9	21.0	44.5	15.6	20.3	11.9	31.3	17.0	13.3	20.3	14.4	15.1	18.9	8.5	21.8	13.1	29.4	37.0	6.5	10.1	4.2	4.7	17.7	49.4	23.3	19.8	7.8
AL162231.3		ENSG00000258728			9	34646645-34657113	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"liver: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;BEWO: 1.1;HeLa: 1.4;HHSteC: 2.1;NB-4: 2.2;THP-1: 1.6;U-2 OS: 1.0"															NA	NA																							3.2	1.9	2.4	5.0	4.4	3.1	2.6	3.0	2.5	2.8	7.5	1.4	4.4	1.5	4.6	2.6	2.5	4.8	3.6	3.7	1.9	1.9	4.1	17.6	2.7	2.3	1.7	1.5	3.5	1.7	1.5	3.5	8.5	2.2	2.1	1.5	3.8	6.1	4.8	2.5	3.5	10.5	3.0	1.6	3.1	2.4	1.9	2.0	3.9	2.6	2.1	3.6	3.2	2.8	1.5	1.0	0.0	0.7	0.0	0.9	1.2	1.0	0.0	0.0	0.7	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.4	0.3	1.5	0.0	0.4	1.0	1.0	0.5	0.9	0.0	0.0	0.0	0.2	0.0	1.2	2.4	4.4	3.0	2.1	1.9	1.9	1.7	1.5	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL11RA		ENSG00000137070	"Interleukin 11 receptor subunit alpha"	Q14626	9	34650702-34661892	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Craniosynostosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 55.3;Late spermatids: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 21.7;HSkMC: 23.5"					"Low region specificity"	"Detected in all"			"HPA013162, CAB032830, HPA036652"	Supported					NA	NA					"CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229"	"unprognostic (7.76e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.71e-2)"	9.6	4.4	6.8	8.5	10.1	5.2	9.4	13.0	8.7	24.4	15.6	23.2	3.4	9.8	14.2	9.2	8.8	12.6	17.7	38.2	7.1	5.9	6.1	14.1	8.6	13.4	9.7	12.7	11.5	3.7	18.6	6.3	8.2	9.8	12.4	5.1	30.9	11.9	7.8	12.6	28.5	9.9	23.6	6.6	9.9	7.9	9.2	11.9	3.4	14.5	18.1	9.5	13.6	10.7	2.5	2.7	3.4	2.7	1.9	6.0	3.3	1.4	3.3	7.2	7.2	10.2	18.3	3.3	8.1	11.2	5.3	7.5	1.1	2.7	1.4	2.2	21.7	2.0	2.9	2.0	2.9	2.4	13.3	5.4	4.5	11.6	0.6	5.1	1.5	2.5	23.5	3.6	2.9	1.0	7.1	3.3	9.5	1.8	3.3	6.7	0.9	2.0	10.6	1.5	1.3	2.0	3.1	1.6	1.5	1.7	1.3	2.1	7.3	1.0	2.2	3.0	4.0	5.7	5.9	3.1	2.5	5.7	1.9	0.0	2.2	1.4	0.6	6.6	1.7	11.9	3.4	2.2	0.0	3.2	2.7	4.4	1.9	6.0	4.7	2.7	2.5	5.9	3.8	0.6	1.9	0.6	1.1	3.2	3.3	6.8	10.1	13.0	8.7	7.1	5.9	9.7	12.7	9.8	11.9	3.0	14.7	0.0	6.7	15.5	18.5	32.2	2.5	1.4	4.5	3.5	13.7	9.5	0.0	1.9	16.6	11.1	4.2	0.0	0.6	3.1	55.3	3.0	0.0	24.5	4.0	22.3	8.7	11.6	2.8	74.5	10.3	5.5	30.4	0.0	3.1	15.3	0.2	3.5	5.3	2.4	9.1	0.0	4.6	4.1	17.8	12.3	10.4	4.9	4.8	0.9
CCL27	"ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine"	ENSG00000213927	"C-C motif chemokine ligand 27"	Q9Y4X3	9	34661880-34664048	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 96.5"	"Group enriched"	"Detected in some"	25	"Basal keratinocytes: 625.7;Suprabasal keratinocytes: 877.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HAP1: 3.5;SuSa: 3.5"					"Not detected"	"Not detected"			HPA073848	Enhanced				"Secreted to blood"	NA	NA	436000				"HPA073848: AB_2732243"																		0.1	0.0	0.1	0.1	0.1	0.1	5.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	96.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	8.0	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	5.5	1.8	1.6	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.3	0.1	0.0	0.2	2.1	3.5	0.0	2.4	2.1	0.0	0.0	1.8	0.8	0.7	0.0	0.0	3.0	1.9	0.6	0.0	0.6	0.0	1.3	0.5	2.3	1.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	2.8	0.0	0.4	1.6	0.0	0.0	0.2	3.5	1.5	0.0	0.0	2.5	2.0	2.0	0.0	0.3	1.0	0.1	0.9	0.4	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	625.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	6.4	0.0	0.0	0.0	0.2	0.7	1.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	0.3	0.0	30.4	0.0	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.5	3.9	1.1	877.6	1.6	0.0	0.0	0.1
AL162231.1		ENSG00000187186			9	34664163-34666112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 68.6"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 34.9;Distal tubular cells: 21.6;Proximal tubular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"					"Low region specificity"	"Detected in all"			HPA069617	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Nucleoli, Endoplasmic reticulum"	"HPA069617: AB_2686161"	"unprognostic (8.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.63e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.00e-2)"	3.0	6.9	12.1	2.1	21.6	1.8	2.9	6.9	20.2	2.3	1.8	1.9	1.1	2.8	4.0	13.9	1.8	1.8	2.2	9.1	11.8	9.5	4.9	2.5	2.2	1.4	9.6	12.2	7.8	6.2	3.4	13.1	2.3	7.0	3.7	1.2	1.8	4.6	2.1	21.9	2.2	2.0	3.8	5.0	1.0	1.4	68.6	5.3	0.6	3.5	2.0	0.7	1.5	2.5	4.0	11.8	12.0	2.5	3.5	2.9	1.6	0.3	6.0	5.6	7.2	4.6	2.3	5.0	4.8	1.4	3.0	3.5	1.0	2.4	0.0	0.6	3.2	6.0	1.4	3.6	1.7	0.5	12.9	0.6	0.0	28.3	1.7	1.1	2.6	4.5	2.4	2.0	1.8	1.9	4.2	0.8	7.4	3.2	7.4	2.2	0.0	0.5	2.6	4.6	5.3	1.6	0.0	5.3	0.9	5.4	0.0	5.8	9.3	3.4	1.1	8.0	3.3	2.8	7.4	1.1	10.7	14.8	3.4	1.1	7.9	2.6	1.0	13.2	1.5	14.6	12.0	2.5	2.6	1.8	1.3	1.7	4.0	2.3	1.0	0.8	1.6	2.9	1.5	3.5	3.5	0.8	11.8	2.0	1.6	12.1	21.6	6.9	20.2	11.8	9.5	9.6	12.2	7.0	5.3	8.9	9.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.5	34.9	0.0	11.6	21.6	12.0	0.0	0.0	0.0	0.0	9.4	10.4	0.0	0.0	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	9.0	0.0	0.0	10.8	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
CCL19	"CKb11, ELC, exodus-3, MIP-3b, SCYA19"	ENSG00000172724	"C-C motif chemokine ligand 19"	Q99731	9	34689567-34691277	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 418.9"	"Cell type enhanced"	"Detected in some"	22	"Basal keratinocytes: 66.3;Melanocytes: 87.7;monocytes: 186.7;Smooth muscle cells: 46.2;Suprabasal keratinocytes: 47.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 118.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"intermediate monocyte: 2.3"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;Daudi: 2.6;HDLM-2: 7.6;HL-60: 1.9;K-562: 1.6;TIME: 3.8"					"Low region specificity"	"Detected in some"			HPA067758	Enhanced				"Secreted to blood"	NA	NA	195000				"HPA067758: AB_2685897"	"prognostic favorable (2.88e-5)"	"prognostic favorable (9.91e-6)"	"unprognostic (8.25e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (7.98e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	22.5	0.6	1.2	82.3	1.1	0.0	10.2	0.8	1.3	5.8	4.7	1.5	1.5	1.0	1.5	5.9	16.3	3.4	10.4	16.5	0.8	0.7	11.8	12.8	13.6	418.9	2.1	1.0	3.4	1.7	0.0	2.0	0.6	1.5	7.0	11.0	7.4	23.1	1.0	0.7	8.7	40.2	4.5	2.2	8.2	9.0	2.8	0.6	73.1	14.9	9.9	90.9	13.4	2.3	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.6	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	1.1	0.8	1.3	0.8	0.7	2.1	1.0	1.5	0.6	0.0	0.0	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	87.7	186.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	46.2	0.2	0.2	47.2	0.0	0.0	0.0	0.1
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710124	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 430.9"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 129.0;Melanocytes: 136.7;Smooth muscle cells: 67.0;Suprabasal keratinocytes: 120.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.7;HL-60: 2.3;K-562: 3.9;RH-30: 2.5;U-937: 1.9"					"Low region specificity"	"Detected in many"			HPA051210	Enhanced				"Secreted to blood"	NA	NA	198000	770000			"HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	24.4	6.5	0.3	83.5	0.4	0.0	18.0	0.3	0.4	13.6	25.5	0.4	5.9	3.7	26.8	23.7	80.1	23.0	23.2	18.8	0.3	0.0	19.6	11.0	30.5	430.9	0.3	0.3	13.8	3.3	0.0	0.4	7.4	0.5	9.4	11.9	0.7	96.9	4.1	4.7	7.6	71.2	10.6	0.3	35.9	10.7	5.5	0.3	2.3	91.0	44.8	181.2	15.7	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	1.0	2.5	0.6	0.0	0.0	0.3	0.5	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.5	0.0	0.8	0.0	0.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3	20.8	38.2	0.0	0.0	129.0	0.0	7.7	0.0	18.7	23.9	1.8	0.0	0.1	0.0	8.4	4.2	47.5	0.0	0.0	3.3	0.2	3.5	0.0	10.5	0.0	0.5	0.0	0.0	49.7	0.8	2.7	0.6	7.4	136.7	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	67.0	0.0	0.2	120.3	0.2	0.0	0.0	0.1
FAM205A	C9orf144B	ENSG00000205108	"Family with sequence similarity 205 member A"	Q6ZU69	9	34723055-34729467	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	243	"testis: 24.3"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 99.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;THP-1: 2.3"									HPA071267	Enhanced		Uncertain	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli fibrillar center"	"HPA071267: AB_2686376"	"unprognostic (2.25e-1)"					"unprognostic (3.66e-3)"		"unprognostic (6.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.73e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.61e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.78e-1)"		"unprognostic (7.34e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
FAM205C	FAM205CP	ENSG00000187791	"Family with sequence similarity 205 member C"	A6NFA0	9	34889064-34895778	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 23.2"	"Group enriched"	"Detected in some"	80	"Early spermatids: 294.6;Late spermatids: 336.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	97	"THP-1: 18.1"															NA	NA						"unprognostic (1.29e-1)"				"unprognostic (1.90e-1)"	"unprognostic (3.64e-2)"		"unprognostic (8.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.73e-2)"		"unprognostic (1.85e-4)"	"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	294.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	336.5	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.6	0.5	0.0	0.0	2.6	1.0	0.0	0.0	0.0	0.0	0.0
PHF24	KIAA1045	ENSG00000122733	"PHD finger protein 24"	Q9UPV7	9	34957608-34982544	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 43.0;testis: 15.9"	"Cell type enhanced"	"Detected in some"	15	"Cone photoreceptor cells: 7.9;Late spermatids: 4.9;Muller glia cells: 12.9;Spermatocytes: 3.9;Spermatogonia: 3.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	45	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 5.4"	"Group enriched"	"Detected in some"	6	"NTERA-2: 3.8;WM-115: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020974	Approved					NA	NA					"HPA020974: AB_1852364"	"unprognostic (5.54e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.30e-1)"	1.2	1.0	14.9	1.2	13.3	0.7	1.1	6.1	43.0	1.1	0.9	1.5	0.0	0.9	1.1	1.0	1.1	1.3	1.0	0.8	12.3	7.5	0.8	0.8	0.9	1.7	6.5	15.6	0.8	0.7	1.0	0.0	0.7	9.0	0.8	1.0	0.6	0.8	0.8	0.8	1.8	0.9	1.2	1.9	0.9	0.8	15.9	0.0	0.0	0.8	0.0	1.6	0.9	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	14.9	13.3	6.1	26.8	12.3	7.5	6.5	15.6	9.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	1.1	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.1	1.8	0.0	0.0	3.9	3.9	0.0	0.0	0.0	0.0	0.0
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 99.4"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 37.5;Smooth muscle cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"myeloid DC: 7.7;neutrophil: 7.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	7.2	6.3	5.9	5.1	7.2	0.9	2.6	8.6	13.0	6.5	19.1	6.2	9.2	3.8	18.5	9.7	15.7	9.6	8.7	29.3	6.6	6.3	3.7	2.0	3.7	2.2	4.7	3.4	6.5	3.1	2.2	8.6	1.4	6.0	13.8	6.2	5.7	3.7	26.2	99.4	1.5	6.1	29.9	4.5	5.6	11.3	8.1	3.5	1.6	4.4	38.0	2.9	23.0	3.6	0.7	7.7	7.6	1.5	0.5	1.3	0.7	2.5	2.1	13.4	7.1	7.9	6.1	1.5	11.2	8.2	17.3	15.4	1.5	0.6	2.4	2.8	12.3	18.2	0.3	5.1	8.8	14.7	3.5	1.6	0.9	3.1	0.7	9.1	0.3	8.1	8.9	0.6	10.2	5.1	7.7	11.0	4.6	0.2	5.2	13.9	1.8	4.2	3.6	6.3	1.1	4.5	3.2	13.9	1.3	2.4	0.2	5.7	9.3	6.0	0.3	1.3	12.1	2.2	0.8	4.9	8.3	18.2	4.3	3.4	1.9	1.3	1.7	9.5	1.0	8.9	0.1	1.5	0.0	0.4	0.4	1.3	0.7	0.3	0.1	7.7	0.3	0.5	1.1	7.6	0.5	0.1	0.2	1.3	0.7	5.9	7.2	8.6	8.5	6.6	6.3	4.7	3.4	6.0	3.5	6.0	1.0	0.9	1.9	1.8	4.1	37.5	2.5	1.4	1.2	0.0	5.9	0.1	0.0	2.1	5.3	5.2	0.7	0.0	3.0	0.5	3.1	1.5	0.0	1.1	4.7	1.6	0.0	2.5	1.5	5.1	1.4	2.8	5.0	1.0	0.0	12.0	4.2	0.0	7.4	3.7	2.5	6.5	19.4	8.0	0.9	2.6	0.7	0.8	0.0	0.6
C9orf131	MGC41945	ENSG00000174038	"Chromosome 9 open reading frame 131"	Q5VYM1	9	35041095-35045991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 46.6"	"Group enriched"	"Detected in some"	32	"Early spermatids: 99.2;Late spermatids: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.0;RT4: 14.0"					"Not detected"	"Not detected"			HPA022029			Approved	Mitochondria		NA	NA			Mitochondria		"HPA022029: AB_10960628"	"unprognostic (1.10e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.90e-4)"	"unprognostic (4.19e-3)"	0.2	0.1	0.2	0.2	0.3	1.3	0.3	0.6	0.3	1.0	0.2	0.2	0.2	0.0	2.2	0.8	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.3	0.7	0.2	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.2	46.6	0.2	0.2	0.3	0.2	0.2	0.3	0.2	1.0	0.1	2.7	0.5	0.9	1.4	0.0	3.4	0.1	0.3	0.8	0.7	0.0	1.0	1.0	0.0	0.0	0.0	0.9	1.8	0.7	0.3	0.0	1.2	2.2	0.0	0.0	0.4	0.3	0.5	1.2	4.0	0.9	0.0	0.4	1.2	0.0	0.5	0.0	0.0	0.0	0.5	1.4	3.4	2.4	0.0	0.5	0.7	1.8	0.6	1.0	0.0	0.0	0.3	0.0	0.3	14.0	0.3	0.0	1.2	0.0	0.5	0.6	0.8	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.9	1.3	0.3	0.5	1.5	2.7	0.5	0.0	0.5	0.0	0.0	0.5	0.4	1.4	0.0	1.0	0.5	0.8	1.3	0.9	0.0	0.1	0.1	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	99.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	26.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.3	0.0	0.5	0.0	0.0	0.0
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 452.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	44.2	17.4	42.3	40.1	43.6	30.7	24.5	19.9	39.0	37.6	26.7	22.3	26.6	27.6	27.0	43.6	19.5	21.1	54.4	13.1	20.6	20.8	40.2	25.4	21.8	53.7	37.0	18.7	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	36.9	18.5	15.9	44.5	20.2	26.1	17.9	29.5	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2	74.5	72.0	80.5	100.9	68.5	80.1	178.9	43.3	71.0	68.2	52.4	111.9	240.5	63.0	177.8	24.1	121.1	90.3	23.3	162.4	147.5	81.6	98.2	61.1	102.4	116.5	69.9	80.8	122.8	57.9	36.5	77.6	66.7	72.6	234.4	63.9	87.7	195.1	56.3	81.7	89.3	82.6	135.8	82.4	127.7	117.9	79.3	452.1	76.6	57.1	105.3
FANCG	"FAG, XRCC9"	ENSG00000221829	"Fanconi anemia complementation group G"	O15287	9	35073835-35080016	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 17.3;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: AB_2679292"	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	5.8	5.0	4.4	7.1	6.5	14.9	7.5	13.9	8.5	6.2	5.9	5.3	8.4	6.7	6.8	3.2	9.2	8.6	4.7	5.9	7.6	4.0	5.2	4.5	5.1	9.9	8.7	4.4	9.2	17.0	6.7	4.8	7.6	6.6	7.0	5.5	3.5	8.7	9.7	2.9	8.9	6.5	6.4	4.2	8.6	5.8	8.9	7.6	25.6	9.3	4.8	9.2	6.8	6.9	6.8	4.8	8.9	2.5	8.8	9.2	3.4	15.7	19.6	14.4	13.3	3.2	5.1	12.1	11.1	8.0	21.8	21.0	9.3	9.9	15.6	7.7	3.5	15.6	9.7	11.9	10.2	8.4	18.3	7.2	11.2	21.0	5.7	0.9	11.3	12.9	4.2	2.0	19.0	8.6	3.8	11.1	19.2	7.3	21.0	11.0	14.0	19.1	15.6	14.9	11.8	15.1	19.9	16.9	11.0	5.1	6.7	7.0	12.7	7.3	10.4	4.1	6.5	13.5	8.2	6.7	10.4	20.7	13.3	14.9	5.7	10.8	9.4	9.2	8.4	14.2	8.9	0.8	7.7	7.4	2.5	6.5	6.8	6.1	5.7	2.2	6.5	4.8	5.0	1.3	8.8	2.3	4.8	9.2	3.4	4.4	6.5	13.9	8.5	7.6	4.0	8.7	4.4	6.6	7.6	3.0	5.8	5.2	3.6	3.9	4.3	1.0	0.0	0.0	2.3	3.5	3.9	8.2	3.3	3.7	0.3	2.8	1.6	0.0	2.0	17.3	3.8	3.5	13.9	1.0	6.5	4.8	1.7	3.7	0.3	0.4	3.1	2.0	3.3	3.6	3.9	3.5	2.3	3.2	3.9	1.7	3.0	0.0	2.7	10.9	23.7	2.3	5.5	5.3	5.0	3.3
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	9.4	16.6	7.2	8.7	11.7	5.4	11.6	12.6	15.6	10.8	11.5	17.8	15.6	14.1	14.0	13.6	12.6	15.8	13.4	9.5	7.4	6.4	16.1	15.2	10.6	13.8	9.0	10.1	15.9	17.5	47.3	13.4	27.6	11.5	13.1	13.2	18.0	17.5	17.4	7.6	10.0	12.9	10.7	11.0	14.2	13.9	16.5	9.7	11.3	20.0	8.3	13.4	13.6	9.9	7.4	13.7	8.0	8.8	7.1	10.0	4.1	15.9	27.4	7.8	11.2	7.0	7.9	14.0	6.8	11.9	16.5	13.5	10.1	16.3	9.0	12.4	8.1	23.0	11.7	13.1	21.3	10.0	9.9	8.4	5.4	17.9	7.6	13.7	7.3	9.4	9.6	23.6	14.6	24.1	13.1	8.5	13.5	5.9	12.9	13.5	8.8	8.5	8.3	5.0	10.0	11.3	8.9	6.3	9.8	18.1	11.1	6.6	8.9	9.4	23.4	5.3	9.0	17.5	4.8	5.1	12.1	10.7	6.5	12.4	7.9	11.6	3.8	13.1	5.4	15.0	7.0	6.7	8.0	9.2	8.8	9.3	5.0	5.1	10.0	13.7	7.4	6.5	7.6	2.4	7.1	5.9	9.5	7.6	4.1	7.2	11.7	12.6	15.6	7.4	6.4	9.0	10.1	11.5	9.7	3.0	11.5	5.2	4.4	2.3	9.1	2.4	20.4	13.4	7.9	15.7	2.0	17.4	0.0	11.1	0.7	3.1	10.6	0.0	12.1	13.5	3.1	3.6	6.9	11.1	10.0	11.1	2.9	4.9	6.3	1.0	4.0	3.9	3.3	8.2	7.8	14.9	8.2	7.0	2.8	5.6	10.9	6.5	2.5	17.4	7.0	1.8	18.9	7.2	8.5	3.1
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		98000	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: AB_2684659"	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	23.2	38.6	20.5	24.8	20.7	26.9	25.3	20.9	30.3	22.1	30.8	19.9	17.4	26.6	26.6	25.5	32.9	28.2	35.4	49.6	18.6	19.1	38.6	67.1	17.1	31.7	18.8	18.8	30.9	48.3	20.4	17.4	28.5	20.7	25.6	33.6	25.0	32.1	25.5	59.2	26.3	39.0	26.7	13.8	23.1	28.7	23.2	14.3	32.4	34.8	46.3	33.8	24.8	21.1	34.7	44.4	20.5	27.1	33.8	40.3	37.7	47.0	54.7	29.4	43.8	21.6	26.0	31.5	23.3	34.4	66.6	48.7	61.6	22.2	39.9	16.5	29.8	47.7	20.2	44.8	52.4	44.6	34.0	41.0	24.4	46.4	58.2	63.3	46.1	28.0	32.9	40.9	54.0	64.9	21.0	43.4	40.7	39.6	24.5	32.5	38.1	41.0	81.8	46.0	35.3	34.6	35.9	24.8	42.6	36.0	28.4	27.3	33.2	13.1	35.5	30.1	21.9	24.6	29.8	23.4	22.8	32.2	18.8	41.1	17.2	29.4	37.6	30.3	29.3	30.5	20.5	27.1	14.8	25.5	23.1	30.0	34.7	28.8	28.7	35.8	30.2	27.8	25.3	4.7	33.8	16.6	44.4	40.3	37.7	20.5	20.7	20.9	30.3	18.6	19.1	18.8	18.8	20.7	14.3	38.7	30.7	67.8	97.0	85.6	32.1	74.2	99.3	64.3	54.6	47.1	7.9	204.6	212.2	112.4	62.9	62.9	121.7	46.7	133.0	205.2	74.7	89.1	82.0	100.2	114.0	17.5	94.8	54.6	32.3	17.5	69.6	50.8	94.5	110.0	124.3	59.7	118.2	126.3	65.4	214.3	28.6	51.8	82.4	68.9	106.7	100.1	139.1	53.3	180.1	119.6
FAM214B	"bA182N22.6, FLJ11560, KIAA1539"	ENSG00000005238	"Family with sequence similarity 214 member B"	Q7L5A3	9	35104112-35116341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.4;granulocytes: 14.6;monocytes: 8.5"	"Cell line enhanced"	"Detected in many"		"TIME: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048831, HPA055751"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048831: AB_2680535, HPA055751: AB_2682906"	"unprognostic (2.91e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.72e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.15e-2)"	13.0	10.3	14.1	12.4	14.9	35.0	6.7	10.4	18.9	7.3	12.0	25.9	10.7	10.9	7.7	7.9	22.4	6.1	12.5	16.5	15.4	14.4	12.5	7.7	13.6	7.4	17.0	11.4	7.5	5.6	10.4	10.9	26.3	20.8	8.6	11.5	9.3	8.6	11.1	8.9	10.9	10.6	11.8	20.5	19.1	10.7	5.8	8.4	3.7	9.1	12.2	12.0	10.4	8.8	0.5	4.4	14.6	8.5	1.7	2.1	2.5	2.9	2.4	6.7	4.8	5.3	8.2	1.4	14.4	13.0	8.0	5.2	1.6	2.0	0.7	4.3	23.2	21.1	1.3	1.1	4.6	5.2	3.7	0.3	3.7	5.2	1.5	5.4	0.9	15.9	5.8	8.3	9.4	6.0	18.7	15.4	3.7	1.9	2.9	16.7	0.8	1.4	4.4	1.2	2.1	3.6	1.6	1.1	0.8	10.5	0.6	0.4	4.4	2.3	1.6	7.7	7.4	2.1	2.4	26.2	11.3	5.5	5.4	5.2	1.9	1.8	0.3	17.8	1.8	12.5	4.7	5.2	4.7	2.1	6.9	0.7	0.5	1.3	1.4	4.4	0.2	0.5	0.9	14.6	1.7	8.5	1.1	0.7	2.5	14.1	14.9	10.4	18.9	15.4	14.4	17.0	11.4	20.8	8.4	0.0	4.6	1.4	4.6	7.4	3.1	6.5	0.0	0.0	3.4	15.7	13.7	2.3	3.3	9.4	9.8	8.6	21.3	0.0	11.1	7.9	7.4	8.1	8.1	5.4	14.1	0.0	5.2	20.3	27.6	49.2	3.1	21.0	15.1	16.2	9.0	8.4	25.8	14.2	7.4	9.0	3.3	6.5	7.2	3.1	5.4	12.7	3.5	4.8	7.6	6.0
UNC13B	"hmunc13, UNC13, Unc13h2"	ENSG00000198722	"Unc-13 homolog B"	O14795	9	35161992-35405338	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 53.6;Alveolar cells type 2: 55.9;Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024493, HPA062300"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments"		Yes	No			Vesicles	"Nucleoplasm, Golgi apparatus, Intermediate filaments"	"HPA024493: AB_1858618, HPA062300: AB_2684742"	"unprognostic (9.73e-3)"	"unprognostic (2.33e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (6.56e-2)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (7.64e-2)"	"prognostic favorable (6.59e-5)"	"unprognostic (3.80e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.34e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.80e-2)"	11.9	12.1	9.3	9.0	18.3	1.4	10.4	16.6	18.8	12.2	21.4	10.1	35.0	11.5	10.6	8.4	14.9	11.1	14.6	11.1	9.2	7.1	22.1	21.5	37.6	2.2	9.5	9.5	7.9	28.7	21.7	13.7	6.3	10.1	20.5	25.1	27.2	20.7	33.6	21.1	14.6	13.0	12.2	9.4	5.0	15.8	16.2	9.1	0.8	12.5	11.6	5.8	8.6	10.4	0.9	1.9	0.0	0.4	0.0	0.3	0.4	5.4	7.2	8.1	13.0	15.6	8.7	6.8	8.9	4.0	6.6	9.0	6.0	2.5	0.0	4.1	11.6	11.7	2.6	20.3	10.3	8.5	0.0	6.5	3.3	20.6	7.7	7.5	1.2	3.7	6.9	8.1	10.4	10.8	10.6	21.3	9.0	7.4	4.6	7.7	4.1	1.1	0.1	7.3	16.9	7.6	0.0	5.0	1.9	9.1	7.1	8.7	9.1	6.2	3.9	6.5	14.0	6.6	4.2	19.5	4.6	4.3	7.1	6.8	7.4	8.8	0.0	5.0	10.3	4.6	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.3	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	9.3	18.3	16.6	18.8	9.2	7.1	9.5	9.5	10.1	9.1	53.6	55.9	0.8	1.2	2.7	37.4	11.0	17.8	10.7	25.0	8.7	90.3	3.2	3.3	6.0	5.6	6.7	14.8	0.0	10.6	1.9	3.1	10.8	2.3	11.1	4.1	6.4	23.6	4.9	2.2	8.5	2.0	3.1	6.8	0.0	28.6	6.7	8.2	14.1	2.8	6.8	42.9	6.5	4.7	7.5	8.3	6.5	2.4	0.0	16.7	2.6
RUSC2	KIAA0375	ENSG00000198853	"RUN and SH3 domain containing 2"	Q8N2Y8	9	35490127-35561898	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.6;classical monocyte: 1.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.6;monocytes: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021297	Uncertain					NA	NA					"HPA021297: AB_1856510"	"unprognostic (4.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.46e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.38e-3)"	17.0	16.4	18.5	6.9	30.3	6.1	7.9	29.5	48.2	14.8	15.0	20.7	4.1	6.3	16.5	7.2	13.4	11.2	11.0	17.5	19.3	17.2	9.5	6.6	9.9	3.4	13.3	23.2	18.0	13.0	8.6	11.0	9.6	21.6	13.5	5.2	14.4	11.1	19.0	35.9	8.8	6.5	17.7	12.8	8.8	7.7	18.6	15.0	0.0	11.3	6.4	2.9	12.9	12.6	0.0	0.3	5.6	1.6	0.0	0.1	0.6	5.8	9.0	3.3	3.1	9.0	8.2	3.6	17.4	10.7	8.2	7.3	2.6	2.4	0.0	5.9	14.4	22.3	1.1	2.9	5.4	3.6	0.0	2.5	1.0	14.4	2.0	13.1	0.0	15.7	7.1	2.9	14.2	14.2	13.3	8.7	2.4	2.4	0.0	13.5	1.7	0.5	0.3	2.5	0.0	4.1	3.5	2.3	0.0	5.2	0.6	0.8	5.6	4.0	8.3	3.2	4.8	5.1	2.0	24.0	12.7	8.6	11.1	8.8	0.1	0.2	0.0	12.5	3.3	8.4	5.6	1.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	18.5	30.3	29.5	48.2	19.3	17.2	13.3	23.2	21.6	15.0	6.0	3.7	0.0	2.5	2.4	13.5	4.7	10.2	4.0	2.3	7.0	13.7	0.4	1.7	5.8	6.8	6.7	0.1	0.0	5.6	5.7	5.4	2.5	5.7	1.9	2.2	12.7	0.0	5.5	3.0	2.5	8.1	2.1	5.0	0.0	0.1	7.3	6.3	0.0	7.1	2.2	6.6	0.0	8.0	7.6	2.7	1.5	0.6	0.0	0.2	0.9
FAM166B		ENSG00000215187	"Family with sequence similarity 166 member B"	A8MTA8	9	35561831-35563899	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 26.8;Club cells: 6.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 11.7;ovarian cancer: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.5;Hep G2: 5.6"					"Low region specificity"	"Detected in many"			HPA045540	Enhanced					NA	NA					"HPA045540: AB_10962627"	"unprognostic (4.18e-5)"	"unprognostic (7.56e-3)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.61e-5)"	"unprognostic (5.66e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (6.20e-6)"	"unprognostic (3.69e-3)"	"unprognostic (9.09e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.52e-5)"	2.8	77.3	0.9	0.7	1.2	0.0	0.7	0.1	0.5	1.3	0.6	3.1	0.3	0.0	0.5	9.4	0.8	26.1	0.9	0.1	1.3	1.5	0.4	0.1	2.7	0.1	0.1	0.2	2.5	0.1	0.0	0.2	0.1	3.8	0.1	0.0	0.7	0.6	0.6	102.9	0.2	0.3	0.3	0.4	0.2	0.0	0.5	0.6	0.1	0.3	1.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	2.5	0.7	0.6	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	1.3	0.2	1.4	0.5	0.9	0.0	0.3	0.0	0.0	5.6	0.0	0.4	0.4	0.0	0.5	0.0	0.5	0.2	0.4	1.9	0.0	0.6	0.0	0.1	0.0	0.4	0.5	0.5	0.6	0.0	0.2	0.0	2.0	0.3	0.8	0.0	0.0	0.0	0.0	1.8	0.6	0.0	1.1	0.7	0.4	0.8	0.0	1.3	0.8	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.2	0.1	0.5	1.3	1.5	0.1	0.2	3.8	0.6	0.0	0.3	0.0	1.1	4.1	0.0	0.2	0.0	26.8	6.8	0.0	2.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	1.3	0.1	0.0	0.2	0.2	0.0	1.8	0.0	0.0	0.0	0.3
TESK1		ENSG00000107140	"Testis-specific kinase 1"	Q15569	9	35605305-35610041	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	30.9	19.4	13.5	10.8	20.5	5.6	25.4	13.4	26.4	14.3	15.2	15.0	9.7	13.7	15.3	13.4	11.0	12.0	13.0	12.8	13.7	13.1	10.5	10.0	11.5	10.7	14.1	10.3	17.0	16.0	13.1	15.7	12.3	12.6	15.1	8.8	14.2	14.6	21.0	47.2	13.7	12.7	16.9	7.3	11.0	12.9	28.4	12.9	9.2	13.0	12.3	9.0	16.6	20.9	1.0	2.3	0.3	1.8	2.1	4.9	1.5	9.5	8.9	6.1	10.2	24.6	10.3	7.0	10.9	9.8	10.2	6.5	5.2	2.7	17.4	6.2	10.9	27.1	3.3	3.9	7.9	1.9	11.2	5.2	2.5	8.5	4.5	14.4	2.1	8.4	10.0	12.5	7.9	10.9	10.9	7.1	8.6	2.9	6.3	10.1	10.5	4.8	10.6	3.8	8.8	10.5	7.5	3.7	4.1	7.5	4.4	5.0	6.1	6.2	7.6	4.6	4.4	9.0	3.2	6.2	22.6	9.7	16.2	6.5	3.8	5.4	6.5	16.4	2.5	5.1	0.0	1.8	0.3	3.4	0.4	3.0	0.8	1.4	4.9	2.1	1.0	1.5	1.6	0.0	2.1	0.8	2.3	0.3	1.5	13.5	20.5	13.4	26.4	13.7	13.1	14.1	10.3	12.6	12.9	6.0	7.7	5.9	5.6	12.8	10.4	1.9	5.1	4.0	3.4	7.0	7.9	3.2	1.7	5.6	33.3	8.7	14.2	0.0	9.0	7.2	8.9	13.5	1.1	9.3	13.1	12.7	9.1	4.9	4.1	27.1	11.2	8.4	13.5	2.8	12.4	11.3	8.3	8.2	13.4	6.1	12.2	6.5	7.8	13.0	5.9	12.2	2.7	6.9	6.1	6.8
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell type enriched"	"Detected in some"	4	"B-cells: 82.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.9	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.7	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.6	0.0	2.8	0.0	8.2	0.7	0.0	0.2	1.7	0.1	0.0	0.1	5.3	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	28.3	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2	0.0	1.1	82.7	0.3	0.9	0.0	0.6	2.5	1.4	0.0	3.5	0.0	0.1	0.0	0.6	0.1	0.5	0.5	0.0	0.6	0.2	0.6	0.4	0.0	0.0	19.7	0.0	1.7	0.6	16.7	0.0	0.9	8.0	0.0	1.8	0.0	0.5	1.2	0.0	0.4	0.3	0.7	0.0	0.8	0.2	1.2	1.0	0.2	4.9	0.3	0.1
SIT1	SIT	ENSG00000137078	"Signaling threshold regulating transmembrane adaptor 1"	Q9Y3P8	9	35649295-35650950	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 56.9;lymphoid tissue: 80.9"	"Group enriched"	"Detected in some"	11	"B-cells: 66.3;T-cells: 47.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	42	"gdT-cell: 21.3;MAIT T-cell: 36.3;memory B-cell: 37.1;memory CD4 T-cell: 45.0;memory CD8 T-cell: 39.8;naive B-cell: 30.9;naive CD4 T-cell: 31.5;naive CD8 T-cell: 31.0;plasmacytoid DC: 33.9;T-reg: 56.9"	"Group enriched"	"Detected in many"	50	"B-cells: 37.1;dendritic cells: 33.9;T-cells: 56.9"	"Group enriched"	"Detected in some"	5	"Daudi: 40.3;HDLM-2: 24.9;JURKAT: 21.4;U-698: 36.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018506	Enhanced					NA	NA					"HPA018506: AB_2669896"	"unprognostic (4.28e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (8.01e-3)"	"prognostic favorable (1.94e-6)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.75e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (8.17e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.34e-2)"	0.8	0.4	0.2	13.8	0.2	0.7	0.6	0.2	0.2	0.6	1.3	0.3	0.5	1.3	0.8	0.4	1.8	0.5	1.3	0.9	0.2	0.2	1.2	0.5	1.6	25.4	0.2	0.2	0.4	0.4	0.0	0.3	0.2	0.3	0.7	1.0	0.4	2.3	0.3	0.4	0.4	11.9	0.2	0.4	23.5	2.1	0.3	0.1	80.9	0.9	0.7	17.9	2.6	0.7	37.1	33.9	0.8	0.2	0.1	56.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.1	0.2	0.1	21.3	0.1	36.3	37.1	45.0	39.8	0.3	30.9	31.5	31.0	0.8	0.1	0.1	33.9	56.9	19.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.0	0.0	66.3	0.0	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	5.3	0.0	0.0	2.5	0.6	0.0	0.0	1.2	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.1	0.2	47.5	0.0	0.0
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: AB_2681128"	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	42.1	23.4	11.1	15.4	10.3	5.4	50.3	17.2	12.9	17.5	35.2	8.5	18.1	15.0	24.9	28.6	22.4	18.2	31.5	31.3	10.2	11.0	13.0	15.0	14.0	14.1	9.7	7.9	15.3	80.2	7.6	10.5	10.8	8.4	22.8	13.7	11.5	14.6	24.5	29.3	9.6	16.0	44.8	9.7	13.5	24.2	9.2	8.8	19.3	14.0	8.8	10.9	38.9	24.1	20.7	32.5	7.6	11.0	16.4	46.9	18.3	7.9	7.2	6.0	7.5	30.2	19.4	3.5	13.4	12.2	8.6	8.1	3.3	2.4	5.2	6.0	17.6	22.3	2.6	4.4	6.5	6.4	15.3	7.1	2.4	10.9	8.1	7.1	3.7	9.5	11.4	7.7	9.2	7.2	16.1	6.0	8.8	3.2	10.0	10.8	5.1	4.2	5.6	4.4	5.7	22.2	6.1	1.4	4.1	28.6	4.3	3.9	6.5	6.9	9.7	6.6	4.7	5.1	4.7	7.5	13.9	7.7	10.0	12.2	4.5	6.6	10.3	25.6	6.0	12.1	7.6	10.6	5.1	36.1	11.0	46.9	20.7	31.7	31.4	11.8	20.1	15.5	21.3	2.1	16.4	6.4	32.5	35.2	18.3	11.1	10.3	17.2	12.9	10.2	11.0	9.7	7.9	8.4	8.8	62.5	23.5	48.4	32.4	62.4	31.1	0.6	61.1	25.4	15.9	78.5	7.9	12.3	14.9	64.0	5.7	40.2	115.3	0.0	122.5	55.2	43.7	39.9	34.5	68.4	86.5	30.2	84.6	43.0	48.7	20.1	55.0	66.1	108.0	39.7	73.5	46.8	82.6	80.7	96.2	54.7	32.0	116.4	97.8	27.9	59.2	58.5	11.6	95.8	40.0	23.7
ARHGEF39	"C9orf100, FLJ14642"	ENSG00000137135	"Rho guanine nucleotide exchange factor 39"	Q8N4T4	9	35658875-35675866	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.7;Erythroid cells: 46.7;Late spermatids: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.4"	"Low region specificity"	"Detected in all"			HPA061299	Uncertain					NA	Yes					"HPA061299: AB_2684473"	"unprognostic (2.93e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.48e-4)"	"unprognostic (1.14e-1)"	"unprognostic (9.75e-2)"	"unprognostic (6.04e-9)"	"unprognostic (3.31e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.46e-1)"	1.6	1.4	0.6	10.0	0.6	3.3	1.3	1.7	0.6	1.4	3.7	0.3	0.7	4.1	2.1	1.6	5.6	0.5	3.6	0.9	1.0	0.6	0.9	1.0	1.4	3.7	0.6	0.0	0.8	1.6	0.0	0.6	2.8	0.6	0.8	2.1	0.4	1.4	0.7	0.6	2.0	5.5	1.4	0.6	2.0	2.7	2.9	0.1	18.0	0.5	1.7	7.1	0.9	1.7	1.8	0.9	1.4	1.2	1.7	3.6	0.7	5.3	8.3	7.9	3.9	0.1	0.3	5.3	4.0	1.5	3.5	3.1	9.2	4.3	3.3	2.4	0.6	4.8	4.2	3.9	2.3	1.4	9.8	6.2	5.4	10.7	3.3	0.0	4.5	8.1	0.3	0.2	1.7	1.0	1.2	1.3	4.9	3.7	3.1	1.5	2.7	1.1	2.5	5.0	3.8	2.7	4.5	6.1	2.0	1.3	2.3	5.6	2.2	2.0	4.4	1.2	3.3	6.5	2.6	0.8	2.6	8.3	2.9	2.8	3.1	3.7	1.5	1.5	2.4	5.5	1.2	1.0	0.8	2.4	0.7	3.6	0.9	1.7	2.4	0.9	1.8	0.6	1.6	1.4	1.7	1.2	0.8	1.9	0.7	0.6	0.6	1.7	0.6	1.0	0.6	0.6	0.0	0.6	0.1	0.0	0.0	2.7	1.4	2.4	1.7	1.0	2.5	1.4	1.2	1.8	0.0	1.4	0.0	0.8	86.7	1.1	1.0	46.7	0.7	16.7	1.9	0.9	0.0	0.6	4.4	0.0	3.4	1.8	3.1	30.7	0.9	2.5	5.0	0.0	2.4	1.9	0.6	0.0	0.4	0.3	1.8	0.0	1.7	2.6	3.3	1.8	1.6	1.9	3.6	0.7
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 1091.5;tongue: 332.2"	"Group enriched"	"Detected in many"	4	"Peritubular cells: 1947.8;Sertoli cells: 2186.0;Smooth muscle cells: 3115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	727	"plasmacytoid DC: 76.4"	"Lineage enriched"	"Detected in single"	727	"dendritic cells: 76.4"	"Cell line enhanced"	"Detected in many"		"BJ: 196.4;fHDF/TERT166: 107.2;hTERT-RPE1: 123.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA047089, HPA053624"	Approved					NA	NA		290000000			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	14.5	8.2	1.8	24.5	1.6	0.7	9.1	3.7	1.7	47.5	101.0	1.4	76.0	8.4	86.6	51.1	166.5	26.8	100.3	34.6	1.9	1.4	9.5	1.1	10.0	5.3	1.5	3.1	29.2	2.2	1.1	2.6	8.6	3.4	72.2	9.6	15.0	21.0	81.0	1091.5	4.2	27.4	231.7	1.6	4.7	48.7	13.4	0.6	0.2	9.3	332.2	22.0	190.7	38.6	0.0	76.4	0.1	0.0	0.0	0.0	0.4	29.7	22.8	16.0	2.6	30.2	80.8	9.8	196.4	80.1	83.2	56.5	0.9	1.9	0.0	17.6	107.2	11.7	0.6	0.2	24.2	38.6	54.9	0.7	0.7	81.3	0.9	48.2	0.1	8.0	94.3	3.8	62.2	0.0	123.3	19.5	1.9	0.3	0.0	83.6	1.1	0.1	2.0	20.2	0.1	1.3	1.3	29.6	0.2	2.5	0.5	0.2	1.0	37.3	0.6	1.3	24.1	0.5	2.1	2.3	1.2	45.4	0.9	56.0	0.0	0.1	0.2	2.8	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.4	0.0	0.4	1.8	1.6	3.7	1.7	1.9	1.4	1.5	3.1	3.4	0.6	3.0	5.5	3.2	76.3	50.7	0.8	590.1	2.5	9.4	22.7	7.0	0.0	10.2	0.0	16.3	3.1	80.7	0.4	0.0	5.0	76.5	194.5	31.7	2.3	1.3	30.2	1.6	2.4	259.7	5.9	15.9	262.1	16.2	64.1	10.8	1.3	9.5	12.0	0.0	1947.8	0.3	0.8	2186.0	3115.2	2.3	25.4	37.4	12.2	3.5	1.6	26.2
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732395	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"		NA	NA		3600000000	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	47.4	23.7	10.9	29.3	16.6	25.1	38.1	9.6	11.8	34.7	64.0	18.8	22.8	13.0	57.4	20.6	41.2	38.3	48.4	30.3	11.1	7.1	30.5	36.1	33.0	26.0	17.9	7.3	39.0	12.8	19.6	14.6	30.4	14.4	39.5	15.5	22.8	14.9	43.6	24.5	16.5	27.6	87.0	12.4	54.1	38.2	17.3	14.1	33.4	20.7	12.5	20.7	72.5	49.6	3.3	6.8	12.7	9.2	4.8	7.1	7.1	11.4	19.2	11.9	16.3	40.9	31.1	13.6	32.0	35.1	31.1	28.2	15.8	5.1	13.9	10.6	59.0	19.7	6.2	13.9	19.9	22.8	31.3	9.0	31.6	24.9	14.0	25.4	19.1	52.8	37.6	9.5	45.7	21.7	42.9	47.6	12.1	10.8	14.3	41.0	5.0	12.8	5.0	9.7	5.2	14.8	17.3	6.9	8.1	15.5	9.2	2.7	11.3	15.6	8.7	10.2	11.3	7.4	13.2	57.3	49.6	19.3	15.1	25.7	5.0	4.9	9.7	38.4	10.3	44.7	6.7	7.0	8.4	7.1	7.8	5.9	3.3	4.2	5.4	5.3	3.2	2.0	4.2	12.7	4.8	9.2	6.8	2.8	7.1	10.9	16.6	9.6	11.8	11.1	7.1	17.9	7.3	14.4	14.1	101.3	67.1	67.7	36.3	35.6	10.9	115.6	40.8	50.9	78.5	50.6	9.8	34.4	19.9	88.6	37.6	106.8	42.8	46.7	54.0	72.5	71.0	43.2	194.8	46.5	103.3	14.3	32.7	76.1	163.8	17.2	92.0	155.9	21.9	147.9	23.2	33.9	81.9	24.6	120.9	45.4	17.3	200.5	199.7	26.8	25.9	23.2	49.2	86.7	23.2	31.2
CREB3	"Luman, LZIP, sLZIP"	ENSG00000107175	"CAMP responsive element binding protein 3"	O43889	9	35732335-35737004	"Predicted membrane proteins, Transcription factors"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030978			Supported	Cytosol		NA	NA			Cytosol		"HPA030978: AB_2673683"	"unprognostic (1.73e-3)"	"unprognostic (9.72e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.62e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.77e-5)"	"unprognostic (1.48e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	15.7	25.1	23.7	12.0	27.6	5.6	19.4	18.5	30.2	25.4	20.3	17.6	28.2	12.8	20.9	22.5	15.0	23.9	25.2	16.3	19.4	21.3	21.3	42.3	15.9	15.3	23.1	17.1	20.2	26.3	22.1	23.1	19.5	17.3	32.9	16.7	17.4	31.7	37.6	12.6	9.9	14.6	26.0	19.6	13.0	20.5	23.0	14.0	9.1	24.4	9.4	14.9	22.0	17.6	17.7	19.4	14.8	16.9	15.9	21.8	15.7	12.3	11.5	12.1	9.1	25.6	16.7	8.0	22.5	36.1	24.1	25.0	12.8	6.0	4.4	9.9	32.9	26.7	4.8	7.8	18.6	15.9	16.5	6.5	3.4	10.2	5.8	32.6	5.7	6.8	14.6	15.3	23.4	22.9	19.7	14.7	8.5	4.9	7.5	24.7	6.1	5.8	2.0	7.6	9.0	15.1	6.5	5.3	5.6	19.4	6.0	5.7	7.8	9.0	8.0	5.3	10.3	12.2	2.4	15.7	16.0	9.0	11.5	13.8	4.3	5.3	5.3	16.7	2.0	17.3	14.8	16.9	6.3	19.2	16.0	20.7	17.7	16.8	21.8	17.9	12.3	13.7	13.4	7.7	15.9	12.8	19.4	18.5	15.7	23.7	27.6	18.5	30.2	19.4	21.3	23.1	17.1	17.3	14.0	26.8	16.2	9.0	41.3	31.8	28.3	10.1	38.2	41.5	27.3	15.7	11.8	41.9	28.2	83.0	124.3	32.4	52.9	0.0	61.5	45.7	42.8	65.2	31.2	20.3	32.9	4.8	25.3	19.0	14.8	350.3	27.9	22.7	47.2	58.7	42.1	33.3	62.6	30.3	39.6	55.4	13.8	32.3	53.6	60.7	24.6	19.8	51.0	26.6	24.2	39.6
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	7.9	13.2	18.2	17.6	8.9	5.4	18.5	10.8	8.5	11.0	11.7	14.6	6.4	8.5	7.9	6.6	23.8	8.3	17.4	7.3	5.6	12.1	11.9	9.2	34.4	15.6	9.8	13.6	22.8	9.3	13.7	9.3	9.8	26.9	28.8	8.6	8.9	16.4	10.2	7.9	3.7	14.1	18.8	16.2	20.9	6.8	7.3	7.2	15.3	18.8	14.9	19.9	6.1	15.2	10.7	23.3	10.4	12.4	20.1	12.0	14.5	10.2	13.1	11.2	7.1	7.1	15.0	5.0	9.3	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5	11.9	10.1	8.0	16.1	6.5	73.4	10.9	20.4	21.4	14.8	26.2	108.0	8.7	18.3	9.9	12.7	13.7	68.4	0.0	10.4	7.6	7.4	14.9	13.9	16.3	7.9	49.3	34.3	26.4	15.4	17.0	11.5	10.1	11.8	7.2	32.8	15.5	12.6	56.1	9.2	16.5	95.2	12.9	9.9	8.6	4.9	8.7	18.5	12.5	30.3	22.5
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758575	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favorable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	13.4	18.2	12.0	11.4	16.8	7.1	12.3	13.7	24.8	12.2	17.7	18.3	23.8	14.9	15.3	12.5	14.0	12.3	12.1	17.6	11.6	11.2	16.7	14.2	13.2	9.8	10.7	14.8	15.0	17.6	32.6	18.3	14.1	13.0	12.9	19.1	15.4	18.3	22.5	25.8	13.1	17.2	14.1	10.6	12.8	16.5	13.2	13.7	11.2	17.3	11.9	13.0	13.5	10.6	4.0	2.1	3.4	1.9	3.7	3.7	0.9	11.3	10.7	12.5	10.3	11.7	12.7	7.4	9.0	13.1	12.5	11.7	9.1	4.3	8.8	6.5	11.4	23.2	6.5	11.9	17.0	10.4	11.7	7.0	7.6	20.4	6.8	11.0	8.2	10.7	12.7	21.7	13.2	16.1	18.0	14.8	6.9	5.1	4.9	11.3	5.3	2.5	2.9	5.2	9.4	12.6	8.3	8.9	6.2	11.0	8.0	9.2	9.9	7.9	11.2	7.3	11.5	9.3	3.9	18.7	10.1	12.8	6.9	7.5	7.4	10.2	9.4	14.4	3.4	12.9	3.4	0.9	1.4	2.6	1.5	3.7	2.8	1.9	3.0	0.6	4.0	2.3	2.4	2.3	3.7	1.9	2.1	1.6	0.9	12.0	16.8	13.7	24.8	11.6	11.2	10.7	14.8	13.0	13.7	6.0	9.3	26.0	21.1	5.0	40.9	16.3	20.4	8.1	10.3	26.2	19.6	9.3	11.6	16.1	16.4	13.4	35.4	0.0	15.2	8.8	6.0	21.5	5.7	15.3	6.4	15.9	41.6	8.0	10.3	27.7	7.8	5.6	1.7	7.2	23.9	21.8	17.1	31.7	10.3	12.9	22.1	6.5	7.2	15.8	4.3	4.5	8.6	15.2	26.3	26.2
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	67	"Early spermatids: 95.5;Late spermatids: 142.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 35.1;PC-3: 44.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"	No	No			Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0	0.0	0.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	95.5	0.3	0.0	0.0	1.8	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	142.6	0.3	0.0	1.7	0.0	0.0	0.8	1.3	0.0	0.7	0.2	0.6	0.0	0.0	0.7	0.4	0.1	0.2	0.0	0.0	1.1
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35792154-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 8.6;Muller glia cells: 8.2;Peritubular cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.1;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 27.6;ASC TERT1: 20.6;BJ hTERT+: 16.8;HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.93e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.59e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.99e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.86e-2)"	9.0	4.8	3.8	1.9	6.4	0.0	7.2	32.7	11.2	29.2	7.8	1.8	4.4	1.8	22.6	9.8	5.3	7.6	5.7	7.6	3.7	4.2	3.7	8.4	4.7	2.3	2.5	5.1	8.0	1.3	2.7	7.9	7.1	11.8	8.3	4.0	8.3	3.3	9.5	7.7	6.2	3.7	17.1	3.9	2.6	4.5	5.5	4.0	0.9	3.2	2.4	2.0	6.2	8.9	0.4	3.1	0.0	0.0	0.1	2.1	0.1	0.0	1.6	1.9	0.0	27.6	20.6	1.2	7.7	16.8	6.2	6.7	4.0	2.7	1.1	2.0	15.0	11.6	0.7	2.3	0.2	5.6	1.3	0.7	1.0	1.8	2.0	15.0	0.1	0.0	20.4	1.1	6.9	0.5	6.1	10.1	1.7	0.5	0.1	11.6	0.5	0.3	0.4	2.6	0.8	2.8	1.3	0.1	0.5	1.0	0.8	0.5	0.6	0.2	0.0	0.3	3.1	0.1	0.0	6.5	6.6	5.1	2.1	0.7	0.2	0.3	3.0	8.4	0.3	3.7	0.0	0.0	0.0	1.1	0.0	0.0	0.4	1.2	0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.1	2.1	0.1	3.8	6.4	32.7	11.2	3.7	4.2	2.5	5.1	11.8	4.0	3.0	4.3	0.0	0.6	1.0	4.0	0.6	0.0	1.4	0.0	0.0	2.0	0.3	0.0	0.4	0.1	2.3	0.1	0.0	0.7	0.1	5.7	1.7	1.1	5.7	0.3	3.2	0.0	2.5	0.3	0.0	8.6	0.0	0.0	0.0	0.9	8.2	0.5	3.1	7.4	0.6	2.1	0.0	1.9	2.8	2.0	1.4	0.2	0.0	1.0	0.3
SPAG8	"BS-84, CT142, HSD-1, hSMP-1, SPAG3"	ENSG00000137098	"Sperm associated antigen 8"	Q99932	9	35808045-35812272	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.7;epididymis: 9.7;fallopian tube: 30.0;testis: 23.6"	"Cell type enhanced"	"Detected in many"	18	"Ciliated cells: 95.0;Early spermatids: 32.1;Late spermatids: 22.4;Spermatocytes: 42.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basal ganglia: 8.6;pons and medulla: 32.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2"					"Low region specificity"	"Detected in all"			HPA068012	Enhanced					NA	NA					"HPA068012: AB_2685941"	"unprognostic (1.01e-4)"	"unprognostic (3.52e-3)"	"unprognostic (6.36e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-3)"	1.0	1.4	2.4	0.9	8.6	1.1	1.1	1.1	3.5	3.7	1.3	9.1	2.7	1.4	1.6	9.7	1.2	30.0	1.6	2.6	4.1	3.2	1.2	0.8	2.9	1.2	1.6	2.8	2.5	1.2	2.2	3.9	1.0	32.7	1.4	0.8	2.5	1.3	3.5	1.3	1.1	1.0	1.0	2.2	1.2	1.2	23.6	4.4	0.9	2.9	0.4	0.9	1.7	0.7	1.3	3.0	4.2	1.8	2.3	2.7	1.0	0.1	0.2	0.0	0.4	4.2	1.4	0.0	0.4	0.2	1.4	0.5	0.8	0.2	0.0	0.0	0.2	0.6	1.0	0.4	1.9	0.2	0.9	0.3	1.3	0.2	0.1	0.3	0.0	0.4	1.1	0.8	1.6	0.8	2.5	1.2	0.1	0.1	1.5	1.5	0.8	0.3	0.1	0.4	0.0	0.8	0.4	0.5	1.3	1.5	0.0	1.5	0.9	0.1	0.1	0.4	0.3	0.9	1.5	1.2	0.3	0.6	0.7	0.1	0.5	0.6	0.1	2.1	1.2	0.8	4.2	1.8	0.0	1.6	1.2	0.5	0.2	1.3	1.8	3.0	1.3	0.9	2.5	0.0	2.3	0.1	0.1	2.7	1.0	2.4	8.6	1.1	3.5	4.1	3.2	1.6	2.8	32.7	4.4	0.0	1.0	0.0	1.0	0.3	4.8	2.9	0.0	95.0	10.3	5.2	7.9	0.3	1.7	0.3	32.1	0.6	0.0	0.0	0.0	0.1	0.8	1.0	1.1	0.0	0.9	3.2	2.9	1.8	0.3	22.4	1.4	1.8	0.0	1.8	0.0	5.0	0.1	0.0	1.1	1.1	8.0	0.0	1.2	42.2	2.1	0.5	0.1	0.8	0.0	0.2
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 537.2;Hepatocytes: 366.2;Proximal tubular cells: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	10.9	9.2	13.8	15.1	16.7	17.5	10.8	12.7	10.6	8.8	21.6	9.8	7.6	14.3	16.0	27.6	13.8	13.8	23.3	15.7	24.8	7.7	14.0	10.0	13.2	14.3	23.4	6.0	11.7	31.3	8.1	41.4	12.0	20.8	19.5	9.8	7.4	24.0	46.1	19.6	11.1	17.5	21.5	7.6	13.3	15.9	12.0	14.9	16.0	10.4	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.0	40.0	18.3	17.9	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2	20.8	10.8	63.0	60.5	40.3	34.2	96.4	124.9	53.5	13.6	76.8	19.6	143.0	537.2	101.9	54.3	49.6	142.5	46.7	149.8	55.2	58.2	44.3	18.4	366.2	96.3	19.1	92.3	63.3	58.2	111.5	37.4	47.7	114.7	71.3	106.7	69.3	83.1	158.4	42.1	463.5	36.6	45.3	71.8	32.1	82.2	40.1	47.5	67.1	120.6	54.5
TMEM8B	"C9orf127, NAG-5, NGX6"	ENSG00000137103	"Transmembrane protein 8B"	A6NDV4	9	35814451-35865518	"Predicted membrane proteins, Transporters"	"Cell adhesion, Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 27.2"	"Lineage enriched"	"Detected in many"	18	"dendritic cells: 27.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052130, HPA062701"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052130: AB_2681740, HPA062701: AB_2684839"	"unprognostic (5.54e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (5.93e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (8.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	9.7	19.5	28.2	5.7	30.4	3.4	9.4	22.9	34.4	15.5	13.0	16.9	14.9	8.7	18.4	11.5	9.3	18.3	12.1	17.8	25.3	14.1	11.3	4.7	10.4	5.9	12.9	21.2	33.3	14.6	28.4	23.6	7.7	18.3	19.3	9.4	17.5	19.9	24.0	19.1	9.2	8.4	18.1	13.0	8.7	13.1	13.6	15.4	5.6	17.3	5.1	4.9	14.2	11.9	0.9	27.2	0.6	1.5	0.5	0.6	1.1	2.9	3.1	11.0	8.6	12.4	10.4	1.3	2.6	5.1	2.9	3.6	1.3	0.8	2.3	6.3	7.1	8.5	1.1	2.9	4.3	2.4	1.8	4.9	0.7	2.2	3.1	8.8	0.2	0.3	9.7	5.6	3.0	3.2	9.4	1.6	10.7	1.0	6.5	5.1	1.1	6.0	1.3	1.6	2.4	4.3	6.7	2.2	5.7	3.0	1.3	2.6	7.7	4.0	1.9	3.9	3.8	3.0	1.1	2.6	6.9	2.2	6.7	1.0	8.7	2.6	2.6	6.3	1.1	4.2	0.4	1.5	0.1	0.6	0.3	0.5	0.9	0.6	0.6	4.7	0.9	0.6	0.5	0.6	0.5	0.3	27.2	0.4	1.1	28.2	30.4	22.9	34.4	25.3	14.1	12.9	21.2	18.3	15.4	11.9	13.5	0.9	7.2	3.9	3.9	10.1	10.2	4.0	7.9	14.0	2.0	29.0	1.7	4.4	20.2	2.9	3.9	0.0	3.4	5.3	7.2	9.2	1.1	2.9	2.9	1.6	6.4	1.3	1.9	9.9	13.6	3.3	10.1	0.0	5.6	8.2	3.2	8.6	18.4	4.1	5.0	6.5	6.1	8.0	4.4	1.4	10.9	3.8	6.3	8.2
FAM221B	C9orf128	ENSG00000204930	"Family with sequence similarity 221 member B"	A6H8Z2	9	35816391-35828747	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.9;testis: 27.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 217.9;Late spermatids: 97.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA026577	Enhanced					NA	NA					"HPA026577: AB_1845810"	"unprognostic (1.23e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-3)"	0.3	0.1	0.3	0.7	0.3	5.2	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	1.1	0.9	0.3	0.9	0.3	0.3	0.6	0.3	0.3	0.4	0.3	0.3	27.3	0.3	0.3	0.3	0.3	0.5	0.3	0.3	1.5	6.9	3.6	0.8	0.6	0.8	0.3	0.6	1.0	1.5	1.9	0.6	0.5	0.9	0.0	0.0	1.1	0.6	0.6	2.0	1.1	0.5	0.5	0.4	0.0	0.4	0.0	0.4	0.0	0.6	0.5	2.7	1.7	0.5	0.8	1.4	0.6	1.8	0.4	1.1	0.2	0.8	0.8	0.2	2.5	0.9	1.0	0.0	1.1	0.0	0.1	0.7	0.4	0.7	1.5	0.0	2.2	1.8	1.5	0.6	1.6	0.0	1.0	0.7	1.1	1.2	1.4	0.7	2.7	0.9	1.3	0.5	0.6	0.3	1.1	0.3	1.0	0.8	0.5	0.7	0.3	0.6	0.7	0.6	0.5	0.4	1.5	0.8	0.8	3.6	0.6	0.3	6.9	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	1.9	0.0	0.4	0.0	3.5	0.3	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	217.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	97.0	2.0	0.0	0.0	0.0	0.2	3.1	0.2	1.5	0.7	0.0	5.9	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.0	1.0
OR13J1		ENSG00000168828	"Olfactory receptor family 13 subfamily J member 1"	Q8NGT2	9	35869263-35870601	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.2;skeletal muscle: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"AN3-CA: 2.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (6.58e-2)"			"unprognostic (2.89e-2)"	"unprognostic (1.82e-1)"			"unprognostic (2.49e-1)"		"unprognostic (9.58e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.68e-1)"		"unprognostic (4.07e-1)"		0.1	0.2	1.2	0.2	1.6	0.0	0.0	0.9	2.2	0.0	0.1			0.4	0.1	0.0	0.4	0.1	0.2	0.6	1.7	0.8	0.1	0.1	0.0	0.2	0.6		0.4	0.0	0.0	0.4	0.1		0.3	0.1		1.1	0.0	1.4	0.5	0.0	0.0	0.8	0.0	0.2	0.2			0.2		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HRCT1	"LGLL338, PRO537, UNQ338"	ENSG00000196196	"Histidine rich carboxyl terminus 1"	Q6UXD1	9	35906192-35907141	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.3"	"Cell type enhanced"	"Detected in many"	22	"Enterocytes: 63.2;Mucus-secreting cells: 49.5;Paneth cells: 238.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.8;HBEC3-KT: 7.6;HeLa: 11.3;Hep G2: 8.5;U-2197: 20.4;U-251 MG: 9.5"					"Low region specificity"	"Detected in all"			HPA067038			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067038: AB_2685767"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.43e-2)"	25.3	1.9	1.9	3.6	2.8	0.4	21.4	0.9	3.4	5.3	16.8	1.8	1.4	11.2	4.2	3.9	6.6	3.5	2.1	7.6	2.6	1.6	17.6	1.8	5.2	5.0	2.4	2.3	2.2	1.6	0.3	0.7	4.7	3.6	3.6	14.8	5.8	4.6	4.0	6.1	4.2	14.3	6.5	1.5	0.8	2.5	5.3	1.4	0.0	3.5	1.2	1.5	4.6	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.6	4.6	0.0	0.2	0.4	0.1	0.0	0.1	1.2	0.0	13.8	0.3	2.6	0.0	0.0	7.6	0.0	0.0	0.0	0.0	11.3	8.5	1.8	0.0	0.0	4.5	3.9	1.5	0.9	0.6	4.7	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	3.5	1.8	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	3.9	0.2	4.1	20.4	9.5	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.8	0.9	3.4	2.6	1.6	2.4	2.3	3.6	1.4	6.0	1.0	0.0	0.4	1.9	1.5	0.6	2.5	1.4	3.4	0.0	0.0	20.6	1.7	0.8	0.0	21.2	63.2	0.0	0.2	6.6	4.2	0.6	0.0	0.4	1.6	0.0	1.2	35.0	0.8	0.0	10.0	0.9	1.7	0.0	49.5	7.5	2.7	238.4	8.9	9.3	2.6	12.9	4.6	0.0	0.2	1.6	2.2	0.0	18.6	0.1
SPAAR	"LINC00961, SPAR"	ENSG00000235387	"Small regulatory polypeptide of amino acid response"	A0A1B0GVQ0	9	35909483-35937153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;breast: 13.7;testis: 16.5"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 1.1;Club cells: 1.2;Proximal tubular cells: 2.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Group enriched"	"Detected in some"	13	"HUVEC TERT2: 22.6;TIME: 26.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.40e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.22e-1)"	12.2	0.6	1.4	0.7	2.4	0.0	13.7	0.3	1.2	0.2	0.9	0.3	0.8	0.3	0.5	0.3	0.6	0.4	0.8	5.6	1.4		3.5	1.3	4.6	0.4	1.4	0.1	0.2	0.5	0.1	0.4	6.9	1.9	0.3	0.4	0.9	0.8	0.5	6.2	0.0	0.6	0.8	1.3	0.4	0.3	16.5	1.4	0.0	1.1	1.2	0.0	0.3	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.0	22.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	26.4	0.0	0.6	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0											0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2S2		ENSG00000278889	"Olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)"	Q9NQN1	9	35957108-35958154	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;BJ: 1.3;BJ hTERT+: 1.9;fHDF/TERT166: 1.3;HeLa: 1.3;HHSteC: 1.6;U-138 MG: 2.2"					"Region enriched"	"Detected in single"	8	"cerebellum: 0.6"							NA	NA																							0.1	0.0		0.0		0.0	0.4		0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	1.0	0.0	0.0	0.4		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036433-36124451	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.3;ASC TERT1: 44.3;BJ: 17.2;BJ hTERT+: 24.7;fHDF/TERT166: 15.2;HSkMC: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		37000000	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	15.9	8.9	6.9	6.3	8.2	1.5	31.7	9.1	7.8	18.9	10.2	8.5	6.2	4.3	18.4	7.5	13.7	12.0	15.6	11.3	8.4	4.9	6.9	6.7	16.7	6.1	8.3	4.9	17.2	3.9	3.7	7.8	12.7	8.3	12.3	7.6	10.5	7.8	8.9	5.7	8.7	7.7	17.3	7.9	8.1	9.8	7.9	8.5	8.4	10.5	9.8	6.2	17.8	16.8	3.5	3.7	1.2	5.5	3.6	8.9	3.1	0.3	0.6	2.1	1.1	55.3	44.3	0.0	17.2	24.7	1.2	3.0	0.0	0.0	0.6	1.6	15.2	1.0	0.1	0.4	0.3	1.7	1.0	0.9	0.6	0.7	0.0	4.4	0.0	3.0	19.7	0.4	1.9	0.7	5.0	3.8	1.3	0.0	0.5	3.2	0.0	1.6	0.2	0.7	0.0	0.5	1.7	1.6	0.0	0.8	0.0	0.2	1.2	0.3	0.2	0.6	2.3	0.0	2.3	11.7	2.4	0.9	1.5	0.9	0.7	0.8	0.7	1.5	2.2	1.5	1.2	3.3	0.9	5.4	3.5	6.1	1.7	7.1	5.7	3.7	3.5	8.9	6.4	0.5	3.6	5.5	2.1	3.2	3.1	6.9	8.2	9.1	7.8	8.4	4.9	8.3	4.9	8.3	8.5	3.0	4.8	7.8	2.6	6.4	14.3	1.6	2.5	4.0	2.3	3.5	13.7	0.7	0.0	5.5	30.6	14.3	0.0	0.0	1.3	6.3	15.6	4.0	9.2	0.8	13.1	7.9	5.8	25.8	8.4	31.4	17.3	7.0	3.3	6.4	1.4	17.7	1.8	0.0	16.6	1.5	7.6	0.0	9.9	25.9	24.0	6.6	0.7	8.5	0.9	1.0
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.9"	"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 191.0;Macrophages: 162.9;monocytes: 200.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;HDLM-2: 25.6;TIME: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		18000000	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	28.5	10.8	8.1	25.5	12.1	32.5	15.6	5.7	11.2	19.9	32.4	23.3	9.1	7.5	40.3	16.8	16.3	18.7	13.0	11.7	9.4	7.1	4.9	3.5	31.2	26.5	14.7	6.5	13.4	2.8	0.4	2.9	4.7	12.3	20.1	17.1	11.6	7.9	21.3	4.8	6.1	14.9	35.5	21.8	21.1	13.8	5.0	13.2	10.1	10.6	7.4	9.4	19.2	14.2	3.3	28.8	92.9	48.6	15.8	24.8	45.5	1.2	1.0	7.6	8.0	26.8	12.8	0.8	12.2	7.4	2.8	5.2	0.4	0.1	0.0	3.8	10.9	7.2	0.0	2.8	0.4	1.7	25.6	2.4	3.0	2.4	0.1	10.6	1.9	10.5	8.6	0.3	16.4	2.8	5.2	22.5	8.2	0.1	1.8	6.5	2.9	9.6	5.2	7.3	0.1	3.9	6.6	16.1	0.3	0.6	0.6	2.0	4.1	1.6	0.8	1.2	16.2	0.8	8.5	45.4	3.9	9.3	3.5	9.8	2.9	0.7	4.4	4.1	12.4	0.9	30.1	48.6	71.9	24.8	22.3	13.1	3.2	17.2	15.8	28.8	3.3	7.3	11.5	92.9	15.8	16.2	2.5	17.6	45.5	8.1	12.1	5.7	9.8	9.4	7.1	14.7	6.5	12.3	13.2	3.0	29.7	14.3	2.0	11.8	0.2	1.6	5.1	40.2	23.9	5.2	0.0	2.7	0.0	16.4	0.6	7.1	4.5	23.3	1.1	2.9	35.5	17.3	51.9	0.4	191.0	0.0	8.1	17.8	102.3	0.9	16.7	162.9	59.1	200.2	27.5	14.0	6.0	10.5	24.4	0.3	0.5	45.3	35.8	1.1	3.2	8.9	2.9	62.3	48.7	2.0
CCIN	"BTBD20, KBTBD14"	ENSG00000185972	Calicin	Q13939	9	36169394-36171334	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 72.9"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 864.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"myeloid DC: 1.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;BJ: 5.5;fHDF/TERT166: 6.6;hTEC/SVTERT24-B: 8.2;TIME: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.10e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.26e-6)"	"unprognostic (1.78e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.74e-3)"	"unprognostic (5.43e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.98e-5)"	"unprognostic (3.27e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	0.2	0.2	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.7	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	72.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.4	3.6	5.5	0.5	0.1	0.2	0.0	0.0	0.0	1.5	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	2.2	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	11.0	0.1	1.8	0.3	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	864.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	1.6	184.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.5	0.1	4.2	2.6	0.0	0.1	0.0	0.0	0.0
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 1086.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA		2100000	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	60.0	64.8	65.0	46.9	60.8	35.4	55.5	68.6	86.3	58.1	71.4	55.5	35.8	65.6	58.1	64.5	63.8	65.2	56.4	31.4	62.6	62.0	72.2	60.0	48.7	53.1	67.1	67.0	78.1	52.8	42.8	47.0	78.2	67.9	53.3	67.6	48.1	58.8	47.6	33.2	47.5	58.3	52.4	71.5	59.6	56.3	48.3	41.9	58.2	77.1	49.4	54.5	46.2	60.5	31.3	57.3	29.1	59.5	22.6	40.5	45.9	59.2	47.6	35.9	27.3	52.4	52.8	57.9	61.5	46.9	49.5	58.3	35.6	26.7	44.8	34.1	40.9	88.0	25.3	45.0	42.7	45.6	30.3	36.3	34.4	48.4	36.3	70.6	36.4	31.8	58.1	47.5	56.8	45.1	46.4	61.1	24.3	29.8	23.7	74.6	20.6	32.6	46.4	57.3	39.3	68.1	31.6	23.8	25.4	66.9	42.5	27.9	46.9	25.7	30.2	50.5	43.8	27.3	45.0	78.1	40.0	45.0	45.7	63.9	15.9	37.3	47.6	49.3	51.2	35.3	29.1	56.6	28.0	26.5	59.5	27.8	31.3	28.9	27.2	57.3	30.6	26.4	22.8	22.2	22.6	45.6	49.5	40.5	45.9	65.0	60.8	68.6	86.3	62.6	62.0	67.1	67.0	67.9	41.9	119.1	126.5	113.2	237.0	175.3	139.0	42.8	198.7	195.4	110.3	171.0	56.9	788.4	393.0	429.4	38.8	221.8	317.2	93.5	293.9	375.3	205.3	232.4	71.6	147.2	759.2	87.4	176.4	320.4	351.1	69.8	243.4	230.3	185.5	340.9	269.6	211.2	383.1	322.6	202.6	507.5	105.0	174.6	193.6	246.1	233.4	168.9	1086.8	114.0	299.8	286.9
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 95.4;Mucus-secreting cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	22.4	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	6.3	3.6	9.0	6.3	12.1	8.3	0.7	8.1	2.6	5.1	2.8	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	3.3	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3	8.9	10.6	4.5	2.8	1.6	7.9	5.9	10.2	18.7	14.8	8.7	5.9	7.5	1.7	9.3	2.8	4.5	18.3	0.0	5.2	7.3	5.1	7.6	9.3	95.4	2.7	11.1	11.1	8.0	5.0	2.3	10.0	4.3	1.7	6.4	67.2	2.0	4.2	23.0	6.0	1.7	6.2	12.9	4.1	1.1	2.7	1.4	16.6	5.0	21.2	5.6
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"Early spermatids: 442.1;Late spermatids: 1049.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favorable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	11.9	8.0	13.1	7.7	14.5	20.3	11.1	18.8	17.0	13.6	14.1	12.2	8.1	6.4	16.3	12.9	10.1	11.7	9.6	9.5	10.0	11.1	12.3	6.8	11.7	14.5	9.2	12.3	24.4	12.8	12.2	5.7	21.2	14.0	15.3	10.1	14.4	10.3	12.8	9.6	8.9	10.2	16.9	8.5	11.4	8.7	46.3	10.0	13.1	14.4	4.3	11.1	16.5	13.5	6.2	4.1	12.2	4.3	8.4	8.7	4.2	9.0	5.2	20.0	11.8	9.2	8.5	19.6	5.7	7.1	7.0	9.2	8.7	5.0	13.7	6.0	10.9	9.2	3.6	12.7	6.6	10.8	12.1	5.4	16.5	7.3	8.5	7.1	12.1	15.1	8.7	7.2	8.8	8.6	11.6	17.7	13.6	3.4	13.2	11.3	3.1	12.4	6.4	13.3	6.0	3.7	11.4	9.0	7.5	11.9	10.5	8.3	9.0	6.4	6.5	6.4	24.4	6.2	12.4	17.4	6.7	10.2	3.9	6.7	8.7	18.1	9.7	6.1	10.2	8.5	12.2	4.3	7.2	7.2	4.1	6.0	5.8	6.5	7.6	4.1	6.2	7.0	7.0	8.0	8.4	4.1	3.3	8.7	4.2	13.1	14.5	18.8	17.0	10.0	11.1	9.2	12.3	14.0	10.0	11.9	13.2	7.3	9.1	15.3	13.4	14.1	12.7	2.7	11.4	7.0	17.7	11.6	8.3	9.5	442.1	22.6	12.5	0.0	10.2	9.9	11.0	16.6	5.8	15.7	9.9	25.4	16.1	22.7	20.0	1049.3	30.5	14.5	18.6	6.4	14.6	14.1	11.6	2.9	37.4	13.4	22.6	12.9	15.8	31.6	18.9	13.0	12.5	17.3	10.5	14.0
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 36.8;Spermatocytes: 10.2;Spermatogonia: 19.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain					NA	Yes					"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.6	18.4	24.8	14.6	3.4	5.9	14.4	26.5	18.7	37.2	45.9	14.0	14.1	11.9	8.5	13.0	32.5	12.3	21.6	16.6	41.1	32.5	8.6	9.4	21.8	14.0	1.3	14.5	11.9	2.1	3.0	28.6	16.3	4.8	18.7	18.6	11.9	19.1	30.4	11.9	18.0	6.8	19.8	16.1	14.4	16.7	16.7	7.6	11.4	12.0	16.8	12.5	14.1	13.6	8.6	14.4	11.4	6.9	9.2	20.1	25.4	16.9	24.1	3.8	13.6	17.9	12.7	10.8	27.2	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4	0.0	0.0	0.0	0.4	4.0	0.0	0.3	0.0	1.4	2.3	0.0	0.0	4.2	0.0	0.8	1.8	0.0	1.2	0.0	1.0	36.8	2.1	0.2	0.0	0.2	8.4	0.0	0.0	1.3	0.6	1.8	1.1	2.3	0.0	5.4	1.3	0.0	1.1	2.9	0.0	0.0	0.0	0.0	0.9	10.2	19.0	1.5	7.4	0.0	3.7	1.4
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Cell type enriched"	"Detected in some"	27	"B-cells: 57.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Group enriched"	"Detected in some"	8	"Daudi: 21.5;REH: 62.5;U-698: 28.2"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.1	62.5	0.1	0.1	0.0	0.0	4.4	1.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0	0.0	0.0	57.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.4	5.0	7.0	7.5	7.3	11.4	6.5	7.3	8.5	5.7	7.8	5.0	3.6	26.4	4.0	5.7	6.7	3.1	6.7	6.9	8.2	12.1	4.7	7.5	8.2	4.3	11.4	12.9	7.5	7.8	10.8	5.9	23.3	10.9	6.5	9.8	20.6	9.2	5.1	3.5	9.9	7.2	7.4	8.1	7.5	48.0	4.7	6.7	7.1	2.9	7.9	5.7	5.2	6.3	6.7	7.2	4.5	8.4	5.8	4.2	5.3	6.0	4.4	3.1	5.8	31.5	6.8	8.4	7.7	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4	32.8	14.4	78.3	25.6	25.1	15.3	9.3	5.1	24.1	20.5	5.2	9.8	13.5	23.2	14.0	40.8	19.1	9.7	0.0	13.7	21.8	25.2	22.7	23.1	10.6	14.4	11.1	18.3	15.4	13.0	15.6	25.0	16.4	15.1	9.0	19.9	18.5	12.5	14.4	18.4	15.4	23.6	6.5	21.7	45.1	42.1	28.5	15.6	27.7	19.5	19.2
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 748.4;Proximal tubular cells: 664.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.9	46.2	26.2	23.9	24.1	26.8	26.5	25.6	34.0	35.0	38.1	17.4	13.9	30.7	15.1	30.0	26.2	14.5	15.0	33.4	20.9	41.0	18.8	18.0	43.0	30.9	38.1	17.1	18.7	31.9	29.4	20.2	26.1	29.6	30.3	21.0	32.9	12.7	30.7	24.5	16.6	17.6	15.9	29.2	20.1	16.4	19.2	17.0	46.6	18.2	10.9	19.6	22.0	42.1	23.9	24.7	23.7	22.1	32.9	19.2	30.9	13.3	22.1	10.1	7.7	20.5	27.3	9.9	28.1	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7	53.6	20.9	43.5	39.7	38.5	33.3	86.0	219.1	29.4	26.1	48.8	19.6	128.8	210.5	67.4	10.2	41.4	82.6	46.7	77.8	76.0	63.3	42.0	49.6	748.4	97.6	22.3	59.7	76.1	83.4	10.4	69.0	49.3	75.9	86.6	59.5	85.7	64.8	60.5	92.6	664.7	23.4	77.6	62.6	17.5	16.2	49.2	74.4	37.9	71.9	35.2
ZBTB5	KIAA0354	ENSG00000168795	"Zinc finger and BTB domain containing 5"	O15062	9	37438114-37465399	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021521	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA021521: AB_2670736"	"unprognostic (2.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.22e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.81e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.80e-1)"	7.9	9.2	6.7	10.8	9.5	16.0	10.6	12.8	11.2	10.6	10.0	15.9	7.0	8.7	11.8	11.5	24.6	8.8	7.7	8.4	8.7	5.9	11.0	17.2	11.3	11.7	14.0	6.9	12.5	12.4	11.4	7.9	11.8	9.9	11.3	8.4	9.8	11.9	16.5	7.4	16.6	11.1	7.6	10.4	10.8	10.1	20.4	11.7	15.2	14.8	7.8	17.8	9.5	12.7	2.7	2.6	0.4	1.2	1.1	3.2	1.2	6.6	7.7	19.9	12.3	5.1	3.6	8.5	5.5	4.3	6.8	5.6	5.7	4.9	13.6	6.0	4.1	5.0	8.1	12.9	4.6	5.2	10.0	6.7	5.0	19.8	6.6	5.0	6.1	4.4	3.5	11.6	3.4	7.2	7.7	7.5	10.9	11.7	11.6	5.0	4.2	12.8	4.5	5.0	7.2	3.9	11.7	9.6	5.1	6.5	6.0	9.2	16.5	5.4	8.7	4.2	10.5	13.9	6.0	5.1	4.8	13.3	2.8	5.2	6.2	6.8	11.9	4.4	5.3	5.0	0.4	1.2	0.2	2.2	0.9	2.6	2.7	1.9	1.9	2.6	2.7	2.9	3.2	0.1	1.1	0.1	0.8	1.5	1.2	6.7	9.5	12.8	11.2	8.7	5.9	14.0	6.9	9.9	11.7	14.9	6.2	4.2	6.7	12.7	1.8	3.1	5.1	4.0	11.4	1.8	5.9	3.1	0.0	3.4	1.8	3.3	3.3	0.0	2.8	1.9	4.3	8.9	1.1	7.4	2.1	12.7	8.1	5.5	2.8	3.3	3.7	1.8	3.3	2.8	4.5	3.9	3.3	3.5	3.5	2.6	4.8	0.0	5.1	7.5	7.2	15.8	4.8	1.9	4.5	6.5
POLR1E	"FLJ13390, FLJ13970, PAF53, PRAF1"	ENSG00000137054	"RNA polymerase I subunit E"	Q9GZS1	9	37485935-37503697	"Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022527, HPA052400"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA022527: AB_1854924, HPA052400: AB_2681815"	"prognostic favorable (2.27e-4)"	"unprognostic (2.09e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.24e-2)"	15.4	12.2	10.5	20.2	11.6	9.3	19.7	10.7	9.0	19.0	13.9	10.0	14.9	7.0	20.5	14.7	15.1	17.3	13.7	14.9	9.1	9.2	7.6	23.9	10.1	15.5	9.0	9.2	36.9	25.9	10.3	9.6	8.7	9.5	17.3	9.3	9.5	19.5	18.4	17.2	13.1	9.0	22.4	10.2	10.8	13.0	11.2	11.5	16.0	15.3	13.3	17.1	21.9	16.8	8.1	3.9	1.4	4.3	9.0	16.9	5.5	19.7	18.6	10.3	16.3	19.3	24.9	6.7	17.6	6.8	18.3	16.2	15.9	6.6	28.8	8.5	20.2	12.4	8.3	25.1	20.9	23.1	27.8	11.8	13.8	23.6	11.3	14.5	26.4	9.8	26.4	7.4	35.7	30.9	11.5	9.2	16.1	36.0	12.7	16.0	9.5	18.2	9.0	18.3	13.6	15.3	16.2	9.5	13.8	9.5	7.4	14.7	12.1	11.7	9.4	15.1	8.9	9.2	17.6	6.3	21.7	33.1	18.5	35.0	7.0	9.8	30.3	7.5	16.8	18.0	0.0	2.5	1.4	10.6	4.3	16.9	7.4	10.2	10.8	3.9	8.1	12.8	11.1	0.8	9.0	3.4	2.7	5.4	5.5	10.5	11.6	10.7	9.0	9.1	9.2	9.0	9.2	9.5	11.5	0.0	6.7	8.5	20.9	25.1	6.4	7.6	15.3	5.3	9.1	0.0	3.9	12.9	6.6	12.3	4.4	7.5	2.7	0.0	18.2	17.4	12.1	6.6	8.1	15.8	6.6	3.2	1.7	3.7	8.6	8.6	13.8	7.3	5.0	8.2	7.3	6.7	14.5	0.0	14.2	4.1	5.7	0.0	17.9	11.5	16.1	15.6	7.0	12.9	12.1	11.6
FBXO10	FBX10	ENSG00000147912	"F-box protein 10"	Q9UK96	9	37510892-37576349	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 30.0;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AF22: 18.0;HHSteC: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002863, HPA072721"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002863: AB_10965996, HPA072721: "	"unprognostic (2.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.93e-5)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-1)"	3.8	7.5	4.8	7.5	8.3	1.2	3.4	4.4	12.1	3.6	6.7	4.9	6.3	2.8	5.0	16.9	4.7	2.8	4.5	4.3	6.3	5.9	3.9	4.0	3.5	7.7	4.0	6.7	3.1	7.4	6.4	20.8	3.1	3.9	4.0	2.9	5.3	15.0	5.2	27.0	2.9	4.8	5.0	3.1	10.1	3.6	12.2	3.3	2.9	11.7	6.0	7.7	4.5	2.9	5.9	0.8	0.0	0.2	0.2	1.1	0.5	1.6	4.1	18.0	4.6	8.4	3.0	1.4	3.2	5.6	3.9	5.9	2.3	1.1	10.5	1.1	3.3	1.6	0.1	6.5	1.5	2.9	5.8	5.2	2.1	3.8	2.0	25.8	5.5	0.7	6.9	1.2	3.5	2.3	2.6	5.5	1.0	7.2	2.9	6.9	1.4	2.1	1.8	8.3	2.4	1.5	4.1	7.9	1.3	2.2	1.1	3.8	9.6	2.0	2.5	2.2	5.5	1.0	5.7	4.3	2.8	4.9	2.5	2.2	3.6	2.8	1.7	2.4	2.2	2.6	0.0	0.1	0.0	0.7	0.2	0.7	5.9	1.1	0.7	0.0	3.2	0.1	0.1	0.0	0.2	0.2	0.8	0.2	0.5	4.8	8.3	4.4	12.1	6.3	5.9	4.0	6.7	3.9	3.3	0.0	0.6	6.1	0.1	0.2	3.3	1.4	0.0	1.4	0.0	1.8	3.9	0.3	0.0	1.2	30.0	0.6	0.0	0.0	1.3	0.7	0.6	0.6	0.0	0.9	3.2	3.2	5.2	6.7	0.3	29.3	0.9	0.0	1.7	1.0	0.5	1.5	1.4	0.0	1.4	1.3	0.9	0.0	0.9	3.1	1.9	0.5	0.2	0.0	0.3	0.3
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592642	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048712	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	33.2	37.8	34.5	31.2	39.7	28.3	44.1	24.3	38.5	26.7	34.7	13.1	28.3	37.5	28.7	32.7	36.9	25.4	31.1	39.6	30.9	34.7	44.3	45.3	24.4	37.4	37.6	26.3	27.4	83.8	12.7	28.8	19.6	32.3	25.2	31.2	17.3	49.6	36.2	51.5	24.1	34.8	34.1	23.9	38.9	31.2	33.0	27.2	24.5	36.3	46.1	37.8	26.7	35.3	59.1	43.1	14.0	33.9	40.2	54.9	50.5	55.1	64.4	38.2	34.2	43.9	43.2	21.1	42.1	27.0	41.1	44.0	68.5	22.9	37.8	34.6	39.9	41.9	19.2	33.9	50.2	42.9	53.1	53.6	33.2	89.6	98.1	36.1	54.4	22.0	37.2	27.6	45.2	44.8	19.5	46.8	42.5	80.8	42.5	41.7	44.2	45.8	47.9	66.5	46.6	40.8	38.9	31.9	55.6	47.0	34.6	33.1	30.4	21.6	29.5	30.7	33.9	20.6	63.8	31.7	28.5	61.0	44.8	64.9	16.2	46.8	63.1	34.9	47.1	43.8	12.3	32.2	14.0	43.0	33.9	52.7	59.1	53.1	47.7	39.0	49.1	54.9	50.5	3.7	40.2	28.5	43.1	42.1	50.5	34.5	39.7	24.3	38.5	30.9	34.7	37.6	26.3	32.3	27.2	26.8	30.2	43.6	35.9	99.7	4.4	20.1	58.6	49.5	53.4	43.6	11.8	22.0	68.0	47.4	168.9	45.6	41.0	0.0	110.0	44.6	34.2	29.9	44.0	129.9	59.4	1.6	17.4	52.2	57.8	127.0	32.5	43.7	59.1	81.2	44.0	6.7	88.5	35.1	29.4	80.6	6.2	0.0	32.3	51.5	22.8	128.0	21.1	47.8	53.1	48.7
FRMPD1	"FRMD2, KIAA0967"	ENSG00000070601	"FERM and PDZ domain containing 1"	Q5SYB0	9	37651000-37746904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.1;testis: 15.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 52.3;Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 66.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042934	Uncertain					NA	NA					"HPA042934: AB_10960422"	"unprognostic (6.41e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.04e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.12e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.91e-2)"	1.0	0.7	3.0	2.9	4.7	4.1	1.4	2.0	5.6	0.5	0.9	2.8	0.2	1.0	1.5	1.0	2.6	1.4	2.5	1.0	3.1	2.7	1.1	1.2	1.1	2.0	4.2	3.8	0.6	1.7	1.3	2.0	0.6	7.2	0.8	0.7	28.1	5.8	0.8	5.7	10.0	1.6	0.5	5.3	0.5	0.8	15.3	4.2	0.0	1.7	0.0	1.5	1.2	0.6	1.8	1.3	5.6	1.3	3.7	1.0	0.4	0.6	0.8	3.1	0.4	0.0	0.0	3.9	1.4	0.1	0.3	0.4	1.5	1.5	0.9	0.5	0.8	1.2	2.2	2.4	1.2	0.9	1.0	0.9	0.4	1.8	0.7	0.0	0.0	0.8	1.6	0.0	1.3	0.6	1.5	0.0	2.3	1.3	0.8	0.6	0.7	0.3	0.5	2.0	0.2	1.6	1.6	2.5	0.4	0.1	2.4	6.4	4.4	0.0	4.0	1.9	1.1	2.1	0.8	0.0	1.4	1.3	1.4	1.0	1.1	1.7	1.3	1.4	0.8	1.0	5.6	1.3	0.8	0.9	1.1	0.7	0.8	0.7	0.7	0.3	1.8	1.0	0.9	3.4	3.7	1.0	1.3	0.7	0.4	3.0	4.7	2.0	5.6	3.1	2.7	4.2	3.8	7.2	4.2	3.0	14.6	0.5	0.3	0.1	52.3	0.8	5.1	2.7	3.4	0.0	143.3	0.2	0.0	0.1	2.7	0.1	0.0	0.0	0.2	0.4	0.3	0.2	4.7	0.5	0.1	1.6	0.0	1.3	0.6	0.8	0.9	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.4	0.0	66.0	0.0	0.0	0.2	1.3	0.4	0.6	0.0	0.0	0.3
TRMT10B	"bA3J10.9, FLJ31455, RG9MTD3"	ENSG00000165275	"TRNA methyltransferase 10B"	Q6PF06	9	37753803-37778972	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021800	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA021800: AB_1856214"	"unprognostic (1.00e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (5.49e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	7.4	10.3	9.9	10.9	10.3	10.1	9.8	13.7	12.3	10.6	11.8	12.7	12.8	8.3	17.3	9.5	10.4	9.6	10.6	7.0	9.9	9.2	8.2	8.0	8.6	13.1	16.4	9.8	15.4	10.5	9.0	13.8	7.4	10.0	14.8	7.1	12.1	10.3	12.1	7.8	20.4	9.7	11.8	12.7	12.1	10.8	5.0	10.4	10.0	12.4	5.6	13.6	14.8	10.1	9.2	4.6	6.6	5.3	4.6	7.6	2.7	5.3	6.3	8.2	7.3	5.0	4.1	3.8	5.3	3.8	5.4	4.7	3.8	4.7	10.0	3.9	4.0	3.2	6.2	3.9	6.4	4.9	4.3	6.9	8.7	15.6	3.9	9.2	8.9	6.3	4.7	6.6	4.7	9.1	6.5	5.5	12.1	7.0	4.4	4.1	3.8	9.1	7.0	7.3	5.6	7.8	9.3	2.9	5.2	5.2	4.9	11.2	10.8	4.3	5.4	4.7	5.4	5.9	6.5	5.4	4.2	6.1	6.7	4.6	5.0	6.8	7.9	2.5	7.1	8.5	6.6	5.3	2.8	6.7	4.6	7.6	6.6	6.0	6.3	2.5	9.2	7.3	6.7	5.4	4.6	3.2	4.6	3.9	2.7	9.9	10.3	13.7	12.3	9.9	9.2	16.4	9.8	10.0	10.4	3.0	6.2	23.8	10.8	6.5	15.5	7.4	10.2	8.1	9.1	3.5	5.9	13.3	10.0	9.6	1.6	12.0	7.8	23.3	11.0	7.0	7.4	11.1	13.9	6.6	7.2	15.9	13.3	9.2	11.4	0.2	13.6	12.3	10.1	7.2	12.9	12.8	8.8	7.0	22.3	6.7	12.8	25.8	8.6	4.4	3.2	6.6	10.2	19.2	9.0	7.8
EXOSC3	"CGI-102, hRrp-40, hRrp40p, p10, RRP40, Rrp40p"	ENSG00000107371	"Exosome component 3"	Q9NQT5	9	37766978-37801437	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020485	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020485: AB_10960685"	"unprognostic (7.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.71e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	14.5	18.2	14.9	18.8	16.3	11.5	16.7	29.2	19.2	14.2	14.0	14.3	12.9	16.1	14.8	13.2	20.6	12.2	8.6	11.5	13.5	13.2	13.2	16.3	10.8	20.6	17.4	8.2	16.0	11.3	13.0	18.1	13.6	14.1	15.9	13.0	13.2	13.5	14.6	14.9	11.9	12.0	17.9	11.7	16.0	15.8	26.9	18.7	23.1	14.6	13.3	22.5	12.9	15.7	34.5	32.6	22.9	33.7	24.4	32.9	33.7	25.9	18.6	10.0	12.8	6.9	5.4	13.3	15.1	5.9	12.6	11.9	24.3	4.4	20.2	11.4	5.6	14.6	10.1	11.1	10.5	14.6	28.2	18.3	16.3	22.6	22.3	7.8	24.8	15.0	3.9	5.5	9.8	6.2	4.1	6.6	14.8	40.3	9.4	9.0	15.8	22.1	19.9	27.1	23.9	20.9	20.1	12.4	10.9	7.1	8.9	14.6	14.7	8.6	7.1	9.5	8.5	9.4	18.2	7.6	10.3	18.7	12.6	23.5	6.6	16.6	26.8	10.2	19.5	11.3	17.8	29.8	22.9	25.0	33.7	31.9	34.5	30.3	32.9	27.7	30.5	30.6	29.5	18.2	24.4	29.8	32.6	32.1	33.7	14.9	16.3	29.2	19.2	13.5	13.2	17.4	8.2	14.1	18.7	20.8	14.5	32.3	25.9	48.1	6.6	6.4	22.9	12.0	10.3	7.0	0.0	51.2	28.2	35.4	50.5	14.0	12.0	0.0	30.2	64.9	23.2	12.7	28.8	10.4	39.7	6.4	10.3	12.9	23.1	7.4	15.5	17.5	18.6	24.4	15.3	8.9	29.5	17.5	12.4	22.3	6.8	25.8	24.7	99.1	59.2	47.3	26.3	20.0	21.5	22.7
DCAF10	"FLJ23201, MGC10765, WDR32"	ENSG00000122741	"DDB1 and CUL4 associated factor 10"	Q5QP82	9	37800502-37867666	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 134.0;Late spermatids: 237.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024160	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA024160: AB_1858802"	"unprognostic (2.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.05e-2)"	12.4	21.1	8.8	8.1	12.0	9.9	12.1	14.8	14.9	14.2	13.3	8.8	13.0	10.0	14.2	12.1	16.9	11.7	10.4	15.3	7.9	7.9	14.5	19.1	10.6	9.3	8.4	9.9	15.6	14.8	25.8	13.7	10.5	10.3	16.0	10.9	10.9	12.9	15.7	16.9	12.6	15.2	13.3	7.6	9.4	11.7	29.7	8.6	19.0	16.2	8.0	8.6	17.3	20.4	3.4	1.2	4.2	3.7	3.0	3.5	0.6	12.2	5.7	6.2	5.9	10.3	14.1	8.1	9.9	9.1	5.6	8.0	2.0	4.5	12.4	4.6	11.4	7.1	4.7	6.2	6.9	6.8	10.5	6.2	5.6	9.3	3.7	18.6	7.2	4.2	12.7	14.0	6.6	23.5	10.7	9.0	7.0	19.6	5.7	8.7	4.4	6.8	3.3	6.8	15.4	5.0	6.8	3.2	6.4	9.0	5.7	7.2	9.9	9.1	10.2	8.0	7.4	8.2	13.6	11.3	6.3	4.9	8.8	6.9	5.5	9.4	7.1	10.0	7.3	8.7	0.9	1.4	4.2	2.3	1.2	1.5	2.6	1.9	2.6	1.2	3.4	3.5	2.0	3.9	3.0	3.7	1.1	1.1	0.6	8.8	12.0	14.8	14.9	7.9	7.9	8.4	9.9	10.3	8.6	14.9	23.7	17.9	23.3	36.2	26.6	15.5	7.6	10.7	23.9	12.2	23.6	14.6	8.3	20.0	134.0	21.2	17.7	0.0	19.0	14.1	22.3	28.9	4.7	38.0	13.4	23.8	18.5	23.4	12.6	237.0	25.9	15.7	25.3	10.0	22.3	22.8	20.1	10.5	36.0	23.8	24.8	38.8	23.8	58.5	7.7	45.8	19.1	15.2	25.1	23.7
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 74.4;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (2.08e-2)"	17.6	9.1	11.7	9.9	12.9	21.2	27.6	11.3	14.2	12.0	10.7	12.0	10.8	15.3	10.3	10.2	12.6	8.1	10.7	11.5	12.9	9.3	13.3	9.7	14.6	10.8	11.9	14.9	11.0	16.7	20.6	12.8	9.7	11.9	10.5	9.0	8.2	13.3	8.4	15.9	11.7	13.4	12.2	11.4	12.6	9.7	18.8	12.4	14.4	9.8	7.6	12.9	9.1	10.2	3.1	1.4	13.4	3.9	2.1	3.6	1.1	8.2	6.6	5.1	8.0	24.5	10.7	5.2	7.0	7.3	6.1	8.9	8.6	3.6	17.4	4.1	16.6	8.6	4.1	13.6	9.9	11.8	11.9	4.2	5.3	18.2	12.0	13.8	8.3	7.8	10.7	11.6	9.1	11.7	9.7	11.0	16.7	11.6	13.9	13.0	4.7	10.0	1.9	6.3	8.5	4.8	7.0	6.8	10.7	6.1	6.0	10.7	6.9	5.6	6.8	4.0	9.0	3.7	9.1	11.9	10.3	12.1	4.8	8.7	5.3	11.2	12.2	13.5	6.1	8.5	13.4	1.9	3.2	2.1	3.9	3.6	3.1	2.3	3.0	1.4	2.2	2.2	2.5	1.5	2.1	1.6	0.6	3.4	1.1	11.7	12.9	11.3	14.2	12.9	9.3	11.9	14.9	11.9	12.4	8.9	0.6	4.2	5.0	4.1	4.3	5.7	2.5	1.4	2.3	1.8	3.9	3.2	14.9	8.3	74.4	3.4	5.1	0.0	6.3	11.8	4.2	3.9	3.5	3.2	10.5	1.6	3.5	0.6	5.9	125.5	3.4	5.0	1.7	9.0	4.2	3.4	7.2	7.0	3.9	13.4	3.4	0.0	3.1	10.2	10.3	5.1	3.3	3.2	3.5	3.4
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37919134-38069211	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 74.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	71	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"OE19: 35.0"									"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	8.6	5.6	7.5	5.3	15.9	7.2	8.0	1.4	12.5	8.2	8.4	16.1	3.2	10.1	6.1	5.6	19.6	5.9	29.4	20.2	8.9	5.0	13.6	34.2	11.6	3.1	17.9	5.3	5.6	17.8	13.7	13.1	7.7	12.6	12.9	7.0	7.6	18.9	11.3	6.4	13.0	9.5	11.9	7.6	6.7	14.1	3.5	16.3	2.7	7.7	10.3	11.1	10.7	11.9	0.0	0.0	8.1	0.0	0.0	0.1	0.0	8.1	12.9	1.4	0.2	1.5	3.6	2.3	9.0	11.0	6.3	4.9	3.0	5.7	0.0	10.9	7.7	14.6	7.8	5.1	13.3	4.4	6.9	10.3	0.0	4.5	9.5	10.0	0.4	0.4	3.2	4.2	9.9	7.6	14.7	6.4	1.3	3.2	2.7	7.3	5.5	1.0	0.4	3.4	35.0	12.3	0.4	3.8	0.4	13.1	2.9	13.9	11.1	1.2	9.8	2.2	11.5	6.2	0.5	7.9	2.9	10.6	1.5	14.3	0.8	0.3	0.1	17.4	0.8	2.8	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	15.9	1.4	12.5	8.9	5.0	17.9	5.3	12.6	16.3	6.0	6.4	0.5	74.8	18.1	0.3	8.1	35.7	2.7	6.8	21.0	7.9	8.6	13.3	14.6	1.8	9.8	10.5	0.0	17.2	1.0	5.7	35.8	0.0	19.8	5.2	0.0	7.5	5.5	1.3	3.4	0.6	2.1	6.8	0.0	10.6	2.0	17.9	8.6	0.4	18.2	1.4	0.0	4.7	0.5	6.8	29.6	3.3	0.0	7.4	45.7
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
IGFBPL1	bA113O24.1	ENSG00000137142	"Insulin like growth factor binding protein like 1"	Q8WX77	9	38408994-38424447	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0"	"Group enriched"	"Detected in some"	4	"basal ganglia: 12.5;olfactory region: 16.2"	"Low region specificity"	"Detected in many"			HPA051354	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			"Nucleoplasm, Vesicles"		"HPA051354: "	"unprognostic (5.63e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.67e-2)"	1.6	2.6	3.8	1.1	11.0	0.3	0.4	4.7	4.7	0.7	1.0	1.0	0.0	1.9	2.1	0.5	0.7	1.0	1.9	3.7	3.3	2.3	0.7	0.6	1.2	0.4	1.4	1.5	0.5	1.6	0.4	7.4	1.1	1.8	1.6	0.7	0.2	0.5	2.9	0.3	0.3	1.2	2.1	0.6	0.4	2.5	3.3	1.5	2.6	27.2	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	67.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	18.6	0.0	0.1	0.0	19.5	0.1	0.0	0.0	69.8	67.7	1.1	0.0	0.0	43.0	0.3	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	11.0	4.7	4.7	3.3	2.3	1.4	1.5	1.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 16.6"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.5	3.5	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	1.9	0.0	0.0	0.9	3.4	3.2	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.6	0.4	0.0	2.3	0.0	3.1	1.7	0.0	7.0	1.6	0.3	0.3	4.3	0.1	0.8	3.6	5.8	2.0	0.0	6.3	6.3	2.1	1.9	1.5	3.0	2.3	0.5	0.1	7.4	2.5	7.9	4.3	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9	0.0	1.0	0.0	1.8	0.6	3.9	6.5	0.0	17.4	5.7	1.8	2.0	0.0	1.7	4.4	4.9	0.0	0.7	0.0	2.0	0.1	0.0	2.0	0.0	0.5	0.1	0.0	4.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	3.6	13.3	3.7	2.9	0.4	0.1	33.7	0.0	0.1	25.6	2.0	1.5	0.0	0.0	2.3	0.7
FAM240B		ENSG00000283329	"Family with sequence similarity 240 member B"	A0A1B0GVZ2	9	38694263-38720428	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.9;tongue: 6.0"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in single"	9	"cerebellum: 0.8"											NA	NA																							0.1	0.0	0.1	0.1	0.1	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.0	0.4	0.1	0.1		0.1	0.1	0.1	0.6	0.1	0.1	0.1	2.6	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	1.5	0.3	0.1	0.1	0.8	0.0	1.6	0.1	0.1	0.2	6.0	0.1	0.1	0.1	1.5	1.6	6.9	0.8	1.2	0.7	0.5	1.0	0.7	0.6	0.8	0.0	1.0	0.5	0.0	0.2	0.2	0.0	2.0	0.7	0.2	0.3	0.0	0.4	1.7	0.0	0.4	0.3	1.0	0.5	0.8	1.8	0.4	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.9	0.0	0.4	0.2	0.9	0.4	0.2	0.9	0.0	1.2	0.0	0.0	0.3	1.1	0.3	0.4	0.2	1.7	0.0	1.2	0.2	0.0	0.4	0.1	1.3	0.8	0.9	1.6	0.4	0.0	0.6	0.0	6.9	0.8	1.5	0.6	0.7	0.5	1.1	0.6	0.6	0.3	1.5	0.6	0.7	3.9	1.2	0.6	1.6	0.4	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein like 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;esophagus: 9.5"	"Cell type enhanced"	"Detected in many"	11	"Ito cells: 22.1;Muller glia cells: 11.5"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	22	"neutrophil: 10.6"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"A549: 12.7;AF22: 15.4;TIME: 9.7;WM-115: 25.7"									HPA047731	Uncertain				"Intracellular and membrane"	NA	NA					"HPA047731: AB_2680137"	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.9	0.1	1.2	0.3	4.8	1.0	2.6	0.4	2.5	0.8	2.4			0.6	0.2	0.2	9.5	1.6	1.1	4.1	1.2	1.3	1.1	0.0	0.8	0.0	0.8		0.0	0.0	0.0	0.3	1.7		1.6	1.4		2.8	1.7	0.0	8.3	1.0	2.5	1.1	2.4	0.1	1.9			1.3		0.3	0.5	1.9	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.7	12.7	15.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.9	3.2	1.3	2.9	0.0	0.0	1.1	0.0	3.4	0.3	0.1	0.2	0.0	0.4	2.8	0.0	1.1	6.5	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	3.9	0.0	0.4	3.5	0.3	0.5	1.4	0.5	4.5	0.0	2.5	1.7	0.0	2.1	9.7	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0											3.0	1.7	0.0	3.4	5.6	0.8	2.5	7.6	2.7	0.0	1.8	2.0	0.7	0.0	0.3	1.3	5.8	0.0	0.0	0.2	0.6	0.9	0.8	0.0	1.8	0.1	0.0	3.4	22.1	1.3	0.8	0.3	0.0	0.0	0.0	0.0	11.5	0.5	0.0	0.0	1.5	0.4	0.0	0.5	0.9	5.8	6.8	0.6	0.0	0.0	2.5
SPATA31A1	"C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2"	ENSG00000204849	"SPATA31 subfamily A member 1"		9	39355669-39361959	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	103	"testis: 10.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 13.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	33	"U-2197: 3.3"															NA	NA																				"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
ANKRD20A2		ENSG00000183148	"Ankyrin repeat domain 20 family member A2"	Q5SQ80	9	40223285-40266392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 1.7;granulocytes: 1.1;Spermatocytes: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.7;U-266/70: 2.8;U-266/84: 5.0"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "					"unprognostic (4.24e-3)"									"unprognostic (9.19e-2)"				0.1	0.1	0.4	0.0	1.4	0.2	0.3	1.0	1.2	0.1	0.4			0.0	0.0	0.5	1.2	0.7	0.1	1.9	0.7	0.7	0.3	0.2	1.2	0.0	0.4		0.0	1.4	1.1	0.8	0.0		0.4	1.1		1.1	0.4	0.3	0.2	0.1	0.0	0.1	1.5	0.0	7.6			0.5		0.0	0.0	0.3	0.1	0.9	0.9	0.0	0.0	0.6	0.0	0.2	1.3	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.6	16.7	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	2.8	5.0	0.0	0.0	0.0	0.8	0.1	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0											0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.2	0.0	0.0	0.1
FOXD4L6		ENSG00000273514	"Forkhead box D4 like 6"	Q3SYB3	9	41126430-41128463	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 1.8;lymphoid tissue: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (2.41e-1)"			"unprognostic (3.41e-1)"									"unprognostic (3.61e-1)"				0.0	0.0		1.5		0.0	0.0		1.8	0.0	0.0			0.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.2	0.1	0.3			0.0	0.2	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.8	0.2	0.3			0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.7	0.2	0.0	0.5	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.1	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.7	0.3	0.0	0.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBWD6	CBWD7	ENSG00000215126	"COBW domain containing 6"	Q4V339	9	41131306-41199261	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"blood: 9.3;liver: 6.1"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 34.9;Melanocytes: 13.5;Suprabasal keratinocytes: 37.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 12.5;PC-3: 19.4"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (9.48e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.28e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.94e-4)"	0.1	5.2	2.2	0.4	2.4	2.0	2.8	1.0	2.0	0.2	0.3			1.2	0.1	0.0	0.2	0.0	1.6	1.3	2.8	1.5	2.1	6.1	0.1	0.0	1.2		0.2	1.3	0.0	0.5	0.0		0.6	0.0		2.8	2.5	4.3	0.4	0.9	0.0	1.2	0.3	0.2	0.1			0.3		0.2	0.2	0.1	4.8	4.0	2.5	9.3	0.6	4.3	2.8	1.4	0.3	0.6	0.3	0.7	1.9	1.2	7.9	8.9	9.2	0.0	3.0	0.9	1.9	0.4	6.4	0.4	1.3	11.7	0.2	0.3	1.9	7.5	0.5	4.2	2.1	0.0	2.3	0.7	0.2	1.1	6.1	7.6	0.7	7.0	0.6	1.0	1.1	12.5	1.2	3.4	0.6	1.9	3.2	19.4	0.8	7.8	2.6	8.2	0.5	0.9	1.0	1.9	0.7	0.9	1.8	0.6	1.2	11.7	0.1	0.9	0.4	0.8	3.5	0.6	10.3	1.2	0.8	0.9	1.6	5.9	2.5	0.8	6.8	1.4	4.8	4.3	3.5	3.3	1.8	3.0	3.4	0.9	0.6	9.3	4.0	1.8	2.8											3.0	6.2	0.0	0.0	34.9	0.0	0.0	0.0	2.7	4.5	5.2	0.0	4.4	3.3	3.7	0.0	0.0	0.0	0.0	4.3	5.7	3.1	0.0	8.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	13.5	2.8	0.0	0.0	4.1	0.0	0.0	7.2	0.0	0.0	2.6	0.0	0.0	37.5	5.3	0.0	0.0	0.0
CNTNAP3B		ENSG00000154529	"Contactin associated protein like 3B"	Q96NU0	9	41890314-42129510	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Endothelial cells: 28.1;Ito cells: 77.3;Muller glia cells: 26.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	9	"neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in some"		"A549: 18.4;AF22: 26.3;WM-115: 17.7"									HPA047731	Uncertain					NA	NA					"HPA047731: AB_2680137"	"unprognostic (2.68e-2)"	"unprognostic (9.63e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.78e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-4)"	4.1	0.6	1.1	0.3	2.2	0.0	4.7	0.5	2.2	1.5	1.1			0.4	1.3	0.0	7.3	1.9	1.3	2.5	1.3	1.4	4.9	1.0	2.1	0.0	0.9		0.4	0.3	0.0	1.2	2.4		1.0	1.7		1.9	1.1	0.7	6.5	0.6	1.9	0.9	1.6	0.5	1.1			0.8		0.1	2.0	1.4	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	18.4	26.3	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.1	0.4	2.3	1.5	1.4	0.0	0.0	0.9	0.0	3.3	1.6	0.6	0.9	0.0	2.0	2.2	0.2	0.3	6.6	4.3	0.0	0.4	0.1	0.0	0.1	0.0	0.0	2.5	0.6	5.6	0.0	0.5	7.1	0.8	0.5	1.9	0.2	0.7	0.0	3.5	0.8	0.0	2.5	4.5	0.1	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.8	17.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0											0.0	4.6	0.0	6.7	3.8	2.9	6.1	2.5	14.7	0.0	3.5	0.0	2.1	0.0	1.6	1.8	28.1	0.0	0.0	2.8	1.0	1.3	1.5	1.1	7.5	0.1	0.0	1.7	77.3	3.8	0.9	0.9	1.0	5.0	0.0	0.6	26.6	2.0	0.0	0.7	6.0	0.5	0.0	1.0	0.7	2.2	4.5	0.6	0.5	0.0	6.2
SPATA31A6	FAM75A6	ENSG00000185775	"SPATA31 subfamily A member 6"	Q5VVP1	9	42183659-42189882	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 1.0"															NA	NA																				"unprognostic (2.23e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31A5	FAM75A5	ENSG00000276581	"SPATA31 subfamily A member 5"	Q5VU36	9	60914374-60920650	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	30	"testis: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31A7	"FAM75A4, FAM75A7, SPATA31A4"	ENSG00000276040	"SPATA31 subfamily A member 7"	Q8IWB4	9	61190003-61196280	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	57	"testis: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.6			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BX088645.1		ENSG00000283378			9	61330717-61453030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 21.7;bone marrow: 14.1"	"Not detected"	"Not detected"											"Cell type enriched"	"Detected in some"	13	"neutrophil: 21.7"	"Lineage enriched"	"Detected in single"	182	"granulocytes: 21.7"	"Cell line enhanced"	"Detected in some"		"A549: 21.5;SiHa: 4.7;TIME: 6.8;WM-115: 18.9"															NA	NA																							0.1	0.0		0.0		14.1	0.0		0.5	0.1	0.0			0.0	0.0	0.0	0.2	0.0	0.0	1.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.1		0.3	0.0	0.5			0.1		0.0	0.0		0.1	0.0	21.7	0.0	0.0	0.0	0.0	1.0	21.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.7	2.3	0.3	1.6	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.4	1.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.7	0.0	0.3	2.4	0.0	0.7	0.3	0.6	4.7	0.1	1.4	0.2	0.1	0.1	6.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD20A4		ENSG00000172014	"Ankyrin repeat domain 20 family member A4"	Q4UJ75	9	64369394-64413142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 40.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.4;Karpas-707: 4.3"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "	"unprognostic (3.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.69e-2)"		"unprognostic (2.56e-1)"		"unprognostic (9.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.84e-2)"	1.5	1.0	0.7	0.2	1.6	3.9	0.9	2.3	1.9	0.3	0.9			0.6	0.5	0.2	1.7	0.5	0.2	1.7	0.8	1.0	0.7	0.1	1.1	0.1	0.6		1.4	2.4	0.0	0.9	1.0		0.4	1.4		0.9	0.0	0.4	0.6	1.2	0.0	0.3	1.0	0.9	2.1			0.7		0.0	0.3	0.6	0.0	1.4	1.7	0.0	0.0	0.8	0.0	0.7	0.4	2.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.0	0.3	1.9	0.2	0.0	4.4	1.4	1.3	0.4	0.7	0.0	1.0	2.0	0.0	0.0	0.1	0.1	0.5	0.6	2.8	3.0	4.3	0.1	0.3	0.8	0.2	0.3	2.5	0.9	0.0	1.0	0.6	0.8	0.5	1.9	0.6	0.2	0.1	2.0	0.5	1.9	0.2	0.9	0.0	1.8	0.5	0.1	0.9	0.6	1.0	0.4	0.0	0.4	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.4	0.0	0.0											3.0	0.0	0.0	0.8	0.5	1.5	5.5	0.0	2.7	0.0	0.0	2.0	0.3	0.0	0.1	2.3	0.4	5.9	0.0	3.2	0.1	0.4	0.4	1.1	0.0	0.0	1.6	2.9	0.6	1.2	0.8	0.0	0.7	0.0	0.0	2.5	0.6	0.8	3.5	1.1	0.1	0.3	0.0	0.9	40.3	2.7	0.5	0.2	1.7	1.7	2.3
FOXD4L5	bA15J10.2	ENSG00000204779	"Forkhead box D4 like 5"	Q5VV16	9	65282101-65285209	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (8.26e-2)"	"unprognostic (6.95e-3)"									"unprognostic (1.58e-1)"			"unprognostic (5.76e-2)"	"unprognostic (2.57e-1)"			0.7	1.1	0.3	0.1	0.5	0.0	0.7	0.6	2.2	0.3	0.1			0.1	0.1	1.1	0.4	0.7	0.1	0.2	1.0	0.5	0.5	0.2	0.3	0.2	0.3		0.2	0.2	0.0	0.2	0.5		0.3	0.0		1.2	0.1	0.5	2.0	0.3	0.0	0.2	0.2	0.4	1.0			0.8		0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.2	1.1	0.7	2.8	0.5	0.3	3.5	0.6	0.2	0.0	0.0	0.7	0.3	2.0	0.4	0.2	0.3	0.0	1.5	0.2	0.2	2.8	1.7	1.8	0.8	0.9	0.0	1.5	2.7	0.2	0.8	0.2	0.6	1.0	0.0	0.2	2.7	1.1	0.3	0.6	0.3	1.0	0.8	0.3	0.9	0.6	2.2	0.7	0.7	1.4	1.4	2.6	0.6	0.3	0.2	1.8	0.9	3.5	0.4	0.4	2.1	1.2	1.1	0.8	1.7	0.5	0.3	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	4.1	6.0	5.2	3.7	6.8	2.5	9.2	8.2	3.7	2.8	3.3			5.4	1.7	4.8	3.3	1.7	2.2	2.4	6.2	6.0	7.6	17.9	1.9	2.6	4.8		2.1	6.6	2.9	4.0	2.9		4.3	5.5		2.2	3.8	2.1	2.8	4.4	2.5	2.6	5.7	2.2	2.1			5.1		4.4	5.4	1.5	5.5	11.7	7.7	14.0	2.5	5.5	9.3	15.0	16.2	5.8	7.4	8.9	4.1	7.0	10.7	7.2	8.5	8.7	2.1	13.9	20.5	6.9	6.2	12.2	11.1	26.3	8.5	16.1	3.3	6.3	5.7	26.2	36.4	6.7	12.9	3.7	7.2	9.9	7.8	6.3	10.7	15.3	7.9	8.1	15.3	8.6	18.2	6.4	13.7	7.1	26.0	17.5	11.2	8.0	20.5	13.5	9.9	7.7	7.8	8.7	6.8	3.1	10.7	31.8	8.6	4.3	3.8	14.2	11.7	12.2	5.0	13.4	4.9	16.1	14.9	14.5	1.6	11.6	7.7	3.4	14.0	3.7	5.5	5.5	4.7	11.7	2.9	5.1	4.1	7.1	2.5	8.5	4.9	4.1	9.3											38.7	47.5	48.4	29.8	57.9	38.4	30.2	33.1	36.1	52.4	19.2	64.8	36.3	18.3	30.3	7.7	18.2	41.3	23.3	34.0	18.7	12.4	16.5	9.3	42.4	14.1	33.4	16.1	15.4	24.3	4.1	19.5	26.9	28.7	55.1	26.5	9.8	28.6	45.6	16.3	31.8	56.7	6.5	25.0	26.5	16.8	74.8	42.2	19.8	27.6	26.5
FOXD4L4	"bA460E7.2, FOXD4L2"	ENSG00000184659	"Forkhead box D4 like 4"	Q8WXT5	9	65736555-65738784	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (6.92e-2)"	"unprognostic (5.48e-2)"			"unprognostic (5.19e-2)"						"unprognostic (7.78e-2)"		"unprognostic (7.93e-3)"	"unprognostic (7.14e-2)"				0.4	0.6	0.3	1.0	1.2	0.0	0.2	1.5	1.3	0.7	0.2			0.0	0.2	0.0	0.2	0.2	0.1	0.4	1.0	0.7	0.2	0.1	0.0	0.1	0.6		0.2	0.0	0.0	0.2	0.2		0.2	0.1		0.4	0.1	0.4	0.0	0.4	0.1	0.2	0.5	0.1	0.5			0.0		0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.5	1.4	0.0	0.2	0.3	0.7	0.0	0.0	0.2	1.0	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.2	0.5	0.0	0.2	0.2	0.7	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.5	0.2	0.7	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.8	1.0	0.4	0.0	0.1	0.2	0.7	0.0	0.1	0.5	0.0	0.4	1.0	0.5	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD20A3		ENSG00000276203	"Ankyrin repeat domain 20 family member A3"	Q5VUR7	9	66106815-66153135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;lung: 1.3;testis: 2.0"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 5.3;Horizontal cells: 4.8;Spermatocytes: 16.4;Spermatogonia: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HDLM-2: 5.2;RPTEC TERT1: 1.4;WM-115: 1.3"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "					"unprognostic (4.27e-2)"													0.1	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	1.1	0.1	0.0	0.0			0.0	0.0	1.3	0.1			0.0	0.0	0.0		0.0		0.0	0.5		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	2.0			0.2		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.5	0.0	0.1	0.1	0.0	5.2	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.0	0.0	1.1	0.2	0.8	1.8	0.0	5.3	0.0	0.0	3.9	0.0	0.0	0.0	2.0	0.0	1.0	0.0	0.9	0.0	0.0	0.6	3.5	0.0	0.1	4.8	0.0	0.6	1.3	1.8	0.3	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.1	16.4	6.5	0.1	0.0	0.0	0.2	1.0
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Ribosome biogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 20.9"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 12.0;Distal tubular cells: 13.3;Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in some"	11	"neutrophil: 20.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.9"	"Low cell line specificity"	"Detected in many"											"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	0.5	0.8		0.1		0.0	2.8		1.4	1.6	0.6			0.3	1.5	0.8	1.4	1.8	0.1	1.8			1.5	0.5	0.9	0.5			3.5	1.1	2.4		0.1		1.8	0.7		1.6	1.4	1.9	4.5	0.0	0.9		1.1	0.6	1.2			2.1		0.9	0.9		1.3	0.4	20.9	0.5	1.8	1.4	0.1	2.8	4.8	4.7	8.8	4.8	5.8	3.6	2.2	4.1	3.1	3.4	0.4	2.2	6.4	2.5	2.1	3.3	7.6	3.7	4.4	3.3	0.2	2.3	1.0	4.0	1.0	5.3	4.0	2.4	4.5	9.8	3.0	4.4	6.4	6.0	4.3	1.3	1.3	3.9	1.6	3.2	2.0	4.0	2.0	8.2	0.3	7.5	2.3	3.3	7.3	6.8	4.1	3.5	1.9	3.4	5.1	2.7	10.3	1.3	4.0	5.1	3.5	2.7	0.8	3.7	1.6	1.8	1.4	4.2	0.5	0.5	1.5	0.6	0.4	0.1	0.6	0.9	0.8	0.2	1.3	1.4	0.7	20.9	1.8	0.4	0.4	0.5	0.1											3.0	2.7	0.5	1.0	0.8	6.4	3.2	0.0	12.0	3.4	0.0	0.0	2.3	13.3	0.9	0.6	0.7	0.9	0.0	0.6	0.7	0.9	0.7	1.1	2.4	1.6	9.5	0.0	0.6	1.3	0.9	2.8	0.1	0.0	0.0	1.8	4.9	0.8	0.0	4.9	4.8	3.9	0.0	0.5	2.6	2.0	1.8	0.8	0.0	1.2	0.9
SPATA31A3	"DKFZp434B204, FAM75A3"	ENSG00000275969	"SPATA31 subfamily A member 3"	Q5VYP0	9	66986304-66992583	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	81	"testis: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	8.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD20A1	"ANKRD20A, DKFZp434A171"	ENSG00000260691	"Ankyrin repeat domain 20 family member A1"	Q5TYW2	9	67859147-67902094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;testis: 6.5"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.6;Ciliated cells: 4.0;Spermatocytes: 6.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 7.1;U-266/70: 11.7;U-266/84: 3.9"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: "	"unprognostic (4.92e-1)"	"unprognostic (4.31e-3)"			"unprognostic (3.97e-1)"			"unprognostic (2.30e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"		0.1	0.0		0.0		0.3	0.1		0.8	0.3	0.2			0.0	0.0	0.1	0.3	0.3	0.0	0.0			0.2	0.1	0.0	0.0			0.0	1.1	0.0		0.0		0.1	0.9		0.2	0.1	0.0	0.4	0.1	0.3		0.8	0.0	6.5			0.5		0.0	0.0		0.0	0.0	2.3	0.1	0.1	0.3	0.0	0.2	0.4	1.4	0.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.4	0.9	1.0	0.4	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.4	7.1	0.0	0.0	1.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3	0.6	1.0	11.7	3.9	0.0	0.5	0.0	1.9	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0											3.0	1.3	0.0	0.0	0.0	0.0	2.6	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	1.1	0.0	1.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	6.3	1.9	0.0	0.0	0.0	0.9	0.0
CBWD3	bA561O23.1	ENSG00000196873	"COBW domain containing 3"	Q5JTY5	9	68232003-68300015	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 34.4"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.71e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.43e-3)"	"unprognostic (5.16e-4)"	3.8	6.0	4.4	6.6	4.9	4.0	6.5	5.7	5.1	2.7	4.7			4.2	2.9	2.1	5.4	3.0	1.8	2.9	4.8	4.4	7.7	11.1	2.9	5.7	4.5		3.6	10.7	4.2	5.0	5.5		4.1	3.2		3.7	3.6	5.2	4.9	7.6	2.8	3.9	5.0	6.3	3.2			5.1		4.3	4.5	3.5	20.3	24.4	34.4	33.9	5.7	14.0	19.9	21.3	15.9	7.8	12.1	5.8	1.9	10.3	10.7	4.2	4.5	5.3	4.4	21.0	24.7	10.4	7.7	21.0	26.2	14.3	21.0	12.4	38.0	9.2	9.5	36.2	21.0	7.4	17.9	11.9	4.8	6.5	8.2	10.8	9.0	10.5	28.3	17.3	20.2	6.6	13.7	20.9	23.9	11.4	25.5	26.7	9.5	24.3	26.9	5.1	9.2	12.1	7.8	17.6	10.6	13.1	15.1	7.6	20.8	5.0	7.0	17.9	11.5	20.5	11.9	47.4	30.3	21.0	26.5	12.6	9.1	33.9	24.8	11.6	27.2	10.0	20.3	10.8	11.9	24.4	18.4	11.7	10.9	34.4	5.7	19.0	18.3	14.0	19.9											23.8	25.9	16.0	14.0	12.9	27.1	24.2	7.6	40.2	34.2	10.4	27.5	11.9	1.7	5.1	3.3	7.5	11.7	0.0	10.0	6.7	4.7	7.5	11.6	7.3	4.6	11.1	4.1	7.4	13.0	1.7	4.6	8.7	5.0	22.6	6.5	4.3	6.9	14.0	2.8	5.0	34.5	6.5	5.3	10.1	5.0	18.7	12.9	10.2	8.1	9.5
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68304905	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0"	"Cell type enriched"	"Detected in single"	12	"monocytes: 1.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.9"									HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.1	0.7	1.4	1.3	0.0	0.0	2.1	2.3	0.3	0.1			0.0	0.0	0.0	0.0	2.4	0.4	0.0	2.6	0.7	0.0	0.0	0.0	1.6	0.5		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.3	0.0	0.0	0.4	0.0	0.0	0.1	2.0	0.0	0.9			0.0		0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.3	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.4	0.0	0.9	0.1	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.8	0.5	0.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 123.0"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		NA	NA		380000	Cytosol		"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758"	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	5.9	13.6	0.8	7.5	1.3	0.0	4.1	2.1	1.5	25.9	52.2	1.8	26.1	2.9	36.9	10.3	22.6	20.9	11.1	31.6	1.0	0.4	2.0	1.5	2.7	5.9	0.9	1.3	9.3	1.9	0.5	1.2	1.7	1.3	37.1	7.6	4.3	2.9	51.1	8.5	2.2	15.4	123.0	1.5	1.7	16.6	4.3	0.9	0.9	2.8	4.5	1.5	57.4	24.5	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	4.2	3.4	2.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	29.8	0.0	20.7	0.9	0.9	0.0	0.0	0.1	0.0	25.9	1.4	0.6	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.8	1.3	2.1	1.5	1.0	0.4	0.9	1.3	1.3	0.9	0.0	1.7	0.0	5.1	2.1	22.3	88.7	0.0	1.4	3.4	12.2	3.9	0.0	1.7	0.1	1.2	35.0	0.0	0.0	0.0	0.1	3.3	2.7	0.0	0.0	0.1	0.0	0.0	31.9	3.2	0.0	7.5	1.9	3.3	1.8	0.0	8.4	0.1	0.0	4.6	0.6	1.1	51.8	36.4	0.1	0.2	2.0	0.0	0.0	0.0	1.3
TMEM252	"C9orf71, MGC34760"	ENSG00000181778	"Transmembrane protein 252"	Q8N6L7	9	68536580-68540867	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 16.0;kidney: 64.2"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 15.1"	"Cancer enriched"	"Detected in many"	17	"renal cancer: 35.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 7.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA079457	Enhanced					NA	NA					"HPA079457: "	"unprognostic (2.64e-1)"		"unprognostic (3.28e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"		"unprognostic (6.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.75e-7)"	"unprognostic (7.63e-2)"	"unprognostic (6.15e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.50e-1)"	0.5	2.0	0.4	0.6	0.4	0.0	0.4	0.9	0.4	0.6	5.6	0.4	0.4	1.0	4.3	0.8	4.3	2.7	0.7	3.0	0.4	0.0	64.2	0.9	0.4	0.4	0.4	0.4	0.6	0.4	0.0	0.4	2.6	0.4	1.8	0.0	0.4	0.4	0.4	0.7	0.2	16.0	0.9	0.4	0.4	1.7	0.6	0.4	0.4	0.4	0.4	0.5	6.0	0.6	0.0	0.1	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.0	1.9	0.0	6.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.9	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705414-69009176	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 22.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 22.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.0	9.5	9.4	8.4	6.5	10.2	4.2	33.4	14.6	5.6	26.9	4.1	10.8	26.1	6.1	2.0	1.2	5.0	7.6	24.6	8.1	11.7	6.1	0.8	12.6	2.1	10.4	6.4	1.4	6.7	21.3	8.5	16.8	32.8	3.3	23.1	28.7	11.6	13.6	3.0	2.4	39.7	2.6	3.7	3.1	19.9	17.6	1.5	0.0	1.6	1.9	3.3	3.5	2.9	3.9	0.9	22.1	0.3	0.0	1.0	0.2	0.0	0.0	23.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	8.9	0.2	7.3	0.0	0.5	2.2	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	5.1	0.1	0.6	0.0	0.1	1.2	39.1	0.7	0.7	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.2	1.7	1.1	0.0	1.6	0.0	3.1	0.3	22.1	0.0	0.0	0.0	3.3	0.2	0.0	0.1	3.9	0.5	0.0	1.2	0.0	0.1	0.9	1.0	0.2	9.4	6.5	33.4	14.6	8.1	11.7	10.4	6.4	32.8	1.5	32.8	27.2	5.2	3.0	0.6	4.6	51.2	5.1	4.0	2.3	5.2	2.0	16.1	23.2	1.3	54.3	3.0	49.9	46.7	12.3	0.7	1.0	2.3	5.7	0.0	3.2	0.0	35.5	1.8	1.3	32.7	2.3	2.2	5.0	0.0	26.7	103.2	5.6	33.1	1.4	0.7	3.1	25.8	46.7	1.2	1.7	0.3	7.3	1.3	23.7	4.3
FAM122A	"C9orf42, MGC17347"	ENSG00000187866	"Family with sequence similarity 122A"	Q96E09	9	68780034-68784608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056646	Approved		Approved	"Nucleoplasm,Nuclear bodies"		No	No			"Nuclear bodies"	Nucleoplasm	"HPA056646: AB_2683202"	"unprognostic (1.88e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.18e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.45e-2)"	"unprognostic (4.58e-3)"	"prognostic favorable (1.34e-5)"	"unprognostic (9.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.89e-2)"	21.0	21.3	13.9	12.0	20.2	9.8	21.4	22.5	24.6	23.1	15.5	17.0	12.4	10.0	20.3	15.6	17.6	19.7	14.4	24.2	13.8	14.3	21.5	21.2	14.1	14.7	16.8	14.2	24.2	17.9	25.3	20.8	21.8	18.0	20.6	14.9	22.4	17.0	19.8	20.0	15.1	15.0	17.6	13.9	17.7	15.0	16.2	14.6	18.1	19.1	14.8	15.4	15.7	16.5	5.8	6.7	4.3	5.1	4.5	9.8	2.5	5.4	3.7	5.1	4.4	17.6	11.5	7.0	7.7	7.3	6.9	5.5	1.3	2.7	11.4	3.9	8.2	5.0	10.2	5.7	5.2	8.6	12.3	6.0	6.3	6.1	4.5	10.9	11.4	4.5	9.3	12.0	6.3	4.9	7.8	6.8	8.3	6.7	13.0	7.3	2.9	6.3	3.0	6.5	12.9	6.6	7.8	7.1	3.5	6.2	4.5	8.2	3.7	5.7	4.8	3.9	7.5	2.9	5.0	8.4	6.4	4.6	11.9	5.7	15.3	6.2	4.7	6.9	7.3	7.1	4.3	5.1	3.7	4.5	4.9	4.0	3.6	4.5	4.9	5.7	5.8	9.8	5.5	2.9	4.5	4.8	6.7	4.9	2.5	13.9	20.2	22.5	24.6	13.8	14.3	16.8	14.2	18.0	14.6	3.0	6.0	19.1	16.1	20.9	17.5	13.9	7.6	25.4	6.8	5.2	15.7	24.6	56.3	13.9	23.4	14.8	11.2	46.7	11.9	13.7	16.9	11.3	17.3	15.3	19.0	7.9	17.2	13.5	19.4	11.4	14.1	17.4	13.5	8.2	15.4	31.5	13.0	13.3	15.9	20.3	18.4	45.3	45.6	36.3	17.7	20.7	25.6	17.5	12.5	15.3
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 55.1;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"									"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.5	0.0	0.0	0.0	0.0	0.0
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.3	9.6	15.8	7.6	7.2	10.7	15.3	8.2	7.3	12.6	9.7	5.1	7.4	20.4	6.4	8.5	13.0	12.4	18.6	18.8	15.9	23.8	21.3	28.6	6.3	37.8	12.4	20.9	12.5	11.9	15.2	12.6	13.7	4.5	16.8	12.6	21.5	20.0	11.6	11.1	5.9	9.2	21.3	23.1	19.2	14.1	10.8	13.9	14.5	9.4	12.2	5.5	8.4	5.5	8.6	11.6	6.2	6.5	10.0	8.3	14.4	10.8	11.9	5.6	4.8	12.1	3.9	17.3	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7	3.0	11.5	20.6	17.3	8.7	6.2	39.9	7.6	5.3	3.4	14.0	3.9	35.6	18.3	16.1	2.0	11.7	3.1	0.0	12.7	16.7	14.6	12.0	6.9	60.1	30.0	0.0	6.9	8.0	14.6	4.6	14.7	15.5	16.9	14.4	11.5	8.3	15.0	0.0	12.4	20.7	1.0	12.9	17.6	3.8	31.7	7.0	12.2	13.1	15.6	11.9
AL358113.1		ENSG00000285130			9	69035750-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2"									"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		1.6	4.3	2.5	1.9	2.1	2.6	2.8	3.6	2.5	1.6	2.8	3.0	2.7	1.6	2.2	1.6	1.6	3.4	1.6	5.8	1.3		2.1	8.8	2.1	3.2	2.8	1.7	3.7	9.4	1.6	1.7	1.6	2.4	4.0	1.6	2.9	2.8	3.2	7.5	1.6	3.0	4.5	1.6	3.1	3.1	3.4	2.1	0.0	2.6	2.0	2.1	2.4	1.3	0.1	1.3	0.1	2.8	0.0	2.6	0.4	0.4	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.7	0.3	0.0	2.9	0.2	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.2	0.0	1.2	0.2	0.8	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	2.6	0.2	0.1	1.3	0.1	1.0	0.1	0.6	0.3	0.1	0.0	2.8	1.3	2.6	0.4											3.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69255208	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 241.2;Rod photoreceptor cells: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"A-431: 53.3"									"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		790000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	25.2	9.5	23.7	8.0	29.7	5.7	20.7	35.6	24.9	9.0	20.0	50.3	20.6	27.2	11.9	7.3	28.9	12.6	13.2	19.8	35.1	12.7	23.3	34.5	23.9	5.8	39.7	20.5	20.9	13.2	43.2	3.6	18.0	32.0	13.5	16.7	19.1	18.0	23.1	8.3	18.6	25.7	15.3	39.7	3.5	30.4	17.8	41.1	11.1	22.5	9.0	10.8	26.5	26.6	0.0	0.2	0.4	4.0	0.0	0.5	0.5	53.3	1.7	4.3	4.8	20.1	19.7	23.3	8.1	6.0	13.0	7.1	6.5	19.5	7.7	8.1	4.5	7.0	32.9	6.9	17.1	14.8	27.3	5.0	7.4	4.6	32.9	5.7	3.0	14.1	15.3	12.3	10.1	6.1	3.7	27.2	2.1	4.5	5.2	6.8	7.5	1.1	0.4	10.4	33.4	11.7	3.9	6.1	0.8	33.4	35.6	1.9	3.3	2.9	20.8	0.6	9.9	6.7	1.6	39.0	9.7	10.5	7.5	8.3	5.4	1.1	0.1	11.2	4.3	3.6	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.4	0.0	4.0	0.1	0.5	0.5	23.7	29.7	35.6	17.5	35.1	12.7	39.7	20.5	32.0	41.1	41.7	21.4	1.4	65.1	57.9	241.2	34.6	50.9	9.4	5.7	3.5	33.4	24.0	0.0	27.8	2.7	42.7	67.5	0.0	20.8	23.1	14.7	83.3	5.7	92.7	4.9	17.5	11.1	25.2	17.0	3.6	27.0	2.8	27.0	4.6	41.5	123.0	32.6	42.5	13.1	1.4	273.3	0.0	10.3	21.3	11.1	56.0	36.2	3.1	36.2	146.9
FAM189A2	"C9orf61, X123"	ENSG00000135063	"Family with sequence similarity 189 member A2"	Q15884	9	69324567-69392558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.1;thyroid gland: 38.0"	"Cell type enhanced"	"Detected in many"	23	"Alveolar cells type 1: 145.9;Club cells: 48.9;Muller glia cells: 40.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;NTERA-2: 8.4;RPTEC TERT1: 3.1;RT4: 3.7;SK-MEL-30: 8.1;SuSa: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029411, HPA057207"	Approved					NA	NA					"HPA029411: AB_10602338, HPA057207: AB_2683369"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.16e-6)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (1.75e-5)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.14e-1)"	3.2	3.1	9.2	1.5	11.6	0.8	13.2	4.5	12.2	25.6	3.9	11.4	8.3	1.8	5.6	2.5	5.3	6.0	2.9	11.5	10.3	4.1	2.0	0.8	21.4	1.3	7.2	4.9	15.0	5.2	8.5	4.7	2.2	20.0	8.9	1.9	6.7	6.4	5.0	40.1	6.7	2.3	6.0	17.1	1.1	9.0	1.5	9.3	3.7	38.0	6.0	1.6	4.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	1.1	1.1	0.0	0.0	1.0	2.7	0.1	2.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	8.4	0.5	0.0	0.0	0.2	0.0	3.1	3.7	0.0	0.1	0.0	0.0	8.1	3.4	0.2	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	11.6	4.5	12.2	10.3	4.1	7.2	4.9	20.0	9.3	145.9	21.8	0.0	5.1	3.0	0.6	11.3	0.0	4.0	48.9	1.8	0.0	0.9	0.0	0.8	0.1	6.8	0.1	0.0	0.6	0.1	0.8	4.4	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	18.6	0.0	0.3	40.4	2.8	0.3	0.0	0.1	0.8	0.0	2.1	0.1	0.4	2.0	0.2	0.0	0.6	1.3
APBA1	"D9S411E, MINT1, X11"	ENSG00000107282	"Amyloid beta precursor protein binding family A member 1"	Q02410	9	69427530-69672306	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 65.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.1;BJ hTERT+: 6.0;HAP1: 17.1;SCLC-21H: 6.7;TIME: 7.7;U-138 MG: 7.1;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061287			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA061287: AB_2684467"	"unprognostic (4.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.21e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.66e-3)"	2.9	2.9	20.2	1.8	18.6	0.6	4.0	15.5	21.7	4.2	4.1	6.2	0.6	1.7	4.0	1.2	3.4	2.6	3.0	2.9	16.0	19.3	2.3	8.7	1.9	1.6	19.1	13.7	7.5	2.9	14.5	3.5	3.1	15.7	2.2	4.2	2.7	5.5	2.8	4.0	3.8	2.1	2.2	5.5	6.0	1.7	3.5	6.7	0.0	1.5	0.6	1.2	2.4	2.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.6	0.0	3.1	2.3	0.1	7.1	6.0	0.1	0.1	0.0	0.0	0.0	3.3	2.9	0.0	0.1	17.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	2.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	2.5	6.7	4.4	0.4	0.9	0.1	0.2	0.0	0.0	7.7	7.1	0.8	0.0	0.5	7.1	3.1	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.0	20.2	18.6	15.5	19.7	16.0	19.3	19.1	13.7	15.7	6.7	0.0	0.0	0.0	1.2	1.5	12.7	3.9	0.0	0.0	0.0	0.0	3.9	0.7	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.4	0.6	0.4	0.0	2.8	2.4	65.2	4.1	3.1	2.5	0.0	2.3	0.7	0.0	1.0	1.5	3.9	0.2	0.0	10.3	0.4	9.6	0.0	1.4	0.9	1.3	2.0	0.3	0.0	0.8	0.4
PTAR1		ENSG00000188647	"Protein prenyltransferase alpha subunit repeat containing 1"	Q7Z6K3	9	69709522-69759959	"Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021248	Uncertain		Approved	"Centriolar satellite,Rods & Rings"		NA	NA			"Centriolar satellite"	"Rods & Rings"	"HPA021248: AB_1855872"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.16e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	16.2	11.2	18.9	13.8	16.8	40.6	18.6	18.7	21.3	17.4	15.8	17.7	13.1	10.2	20.3	11.1	14.8	16.0	13.0	15.8	20.1	8.8	22.2	19.9	19.1	15.9	18.8	12.6	21.5	19.1	27.1	21.5	17.0	14.9	12.4	21.5	17.4	17.8	13.6	23.3	15.8	17.6	15.3	16.5	16.2	13.1	14.9	20.3	38.9	16.2	8.9	14.0	17.4	18.2	4.0	3.4	13.2	6.3	4.8	6.8	2.5	7.8	10.1	13.0	6.5	12.4	15.9	7.5	18.6	13.4	6.4	7.1	3.4	5.3	7.9	9.0	14.7	6.1	12.7	29.9	7.1	14.7	8.1	8.0	13.0	18.0	7.2	12.3	10.9	11.0	9.8	6.7	11.8	17.0	11.5	10.8	13.7	8.2	17.6	16.5	2.1	9.0	3.8	17.2	7.8	7.3	9.3	21.2	5.8	14.7	7.6	9.9	12.1	12.8	5.4	9.6	13.0	3.9	4.9	19.4	16.0	14.7	12.7	15.1	11.8	12.0	5.1	10.8	10.4	28.3	6.8	4.6	6.3	5.2	6.3	4.7	4.0	4.3	3.7	3.4	2.7	4.9	5.3	13.2	4.8	3.5	2.0	6.8	2.5	18.9	16.8	18.7	21.3	20.1	8.8	18.8	12.6	14.9	20.3	32.8	16.3	15.1	16.9	14.8	28.5	15.7	43.3	14.7	13.6	31.4	76.6	15.0	13.3	11.1	12.4	18.8	13.3	0.0	6.8	12.1	14.5	19.6	17.3	29.0	11.0	31.8	10.9	17.8	31.5	16.3	28.7	14.5	30.4	9.0	27.0	28.8	9.6	14.0	21.5	32.4	53.4	25.8	19.1	55.6	8.5	13.4	8.0	20.8	19.9	22.7
C9orf135		ENSG00000204711	"Chromosome 9 open reading frame 135"	Q5VTT2	9	69820793-69906232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.6;fallopian tube: 31.8;pituitary gland: 35.4;testis: 18.4"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 279.7;Cone photoreceptor cells: 72.6;Early spermatids: 105.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 7.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 3.3;naive CD8 T-cell: 4.0;T-reg: 3.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.5;NTERA-2: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021261, HPA021325"	Uncertain					NA	NA					"HPA021261: AB_1845811, HPA021325: AB_1845812"	"unprognostic (1.05e-2)"			"unprognostic (4.39e-1)"	"unprognostic (1.97e-1)"			"unprognostic (1.39e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.22e-3)"	"unprognostic (5.72e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.60e-2)"		0.1	0.5	3.2	0.1	2.4	0.1	0.1	0.0	0.1	0.8	0.1	3.1	0.0	0.1	0.6	9.8	0.1	31.8	1.3	0.1	2.2	2.2	1.3	0.3	7.0	0.1	0.3	0.0	3.2	0.7	3.1	35.4	0.1	17.6	0.1	0.1	0.4	0.2	0.4	0.5	0.1	0.1	0.1	0.4	0.1	0.2	18.4	0.4	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.0	3.3	4.0	0.0	0.0	0.0	0.0	3.6	0.1	3.2	2.4	0.0	0.1	2.2	2.2	0.3	0.0	17.6	0.4	0.0	1.3	0.0	0.0	0.3	0.0	2.4	0.0	279.7	35.2	1.8	72.6	0.1	14.9	0.3	105.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.1	0.0	1.7	0.0	0.0	5.6	2.3	0.6	0.0	0.0	0.0	0.4	0.3	0.0	0.7	1.9	0.3	0.0	0.0	16.4	1.1	0.1	0.0	0.0	0.0	0.3
MAMDC2	MGC21981	ENSG00000165072	"MAM domain containing 2"	Q7Z304	9	70043581-70226970	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.6"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021814, HPA022249"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Nuclear speckles, Plasma membrane"		"HPA021814: AB_1853508, HPA022249: AB_2139157"	"unprognostic (1.88e-1)"	"unprognostic (3.16e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (2.79e-3)"	9.0	4.3	0.6	11.1	0.5	0.0	14.7	0.6	0.8	32.3	27.7	0.3	9.1	4.3	40.7	33.7	31.6	28.7	44.9	13.5	0.6	0.6	2.0	1.0	42.4	2.3	0.7	0.8	35.5	2.4	1.0	0.8	2.6	1.3	13.9	6.6	16.1	5.4	10.8	15.5	5.0	14.2	46.3	2.6	12.0	10.7	20.0	0.0	0.3	6.8	24.6	6.1	36.4	27.5	0.0	0.3	0.0	0.0	2.6	0.6	0.0	0.1	0.0	0.2	0.0	23.0	7.8	0.7	4.5	2.0	1.0	1.9	0.0	0.5	0.0	0.3	0.8	0.6	3.6	0.0	0.3	0.9	0.0	0.0	0.0	7.4	0.0	24.0	0.0	0.0	1.4	0.2	0.6	0.4	8.2	1.9	0.0	0.0	0.2	29.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.6	2.8	10.1	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.0	28.7	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.8	0.6	0.6	0.7	0.8	1.3	0.0	0.0	1.0	0.0	0.4	5.5	0.4	3.1	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.0	37.9	2.9	0.0	0.0	0.2	5.7	21.0	0.1	1.1	0.0	2.6	0.0	0.0	0.0	0.0	9.1	89.5	0.7	10.1	0.0	0.0	15.4	0.3	0.0	77.1	0.3	0.2	38.8	25.0	0.3	0.4	4.3	0.2	0.0	0.0	0.0
SMC5	"KIAA0594, SMC5L1"	ENSG00000198887	"Structural maintenance of chromosomes 5"	Q8IY18	9	70258962-70354888	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054900	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA054900: AB_2682634"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	12.8	9.0	11.5	21.6	13.7	20.8	15.3	34.2	14.7	15.3	14.2	6.9	16.7	12.2	14.4	12.8	14.3	15.5	12.9	13.1	10.7	7.3	10.1	13.3	14.3	15.6	15.0	9.5	33.2	19.9	10.7	30.0	15.9	12.2	15.6	15.9	5.5	17.5	24.3	36.9	11.3	16.9	18.8	13.3	13.9	13.1	11.7	14.6	20.2	13.5	11.1	14.2	14.9	22.9	11.5	11.3	14.7	9.4	9.8	11.9	5.2	22.8	5.7	14.4	8.8	8.4	15.9	11.4	15.9	13.9	8.7	9.5	2.2	12.5	22.9	5.2	11.9	7.6	21.0	15.5	10.5	17.5	10.3	5.5	13.3	9.4	6.8	10.7	21.6	13.8	11.1	7.4	11.7	13.5	13.9	9.0	13.8	9.8	9.3	16.1	3.5	28.4	7.6	11.0	17.6	8.1	16.9	23.8	7.1	8.8	11.3	10.3	7.8	15.7	10.1	4.4	11.0	6.0	9.2	9.9	11.7	12.4	15.9	21.6	11.4	15.2	16.0	9.9	11.4	13.9	14.7	7.7	12.8	11.9	8.4	11.1	10.1	10.2	11.0	5.9	11.5	11.5	10.4	5.1	9.8	9.4	11.3	10.5	5.2	11.5	13.7	34.2	14.7	10.7	7.3	15.0	9.5	12.2	14.6	53.6	61.1	43.6	93.1	40.5	21.7	31.9	22.9	62.9	85.3	19.2	27.5	25.9	8.3	51.5	33.8	35.8	28.5	0.0	48.3	28.4	30.3	90.1	48.7	22.6	14.4	36.5	27.0	11.1	24.3	10.2	49.5	28.0	23.6	72.1	34.7	18.0	48.9	40.3	55.9	10.5	37.9	25.8	53.7	75.1	58.1	36.6	29.7	34.6	40.2	84.3
KLF9	BTEB1	ENSG00000119138	"Kruppel like factor 9"	Q13886	9	70384597-70414624	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.7;ASC TERT1: 31.6;HHSteC: 40.6;HSkMC: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029308			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA029308: AB_10601923"	"unprognostic (2.12e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (4.34e-1)"	"unprognostic (5.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (6.59e-6)"	"unprognostic (1.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	35.9	15.3	6.8	8.8	25.8	6.1	25.7	42.6	21.4	10.2	20.0	9.7	16.1	6.0	19.6	13.2	17.0	22.2	17.8	18.2	8.4	4.0	26.2	36.7	22.6	5.1	26.3	8.0	22.1	21.3	13.0	8.6	3.9	14.7	12.4	11.0	20.4	31.4	10.7	38.9	12.6	17.6	25.0	12.0	8.6	16.7	5.5	25.2	1.9	24.0	20.3	5.4	15.4	11.9	2.8	1.7	2.8	0.7	0.7	2.8	0.6	0.1	0.2	0.0	2.8	22.7	31.6	0.3	1.4	9.8	0.5	1.1	0.0	1.3	0.0	1.1	2.6	0.7	0.0	4.3	6.6	1.0	0.0	3.4	1.5	4.8	0.8	40.6	0.7	4.0	27.0	6.8	0.4	9.6	13.7	8.7	0.6	2.9	6.0	3.7	0.4	0.1	2.1	0.2	0.4	1.4	0.0	1.3	3.7	1.8	0.0	0.4	1.9	13.4	7.8	15.4	0.9	2.6	2.3	11.8	2.6	1.9	3.0	0.7	4.3	4.6	0.2	2.3	2.3	13.0	2.8	0.5	0.3	1.6	0.3	2.3	2.8	2.1	1.6	1.2	2.5	2.8	1.6	0.0	0.7	0.7	1.7	2.2	0.6	6.8	25.8	42.6	21.4	8.4	4.0	26.3	8.0	14.7	25.2	38.7	21.0	13.2	56.7	42.7	40.6	62.7	48.4	18.7	28.4	14.0	19.6	0.1	26.6	7.4	17.2	139.1	35.5	0.0	11.6	0.2	78.1	86.9	7.0	140.6	3.5	76.3	13.3	97.6	59.8	11.6	84.0	36.1	37.1	4.6	29.3	151.3	10.9	28.5	79.9	29.8	8.8	77.6	214.2	1.0	3.9	29.9	0.0	24.5	27.3	22.8
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 278.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.4"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.1	0.1	1.3	3.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	0.0	0.0	1.2	4.5	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	1.0	0.0	1.3	0.0	0.2	0.0	0.4	0.2	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9	3.0	4.0	0.0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0.0	5.0	0.0	3.9	1.3	0.0	0.0	0.2	0.0	1.5	0.4	0.0	0.0	0.2	1.6	14.8	0.6	0.0	1.7	5.2	1.1	0.0	0.0	0.0	278.6	0.1	0.0	8.5	25.8	4.7	0.0	1.0	1.5	0.4	0.6	0.2	0.8	0.0	0.3
TMEM2		ENSG00000135048	"Transmembrane protein 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.6"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.6;BEWO: 34.0;OE19: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044889	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		130000	"Plasma membrane"	Vesicles	"HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	23.3	3.9	6.0	10.5	4.4	12.4	13.6	8.9	6.0	3.0	18.6	1.9	10.1	12.2	4.5	5.2	4.4	4.9	19.2	9.5	8.6	3.6	9.3	24.9	35.7	14.0	4.0	4.1	3.1	9.2	24.0	9.5	67.6	4.3	5.5	13.1	7.9	9.5	10.2	5.5	6.4	20.0	5.5	5.1	15.6	14.5	3.7	2.4	6.4	8.0	4.6	8.8	11.4	6.8	6.3	0.9	5.5	2.1	0.5	4.1	1.4	5.8	28.0	36.6	1.7	3.8	6.9	34.0	19.7	12.6	13.7	10.1	7.8	8.0	0.1	5.9	5.0	3.0	8.7	11.8	2.7	18.6	0.7	3.6	10.0	5.9	20.8	5.9	0.0	2.7	7.1	3.0	10.6	2.4	3.6	18.0	0.8	1.4	3.0	7.4	4.9	1.1	0.1	7.6	36.1	2.7	0.9	10.9	0.7	8.6	18.9	1.8	0.2	5.1	3.6	5.3	11.8	2.5	0.3	7.8	9.3	10.5	5.1	9.8	0.6	8.4	0.3	1.8	0.9	11.7	0.2	2.1	5.5	2.7	1.9	0.8	0.7	2.9	2.6	0.9	6.3	4.1	2.0	4.5	0.5	1.8	0.2	3.9	1.4	6.0	4.4	8.9	6.0	8.6	3.6	4.0	4.1	4.3	2.4	32.8	30.4	9.4	38.3	26.8	5.5	0.0	33.1	4.0	17.0	0.0	9.8	36.3	0.0	0.0	10.6	37.9	75.4	0.0	0.0	12.0	19.0	42.5	4.6	27.6	35.9	0.0	9.7	115.4	56.5	2.9	2.8	14.9	16.9	0.0	32.3	73.6	0.0	26.4	1.1	0.0	35.2	6.5	20.8	1.0	0.6	19.2	75.1	62.3	28.3	40.3
ABHD17B	"C9orf77, CGI-67, FAM108B1"	ENSG00000107362	"Abhydrolase domain containing 17B"	Q5VST6	9	71862452-71910931	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.2"	"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047862	Uncertain					NA	NA					"HPA047862: AB_10959595"	"unprognostic (7.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.03e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.53e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (4.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.34e-2)"	7.7	6.6	16.5	6.9	25.0	18.0	8.2	14.4	21.6	9.0	12.0	43.3	2.3	18.1	9.5	4.6	13.5	9.6	9.1	5.8	23.6	13.8	13.4	13.6	7.5	10.8	44.0	13.6	7.6	6.4	12.7	5.8	7.8	24.3	11.0	11.2	9.0	9.4	5.1	13.6	11.2	14.9	9.4	30.4	8.9	8.9	11.1	38.2	46.2	8.8	3.6	10.7	11.8	8.8	7.2	5.7	8.1	3.8	6.6	4.9	1.7	6.3	6.1	14.0	8.1	7.3	4.5	12.3	7.0	7.6	6.1	5.2	1.8	4.0	15.4	6.5	4.7	5.1	12.6	13.6	4.6	7.1	7.9	8.1	9.0	10.3	5.9	5.1	10.6	14.6	5.6	6.5	5.5	4.9	5.5	7.9	26.0	7.3	7.0	5.2	2.9	27.4	8.4	21.2	8.0	8.7	36.8	10.7	0.1	7.0	12.8	9.3	10.8	7.4	8.0	6.0	10.5	2.6	7.7	6.3	5.9	7.7	10.9	5.6	6.9	8.1	12.2	4.7	7.6	2.9	8.1	3.8	4.1	3.1	1.4	3.0	4.2	3.8	4.3	4.8	7.2	3.2	4.5	2.9	6.6	1.3	5.7	4.9	1.7	16.5	25.0	14.4	20.8	23.6	13.8	44.0	13.6	24.3	38.2	6.0	4.6	13.2	28.4	15.1	13.8	7.0	5.1	17.4	10.3	5.2	11.8	9.1	10.0	7.3	15.6	8.2	22.1	0.0	5.0	6.9	9.6	21.5	17.3	8.2	5.1	4.8	8.5	10.4	4.7	6.0	10.6	7.0	5.0	6.4	22.8	24.7	3.9	14.2	9.9	9.9	54.4	0.0	16.1	33.6	20.2	8.5	6.1	25.4	10.6	41.0
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: AB_2681229, HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	13.4	12.7	15.5	10.1	26.0	8.9	14.7	11.2	18.8	12.8	12.9	18.2	15.0	19.3	14.1	14.3	18.4	11.6	12.0	10.5	14.9	13.8	12.3	13.1	10.4	13.0	24.5	13.3	16.9	14.7	9.8	16.9	13.9	15.2	13.1	13.7	14.3	14.7	9.8	14.6	18.4	16.3	15.2	21.1	10.7	11.2	9.2	21.9	14.5	14.8	15.9	12.9	18.8	15.5	11.3	13.1	16.1	9.9	17.1	14.6	9.3	7.7	5.1	9.1	7.4	9.6	17.4	9.3	10.0	15.5	8.1	7.9	1.1	4.7	12.7	5.1	8.6	8.5	14.3	9.5	9.5	11.2	8.9	4.7	7.8	7.5	6.4	10.3	11.4	6.4	14.1	13.0	8.1	17.8	12.7	9.9	12.3	9.2	8.6	10.2	4.0	13.7	8.0	8.6	12.5	12.6	8.1	15.8	0.3	11.5	11.3	7.6	10.0	4.9	12.7	16.5	10.4	4.5	6.6	8.7	7.5	9.6	16.9	7.3	8.6	14.1	5.8	10.1	8.7	4.8	16.1	8.9	12.6	13.4	9.9	13.7	10.9	11.5	11.5	9.3	11.3	14.0	14.6	9.9	17.1	8.3	13.1	10.5	9.3	15.5	26.0	11.2	18.8	14.9	13.8	24.5	13.3	15.2	21.9	6.0	14.2	13.0	11.4	6.8	10.6	10.8	5.1	9.4	11.4	5.2	7.9	17.8	18.3	12.3	6.1	11.6	23.0	0.0	17.3	15.9	12.4	13.2	18.4	8.7	12.9	4.8	6.3	16.0	12.4	4.5	19.2	13.3	3.3	11.8	17.8	11.2	14.2	17.5	12.4	15.1	11.5	12.9	12.7	13.0	14.2	8.5	9.0	12.2	16.3	17.9
C9orf57		ENSG00000204669	"Chromosome 9 open reading frame 57"	Q5W0N0	9	72051376-72072721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	114	"testis: 31.4"	"Cell type enriched"	"Detected in some"	16	"Spermatocytes: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 3.2"															NA	NA								"unprognostic (3.26e-2)"				"unprognostic (1.15e-1)"							"unprognostic (5.05e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;intestine: 54.5;liver: 27.6"	"Group enriched"	"Detected in many"	7	"Enterocytes: 113.2;Hepatocytes: 49.7;Paneth cells: 91.2;Proximal tubular cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 11.1;EFO-21: 44.1;HeLa: 15.4;hTCEpi: 20.6;OE19: 50.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1300000	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.5	1.7	26.7	1.8	27.7	0.5	0.5	0.4	33.8	1.0	20.6	0.9	7.7	47.4	2.4	0.6	0.5	4.7	13.1	0.5	25.7	15.0	21.4	27.6	0.5	0.5	2.9	27.4	0.4	1.7	10.8	1.7	10.3	0.8	0.4	5.5	0.0	0.4	4.1	1.1	1.6	54.5	0.5	0.6	0.5	2.0	1.0	0.2	0.0	0.4	1.0	2.6	3.4	0.5	1.4	0.5	3.0	0.7	1.0	1.0	0.1	11.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	8.1	0.0	0.0	1.0	6.3	0.0	44.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.3	0.3	2.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.3	1.0	0.6	0.3	0.6	0.5	0.4	0.3	1.4	0.7	0.7	1.9	1.0	0.4	0.5	0.5	0.1	26.7	27.7	0.4	33.8	25.7	15.0	2.9	27.4	0.8	0.2	0.0	0.3	1.7	0.5	0.0	0.0	0.6	12.7	0.0	0.0	0.0	0.0	0.1	3.3	9.2	1.0	0.0	113.2	0.0	9.7	1.0	0.4	0.6	0.0	49.7	0.2	0.0	4.6	1.3	1.0	0.0	0.3	0.0	0.0	1.0	11.2	0.0	4.4	91.2	0.0	84.2	0.0	0.0	0.3	0.4	4.2	0.1	1.6	0.0	7.8	0.8
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351425-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	82.5	57.6	26.9	15.5	35.2	36.6	57.1	31.7	34.3	28.6	23.1	20.3	31.4	10.8	25.7	35.5	29.0	27.4	28.7	33.0	24.3	22.6	32.6	56.5	31.6	23.6	24.3	21.1	59.3	20.9	17.0	45.4	22.4	25.1	24.0	15.1	22.4	17.2	52.7	207.5	17.6	15.8	28.4	25.9	24.1	23.2	26.7	21.7	14.6	23.1	29.5	16.5	39.2	29.3	7.0	13.6	15.4	32.1	8.6	6.8	7.8	22.2	22.8	26.9	11.9	34.8	16.6	20.3	26.3	36.7	14.2	11.1	2.8	21.0	12.4	16.0	41.2	20.1	24.9	62.0	10.3	21.3	83.9	9.6	9.8	13.1	13.9	25.7	14.0	14.6	21.7	19.1	14.8	16.6	33.1	25.1	12.0	9.4	16.4	16.6	5.9	18.3	8.0	34.7	20.9	15.9	14.3	14.0	13.1	46.2	21.6	19.7	17.6	16.6	18.3	21.5	29.2	8.1	12.3	19.1	11.8	14.6	20.8	18.0	23.7	20.6	6.5	15.9	9.6	29.2	15.1	13.6	15.4	5.2	21.6	5.7	7.0	6.8	6.6	13.6	6.2	6.3	5.6	12.2	8.6	32.1	2.9	4.8	7.8	26.9	35.2	31.7	34.3	24.3	22.6	24.3	21.1	25.1	21.7	163.8	158.6	37.3	496.3	301.3	88.2	288.5	91.7	88.3	127.4	125.6	70.7	117.4	126.0	118.6	62.4	115.1	102.1	46.7	122.4	145.8	149.1	300.6	109.4	271.5	176.8	38.1	131.1	95.2	243.2	35.2	109.6	177.8	197.4	297.6	71.5	51.7	193.5	79.3	87.7	95.7	65.3	84.1	204.0	123.7	99.9	254.7	189.3	64.8	81.2	398.4
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838230	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.0"	"Cell type enhanced"	"Detected in some"	8	"Cytotrophoblasts: 3.3;Early spermatids: 3.7;Glandular cells: 3.2;Urothelial cells: 5.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;HAP1: 10.5;NTERA-2: 4.3;SuSa: 1.6;U-266/84: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.2	0.0	0.9	0.0	0.7	0.0	0.2	0.2	1.1	3.0	0.0			0.0	0.2	1.3	0.7	0.7	0.2	0.0	0.7	0.5	1.4	0.0	0.0	0.0	1.0		0.2	0.0	0.0	0.0	1.1		0.7	0.0		0.0	0.3	0.2	0.0	0.0	0.0	1.5	0.0	0.0	1.1			0.0		0.3	1.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	10.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0											0.0	0.0	0.0	2.2	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	3.3	0.0	0.1	3.7	0.4	0.0	0.0	0.5	2.1	0.4	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.0	1.0	0.0	0.9	0.4	0.0	0.0	2.9	0.0	0.0	0.4	1.2	3.0	0.0	2.2	0.0	0.0	5.9
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5"					"Region enriched"	"Detected in all"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	294.7	0.0	0.0	1.7	0.0	0.1	10.2	0.0	0.0	0.0	9.9	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	90.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.5	0.0	1.1	0.0	11.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	3.3	0.1	52.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9	89.3	82.8	17.6	12.3	2.4	0.0	2.8	211.5	583.5	271.8	109.9	0.0	1.1	330.0	52.4	8.7	10.5	29.0	23.3	296.8	1.1	30.2	1.8	152.7	620.8	115.7	0.0	52.7	105.0	82.2	16.5	376.3	13.6	6.8	5.4	141.2	0.0	193.4	16.9	194.8	295.4	0.3	25.8	9.2	3.6	3.8	2.8	2.1	20.0	42.1	18.3
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	66.2	104.7	4.7	4.9	66.8	63.6	0.3	114.8	71.8	47.5	32.2	3.0	59.9	0.1	38.0	100.1	105.0	81.6	10.1	69.5	37.7	37.5	0.7	5.1	31.1	0.1	53.3	11.0	2.5	36.6	57.6	48.0	94.4	44.0	67.3	6.0	21.0	2.8	58.5	0.2	19.5	6.0	5.9	26.5	42.6	0.0	26.7	0.2	106.8	14.0	0.0	0.0	39.5	1.0	26.5	65.5	0.2	1.7	83.1	55.7	35.1	76.5	58.9	0.4	0.1	0.2	128.7	10.3	83.8	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1	541.9	512.9	7.3	2232.0	752.1	0.0	11.9	17.8	1060.0	889.5	59.3	0.0	1215.0	0.0	156.6	6.3	398.1	0.8	0.0	20.0	1352.9	735.1	1709.3	2387.0	2.5	570.9	0.0	5.1	113.5	449.6	2.3	206.0	1058.5	291.8	475.3	1.8	0.2	431.7	0.0	8.9	3.1	0.0	64.7	275.6	0.7	2.9	522.6	5914.0	282.4	0.5	4139.3
RORB	"NR1F2, ROR-BETA, RZRB"	ENSG00000198963	"RAR related orphan receptor B"	Q92753	9	74497365-74693177	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;cervix, uterine: 20.8"	"Group enriched"	"Detected in many"	5	"Horizontal cells: 1322.1;Muller glia cells: 409.4"	"Group enriched"	"Detected in some"	5	"glioma: 2.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HHSteC: 18.3;HSkMC: 10.1;JURKAT: 18.1;MOLT-4: 5.1;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008393	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008393: AB_1079830"	"unprognostic (6.89e-3)"	"unprognostic (4.06e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.81e-8)"	"unprognostic (5.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.00e-2)"	3.1	7.9	8.3	1.2	11.1	1.0	1.4	1.8	35.5	20.8	1.3	2.1	2.2	1.1	8.9	0.9	1.7	1.5	4.5	3.9	5.6	7.0	2.0	1.0	2.0	0.9	4.1	18.7	1.4	1.1	1.1	4.0	10.6	6.1	10.5	1.6	18.7	1.2	11.7	0.9	1.3	1.1	1.7	6.7	1.0	1.6	2.0	3.7	2.2	1.5	0.0	1.5	2.3	2.2	0.2	0.2	1.8	0.2	0.6	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.5	10.1	0.0	0.0	0.0	0.0	0.0	18.1	0.0	2.8	0.0	0.1	5.1	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.4	2.5	0.0	1.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	1.8	0.6	0.1	0.2	0.0	0.0	8.3	11.1	1.8	35.5	5.6	7.0	4.1	18.7	6.1	3.7	0.0	3.7	0.0	0.6	1.4	160.1	11.7	0.0	1.4	0.0	0.0	113.9	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.4	5.4	2.3	1.1	0.0	0.6	1322.1	0.0	1.3	0.0	0.5	0.0	1.3	1.7	0.0	0.0	409.4	0.1	0.0	0.0	5.7	181.1	0.0	3.1	0.5	0.1	0.4	0.1	0.8	0.0	0.8
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 28.8;Paneth cells: 10.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.1	1.7	0.2	0.2	0.0	0.0	7.7	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.5	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.0	2.6	0.1	0.9	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.0	7.4	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.8	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5	0.0	1.7	0.0	1.7	0.1	0.2	0.6	0.0	1.4	2.3	3.5	0.0	0.2	0.0	0.0	2.5	0.7	28.8	0.0	0.0	0.1	0.3	1.1	0.0	0.0	0.0	0.0	3.5	4.9	0.3	0.4	0.0	0.2	0.0	0.0	3.3	0.1	0.0	10.5	0.4	0.0	2.3	0.0	0.3	1.5	2.3	0.9	0.1	0.0	2.6	0.9
C9orf40	FLJ10110	ENSG00000135045	"Chromosome 9 open reading frame 40"	Q8IXQ3	9	74946581-74952886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 43.7;Spermatocytes: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042167	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		290000	"Nucleoplasm, Cytosol"	Centrosome	"HPA042167: AB_10797382"	"unprognostic (2.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.15e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	6.2	4.0	8.3	9.7	8.0	9.0	18.8	8.1	12.4	5.1	9.9	5.6	2.8	14.3	5.2	3.0	5.2	3.6	5.0	3.6	7.4	8.4	4.1	5.1	2.8	8.4	8.4	5.6	4.2	3.5	6.6	4.4	6.5	6.7	3.9	9.2	2.2	3.0	4.8	4.7	3.5	18.7	4.9	11.2	5.4	3.6	31.1	5.1	10.5	3.0	3.4	8.0	5.0	16.0	1.8	0.9	5.3	0.5	0.0	2.1	0.3	16.8	3.7	9.7	3.9	3.9	5.1	18.1	13.5	4.2	9.4	10.2	1.0	5.3	15.3	4.0	3.3	15.8	5.0	7.6	0.7	15.1	20.6	11.8	8.1	6.8	6.4	3.2	9.7	12.9	2.5	5.1	5.2	3.7	3.8	2.9	11.2	11.4	10.4	12.3	4.7	17.1	11.4	11.4	8.9	11.4	16.0	7.6	3.7	3.9	4.1	10.6	4.7	5.9	5.0	4.0	9.0	6.1	7.5	3.7	8.5	9.6	11.6	11.7	20.0	14.9	9.7	6.5	10.9	9.1	1.8	0.2	5.3	1.0	0.4	0.4	1.8	1.1	1.0	0.2	1.3	2.1	1.3	0.5	0.0	0.5	0.9	1.2	0.3	8.3	8.0	8.1	12.4	7.4	8.4	8.4	5.6	6.7	5.1	3.0	0.3	6.0	3.5	2.2	7.2	43.7	0.0	1.4	0.0	3.5	7.9	15.9	1.7	2.7	9.5	8.6	12.7	0.0	2.7	19.6	4.0	2.4	0.0	3.4	9.3	1.6	1.2	9.2	3.3	1.3	4.0	1.7	1.7	3.6	4.9	4.5	2.9	8.6	4.9	1.4	13.1	0.0	4.2	46.8	10.7	4.5	10.3	3.2	15.2	3.8
CARNMT1	"C9orf41, FLJ25795"	ENSG00000156017	"Carnosine N-methyltransferase 1"	Q8N4J0	9	74981020-75028423	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 178.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026756	Uncertain					NA	NA					"HPA026756: AB_1845824"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	7.7	8.3	8.0	12.9	17.5	8.4	8.5	22.9	11.6	11.3	13.5	5.7	11.3	14.6	10.0	10.7	15.8	7.8	10.9	7.5	7.6	6.0	14.9	20.2	7.3	10.6	6.3	7.9	8.8	16.5	16.1	12.5	7.6	5.4	10.7	10.5	7.7	13.9	12.3	9.6	10.2	23.3	8.7	6.6	9.9	9.0	22.1	8.6	15.1	16.6	8.7	11.0	9.7	12.8	3.5	1.5	2.1	1.7	3.1	4.7	1.4	14.5	8.8	3.7	9.6	6.2	13.2	13.8	12.9	5.6	5.1	4.7	2.2	10.0	23.1	6.9	9.6	11.0	14.6	11.3	14.2	14.7	20.1	8.7	11.7	9.0	10.2	7.5	21.2	11.6	8.9	7.2	9.7	10.1	7.7	10.4	8.7	9.9	20.9	10.0	4.0	15.5	5.9	17.2	18.2	7.9	7.5	11.1	13.9	13.6	10.5	3.7	2.0	9.9	26.4	5.0	7.1	13.3	6.5	8.0	8.5	11.1	10.2	11.3	14.9	18.9	7.0	13.3	14.8	5.4	0.0	1.0	2.1	3.2	1.7	4.5	3.5	3.2	4.7	1.2	1.9	3.6	3.8	0.4	3.1	1.0	1.5	4.1	1.4	8.0	17.5	22.9	11.6	7.6	6.0	6.3	7.9	5.4	8.6	6.0	9.4	2.2	10.8	0.0	13.1	0.0	17.8	8.1	12.5	26.2	9.8	6.1	21.6	6.2	178.1	6.0	5.4	0.0	10.2	10.9	4.3	11.6	2.3	27.0	7.4	19.1	7.0	9.2	9.8	25.4	6.9	5.1	0.0	4.6	17.0	5.0	8.4	10.5	10.3	25.3	9.8	0.0	0.0	13.1	9.1	0.0	4.2	13.8	14.9	13.2
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.9;Karpas-707: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	15.5	7.7	11.1	15.9	10.7	6.9	14.3	21.5	14.6	13.2	15.2	5.8	20.1	12.2	8.1	15.6	24.6	9.4	10.9	9.4	10.2	9.7	22.1	40.3	15.4	19.9	10.8	9.7	15.2	30.6	45.8	18.1	19.7	10.2	15.9	10.3	10.9	29.5	17.7	15.0	15.6	26.6	8.3	8.7	18.8	13.6	6.7	8.9	14.4	31.6	11.2	22.0	12.6	14.8	6.7	8.8	7.3	6.7	8.2	24.2	10.1	5.1	1.1	1.5	3.5	12.2	16.5	8.3	7.5	11.8	1.9	3.1	0.0	13.6	3.0	4.5	7.2	3.6	9.0	1.7	5.0	6.0	29.9	1.8	2.1	2.4	2.6	10.9	2.0	0.4	11.4	12.9	3.1	6.4	11.4	13.0	5.2	0.2	36.8	13.2	3.8	1.9	1.8	1.9	19.4	4.7	0.6	13.5	19.3	15.3	9.2	1.0	0.2	3.2	3.3	4.2	10.3	8.5	2.2	8.9	6.5	1.2	5.9	2.0	16.3	13.0	1.8	10.6	2.2	6.6	7.3	2.7	4.5	13.9	2.5	16.7	6.7	24.2	16.0	3.1	3.9	22.1	16.7	5.2	8.2	6.7	8.8	15.4	10.1	11.1	10.7	21.5	14.6	10.2	9.7	10.8	9.7	10.2	8.9	35.7	17.1	17.1	33.3	18.7	8.5	15.1	15.3	20.1	22.7	22.7	7.9	52.7	44.7	25.5	14.0	20.7	33.3	0.0	31.3	65.3	17.5	21.3	1.1	34.4	51.6	11.1	4.1	39.3	19.7	24.5	21.9	10.5	25.3	102.8	28.0	9.6	23.2	24.6	11.7	75.6	7.6	12.9	15.2	6.6	3.8	23.6	38.1	29.9	22.4	26.0
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088543-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 448.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 73.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol		NA	NA		190000	Cytosol		"HPA020514: AB_2670461"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	25.8	18.5	19.1	29.8	22.7	24.2	30.6	12.2	25.5	18.5	19.9	16.7	9.0	18.0	11.5	19.4	62.0	11.9	20.7	21.7	19.5	14.4	20.3	30.9	32.5	36.9	21.5	18.6	10.6	14.8	33.4	12.7	41.5	21.5	14.0	22.6	12.4	24.0	13.8	7.4	31.0	24.8	13.8	22.5	52.9	19.1	9.6	17.8	21.3	16.1	17.2	38.9	26.1	30.1	18.7	25.4	84.5	40.1	27.2	30.8	40.9	16.7	4.0	1.9	2.8	11.8	10.9	20.7	17.9	11.8	6.9	6.3	2.0	12.7	17.4	9.0	14.6	8.8	27.9	3.2	12.9	19.9	73.4	4.0	9.6	6.2	10.3	9.6	17.2	36.2	7.6	12.5	8.0	5.6	6.1	22.9	14.9	3.2	40.0	16.5	8.7	25.7	10.8	3.6	39.6	7.7	4.9	13.3	15.3	14.4	24.1	1.6	0.1	13.2	18.7	8.6	15.5	24.6	19.5	21.5	14.4	5.0	27.5	7.5	7.7	12.4	6.5	17.2	20.1	11.6	50.9	30.8	75.5	29.3	33.0	30.8	18.7	20.5	24.0	25.4	16.5	11.8	20.6	84.5	27.2	40.1	19.0	27.5	40.9	19.1	22.7	12.2	25.5	19.5	14.4	21.5	18.6	21.5	17.8	20.8	26.1	58.4	52.5	73.0	2.9	6.7	30.6	18.7	21.6	31.4	5.9	102.0	64.6	43.9	8.0	51.3	60.1	0.0	46.0	197.4	51.6	40.1	135.0	27.1	196.0	9.5	26.2	79.2	180.5	4.2	22.2	143.3	72.6	448.2	31.4	5.8	47.2	91.7	14.5	51.6	7.5	19.4	35.8	4.6	15.3	100.1	112.0	179.9	33.8	77.0
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.7;Horizontal cells: 52.4;Muller glia cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.9;HaCaT: 22.2;RH-30: 14.7;RPTEC TERT1: 20.6;U-2 OS: 32.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.9	2.2	0.2	0.1	0.0	8.4	0.9	0.3	0.6	0.3	0.0	22.2	1.1	0.6	0.1	0.2	1.9	2.9	1.6	0.7	0.4	0.8	1.3	3.0	0.2	0.5	0.2	0.1	4.6	1.5	3.3	1.0	1.6	5.3	3.3	5.0	10.8	1.9	0.9	0.6	14.7	0.9	20.6	1.2	0.2	0.2	3.3	0.7	0.2	4.8	1.2	3.6	3.6	0.7	32.2	1.8	0.9	0.2	0.1	0.4	2.5	1.2	12.2	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4	6.0	4.5	0.0	4.1	5.8	4.4	3.7	10.2	17.4	20.5	5.2	0.0	1.4	0.0	5.2	19.6	8.9	67.7	0.0	5.4	25.1	17.5	1.4	0.0	0.9	2.8	52.4	1.2	14.1	4.0	31.4	19.0	3.4	1.7	3.6	8.8	43.7	7.8	17.5	23.7	3.3	1.2	19.4	8.2	1.1	1.5	2.6	2.1	6.4	16.1	0.7
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385517-76394517	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (1.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	8.1	15.4	24.8	9.8	31.0	15.2	8.7	15.3	27.7	8.9	22.1	5.7	6.2	23.9	9.5	14.3	9.4	10.0	14.5	11.4	33.0	33.5	19.4	23.6	8.8	7.4	22.8	13.2	10.8	11.9	10.3	16.5	26.0	28.3	9.6	16.8	13.3	9.1	7.6	10.3	3.8	39.3	8.5	10.2	8.2	20.3	12.2	8.0	8.1	14.4	5.7	11.6	9.2	7.3	4.9	9.6	3.8	16.3	6.8	6.7	7.8	9.8	10.6	6.5	8.4	9.7	9.7	19.6	11.5	8.5	8.3	6.5	3.7	6.1	16.1	13.7	8.2	15.2	10.7	8.8	7.4	16.6	4.8	8.6	5.1	14.8	12.0	17.6	16.8	12.2	6.5	13.6	9.9	10.9	9.3	26.7	13.9	13.5	13.4	16.5	9.2	21.6	6.2	8.4	22.9	11.3	12.1	8.6	4.1	38.0	4.9	16.6	6.1	12.3	17.3	10.1	8.8	4.4	9.3	16.7	8.8	15.9	18.9	16.1	14.6	14.5	5.6	14.5	15.1	12.0	3.8	8.1	2.8	4.4	16.0	6.7	4.9	6.5	5.2	9.6	4.0	6.3	6.0	1.2	6.8	16.3	3.6	6.1	7.8	24.8	31.0	15.3	27.7	33.0	33.5	22.8	13.2	28.3	8.0	14.9	8.6	15.2	14.2	40.3	49.7	29.9	28.1	26.8	19.4	40.1	19.6	37.4	51.4	55.2	161.1	40.7	67.5	70.0	168.8	297.5	21.6	23.6	11.5	32.1	30.7	11.1	27.1	62.6	51.2	78.7	20.4	25.3	28.7	12.6	24.6	39.5	147.1	66.6	61.2	98.3	23.1	0.0	23.6	85.0	58.5	35.4	103.3	20.8	29.9	24.0
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1, core 2"	Q02742	9	76419850-76507416	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.0;parathyroid gland: 57.8"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 26.5;Kupffer cells: 29.1;Undifferentiated cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 26.3;HSkMC: 22.3;U-2197: 18.7"	"Group enriched"	"Detected in some"	6	"cerebellum: 8.2;olfactory region: 30.1"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		NA	NA		72000	"Nuclear speckles"		"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.96e-4)"	5.6	1.1	1.6	7.9	3.9	2.2	8.2	10.9	2.7	5.3	24.5	0.7	3.0	23.2	5.2	1.2	2.1	1.8	4.1	3.1	2.1	1.4	1.4	1.0	4.5	9.2	1.6	2.1	0.9	2.0	57.8	1.9	3.9	1.0	4.9	4.6	0.5	9.1	1.8	0.8	1.5	32.0	2.5	1.2	7.6	18.6	1.4	0.6	2.8	16.9	1.2	6.4	2.4	3.3	9.4	4.7	16.8	6.4	4.7	1.9	1.6	2.4	0.2	0.1	0.0	3.1	15.2	3.7	10.2	4.6	8.3	5.9	2.5	0.6	1.7	1.0	7.6	1.6	2.2	5.2	4.2	9.3	1.2	0.8	4.3	0.2	0.4	26.3	3.1	1.5	22.3	1.1	8.0	8.7	6.8	7.6	2.2	0.0	1.8	8.2	3.8	1.7	5.1	4.8	6.4	0.6	2.8	5.1	0.8	9.7	4.5	1.1	0.0	1.2	1.4	0.0	3.8	0.0	2.2	3.1	5.2	3.4	18.7	4.4	2.6	0.5	0.0	10.5	5.4	1.3	4.3	2.7	16.8	1.3	6.4	0.4	1.3	1.5	1.3	4.7	9.4	0.2	1.0	0.9	4.7	5.7	2.3	1.9	1.6	1.6	3.9	10.9	2.7	2.1	1.4	1.6	2.1	1.0	0.6	0.0	1.7	2.2	3.5	0.8	0.0	0.8	0.0	9.4	9.1	3.5	0.0	1.6	0.0	1.3	19.4	4.2	16.9	0.0	22.1	17.9	4.1	9.1	10.4	0.0	7.4	0.0	26.5	6.2	29.1	9.7	0.0	11.2	1.7	1.0	12.5	0.0	8.5	15.6	1.1	1.3	0.1	0.0	1.0	1.8	2.4	0.3	15.9	4.3	26.5	0.9
PRUNE2	"A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367"	ENSG00000106772	"Prune homolog 2"	Q8WUY3	9	76611376-76906087	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 89.3"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 47.7;Intestinal endocrine cells: 52.1;Mucus-secreting cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.9;LHCN-M2: 34.3;RH-30: 29.7;RPTEC TERT1: 16.8"	"Low region specificity"	"Detected in all"							"HPA022470, HPA031079"	Uncertain					NA	NA					"HPA022470: AB_1845832, HPA031079: AB_10603230"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.80e-4)"	6.1	18.3	14.1	10.2	28.9	2.6	3.1	47.9	34.5	7.8	45.6	16.4	18.5	5.8	23.9	14.9	26.4	19.0	12.8	5.6	14.6	13.8	12.1	2.2	4.5	2.6	30.4	14.8	3.6	4.0	4.2	22.3	3.7	18.9	37.2	14.9	11.3	10.2	50.8	7.8	2.3	12.5	89.3	19.5	3.8	21.3	4.2	29.5	0.0	1.4	4.6	2.6	38.1	13.8	0.7	1.9	1.8	2.8	1.2	0.6	0.7	0.0	0.0	0.6	0.0	21.9	10.6	0.0	0.7	1.5	2.5	6.1	0.1	0.0	0.1	1.6	1.8	5.6	0.0	0.0	0.0	7.6	0.1	1.2	2.5	1.5	0.0	3.6	0.0	0.1	12.3	0.0	11.1	0.3	6.4	5.9	0.1	0.0	8.7	34.3	0.0	1.8	0.7	1.6	0.0	0.0	0.2	29.7	0.1	16.8	0.0	7.3	0.0	0.0	0.1	2.0	1.2	0.0	0.3	4.9	6.0	0.3	14.3	0.4	9.3	1.2	0.0	4.8	0.1	0.0	1.2	2.2	0.3	0.1	2.8	0.6	0.0	0.2	0.0	1.9	0.7	0.0	0.0	1.8	1.2	1.2	0.4	0.0	0.7	14.1	28.9	47.9	20.7	14.6	13.8	30.4	14.8	18.9	29.5	0.0	0.6	0.0	0.4	2.1	47.7	4.9	0.0	17.4	1.2	10.4	0.0	0.0	1.7	0.0	12.1	3.6	2.1	0.0	0.4	0.1	2.1	6.3	0.0	0.0	2.9	14.3	52.1	20.3	3.0	24.7	0.9	3.1	5.0	0.0	27.0	10.0	0.5	5.8	1.4	16.1	5.4	0.0	8.4	2.3	1.5	1.3	0.0	0.0	2.8	0.4
FOXB2	bA159H20.4	ENSG00000204612	"Forkhead box B2"	Q5VYV0	9	77019655-77020953	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"brain: 2.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 5.5"	"Region enriched"	"Detected in single"	16	"hypothalamus: 1.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.1;hypothalamus: 6.4;midbrain: 2.0;pons and medulla: 2.0"	HPA067947	Uncertain					NA	NA					"HPA067947: AB_2685930"										"unprognostic (2.02e-1)"		"unprognostic (8.58e-2)"			"unprognostic (2.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0			0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VPS13A	"CHAC, KIAA0986"	ENSG00000197969	"Vacuolar protein sorting 13 homolog A"	Q96RL7	9	77177353-77421541	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021652, HPA021662"	Supported					NA	NA		29000			"HPA021652: AB_1858759, HPA021662: AB_1858760"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.68e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.69e-3)"	"unprognostic (9.67e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-2)"	10.0	14.2	20.1	11.9	13.6	20.3	9.9	22.6	17.6	9.0	17.2	3.0	13.3	21.0	12.4	11.2	14.9	10.0	14.4	17.9	11.2	5.6	13.9	9.9	10.6	10.9	4.9	16.7	7.4	15.7	18.9	30.0	5.0	13.3	12.4	15.5	5.8	12.8	13.0	29.8	20.4	24.2	13.3	7.4	13.3	16.1	20.8	6.2	18.3	11.6	11.8	10.0	14.2	12.9	2.8	4.7	5.8	0.4	2.2	2.8	0.4	15.0	7.6	6.9	5.9	6.5	5.7	10.4	8.4	7.6	7.4	8.5	3.0	6.9	11.9	4.0	7.8	9.0	20.6	10.2	8.3	13.2	11.1	8.1	15.6	14.6	7.5	6.4	20.2	10.5	3.6	12.6	10.9	13.5	13.1	10.5	11.7	10.2	13.0	4.4	7.0	15.4	7.0	7.6	8.7	6.2	11.3	13.1	4.8	10.7	14.8	10.0	10.1	10.5	6.9	4.7	13.1	4.7	4.5	13.7	7.9	8.6	10.8	10.6	7.3	6.8	6.2	8.2	9.6	3.1	5.8	0.4	4.1	2.8	0.2	2.7	1.8	2.1	2.0	0.3	2.8	1.8	2.0	0.5	2.2	0.2	4.7	1.4	0.4	20.1	13.6	22.6	17.6	11.2	5.6	4.9	16.7	13.3	6.2	59.6	33.2	14.6	22.9	29.3	27.8	69.7	33.1	34.8	47.8	27.9	55.0	13.2	3.3	15.2	91.2	25.3	81.4	0.0	16.1	4.3	17.8	20.8	18.5	31.6	7.3	11.1	84.2	35.6	14.2	40.8	12.7	7.7	21.9	15.4	32.6	17.4	32.6	34.5	14.9	14.9	18.0	32.3	21.7	76.0	61.5	27.4	7.4	28.7	29.9	24.4
GNA14		ENSG00000156049	"G protein subunit alpha 14"	O95837	9	77423079-77648307	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 30.8;Early spermatids: 43.0;Ito cells: 49.1;Late spermatids: 25.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	72	"basophil: 17.7"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 17.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.8;HUVEC TERT2: 3.3;PC-3: 6.7;THP-1: 3.3;U-2197: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA					"HPA048886: AB_2680544"	"unprognostic (7.80e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-4)"	"unprognostic (2.48e-6)"	"unprognostic (6.35e-3)"	"unprognostic (3.34e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-1)"	5.4	2.7	8.1	5.7	12.5	0.3	2.8	0.7	7.7	6.9	5.8	2.7	5.9	2.2	21.3	6.6	5.9	4.6	9.5	5.4	10.6	2.5	8.4	7.1	14.8	6.6	2.7	3.7	9.0	2.2	1.3	3.9	8.2	7.4	8.4	7.4	4.8	18.0	17.2	1.1	1.3	3.4	16.7	20.5	8.3	4.3	2.4	1.5	0.3	20.9	1.2	2.6	7.3	5.7	0.0	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	4.8	2.2	0.6	0.1	1.3	0.0	2.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.0	0.1	2.0	0.1	0.4	1.9	0.9	6.7	0.0	0.0	0.0	0.0	2.5	0.3	0.3	1.7	0.9	0.0	2.8	0.6	3.3	0.9	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.2	0.3	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	8.1	12.5	0.7	7.7	10.6	2.5	2.7	3.7	7.4	1.5	0.0	0.6	0.0	1.6	0.6	0.0	0.7	0.0	30.8	11.4	0.0	0.0	0.0	0.0	0.7	43.0	7.1	0.7	0.0	0.9	0.1	3.7	1.2	4.6	1.0	0.3	0.0	2.9	49.1	2.8	25.7	3.4	0.2	1.7	0.0	14.7	0.0	0.1	2.9	1.8	4.3	0.0	0.0	0.8	0.4	0.2	0.5	0.1	0.0	2.9	4.2
GNAQ	"G-ALPHA-q, GAQ"	ENSG00000156052	"G protein subunit alpha q"	P50148	9	77716087-78031458	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 18.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 18.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010036, HPA048886"	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		28000000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB010036: AB_631536, HPA048886: AB_2680544"	"unprognostic (2.10e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.11e-7)"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-1)"	12.7	12.6	24.3	9.9	20.8	21.8	11.6	12.5	29.6	13.1	16.6	17.1	9.1	7.9	13.7	11.2	13.1	10.0	11.6	5.6	24.2	18.3	12.1	12.3	23.1	11.8	19.1	14.6	13.5	8.5	12.7	7.6	12.1	14.3	13.0	16.0	10.4	9.8	15.9	5.9	5.1	9.0	18.2	23.9	5.8	15.5	6.0	14.8	18.6	13.3	4.0	4.8	14.5	13.1	0.8	2.8	18.4	3.5	3.3	2.0	1.2	12.0	13.7	12.2	13.4	15.5	15.9	17.6	16.4	12.4	7.2	8.7	4.2	9.9	0.0	13.3	15.0	10.1	19.8	9.1	9.9	9.0	0.4	5.3	33.0	12.0	8.4	14.0	20.1	12.4	10.8	12.2	13.9	14.2	15.0	17.7	29.8	5.8	0.1	12.6	15.3	23.2	12.8	9.9	19.4	1.9	8.6	15.0	0.1	16.4	25.8	13.7	20.9	11.8	10.0	12.3	12.0	9.1	7.5	22.1	12.7	0.8	17.2	9.5	0.1	0.0	0.1	8.8	11.9	13.1	18.4	2.2	4.6	0.8	1.9	1.6	0.8	1.8	1.0	2.4	0.8	2.0	1.6	7.7	3.3	3.5	2.8	1.9	1.2	24.3	20.8	12.5	24.0	24.2	18.3	19.1	14.6	14.3	14.8	163.8	71.4	6.4	33.6	42.0	29.9	5.9	43.3	42.8	35.2	73.3	15.7	39.3	6.6	28.1	13.1	85.4	69.5	46.7	34.7	42.2	42.9	51.3	49.7	51.3	47.8	77.9	88.6	107.4	139.4	6.8	36.5	92.7	45.5	72.1	90.6	37.0	44.3	48.9	49.1	35.4	4.2	25.8	40.1	4.7	6.6	18.9	24.3	21.8	67.3	50.3
CEP78	"C9orf81, FLJ12643"	ENSG00000148019	"Centrosomal protein 78"	Q5JTW2	9	78236062-78279690	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Cone-rod dystrophy, Deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 51.9;Spermatocytes: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 23.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 23.0;T-cells: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048846	Approved					NA	NA					"HPA048846: AB_2680537"	"unprognostic (4.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.93e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.34e-1)"	4.2	6.0	9.6	7.1	10.8	16.5	7.5	12.7	9.9	7.3	6.0	10.0	3.2	4.7	9.7	5.8	6.5	6.6	4.2	3.5	9.6	7.2	7.0	6.8	5.5	9.3	10.3	8.7	8.3	5.2	10.2	7.7	6.6	8.2	6.0	7.1	8.1	5.5	6.0	3.2	6.1	5.4	8.1	9.0	8.0	5.5	22.5	10.6	22.2	7.4	3.0	12.2	6.4	6.8	3.2	2.5	0.4	3.0	23.0	12.0	4.9	16.6	8.0	17.5	10.8	3.2	5.5	12.2	13.9	6.0	9.0	10.9	1.4	4.7	14.9	6.9	4.9	12.5	19.6	27.4	8.2	12.9	13.3	8.8	8.0	9.2	5.9	2.8	13.5	7.8	2.9	1.8	9.6	6.5	4.1	12.9	15.9	6.3	12.4	11.4	10.3	16.9	6.5	18.8	18.5	7.5	16.7	21.0	4.4	5.0	7.1	16.4	11.4	18.1	5.5	4.5	14.2	6.8	3.6	6.9	7.6	12.6	14.8	13.1	7.3	9.1	9.8	6.4	9.2	12.4	0.4	0.5	0.4	12.0	2.0	5.8	3.2	5.2	10.7	1.4	2.3	2.6	8.5	0.3	23.0	3.0	2.5	7.7	4.9	9.6	10.8	12.7	9.9	9.6	7.2	10.3	8.7	8.2	10.6	23.8	8.6	9.3	7.9	4.5	24.7	7.9	7.6	30.8	7.9	1.8	104.1	8.4	5.0	7.4	7.7	7.1	1.1	0.0	5.6	17.6	5.6	4.1	4.7	8.3	8.2	3.2	7.5	5.5	3.2	4.9	13.8	6.4	1.7	7.2	5.9	14.5	4.6	5.1	14.2	4.1	51.9	0.0	9.9	70.7	23.2	4.3	3.3	33.0	8.3	4.2
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 129.9;Proximal tubular cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 147.9;SK-MEL-30: 90.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.7	18.0	15.2	26.9	4.5	5.3	35.9	22.7	16.2	11.6	21.7	4.6	5.2	17.4	10.1	51.1	10.5	26.6	25.9	25.1	17.4	17.0	9.2	5.9	8.3	35.4	41.6	33.1	10.7	16.9	147.9	15.3	41.1	2.8	10.5	68.0	6.3	44.8	9.6	10.0	11.3	5.3	34.8	50.3	19.7	5.6	9.8	20.4	15.8	6.2	6.9	16.0	6.3	10.9	90.5	10.0	5.2	41.8	2.4	2.9	9.5	10.8	18.4	30.5	28.1	0.1	34.2	26.2	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0	0.0	0.0	16.4	6.8	37.3	0.8	0.5	0.0	2.7	0.0	10.4	0.0	25.8	53.0	14.1	1.3	2.1	0.7	46.7	41.7	10.5	2.4	14.9	0.0	129.9	4.4	4.8	3.5	3.7	3.2	1.7	4.6	1.8	18.6	6.4	2.0	22.2	28.4	0.0	1.8	244.0	1.3	0.0	1.0	1.4	2.8	44.4	7.8	4.4	3.0	11.2
TLE4	"E(spI), ESG, GRG4"	ENSG00000106829	"Transducin like enhancer of split 4"	Q04727	9	79571773-79726882	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 66.2"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 722.1;Late spermatids: 937.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 33.0;BJ hTERT+: 32.9;BJ hTERT+ SV40 Large T+: 31.0;fHDF/TERT166: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065357			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065357: AB_2685479"	"unprognostic (6.68e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.94e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.94e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	6.1	11.6	11.6	11.6	25.3	40.0	6.9	22.5	21.2	7.4	7.3	28.8	3.6	6.0	11.4	5.5	12.8	10.3	13.0	6.2	14.7	11.3	5.6	4.4	8.9	10.8	28.9	15.0	26.1	5.3	14.0	45.2	14.6	20.4	4.9	8.6	8.6	7.5	7.1	23.8	13.5	8.0	11.2	31.2	12.4	10.5	66.2	30.3	18.8	8.1	5.1	14.2	12.2	9.3	1.2	2.2	17.3	4.7	2.3	4.8	2.0	0.0	5.9	24.1	0.1	4.4	3.7	7.4	33.0	32.9	31.0	12.3	0.8	3.4	2.7	0.0	51.5	4.5	6.9	1.6	5.8	15.0	11.8	10.2	0.0	2.9	0.1	4.7	7.0	4.3	4.2	4.3	8.8	1.7	8.8	8.0	4.7	0.5	7.2	10.3	0.2	9.1	3.0	7.6	4.2	1.5	8.3	12.7	2.3	1.9	0.9	9.9	14.7	4.6	0.6	0.0	11.8	0.0	8.1	11.5	12.0	0.0	0.2	1.6	4.7	7.6	3.5	4.2	6.1	5.5	17.3	3.4	12.9	3.9	4.7	4.8	1.1	2.1	2.9	2.2	1.2	1.2	2.1	9.2	2.3	3.6	0.8	0.5	2.0	11.6	25.3	22.5	21.2	14.7	11.3	28.9	15.0	20.4	30.3	6.0	20.8	54.1	48.8	107.4	74.6	15.3	61.1	24.1	25.0	14.0	119.8	55.1	3.3	11.6	722.1	49.7	119.6	0.0	19.5	58.1	45.9	27.8	20.7	12.8	42.0	206.6	24.2	36.8	152.5	937.0	97.8	71.8	40.5	27.9	68.5	23.4	25.3	203.4	43.9	15.3	271.5	71.1	60.8	39.3	150.1	79.4	54.3	87.1	54.2	84.6
TLE1	"ESG, ESG1, GRG1"	ENSG00000196781	"Transducin like enhancer of split 1"	Q04724	9	81583683-81689305	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 116.4;Spermatogonia: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011482, HPA071396"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011482: AB_443210, HPA071396: AB_2686392"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (4.09e-1)"	26.4	20.1	27.5	12.2	23.1	24.3	23.0	20.3	22.0	25.7	15.2	9.7	13.8	4.0	22.8	19.2	12.7	18.6	19.3	8.1	31.8	9.3	8.6	33.9	9.1	18.8	14.0	20.0	18.1	37.2	5.6	7.9	12.1	14.2	14.6	12.5	13.3	29.0	18.1	54.1	11.8	11.9	20.1	10.5	22.6	15.4	15.0	20.5	2.1	11.0	15.3	8.3	12.9	24.7	6.9	2.0	8.7	0.1	4.9	3.5	0.6	22.9	15.6	15.1	0.0	16.1	9.0	33.6	1.4	4.2	2.5	3.7	2.4	8.5	0.0	15.3	9.6	21.5	12.7	0.2	7.4	2.7	0.0	14.4	0.0	3.2	24.1	9.2	0.0	0.4	4.3	16.6	8.7	17.5	7.6	10.8	6.7	0.0	7.7	8.8	24.5	2.7	0.1	29.6	12.9	9.3	21.3	12.7	1.7	16.0	11.4	8.7	10.9	1.2	12.4	7.5	15.7	9.4	10.7	9.2	6.8	7.5	3.6	10.7	0.2	0.0	0.5	9.6	0.0	12.6	8.7	0.0	5.0	2.5	0.0	3.5	6.9	0.2	1.0	0.6	6.6	0.0	0.2	0.0	4.9	0.1	2.0	0.0	0.6	27.5	23.1	20.3	22.0	31.8	9.3	14.0	20.0	14.2	20.5	0.0	6.2	33.3	18.3	48.4	28.0	5.3	40.8	18.7	13.6	14.0	15.7	52.9	13.3	37.5	0.7	37.2	25.3	0.0	20.3	62.7	23.8	31.9	0.0	54.2	6.9	15.9	27.6	23.9	3.5	2.4	21.0	8.2	43.9	13.6	21.1	35.7	43.9	31.7	32.2	2.5	6.3	116.4	40.6	1.6	119.9	38.1	42.4	26.1	31.2	27.2
SPATA31D4	"FAM75D4, FLJ43859"	ENSG00000189357	"SPATA31 subfamily D member 4"		9	81928514-81934948	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	78	"testis: 7.8"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 29.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	7.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31D3	"FAM75D3, FLJ44082"	ENSG00000186788	"SPATA31 subfamily D member 3"	P0C874	9	81943586-81950038	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	99	"testis: 9.9"	"Cell type enriched"	"Detected in some"	13	"Early spermatids: 16.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	9.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31D1	"FAM75D1, FLJ46321"	ENSG00000214929	"SPATA31 subfamily D member 1"	Q6ZQQ2	9	81988772-81995256	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"testis: 13.3"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 8.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HDLM-2: 3.7"									HPA047897	Uncertain					NA	NA					"HPA047897: AB_2680204"															"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979585-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 74.7;Ciliated cells: 144.6;Club cells: 84.2;Glandular cells: 74.9;Mucus-secreting cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 27.9;RT4: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	0.7	0.8	2.1	7.0	0.7	1.6	9.0	0.6	2.2	1.7	8.2	0.6	15.5	2.8	1.8	9.6	7.1	2.9	23.5	0.7	1.3	1.1	4.2	2.0	6.8	0.4	0.7	0.4	1.6	23.9	2.7	13.4	5.1	1.7	10.4	7.6	3.7	22.2	12.0	0.6	2.2	10.4	1.2	0.7	0.6	20.3	2.4	0.2	4.8	20.1	3.7	10.0	8.1	5.5	7.6	5.2	13.9	3.0	5.0	5.4	0.8	7.8	8.6	1.2	1.2	0.2	0.3	3.6	0.9	0.2	0.9	2.1	5.1	9.6	2.4	8.9	0.3	6.1	8.9	0.3	0.2	1.1	1.0	9.3	1.5	6.7	1.3	0.1	1.1	1.1	0.3	3.8	4.1	0.2	1.4	0.0	1.5	1.6	10.6	0.1	15.8	1.5	1.4	6.9	27.9	3.5	1.6	2.7	3.4	9.8	21.2	3.4	4.9	1.8	14.8	0.7	4.5	13.2	1.1	1.6	1.9	9.9	1.4	1.1	7.2	6.4	1.0	3.8	0.7	2.1	7.3	3.0	2.5	5.2	1.9	5.0	4.7	4.9	4.1	1.4	7.6	5.4	4.7	13.9	5.0	2.2	5.2	3.7	0.8	2.1	0.7	0.6	2.2	1.3	1.1	0.7	0.4	1.7	0.2	71.5	74.7	0.0	3.0	0.7	1.3	0.4	38.2	144.6	84.2	8.7	3.9	5.1	6.6	26.1	0.4	0.6	35.4	0.0	32.2	9.3	0.6	74.9	20.9	1.0	0.7	0.0	3.5	0.6	0.0	1.3	0.3	0.6	1.7	2.8	70.8	0.0	40.9	26.9	0.0	5.6	1.2	0.0	2.1	0.1	2.5	0.6	6.3	0.0	17.4	32.7
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 48.5;skeletal muscle: 42.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.8;monocytes: 4.7"	"Cell line enhanced"	"Detected in some"		"HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	12.7	4.6	3.5	2.8	2.3	3.0	16.8	2.0	3.0	4.6	7.1	1.7	14.3	1.9	5.5	9.8	4.1	1.9	2.9	48.5	3.2	4.5	11.7	0.7	2.9	0.9	3.6	1.7	1.4	1.4	8.9	6.1	8.7	2.9	5.1	4.1	5.3	2.1	35.3	42.1	1.6	10.9	3.5	2.8	4.3	2.2	6.1	0.8	0.0	8.8	11.1	0.7	3.8	5.0	0.6	0.6	3.8	4.7	0.4	0.6	9.2	0.0	2.1	1.8	0.1	0.3	0.1	0.1	2.0	0.1	0.0	0.0	0.2	2.5	0.4	2.3	0.9	0.4	0.1	0.1	0.0	0.0	0.1	0.1	11.2	2.4	1.3	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.2	23.5	3.5	0.0	1.5	37.7	3.1	4.9	13.9	6.7	0.7	0.1	0.4	0.3	0.8	0.4	2.1	0.1	0.3	0.0	1.4	0.2	0.1	0.0	0.5	3.6	1.4	0.0	2.8	0.0	0.4	4.7	0.6	0.5	0.2	0.1	0.4	0.6	0.1	0.0	3.8	0.4	2.1	0.6	0.0	9.2	3.5	2.3	2.0	3.0	3.2	4.5	3.6	1.7	2.9	0.8	20.8	0.6	0.0	1.0	0.9	102.0	66.5	10.2	0.0	2.3	1.8	74.6	0.3	14.9	2.5	112.3	13.1	26.2	0.0	1.7	0.9	2.1	1.0	0.0	0.2	0.8	95.3	1.2	3.1	4.6	100.0	2.0	1.5	0.0	0.0	19.4	2.0	2.0	7.0	4.6	8.7	4.7	71.1	28.9	1.6	1.4	1.1	0.1	0.0	1.6	1.3
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK, gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9;liver: 39.1"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 68.0;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	4.3	6.1	9.4	2.9	20.3	2.2	4.5	12.3	8.3	2.3	11.3	7.0	3.1	14.2	2.5	7.4	4.1	6.8	4.5	2.8	7.6	8.6	27.2	39.1	3.7	4.7	7.3	6.3	3.2	6.6	3.6	5.2	1.8	6.2	4.2	4.7	5.2	4.6	5.0	1.2	3.3	20.2	3.5	7.0	4.2	4.3	2.0	6.8	14.5	7.0	1.2	4.3	2.8	2.1	17.5	9.6	35.9	20.5	15.0	23.0	11.4	3.4	8.2	1.1	1.3	3.7	5.4	6.0	2.3	6.9	2.6	2.1	2.1	3.0	4.3	4.0	3.7	2.5	5.7	0.9	1.6	2.8	9.5	1.0	1.6	3.2	9.4	16.4	1.0	2.0	3.7	2.2	5.7	5.4	3.9	5.9	10.3	1.3	4.6	3.8	19.0	2.6	1.0	0.9	13.8	3.7	3.2	3.1	2.5	6.9	4.0	5.3	6.8	5.5	4.3	5.8	1.6	4.3	5.8	6.0	1.1	0.8	10.7	4.4	6.6	7.6	0.6	5.9	1.8	2.1	35.9	6.1	8.6	14.7	10.6	12.3	17.5	12.7	12.1	8.5	11.4	10.2	13.8	1.1	15.0	20.5	9.6	23.0	11.4	9.4	20.3	12.3	8.3	7.6	8.6	7.3	6.3	6.2	6.8	11.9	5.4	5.9	2.6	6.1	7.5	8.7	15.3	22.7	9.1	5.2	0.0	6.3	68.0	10.1	0.3	6.0	10.8	0.0	14.3	3.8	8.4	5.2	19.7	37.2	10.0	9.5	7.0	3.1	9.5	1.1	4.0	7.7	11.8	27.9	10.6	17.7	5.2	11.5	3.9	149.6	3.1	0.0	9.5	1.1	1.5	5.1	2.5	17.5	7.8	2.7
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659963-83708203	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: AB_2682398"	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	26.8	33.9	27.2	26.2	38.7	41.1	38.1	35.0	42.2	24.9	24.4	21.2	27.8	21.9	29.1	22.2	30.5	21.4	21.0	34.5	28.9	32.1	31.6	40.8	23.3	25.8	30.0	27.8	21.5	28.1	36.0	29.5	30.4	37.2	26.5	23.7	15.2	23.8	28.9	79.1	27.8	27.6	26.9	33.9	28.6	23.1	22.9	23.3	59.8	25.7	16.2	34.8	24.8	27.3	16.0	19.2	23.4	25.0	24.7	18.8	14.9	43.9	40.7	29.9	23.1	24.9	26.6	49.6	41.1	36.5	43.7	33.2	16.7	31.4	43.7	26.6	34.3	41.7	50.6	41.4	29.2	45.5	23.0	19.2	26.8	31.3	25.9	33.0	32.5	29.5	22.0	36.8	36.8	51.3	27.0	32.6	21.0	28.9	31.3	35.7	26.1	45.4	18.0	39.1	41.6	37.4	33.7	33.5	22.8	28.5	19.2	27.0	30.2	38.0	38.2	29.3	30.9	19.1	23.6	32.3	28.0	26.1	46.2	41.1	43.9	62.0	21.4	41.6	24.0	33.8	23.4	17.1	17.6	16.6	25.0	16.2	16.0	14.5	15.2	19.2	15.5	14.7	16.0	18.5	24.7	23.1	8.2	18.8	14.9	27.2	38.7	35.0	38.7	28.9	32.1	30.0	27.8	37.2	23.3	32.8	35.6	44.2	53.6	91.8	58.5	67.1	20.4	26.8	45.5	21.0	19.6	52.3	16.6	46.7	25.2	35.9	44.6	0.0	46.1	65.6	43.2	59.5	49.6	65.2	47.2	71.5	49.3	27.0	44.2	14.7	22.7	44.6	40.5	33.3	38.0	27.6	56.0	40.3	26.2	29.3	30.6	38.8	45.3	69.1	46.4	80.8	137.4	30.9	34.3	72.7
GKAP1	"FKSG21, GKAP42"	ENSG00000165113	"G kinase anchoring protein 1"	Q5VSY0	9	83739421-83829516	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 98.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 991.0;Late spermatids: 314.1;Spermatocytes: 374.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035117, HPA035118, HPA066173"	Enhanced	Supported	Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740"	"unprognostic (1.91e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.66e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.18e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (9.73e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.24e-3)"	4.4	4.2	6.0	2.8	6.1	2.5	9.2	15.6	6.1	4.7	5.0	4.1	6.6	3.0	5.5	4.5	3.2	3.9	3.4	9.0	6.1	6.8	4.2	5.1	2.9	2.6	6.5	3.1	7.0	5.2	6.2	7.9	2.0	6.1	6.6	2.7	3.2	4.2	5.9	25.0	1.7	3.0	8.1	8.0	2.4	3.5	98.8	7.2	8.4	8.1	5.2	2.7	6.0	14.7	1.9	0.6	3.0	0.8	5.3	1.9	0.1	4.8	6.0	4.4	5.8	0.6	0.0	6.3	1.9	1.5	3.0	3.1	0.8	2.7	7.5	1.9	0.8	10.1	1.0	4.4	0.5	5.2	9.0	3.9	4.3	3.0	4.3	6.5	2.0	0.4	0.2	3.5	1.5	1.6	8.8	2.7	7.3	3.5	6.3	0.9	4.6	10.5	6.9	3.6	2.3	3.1	7.5	9.9	2.6	3.1	0.8	14.8	8.8	4.3	2.0	3.4	7.1	0.8	4.1	0.9	1.0	7.1	0.7	3.3	10.4	22.7	3.0	2.2	1.4	1.2	3.0	0.8	0.6	1.4	0.0	1.3	1.7	1.3	1.5	0.6	1.9	1.0	1.9	2.5	5.3	0.3	0.3	1.5	0.1	6.0	6.1	15.6	6.1	6.1	6.8	6.5	3.1	6.1	7.2	6.0	9.1	10.2	16.1	6.3	45.6	47.4	12.7	6.7	2.3	14.0	43.2	7.1	11.6	8.8	991.0	11.7	6.2	23.3	5.8	2.3	4.7	20.1	2.3	18.8	3.5	114.4	12.6	10.4	3.2	314.1	24.5	5.2	10.1	1.0	12.0	43.9	6.4	6.8	20.1	11.6	73.0	25.8	8.4	374.4	52.7	4.0	2.4	12.1	10.8	8.1
KIF27	DKFZp434D0917	ENSG00000165115	"Kinesin family member 27"	Q86VH2	9	83836698-83921465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.7"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 75.0;Early spermatids: 137.7;Late spermatids: 100.4;Spermatocytes: 55.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 15.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 15.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.75e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-1)"	4.1	3.7	5.4	2.9	9.3	3.1	5.0	4.0	7.5	6.6	3.8	6.0	9.1	3.2	7.1	11.9	3.7	10.8	4.3	3.9	6.1	4.7	4.5	3.9	5.1	3.5	4.9	3.6	7.2	5.3	7.6	14.5	5.3	21.3	4.8	3.2	5.2	5.3	5.5	3.8	5.6	3.8	4.9	5.4	4.3	4.4	31.7	6.2	8.4	15.1	3.9	3.0	3.5	4.6	1.4	1.2	15.7	0.7	1.1	1.0	0.3	6.3	6.6	5.0	7.7	3.6	3.6	9.7	3.2	3.6	2.0	1.6	1.7	3.4	0.7	2.8	1.5	6.0	5.7	2.2	2.3	2.5	6.4	1.7	1.9	2.2	2.7	5.6	4.7	1.8	2.2	5.4	2.8	7.5	7.6	3.0	7.3	2.0	2.5	0.8	4.7	6.1	4.5	2.8	4.5	3.4	6.1	4.8	1.5	3.6	2.1	5.5	4.5	4.4	1.1	3.8	7.0	2.3	3.7	1.6	3.6	4.0	3.6	3.0	4.2	3.0	0.9	2.1	1.9	3.5	1.3	0.7	2.2	0.6	0.7	0.6	1.4	0.7	0.6	0.7	1.1	1.0	0.6	15.7	1.1	0.2	1.2	0.1	0.3	5.4	9.3	4.0	7.5	6.1	4.7	4.9	3.6	21.3	6.2	6.0	9.8	0.0	4.4	3.1	5.5	8.3	2.5	75.0	23.9	3.5	15.7	2.2	1.7	3.3	137.7	4.9	1.9	0.0	3.3	1.5	2.9	3.5	3.5	2.0	1.2	11.1	1.7	3.7	1.3	100.4	9.2	3.0	3.3	1.0	2.8	11.5	2.1	2.6	6.3	2.1	13.3	6.5	3.9	55.7	20.9	2.0	2.2	2.2	2.3	1.8
C9orf64	MGC10999	ENSG00000165118	"Chromosome 9 open reading frame 64"	Q5T6V5	9	83938311-83956986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054903, HPA066190"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA054903: AB_2682636, HPA066190: AB_2685633"	"unprognostic (2.07e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.48e-3)"	12.6	17.1	8.7	8.5	10.3	2.3	14.7	8.0	9.7	12.1	13.5	12.2	10.8	24.5	13.8	12.7	8.2	12.5	8.6	9.7	7.9	9.0	14.6	25.4	9.3	9.5	9.4	6.1	12.4	15.9	18.9	13.6	9.8	9.9	12.1	9.0	11.6	9.9	10.0	10.3	6.0	22.5	11.3	8.0	8.9	10.8	11.1	8.0	16.3	26.0	6.7	8.3	11.9	10.1	4.1	12.4	10.0	12.5	13.2	7.4	4.6	12.2	10.6	0.2	0.0	5.5	7.4	13.0	8.2	2.3	7.7	8.6	9.5	11.1	0.0	6.8	8.8	3.1	7.6	0.0	0.3	10.0	13.1	7.0	5.4	13.5	18.3	12.6	0.0	16.5	8.5	10.7	7.4	0.0	1.7	4.9	0.0	13.1	0.1	9.2	12.0	2.5	0.4	10.1	7.7	5.2	0.0	16.3	0.5	6.2	2.1	10.5	10.3	14.4	3.4	10.8	0.2	4.5	10.5	1.5	0.9	11.1	17.2	2.3	3.5	0.2	0.4	7.3	0.5	5.5	7.4	11.0	10.0	7.4	12.4	7.0	2.9	5.6	7.4	12.4	4.1	6.2	7.4	4.9	13.2	12.5	8.8	5.9	4.6	8.7	10.3	8.0	9.7	7.9	9.0	9.4	6.1	9.9	8.0	11.9	9.6	0.0	4.1	1.9	4.0	4.8	5.1	8.1	2.3	3.5	3.9	10.8	10.0	9.7	4.3	3.8	8.5	0.0	7.8	16.0	5.6	3.1	9.2	22.2	10.7	3.2	4.1	6.7	15.1	2.3	7.5	6.4	1.7	13.6	5.6	12.6	8.3	4.9	10.3	12.6	6.6	0.0	6.6	8.4	5.3	1.3	3.7	4.4	8.0	2.6
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		5000000	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	79.0	92.0	70.0	80.7	81.7	146.9	97.2	88.0	104.8	77.9	70.0	68.8	80.9	74.5	96.3	69.0	95.8	79.6	67.5	80.4	68.2	71.5	76.0	90.9	77.7	125.0	80.9	72.9	96.5	102.8	91.4	74.5	92.3	67.3	69.4	75.2	58.6	76.5	104.6	101.4	78.7	76.7	100.9	86.3	96.1	72.5	60.3	78.6	162.5	79.9	80.8	106.9	81.0	77.1	59.7	76.1	92.7	71.0	75.6	73.2	136.4	122.3	84.6	145.5	86.1	69.9	77.5	116.9	86.6	107.7	108.5	102.2	70.8	87.7	145.4	59.6	90.6	94.1	94.1	145.4	105.1	132.5	99.9	85.6	102.0	74.2	100.3	92.6	126.4	101.3	78.8	80.4	92.5	123.1	81.8	110.4	82.7	103.7	74.7	106.7	107.3	156.7	86.7	129.2	124.4	82.4	136.9	116.0	96.9	105.1	101.0	94.4	112.1	91.1	97.2	86.3	105.3	96.2	107.5	90.3	75.6	89.1	76.6	112.8	78.7	103.0	105.6	72.2	102.4	106.8	77.4	71.0	90.1	53.9	69.2	67.3	59.7	62.5	61.2	76.1	56.8	65.1	59.3	92.7	75.6	65.8	45.2	73.2	136.4	70.0	81.7	88.0	104.8	68.2	71.5	80.9	72.9	67.3	78.6	190.6	233.2	308.4	456.1	449.4	175.4	171.5	206.4	338.6	282.1	249.5	84.4	518.7	334.9	379.2	22.5	338.4	245.6	163.5	321.8	621.5	373.1	281.2	324.9	300.6	341.5	147.8	371.7	237.6	349.5	31.1	309.8	311.8	310.4	423.8	309.1	344.3	335.2	270.0	301.9	310.5	156.5	271.7	398.2	345.1	248.3	392.2	609.3	308.9	346.3	397.3
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980711-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 35.7"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 51.0;Late spermatids: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	9.3	9.9	6.2	16.6	7.5	3.9	5.1	13.1	6.1	5.7	7.6	2.9	5.9	7.6	4.1	6.3	7.7	7.5	3.5	3.8	5.3	8.5	5.5	6.3	7.0	13.2	7.4	3.5	5.4	10.0	9.1	7.5	11.0	9.6	6.6	9.1	3.9	7.7	6.3	6.4	5.4	10.5	4.0	8.1	21.0	7.1	11.7	4.8	35.7	7.3	6.3	11.4	5.6	4.5	4.3	9.8	14.4	8.1	5.1	3.9	3.7	14.0	9.6	20.3	7.0	3.1	4.9	19.1	14.0	8.0	12.9	11.8	4.6	9.5	29.7	5.1	6.9	12.9	20.4	13.5	6.7	15.0	17.0	3.4	12.5	7.8	5.8	4.5	23.0	12.9	4.3	4.4	10.2	7.6	4.0	6.1	17.0	9.3	15.3	13.4	9.9	28.6	8.0	17.4	17.2	9.2	26.5	19.9	11.0	5.9	6.0	17.4	10.7	13.1	10.0	5.4	9.3	10.7	10.2	4.3	13.3	8.7	13.1	11.1	6.6	13.9	11.3	8.5	10.0	14.4	14.4	6.1	11.2	2.8	7.3	3.3	4.3	3.3	2.9	9.8	4.0	3.2	3.7	10.6	5.1	8.1	2.8	3.9	3.7	6.2	7.5	13.1	6.1	5.3	8.5	7.4	3.5	9.6	4.8	8.9	6.1	6.4	2.9	2.4	2.3	7.3	0.0	12.0	12.5	1.8	3.9	5.4	5.0	4.7	51.0	3.8	6.3	23.3	2.6	12.5	2.3	4.8	4.6	11.5	6.8	9.5	6.4	7.4	10.5	50.5	2.0	5.4	11.8	1.8	9.6	8.5	2.4	5.5	2.1	4.1	3.7	0.0	1.0	32.3	22.7	4.3	3.5	2.2	7.6	2.2
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 7.6;Ductal cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA					"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.9	0.0	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.5	0.0	0.1	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.7	7.6	4.0	1.2	1.8	0.0	0.1	0.0	17.3	1.0	0.0	0.3	0.0	2.6	0.1	0.1	0.1	1.1	0.0	1.9	0.0	2.9	0.0	2.4	1.3	0.0	0.7	0.0	1.8	3.4	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.0	2.4	0.1
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell type enhanced"	"Detected in many"	12	"Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Approved	Cytosol		NA	NA		13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	11.7	0.8	0.9	13.4	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1	0.0	0.3	0.0	1.0	50.4	24.4	8.7	0.0	2.7	0.0	8.7	5.9	0.0	23.2	26.5	1.5	4.5	0.0	0.0	0.6	0.1	10.6	0.9	0.0	0.0	0.2	228.8	0.0	5.5	0.0	1.7	96.4	1.2	16.9	1.0	0.0	248.1	0.5	7.2	45.3	7.9	9.1	122.9	96.9	0.7	1.1	21.5	0.0	0.0	5.4	0.8
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 96.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057208, HPA071094"	Approved		Approved	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA057208: AB_2683370, HPA071094: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.9	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.2	3.0	5.1	18.4	3.8	4.6	8.0	1.7	7.8	5.6	4.3	19.5	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.6	6.6	4.2	14.5	2.9	7.2	9.5	3.9	14.8	2.0	4.6	11.0	8.4	11.7	10.6	4.0	10.1	6.2	5.6	7.9	3.2	20.4	14.5	5.0	5.5	9.1	16.8	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4	59.6	13.8	5.4	2.3	7.0	29.1	39.1	0.0	18.7	21.6	3.5	96.2	3.7	6.6	4.8	44.2	7.5	2.7	0.0	3.5	3.5	4.5	3.7	25.5	3.6	7.2	33.4	7.5	10.4	38.6	49.1	1.7	22.6	3.3	9.0	4.9	16.0	4.6	0.0	2.5	6.1	56.8	12.9	7.2	25.0	27.2	9.4	2.4	20.8	3.8	1.6
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N(alpha)-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86022298	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021547	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA021547: AB_1853505"	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	11.3	19.5	15.2	16.4	14.6	9.7	17.1	20.1	17.6	13.4	16.5	12.5	22.9	14.9	20.5	21.0	16.8	13.5	14.4	14.2	16.6	14.0	16.0	14.3	10.8	10.2	14.6	16.2	16.2	16.4	19.1	25.5	16.9	14.4	17.4	19.5	13.0	16.3	20.0	28.7	13.4	17.4	16.4	14.1	10.3	13.4	25.7	15.1	10.0	19.8	15.8	12.7	14.4	13.5	12.2	5.8	8.9	4.7	5.9	9.6	4.4	22.9	16.0	16.0	12.5	9.4	11.3	25.1	14.5	14.2	16.3	13.8	11.0	15.9	7.8	8.5	14.7	13.7	32.2	14.6	17.0	17.5	19.5	10.5	17.2	17.4	15.0	17.5	26.3	15.6	11.7	14.8	17.4	25.8	11.4	15.3	16.2	21.0	15.3	15.4	15.8	14.7	15.3	16.1	27.7	16.4	12.6	22.7	12.1	17.8	20.9	14.6	13.0	16.5	14.6	12.8	17.3	11.7	11.1	12.1	10.5	13.2	17.5	13.4	20.5	25.1	5.3	13.4	11.4	10.7	2.0	4.6	8.9	7.0	4.7	9.3	12.2	7.7	6.5	5.8	12.2	9.6	7.7	2.1	5.9	3.2	3.8	6.4	4.4	15.2	14.6	20.1	17.6	16.6	14.0	14.6	16.2	14.4	15.1	3.0	13.1	12.0	17.1	14.4	24.0	19.6	10.2	32.1	21.6	10.4	21.6	18.4	1.7	16.5	5.9	11.9	11.1	0.0	22.5	15.1	13.4	18.4	11.5	8.9	10.6	20.6	20.1	8.6	9.5	3.6	8.6	12.9	13.5	11.8	15.0	22.0	15.4	14.0	11.0	7.1	32.7	12.9	16.5	58.6	33.7	14.4	26.0	12.8	14.6	17.4
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 83.7;stomach 1: 114.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 319.9;Paneth cells: 285.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		70000000	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	6.1	53.6	23.3	15.6	18.2	1.9	11.6	23.1	27.7	21.0	53.1	16.5	6.0	62.8	11.9	9.3	4.2	11.1	83.7	4.0	24.7	26.3	22.0	6.6	4.4	2.8	17.4	20.4	11.1	19.5	7.8	15.1	5.3	22.3	39.9	45.5	10.9	43.0	3.5	2.6	4.6	16.5	8.4	25.5	11.3	114.2	5.0	16.4	5.0	19.5	7.9	36.6	11.6	11.0	1.2	2.2	7.2	5.9	1.2	5.7	2.5	29.5	29.0	21.8	24.6	28.1	16.3	23.0	13.5	9.8	21.3	17.3	14.2	59.3	0.6	13.4	26.1	20.6	22.9	13.3	13.3	15.5	1.0	21.2	9.2	19.3	0.7	16.7	13.6	7.4	24.7	7.2	20.0	7.3	26.8	36.3	4.4	5.7	0.9	12.0	13.9	1.6	10.2	34.3	38.7	21.0	8.7	24.9	4.5	35.5	12.7	24.6	15.4	18.4	40.0	15.1	14.7	22.5	14.0	23.1	5.6	15.7	16.8	16.0	79.6	7.5	0.2	24.1	6.1	12.1	2.1	5.5	0.8	5.7	3.9	0.7	1.1	0.5	0.8	0.7	1.2	0.7	1.3	7.2	1.2	5.9	2.2	0.3	2.5	23.3	18.2	23.1	20.8	24.7	26.3	17.4	20.4	22.3	16.4	8.9	11.7	0.0	9.8	2.1	16.9	4.3	71.4	69.6	61.4	33.2	7.9	5.4	21.6	148.1	319.9	21.5	193.3	0.0	197.4	30.2	20.6	130.5	1.1	12.5	9.8	63.5	70.2	9.8	7.5	196.5	17.0	3.3	21.9	1.0	76.8	15.7	203.7	285.1	12.4	11.5	6.1	0.0	10.3	8.9	34.3	0.9	5.4	4.3	129.2	17.6
C9orf153	bA507D14.1	ENSG00000187753	"Chromosome 9 open reading frame 153"	Q5TBE3	9	86220265-86259657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 24.5"	"Group enriched"	"Detected in some"	70	"Early spermatids: 170.5;Late spermatids: 185.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 4.5"									HPA079466			Approved	"Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Nuclear bodies, Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA079466: "	"unprognostic (2.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.30e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.01e-6)"	"unprognostic (9.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.10e-1)"	0.1	0.2	0.1	0.1	0.1	2.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.0	0.6	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	24.5	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.5	0.6	0.2	0.8	1.1	0.0	0.6	2.2	0.0	1.2	0.1	1.3	1.6	1.2	0.0	0.0	0.8	0.0	2.5	2.4	0.9	2.3	1.7	0.5	1.2	2.0	1.6	0.6	1.0	0.1	2.8	0.4	0.1	0.4	1.1	0.3	4.5	1.5	0.0	0.0	1.0	2.8	0.0	1.9	1.7	0.1	0.8	0.4	0.7	0.1	1.6	0.4	0.8	3.0	0.3	0.0	0.3	0.1	0.0	0.0	0.4	1.1	0.0	0.6	0.2	0.9	2.1	0.2	0.8	2.0	0.3	0.7	0.1	0.5	1.0	0.6	0.2	0.1	1.1	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.8	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	170.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.9	2.6	0.0	1.7	0.0	0.0	0.6	0.1	0.0	0.7	0.0	0.0	0.0	0.2	1.8	1.3	0.1	0.1	0.0	0.0	0.3
ISCA1	"HBLD2, hIscA, ISA1, MGC4276"	ENSG00000135070	"Iron-sulfur cluster assembly 1"	Q9BUE6	9	86264546-86283102	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 897.5;Late spermatids: 439.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042789	Uncertain					NA	NA					"HPA042789: AB_10797022"	"unprognostic (1.14e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.00e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (4.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.31e-1)"	18.7	25.6	23.6	8.0	28.7	32.6	17.8	26.3	30.9	13.8	13.2	12.9	12.4	14.5	15.5	12.6	12.2	15.4	13.4	31.1	23.7	28.7	31.2	22.9	11.4	8.6	27.1	19.5	18.8	18.9	18.8	17.3	18.0	24.3	14.2	13.7	13.5	10.8	17.5	43.5	9.0	12.3	15.4	19.2	9.7	12.3	23.5	14.8	8.6	20.6	20.6	7.7	14.4	13.4	13.2	13.0	25.7	11.1	13.8	20.5	15.8	18.0	13.3	18.9	25.6	37.2	16.6	23.6	19.4	13.7	19.6	11.5	10.0	10.0	12.3	13.4	15.6	14.7	16.5	18.3	15.0	14.3	27.8	12.8	20.2	15.5	18.5	17.6	17.7	10.9	18.5	23.9	13.1	12.6	16.8	15.5	18.3	10.4	23.4	16.7	18.5	19.9	9.8	37.0	26.2	28.0	13.5	25.2	16.4	27.6	17.5	27.4	20.2	16.7	27.3	22.6	18.8	9.3	10.3	12.5	11.3	13.7	19.6	25.0	18.4	35.7	8.7	22.6	12.4	13.8	25.7	11.1	21.3	15.2	9.1	17.8	13.2	18.4	15.7	7.9	11.7	20.2	19.3	18.0	13.8	9.6	13.0	20.5	15.8	23.6	28.7	26.3	30.9	23.7	28.7	27.1	19.5	24.3	14.8	26.8	16.7	51.0	66.8	54.1	48.5	40.8	50.9	33.5	5.7	27.9	19.6	64.5	119.3	58.6	897.5	36.8	43.9	93.5	38.7	79.1	42.6	59.5	16.1	75.0	40.1	63.5	51.6	39.3	22.2	439.8	52.3	32.8	52.3	33.3	36.0	54.1	52.7	40.2	46.0	93.9	38.7	32.3	58.7	60.8	52.8	45.9	95.3	44.8	35.2	48.9
ZCCHC6	"FLJ13409, KIAA1711, PAPD6, TUT7"	ENSG00000083223	"Zinc finger CCHC-type containing 6"	Q5VYS8	9	86287733-86354454	"Enzymes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 42.1;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020615, HPA020620"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA020615: AB_1858983, HPA020620: AB_1858984"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.40e-1)"	11.2	9.3	7.7	22.6	11.2	17.0	17.3	9.7	13.7	10.8	13.5	5.6	12.8	9.4	8.6	8.1	23.1	8.3	10.3	10.1	9.4	5.2	7.4	33.1	16.3	19.5	9.8	5.1	9.0	12.9	9.2	18.6	33.3	9.0	19.3	10.8	4.5	14.0	13.6	12.5	30.9	15.6	9.7	13.6	22.2	11.7	10.3	10.7	23.3	8.7	15.2	16.9	13.7	14.3	4.4	4.3	42.1	15.7	4.5	5.7	2.9	9.9	10.8	6.4	9.3	16.5	25.1	7.9	13.6	13.3	6.0	7.0	4.9	8.9	14.2	12.4	9.0	6.2	17.6	7.6	7.7	9.0	16.6	4.1	10.2	11.5	9.1	14.0	11.6	14.9	16.6	16.1	9.6	11.4	9.5	10.1	7.9	9.6	15.4	16.8	10.7	9.7	7.0	5.2	17.2	7.3	4.9	11.2	6.5	10.7	19.6	4.7	3.7	8.3	11.0	4.7	8.2	4.1	5.3	15.5	5.8	7.0	10.2	9.3	17.8	13.9	10.6	13.8	7.0	7.6	11.5	7.1	7.1	5.7	9.1	4.9	4.4	3.2	4.1	4.3	4.4	3.7	4.0	42.1	4.5	15.7	2.0	3.0	2.9	7.7	11.2	9.7	13.7	9.4	5.2	9.8	5.1	9.0	10.7	59.6	30.7	5.3	28.7	28.0	13.1	0.0	12.7	26.8	37.5	0.0	17.7	18.4	0.0	0.0	77.5	14.4	23.4	0.0	0.0	14.3	9.9	42.1	45.1	45.3	20.1	17.5	16.0	17.2	62.4	17.6	15.8	40.3	30.4	0.0	18.3	11.4	0.0	20.7	12.4	0.0	14.9	12.9	10.3	19.8	7.8	35.4	77.3	27.7	17.7	54.5
GAS1		ENSG00000180447	"Growth arrest specific 1"	P54826	9	86944363-86947189	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Growth arrest"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 61.8"	"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 57.5;Muller glia cells: 106.0;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.7;ASC diff: 13.5;BJ hTERT+: 26.7;HSkMC: 19.1;RH-30: 40.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB024164, HPA036085, HPA066902"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746"	"unprognostic (2.78e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.97e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.46e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (1.96e-5)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (3.59e-2)"	26.5	2.9	0.9	8.3	1.1	0.0	14.0	1.3	1.3	26.4	9.1	2.1	15.0	0.9	61.8	37.1	10.0	20.9	11.8	9.9	1.0	0.5	4.5	0.8	4.1	5.7	1.8	0.8	31.5	4.3	0.8	3.2	50.1	2.0	18.1	1.0	8.7	4.8	8.9	8.1	10.1	3.4	24.5	0.9	1.2	6.3	18.9	0.5	3.6	6.0	3.8	1.6	11.3	15.6	0.0	0.8	0.0	0.0	0.1	0.6	0.0	0.0	0.0	3.3	19.7	13.5	5.1	0.3	3.7	26.7	1.3	1.1	0.0	0.0	0.0	0.2	6.9	0.1	0.2	0.0	0.1	0.5	2.2	7.6	0.0	11.1	0.0	6.9	0.0	0.3	19.1	2.9	0.4	2.4	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.1	4.1	0.1	0.0	3.9	40.7	0.0	0.2	0.0	0.4	1.7	5.5	0.0	5.8	2.3	0.0	0.1	0.0	5.8	1.6	0.4	1.3	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.9	1.1	1.3	1.2	1.0	0.5	1.8	0.8	2.0	0.5	0.0	1.1	0.0	8.0	23.0	6.5	5.8	0.0	0.0	1.2	14.0	9.8	17.4	8.3	0.6	0.0	6.1	0.0	0.0	0.3	3.8	57.5	1.9	0.0	0.0	5.2	4.8	0.0	23.4	0.6	0.0	30.0	1.0	16.9	0.0	0.0	106.0	0.3	0.0	11.7	2.2	2.8	38.8	10.3	0.1	0.7	10.9	3.8	0.0	0.0	0.3
DAPK1	"DAPK, ROCO3"	ENSG00000196730	"Death associated protein kinase 1"	P53355	9	87497228-87708633	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Apoptosis, Translation regulation"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 94.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	55	"dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 38.8;HUVEC TERT2: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB037302, HPA040472, HPA048436"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (8.31e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-3)"	14.6	4.9	10.4	8.8	25.5	3.8	4.1	2.9	17.6	8.1	16.6	6.5	8.1	7.8	8.7	16.1	4.5	12.2	21.6	4.1	12.4	8.1	14.7	21.3	28.6	8.5	4.6	10.4	32.7	21.2	4.8	16.6	94.7	6.6	5.1	7.5	5.9	9.3	7.3	1.5	3.7	11.0	8.1	4.8	16.4	15.0	6.3	7.3	34.5	7.2	1.5	5.2	13.2	10.5	0.1	5.3	6.9	11.9	0.1	0.1	2.1	0.0	18.3	8.8	6.2	0.2	0.1	14.0	1.2	1.7	7.2	8.2	2.6	0.1	0.1	1.8	0.3	0.1	17.1	5.4	0.4	3.1	0.1	4.4	8.8	2.5	8.9	7.9	0.0	38.8	0.5	2.9	1.3	0.5	11.3	22.0	2.5	6.6	3.7	6.0	0.5	2.6	0.0	10.0	16.9	0.0	0.7	7.8	0.0	20.1	18.3	4.0	4.5	0.0	1.8	7.7	13.5	0.0	5.8	0.1	0.0	0.1	0.0	0.0	14.6	3.0	0.0	0.1	2.4	1.2	1.3	5.3	6.9	0.0	11.9	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	1.6	0.1	11.7	5.3	0.0	2.1	10.4	25.5	2.9	17.6	12.4	8.1	4.6	10.4	6.6	7.3	47.6	65.3	5.9	0.6	3.2	19.8	1.9	40.8	16.0	40.9	21.0	2.0	5.6	1.7	27.2	1.2	13.0	2.1	0.0	20.1	14.4	11.4	3.9	23.1	16.3	21.3	17.5	0.0	79.2	64.1	2.2	13.8	42.1	11.8	30.7	7.7	14.5	31.5	1.7	12.7	5.9	2.9	0.0	2.3	3.9	4.1	2.8	11.9	0.7	2.8	9.3
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87725519-87731393	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 237.0"	"Cell type enhanced"	"Detected in all"	8	"Cytotrophoblasts: 935.7;Extravillous trophoblasts: 843.2;Hofbauer cells: 1004.8;Ito cells: 672.8;Syncytiotrophoblasts: 1290.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 31.0;non-classical monocyte: 44.3"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 201.6;HSkMC: 93.2"									"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	60.3	21.5	10.4	27.2	24.6	18.4	23.3	6.9	12.3	14.8	23.2	14.1	13.7	9.0	24.1	22.3	11.4	25.7	20.7	37.7	10.7	11.4	65.4	98.0	53.1	80.5	18.9	7.7	25.0	14.3	18.8	18.0	237.0	18.4	19.4	13.0	23.2	22.0	23.5	29.3	9.1	12.0	36.6	16.1	108.1	17.5	14.1	15.7	6.8	19.2	9.4	10.1	41.3	26.5	0.0	1.7	0.1	44.3	0.0	4.3	2.4	6.4	37.4	2.6	4.4	47.1	201.6	15.7	20.8	60.7	17.9	22.4	3.6	5.9	0.0	9.8	26.9	56.7	5.5	3.4	6.8	14.8	0.1	3.3	1.1	10.6	8.7	30.5	0.0	4.5	93.2	11.4	29.2	11.4	15.6	14.1	0.0	12.1	0.0	25.7	10.8	0.0	0.7	4.9	10.1	7.1	1.5	1.5	0.0	12.5	3.4	3.7	4.6	4.3	9.8	23.9	15.6	1.1	7.4	22.0	16.0	8.7	58.4	8.8	1.6	6.0	0.0	58.7	0.0	5.2	0.1	3.5	0.1	0.0	31.0	0.0	0.0	1.8	0.0	1.7	0.0	4.3	0.3	0.1	0.0	44.3	0.1	0.3	2.4	10.4	24.6	6.9	11.7	10.7	11.4	18.9	7.7	18.4	15.7	38.7	60.6	38.5	79.1	33.5	37.4	87.3	84.1	56.2	38.7	71.5	17.7	935.7	23.2	77.5	3.5	75.9	8.6	46.7	82.1	843.2	226.1	43.7	27.8	100.7	1004.8	12.7	11.1	672.8	182.1	10.4	145.3	481.4	60.8	19.8	7.7	78.6	55.2	2.9	176.0	107.8	35.6	90.5	103.2	144.4	46.2	29.6	1290.9	15.3	8.8	43.0
SPATA31E1	"C9orf79, FAM75E1, FLJ35866"	ENSG00000177992	"SPATA31 subfamily E member 1"	Q6ZUB1	9	87882826-87888899	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	139	"testis: 18.6"	"Group enriched"	"Detected in some"	94	"Early spermatids: 42.3;Late spermatids: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;hTEC/SVTERT24-B: 1.2;Karpas-707: 1.1;SCLC-21H: 4.5"									HPA024253	Enhanced					NA	NA					"HPA024253: AB_1845839"													"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL353572.3		ENSG00000283205			9	87956214-87956883	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	38	"testis: 9.5"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"U-2 OS: 1.6"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	9.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDK20	"CCRK, p42"	ENSG00000156345	"Cyclin dependent kinase 20"	Q8IZL9	9	87966441-87974753	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 25.4;Spermatocytes: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.2"	"Group enriched"	"Detected in many"	7	"NK-cells: 7.2;T-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.4;THP-1: 21.7"	"Low region specificity"	"Detected in all"							"HPA007666, HPA027379, HPA027401"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553"	"unprognostic (4.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.69e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (2.32e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.04e-2)"	"prognostic favorable (2.12e-5)"	"unprognostic (8.24e-3)"	"unprognostic (5.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.42e-2)"	2.6	16.2	10.8	2.4	13.0	1.6	4.1	8.7	17.1	8.7	5.0	6.1	5.1	5.3	7.2	6.0	2.8	19.5	5.6	3.0	8.6	10.7	8.2	3.2	4.0	2.0	5.8	14.3	9.5	4.8	7.6	10.8	3.1	9.3	6.1	3.4	7.7	3.6	8.6	2.1	3.6	7.6	5.5	3.1	1.6	3.7	17.7	5.2	0.8	6.8	1.2	1.1	6.3	3.0	0.1	0.8	0.4	0.8	7.2	5.0	1.3	2.4	3.0	2.4	7.6	1.7	2.4	1.0	2.2	4.2	5.9	5.5	0.7	3.6	0.0	3.3	3.6	10.3	3.1	0.0	2.1	2.4	5.9	2.5	0.0	1.9	0.0	7.4	2.8	3.4	1.9	4.4	9.3	3.8	4.6	0.0	5.3	0.3	0.0	1.7	7.1	1.9	0.8	1.9	5.3	1.1	0.0	0.0	0.1	7.4	2.0	14.4	4.1	2.5	3.0	3.6	0.8	3.3	21.7	0.0	2.6	1.0	0.5	2.4	3.8	3.6	0.0	9.3	1.9	2.8	0.0	0.7	0.4	1.3	0.8	0.5	0.0	3.0	1.9	0.7	0.1	5.0	3.2	0.1	7.2	0.7	0.8	2.7	1.3	10.8	13.0	8.7	17.1	8.6	10.7	5.8	14.3	9.3	5.2	3.0	4.1	0.0	1.5	1.9	5.2	2.0	2.5	25.4	5.7	1.8	2.0	3.6	1.7	4.2	4.7	0.5	5.4	0.0	1.3	1.9	3.3	2.5	1.1	0.9	0.9	7.9	0.0	0.6	0.0	1.7	4.0	1.1	0.0	0.0	2.0	4.8	1.5	0.0	6.3	5.3	13.5	6.5	2.3	25.0	2.9	1.9	3.3	0.5	2.9	0.7
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388419-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 158.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000162: AB_1080079, HPA068784: AB_2686033"	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	12.2	15.0	28.3	9.4	34.2	7.0	19.7	22.6	38.0	34.9	14.4	23.7	10.2	10.4	34.4	44.0	15.5	28.6	17.5	15.6	27.1	28.7	24.9	11.3	14.1	8.3	21.7	27.2	32.2	12.2	28.4	19.6	26.9	26.3	21.6	14.1	16.8	12.9	24.6	3.5	13.4	12.1	25.7	22.0	9.9	11.6	18.5	15.9	12.7	22.9	6.8	9.1	15.4	21.3	4.5	8.1	8.1	4.2	4.2	7.8	4.9	23.6	11.8	19.5	16.5	13.3	15.7	22.9	23.8	22.1	27.3	20.0	8.7	13.8	13.2	14.1	29.1	17.6	36.4	14.5	21.6	31.4	13.8	8.9	6.3	24.9	9.2	12.3	14.3	6.9	13.0	22.6	18.4	26.0	26.9	15.5	16.8	8.0	0.0	30.5	16.3	24.2	6.5	32.1	19.8	11.1	32.5	21.2	4.2	24.6	16.7	27.7	20.8	28.2	17.8	10.4	23.6	13.7	11.4	14.7	18.1	19.3	26.8	16.8	5.5	8.2	11.4	21.9	13.3	16.8	8.1	4.2	6.4	6.7	3.8	7.1	4.5	5.0	6.9	8.1	3.4	7.1	7.8	0.6	4.2	3.3	3.8	4.5	4.9	28.3	34.2	22.6	38.0	27.1	28.7	21.7	27.2	26.3	15.9	47.6	12.5	2.9	22.2	35.5	21.1	34.1	33.1	20.1	19.4	41.8	23.6	24.0	21.6	21.8	158.1	21.1	19.0	23.3	15.9	38.4	35.2	28.1	33.5	15.5	28.0	23.8	39.6	20.3	31.4	87.6	31.1	18.9	20.3	11.8	26.4	39.4	21.2	18.7	41.8	39.9	13.7	25.8	26.2	24.7	65.2	39.1	20.8	10.2	19.5	25.7
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88535101-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.6;Proximal tubular cells: 12.2"	"Group enriched"	"Detected in some"	7	"breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	7.2	0.4	1.6	1.0	1.6	4.4	3.2	0.6	1.1	6.7	0.5	2.0	0.4	0.6	6.2	9.7	0.8	6.6	0.7	0.5	1.8	2.9	4.4	5.1	0.4	0.4	1.3	1.0	11.7	0.5	0.0	0.7	3.9	1.2	0.8	0.0	2.0	1.4	3.7	1.0	1.3	0.5	0.4	1.8	0.8	0.5	2.2	0.4	0.4	1.2	0.4	0.4	1.2	1.5	1.2	1.1	4.8	1.0	1.7	2.4	0.7	2.0	4.2	1.7	1.5	0.2	1.1	1.2	3.9	1.0	0.5	0.7	0.9	1.3	1.0	1.6	0.4	1.0	2.0	0.6	0.2	1.4	0.6	1.3	1.9	4.0	1.3	0.8	1.2	1.4	0.8	0.3	0.4	0.4	0.6	0.0	1.4	1.3	4.2	1.0	1.0	1.1	1.9	2.1	0.7	0.9	0.8	0.8	1.4	15.3	1.4	1.1	0.7	2.3	1.3	0.7	1.1	1.7	1.0	1.5	1.5	2.9	2.1	0.9	1.4	1.2	1.1	1.3	1.6	1.0	4.8	1.0	2.3	2.1	0.5	2.1	0.8	1.2	2.4	0.3	1.2	2.1	2.4	2.8	1.7	0.5	1.1	2.0	0.7	1.6	1.6	0.6	1.1	1.8	2.9	1.3	1.0	1.2	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.5	8.6	0.0	0.0	0.0	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.1	12.2	0.7	0.0	0.8	0.3	0.4	0.1	0.9	0.0	0.0	1.8
C9orf47	"bA791O21.3, C9orf108, FLJ37523"	ENSG00000186354	"Chromosome 9 open reading frame 47"	Q6ZRZ4	9	88990863-88996140	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 12.9"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"classical monocyte: 2.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 6.6;ASC diff: 3.2;HeLa: 5.6;JURKAT: 3.5"									CAB009902	Approved				"Secreted - unknown location"	NA	NA					"CAB009902: AB_2184764"	"unprognostic (6.51e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.94e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.19e-6)"	"unprognostic (5.61e-2)"	"unprognostic (3.72e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.77e-2)"	1.7	5.3	0.6	1.0	0.7	0.8	2.3	0.0	0.7	1.8	1.0			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1.0	1.7	0.4		0.4	1.7	0.0	3.3	1.2		1.9	0.2		0.3	0.8	0.0	0.0	0.8	1.4	0.5	1.7	1.0	0.0			0.7		0.5	0.9	1.9	0.0	0.2	0.3	2.2	0.0	0.0	0.4	0.0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.5	0.0	0.1	0.0	5.6	0.0	0.0	0.4	0.0	0.2	0.1	0.7	0.0	0.2	0.7	3.5	0.3	0.0	0.0	0.5	1.6	1.4	0.4	0.0	0.3	0.7	0.0	0.0	0.0	0.6	0.2	0.5	0.3	0.1	0.0	0.7	0.1	1.8	1.8	0.6	1.4	1.1	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4											0.0	0.0	0.0	2.0	2.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	1.2	1.0	0.0	0.0	0.2	3.2	0.0	0.6	0.0	0.0	0.3	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	12.9	1.4	0.0	0.2	0.3	0.2	0.0	0.0	0.6
S1PR3	"EDG-3, EDG3"	ENSG00000213694	"Sphingosine-1-phosphate receptor 3"	Q99500	9	88991447-89005010	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 16.8;Sertoli cells: 64.7;Smooth muscle cells: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"classical monocyte: 9.8"	"Lineage enriched"	"Detected in single"	23	"monocytes: 9.8"	"Cell line enhanced"	"Detected in many"		"AF22: 35.2;ASC diff: 49.1;ASC TERT1: 49.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA						"prognostic favorable (5.91e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (4.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.37e-1)"	15.5	20.4	4.0	7.8	5.1	2.2	9.6	2.2	3.5	24.1	9.5	7.4	5.1	3.5	12.9	10.0	31.5	16.6	19.0	20.3	4.1	3.7	17.5	14.3	6.2	8.4	8.3	2.8	12.2	9.1	1.0	12.6	12.4	10.8	31.7	2.9	20.1	5.1	10.1	3.1	2.3	7.3	27.8	11.6	12.5	10.0	4.9	3.6	9.4	4.0	4.3	7.3	14.2	29.3	0.1	0.2	0.4	9.8	0.2	0.1	2.6	0.1	5.2	35.2	1.8	49.1	49.9	0.0	7.4	18.4	5.2	5.2	0.0	0.0	0.0	0.1	11.0	5.1	0.0	0.1	5.3	3.5	0.0	0.3	0.0	7.4	0.0	4.2	2.3	0.0	8.9	0.3	6.7	1.2	4.0	9.0	4.7	0.6	0.0	1.4	4.9	4.0	2.4	3.3	0.2	1.8	0.4	0.0	0.0	0.1	2.1	0.4	2.5	6.9	1.7	0.0	7.3	0.8	2.1	17.9	7.8	3.2	8.4	1.2	0.0	0.0	0.0	11.3	2.0	2.7	0.4	9.8	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.2	0.0	2.6	4.0	5.1	2.2	3.5	4.1	3.7	8.3	2.8	10.8	3.6	0.0	1.7	0.0	9.8	9.0	1.1	6.2	0.0	5.3	2.3	1.8	2.0	16.8	0.0	0.3	0.0	5.4	0.0	0.0	0.4	1.2	13.1	5.9	0.0	1.1	2.2	3.2	0.0	1.3	1.9	0.0	3.4	1.6	0.0	0.0	0.0	7.8	1.4	0.0	6.3	1.3	1.5	64.7	19.3	0.0	0.9	2.9	4.6	0.0	0.0	5.4
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178767	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 2: 16.0;Bipolar cells: 7.0;Muller glia cells: 6.1"	"Cancer enhanced"	"Detected in some"		"glioma: 5.1"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7"	"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 17.1;hTERT-RPE1: 18.9;RT4: 6.3;SH-SY5Y: 6.3;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.6	10.8	15.7	0.8	20.8	0.5	1.8	0.8	35.1	7.3	1.2	2.3	0.0	1.1	1.5	1.7	1.5	2.2	2.7	1.0	14.2	4.7	1.4	0.6	6.0	0.8	3.1	24.7	0.7	4.4	10.4	1.0	0.8	5.2	1.5	1.4	0.0	6.4	1.4	0.9	1.8	0.9	1.8	1.5	0.6	0.8	1.0	1.3	0.0	1.3	0.0	0.8	1.7	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	17.1	0.0	3.8	1.2	0.0	1.2	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.2	0.0	2.6	0.0	1.7	0.0	18.9	4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	2.2	0.2	0.2	0.2	0.0	3.5	3.7	6.3	2.3	6.3	0.4	0.0	0.0	0.1	0.0	0.3	2.6	0.7	0.1	1.0	0.1	0.0	0.0	0.0	9.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	20.8	0.8	31.5	14.2	4.7	3.1	24.7	5.2	1.3	0.0	16.0	0.0	0.2	0.1	7.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	0.0	0.8	0.1	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.9	1.4	0.0	1.7	0.0	0.0	6.1	0.1	0.0	3.5	0.3	0.4	0.0	0.8	0.2	0.1	0.5	0.3	0.0	0.0	0.9
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 581.2;Spermatogonia: 464.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	84.0	72.1	44.1	29.5	13.0	11.9	32.2	50.1	27.0	55.5	44.5	29.6	41.8	63.0	29.7	18.7	98.8	59.2	52.9	38.6	63.9	49.1	42.8	31.9	52.8	78.5	5.6	65.0	36.4	4.3	8.9	39.7	35.1	21.2	51.3	51.9	38.0	55.2	71.1	63.1	51.0	114.6	64.4	99.0	66.6	44.2	48.5	37.6	43.5	19.3	37.4	22.3	41.6	40.4	40.4	43.2	48.6	37.8	29.1	24.0	45.6	58.0	72.8	44.8	90.7	50.8	35.4	37.7	34.1	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6	35.7	93.0	97.3	70.9	248.9	4.2	55.0	5.1	12.0	17.0	14.0	0.0	149.0	19.9	15.2	25.4	26.7	39.1	350.4	9.7	329.6	72.5	59.4	147.1	19.5	152.7	0.0	117.0	28.3	40.0	59.4	23.9	84.8	133.3	33.3	56.8	24.6	23.3	46.9	15.6	148.6	6.0	45.3	99.9	581.2	464.7	261.3	166.8	40.1	104.9	59.3
SECISBP2	SBP2	ENSG00000187742	"SECIS binding protein 2"	Q96T21	9	89318506-89359662	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 257.7;Late spermatids: 318.0;Spermatocytes: 306.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044314, HPA054905"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA044314: AB_10964885, HPA054905: "	"unprognostic (1.07e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.00e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (8.98e-9)"	"unprognostic (5.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.55e-3)"	17.3	24.8	19.5	23.1	26.6	26.4	30.0	28.3	28.9	22.1	22.5	21.7	19.8	20.5	28.1	26.0	16.7	23.3	17.7	13.4	22.5	15.9	26.8	25.4	30.0	25.6	20.6	16.2	36.7	34.3	26.9	33.9	29.9	21.0	21.0	24.9	21.3	26.8	21.3	32.6	25.8	23.6	21.3	24.7	29.7	23.2	58.2	22.8	26.6	31.5	11.8	23.4	19.9	26.3	14.1	11.7	21.5	9.5	9.1	16.1	5.9	13.4	9.2	25.3	14.6	11.9	13.0	18.3	7.8	9.7	9.4	9.3	5.1	11.4	20.2	6.9	7.3	15.0	17.1	17.0	7.9	8.7	13.3	10.1	9.9	7.2	13.0	10.4	19.8	14.9	8.1	15.0	7.9	9.5	10.4	11.6	27.2	12.6	24.0	8.9	12.5	27.1	10.2	26.2	34.0	9.1	13.1	12.4	13.2	10.5	10.4	18.5	18.2	7.1	15.8	20.5	17.6	14.0	17.2	10.7	9.1	10.6	12.2	12.0	29.3	18.6	8.4	15.9	12.9	13.1	12.2	7.6	12.7	10.4	7.9	10.1	12.9	10.7	10.2	6.7	14.1	16.1	13.5	21.5	9.1	9.5	11.7	12.5	5.9	19.5	26.6	28.3	28.9	22.5	15.9	20.6	16.2	21.0	22.8	41.7	47.6	35.6	60.3	17.3	105.5	15.1	20.4	41.5	39.8	38.4	86.4	55.5	36.5	33.4	257.7	36.0	38.4	23.3	27.3	41.2	27.2	56.9	34.7	33.3	23.6	54.0	35.8	27.0	31.8	318.0	37.2	26.3	20.3	27.9	51.3	45.0	31.3	46.0	24.1	44.6	111.0	32.3	24.5	306.3	193.7	22.2	76.8	43.3	47.0	55.5
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.1;skeletal muscle: 43.3"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 41.5;T-cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.5;HMC-1: 32.8;JURKAT: 29.4;MOLT-4: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved					NA	NA		4100000			"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (4.06e-5)"	3.9	5.6	18.0	18.6	20.7	14.3	3.6	7.7	20.9	4.0	5.9	54.0	3.1	6.1	3.9	7.4	9.3	6.6	7.2	4.9	28.2	18.8	8.4	2.0	6.7	32.0	42.6	15.0	4.1	4.6	4.9	5.3	3.2	27.5	4.9	5.8	2.9	6.7	4.2	43.3	8.8	9.6	3.3	107.1	19.2	9.4	6.1	23.3	25.3	4.9	3.1	27.6	8.3	5.3	2.6	4.6	21.2	4.1	4.7	14.0	7.8	4.0	3.0	2.8	4.1	0.1	0.2	6.4	0.4	0.2	0.8	0.6	2.0	4.5	15.3	1.7	0.0	3.3	2.1	2.5	1.2	0.3	42.5	2.5	6.4	1.0	0.2	0.5	8.5	32.8	0.1	0.9	0.2	0.1	0.1	1.6	29.4	1.5	10.4	0.0	6.6	38.5	10.7	6.9	8.0	0.1	12.3	0.9	4.3	5.5	4.2	6.6	4.4	1.1	3.6	0.1	4.1	3.3	4.6	1.0	0.0	2.6	0.3	1.9	11.7	5.0	2.2	1.9	10.3	2.5	7.3	4.1	20.4	13.3	3.8	8.0	2.6	10.6	11.1	1.5	1.6	12.2	14.0	21.2	4.7	4.1	4.6	9.5	7.8	18.0	20.7	7.7	20.9	28.2	18.8	42.6	15.0	27.5	23.3	6.0	21.5	24.2	2.9	4.0	10.2	14.8	5.1	5.3	9.1	10.4	2.0	7.5	3.3	5.0	1.7	4.9	0.5	0.0	2.9	1.8	4.8	6.7	41.5	1.7	17.0	31.8	1.7	5.5	26.2	2.2	6.9	21.6	1.7	5.4	6.4	8.6	3.2	0.0	14.2	14.4	4.8	0.0	2.1	0.7	22.6	4.6	3.1	50.3	3.3	6.7
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605013-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"placenta: 65.6"	"Cell type enriched"	"Detected in many"	8	"Syncytiotrophoblasts: 1345.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 47.8;SCLC-21H: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA023606	Approved					NA	NA					"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	7.0	23.6	4.6	4.4	7.7	8.4	6.7	4.8	5.4	23.3	7.4	2.8	12.0	4.2	21.3	6.5	6.1	6.4	5.9	53.4	4.1	3.8	6.7	48.4	4.6	1.5	5.3	3.7	14.1	28.7	4.9	25.4	65.6	7.4	12.7	1.6	3.0	14.7	10.2	58.0	5.5	6.0	5.5	6.7	1.3	6.5	13.0	3.0	0.8	8.4	26.8	2.6	5.1	6.2	0.0	0.2	8.0	0.3	0.0	0.1	0.1	1.2	0.0	6.8	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.3	1.0	2.2	0.0	0.0	47.8	0.4	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	0.1	0.4	6.3	1.1	0.1	0.5	2.0	0.4	0.0	0.3	25.2	5.7	0.4	2.6	0.0	1.3	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.1	4.6	7.7	4.8	5.4	4.1	3.8	5.3	3.7	7.4	3.0	6.0	50.9	0.5	17.9	25.3	38.5	139.3	68.8	34.8	33.0	10.4	5.9	64.8	77.9	10.9	1.3	20.7	22.6	0.0	37.3	9.4	67.6	115.9	18.5	161.3	53.6	3.2	52.5	8.6	11.6	7.4	78.2	47.7	33.7	19.0	25.9	28.3	24.6	5.7	42.8	35.3	19.1	129.4	86.5	1.1	1.6	17.1	1345.9	12.1	9.3	8.4
DIRAS2	"Di-Ras2, DKFZp761C07121"	ENSG00000165023	"DIRAS family GTPase 2"	Q96HU8	9	90609832-90643105	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 65.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 58.2;Horizontal cells: 66.7;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;EFO-21: 3.6;SCLC-21H: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.27e-5)"	"unprognostic (3.94e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.05e-1)"	0.9	2.8	6.1	0.9	24.5	1.1	1.4	64.5	65.3	8.5	1.1	2.1	0.0	2.4	1.1	1.1	0.9	1.2	4.6	0.8	13.6	5.4	1.4	1.0	0.9	1.0	4.3	23.0	0.8	1.8	3.3	0.6	1.3	3.9	0.9	0.9	2.2	2.1	1.1	0.8	1.5	2.7	0.9	6.2	1.0	1.7	1.0	0.9	0.0	2.9	0.0	0.8	0.8	0.3	1.9	1.0	1.9	1.6	1.6	0.9	0.4	0.1	1.4	12.5	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.1	0.6	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.3	0.2	0.4	0.0	0.2	2.3	0.3	0.0	0.1	0.0	0.4	0.1	0.1	1.0	0.1	0.6	0.3	0.1	0.3	0.1	0.2	0.2	0.2	0.2	1.8	1.6	1.6	0.7	0.3	0.4	0.8	0.8	0.6	0.2	1.9	0.9	0.9	1.9	1.6	0.6	1.0	0.2	0.4	6.1	24.5	64.5	41.4	13.6	5.4	4.3	23.0	3.9	0.9	0.0	0.0	0.0	0.0	0.1	58.2	0.4	5.1	0.0	0.0	3.5	2.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	66.7	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	8.5	0.0	0.0	0.0	0.6	20.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	39.4	1.1	0.0	1.3	6.1	0.8	3.2	0.0	0.0	5.4	22.7	0.0	0.0	0.0	31.3	20.9	0.0	4.5	0.0	0.4	0.0	0.0	4.9	0.6	3.2	0.0	4.8	0.0	13.7	0.2	14.8	0.0	26.2	0.0	10.8	0.8	5.9	2.1	1.8	0.0	2.8	0.0	0.1	2.5	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.6	0.0	22.1	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9	11.9	22.7	53.8	3.7	3.1	0.9	1.6	12.7	12.0	17.0	14.0	0.0	1.2	13.3	12.6	5.5	1.1	18.4	0.0	10.9	1.3	1.1	1.8	40.6	0.9	63.0	0.0	9.9	4.9	79.3	4.7	0.6	66.0	11.8	24.4	23.8	0.0	15.3	28.1	0.0	0.3	0.1	6.5	1.0	0.7	0.7	5.0	1.1	5.3	24.7	6.5
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 162.5;Proximal tubular cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.6	4.5	6.3	3.2	7.9	8.5	9.8	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.4	9.7	6.8	9.4	5.2	4.6	41.8	8.0	3.7	4.9	15.0	6.0	5.3	3.9	7.0	6.6	2.6	9.0	7.6	3.9	5.6	5.1	8.2	3.8	4.4	7.3	12.0	7.9	11.3	6.5	4.3	5.1	9.3	14.1	2.5	6.5	4.7	6.2	14.9	7.8	15.1	2.7	3.5	4.0	3.2	4.1	4.7	4.0	9.4	7.9	1.8	5.1	4.3	2.2	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1	0.0	7.7	5.2	22.9	4.6	17.8	32.7	28.1	13.4	4.5	26.2	23.6	37.5	162.5	21.0	2.6	11.2	33.1	23.3	14.0	23.8	11.3	45.7	1.1	16.0	11.6	12.7	22.0	11.1	9.4	1.0	13.3	7.6	11.8	44.1	16.4	8.5	13.9	23.7	10.6	92.2	32.2	12.9	7.5	9.4	11.7	3.6	30.4	13.1	23.0	22.0
NFIL3	"E4BP4, IL3BP1, NF-IL3A, NFIL3A"	ENSG00000165030	"Nuclear factor, interleukin 3 regulated"	Q16649	9	91409045-91423862	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Smooth muscle cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 22.8;neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 22.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HDLM-2: 44.3;hTCEpi: 36.7;hTERT-HME1: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003261	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA003261: AB_1079477"	"unprognostic (2.18e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.23e-6)"	"unprognostic (5.44e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.37e-2)"	34.9	34.3	6.0	14.2	10.7	73.6	80.5	8.0	9.8	21.0	14.4	2.7	7.0	7.1	18.3	18.7	11.1	24.1	19.0	20.8	7.2	4.0	11.4	32.4	20.2	16.3	7.6	4.1	37.5	11.9	7.2	9.0	17.9	16.8	22.7	8.9	3.5	6.5	12.3	51.7	15.4	7.7	24.4	22.4	6.9	13.8	12.2	7.4	2.3	11.4	6.1	4.7	28.8	69.6	0.2	0.5	22.8	0.8	0.0	0.7	0.3	4.5	2.7	3.3	1.8	40.4	31.5	16.1	5.4	15.6	6.2	9.4	1.8	2.2	2.0	3.3	4.4	18.1	2.9	3.8	5.4	7.1	44.3	1.6	2.1	2.7	15.4	33.0	2.9	13.2	31.9	36.7	5.5	39.1	3.5	2.7	5.1	3.5	23.0	4.0	2.2	0.3	3.9	2.5	7.8	2.4	7.2	3.6	2.9	7.6	2.1	4.1	3.0	3.7	3.4	5.3	6.1	1.9	3.9	2.9	13.6	3.0	11.7	2.7	19.8	4.5	0.8	7.2	2.8	2.4	22.8	0.8	5.4	0.7	0.4	0.3	0.2	0.0	0.2	0.5	0.0	0.1	0.1	14.7	0.0	0.5	0.3	0.0	0.3	6.0	10.7	8.0	9.8	7.2	4.0	7.6	4.1	16.8	7.4	20.8	36.2	2.9	13.1	41.0	14.6	72.2	10.2	9.4	17.0	0.0	15.7	7.5	8.3	7.4	21.3	31.9	18.6	0.0	8.4	14.7	30.2	31.9	9.2	25.1	10.1	19.1	15.4	13.5	30.3	4.5	10.0	26.0	32.1	18.0	7.4	17.0	9.3	8.6	11.0	7.3	13.7	6.5	115.4	0.7	1.9	34.5	19.3	6.9	7.1	12.6
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950162	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 9.7;Fibroblasts: 9.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 6.6"	"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 3.9"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.3;HHSteC: 32.4;HSkMC: 26.9;U-266/70: 18.7;U-266/84: 12.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 13.5"	HPA021868	Uncertain					NA	NA					"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	4.4	4.3	0.7	5.3	1.1	0.0	3.6	0.2	0.8	23.4	20.7	2.9	11.1	1.9	29.1	9.1	8.0	8.1	18.7	8.5	1.0	0.9	2.0	0.5	4.2	0.7	0.3	0.0	19.1	3.1	20.3	1.3	7.1	6.6	20.3	2.1	11.0	1.2	13.1	1.1	2.9	6.2	30.0	0.3	4.7	10.5	5.2	0.3	2.6	7.9	1.9	3.3	23.7	18.1	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	12.3	0.0	2.7	0.2	3.5	0.2	3.2	2.1	3.9	0.0	0.0	0.0	0.0	0.6	1.9	0.1	2.5	0.0	0.9	0.0	2.0	0.0	9.4	0.0	32.4	0.0	0.0	26.9	0.0	2.8	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.2	0.0	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.6	0.2	0.0	0.0	2.7	7.3	0.1	0.0	0.0	2.4	1.0	0.0	18.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.8	1.0	0.9	0.3	0.0	6.6	0.3	0.0	0.0	0.0	9.7	2.7	1.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	3.5	1.1	0.0	0.0	1.3	0.1	9.1	8.3	1.1	0.0	0.7	0.0	2.9	0.6	0.0	6.0	5.5	0.0	5.0	2.8	2.8	6.8	0.8	0.0	8.5	0.0	0.2	6.5	3.9	1.0	6.8	1.9	0.3	0.0	0.8	4.4
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 76.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: AB_2685148"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.4	16.8	11.6	9.7	28.4	22.2	20.1	19.4	24.9	16.8	18.3	10.5	38.7	10.2	12.4	24.6	20.4	48.5	12.5	16.5	19.6	11.8	7.3	9.4	9.5	10.2	21.4	15.5	12.7	19.9	20.0	17.4	18.9	16.0	15.3	11.0	21.9	12.7	19.1	19.9	9.7	3.8	15.6	20.9	12.2	10.8	14.1	7.8	16.7	11.3	9.4	8.8	26.2	20.1	11.8	14.5	10.3	9.2	19.4	16.4	12.7	18.8	13.5	9.2	12.6	5.7	19.6	7.7	19.6	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1	35.7	41.3	10.3	9.6	9.4	8.1	3.7	2.5	40.2	35.2	34.9	13.7	10.9	8.3	46.0	76.8	8.7	7.7	0.0	49.5	11.1	12.2	7.8	23.2	4.4	9.7	6.4	2.4	6.7	6.5	22.6	5.8	22.2	11.8	28.9	6.2	11.3	47.8	4.0	5.6	22.6	7.9	12.9	10.3	33.1	25.8	8.0	18.2	11.4	6.0	13.2
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.0	36.3	20.3	32.0	33.5	37.8	32.2	37.2	35.5	29.5	36.1	12.7	22.6	47.6	14.7	57.4	32.5	43.9	62.6	48.4	37.3	29.9	23.3	29.0	31.3	22.6	70.8	39.5	21.5	36.8	54.4	51.4	85.1	19.4	31.0	57.2	51.1	43.3	41.4	25.5	36.5	15.4	32.9	74.5	33.6	25.6	30.9	22.9	24.3	17.6	26.0	21.6	25.2	27.7	35.0	22.9	22.2	24.8	22.8	21.8	27.3	36.0	30.2	31.7	40.5	25.2	51.0	30.5	40.2	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9	17.9	25.5	29.7	27.4	60.8	34.2	44.5	40.8	24.1	27.3	17.4	43.2	23.5	13.3	22.2	8.9	20.8	5.4	0.0	25.9	26.2	31.1	25.2	36.9	26.0	15.7	9.5	11.5	16.0	21.6	4.0	26.4	17.7	13.5	11.8	23.8	15.5	26.0	8.6	27.6	29.1	34.6	6.5	32.5	39.2	38.1	59.2	14.5	18.7	26.3	27.4
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	15.8	11.5	11.6	14.6	20.0	8.5	13.6	15.9	15.9	15.1	13.2	7.3	12.1	6.4	16.4	11.1	14.1	13.0	9.4	9.4	13.7	8.2	10.6	8.9	9.5	13.6	17.9	8.4	17.5	11.1	25.3	23.6	11.8	13.4	14.0	11.0	5.2	11.0	13.2	15.0	12.9	10.7	14.6	19.5	15.7	10.6	7.7	17.8	18.7	15.2	11.2	15.1	16.3	16.2	13.6	12.2	13.6	14.7	12.6	17.5	6.6	8.1	13.2	6.1	12.3	13.9	11.8	8.4	9.3	7.3	10.0	9.6	4.7	8.5	25.6	8.2	9.8	16.6	16.9	21.8	13.0	11.1	16.0	9.9	18.2	13.2	10.5	9.4	30.3	13.9	12.4	9.6	11.2	15.7	8.2	12.3	7.6	27.6	7.9	11.5	13.1	21.1	10.6	10.3	11.6	12.6	12.8	18.0	10.4	5.2	5.5	11.4	5.6	12.8	11.2	7.8	8.3	4.5	9.6	11.9	9.3	6.0	13.1	9.7	8.0	17.9	13.9	8.6	17.5	11.9	13.6	8.3	11.3	12.5	11.1	17.5	13.6	11.9	12.0	12.2	12.6	14.6	12.5	3.2	12.6	14.7	10.3	13.2	6.6	11.6	20.0	15.9	15.9	13.7	8.2	17.9	8.4	13.4	17.8	17.9	33.1	27.4	15.8	11.6	18.5	25.6	12.7	32.1	23.9	10.4	9.8	16.1	13.3	20.5	9.0	20.2	8.8	23.3	11.2	17.4	13.2	11.2	48.8	9.6	23.0	27.0	8.6	20.3	16.1	6.8	29.7	19.8	10.1	27.1	14.3	13.7	15.3	7.0	22.3	12.4	16.8	6.5	13.4	46.1	37.9	13.9	12.2	15.2	17.9	9.6
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: AB_2683860"	"unprognostic (5.48e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.1	5.1	2.9	3.2	6.7	8.4	4.7	10.5	8.4	2.3	4.6	10.1	3.9	2.7	9.7	9.6	6.8	4.6	9.8	14.4	8.0	10.3	4.5	3.3	1.5	21.1	10.0	3.4	2.6	10.2	6.6	1.4	5.3	10.0	11.1	14.7	8.0	5.0	29.6	6.4	5.7	15.0	9.5	10.0	11.6	11.3	1.6	8.0	15.8	5.5	9.5	6.1	3.0	5.3	3.2	6.5	2.5	10.3	5.1	15.5	12.0	9.8	11.4	13.3	11.5	10.5	9.3	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5	0.0	0.3	1.5	3.6	56.2	6.4	2.0	2.5	0.0	1.2	0.0	7.9	2.7	1.7	0.9	15.3	3.1	0.7	0.0	2.0	8.2	5.6	2.1	0.0	0.8	13.9	1.6	1.2	1.3	1.3	3.6	4.0	3.0	13.5	0.0	0.6	2.5	1.2	0.0	4.6	1.1	7.5	6.5	6.7	11.1	5.7	88.2	3.2	4.3	1.7	2.4
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 137.8;Leydig cells: 153.9;Peritubular cells: 199.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.1;HSkMC: 8.1;JURKAT: 11.6;MOLT-4: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	23.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8	6.0	1.0	0.0	0.0	3.8	0.6	2.4	0.0	5.3	13.6	3.5	0.0	1.6	0.0	0.0	1.2	3.5	0.0	0.0	0.0	1.5	137.8	0.2	1.1	0.0	4.2	0.0	0.0	30.7	0.3	1.3	153.9	1.2	1.7	0.0	0.0	0.0	0.0	0.0	199.4	0.0	0.2	6.5	11.8	0.6	0.3	4.0	4.8	0.0	0.0	0.1
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92414245-92424461	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Fibroblasts: 27.7;Leydig cells: 90.6;Peritubular cells: 103.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 12.6;ASC TERT1: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		14000000	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	14.0	7.9	2.2	1.2	4.3	0.0	14.6	3.7	3.4	20.3	8.3	1.0	8.0	0.8	8.2	19.3	14.0	8.7	8.9	20.2	2.8	1.7	2.9	0.8	12.2	0.8	7.0	5.4	15.3	1.8	1.5	4.2	11.5	6.0	13.6	2.2	14.2	2.3	4.2	2.8	3.5	3.7	13.9	19.3	0.7	5.0	12.8	1.3	0.2	9.2	14.5	3.2	22.1	7.6	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	12.6	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	2.2	4.3	3.7	3.4	2.8	1.7	7.0	5.4	6.0	1.3	0.0	0.0	0.0	0.2	2.4	0.6	1.1	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	27.7	0.1	0.0	0.0	0.3	0.0	0.0	16.5	0.3	1.3	90.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	103.6	0.0	1.3	0.0	3.4	0.2	0.1	2.4	0.0	0.0	0.0	0.1
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		33000	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.7	0.0	2.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4	0.0	1.4	0.0	0.0	59.6	0.5	3.6	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	0.3	5.8	0.0	0.0	0.0	0.0	60.7	0.0	1.1	0.4	0.2	0.0	0.0	22.7	0.0	0.2	5.5	0.5	13.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.6	38.8	29.5	0.0	0.0	23.6	0.0	0.0	0.0	0.0
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Fibroblasts: 43.8;Hepatocytes: 36.8;Leydig cells: 113.1;Peritubular cells: 65.4;Smooth muscle cells: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.4;ASC TERT1: 20.8;HSkMC: 21.9;hTCEpi: 24.9;hTERT-HME1: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035347	Approved				"Secreted to extracellular matrix"	NA	NA		5500000			"HPA035347: AB_10669856"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	43.3	5.0	5.4	7.2	4.3	0.0	18.6	9.5	1.9	20.9	6.5	5.4	11.6	2.9	14.7	27.5	8.4	11.6	11.2	13.8	9.3	3.6	10.1	28.2	8.8	2.3	11.0	4.2	34.6	1.9	4.9	4.7	1.4	17.8	16.4	2.4	5.8	3.4	8.1	6.0	5.8	5.4	10.1	15.8	0.5	2.8	15.4	7.4	1.1	8.3	15.5	2.4	13.7	8.8	0.3	0.6	0.0	0.5	0.1	0.5	0.0	0.4	0.0	0.2	0.0	11.4	20.8	0.7	0.4	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.1	0.2	0.3	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.0	1.9	0.1	0.0	21.9	24.9	0.5	6.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	5.4	4.3	9.5	1.9	9.3	3.6	11.0	4.2	17.8	7.4	0.0	2.9	0.0	0.1	10.2	2.5	4.5	0.0	5.3	3.4	0.0	2.0	0.0	0.0	0.0	3.8	2.9	0.7	0.0	0.0	9.4	43.8	0.1	0.0	36.8	0.4	0.0	0.0	3.7	1.9	5.5	113.1	1.1	5.0	0.0	0.0	0.0	0.0	0.0	65.4	6.7	2.8	25.8	33.0	0.7	0.6	8.0	0.7	0.0	0.0	0.1
IPPK	"C9orf12, FLJ13163, INSP5K2, IP5K, IPK1"	ENSG00000127080	"Inositol-pentakisphosphate 2-kinase"	Q9H8X2	9	92613184-92670265	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020603	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA020603: AB_1851853"	"unprognostic (3.51e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.26e-9)"	"unprognostic (1.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.28e-4)"	5.0	7.5	7.6	5.2	12.3	8.3	7.5	13.4	14.1	7.9	4.7	9.7	6.8	3.7	6.0	5.9	29.7	6.4	5.3	8.1	7.9	5.9	5.2	5.8	4.9	6.0	7.1	5.7	6.5	4.2	11.3	11.0	7.1	10.0	5.1	5.3	6.0	10.8	4.3	6.9	31.5	4.6	6.3	6.4	5.8	4.8	12.0	7.7	5.7	5.5	17.8	16.1	4.9	13.7	4.2	3.9	5.8	3.2	1.4	7.5	3.1	11.9	6.4	5.9	5.1	7.3	5.5	19.7	8.6	5.3	8.8	5.0	4.0	4.7	7.5	4.3	11.9	7.8	17.2	10.4	11.9	7.4	9.2	6.7	6.1	13.6	6.1	5.2	10.3	7.2	5.4	11.8	10.5	8.2	8.0	6.5	6.2	8.2	9.1	8.6	16.3	5.9	4.8	10.1	13.2	9.5	5.2	6.4	3.0	5.2	7.3	12.4	7.3	6.9	28.7	5.0	6.1	6.8	2.6	12.6	6.5	7.4	18.3	8.9	8.4	9.7	4.2	8.5	4.7	6.3	0.0	2.3	5.8	6.4	3.1	7.3	4.1	5.6	5.7	3.6	4.2	4.4	4.8	3.6	1.4	3.2	3.9	7.5	3.1	7.6	12.3	13.4	14.1	7.9	5.9	7.1	5.7	10.0	7.7	3.0	4.3	1.5	5.2	22.6	8.3	0.3	0.0	0.0	3.4	1.8	5.9	7.8	5.0	5.2	8.3	5.8	3.3	0.0	6.9	11.0	4.3	5.0	0.0	2.6	4.4	14.3	6.4	10.4	5.9	26.7	2.8	3.9	3.3	1.8	3.4	4.5	6.5	0.0	2.8	3.1	4.1	6.5	2.7	15.7	16.8	25.7	19.1	4.4	3.3	9.0
BICD2	KIAA0699	ENSG00000185963	"BICD cargo adaptor 2"	Q8TD16	9	92711363-92764812	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 65.5;Suprabasal keratinocytes: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023013, HPA024452"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA023013: AB_1845352, HPA024452: AB_1845353"	"unprognostic (9.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.54e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.39e-2)"	10.4	7.8	13.9	8.9	12.5	7.2	7.1	13.2	13.1	13.1	9.9	7.7	7.9	3.2	9.7	4.5	27.2	7.2	6.7	15.6	11.8	5.8	7.5	5.2	9.1	9.3	13.4	9.8	8.4	7.2	21.7	3.8	9.8	11.9	7.4	3.7	6.6	9.1	10.0	13.9	40.3	5.9	9.7	9.2	11.3	5.9	5.9	11.0	8.5	6.2	16.3	18.2	10.6	17.2	3.3	5.2	10.5	7.5	1.5	2.4	2.0	14.3	11.9	8.9	9.1	17.3	12.0	12.6	14.0	10.1	8.0	6.3	7.0	6.5	16.2	9.1	15.5	10.2	45.2	9.9	22.2	9.1	7.7	10.8	8.5	11.6	9.6	10.3	11.8	13.9	12.2	31.1	13.3	10.2	9.5	11.8	7.0	8.4	12.6	17.4	9.4	11.2	7.4	6.1	10.6	14.7	12.3	19.3	8.6	12.8	12.1	6.2	9.6	9.8	9.1	6.3	9.3	3.7	5.5	15.8	14.8	9.9	24.9	15.1	10.5	7.6	14.4	12.5	7.3	12.9	2.2	4.4	5.6	1.8	5.2	1.8	2.7	2.0	2.4	5.2	3.3	1.9	1.7	10.5	1.5	7.5	4.5	1.2	2.0	13.9	12.5	13.2	13.1	11.8	5.8	13.4	9.8	11.9	11.0	26.8	10.1	12.4	12.7	65.5	12.3	46.2	7.6	14.7	19.4	7.0	5.9	7.4	3.3	8.5	5.1	13.5	1.0	0.0	4.3	5.5	22.3	7.8	23.1	6.7	12.6	14.3	10.4	17.8	32.0	5.0	19.5	24.3	15.1	9.0	2.2	3.9	7.5	3.1	31.5	5.8	5.5	19.4	19.8	7.9	8.4	114.4	6.1	10.2	2.3	15.8
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92845031-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.0"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	6.5	6.6	9.9	5.4	14.6	10.1	6.5	33.0	13.9	7.7	4.8	7.8	4.7	3.7	7.0	5.3	4.2	6.2	4.7	4.9	11.7	7.0	7.3	5.2	5.8	6.6	12.5	7.1	9.1	4.5	12.1	14.0	7.9	12.6	7.0	5.2	4.6	5.0	6.3	3.7	4.2	5.0	6.2	17.1	7.7	6.0	4.8	13.5	2.8	9.0	1.9	7.9	7.3	5.8	5.6	2.5	5.3	3.5	4.5	7.4	3.0	4.1	5.1	6.7	4.3	3.5	4.3	0.0	3.4	5.5	6.1	6.7	1.6	3.2	3.6	3.0	2.7	4.3	6.8	4.9	5.1	6.5	5.8	2.1	3.1	4.1	3.3	5.4	2.5	5.6	4.8	3.9	6.7	7.1	4.5	5.3	4.0	3.3	14.6	6.5	4.2	3.7	1.2	5.6	4.7	2.5	3.1	8.2	2.6	3.2	4.8	4.7	4.2	6.0	1.7	3.4	5.3	0.4	2.0	5.7	5.5	5.3	2.8	2.4	5.5	2.7	2.1	3.6	2.1	4.3	1.4	2.5	5.3	5.3	3.5	6.5	3.7	5.4	4.4	2.2	5.6	7.4	6.7	1.4	4.5	3.1	2.5	4.4	3.0	9.9	14.6	33.0	13.9	11.7	7.0	12.5	7.1	12.6	13.5	0.0	1.0	0.0	0.5	0.1	4.2	1.7	0.0	6.7	7.9	1.8	0.0	0.9	1.7	1.1	0.5	0.9	0.8	0.0	0.4	0.9	0.7	0.4	2.3	0.2	0.7	4.8	0.0	0.0	0.8	0.0	0.6	0.2	0.0	0.0	0.9	3.1	0.7	0.9	1.4	1.3	3.5	0.0	1.0	0.5	0.8	0.1	0.6	1.3	0.5	0.5
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947451-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.2;lymphoid tissue: 48.1"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 52.4;Late spermatids: 74.6;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.0;Karpas-707: 29.2;RT4: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA020963: AB_2670542, HPA021018: AB_2670564"	"unprognostic (5.66e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	3.1	1.5	2.3	20.5	2.5	23.4	3.5	0.5	1.6	1.8	3.1	3.1	1.6	1.9	2.8	2.5	2.8	2.5	3.1	1.5	2.2	2.0	4.6	2.1	7.5	30.5	3.3	1.0	1.1	5.7	0.1	1.0	2.6	2.6	3.2	1.4	2.2	6.6	1.0	0.7	3.1	10.1	1.5	6.3	28.1	2.6	3.9	2.5	48.1	3.5	2.1	25.8	7.7	3.2	11.3	10.3	49.2	24.7	10.5	15.7	17.1	6.4	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.0	4.4	5.2	0.3	0.0	0.0	4.2	0.3	0.0	0.0	9.0	0.0	8.2	0.0	0.3	0.0	2.2	21.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.3	29.2	0.0	10.7	9.6	9.2	0.2	2.1	0.5	9.5	0.0	7.4	0.0	16.5	0.6	0.2	0.0	7.1	0.2	0.2	2.8	9.7	0.0	0.0	0.3	0.0	0.0	2.9	2.9	2.4	1.5	4.6	0.0	34.0	13.4	36.7	15.1	17.3	15.5	8.5	15.6	14.1	10.3	11.3	15.7	13.3	49.2	10.5	24.7	4.7	13.5	17.1	2.3	2.5	0.5	1.6	2.2	2.0	3.3	1.0	2.6	2.5	20.8	11.6	2.7	0.7	0.7	0.0	2.2	2.5	0.0	3.4	8.7	0.0	2.1	0.0	5.5	52.4	1.4	0.0	0.0	0.2	2.9	0.8	0.0	18.5	0.6	12.6	0.0	1.7	2.5	17.8	74.6	0.3	12.6	1.7	2.8	0.3	0.3	0.4	0.0	0.4	0.6	4.2	0.0	0.9	1.6	1.9	0.9	3.8	38.3	0.1	0.4
SUSD3	MGC26847	ENSG00000157303	"Sushi domain containing 3"	Q96L08	9	93058688-93085138	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.8;testis: 64.8"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 27.5;Hepatocytes: 48.7;Hofbauer cells: 38.0;Proximal tubular cells: 50.4;T-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 51.7;Karpas-707: 11.5;MCF7: 12.5;NB-4: 26.4;RPMI-8226: 28.0;THP-1: 11.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042310	Uncertain					NA	NA					"HPA042310: AB_10796902"	"prognostic favorable (5.13e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.34e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.33e-2)"	3.2	1.0	3.3	16.9	3.2	18.7	8.0	1.2	3.2	8.3	3.3	8.5	0.6	2.2	11.6	12.8	1.9	18.2	1.9	1.0	2.4	2.7	18.5	13.9	3.8	25.8	4.0	2.3	20.9	0.8	0.2	3.2	1.4	3.7	1.8	0.9	3.0	7.5	1.5	0.4	1.6	9.7	3.0	5.4	20.2	1.9	64.8	3.1	13.9	2.5	0.8	19.9	3.0	3.7	20.4	9.2	16.7	3.9	2.2	52.8	17.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.1	1.1	0.4	51.7	0.2	0.2	0.0	0.1	0.8	0.0	0.0	4.5	0.0	7.0	0.0	0.8	3.4	0.0	1.6	3.6	0.2	0.0	0.0	0.0	0.0	0.0	2.1	11.5	0.0	12.5	0.0	26.4	0.6	0.4	1.6	2.2	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	6.8	11.9	0.1	0.0	0.0	0.0	0.0	2.3	1.2	3.2	0.0	0.0	0.1	0.1	3.9	16.7	5.7	3.4	6.4	20.4	30.1	10.5	9.2	14.4	52.8	21.3	1.3	2.2	0.6	0.8	39.8	17.0	3.3	3.2	1.2	3.2	2.4	2.7	4.0	2.3	3.7	3.1	0.0	7.9	27.5	0.1	0.6	0.2	0.6	15.3	1.4	0.0	0.0	3.9	0.8	8.3	0.6	2.4	0.4	0.0	0.0	0.2	1.5	1.5	0.6	3.5	48.7	38.0	0.0	0.0	1.8	10.8	9.0	5.2	8.5	1.7	1.0	0.1	0.5	0.4	0.0	4.9	50.4	7.8	0.0	0.9	2.1	2.7	0.3	1.1	30.9	0.4	0.2
CARD19	"bA370F5.1, BinCARD, C9orf89, MGC11115"	ENSG00000165233	"Caspase recruitment domain family member 19"	Q96LW7	9	93096218-93113283	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010921, HPA010990, HPA038297"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938"	"unprognostic (7.26e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	15.1	17.8	9.9	8.1	10.6	6.8	19.6	19.8	15.0	13.5	18.1	13.9	6.4	13.7	13.8	14.2	12.9	12.3	13.0	14.5	9.7	7.5	18.1	12.2	12.0	7.8	14.8	10.7	9.6	9.1	6.1	8.1	7.6	13.7	10.2	7.6	9.9	12.1	10.7	15.5	14.6	12.2	12.5	12.5	12.5	15.7	19.9	10.3	5.3	10.0	13.4	7.1	15.5	12.6	5.6	17.3	23.0	21.7	9.2	11.5	12.3	12.1	11.9	1.4	3.5	1.9	3.7	5.0	10.1	5.0	7.1	3.2	2.9	4.1	2.6	7.1	3.6	5.1	21.2	1.2	8.1	0.6	50.0	4.7	4.6	2.5	6.7	8.1	4.1	4.4	9.3	2.6	5.1	2.0	7.0	8.2	2.3	2.0	4.9	4.8	24.1	4.4	11.1	1.4	7.7	27.1	2.9	8.0	10.6	8.7	4.5	3.7	6.7	5.4	2.6	11.0	0.0	6.0	4.3	8.1	3.6	7.3	6.8	3.1	3.9	3.6	0.5	14.9	4.2	12.4	14.1	21.7	12.8	6.1	16.0	6.2	5.6	6.0	6.5	17.3	3.3	5.5	5.5	23.0	9.2	9.1	6.2	11.5	12.3	9.9	10.6	19.8	15.0	9.7	7.5	14.8	10.7	13.7	10.3	20.8	18.1	6.7	38.6	0.0	10.2	0.0	25.5	4.0	10.3	15.7	15.7	18.5	53.0	70.5	28.5	24.8	23.6	0.0	51.8	27.7	20.8	42.0	27.9	12.4	72.1	4.8	15.2	34.4	46.4	9.3	42.3	64.9	0.0	71.3	25.5	15.1	83.4	7.0	41.1	43.9	21.6	58.2	0.0	75.2	29.6	0.0	18.1	22.4	21.0	66.8
NINJ1	NIN1	ENSG00000131669	"Ninjurin 1"	Q92982	9	93121489-93134288	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.2"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 430.2;monocytes: 299.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 149.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 149.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 48.1;HHSteC: 43.8;MCF7: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045063	Uncertain					NA	NA					"HPA045063: AB_10964133"	"unprognostic (1.23e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.46e-3)"	20.7	42.5	14.8	15.2	15.5	92.9	30.5	7.5	14.7	14.9	19.9	20.4	9.6	10.6	12.9	27.0	14.7	14.9	16.5	27.1	14.3	14.6	39.0	51.7	24.3	28.1	17.1	7.2	16.9	17.9	39.3	20.2	37.3	15.6	18.9	7.3	24.6	31.9	25.7	16.9	30.7	15.4	17.2	20.7	34.7	13.5	21.7	12.9	11.4	43.8	13.7	13.4	25.4	14.3	0.6	6.7	149.2	29.5	3.9	9.0	15.3	10.5	16.5	3.4	7.2	12.6	5.0	13.3	7.7	21.9	11.2	6.9	7.2	3.6	0.1	3.7	7.4	12.4	11.0	3.8	21.3	2.4	24.4	7.3	1.6	4.2	48.1	43.8	1.1	3.4	16.7	20.9	10.7	5.8	34.8	10.6	4.1	1.1	12.0	2.5	46.8	3.3	3.4	4.6	13.0	13.6	5.9	2.5	18.9	9.0	4.5	1.0	4.7	16.2	25.6	9.9	6.0	19.8	7.4	7.5	3.9	11.5	8.1	5.3	6.8	2.6	0.2	11.9	3.5	3.0	9.8	27.1	69.4	6.6	27.3	9.0	0.6	6.1	5.6	6.7	0.2	7.5	5.2	149.2	3.9	29.5	0.9	6.3	15.3	14.8	15.5	7.5	14.7	14.3	14.6	17.1	7.2	15.6	12.9	26.8	38.2	13.7	83.7	101.8	2.3	26.6	58.6	2.7	31.8	38.4	0.0	109.8	109.5	86.6	2.1	46.7	23.4	0.0	90.1	67.0	78.7	64.1	47.2	36.4	430.2	1.6	17.3	22.7	131.8	10.5	38.9	172.3	140.0	299.4	18.9	48.7	57.0	24.6	68.2	194.8	2.7	12.9	88.6	0.5	7.2	118.6	61.3	41.5	18.0	50.4
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.9	8.2	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.6	0.1	11.5	1.5	0.0	0.8	0.2	6.5	0.0	0.0	0.0	7.5	0.0	3.5	18.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.0	0.0	6.0	0.1	0.1	7.3	4.4	0.2	0.0	0.0	9.3	0.0	0.7	23.9	9.4	1.5	6.5	0.6	0.8	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0											0.0	0.0	0.8	8.1	1.1	57.3	56.7	30.6	5.3	9.1	0.0	151.2	11.9	0.0	11.7	0.9	0.5	34.4	0.0	8.0	5.6	1.1	12.9	0.0	0.0	2.9	1.6	31.2	0.6	1.0	1.9	0.9	0.0	1.7	1.0	57.9	60.6	3.3	42.1	5.6	0.7	101.2	12.9	4.4	0.4	6.6	4.8	13.0	0.0	51.8	6.4
C9orf129	bA165J3.3	ENSG00000204352	"Chromosome 9 open reading frame 129"	Q5T035	9	93318199-93346414	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in many"	4	"brain: 12.7;testis: 4.3"	"Group enriched"	"Detected in some"	41	"Early spermatids: 17.5;Late spermatids: 49.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NTERA-2: 7.0"									HPA071515			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA071515: "	"unprognostic (1.12e-1)"				"unprognostic (2.46e-2)"	"unprognostic (1.23e-1)"		"unprognostic (9.47e-2)"		"unprognostic (1.25e-1)"		"unprognostic (1.84e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.45e-1)"			0.7	0.6	5.9	1.3	7.2	0.7	0.7	4.7	12.7	1.4	0.8	0.7	0.0	1.1	0.9	2.0	1.0	1.3	0.6	0.9	4.3	5.7	0.6	0.7	0.7	0.7	3.2	9.3	0.6	1.1	0.6	0.6	0.8	4.3	1.0	0.8	0.6	0.6	1.2	1.3	0.6	0.8	1.0	2.1	1.0	1.1	4.3	1.1	0.0	0.7	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	7.2	4.7	12.7	4.3	5.7	3.2	9.3	4.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0
FAM120AOS	C9orf10OS	ENSG00000188938	"Family with sequence similarity 120A opposite strand"	Q5T036	9	93446494-93453592	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021475	Approved					NA	NA					"HPA021475: AB_2670718"	"unprognostic (1.20e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.10e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (3.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (6.04e-4)"	"unprognostic (2.33e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.42e-1)"	18.2	18.4	20.5	18.4	19.7	9.5	22.4	12.5	23.1	17.0	22.5	20.0	19.4	13.1	17.3	34.8	17.4	15.6	17.9	21.8	16.9	17.8	20.4	16.9	16.1	13.9	18.0	15.5	19.3	23.8	29.3	32.1	48.4	18.4	23.7	23.6	28.1	17.5	20.1	18.2	18.0	20.6	19.2	17.8	14.9	21.7	9.1	13.2	21.9	27.6	11.1	18.5	19.4	22.8	15.0	11.1	12.6	14.2	10.6	11.7	6.1	16.5	15.3	11.0	12.0	16.1	7.0	17.7	10.6	11.1	11.7	9.0	11.5	13.3	14.5	13.4	11.6	16.5	21.2	11.3	10.9	10.8	23.2	9.0	14.7	14.4	12.8	16.2	12.1	9.5	8.9	15.4	11.0	18.7	12.6	12.6	12.0	15.2	20.6	10.9	38.9	15.5	5.7	15.1	22.7	17.0	13.1	15.1	14.3	15.8	14.9	23.6	11.3	15.5	16.8	15.2	13.5	18.0	9.2	8.2	7.3	11.6	25.1	14.5	15.0	19.5	6.2	11.9	7.5	14.8	10.8	12.3	7.8	6.5	11.9	8.5	15.0	9.8	8.6	10.1	11.0	11.7	9.0	12.6	10.6	14.2	11.1	9.2	6.1	20.5	19.7	12.5	23.1	16.9	17.8	18.0	15.5	18.4	13.2	32.8	35.5	24.1	39.8	11.2	26.1	35.0	12.7	34.8	61.4	17.4	13.7	86.9	33.2	30.0	0.4	26.0	41.6	0.0	42.3	121.2	27.7	44.1	22.0	19.4	35.8	6.4	27.2	17.8	24.1	2.5	22.2	20.4	11.8	43.3	31.5	21.5	29.2	30.9	31.5	27.6	26.0	25.8	31.6	12.4	16.4	22.6	208.2	24.0	28.3	49.2
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451722-93566107	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA019734: AB_1848369, HPA055800: AB_2682925"	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	25.7	35.1	23.3	28.6	19.1	15.7	23.0	22.1	21.8	26.1	27.0	14.9	32.2	21.3	33.2	17.2	26.0	24.2	24.1	22.1	20.5	11.0	21.2	33.2	25.7	26.4	18.4	12.6	25.5	34.4	40.6	16.8	24.6	20.0	17.4	26.0	15.9	27.7	22.4	71.5	17.6	23.6	23.3	17.7	21.7	25.3	7.5	17.7	19.5	19.8	23.8	17.6	46.5	33.1	4.7	6.6	15.2	9.2	4.2	7.5	3.5	47.1	38.7	8.8	25.2	26.4	33.2	27.6	33.2	29.3	25.5	18.8	12.5	29.3	30.8	19.0	41.8	20.3	51.0	23.4	38.8	19.9	30.6	17.0	16.8	34.6	19.8	29.6	28.5	23.0	32.2	24.2	28.9	46.4	25.3	36.4	21.9	19.2	25.9	27.6	52.8	27.9	16.2	11.3	56.6	36.3	16.3	23.5	25.8	31.0	28.5	23.6	14.5	37.5	45.7	22.7	9.1	24.8	18.7	37.6	27.8	20.0	34.0	36.1	20.4	20.0	11.9	30.0	25.8	24.6	3.0	7.1	5.0	5.4	8.1	5.1	4.7	5.2	5.6	6.6	4.1	3.6	5.1	15.2	4.2	9.2	4.6	7.5	3.5	23.3	19.1	22.1	21.8	20.5	11.0	18.4	12.6	20.0	17.7	41.7	72.9	25.7	37.7	90.8	28.8	107.4	79.0	48.2	76.2	71.5	47.1	61.6	18.3	44.8	23.5	54.4	108.9	23.3	65.0	83.1	53.6	103.2	47.4	158.9	64.4	38.1	88.2	64.4	144.2	6.4	61.9	69.8	50.6	35.1	160.3	34.0	71.4	70.2	61.5	66.1	29.6	38.8	67.9	13.1	13.5	99.9	86.5	44.8	129.3	93.7
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576407-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"Early spermatids: 142.5;Late spermatids: 473.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Nucleoli rim"	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	16.8	14.6	17.4	17.7	22.2	16.7	23.2	33.1	19.0	19.8	18.1	27.8	18.6	11.3	22.0	15.9	14.5	18.4	16.7	19.1	15.3	14.5	10.8	9.3	17.8	20.7	23.1	15.6	27.1	18.5	22.6	21.7	17.6	16.6	18.6	10.6	16.9	19.0	21.9	27.8	21.4	13.3	24.9	18.5	21.4	15.9	9.6	18.2	19.8	18.8	12.0	12.1	16.4	32.5	2.5	3.8	5.0	2.6	1.0	4.0	2.2	9.3	7.8	16.4	13.4	10.5	8.2	8.5	7.4	9.9	10.7	7.7	3.6	5.5	6.7	5.5	9.5	9.6	18.3	10.3	7.1	5.7	17.9	6.8	5.4	8.9	5.6	9.4	10.6	18.6	8.2	12.3	5.0	8.5	10.5	8.5	10.3	7.8	11.5	7.4	20.6	20.2	11.8	4.3	16.3	6.8	22.8	12.7	2.6	6.8	11.8	21.6	10.7	7.7	12.7	6.7	5.0	8.5	18.7	9.9	10.2	8.8	11.1	10.5	9.3	1.5	5.0	5.6	6.5	11.4	1.1	2.6	2.5	3.3	1.4	3.1	1.8	3.3	2.1	2.7	2.5	3.6	4.0	5.0	1.0	2.0	3.8	1.9	2.2	17.4	22.2	33.1	19.0	15.3	14.5	23.1	15.6	16.6	18.2	14.9	13.6	5.1	5.8	6.8	13.9	13.8	5.1	18.7	20.5	5.2	7.9	6.2	0.0	5.3	142.5	12.0	4.9	23.3	4.9	3.1	8.5	7.5	16.2	6.8	4.9	9.5	15.6	8.0	11.1	473.2	18.4	7.6	3.3	1.8	7.9	9.9	5.2	2.9	19.1	3.0	7.5	19.4	10.3	1.4	2.5	6.9	5.0	7.0	7.0	7.2
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951622-93955372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 59.7"	"Cell type enhanced"	"Detected in single"	23	"Early spermatids: 2.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 15.6;HMC-1: 37.3;NTERA-2: 11.0;THP-1: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	4.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.2	2.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.4	1.5	0.0	0.2	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	59.7	5.6	0.0	0.0	0.5	12.3	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	11.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	3.2	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.3"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	7.0	12.0	7.6	4.4	32.3	1.5	6.4	4.7	16.4	4.7	4.9	25.3	1.4	3.1	6.2	4.9	4.4	4.4	4.7	10.0	12.1	6.9	5.1	2.4	6.8	3.7	13.9	8.9	6.3	12.2	6.8	8.9	3.7	19.9	5.6	5.9	4.1	4.3	4.4	7.0	6.2	3.6	8.3	20.5	3.0	7.1	15.0	13.0	1.6	5.1	1.3	3.9	4.9	3.6	1.1	0.3	0.0	0.2	0.0	2.0	0.1	6.1	2.7	4.9	6.3	6.1	8.5	6.5	4.5	3.2	4.6	3.9	2.6	5.2	5.2	3.1	3.4	10.6	4.9	5.0	2.9	4.5	7.0	1.4	1.2	7.2	2.8	8.0	1.4	4.0	8.4	10.5	7.0	9.8	2.8	4.9	8.6	3.0	0.0	8.6	3.3	5.2	2.2	3.4	5.0	5.1	5.6	9.7	0.0	2.6	1.5	4.3	5.5	6.2	5.8	9.7	6.8	3.1	2.5	6.9	6.2	3.8	9.5	5.4	7.6	8.4	0.7	4.6	2.5	8.6	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.1	0.0	0.3	1.1	2.0	0.7	0.0	0.0	0.2	0.2	0.0	0.1	7.6	32.3	4.7	16.4	12.1	6.9	13.9	8.9	19.9	13.0	0.0	7.7	1.9	2.6	4.2	10.5	8.4	2.5	1.4	1.2	5.2	9.8	0.3	3.3	2.9	8.0	5.7	0.9	0.0	2.5	1.6	5.0	1.9	5.7	0.8	2.7	4.8	3.4	6.2	0.3	3.8	3.4	2.7	3.3	0.0	2.4	2.3	5.0	1.1	13.4	1.0	9.8	19.4	4.8	12.0	15.9	3.8	0.2	2.5	2.3	1.7
ZNF169	MGC51961	ENSG00000175787	"Zinc finger protein 169"	Q14929	9	94259311-94301454	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041769, HPA061185"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	"Vesicles, Cytosol"	"HPA041769: AB_2677662, HPA061185: "	"unprognostic (1.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.27e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.45e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.49e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-4)"	4.5	4.2	6.5	8.5	10.9	5.9	7.8	12.7	13.5	7.4	6.7	8.3	4.4	5.6	7.7	8.7	4.1	7.5	5.7	4.6	8.6	5.7	5.5	3.2	5.0	11.0	9.8	8.5	9.4	5.2	5.9	4.9	4.3	8.2	6.6	11.1	5.8	7.2	5.6	8.6	10.0	8.6	6.6	7.1	10.6	8.1	4.3	9.5	10.5	8.0	5.0	10.0	6.9	6.5	9.5	4.5	6.1	6.9	6.7	9.1	3.4	3.9	3.5	3.9	6.9	1.9	4.9	4.4	1.4	2.7	3.0	3.2	2.3	6.0	9.5	1.9	2.3	3.3	7.9	8.0	3.6	4.1	5.5	8.6	6.7	7.9	4.4	2.8	10.1	6.9	4.2	4.0	2.6	4.2	3.9	3.8	9.3	6.0	3.0	3.9	3.8	4.7	5.6	6.4	8.3	4.3	4.1	2.8	3.1	2.7	3.6	4.1	4.9	2.7	4.8	2.0	4.1	3.1	4.4	4.1	2.9	3.6	3.5	3.0	5.2	1.9	2.0	2.6	6.7	2.7	3.2	6.5	6.1	5.5	6.9	6.9	6.3	6.2	3.9	4.5	9.5	6.7	9.1	5.6	6.7	5.0	4.2	6.5	3.4	6.5	10.9	12.7	13.5	8.6	5.7	9.8	8.5	8.2	9.5	3.0	0.3	2.7	1.7	0.2	5.0	0.8	0.0	2.7	3.4	1.8	3.9	0.4	0.0	0.9	0.9	2.2	2.4	0.0	0.7	0.6	0.9	1.6	0.0	1.0	0.7	4.8	1.2	1.3	4.4	0.6	5.5	2.3	0.0	1.8	2.5	2.8	1.0	2.5	3.2	0.3	4.4	0.0	1.1	4.8	2.2	0.4	0.3	3.9	1.5	1.8
NUTM2F	"DKFZp434I1117, FAM22F"	ENSG00000130950	"NUT family member 2F"	A1L443	9	94318196-94328644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	9	"testis: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NTERA-2: 5.5"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (1.40e-1)"	"unprognostic (4.93e-3)"	"unprognostic (4.16e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.03e-1)"		"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.72e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.14e-1)"		"unprognostic (1.83e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	5.5			0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.7	13.1	10.2	28.8	20.7	20.9	25.3	22.0	22.5	22.1	8.4	31.1	31.3	15.1	21.7	26.1	57.4	15.6	16.1	22.0	22.3	8.4	10.7	16.1	12.6	20.5	33.8	20.0	18.9	24.4	23.8	18.3	12.6	19.2	17.2	20.3	18.6	29.9	19.7	24.7	19.4	19.2	38.0	13.5	12.4	30.1	10.1	24.0	20.0	12.6	16.6	21.5	25.5	26.7	16.4	11.6	20.0	20.6	23.6	16.7	36.2	23.3	20.6	25.5	8.6	21.0	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2	6.0	21.9	13.7	20.2	0.0	11.2	0.0	17.8	13.4	12.5	41.8	3.9	12.4	6.6	15.2	2.6	11.3	7.1	0.0	16.4	22.4	13.2	30.5	3.5	10.4	25.8	4.8	7.0	27.0	63.5	2.1	15.5	18.5	0.0	10.8	26.6	18.1	22.0	15.8	15.2	5.7	9.1	12.9	0.0	10.4	17.5	0.0	16.0	13.8	14.9	41.4
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell type enhanced"	"Detected in some"	29	"Exocrine glandular cells: 1.2;Spermatogonia: 3.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.1	0.0	0.0	0.1	0.0	3.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	5.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	4.9	1.1	0.0	0.2	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 322.6;Proximal tubular cells: 631.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	64.2	0.0	1.1	0.2	10.4	2.3	0.0	0.2	0.4	0.0	42.1	0.2	1.2	0.1	12.3	0.0	0.2	7.3	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.2	30.5	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8	71.5	142.5	10.2	6.5	0.7	0.0	0.6	107.0	13.4	68.2	59.3	0.0	9.7	94.5	14.4	0.0	1.8	32.6	23.3	56.4	1.6	1.7	17.4	45.2	322.6	187.5	0.0	30.7	11.1	49.8	0.8	1.4	103.2	11.8	0.0	49.9	2.1	23.8	68.4	3.9	631.0	0.0	6.5	1.2	0.6	0.1	0.9	8.5	13.1	59.5	51.2
C9orf3	"AOPEP, AP-O, APO, C90RF3, FLJ14675"	ENSG00000148120	"Chromosome 9 open reading frame 3"	Q8N6M6	9	94726701-95087218	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 187.3;Smooth muscle cells: 202.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	6.2	8.5	6.8	9.1	12.7	2.4	11.3	10.5	10.3	14.0	17.8	24.6	24.1	5.1	28.8	15.0	20.2	16.0	17.9	29.9	8.9	5.9	12.7	28.1	10.9	3.1	11.3	6.1	11.7	24.7	25.0	11.1	24.4	11.3	22.1	6.8	11.4	13.1	17.6	29.8	39.1	8.1	32.2	11.6	6.8	10.8	6.4	11.4	3.3	11.6	23.7	7.8	12.9	25.1	5.4	5.8	2.1	3.6	3.4	3.6	1.8	4.6	20.6	2.2	3.9	2.3	3.0	8.8	4.4	2.0	4.7	2.8	4.4	6.0	1.4	3.8	7.4	6.6	18.2	4.1	4.2	2.3	9.6	3.2	1.3	18.7	3.9	4.8	1.2	1.0	3.1	17.6	4.1	2.7	12.6	2.6	2.2	2.1	1.9	8.5	6.7	1.7	1.5	2.9	5.5	8.6	2.7	7.2	1.7	8.1	4.1	4.6	6.9	7.5	7.0	1.6	6.3	7.7	0.9	2.0	2.0	2.0	8.3	2.3	1.7	2.2	0.7	7.0	1.1	3.6	0.3	3.6	2.1	3.6	2.5	2.3	2.4	3.0	3.3	5.8	5.4	2.3	2.7	1.3	3.4	1.7	5.2	1.9	1.8	6.8	12.7	10.5	10.3	8.9	5.9	11.3	6.1	11.3	11.4	20.8	26.6	2.0	151.6	128.8	21.9	142.0	61.1	30.8	31.8	12.2	17.7	55.1	38.1	34.9	33.0	58.5	10.1	0.0	83.2	34.0	56.4	54.9	3.5	70.1	8.0	11.1	10.9	21.5	6.2	19.5	17.5	5.9	187.3	1.8	8.5	71.9	51.7	14.4	100.0	32.7	12.4	12.9	202.8	14.3	20.0	131.6	73.8	3.5	9.5	61.6
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"Fanconi anemia complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 29.7"	"Group enriched"	"Detected in many"	5	"Early spermatids: 190.4;Late spermatids: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in all"		"RH-30: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017793: , HPA030771: AB_2673604"	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	4.9	2.7	4.3	8.6	7.0	3.6	4.6	29.7	7.7	4.6	6.4	4.9	5.1	7.1	6.3	4.1	4.5	3.6	5.2	3.2	4.0	2.7	10.0	25.7	6.7	3.7	7.3	1.6	3.3	5.4	2.9	12.1	4.3	6.7	4.4	6.1	4.0	4.0	4.2	4.5	7.7	8.1	2.9	6.4	3.4	4.4	19.6	7.3	7.9	4.3	3.2	6.0	3.5	4.0	1.0	1.3	10.4	1.7	0.3	1.5	0.7	13.6	9.2	12.2	10.6	1.2	3.2	7.7	5.9	3.9	9.5	8.8	10.5	5.8	7.8	4.2	4.3	7.3	16.7	12.3	5.2	5.2	7.4	5.8	6.1	10.4	5.4	2.0	6.1	6.8	2.7	2.2	7.6	3.4	2.6	5.2	7.6	9.1	3.4	6.8	9.6	5.7	3.5	5.8	14.5	5.2	12.2	31.5	3.6	3.9	3.5	17.7	9.4	11.3	4.0	3.4	6.4	4.2	5.1	2.5	8.3	12.2	9.1	8.4	3.6	6.6	4.1	4.5	5.6	9.8	10.4	0.4	0.0	1.3	0.8	1.3	1.0	0.7	1.5	0.4	1.0	1.2	1.0	0.1	0.3	1.7	1.3	1.3	0.7	4.3	7.0	29.7	7.7	4.0	2.7	7.3	1.6	6.7	7.3	3.0	2.1	0.0	2.3	2.3	5.4	1.6	5.1	1.4	3.4	0.0	3.9	2.3	1.7	4.1	190.4	4.3	3.3	0.0	3.6	4.0	2.0	2.5	5.7	25.1	1.8	9.5	0.0	4.3	2.7	63.3	6.1	1.3	1.7	3.6	4.5	2.6	3.4	0.0	2.1	7.7	4.2	0.0	1.6	13.0	10.6	2.4	1.9	1.0	3.8	2.5
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease mutation, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Late spermatids: 165.3;Leydig cells: 176.9;Peritubular cells: 417.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.8;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB013717: , HPA075072: AB_2686733"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	4.1	3.8	6.7	6.0	9.5	0.7	7.9	21.0	6.4	28.5	12.5	6.1	8.0	7.8	16.2	4.2	3.0	7.4	13.2	2.8	7.0	6.6	4.9	2.2	7.1	4.5	9.5	3.2	5.2	10.8	3.4	4.0	3.7	6.9	6.9	12.3	11.2	6.9	9.5	2.7	4.3	10.9	8.5	5.1	3.8	12.1	14.3	7.9	1.0	6.3	1.9	3.2	11.3	6.9	1.0	0.0	0.0	0.0	0.3	8.9	1.8	5.1	2.5	10.9	6.8	1.6	2.7	6.2	1.0	0.9	1.2	0.7	2.5	2.5	4.1	1.8	1.9	2.3	11.8	6.2	0.8	0.7	4.0	4.1	0.0	2.5	1.1	1.5	0.1	2.3	2.5	1.3	1.1	0.8	2.3	2.2	1.8	3.6	4.8	0.5	1.0	0.0	1.6	15.8	3.7	1.0	0.0	8.3	2.1	0.8	0.7	7.5	3.7	3.7	3.6	1.6	10.6	0.9	1.1	0.5	1.4	7.2	7.3	0.7	9.7	8.4	2.7	2.0	2.0	37.6	0.0	0.0	0.0	8.9	0.0	5.3	1.0	1.7	3.8	0.0	0.3	2.8	3.2	0.0	0.3	0.0	0.0	1.4	1.8	6.7	9.5	21.0	6.4	7.0	6.6	9.5	3.2	6.9	7.9	0.0	5.4	0.9	2.8	3.5	17.4	5.1	10.2	1.4	2.3	0.0	39.3	2.0	5.0	2.5	80.9	3.7	1.3	0.0	3.5	1.6	6.9	5.8	1.1	1.0	0.7	19.1	20.8	3.1	0.8	165.3	176.9	0.8	11.8	0.0	11.2	71.0	2.6	3.5	417.9	1.1	13.5	38.8	4.2	3.3	33.2	3.9	1.1	4.3	5.0	1.1
ERCC6L2	"C9orf102, FLJ37706, RAD26L"	ENSG00000182150	"ERCC excision repair 6 like 2"	Q5T890	9	95875701-96014571	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021260, HPA022422"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021260: AB_1859544, HPA022422: "	"unprognostic (6.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (8.70e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.39e-2)"	13.5	13.9	14.6	12.7	17.4	7.6	13.6	21.8	19.3	17.7	12.9	13.2	13.9	10.4	18.7	11.8	11.6	11.4	11.8	13.3	14.0	9.7	12.4	11.7	12.7	15.0	15.3	12.2	21.7	10.6	26.2	22.0	11.7	16.1	15.5	11.5	11.0	11.2	12.7	13.9	10.1	13.5	16.1	12.1	15.8	13.4	12.5	15.4	29.7	20.3	7.1	12.4	17.4	13.8	7.3	12.7	4.3	5.3	5.1	12.9	4.0	11.4	14.6	17.3	12.4	6.8	11.6	8.3	10.2	10.4	10.4	11.9	11.2	5.1	13.0	5.7	14.6	14.9	14.3	16.6	7.1	15.4	9.3	8.0	11.7	11.1	7.2	6.6	14.9	11.6	10.3	7.3	12.8	10.2	9.6	9.7	13.4	15.1	7.3	10.7	9.2	12.4	5.6	12.9	12.3	8.8	11.6	22.5	4.6	8.8	10.5	16.2	12.4	7.2	7.6	7.3	9.4	7.1	7.7	10.2	11.7	14.9	14.4	12.0	4.9	7.4	6.2	11.3	7.1	16.9	3.2	4.4	4.3	8.7	5.3	8.4	5.7	8.3	9.3	4.8	7.3	12.9	9.4	2.7	5.1	4.2	12.7	9.9	4.0	14.6	17.4	21.8	19.3	14.0	9.7	15.3	12.2	16.1	15.4	14.9	15.2	4.7	11.1	4.4	0.0	15.9	7.6	21.4	18.2	0.0	0.0	4.5	0.0	7.6	6.2	7.2	5.9	23.3	7.0	2.8	7.5	8.6	15.0	6.0	5.5	0.0	4.7	8.0	9.1	3.0	24.7	10.6	3.3	8.2	7.1	0.0	6.3	3.5	26.2	2.8	0.0	19.4	10.3	15.2	9.6	3.9	4.0	12.8	5.6	7.5
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 41.9"	"Cell type enriched"	"Detected in some"	8	"Leydig cells: 100.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	0.5	0.4	1.0	0.5	1.0	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1.0	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.0	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.4	0.3	0.0	0.4	0.0	0.2	0.1	0.0	1.6	0.0	0.0	1.7	0.0	0.0	7.8	100.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	12.0	0.0	0.2	0.0	0.5	0.3	1.9	0.3	0.1	0.0	0.2	0.0
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96320706-96383710	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.6"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	8.7	6.1	5.9	7.8	13.6	4.6	8.8	1.6	10.8	7.9	23.8	21.2	4.2	30.7	8.3	8.7	8.7	7.8	16.2	7.3	7.8	5.2	20.1	27.9	13.2	17.6	13.7	4.7	10.5	26.0	8.0	5.1	10.5	9.2	8.0	22.6	13.1	8.5	5.3	2.8	5.7	39.6	11.2	14.3	6.5	18.7	5.1	9.8	2.7	14.3	5.0	7.5	10.0	8.0	1.5	2.4	1.6	1.4	1.9	5.3	1.0	11.3	8.9	5.6	11.5	7.1	14.7	10.6	5.1	10.8	7.9	6.7	18.2	37.6	0.2	8.5	4.5	18.6	16.5	7.7	8.0	7.0	5.3	6.3	4.1	3.7	31.2	10.5	0.0	0.0	12.0	9.5	6.1	17.4	15.6	17.2	0.0	7.6	0.1	8.7	7.7	0.0	0.0	4.9	21.2	10.3	0.0	0.0	0.0	18.8	6.9	2.1	13.1	4.4	8.9	22.6	19.4	5.6	8.2	15.3	5.5	5.9	7.9	4.9	0.0	0.3	0.0	11.3	0.0	7.5	1.6	1.4	1.0	1.8	1.0	2.4	1.5	2.2	3.5	2.4	0.3	0.7	1.7	0.1	1.9	0.8	0.1	5.3	1.0	5.9	13.6	1.6	10.8	7.8	5.2	13.7	4.7	9.2	9.8	8.9	8.3	0.9	7.2	4.6	0.5	6.9	30.6	6.7	5.7	12.2	2.0	23.1	10.0	6.1	0.1	11.3	52.6	0.0	21.1	37.7	5.0	13.5	4.6	41.4	17.3	1.6	9.2	10.4	16.1	0.2	10.0	9.4	16.9	7.2	45.1	7.7	22.3	38.6	5.6	18.0	3.5	12.9	7.6	1.5	1.9	4.6	22.2	8.4	27.7	13.9
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418329	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.8;lymphoid tissue: 21.5"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 8.9;Sertoli cells: 6.5;Spermatocytes: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	7	"T-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	2.7	1.2	2.1	8.9	4.6	23.8	4.4	2.9	3.9	2.2	4.9	2.9	1.7	3.2	1.3	2.1	4.5	1.3	3.0	4.6	2.5	2.1	3.3	12.0	2.6	4.7	4.4	2.0	2.2	1.8	3.9	0.6	3.7	3.8	1.4	3.8	2.1	3.2	0.6	3.9	3.9	3.2	2.6	4.3	3.4	2.4	9.6	4.3	21.5	1.3	6.5	5.0	2.1	2.5	0.1	0.2	0.1	0.2	0.1	1.8	0.7	13.3	5.5	5.4	4.9	2.1	3.0	7.4	18.7	11.1	9.3	11.2	3.4	9.5	10.2	8.0	8.9	7.0	16.5	6.3	6.8	11.1	11.1	5.5	7.4	10.6	2.8	0.0	10.3	9.1	0.5	0.4	7.5	3.8	2.0	3.4	7.2	6.7	24.9	11.9	8.9	15.8	8.5	3.7	14.8	9.1	8.0	27.6	6.2	2.7	9.0	9.6	6.7	8.2	9.9	5.7	4.6	5.2	9.2	3.0	15.4	8.8	14.1	14.1	9.7	16.4	4.2	9.3	9.1	12.9	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.8	1.2	0.2	0.1	1.1	1.3	0.0	0.1	0.2	0.1	1.8	0.7	2.1	4.6	2.9	3.9	2.5	2.1	4.4	2.0	3.8	4.3	0.0	0.0	2.2	1.0	8.9	0.6	2.2	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.4	0.6	0.6	0.6	0.0	1.0	3.5	1.7	0.4	0.0	3.9	1.7	0.0	0.0	1.3	2.5	0.6	0.6	1.5	3.3	0.0	1.9	0.5	0.5	0.0	0.7	2.2	1.5	6.5	2.5	7.2	1.4	5.6	0.7	2.5	2.5	0.1
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450201-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 193.7;Late spermatids: 710.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055969, HPA062366"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA055969: AB_2682991, HPA062366: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	13.2	11.9	31.2	6.1	44.8	1.7	6.5	14.1	40.6	7.9	5.5	12.4	1.5	3.0	8.2	6.8	7.2	5.3	8.1	19.1	26.1	24.9	23.5	5.7	6.1	6.8	27.1	20.5	11.7	4.8	13.8	7.4	3.4	31.6	8.3	4.2	8.4	4.1	10.6	9.4	6.1	3.3	10.6	19.4	5.0	5.0	21.8	13.0	0.4	11.2	2.2	4.9	7.6	6.5	4.1	0.1	0.3	0.8	1.0	4.0	0.7	7.3	8.4	10.7	11.4	23.7	20.3	7.6	10.0	11.2	7.5	8.2	12.5	12.3	3.7	5.0	14.8	24.0	5.4	8.9	1.9	6.1	4.5	5.3	1.4	4.0	20.8	12.1	0.3	1.5	8.2	3.4	8.6	6.8	11.5	5.3	4.3	1.7	11.1	13.5	7.5	0.1	2.3	5.0	10.3	8.2	3.8	9.3	0.1	12.8	3.2	6.8	4.6	5.3	3.2	15.9	8.3	2.3	1.6	9.1	10.4	2.4	19.0	8.4	7.0	6.9	1.6	8.3	2.9	15.3	0.0	0.1	0.0	1.4	0.3	1.4	4.1	4.0	3.2	0.0	1.7	2.8	2.8	0.3	1.0	0.8	0.1	3.0	0.7	31.2	44.8	14.1	33.8	26.1	24.9	27.1	20.5	31.6	13.0	0.0	6.1	3.4	7.8	10.2	22.0	10.6	15.3	1.4	9.1	17.4	0.0	2.2	14.9	3.7	193.7	17.8	0.8	0.0	5.0	6.7	7.8	8.5	1.1	5.0	5.5	22.3	12.6	13.5	1.5	710.5	12.7	4.0	16.9	3.6	0.9	17.1	4.8	0.0	22.3	39.6	11.3	6.5	17.6	18.6	5.9	6.9	1.1	7.5	1.1	5.1
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619830	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.9"	"Lineage enhanced"	"Detected in many"		"granulocytes: 9.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;ASC TERT1: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013312, HPA064747"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013312: AB_1846354, HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	7.3	6.2	6.8	3.0	7.5	4.4	15.7	2.4	6.6	5.3	5.0	14.8	7.1	4.5	4.0	3.7	3.5	7.1	5.9	8.2	6.0	4.6	9.1	16.0	4.9	1.8	9.5	4.0	5.8	7.3	17.1	5.2	3.4	7.1	5.7	5.4	8.3	3.8	7.2	2.2	3.3	7.7	4.2	9.3	2.2	9.3	16.9	8.2	0.2	13.6	2.2	2.1	10.4	10.3	1.6	0.0	9.9	0.0	0.1	2.9	0.8	5.2	2.9	3.1	3.2	15.2	22.8	8.5	3.8	5.1	2.5	4.1	9.9	8.3	0.0	3.7	8.0	6.2	5.9	4.4	3.0	3.0	1.3	4.1	0.8	1.0	7.8	2.5	0.0	0.1	9.4	1.5	2.7	2.5	3.0	0.5	0.0	3.0	0.6	3.5	2.5	0.0	0.8	5.8	5.9	2.5	0.0	1.9	0.1	4.0	8.1	0.9	4.9	2.7	0.8	1.5	11.0	0.7	1.7	1.5	2.5	3.0	6.6	2.8	0.1	0.0	0.0	2.7	0.0	6.0	9.9	0.0	3.1	2.9	0.0	1.6	1.6	1.3	2.3	0.0	0.8	2.3	1.4	0.0	0.1	0.0	0.0	1.6	0.8	6.8	7.5	2.4	6.6	6.0	4.6	9.5	4.0	7.1	8.2	6.0	9.1	2.4	7.4	8.0	6.4	14.5	10.2	16.0	14.8	8.7	7.9	5.3	6.6	4.8	28.7	4.7	8.5	0.0	5.7	2.5	9.3	10.2	13.9	27.2	8.6	7.9	2.4	8.0	1.0	27.6	8.3	4.1	8.5	3.6	7.6	10.9	6.9	6.5	11.0	14.1	11.7	25.8	22.0	3.7	5.5	6.8	2.9	5.0	7.2	8.1
AAED1	C9orf21	ENSG00000158122	"AhpC/TSA antioxidant enzyme domain containing 1"	Q7RTV5	9	96639577-96655303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021294	Approved					NA	NA					"HPA021294: AB_1845818"	"unprognostic (4.17e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.70e-2)"	27.7	7.4	4.9	7.4	6.3	12.5	20.5	2.6	4.8	11.5	10.5	6.2	3.0	4.6	11.2	11.2	11.6	11.3	11.2	41.9	5.1	4.8	13.7	11.1	13.1	15.8	7.3	3.3	13.9	10.5	4.5	6.0	8.0	5.6	9.9	5.6	9.4	6.0	5.1	26.6	7.0	7.4	14.0	10.0	15.3	8.2	10.7	5.2	2.9	19.1	11.1	7.5	16.3	10.0	6.7	5.4	25.7	7.1	3.6	6.9	1.9	7.1	3.7	1.8	6.4	15.4	26.5	7.3	7.8	12.0	6.8	6.5	8.2	8.1	0.2	6.5	12.8	13.1	6.8	6.3	3.8	4.0	7.0	3.9	4.1	3.3	6.8	11.8	3.2	11.7	12.6	6.7	4.7	6.0	6.7	5.8	2.9	7.9	3.1	6.9	5.0	0.1	5.7	2.5	2.9	7.0	0.1	5.4	0.1	9.4	1.7	2.9	3.7	5.7	5.0	4.2	5.7	1.9	5.9	10.6	11.4	4.7	11.0	5.2	8.2	3.6	2.7	4.9	3.0	10.4	25.7	6.5	13.9	6.8	7.1	6.9	6.7	6.4	6.7	5.4	5.3	3.4	5.7	1.3	3.6	6.3	3.5	6.4	1.9	4.9	6.3	2.6	4.3	5.1	4.8	7.3	3.3	5.6	5.2	20.8	13.7	17.6	56.0	41.3	1.1	17.3	17.8	24.1	11.4	12.2	2.0	13.0	11.6	8.3	31.2	27.2	3.9	0.0	9.9	59.5	20.5	30.3	49.5	8.9	50.9	7.9	47.1	29.4	29.5	40.4	31.9	50.1	59.1	13.6	2.9	5.2	10.9	4.8	14.9	18.3	1.3	12.9	96.7	20.5	8.1	26.2	5.3	15.8	5.8	22.1
ZNF510	KIAA0972	ENSG00000081386	"Zinc finger protein 510"	Q9Y2H8	9	96755865-96778129	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049139	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA049139: AB_2680651"	"unprognostic (2.70e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.18e-2)"	9.1	9.2	10.9	6.5	15.7	5.7	12.7	23.0	13.9	14.4	8.8	6.3	11.6	4.6	11.5	8.1	7.9	10.7	6.5	7.4	11.5	10.3	8.9	8.5	8.4	11.4	8.6	12.3	14.9	10.7	13.5	19.8	6.9	10.1	12.6	9.3	5.2	7.5	11.2	9.2	6.2	6.8	11.3	9.2	10.1	6.8	8.2	9.1	14.9	11.2	4.3	13.3	13.9	10.7	5.9	1.3	3.8	2.9	6.4	7.7	2.1	5.1	5.2	11.5	8.5	9.8	9.2	5.9	5.8	11.4	9.7	8.6	4.9	3.8	6.7	3.1	6.1	9.5	11.2	3.3	5.4	8.7	10.7	5.5	9.4	9.7	2.5	5.8	3.6	6.2	7.9	7.2	8.3	10.4	9.1	9.3	12.9	9.6	6.5	9.4	4.6	10.4	4.8	8.1	7.5	5.3	6.8	18.8	3.3	5.1	4.9	11.9	9.5	11.2	5.2	5.7	8.4	3.8	6.8	8.2	6.2	5.9	7.0	6.7	11.4	12.0	4.9	3.5	2.5	6.2	2.3	1.2	3.8	3.8	1.9	7.7	3.6	5.0	3.0	1.0	5.9	5.7	5.2	0.4	6.4	2.9	1.3	7.1	2.1	10.9	15.7	23.0	13.9	11.5	10.3	8.6	12.3	10.1	9.1	3.0	2.7	2.0	1.4	1.4	10.5	4.4	0.0	4.0	3.4	3.5	2.0	2.0	1.7	1.9	5.0	2.7	1.0	0.0	2.3	1.2	1.7	1.4	1.1	1.0	1.7	15.9	1.2	5.5	3.4	5.6	5.5	2.2	5.0	1.0	1.8	3.8	1.3	1.7	3.9	1.5	7.0	6.5	1.4	3.2	4.9	1.3	0.7	3.2	1.4	1.0
ZNF782	FLJ16636	ENSG00000196597	"Zinc finger protein 782"	Q6ZMW2	9	96816472-96875623	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011013	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA011013: AB_1080758"	"unprognostic (5.51e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.63e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.95e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.39e-2)"	5.3	4.2	7.4	7.4	8.4	2.5	7.6	19.8	8.0	7.5	5.3	6.9	5.9	6.1	7.9	8.5	5.2	5.5	5.8	4.0	6.8	4.5	7.1	5.5	4.4	5.9	5.9	4.8	9.3	12.7	11.8	15.1	4.9	7.7	7.5	6.9	5.4	8.0	7.3	9.2	8.6	7.1	5.3	6.5	6.4	6.6	13.9	8.3	6.0	8.8	2.5	7.4	5.6	10.8	2.3	0.2	0.7	0.5	1.0	2.2	0.4	2.9	2.3	5.8	8.9	1.6	2.2	4.0	2.8	2.8	4.6	3.4	2.7	3.1	5.7	3.7	2.0	5.4	4.1	5.1	1.8	4.5	5.7	2.2	5.3	4.7	2.7	1.7	7.3	3.7	1.3	3.8	3.7	1.9	2.2	1.5	7.0	7.0	5.8	2.7	5.0	7.6	3.6	4.3	5.2	5.1	6.8	7.1	1.9	3.1	1.9	5.9	4.5	3.8	2.3	3.0	4.9	4.3	4.2	3.3	6.0	3.5	6.0	3.1	5.5	3.9	2.7	2.5	1.8	4.3	0.0	0.5	0.2	1.1	0.5	2.2	2.0	1.0	0.0	0.2	2.3	0.9	0.7	0.7	1.0	0.2	0.2	0.6	0.4	7.4	8.4	19.8	8.0	6.8	4.5	5.9	4.8	7.7	8.3	0.0	5.5	0.9	1.4	1.6	5.7	1.4	0.0	1.4	0.0	1.8	7.9	0.7	0.0	1.3	5.6	1.6	1.7	0.0	1.5	0.2	0.5	1.7	5.7	1.0	1.1	3.2	0.0	1.8	0.6	6.9	1.7	0.7	0.0	3.6	1.4	2.2	1.0	0.0	2.8	1.6	6.5	0.0	1.0	8.6	2.4	0.9	0.6	0.7	1.2	1.8
MFSD14C	"HIATL2, MGC12945"	ENSG00000196312	"Major facilitator superfamily domain containing 14C"	Q5VZR4	9	96887373-97013708	"Predicted membrane proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 25.4;Club cells: 38.7;Collecting duct cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 21.3"															NA	NA						"unprognostic (3.81e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.12e-1)"	6.6	6.0	9.1	8.2	14.1	10.9	10.7	8.1	11.2	9.4	5.0	6.3	4.9	4.8	7.6	10.5	9.3	5.5	7.7	7.3	7.8	5.0	5.2	7.4	8.3	7.3	9.5	6.6	13.0	8.8	4.6	6.0	5.3	6.0	9.9	4.0	7.1	7.9	8.4	8.3	13.2	4.8	10.8	5.9	6.5	8.0	11.3	6.7	4.5	8.1	2.8	6.4	7.3	11.7	2.5	2.9	9.3	2.4	0.7	1.6	0.4	5.3	1.2	2.3	1.3	1.5	8.3	3.3	2.8	0.9	3.4	3.2	3.5	1.9	1.4	0.8	3.7	9.1	4.9	21.3	2.4	4.2	10.8	10.5	9.0	2.5	2.8	0.1	2.0	4.6	3.0	2.9	2.2	1.0	3.2	2.8	4.2	3.2	2.2	7.0	1.0	6.8	1.8	2.2	1.9	6.5	2.2	2.1	0.6	6.6	3.2	11.0	1.1	0.6	1.2	1.8	2.3	1.3	1.9	2.3	5.0	1.6	1.3	1.8	1.2	0.5	4.9	8.4	0.8	2.1	9.3	2.4	2.0	1.5	2.2	0.5	2.5	0.7	0.5	0.8	2.1	1.6	1.4	4.9	0.7	1.4	2.9	0.5	0.4	9.1	14.1	8.1	10.6	7.8	5.0	9.5	6.6	6.0	6.7	20.8	20.5	0.0	4.9	0.0	4.9	0.0	5.1	25.4	38.7	26.2	5.9	1.1	8.3	11.9	5.2	2.0	0.0	0.0	10.8	1.0	0.0	3.6	11.6	0.4	1.5	4.8	0.0	0.0	2.8	1.3	1.4	5.3	0.0	12.6	0.4	2.8	9.6	0.0	1.8	4.5	7.6	0.0	0.0	3.9	5.8	0.0	0.5	0.0	0.4	6.8
NUTM2G	FAM22G	ENSG00000188152	"NUT family member 2G"	Q5VZR2	9	96928310-96940253	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"testis: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.6;SiHa: 4.4"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA064635: "	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.52e-2)"	0.1	0.4	0.1	0.4	0.2	1.9	0.2	0.5	0.2	0.2	0.2			0.2	0.5	0.0	0.7	0.3	0.8	0.2	0.2	0.2	0.4	0.2	0.5	1.1	0.2		0.8	0.6	0.0	0.3	0.4		0.5	0.0		1.4	0.0	2.6	3.1	0.4	0.0	0.4	1.2	0.6	6.2			0.7		0.0	0.4	0.6	1.6	1.2	1.5	0.6	0.0	0.7	0.0	1.6	1.5	1.3	2.2	0.0	0.0	1.6	0.7	0.0	0.0	0.0	4.6	0.6	1.6	0.3	0.0	1.4	2.1	0.0	0.0	0.0	1.1	1.9	1.5	3.7	2.1	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.4	1.2	0.0	2.6	0.9	1.8	2.4	1.6	1.1	1.2	1.6	0.2	0.0	1.7	2.0	0.5	4.4	0.5	0.2	0.7	0.4	0.0	1.0	2.5	1.0	0.8	0.9	0.6	0.1	0.9	0.3	0.7	1.1	0.0	0.6	1.5	0.7	0.6	0.0	0.3	0.3	0.5	0.3	1.6	0.3	0.5	0.6	0.0	0.6	1.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Group enriched"	"Detected in many"	9	"BEWO: 92.0;SuSa: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	5.9	1.8	2.0	5.3	0.1	0.0	92.0	0.0	0.0	1.3	1.0	12.1	5.9	0.0	0.5	0.0	8.8	11.4	9.8	7.2	1.9	0.0	1.3	0.2	0.6	1.8	0.0	0.0	0.8	0.0	2.4	0.3	0.3	0.1	0.4	1.7	0.2	0.0	2.3	2.2	0.1	0.0	12.2	12.0	1.7	0.0	4.4	0.1	1.8	0.7	0.5	0.9	6.0	2.1	2.1	118.9	3.8	0.7	0.0	0.3	6.0	0.0	0.6	1.2	3.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0	0.0	0.6	1.5	13.2	27.0	4.4	0.8	0.0	0.0	3.4	1.8	9.8	114.1	1.7	1.2	1.5	1.5	1.2	0.0	0.7	136.0	2.6	7.1	0.0	0.0	11.8	0.0	1.7	0.6	0.0	9.6	3.7	1.6	0.0	0.0	0.9	4.5	0.6	1.7	1.1	11.1	26.0	6.5	0.8	34.6	32.6	10.5	56.3	0.0	3.7	6.4
CCDC180	"BDAG1, C9orf174, DKFZp434I2420, KIAA1529"	ENSG00000197816	"Coiled-coil domain containing 180"	Q9P1Z9	9	97307304-97378524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 54.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 104.4;Early spermatids: 106.3;Late spermatids: 128.7;Spermatocytes: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;memory B-cell: 1.5"	"Group enriched"	"Detected in many"	14	"B-cells: 1.5;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 6.6;U-266/70: 9.6;U-266/84: 6.8"	"Low region specificity"	"Detected in some"													NA	NA						"unprognostic (9.92e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.50e-3)"	0.5	0.8	1.2	0.3	4.1	0.3	1.1	8.4	2.2	1.2	0.9	4.8	0.7	0.0	1.8	5.7	0.5	8.4	0.6	0.7	1.5	1.5	1.0	0.5	3.1	0.7	1.4	0.3	2.7	0.9	1.4	5.4	0.9	8.1	1.1	0.6	0.5	0.7	0.9	0.8	0.3	0.7	1.2	1.6	0.9	0.6	54.4	1.2	0.9	4.2	0.3	0.5	0.7	1.0	1.5	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.9	1.5	0.9	1.1	3.4	0.0	0.6	1.1	1.1	0.9	1.5	0.9	0.0	1.8	0.0	0.9	0.0	1.1	0.0	0.3	6.6	0.6	2.3	1.8	0.8	0.3	2.8	3.7	1.9	1.3	0.0	0.5	4.0	0.0	2.9	1.5	1.3	0.0	0.2	0.6	3.0	1.1	0.0	0.2	0.0	0.3	0.4	0.8	1.1	1.5	1.3	0.3	0.0	1.0	0.5	1.0	0.8	0.0	1.1	0.5	2.9	1.6	9.6	6.8	0.0	0.2	0.0	2.8	0.0	0.0	0.0	1.1	0.0	0.6	1.5	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.2	4.1	8.4	2.2	1.5	1.5	1.4	0.3	8.1	1.2	0.0	10.9	0.0	0.5	0.3	12.2	0.6	2.5	104.4	19.4	0.0	19.6	0.1	1.7	0.3	106.3	1.4	0.4	0.0	1.2	0.0	0.8	0.4	9.2	0.0	0.4	12.7	1.2	3.7	0.6	128.7	1.7	1.9	1.7	4.6	0.8	4.4	0.3	0.0	2.8	11.2	27.5	0.0	0.5	49.3	5.1	0.1	0.3	1.5	1.1	0.3
TDRD7	PCTAIRE2BP	ENSG00000196116	"Tudor domain containing 7"	Q8NHU6	9	97411950-97496125	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	RNA-binding	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 33.9;Rod photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.9;HDLM-2: 25.1;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020800, HPA022250, HPA024529"	Enhanced		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"CAB020800: , HPA022250: , HPA024529: AB_1857869"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (2.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"prognostic favorable (4.76e-5)"	"unprognostic (4.03e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.67e-1)"	9.5	7.1	10.6	9.1	11.5	8.9	7.7	7.1	10.2	8.8	12.8	8.9	3.7	14.0	9.8	6.0	10.5	8.2	9.2	5.7	8.6	6.6	6.4	7.3	9.8	7.0	10.2	8.8	8.3	9.7	12.5	9.3	7.9	11.6	7.1	12.7	19.0	8.8	7.0	5.1	6.1	16.5	9.6	12.6	8.8	7.6	31.1	9.8	9.3	7.3	4.7	7.3	12.1	8.6	4.3	4.6	9.8	6.1	1.6	2.9	1.8	7.7	5.4	0.0	1.8	4.2	5.5	4.6	4.9	12.4	17.0	19.1	6.9	6.6	0.5	2.4	6.9	26.9	5.9	4.5	2.5	4.6	25.1	3.9	3.5	2.7	5.0	3.8	7.9	8.5	1.8	5.0	5.6	0.5	5.1	7.3	3.8	1.9	0.4	4.4	4.6	3.9	3.9	0.8	9.1	2.9	1.7	2.8	0.1	4.1	5.2	0.8	2.3	6.8	3.1	18.6	3.0	1.8	24.8	7.4	2.1	2.1	5.4	3.7	2.6	3.0	0.4	5.0	4.3	5.5	2.4	3.1	9.8	1.7	6.1	2.4	4.3	2.4	1.8	4.6	3.4	1.8	2.9	5.7	1.6	5.8	0.9	1.6	1.8	10.6	11.5	7.1	10.2	8.6	6.6	10.2	8.8	11.6	9.8	0.0	4.0	4.5	2.4	1.4	6.5	5.2	2.5	16.0	4.5	3.5	17.7	1.3	5.0	4.0	33.9	4.3	8.3	0.0	4.3	1.9	1.5	2.0	0.0	2.4	4.3	4.8	5.8	3.1	3.7	19.8	4.0	4.6	1.7	11.8	7.0	7.8	5.2	7.6	3.5	2.9	41.7	6.5	1.4	19.1	13.6	1.9	0.6	2.6	6.3	3.2
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601748	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.7;skeletal muscle: 112.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 51.5;Erythroid cells: 140.2;Horizontal cells: 96.9"	"Cancer enhanced"	"Detected in many"		"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 12.4;HDLM-2: 48.0;K-562: 16.3;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051202	Enhanced					NA	NA		900000			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	7.9	35.6	10.9	3.4	11.9	11.1	5.9	18.1	17.2	17.3	9.8	6.0	8.9	3.3	27.6	7.1	10.8	16.0	5.3	71.7	7.1	6.1	3.6	21.9	5.2	2.3	4.6	9.3	24.8	7.6	9.5	13.6	2.4	12.8	10.7	4.5	10.4	3.3	6.1	112.7	2.9	3.8	22.6	15.9	1.9	6.0	3.2	5.3	0.0	8.7	36.9	2.3	15.4	19.7	4.6	1.2	2.0	0.9	1.7	5.2	3.1	1.7	0.4	0.0	0.2	2.0	0.2	0.6	0.3	2.9	0.0	0.0	0.4	0.5	0.0	12.4	0.0	2.8	0.1	0.5	0.0	0.0	48.0	1.8	2.3	3.0	0.2	0.0	0.0	4.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	16.3	0.0	0.0	0.7	0.0	0.3	0.6	0.5	0.2	0.0	1.7	0.0	0.0	0.3	0.2	51.4	1.5	0.0	0.8	0.7	0.6	2.5	0.2	0.0	1.9	1.4	0.3	6.2	1.3	0.0	2.3	1.6	2.7	2.0	0.7	1.2	3.3	0.7	3.1	3.1	2.6	1.9	1.2	4.6	1.8	2.1	0.2	1.7	0.9	0.4	5.2	3.1	10.9	11.9	18.1	17.2	7.1	6.1	4.6	9.3	12.8	5.3	6.0	6.2	2.7	0.9	2.1	1.2	51.5	2.5	0.0	0.0	0.0	5.9	0.1	0.0	0.2	0.6	9.8	0.0	140.2	5.8	0.4	2.7	1.7	10.4	16.4	0.8	96.9	2.9	11.1	11.6	0.6	9.5	3.1	16.9	0.0	0.2	0.5	7.5	0.0	6.3	0.0	1.3	19.4	14.6	2.4	6.0	0.9	0.1	4.5	0.0	0.9
TSTD2	"C9orf97, PP4189"	ENSG00000136925	"Thiosulfate sulfurtransferase like domain containing 2"	Q5T7W7	9	97600080-97633575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022537, HPA024241, HPA064304"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: AB_2685238"	"unprognostic (7.24e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (2.21e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	11.9	11.8	11.9	7.4	11.6	3.3	12.1	18.9	15.1	14.2	12.4	14.9	10.6	6.9	14.8	10.6	10.0	12.7	11.0	14.9	9.8	8.4	12.8	14.4	11.0	8.9	12.4	9.5	17.2	15.7	19.8	17.0	13.9	12.5	12.2	11.3	11.1	10.2	13.1	21.1	9.2	9.7	14.4	13.8	8.7	11.2	11.6	12.4	10.6	16.2	12.1	12.0	14.4	9.7	6.2	6.5	5.2	7.0	11.2	10.4	5.3	10.9	8.6	13.8	8.9	9.3	7.8	12.1	7.2	8.8	9.9	10.4	8.5	3.6	11.4	3.5	9.1	11.9	15.1	12.3	7.0	11.2	7.6	5.5	7.8	9.9	6.4	10.9	11.5	10.3	10.3	12.0	9.6	17.0	9.0	7.5	11.9	13.9	8.6	8.5	5.3	13.6	5.7	11.3	14.0	8.4	11.3	20.4	5.9	6.8	5.0	10.0	7.8	9.2	6.4	8.4	11.1	4.9	6.5	7.9	8.6	8.3	10.1	8.1	12.3	16.1	5.9	7.2	5.8	6.2	4.3	3.9	5.2	6.4	7.0	10.4	5.8	6.4	7.7	6.5	6.2	7.2	6.9	1.6	11.2	5.2	2.9	3.6	5.3	11.9	11.6	18.9	15.1	9.8	8.4	12.4	9.5	12.5	12.4	17.9	11.7	7.8	3.6	1.4	25.8	15.2	7.6	21.4	23.9	1.8	23.6	5.9	14.9	7.4	15.6	6.7	4.9	23.3	6.3	3.6	5.4	4.5	19.7	11.6	4.6	20.6	18.4	6.2	5.7	5.9	7.5	3.5	5.0	4.6	5.1	12.0	9.0	4.3	9.9	6.4	20.3	19.4	5.4	19.0	25.6	3.6	9.2	5.3	4.9	3.3
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633626-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	18.5	17.2	19.8	27.4	26.2	37.2	23.6	25.5	27.1	17.0	21.9	18.7	19.8	18.0	19.2	15.3	21.7	15.9	16.3	20.4	23.7	17.8	17.9	22.7	17.3	25.9	16.6	23.8	22.8	22.0	17.1	26.9	20.3	22.6	18.4	25.7	18.1	18.3	17.7	25.5	22.4	19.3	16.3	18.7	20.5	19.4	26.8	17.8	36.1	22.5	15.1	25.0	18.5	19.4	7.6	13.7	12.9	14.6	14.9	10.0	7.7	24.3	16.8	18.9	17.6	13.3	13.4	18.4	18.7	10.9	17.1	16.1	22.4	12.8	21.0	8.1	16.8	16.3	27.6	30.0	21.3	24.6	14.0	9.7	19.4	25.3	14.0	13.0	25.8	20.2	10.1	10.7	19.9	15.4	12.3	17.7	16.1	28.6	11.8	28.6	17.6	18.7	13.7	20.4	34.8	18.2	18.0	43.8	8.4	13.9	18.2	24.1	16.2	18.7	16.4	9.7	16.8	10.2	15.8	14.8	13.4	12.5	26.6	19.2	11.5	14.0	10.9	12.3	20.1	17.6	12.9	11.4	11.0	8.7	14.6	9.9	6.5	9.9	9.1	13.7	7.6	8.7	10.0	3.5	14.9	14.3	5.9	8.6	7.7	19.8	26.2	25.5	27.1	23.7	17.8	16.6	23.8	22.6	17.8	6.0	12.0	5.8	5.1	12.0	20.2	21.7	2.5	14.7	14.8	8.7	19.6	11.5	3.3	7.8	12.7	8.7	10.7	0.0	6.0	12.8	9.3	6.9	8.1	14.8	10.5	20.6	8.7	8.0	13.7	6.8	6.1	9.5	5.0	14.4	11.4	10.1	8.6	8.6	7.1	4.5	23.7	6.5	9.2	16.8	15.2	6.5	12.0	8.5	8.9	7.4
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697357	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA056856"	Supported		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"CAB000155: , HPA056856: AB_2683258"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.55e-3)"	"prognostic favorable (4.28e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.17e-1)"	18.7	17.5	20.1	17.1	21.0	10.6	17.4	26.8	20.8	20.3	25.2	17.2	11.7	20.6	25.5	15.4	18.9	15.0	19.5	12.9	17.2	15.3	24.9	24.2	14.8	16.7	18.6	17.5	17.2	14.5	23.0	23.1	12.8	17.7	20.3	13.6	16.4	16.1	21.7	43.3	16.3	22.2	27.5	17.1	16.2	25.1	6.4	15.8	15.7	31.5	11.9	21.6	22.0	16.4	22.2	23.4	12.7	15.8	19.7	21.6	11.3	23.0	5.4	8.1	10.0	9.9	9.7	5.6	6.3	10.0	11.5	7.8	14.1	19.4	13.0	6.1	6.9	7.7	11.6	6.4	7.6	9.8	8.9	12.9	10.2	11.8	7.8	10.8	12.1	12.4	8.4	8.2	5.3	5.5	7.8	12.8	10.8	14.1	10.2	6.3	7.2	15.7	14.6	5.5	22.0	9.0	16.0	17.3	11.0	18.3	9.0	11.4	11.5	9.0	6.9	8.1	6.4	10.1	7.3	8.0	4.0	10.1	15.9	13.6	18.1	14.5	8.2	10.0	8.7	7.9	6.0	13.3	12.7	16.2	13.1	18.7	19.5	17.7	15.6	13.5	22.2	21.6	18.6	1.5	19.7	15.8	23.4	18.3	11.3	20.1	21.0	26.8	20.8	17.2	15.3	18.6	17.5	17.7	15.8	23.8	31.5	27.5	17.4	15.3	99.5	29.1	50.9	34.8	40.9	21.0	76.6	27.4	102.8	31.2	1.2	29.2	16.9	0.0	33.5	8.3	24.2	16.3	29.0	40.6	30.4	79.4	21.5	17.8	17.5	2.6	40.9	29.8	13.5	49.5	21.3	71.6	24.5	21.0	44.6	38.3	99.8	32.3	31.9	12.8	16.4	16.4	11.7	25.3	26.3	20.2
FOXE1	"FKHL15, FOXE2, HFKH4, TITF2, TTF-2"	ENSG00000178919	"Forkhead box E1"	O00358	9	97853254-97856715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"thyroid gland: 115.1"	"Cell type enhanced"	"Detected in some"	19	"Cardiomyocytes: 1.8;Spermatogonia: 3.7;Urothelial cells: 2.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 84.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.9;BJ hTERT+: 6.8;HaCaT: 6.3;HeLa: 16.2;RPTEC TERT1: 16.1;SiHa: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (8.78e-3)"	"unprognostic (9.18e-3)"		"unprognostic (3.79e-5)"	"unprognostic (2.19e-4)"	"unprognostic (8.29e-3)"		"unprognostic (1.04e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.05e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	115.1	4.7	20.4	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.2	0.0	10.9	3.7	0.0	0.0	0.0	0.0	0.0	1.1	6.8	0.8	1.2	0.0	0.9	0.0	0.5	0.0	0.0	6.3	0.7	0.1	3.4	0.0	0.6	0.0	16.2	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	16.1	1.0	0.0	0.0	11.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.7	0.3	0.0	0.0	0.0	2.0
TRMO	"C9orf156, HSPC219"	ENSG00000136932	"TRNA methyltransferase O"	Q9BU70	9	97904489-97922570	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 27.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021281, HPA052197"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021281: AB_2670649, HPA052197: AB_2681758"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-2)"	"prognostic favorable (4.81e-10)"	"unprognostic (1.97e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.39e-2)"	12.2	15.9	13.6	22.5	14.2	20.4	19.3	15.9	14.9	13.5	10.0	19.2	14.9	9.4	15.1	17.3	12.9	15.0	10.6	9.1	13.0	12.3	13.9	17.6	17.9	23.0	14.2	16.3	13.9	13.7	15.7	26.7	10.4	13.3	14.0	11.6	13.4	19.7	11.7	14.1	15.0	14.8	10.1	15.0	20.8	12.8	18.2	14.2	22.8	26.1	10.3	19.1	11.9	10.7	15.8	13.4	28.8	13.7	11.9	25.8	12.0	14.9	9.6	5.2	6.3	6.5	5.4	9.0	7.7	8.8	12.2	9.2	13.3	10.9	9.5	5.3	7.4	13.8	14.2	8.4	6.1	9.6	11.2	6.9	7.6	11.6	11.8	13.6	14.7	12.8	9.5	13.6	6.6	5.7	7.4	5.4	7.6	12.2	12.1	8.4	21.7	6.2	10.2	7.2	16.3	10.8	7.6	11.5	6.9	11.4	12.2	9.4	8.2	5.8	12.2	12.4	4.6	5.3	8.2	8.1	6.8	6.8	14.1	11.5	13.4	9.5	4.8	7.1	7.7	5.9	20.1	12.8	28.8	12.9	13.7	15.9	11.9	19.8	15.5	13.4	15.8	25.8	17.9	20.9	11.9	9.1	7.8	20.2	12.0	13.6	14.2	15.9	14.9	13.0	12.3	14.2	16.3	13.3	14.2	11.9	4.0	7.8	13.4	0.0	8.7	0.0	7.6	10.7	12.5	5.2	0.0	7.7	6.6	7.8	27.5	3.7	2.6	0.0	8.5	6.1	4.1	4.9	0.0	6.4	9.5	6.4	2.4	3.1	8.9	10.5	4.6	2.8	0.0	8.2	7.0	11.6	8.4	7.0	6.7	7.0	4.2	6.5	0.0	14.8	14.5	0.0	15.3	10.2	4.9	6.4
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 71.1;placenta: 20.2;testis: 32.5"	"Group enriched"	"Detected in some"	149	"Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.2"	"Group enriched"	"Detected in many"	27	"granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2"	"Cell line enriched"	"Detected in some"	4	"K-562: 77.0"					"Region enriched"	"Detected in all"	5	"cerebellum: 55.9"	"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.3	0.2	0.2	0.4	0.2	71.1	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.3	1.0	0.2	0.2	0.3	0.9	5.4	0.5	0.2	0.0	0.6	0.2	0.0	0.3	20.2	1.1	0.2	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.3	2.8	0.2	32.5	0.0	17.1	0.3	0.2	0.5	1.4	4.8	0.0	0.1	2.1	0.1	2.9	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	77.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.1	0.8	0.0	2.3	1.1	0.1	0.0	8.2	3.3	1.0	2.9	0.0	0.0	1.2	4.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1388.7	0.0	0.0	724.2	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.3	1114.5	5.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	6.5	0.0	7.2	3.3	0.0	0.5	0.0	0.0	0.0
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	71.5	38.7	43.2	36.0	24.3	43.0	39.4	37.2	33.0	40.0	33.7	48.5	35.2	87.8	22.3	24.9	30.5	47.4	58.1	42.0	45.9	56.9	32.8	76.0	33.2	52.3	31.3	130.1	44.3	32.5	30.7	32.1	66.3	32.6	34.7	78.8	146.1	62.2	30.8	95.5	98.2	115.7	16.8	70.3	38.5	58.7	67.3	41.7	26.1	30.0	34.9	30.5	43.6	42.7	38.1	22.2	24.1	48.7	42.0	26.1	42.3	32.8	39.0	56.5	63.8	53.0	24.2	52.3	48.6	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6	80.4	91.7	174.3	178.4	160.5	57.6	74.9	101.9	53.5	93.3	71.5	23.6	273.1	82.9	105.6	102.1	109.0	128.4	327.1	148.0	437.2	99.8	129.7	116.6	84.4	250.6	112.8	144.0	112.3	244.5	70.6	135.4	174.1	121.4	164.1	222.6	53.5	126.7	126.7	136.5	75.6	33.5	148.8	133.5	138.6	318.8	134.8	278.6	173.4	278.8	183.9
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056739-98083075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		200000	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	17.2	10.1	8.8	20.2	11.4	22.2	16.4	7.0	11.7	20.2	47.6	6.4	17.0	19.4	11.0	15.1	18.6	10.4	25.0	20.9	14.4	12.4	15.0	49.6	17.1	20.1	11.5	10.6	14.1	59.2	6.1	16.3	15.8	12.1	37.2	49.6	9.4	80.0	18.3	11.9	10.3	18.9	11.0	9.0	22.2	28.3	11.5	9.8	10.6	19.7	15.2	25.0	15.7	14.8	12.3	41.9	16.4	49.8	7.4	12.1	18.3	73.9	21.9	6.5	18.7	13.1	14.2	14.1	23.7	18.6	19.4	15.9	26.1	10.6	22.8	11.5	26.0	20.5	26.3	12.0	20.3	16.2	18.3	18.0	13.5	24.5	52.1	36.3	15.2	11.1	11.9	13.9	20.6	23.6	22.6	20.6	11.4	24.5	23.8	14.1	50.8	10.2	22.0	11.2	53.6	28.4	19.8	17.8	23.2	15.4	22.7	13.2	6.9	15.2	82.5	20.1	7.5	27.3	16.5	53.6	15.1	14.7	38.7	24.2	22.2	18.4	8.7	17.9	18.5	11.7	5.3	42.1	6.0	8.0	49.8	12.1	12.3	10.5	8.3	41.9	10.1	11.5	7.8	16.4	7.4	43.0	38.4	11.9	18.3	8.8	11.4	7.0	11.7	14.4	12.4	11.5	10.6	12.1	9.8	26.8	52.4	47.0	107.6	62.3	8.1	21.5	53.5	151.3	77.3	21.0	17.7	73.6	59.7	41.8	35.3	57.3	177.1	0.0	89.0	121.2	62.1	166.7	43.8	28.6	139.8	9.5	62.4	25.2	52.6	53.6	30.0	94.4	123.2	58.7	195.9	13.3	63.2	189.8	24.8	47.7	7.0	12.9	96.2	7.2	16.9	54.0	126.1	27.7	245.2	195.9
TRIM14	KIAA0129	ENSG00000106785	"Tripartite motif containing 14"	Q14142	9	98069275-98119212	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 70.7;Kupffer cells: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053217	Uncertain					NA	NA					"HPA053217: AB_2682082"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.55e-3)"	"unprognostic (4.57e-2)"	9.2	3.3	6.4	20.2	7.6	6.4	6.2	1.4	5.4	5.2	15.4	4.2	1.1	18.1	3.8	4.9	16.8	3.8	10.8	4.1	5.9	4.4	13.4	19.8	14.3	24.4	5.2	3.5	4.5	3.9	15.0	5.0	5.7	5.6	8.2	10.7	4.7	7.7	3.5	1.0	6.0	31.8	5.3	5.8	30.4	7.0	6.2	5.7	35.2	3.2	3.7	19.5	8.9	7.4	4.4	8.0	2.4	27.7	6.2	11.5	7.5	10.0	5.2	0.2	4.7	0.0	1.7	3.5	5.9	11.6	33.2	28.7	10.0	6.1	13.4	4.9	6.5	19.8	11.6	10.2	6.8	10.2	17.1	8.3	3.9	8.3	9.8	7.3	21.0	4.4	1.0	3.3	4.8	6.3	4.4	4.2	15.2	15.5	6.4	3.0	13.0	16.5	6.7	5.9	22.7	16.5	10.6	0.6	6.8	2.6	6.3	1.6	1.4	8.5	17.9	5.7	1.2	4.7	12.2	2.9	1.4	3.5	0.5	8.2	2.8	3.2	4.5	3.8	16.6	4.6	0.4	7.4	1.0	8.1	14.5	8.9	4.4	9.3	8.4	7.9	3.3	7.4	6.2	2.4	6.2	27.7	8.0	11.5	7.5	6.4	7.6	1.4	5.4	5.9	4.4	5.2	3.5	5.6	5.7	3.0	9.1	13.8	10.9	2.5	9.8	0.9	12.7	14.7	14.8	5.2	70.7	4.1	3.3	5.1	7.4	2.5	34.1	0.0	12.0	12.8	1.9	14.9	1.1	20.2	14.6	3.2	12.1	7.4	61.7	6.7	0.3	21.7	1.7	3.6	15.9	2.0	10.8	14.0	1.4	17.8	4.4	0.0	1.2	16.3	2.7	2.9	2.7	20.0	15.3	15.8
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192640	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 36.1"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 38.2;Enterocytes: 69.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;OE19: 26.3;SK-BR-3: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.6	0.8	1.2	6.9	1.8	8.1	2.9	9.3	2.4	3.9	22.0	0.7	1.3	20.8	2.0	2.2	13.6	2.7	27.7	1.5	1.3	3.0	1.4	2.9	7.5	1.6	2.6	1.3	1.5	1.4	2.8	5.2	3.5	3.3	9.0	7.9	1.2	5.4	1.9	0.9	6.3	36.1	1.9	0.6	3.8	6.6	11.4	0.6	5.6	1.1	3.6	6.6	7.7	6.2	0.6	0.7	10.9	7.0	1.5	11.1	1.4	3.9	1.4	0.3	0.9	0.6	0.6	32.3	0.3	0.3	1.0	1.6	8.9	0.6	0.0	4.5	0.6	1.5	11.0	3.7	6.0	0.6	3.2	0.8	0.1	5.6	7.9	1.3	3.6	0.3	0.2	7.4	0.5	9.1	0.3	0.3	4.7	3.1	1.8	0.1	2.9	0.7	3.6	4.1	26.3	1.0	2.8	0.0	0.1	0.6	11.1	0.8	1.1	2.0	21.8	0.7	7.6	2.5	6.0	0.3	0.1	4.8	0.1	1.1	0.3	1.8	0.3	0.2	1.2	1.3	7.7	1.5	10.9	2.4	3.0	5.5	0.6	4.1	3.8	0.5	0.6	2.7	3.5	1.1	1.5	7.0	0.7	11.1	1.4	1.2	1.8	9.3	2.4	1.3	3.0	2.6	1.3	3.3	0.6	11.9	23.8	0.9	17.5	6.0	1.5	1.2	38.2	20.1	35.2	0.0	3.9	8.5	0.0	3.0	2.2	1.9	69.1	0.0	4.5	31.7	3.1	14.5	0.0	3.2	5.8	1.6	6.9	1.3	11.0	3.0	0.0	4.9	0.0	0.0	14.0	0.5	13.8	17.3	0.4	1.4	1.5	0.0	1.9	0.5	3.2	8.7	13.3	8.7	25.7	26.0
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98198999-98255721	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 53.6;Hofbauer cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 27.5;HaCaT: 36.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	13.1	4.1	6.6	7.0	15.6	14.5	7.6	7.7	7.6	7.8	12.0	17.8	6.0	15.5	4.4	4.3	25.3	4.4	5.3	2.2	9.5	7.4	4.6	12.6	27.4	4.5	15.2	5.3	4.3	3.0	4.5	3.1	11.9	9.0	8.1	5.9	6.2	10.1	8.8	3.3	18.8	15.2	5.7	14.3	6.7	5.1	3.1	12.2	4.7	7.1	14.7	16.8	14.7	11.6	0.9	7.0	8.1	18.4	0.7	3.9	6.4	27.5	4.0	0.2	0.9	3.1	6.1	9.1	12.2	6.8	8.9	7.4	2.6	12.1	0.4	9.3	7.1	1.9	36.4	0.2	13.6	3.1	0.9	0.5	0.2	14.1	2.0	14.6	0.6	1.1	8.4	22.5	8.9	22.3	15.8	3.1	0.7	0.8	0.3	7.0	3.5	0.1	1.6	0.6	2.7	2.3	0.4	1.8	0.0	13.6	17.2	0.3	0.5	4.1	9.1	1.2	0.6	3.0	0.9	19.0	10.9	3.3	1.8	4.9	0.6	0.5	0.2	11.1	1.0	1.2	1.1	18.4	5.5	1.9	10.8	1.3	0.9	2.8	1.6	7.0	0.6	1.2	1.4	8.1	0.7	8.0	0.9	3.9	6.4	6.6	15.6	7.7	7.6	9.5	7.4	15.2	5.3	9.0	12.2	53.6	12.2	1.9	11.4	7.3	2.4	0.6	7.6	5.3	20.5	3.5	0.0	18.5	3.3	3.7	1.5	3.1	15.0	0.0	2.8	9.4	2.1	3.8	0.0	4.7	31.3	1.6	7.5	0.6	19.8	1.0	1.7	9.3	3.3	3.6	11.1	2.9	8.7	7.0	0.7	2.5	2.2	0.0	2.0	1.6	2.8	9.5	14.5	1.9	4.2	11.1
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288082-98709197	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 52.7"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 87.5;Early spermatids: 83.9;Late spermatids: 26.5"	"Group enriched"	"Detected in many"	10	"glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 11.1;fHDF/TERT166: 5.5;HUVEC TERT2: 23.0;U-138 MG: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved				NA	NA					"CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993"	"unprognostic (2.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.09e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	0.9	4.4	13.6	1.0	14.6	0.8	0.9	19.7	52.7	0.8	0.9	2.1	0.0	0.8	1.1	1.1	0.9	0.8	0.9	0.9	14.6	11.1	0.9	0.9	1.0	0.9	7.6	17.6	0.8	0.8	0.9	0.3	0.9	10.3	0.9	0.8	0.6	0.9	0.9	3.2	0.9	0.8	1.0	2.2	0.9	1.0	1.3	0.2	0.0	2.3	0.0	1.1	1.5	0.1	0.7	0.7	1.7	1.1	1.7	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	1.0	11.1	2.2	2.4	4.3	0.0	0.1	0.0	0.7	5.5	0.5	0.0	0.1	0.2	0.8	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.8	0.2	0.0	23.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.6	3.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	1.0	9.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	1.7	0.4	0.8	0.6	0.7	1.0	0.7	0.7	0.7	0.4	0.6	0.8	0.9	1.2	1.7	1.1	0.7	1.0	0.4	13.6	14.6	19.7	35.0	14.6	11.1	7.6	17.6	10.3	0.2	0.0	0.0	0.0	0.0	0.1	87.5	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	83.9	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.5	0.3	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.0	0.5	0.6	0.7	0.1	0.3	0.0	0.0	0.0
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favorable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.0	3.7	5.8	4.3	9.9	1.8	4.8	31.2	9.5	7.3	6.5	9.4	2.6	5.9	6.0	7.4	7.5	7.8	7.7	2.9	6.9	6.1	7.7	1.8	7.2	3.4	10.1	4.4	9.6	18.1	10.0	2.8	2.8	11.4	3.6	7.3	4.2	3.1	3.5	3.3	4.4	5.4	8.9	6.1	2.5	7.7	6.1	9.2	1.8	13.4	2.4	4.5	5.4	6.4	0.9	0.0	0.0	0.1	0.0	2.1	0.2	5.2	7.9	7.3	12.8	6.1	5.0	4.9	3.8	6.6	4.3	5.2	4.3	3.8	9.7	2.9	5.4	6.2	15.6	5.3	6.4	2.3	13.5	5.5	2.3	4.7	1.8	6.0	1.2	1.6	6.1	8.1	5.9	6.0	5.3	4.9	9.0	16.3	2.3	3.3	8.7	0.5	2.5	11.5	23.5	8.6	6.5	18.1	0.7	7.7	3.3	4.7	5.4	1.6	9.4	4.3	6.2	0.0	2.7	4.9	4.5	4.9	12.2	3.7	4.5	7.6	1.6	6.3	4.4	6.4	0.0	0.1	0.0	1.3	0.0	0.7	0.9	0.7	2.1	0.0	0.6	1.8	0.9	0.0	0.0	0.0	0.0	1.1	0.2	5.8	9.9	31.2	9.5	6.9	6.1	10.1	4.4	11.4	9.2	6.0	8.0	2.4	0.7	1.5	6.1	4.4	12.7	5.3	4.5	12.2	7.9	2.3	3.3	3.6	2.9	3.1	4.2	0.0	7.7	2.5	3.4	3.4	1.1	1.5	1.6	0.0	4.7	1.8	1.5	4.9	2.6	1.1	0.0	1.0	6.8	1.4	7.0	3.5	4.2	5.0	0.6	0.0	2.3	4.2	4.9	1.0	0.9	2.1	7.6	2.4
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807699-98850081	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.7"	"Cell type enhanced"	"Detected in many"	13	"Mucus-secreting cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 17.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 41.8;U-2197: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048292	Enhanced				"Intracellular and membrane"	NA	NA		15000			"HPA048292: AB_2680343"	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	7.5	1.7	1.0	9.5	2.3	0.6	3.7	17.7	1.6	4.0	29.6	1.7	7.4	14.6	1.8	34.7	15.2	3.2	20.5	1.1	1.4	1.6	2.9	0.4	13.8	1.1	3.3	1.0	1.0	9.2	4.0	3.1	1.0	2.7	4.2	24.8	4.0	15.2	6.6	1.1	2.6	22.4	15.4	1.3	1.5	23.5	3.4	1.1	2.8	9.3	8.1	23.9	9.0	3.4	0.8	0.4	1.6	0.0	2.2	2.5	0.4	1.7	1.3	1.1	4.5	3.4	2.7	0.0	0.4	0.7	0.7	1.5	0.2	7.2	0.0	1.7	0.3	4.1	12.6	1.0	0.4	0.5	8.4	0.6	0.8	0.0	0.0	0.1	0.5	0.1	1.3	0.3	2.1	0.0	0.9	0.8	6.4	9.6	0.0	0.2	4.5	0.8	1.5	5.6	41.8	1.8	2.1	0.1	0.0	0.8	2.5	4.2	0.4	0.1	10.3	1.0	2.7	1.5	1.4	1.4	0.0	0.1	54.3	0.0	0.7	1.5	0.7	12.7	0.0	0.3	0.0	0.0	1.6	1.4	0.0	2.5	0.1	1.9	0.8	0.2	0.8	2.3	1.5	0.1	2.2	0.0	0.4	0.1	0.4	1.0	2.3	17.7	1.6	1.4	1.6	3.3	1.0	2.7	1.1	3.0	22.6	0.9	1.3	2.2	0.9	0.5	25.5	13.4	14.8	10.4	15.7	0.9	0.0	6.4	1.4	0.7	29.9	0.0	21.7	1.5	5.6	10.5	2.3	0.0	2.1	0.0	19.1	0.0	0.3	1.1	2.0	1.7	0.0	0.0	122.4	0.3	23.8	31.7	7.1	3.0	0.1	0.0	1.2	4.7	12.1	1.1	0.9	3.8	33.7	8.2
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	22	"Fibroblasts: 113.2;Leydig cells: 302.6;Peritubular cells: 454.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.3;BJ hTERT+: 27.8;HDLM-2: 11.8;K-562: 9.0;U-2197: 23.0;U-87 MG: 10.5;WM-115: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.4	1.3	0.0	13.3	27.8	0.7	0.2	0.0	0.0	0.1	0.4	2.8	0.1	0.0	0.0	0.0	0.1	11.8	0.0	0.1	6.7	0.0	0.5	0.2	1.3	3.9	0.0	3.0	0.1	0.0	0.0	0.0	9.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	7.4	0.1	0.0	0.0	0.0	0.0	0.4	2.0	3.5	0.1	0.1	0.3	0.0	0.0	0.3	23.0	0.2	0.1	0.0	0.0	10.5	0.1	15.6	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4	0.0	0.0	0.0	0.1	17.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.1	5.2	71.7	0.0	0.0	0.7	3.0	113.2	0.8	0.0	0.0	7.0	0.0	0.0	0.0	0.3	11.0	302.6	1.0	16.9	1.0	0.0	0.0	0.8	0.0	454.3	0.0	0.0	12.9	16.5	1.7	1.4	14.3	6.4	0.0	0.0	0.1
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 114.1;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	11.1	6.9	10.3	11.5	14.6	20.0	15.4	12.6	11.3	14.4	20.0	11.0	5.5	7.4	18.8	8.0	13.2	10.9	14.9	9.7	7.8	7.5	16.0	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11.0	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13.0	10.2	1.6	2.0	13.1	2.4	4.0	8.3	1.9	3.4	5.2	31.4	9.7	7.3	5.4	4.7	11.7	12.9	11.0	12.3	5.2	2.5	7.6	3.6	9.1	8.7	8.1	10.6	9.1	14.8	19.9	3.3	11.4	5.7	4.6	12.1	7.0	27.9	11.2	9.8	17.1	8.1	6.9	1.9	2.9	15.8	3.2	15.0	5.3	1.0	8.0	6.7	3.2	3.1	2.8	68.5	3.2	2.7	0.8	8.5	9.9	9.1	40.7	12.2	13.5	7.5	9.6	3.6	8.2	7.1	35.0	7.1	3.3	3.3	5.2	17.2	12.1	7.0	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2.0	1.3	3.5	6.7	4.9	4.0	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4	6.0	9.1	9.3	6.5	20.9	7.2	6.3	5.1	1.4	10.3	57.6	0.0	17.0	0.0	14.1	114.1	14.5	3.3	23.3	27.1	5.9	46.2	13.4	29.9	11.5	43.1	0.0	9.2	8.0	20.9	74.1	8.9	36.3	33.7	19.0	6.6	2.9	25.9	3.5	12.7	12.2	1.6	32.3	22.2	8.0	10.5	14.2	16.2	11.5	7.2	8.4
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"		No	No			"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	23.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.1	9.9	21.4	23.4	14.5	26.4	16.5	19.1	5.7	9.1	19.9	15.8	17.1	4.6	10.9	10.5	26.9	15.5	5.3	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	12.9	9.2	7.8	13.5	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7	11.9	22.2	18.6	17.3	20.7	11.4	6.0	20.4	14.7	14.8	22.7	2.0	44.0	18.3	32.0	22.1	17.7	16.9	0.0	30.7	28.2	25.8	31.0	7.0	52.1	25.7	9.5	12.0	24.5	25.6	16.5	24.7	22.6	20.3	93.8	19.7	13.4	30.1	14.0	23.7	31.7	7.0	6.5	18.9	20.2	23.7	20.7	74.6	15.9	16.8	28.9
SEC61B		ENSG00000106803	"Sec61 translocon beta subunit"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"monocytes: 2395.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	26.2	39.8	20.3	27.1	20.7	41.1	37.2	12.6	20.2	36.5	26.2	15.8	47.9	28.5	32.1	52.7	29.3	26.8	26.4	19.8	19.3	17.7	42.0	153.0	31.9	49.3	19.9	14.8	31.6	175.5	13.6	38.5	36.3	17.7	28.9	19.8	21.3	116.6	50.8	16.9	20.5	31.2	21.0	20.1	41.4	29.7	19.9	16.8	43.8	49.3	29.2	35.9	24.5	24.0	36.9	173.3	71.5	48.5	31.0	52.5	47.1	37.7	37.1	42.9	42.5	42.5	54.5	51.9	56.4	59.3	53.5	46.7	53.0	29.9	51.9	43.2	51.5	58.1	46.8	30.0	45.0	25.8	54.6	41.8	27.1	36.1	74.8	92.7	46.5	34.9	48.6	69.6	42.0	37.6	47.7	65.1	42.6	42.4	101.6	50.3	69.6	42.2	68.1	34.3	90.6	87.3	41.0	36.5	66.9	57.8	27.3	44.7	31.7	31.6	73.6	72.2	35.4	28.5	64.4	45.5	38.3	45.7	63.9	46.8	54.8	36.8	33.2	63.9	30.1	25.2	71.5	48.5	44.5	39.1	38.4	52.5	36.9	43.3	39.3	49.4	25.0	27.5	30.1	40.6	31.0	33.2	173.3	38.3	47.1	20.3	20.7	12.6	20.2	19.3	17.7	19.9	14.8	17.7	16.8	95.3	187.1	256.1	245.3	351.6	50.7	48.6	280.2	210.1	184.2	190.1	29.5	281.8	537.2	460.0	124.8	278.2	231.9	23.3	685.9	442.0	377.2	528.8	210.1	851.3	458.0	50.9	289.9	218.5	275.4	31.8	303.8	326.5	470.7	2395.0	308.0	128.3	615.7	260.3	286.0	654.7	66.5	135.8	230.8	200.9	174.6	387.6	463.2	262.1	249.2	374.6
NR4A3	"CHN, CSMF, MINOR, NOR1"	ENSG00000119508	"Nuclear receptor subfamily 4 group A member 3"	Q92570	9	99821855-99866891	"Cancer-related genes, Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 80.6"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 218.8;granulocytes: 120.9;Melanocytes: 84.4;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.3;NK-cells: 1.3"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 21.5;HeLa: 7.4;SK-MEL-30: 14.8;U-266/70: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043360	Uncertain					NA	NA					"HPA043360: AB_10961186"	"prognostic favorable (5.97e-4)"	"unprognostic (6.92e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.69e-1)"	19.9	46.5	3.5	10.2	4.5	22.1	5.9	1.6	5.0	9.7	4.8	9.5	6.3	0.8	10.7	6.1	3.1	15.7	16.6	37.3	4.1	2.5	3.8	7.1	12.4	1.2	1.6	3.1	37.2	4.0	4.0	12.2	4.7	5.0	12.0	3.2	7.0	1.6	80.6	28.5	1.5	4.2	23.0	5.1	2.6	9.0	1.3	3.4	7.6	4.2	15.5	1.9	23.5	7.5	0.0	0.2	1.3	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.1	1.2	0.4	1.0	1.3	21.5	0.2	0.3	0.2	0.1	0.1	0.3	0.5	0.4	0.1	0.4	0.0	0.1	1.8	0.3	0.1	7.4	0.0	0.1	0.1	2.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.2	0.0	0.1	0.6	0.0	1.0	0.0	0.0	0.1	0.4	0.4	2.4	1.7	14.8	0.2	0.0	0.0	0.1	1.4	0.4	1.7	0.1	8.8	0.1	0.0	0.9	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	3.5	4.5	1.6	5.0	4.1	2.5	1.6	3.1	5.0	3.4	11.9	22.4	0.9	7.4	70.6	0.7	218.8	2.5	18.7	14.8	15.7	9.8	1.8	0.0	0.1	1.3	7.3	0.6	0.0	1.4	1.2	43.7	5.1	120.9	0.5	10.3	0.0	26.1	8.6	16.8	1.2	1.4	35.2	84.4	74.9	2.2	1.0	0.2	0.3	1.1	0.0	0.8	0.0	116.4	0.3	1.4	51.9	4.7	5.0	0.9	2.3
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906633-99970341	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	15.1	15.8	13.5	16.4	16.3	13.6	16.1	10.8	17.8	19.4	18.5	14.2	29.3	13.4	21.7	25.2	19.9	12.0	14.9	14.5	13.8	13.2	14.3	26.0	13.2	11.9	15.4	14.2	18.2	17.8	25.5	37.1	17.6	14.1	18.2	14.6	16.3	20.6	28.7	28.5	20.6	18.9	20.4	19.1	13.3	15.0	12.0	10.4	17.0	21.8	18.3	15.9	18.8	17.8	7.4	4.9	15.5	8.1	14.3	10.4	4.5	10.7	9.8	10.0	12.0	11.4	11.6	19.9	8.2	12.2	9.3	8.0	12.2	14.4	21.0	8.2	8.7	15.0	12.3	8.3	11.5	7.5	18.3	6.8	13.5	12.9	7.4	13.3	19.8	4.9	11.4	13.4	10.0	15.2	9.8	10.8	18.2	18.7	11.7	7.0	13.1	11.8	5.4	8.8	14.0	7.9	10.1	17.7	9.6	12.3	12.5	5.8	10.3	16.6	12.7	8.1	6.7	12.6	5.5	8.5	6.2	8.8	10.0	6.6	16.6	20.2	4.2	8.7	8.3	6.7	15.5	4.2	7.3	7.4	4.5	10.3	7.4	9.1	8.2	4.9	5.9	10.4	9.8	4.3	14.3	8.1	3.1	4.9	4.5	13.5	16.3	10.8	17.8	13.8	13.2	15.4	14.2	14.1	10.4	14.9	21.7	14.5	18.1	9.4	14.0	16.9	10.2	24.1	22.7	22.7	19.6	20.4	24.9	15.8	40.4	13.7	9.7	0.0	17.1	15.8	11.1	23.3	25.4	23.1	9.2	9.5	24.2	20.9	8.3	24.8	23.9	15.1	8.5	27.1	15.7	20.3	14.1	15.9	17.0	15.7	12.9	38.8	13.9	25.9	16.6	10.7	22.9	16.6	13.1	12.9
ERP44	"KIAA0573, PDIA10, TXNDC4"	ENSG00000023318	"Endoplasmic reticulum protein 44"	Q9BS26	9	99979179-100099040	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001318	Supported				"Intracellular and membrane"	NA	NA		10000000			"HPA001318: AB_1080427"	"unprognostic (8.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.31e-1)"	18.1	18.7	14.1	18.5	13.7	15.3	26.7	22.4	17.1	17.6	17.9	10.3	28.8	18.2	17.2	34.3	21.8	15.3	14.9	20.0	13.0	10.9	20.7	57.1	22.1	29.9	14.3	9.5	15.7	41.8	16.5	19.0	30.3	12.6	16.4	20.0	10.0	25.9	39.5	13.5	14.5	25.6	16.8	12.4	18.4	20.4	10.5	11.7	15.5	23.7	18.1	18.4	15.2	16.8	15.0	20.0	22.4	30.5	14.1	12.5	17.1	8.0	6.5	9.4	10.6	34.2	16.4	17.2	17.8	24.4	12.6	16.7	13.7	23.5	20.7	11.8	20.1	18.8	29.5	11.5	12.5	11.5	10.6	6.5	7.7	6.8	9.9	30.1	13.9	12.3	18.3	19.0	11.0	16.0	12.0	15.4	7.0	14.9	16.2	10.2	12.4	9.4	9.8	9.7	31.6	8.5	8.3	15.8	14.2	16.1	9.3	7.4	8.6	14.6	18.2	12.3	14.6	6.8	14.4	10.6	9.4	8.9	12.4	7.7	9.3	8.2	7.0	14.4	9.2	12.7	14.7	24.6	21.9	11.6	25.8	11.1	15.0	11.6	12.5	20.0	14.2	8.9	10.4	22.4	14.1	30.5	12.6	12.3	17.1	14.1	13.7	22.4	17.1	13.0	10.9	14.3	9.5	12.6	11.7	50.6	36.1	83.4	71.7	38.5	35.4	31.9	48.4	29.4	34.2	31.4	17.7	124.1	14.9	88.0	5.5	57.8	87.6	23.3	98.2	109.8	63.4	72.7	70.3	61.0	151.5	28.6	50.9	64.4	74.1	7.6	56.7	104.0	60.8	128.0	62.8	33.8	90.6	80.6	63.6	39.5	26.8	71.1	65.3	54.2	28.1	43.3	191.8	61.0	71.6	71.4
INVS	NPHP2	ENSG00000119509	Inversin	Q9Y283	9	100099256-100301000	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Calmodulin-binding, Developmental protein"	"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.2;Late spermatids: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049994			Approved	Cytosol		NA	NA			Cytosol		"HPA049994: "	"unprognostic (3.84e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (6.35e-4)"	"unprognostic (3.53e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.83e-1)"	11.9	13.4	9.5	10.7	15.8	7.9	10.1	18.6	15.7	13.4	11.3	14.6	12.4	7.6	16.5	12.3	9.2	10.3	10.4	9.7	10.4	7.1	16.4	17.1	10.2	10.2	15.8	8.5	19.2	9.7	20.9	26.0	11.1	12.1	12.0	9.1	12.8	8.2	10.4	7.2	7.0	9.4	11.9	15.3	10.1	9.1	12.0	15.5	16.9	12.5	4.6	10.7	10.4	15.4	6.0	3.5	3.9	3.8	4.7	5.3	2.6	6.7	12.4	10.3	11.0	13.3	11.0	8.6	7.9	8.6	7.2	5.8	6.5	4.2	15.6	4.7	9.4	13.1	10.5	8.2	10.4	6.0	12.2	5.5	11.8	10.8	6.7	9.8	11.8	9.8	11.1	13.0	7.7	15.3	9.9	12.9	10.8	10.2	9.6	7.5	6.0	9.3	4.7	6.1	12.2	7.5	8.5	18.2	3.7	6.7	6.3	9.6	7.6	9.0	5.6	9.0	8.8	3.9	6.5	9.6	8.4	6.0	8.4	5.9	9.9	11.7	3.2	8.7	5.1	4.4	0.0	2.5	3.9	4.9	1.7	4.3	5.3	4.1	2.6	3.5	6.0	5.3	5.1	0.2	4.7	3.8	3.5	2.6	2.6	9.5	15.8	18.6	15.7	10.4	7.1	15.8	8.5	12.1	15.5	3.0	2.6	0.9	5.7	1.5	4.1	2.5	10.2	0.0	3.4	0.0	7.9	3.2	3.3	2.0	20.2	3.7	1.6	0.0	1.0	3.2	2.2	2.2	1.1	3.2	3.1	6.4	1.2	0.6	3.4	22.0	4.4	1.9	0.0	3.6	1.4	2.5	1.7	2.0	3.2	5.7	5.7	0.0	3.0	8.6	4.3	1.4	2.9	4.3	1.7	3.4
TEX10	"bA208F1.2, FLJ20287, Ipi1"	ENSG00000136891	"Testis expressed 10"	Q9NXF1	9	100302077-100352939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045434			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045434: AB_10965650"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.28e-2)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-3)"	"unprognostic (9.63e-3)"	11.1	8.5	7.6	14.0	10.1	12.2	11.3	12.6	11.1	12.2	9.5	7.7	7.5	6.1	14.2	9.9	12.5	12.1	10.3	10.4	7.7	7.1	7.5	7.9	9.7	15.1	7.3	5.9	14.9	10.3	9.8	13.5	25.4	9.4	10.2	8.1	6.3	10.2	9.1	25.4	16.2	8.7	11.8	9.9	14.4	9.2	24.5	7.2	32.9	10.0	10.2	15.0	11.2	11.9	13.0	9.3	12.4	9.0	9.9	12.6	7.2	11.7	12.9	17.0	19.0	6.2	11.1	26.3	14.8	15.4	19.4	18.1	13.2	13.9	33.4	8.0	9.6	17.9	16.0	24.2	19.1	22.8	13.4	10.7	18.1	8.4	11.5	13.4	26.2	13.6	9.6	10.8	19.7	20.9	9.6	10.5	11.9	20.2	11.0	25.0	18.4	19.1	16.8	34.7	22.9	15.6	18.7	29.0	10.1	14.3	7.7	15.1	12.8	8.1	13.5	13.1	10.9	5.6	7.7	10.7	13.0	11.5	17.3	13.8	7.8	13.2	13.4	13.2	11.8	13.4	12.4	7.6	2.5	9.8	9.0	10.7	12.7	10.0	9.8	9.3	13.0	10.7	12.6	1.9	9.9	6.7	5.4	11.4	7.2	7.6	10.1	12.6	11.1	7.7	7.1	7.3	5.9	9.4	7.2	3.0	9.4	10.0	8.3	19.7	6.7	10.6	0.0	6.7	17.0	8.7	11.8	44.5	3.3	5.8	9.9	8.3	2.1	0.0	7.5	12.7	13.0	6.1	16.2	6.8	8.4	7.9	5.1	6.7	3.8	10.0	8.1	7.5	16.9	7.2	5.2	3.4	6.3	5.3	7.4	3.0	5.9	0.0	12.8	28.4	34.5	19.7	38.6	6.5	6.0	7.1
MSANTD3	"C9orf30, MGC17337"	ENSG00000066697	"Myb/SANT DNA binding domain containing 3"	Q96H12	9	100427156-100451711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062662: AB_2684826"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.66e-5)"	"prognostic unfavorable (3.23e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.61e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.16e-2)"	11.4	12.5	17.0	16.8	17.5	14.7	21.2	22.7	22.6	15.1	13.2	15.8	5.5	8.8	16.4	12.2	12.6	8.6	19.3	21.5	16.9	14.9	13.0	15.1	15.5	9.3	19.6	18.2	11.1	15.0	10.4	11.3	16.7	20.1	11.6	10.1	9.7	10.9	14.9	21.5	10.9	7.9	20.4	17.6	7.2	11.6	7.8	14.5	5.4	18.2	11.6	11.0	17.3	13.0	3.7	1.5	9.0	0.6	5.7	6.2	2.7	14.9	13.6	9.9	9.7	15.5	18.2	11.2	21.7	24.5	21.3	16.0	8.5	14.1	9.0	11.1	21.3	47.7	17.1	6.7	22.8	25.1	13.2	4.6	4.2	10.9	7.1	16.2	6.0	5.3	8.0	9.8	19.1	37.8	20.1	24.3	7.7	7.5	3.4	31.5	10.7	8.0	4.4	14.6	16.3	23.6	9.5	26.1	2.7	22.0	4.2	11.7	14.6	7.8	6.9	18.5	12.0	2.9	6.8	26.4	27.5	34.8	21.4	32.3	4.9	9.1	4.1	38.4	4.1	20.7	9.0	0.6	3.3	4.2	0.3	6.2	3.6	3.6	5.0	1.5	3.7	4.4	4.0	0.5	5.7	0.2	0.8	2.9	2.7	17.0	17.5	22.7	22.6	16.9	14.9	19.6	18.2	20.1	14.5	14.9	3.4	1.4	7.5	5.3	16.0	13.3	10.2	9.4	9.1	7.0	2.0	28.2	26.6	24.5	1.5	10.5	1.3	0.0	21.1	11.6	8.9	7.2	3.5	8.3	9.9	19.1	9.2	8.0	1.6	3.0	6.9	6.6	6.8	39.7	4.4	6.3	36.9	5.7	8.1	5.3	7.9	6.5	8.2	2.3	11.7	3.8	9.0	6.9	5.8	4.3
MSANTD3-TMEFF1	C9orf30-TMEFF1	ENSG00000251349	"MSANTD3-TMEFF1 readthrough"		9	100442271-100577636	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	6	"brain: 21.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 40.5;NTERA-2: 20.5;SCLC-21H: 21.8;SuSa: 30.2"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.53e-3)"	"unprognostic (1.95e-3)"	"unprognostic (5.92e-2)"		"unprognostic (5.32e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.39e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.46e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	0.6	0.6	7.7	1.1	4.9	0.0	0.5	7.1	21.4	2.3	0.8			0.0	3.5	1.0	0.6	0.6	1.1	0.7	5.5	3.9	0.4	0.0	0.5	0.0	2.9		1.2	0.0	0.1	0.0	1.1		1.1	0.6		0.0	2.0	0.3	0.0	0.3	2.8	3.5	0.0	0.2	3.3			3.7		0.2	0.9	0.1	0.2	1.0	1.0	0.0	0.0	1.0	0.7	1.1	1.8	40.5	3.3	5.0	2.8	6.7	4.4	3.1	3.3	3.5	0.2	1.2	0.8	2.2	3.9	9.3	0.7	12.7	1.3	7.6	3.1	2.4	0.2	1.3	0.6	2.5	0.8	0.7	1.2	1.1	3.2	3.8	7.4	8.2	7.7	0.8	0.5	6.5	0.7	5.0	0.7	20.5	3.4	1.7	6.0	17.2	0.1	3.2	0.4	21.8	10.2	1.4	0.9	2.1	30.2	0.4	2.5	2.9	3.5	3.6	4.0	3.9	1.9	4.3	3.7	5.3	0.5	3.3	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.4	0.3	1.0	0.2	0.3	0.5	1.0	0.0	0.0	0.0	0.0	0.7											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEFF1	"C9orf2, CT120.1, H7365"	ENSG00000241697	"Transmembrane protein with EGF like and two follistatin like domains 1"	Q8IYR6	9	100473113-100577636	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 21.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;BEWO: 9.8;NTERA-2: 19.8;REH: 13.3;SCLC-21H: 16.9;SH-SY5Y: 11.3"	"Low region specificity"	"Detected in all"							HPA051501	Uncertain					NA	NA					"HPA051501: AB_2681509"	"unprognostic (1.96e-1)"	"unprognostic (2.30e-1)"		"unprognostic (9.69e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.02e-2)"		"unprognostic (3.59e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.04e-6)"	"unprognostic (1.30e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.44e-3)"	1.2	1.2	5.0	1.0	13.9	1.2	1.1	1.4	21.1	1.6	1.3	15.0	0.0	1.0	3.0	1.0	1.0	1.2	1.6	1.0	9.1	8.9	1.2	1.0	1.1	1.4	10.3	7.9	1.0	1.0	1.1	0.4	1.8	11.7	1.5	1.1	0.1	1.1	1.4	1.0	1.0	1.3	1.4	13.8	1.2	1.3	4.1	12.6	0.0	3.1	0.0	1.1	1.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	7.9	0.4	0.1	0.2	9.8	0.6	0.1	0.4	0.5	0.5	0.1	0.0	1.8	0.3	0.1	0.0	3.0	0.0	0.5	0.0	4.3	0.0	0.2	0.4	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.3	1.2	3.5	0.1	0.0	0.6	0.0	4.9	0.0	19.8	0.0	0.2	13.3	6.8	0.0	0.3	0.0	16.9	11.3	0.0	0.0	0.2	4.7	0.0	0.0	1.8	1.5	2.6	0.1	0.6	3.1	2.2	2.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	13.9	1.4	15.4	9.1	8.9	10.3	7.9	11.7	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100587906	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 83.8;tongue: 52.4"	"Cell type enhanced"	"Detected in some"	13	"Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.3;SCLC-21H: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	3.5	0.0	0.3	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.2	2.7	1.9	0.0	0.1	16.4	0.5	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.8	0.0	83.8	0.1	0.0	0.1	0.7	0.0	0.1	1.4	0.0	0.1	0.2	52.4	1.6	0.0	0.0	0.4	0.3	1.4	0.4	0.7	0.7	0.0	0.5	0.4	7.4	2.7	1.6	2.4	5.3	1.3	1.0	1.0	1.2	0.0	0.5	0.3	0.3	0.6	2.6	0.3	3.5	0.1	2.1	1.7	2.5	0.0	1.2	0.0	0.5	0.3	0.4	5.9	0.3	1.0	0.6	1.8	1.3	1.8	0.2	0.3	4.6	0.1	2.0	0.3	10.3	1.1	0.8	3.0	6.9	0.0	0.8	0.4	15.8	4.2	0.2	0.3	1.4	5.0	0.2	0.2	1.3	1.8	1.5	1.3	1.1	0.4	1.3	0.7	2.0	0.1	1.3	0.6	0.3	0.2	0.5	0.4	0.2	0.2	0.7	0.5	0.1	0.4	0.5	0.5	1.4	0.7	0.3	0.3	0.2	0.0	0.3	0.6	0.5	0.3	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028709-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.5;kidney: 24.4"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 31.5;Proximal tubular cells: 27.8"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 5.8;SCLC-21H: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.8	0.9	12.6	0.7	38.5	0.7	1.4	1.7	24.4	1.0	0.9	7.6	0.0	0.8	0.8	5.2	0.8	1.0	0.9	0.8	12.7	7.0	24.4	5.0	2.8	0.7	7.5	5.5	0.7	1.1	0.7	0.1	0.8	5.3	1.0	1.0	0.1	1.1	0.8	0.8	0.8	0.8	0.8	10.2	0.7	0.9	1.5	9.3	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.9	10.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	38.5	1.7	6.4	12.7	7.0	7.5	5.5	5.3	9.3	0.0	4.6	0.0	0.0	0.0	2.2	0.0	2.5	0.0	1.2	0.0	0.0	0.0	31.5	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.1	0.0	1.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	27.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 745.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		470000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.1	0.0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1.0	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.8	0.4	89.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	745.7	0.0	0.0	0.0	11.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
MRPL50	"FLJ20493, MRP-L50"	ENSG00000136897	"Mitochondrial ribosomal protein L50"	Q8N5N7	9	101387633-101398614	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA022925	Approved					NA	NA					"HPA022925: AB_1854117"	"unprognostic (6.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.21e-10)"	"unprognostic (7.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	12.7	22.9	15.6	10.8	22.4	4.9	16.7	30.0	21.2	11.7	11.2	10.2	8.9	11.9	11.5	18.6	11.9	11.6	10.3	19.6	15.3	14.9	18.6	23.2	9.9	13.9	16.9	13.6	17.4	16.5	15.7	21.8	11.4	16.7	14.3	12.4	8.7	11.3	12.1	15.4	8.0	11.4	10.2	16.0	14.7	13.5	9.8	17.1	12.8	13.7	14.6	15.5	11.0	9.3	15.8	12.5	7.4	11.4	11.1	19.1	12.1	6.5	7.9	12.7	7.4	8.9	9.6	9.0	8.5	8.2	9.5	8.0	10.7	6.6	16.1	5.5	6.6	11.7	15.2	12.3	10.2	10.3	9.7	7.4	7.9	9.0	30.8	9.6	14.2	7.6	7.8	11.9	7.6	14.1	7.1	8.5	8.5	16.5	8.7	9.6	10.7	8.7	10.5	13.9	38.8	10.9	8.9	18.0	10.0	13.9	7.3	12.2	9.1	9.1	9.2	9.4	9.1	6.4	8.9	7.0	6.5	9.6	11.2	8.0	6.5	19.3	6.7	8.3	8.4	9.1	5.9	10.0	7.4	11.6	11.4	13.7	15.8	16.2	13.1	12.5	13.9	19.1	16.9	1.7	11.1	11.3	10.1	17.4	12.1	15.6	22.4	30.0	21.2	15.3	14.9	16.9	13.6	16.7	17.1	14.9	21.0	39.9	90.8	80.4	18.4	68.6	25.5	21.4	17.0	54.1	11.8	66.2	129.3	59.8	2.8	40.3	16.7	46.7	60.7	58.4	41.3	64.2	44.9	41.9	45.8	4.8	19.0	27.0	22.1	6.1	31.7	37.3	28.7	31.5	23.9	19.0	62.7	29.2	38.2	139.2	15.3	45.3	54.5	37.5	37.4	86.8	64.0	34.1	28.5	122.0
ZNF189		ENSG00000136870	"Zinc finger protein 189"	O75820	9	101398873-101410660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 61.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034814	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA034814: AB_10601030"	"unprognostic (3.87e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.57e-2)"	15.6	15.8	15.1	6.3	28.2	2.8	11.6	13.9	15.9	9.5	9.0	16.8	9.0	8.6	10.0	61.6	5.5	7.8	16.3	10.9	18.7	9.3	10.6	12.5	6.8	6.8	15.4	11.4	11.8	23.0	11.2	23.6	6.3	14.1	10.3	7.5	5.0	6.7	9.4	11.6	4.4	9.7	9.7	25.1	9.9	8.7	9.3	16.1	8.5	9.6	3.7	10.2	6.1	8.0	3.6	2.2	4.1	3.0	3.6	4.7	1.9	5.5	4.6	15.0	10.9	13.5	9.5	7.2	8.0	12.3	9.4	8.2	9.7	4.4	7.5	5.4	9.6	9.9	10.9	7.5	7.6	8.4	9.9	5.2	8.2	7.2	20.6	10.1	8.5	7.2	11.5	10.5	8.3	13.0	12.9	11.6	9.2	9.7	10.9	13.8	3.1	10.2	3.7	10.8	12.3	5.2	7.3	21.5	5.7	8.9	6.5	15.6	9.8	8.6	6.0	8.6	10.3	4.9	10.9	9.7	9.2	6.7	7.6	6.1	10.4	16.0	3.6	8.0	3.4	9.3	1.3	2.5	4.1	2.3	3.0	2.4	2.8	4.0	4.7	2.2	3.6	4.7	4.1	1.4	3.6	2.3	1.7	2.0	1.9	15.1	28.2	13.9	15.9	18.7	9.3	15.4	11.4	14.1	16.1	8.9	5.4	2.4	7.4	8.8	7.9	20.2	22.9	8.1	12.5	1.8	3.9	3.6	8.3	5.3	1.9	9.0	4.9	0.0	15.9	1.7	8.0	5.2	9.2	7.8	4.7	7.9	5.2	8.0	14.0	1.5	10.3	6.6	6.8	1.8	5.3	6.7	8.4	4.9	10.3	11.4	3.3	12.9	9.2	6.2	3.4	5.6	1.6	5.4	3.6	3.5
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 2651.5;Proximal tubular cells: 6429.5"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA002198, CAB020827"	Enhanced					NA	NA		930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.4	0.0	3.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.5	0.2	0.4	0.0	0.2	3.1	15.6	0.0	0.0	2.6	13.5	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.4	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	48.6	0.0	0.0	1.0	0.9	448.4	0.0	0.0	143.1	0.0	0.0	525.6	3.8	0.0	0.0	62.6	46.7	221.2	0.0	0.0	0.0	0.0	2651.5	0.2	3.2	0.0	50.3	57.0	0.0	0.0	0.0	0.0	6.4	2.6	0.4	297.3	28.8	0.0	6429.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	5.0	1.5	0.0
TMEM246	"C9orf125, MGC12992"	ENSG00000165152	"Transmembrane protein 246"	Q9BRR3	9	101473171-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.4;hTERT-RPE1: 16.4;OE19: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.4	10.2	10.8	3.1	19.4	0.8	2.9	23.2	31.1	17.1	12.6	7.6	1.6	8.0	5.9	4.0	11.0	13.5	7.0	27.3	17.6	20.6	4.6	2.6	5.4	0.8	10.8	14.3	19.4	10.9	19.6	9.2	1.0	23.2	7.0	10.8	8.1	4.6	9.7	4.3	11.2	7.1	6.7	8.5	1.8	15.1	2.9	4.0	0.0	4.3	4.4	2.9	4.7	8.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	8.1	6.3	0.0	0.2	0.1	0.0	5.4	7.9	3.9	7.9	0.4	4.3	0.0	1.8	9.8	0.4	12.8	0.0	8.9	2.4	0.0	3.2	4.4	6.1	0.0	0.3	0.0	0.0	3.5	14.4	0.0	2.1	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	7.8	26.2	0.0	0.0	3.2	0.0	5.9	1.5	10.7	10.1	3.0	0.0	0.0	1.6	0.0	7.5	0.0	6.1	3.8	0.0	0.0	0.5	0.0	0.0	8.7	0.0	2.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	10.8	19.4	23.2	31.1	17.6	20.6	10.8	14.3	23.2	4.0	20.8	0.3	0.0	13.2	4.7	38.3	42.4	33.1	9.4	10.3	15.7	3.9	0.0	0.0	12.9	2.2	5.9	16.1	0.0	15.0	0.1	1.5	11.6	0.0	6.2	0.0	15.9	23.6	1.3	0.3	0.8	4.9	0.0	0.0	1.0	35.3	1.4	12.8	38.6	10.6	4.2	4.4	12.9	5.2	2.3	1.0	8.7	0.0	0.0	26.7	23.0
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533851-101563344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	16.4	17.1	24.6	17.0	24.9	12.1	17.7	24.4	26.3	18.6	16.4	27.7	15.9	10.1	18.3	18.7	20.4	19.1	13.2	24.1	22.3	22.1	20.5	14.4	14.9	15.5	25.2	20.7	21.1	19.5	31.5	23.1	15.1	30.0	21.6	16.1	16.8	16.2	17.7	32.0	16.3	12.5	23.6	28.8	17.0	13.9	28.2	25.8	21.2	22.0	15.3	18.6	21.1	19.0	13.0	12.5	21.0	23.5	13.8	18.6	10.4	9.7	24.8	14.3	15.7	17.7	14.0	12.2	17.0	13.7	17.1	15.0	15.0	10.4	21.6	9.2	13.1	14.3	24.8	16.6	14.5	17.6	22.5	7.7	11.5	22.7	15.0	13.0	19.8	13.9	13.7	15.6	15.1	19.6	12.9	10.0	8.0	10.9	12.8	18.5	12.7	15.4	5.3	31.6	22.0	12.6	14.9	49.6	10.7	7.0	9.4	15.3	19.3	24.1	12.9	14.0	15.0	11.6	9.4	14.1	15.9	16.0	11.3	14.3	13.9	42.7	11.8	14.0	7.5	19.2	21.0	12.7	19.1	18.6	17.5	14.0	13.0	15.4	13.9	12.5	11.2	16.2	14.9	13.9	13.8	23.5	7.9	11.9	10.4	24.6	24.9	24.4	26.3	22.3	22.1	25.2	20.7	30.0	25.8	23.8	24.5	7.5	8.1	5.7	29.1	42.4	10.2	33.5	26.1	21.0	5.9	13.6	5.0	14.3	26.2	11.3	12.2	0.0	12.1	9.6	11.5	7.2	20.9	16.8	14.4	41.3	23.6	7.4	23.8	15.2	16.7	20.0	10.1	27.9	10.7	27.6	10.2	15.3	22.3	9.1	23.0	32.3	14.4	24.7	15.8	5.1	6.4	16.0	12.0	5.4
GRIN3A	GluN3A	ENSG00000198785	"Glutamate ionotropic receptor NMDA type subunit 3A"	Q8TCU5	9	101569353-101738580	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 17.3"	"Cell type enhanced"	"Detected in some"	21	"Cone photoreceptor cells: 3.9;Early spermatids: 1.4;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 3.3;non-classical monocyte: 2.5"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.3"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (7.10e-3)"	"unprognostic (3.01e-5)"	"unprognostic (3.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.06e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.87e-1)"	"unprognostic (9.41e-2)"	0.6	0.6	7.4	0.8	4.2	0.5	0.7	0.4	17.3	4.1	1.0	2.6	0.0	0.6	1.0	1.0	0.5	0.6	0.5	1.2	6.8	6.4	0.6	0.6	0.7	1.1	3.8	12.4	2.4	0.5	0.4	0.4	0.4	4.6	1.8	0.8	2.7	0.6	2.6	0.7	1.0	0.7	0.7	3.0	1.8	0.6	1.0	2.3	0.0	0.5	0.0	0.8	0.5	0.6	0.0	0.4	0.1	3.3	0.0	0.4	0.2	0.0	0.2	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.0	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.3	0.7	0.1	0.5	0.3	0.4	0.1	0.0	0.3	6.4	0.7	0.2	0.2	0.2	0.6	0.2	0.3	0.3	0.4	0.1	0.7	0.3	0.6	1.0	0.3	0.7	0.3	1.2	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.4	0.2	7.4	4.2	0.4	13.4	6.8	6.4	3.8	12.4	4.6	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591615-101595021	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 81.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Low region specificity"	"Detected in single"							HPA047157	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA047157: AB_2679960"												"unprognostic (8.81e-2)"			"unprognostic (2.65e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.7	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	6.5	0.0	319.9	3.0	0.0	0.0	0.0	0.0	0.0
CYLC2		ENSG00000155833	"Cylicin 2"	Q14093	9	102995311-103018488	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	61	"testis: 34.0"	"Group enriched"	"Detected in some"	177	"Early spermatids: 1820.7;Late spermatids: 2014.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 1.1"															NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.0	0.0	1.1	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.4	0.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.9	0.5	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1820.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2014.1	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	10.8	4.2	0.0	0.0	0.0	0.0	0.0
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 96.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA071309: AB_2686385"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.3	14.2	16.0	14.8	3.4	5.0	15.0	17.0	8.1	15.3	12.9	12.3	14.3	35.2	8.3	8.7	13.2	31.2	23.1	11.0	20.7	22.3	9.7	21.2	22.7	7.9	0.9	12.8	21.4	3.2	2.3	20.7	8.4	5.2	10.8	22.7	17.0	29.0	13.8	8.9	33.3	6.6	13.8	14.9	11.2	22.3	45.9	13.2	6.5	6.7	15.1	11.7	20.3	9.5	5.0	7.0	19.1	8.7	8.6	18.6	19.6	25.7	21.2	10.6	35.7	20.6	12.1	18.8	22.5	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7	23.8	11.0	20.1	9.5	24.3	34.1	38.9	7.6	10.7	14.8	15.7	7.9	30.9	29.9	16.5	27.3	15.5	6.5	0.0	17.9	78.9	14.2	5.9	21.9	6.8	37.8	27.0	4.7	19.6	12.1	20.4	17.3	20.0	6.8	27.1	11.4	14.5	14.2	7.0	11.7	13.3	18.4	12.9	17.5	56.4	96.0	20.3	21.6	14.9	24.7	6.7
OR13F1		ENSG00000186881	"Olfactory receptor family 13 subfamily F member 1"	Q8NGS4	9	104504263-104505222	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C4		ENSG00000148136	"Olfactory receptor family 13 subfamily C member 4"	Q8NGS5	9	104526253-104527209	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C3		ENSG00000204246	"Olfactory receptor family 13 subfamily C member 3"	Q8NGS6	9	104535749-104536856	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	9	"testis: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Not detected"	"Not detected"							HPA053978	Uncertain					NA	NA					"HPA053978: AB_2682330"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C8		ENSG00000186943	"Olfactory receptor family 13 subfamily C member 8"	Q8NGS7	9	104569168-104570130	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"blood: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	13	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0			0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C5		ENSG00000277556	"Olfactory receptor family 13 subfamily C member 5"	Q8NGS8	9	104598457-104599413	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"pancreas: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;CACO-2: 1.0;HEL: 1.6"															NA	NA																					"unprognostic (4.88e-2)"		0.0	0.6		0.0		0.2	0.0		0.2	0.0	0.0			0.0	0.0	0.4	0.0	0.9	0.4	0.0			0.3	0.6	0.0	0.0			0.5	1.0	0.0		0.0		0.0	0.0		0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.6		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
OR13C2		ENSG00000276119	"Olfactory receptor family 13 subfamily C member 2"	Q8NGS9	9	104604671-104605627	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"ASC diff: 1.5"															NA	NA																							0.7	0.0		0.0		0.0	0.0		0.6	0.0	0.0			0.0	0.0	0.6	0.0	0.8	0.2	0.0			0.1	0.7	0.0	0.0			0.2	0.0	0.0		0.0		0.0	0.1		0.7	0.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.5		0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13C9		ENSG00000136839	"Olfactory receptor family 13 subfamily C member 9"	Q8NGT0	9	104617248-104618204	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"pituitary gland: 1.2;skeletal muscle: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0			0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	1.2	0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR13D1		ENSG00000179055	"Olfactory receptor family 13 subfamily D member 1"	Q8NGV5	9	104694379-104695485	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	6	"testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 1.0"	"Not detected"	"Not detected"							HPA055921	Uncertain					NA	NA					"HPA055921: AB_2682970"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.1	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NIPSNAP3A	"DKFZp564D177, FLJ13953, HSPC299, MGC14553"	ENSG00000136783	"Nipsnap homolog 3A"	Q9UFN0	9	104747688-104760122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA042491	Approved					NA	NA		230000			"HPA042491: AB_2678023"	"unprognostic (1.03e-1)"	"unprognostic (9.13e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	17.4	28.5	28.2	16.9	18.8	22.2	29.8	8.8	29.7	18.7	24.8	14.7	17.2	16.5	13.3	14.1	19.1	13.7	10.8	36.4	24.2	22.5	19.4	32.5	20.1	21.8	27.3	21.0	10.0	13.2	7.5	15.7	21.5	24.0	14.6	26.0	7.6	11.9	15.1	8.4	15.9	16.2	16.7	37.7	14.4	18.6	9.8	20.9	14.3	15.5	15.4	10.8	14.0	15.7	7.7	34.0	13.3	24.2	12.4	6.1	12.8	7.8	6.9	4.1	3.6	7.5	13.4	8.5	24.7	9.6	24.8	21.2	8.0	12.8	12.5	10.6	20.2	7.6	13.6	13.1	10.7	13.5	7.2	12.2	22.0	10.5	9.2	13.7	27.0	17.0	16.1	28.7	10.2	7.7	13.9	27.8	18.8	23.1	8.3	19.0	16.8	22.3	15.4	4.6	18.8	12.5	17.8	14.3	12.6	21.5	4.7	14.1	9.4	15.5	9.9	6.9	11.9	23.8	23.3	20.1	12.7	7.4	13.4	7.2	5.9	6.9	6.7	13.0	23.2	6.8	13.2	20.2	13.3	4.7	24.2	5.8	7.7	4.8	5.1	34.0	5.5	6.1	5.8	1.4	12.4	20.4	17.3	4.6	12.8	28.2	18.8	8.8	29.7	24.2	22.5	27.3	21.0	24.0	20.9	20.8	13.3	19.4	17.3	25.0	7.8	11.7	17.8	14.7	15.9	27.9	2.0	33.0	87.9	23.9	2.8	15.8	18.8	23.3	24.0	26.6	24.9	10.8	51.8	35.1	71.1	3.2	24.2	25.2	45.8	2.9	17.5	35.3	35.4	79.4	31.9	7.0	22.7	10.5	20.5	32.3	4.7	25.8	18.9	13.6	18.3	33.9	25.7	13.8	33.8	22.1
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764157-104777457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 28.6;skeletal muscle: 34.6"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 19.0;Ito cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 1.7;granulocytes: 6.5"	"Cell line enhanced"	"Detected in some"		"REH: 7.6;THP-1: 5.3;U-266/70: 5.9"					"Low region specificity"	"Detected in all"			HPA042491	Uncertain					NA	NA					"HPA042491: AB_2678023"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	14.4	8.4	6.1	2.1	11.3	1.2	10.1	3.7	7.8	4.0	1.7	1.5	4.2	1.5	5.0	4.5	3.1	3.5	3.0	28.6	4.4	6.8	2.3	1.3	2.1	2.2	4.4	7.7	5.4	4.7	2.5	8.0	5.1	5.0	5.1	1.7	3.8	2.2	5.9	34.6	1.7	1.9	3.2	3.4	2.5	1.9	2.0	2.8	0.4	3.1	14.1	2.8	2.2	2.5	3.5	1.7	6.5	0.5	0.8	0.6	0.5	0.0	0.3	0.5	0.2	2.0	1.8	1.4	0.4	0.9	1.3	0.6	0.3	0.8	0.9	0.3	0.8	0.0	0.0	0.6	0.5	0.5	0.0	0.6	3.5	1.9	0.2	1.6	0.6	0.8	1.4	0.7	0.5	0.1	1.6	0.5	1.4	3.1	0.2	0.2	0.4	1.5	3.2	0.7	0.0	0.5	7.6	0.0	0.2	0.5	0.4	1.3	4.0	4.7	0.0	0.4	0.4	3.7	5.3	0.3	0.6	1.6	0.7	0.1	5.9	2.3	0.1	0.0	0.3	0.1	6.5	0.1	2.4	0.2	0.1	0.0	3.5	0.4	0.0	1.7	2.0	0.6	0.3	0.0	0.8	0.5	1.2	0.0	0.5	6.1	11.3	3.7	7.8	4.4	6.8	4.4	7.7	5.0	2.8	0.0	1.4	2.7	1.5	0.3	4.4	19.0	0.0	4.0	0.0	3.5	0.0	0.6	5.0	0.5	0.0	2.2	0.0	0.0	0.2	0.2	1.3	0.3	1.1	0.0	4.8	0.0	1.2	7.4	1.6	0.0	2.3	2.3	0.0	6.4	0.0	0.9	0.1	0.0	6.3	0.0	0.3	0.0	3.3	0.1	1.1	0.6	0.7	0.0	0.0	0.1
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781002-104928237	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.0;U-87 MG: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	25.7	38.1	6.3	9.8	13.1	15.8	23.0	2.3	8.5	8.2	14.8	8.0	6.5	4.4	7.8	9.6	7.0	7.9	13.6	10.7	7.5	3.7	7.1	33.3	12.7	29.4	18.9	2.3	8.7	5.4	1.8	3.3	20.1	10.2	9.4	9.4	7.7	6.3	8.7	21.3	12.1	8.1	25.2	16.1	12.8	7.3	8.8	8.0	16.9	5.8	2.2	5.0	16.4	20.0	1.8	0.2	11.6	1.5	0.1	0.6	0.1	0.0	2.7	2.2	0.0	6.5	2.5	2.0	2.8	10.9	0.9	1.0	0.4	0.4	3.8	3.1	2.8	10.7	0.0	1.2	0.1	0.8	0.0	0.0	0.4	0.9	9.5	11.8	0.0	6.7	17.0	0.7	11.1	0.2	10.6	1.0	0.3	0.0	9.8	0.2	0.3	2.3	5.2	3.1	0.5	0.8	0.0	0.0	0.2	1.8	1.8	0.3	0.1	2.9	0.5	0.6	4.5	0.0	1.9	1.0	3.0	0.2	3.9	3.1	3.8	1.8	2.3	39.0	0.0	0.0	2.2	0.8	11.6	0.2	1.0	0.2	1.2	0.3	0.0	0.2	1.8	0.6	0.0	10.6	0.1	1.5	0.1	0.1	0.1	6.3	13.1	2.3	4.0	7.5	3.7	18.9	2.3	10.2	8.0	98.3	9.4	5.1	4.8	26.4	11.9	7.8	12.7	2.7	9.1	10.4	45.2	21.2	0.0	3.8	1.5	9.3	3.2	0.0	1.4	4.6	28.8	3.1	46.1	162.2	63.2	0.0	8.7	25.2	103.3	0.7	28.7	31.4	25.3	2.8	2.4	0.1	4.9	3.5	26.5	17.0	5.5	45.3	16.4	1.2	0.7	16.9	7.4	4.4	2.3	8.9
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.5;ASC TERT1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		270000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.9	5.8	1.6	1.9	73.5	58.1	5.0	5.8	15.3	3.8	5.1	6.2	18.5	9.2	3.0	22.0	4.3	13.8	4.7	8.4	6.5	8.0	3.8	11.5	4.1	7.7	4.9	2.2	5.9	32.2	6.9	7.3	6.6	9.8	12.0	4.8	0.3	19.2	4.3	9.8	9.1	2.6	8.9	12.3	5.6	1.9	6.1	6.9	5.2	16.3	7.7	3.0	8.2	9.1	8.2	9.9	9.0	6.9	10.2	3.8	3.4	4.1	4.2	14.8	9.8	6.9	7.4	5.0	5.0	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4	32.8	21.6	15.9	31.4	62.7	7.6	9.3	56.0	14.7	9.1	101.2	221.9	44.4	3.3	16.4	2.4	38.4	140.4	0.0	31.4	7.9	49.9	25.3	98.1	132.6	20.0	6.4	151.0	54.0	50.8	2.9	101.8	39.6	70.9	122.6	158.5	6.7	33.4	123.8	75.0	23.3	44.8	38.8	27.0	1.4	1.7	65.0	59.0	15.3	134.8	29.5
FSD1L	"CCDC10, CSDUFD1, FSD1CL, FSD1NL"	ENSG00000106701	"Fibronectin type III and SPRY domain containing 1 like"	Q9BXM9	9	105447796-105552433	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	20	"Cone photoreceptor cells: 398.6;Early spermatids: 84.6;Rod photoreceptor cells: 118.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035138	Approved					NA	NA					"HPA035138: AB_10601324"	"unprognostic (9.28e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.17e-5)"	"unprognostic (4.20e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.22e-3)"	2.5	6.9	9.5	3.9	15.2	4.1	3.2	11.1	19.6	3.6	4.9	8.3	6.7	8.6	4.3	6.3	2.2	14.5	3.0	7.4	10.0	13.0	4.2	1.8	4.3	3.0	11.3	8.7	2.8	3.2	7.6	18.9	2.0	20.6	3.2	4.8	7.6	2.3	3.8	11.1	2.4	6.7	3.3	15.5	2.8	4.2	12.2	7.4	2.0	4.1	6.0	3.1	2.4	2.3	5.5	2.1	1.2	2.9	1.7	2.5	0.9	3.6	4.1	6.5	3.7	1.7	3.6	2.2	3.2	2.1	3.1	2.8	2.0	1.4	9.5	1.3	3.1	3.3	1.4	4.9	1.8	4.3	11.5	1.6	1.6	5.3	2.4	2.3	5.6	3.7	1.8	1.6	4.3	6.7	3.8	2.4	4.7	1.9	5.6	2.3	1.2	8.9	3.0	4.0	0.4	2.6	11.4	4.3	0.7	2.5	0.8	13.2	6.3	3.6	0.9	2.6	2.7	4.2	1.6	2.8	5.0	3.1	4.2	4.5	3.1	10.4	2.5	3.3	3.1	1.6	1.2	2.9	0.1	1.7	1.6	0.8	5.5	2.5	1.8	1.8	2.3	0.3	1.1	1.2	1.7	1.5	2.1	0.6	0.9	9.5	15.2	11.1	14.8	10.0	13.0	11.3	8.7	20.6	7.4	3.0	0.6	6.0	1.5	0.9	21.4	4.9	2.5	46.8	4.5	7.0	398.6	0.3	1.7	11.6	84.6	2.8	4.7	0.0	3.4	1.1	3.1	1.3	13.9	1.0	3.5	49.3	10.3	0.6	1.6	45.5	4.6	5.0	10.1	28.9	5.5	11.8	5.4	2.9	6.3	1.5	118.5	12.9	3.3	24.5	26.0	0.6	0.0	2.9	4.5	0.1
FKTN	"FCMD, LGMD2M"	ENSG00000106692	Fukutin	O75072	9	105558130-105641118	"Disease related genes, Predicted intracellular proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012820	Approved					NA	NA					"HPA012820: AB_1848478"	"unprognostic (3.48e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (2.41e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (3.02e-4)"	7.7	9.7	8.5	7.4	15.9	1.2	10.6	13.6	18.0	8.9	9.7	13.1	11.5	7.5	11.4	9.9	8.3	9.1	7.4	8.0	12.1	9.0	10.5	8.0	7.4	9.1	10.2	16.0	12.0	12.3	21.1	14.6	10.0	15.7	8.7	11.4	7.3	7.9	9.3	7.3	9.3	7.3	9.0	10.6	7.7	9.8	7.7	12.5	7.2	12.6	8.7	6.9	7.9	7.9	1.9	3.3	0.1	1.9	0.6	1.9	1.1	6.5	6.7	6.8	6.1	10.7	16.8	8.2	12.3	11.5	8.3	8.3	4.4	11.5	4.2	6.5	12.4	8.9	11.3	6.8	8.8	11.3	7.8	4.7	3.1	7.3	2.9	8.6	6.4	2.9	13.6	7.9	11.1	15.9	10.7	7.0	4.8	3.7	4.9	15.3	7.0	4.6	3.3	6.3	6.2	8.2	2.9	17.8	2.8	7.3	2.3	7.5	5.2	10.5	8.1	6.3	7.1	17.3	4.5	9.1	8.3	4.8	15.8	10.6	7.4	11.8	2.9	7.9	6.3	11.9	0.1	1.6	0.0	0.9	1.9	1.2	1.9	1.7	1.9	3.3	1.5	1.7	1.5	0.0	0.6	0.6	1.6	0.9	1.1	8.5	15.9	13.6	18.0	12.1	9.0	10.2	16.0	15.7	12.5	6.0	7.7	2.2	3.8	2.9	20.1	8.5	12.7	8.1	5.7	7.0	7.9	2.2	1.7	4.2	2.2	4.9	2.8	0.0	2.9	2.9	6.2	4.2	2.3	5.1	3.7	22.3	4.1	9.2	3.8	0.4	5.8	2.4	8.5	1.8	8.1	8.0	2.7	3.5	8.5	3.3	13.7	6.5	4.7	9.8	4.1	3.4	0.7	4.3	6.9	2.8
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"blood: 8.8;kidney: 4.6;skeletal muscle: 17.3"	"Cell type enhanced"	"Detected in some"	16	"Cone photoreceptor cells: 3.9;Distal tubular cells: 6.6;Intestinal endocrine cells: 3.4;Muller glia cells: 1.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"					"Group enriched"	"Detected in some"	21	"memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	18	"B-cells: 8.8;dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;HAP1: 4.9;K-562: 12.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"	0.1	0.3	0.5	0.1	0.7	0.0	0.0	0.3	0.6	0.2	0.0			0.0	0.2	0.9	0.1	0.2	0.0	0.3	0.4	0.5	4.6	0.3	0.0	0.2	0.7		0.3	0.1	0.0	0.8	0.1		0.1	0.1		0.0	0.2	17.3	0.1	0.1	0.0	0.8	0.3	0.0	0.6			0.1		0.4	0.1	0.0	8.8	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.7	2.5	0.7	0.3	0.0	0.3	0.1	0.3	0.1	0.4	3.4	0.2	0.1	0.3	0.0	0.7	0.1	4.9	0.0	0.2	0.6	0.5	1.1	0.0	0.0	0.2	0.6	1.9	0.3	0.6	0.1	0.2	0.2	0.0	0.8	12.9	0.3	0.4	0.3	0.8	0.7	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.9	1.2	0.2	0.3	0.2	0.1	0.2	2.1	0.5	0.3	0.8	0.7	1.1	1.0	2.0	0.1	0.2	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.4	1.1	0.9	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694544-105776612	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.9"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 220.6;Late spermatids: 366.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain					NA	NA					"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	8.8	10.0	6.0	4.0	7.4	10.4	17.4	4.1	5.7	6.8	7.4	10.4	2.8	4.0	5.5	11.0	4.8	4.5	4.2	28.3	6.6	6.1	18.6	11.7	5.7	8.1	12.5	3.4	11.7	4.1	5.3	16.6	2.9	7.9	5.1	7.3	9.2	4.2	4.4	43.9	4.0	6.4	5.2	10.4	3.6	4.3	21.1	9.0	3.3	17.9	15.6	3.0	7.5	8.2	26.3	24.2	24.5	13.3	12.0	20.2	11.3	5.9	9.3	7.2	11.4	42.1	9.3	15.4	8.8	5.6	8.4	8.8	14.4	8.2	13.8	4.4	3.0	13.6	4.3	10.4	4.9	9.2	10.4	14.1	5.6	6.5	8.8	5.9	17.0	12.2	8.7	4.4	5.7	8.3	2.6	3.3	9.7	29.6	12.4	5.1	16.5	11.7	5.1	5.6	17.4	10.2	7.9	22.8	6.6	3.8	5.0	12.7	3.1	8.8	14.5	6.3	5.1	18.1	12.0	1.7	7.7	7.7	29.3	8.8	15.2	37.6	6.8	14.3	18.8	15.3	5.8	9.7	24.5	6.7	13.3	8.7	26.3	9.2	7.9	10.8	24.7	20.2	12.5	1.4	12.0	11.5	24.2	7.8	11.3	6.0	7.4	4.1	5.7	6.6	6.1	12.5	3.4	7.9	9.0	0.0	2.4	10.3	19.8	27.0	12.2	48.5	17.8	4.0	2.3	24.4	27.5	8.2	56.3	6.4	220.6	8.2	11.8	0.0	5.9	14.5	10.8	30.3	15.1	23.1	29.9	11.1	30.6	2.5	7.3	366.7	78.9	26.7	30.4	25.2	11.2	27.6	7.3	14.0	42.1	31.4	11.8	116.4	51.3	129.7	51.9	28.5	17.7	10.0	19.9	10.7
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863097-107013634	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	4.8	11.9	10.4	5.0	11.0	0.8	6.4	25.4	9.5	10.4	6.5	13.2	7.7	2.3	13.3	5.1	10.7	9.1	6.0	8.6	10.6	6.6	5.6	2.9	5.3	1.8	8.1	7.8	11.5	2.1	18.1	10.0	5.6	10.0	11.4	6.4	8.1	12.6	11.9	22.1	11.2	3.3	10.8	9.7	4.8	3.3	9.1	9.8	1.5	11.7	5.4	2.5	5.6	9.3	0.4	0.5	1.1	0.6	1.8	1.7	0.3	3.2	7.6	15.2	10.4	5.1	3.8	2.2	2.0	2.9	2.0	2.2	9.3	3.3	0.0	5.7	2.1	9.3	5.1	9.8	9.0	2.5	0.1	1.3	0.0	2.5	0.0	2.0	1.6	0.3	3.5	4.1	4.5	12.5	5.4	1.0	4.0	0.0	4.2	5.5	5.7	1.8	0.1	11.6	0.0	7.4	0.0	10.2	0.2	5.8	2.8	7.0	8.0	3.8	0.1	3.3	10.1	7.8	0.0	1.0	2.6	9.0	5.9	6.3	0.0	0.1	0.1	4.3	0.2	9.3	1.1	0.2	0.3	0.7	0.4	1.2	0.3	0.7	0.3	0.3	0.4	1.7	0.5	0.7	1.8	0.6	0.5	0.3	0.3	10.4	11.0	25.4	7.7	10.6	6.6	8.1	7.8	10.0	9.8	20.8	23.2	1.3	10.3	29.9	56.8	21.4	20.4	13.4	12.5	7.0	29.5	9.6	5.0	6.7	52.2	23.3	6.3	0.0	2.3	4.1	10.4	13.6	16.2	0.0	1.6	17.5	16.1	39.3	1.0	10.4	13.6	1.3	11.8	3.6	19.9	20.3	4.8	0.0	25.5	14.7	38.6	25.8	19.8	1.2	12.8	10.0	2.6	0.0	16.8	6.4
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332194	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Late spermatids: 940.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		8200000	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	41.0	30.1	21.9	23.5	24.5	37.0	28.9	33.3	28.1	28.9	31.4	18.4	28.2	21.8	27.0	38.0	45.3	22.6	24.1	45.5	22.2	23.0	29.7	82.0	27.7	20.7	20.8	23.3	31.6	45.9	21.0	24.8	66.1	25.6	31.1	25.9	17.3	28.7	25.8	98.2	38.2	29.1	29.4	22.6	29.8	23.0	38.5	18.6	32.8	30.4	34.0	27.1	42.1	32.6	5.2	2.5	7.1	2.7	5.0	4.9	1.2	32.4	29.0	41.0	26.3	28.2	44.8	46.3	50.5	41.6	44.9	30.9	47.9	35.6	45.6	20.5	55.1	40.8	45.7	56.5	44.9	45.5	31.0	18.5	23.7	30.5	36.6	37.6	42.4	20.4	37.5	42.0	43.0	64.9	35.8	31.2	20.3	38.2	34.4	40.5	53.1	41.3	21.6	43.6	58.0	33.8	30.9	53.8	21.6	38.6	30.8	37.5	25.4	34.9	49.4	31.0	64.7	50.4	17.4	28.6	33.6	33.0	41.4	37.7	23.6	43.2	24.7	35.8	25.3	35.2	1.7	2.7	2.3	4.4	2.7	4.9	4.0	2.6	3.7	2.2	5.2	4.4	3.5	7.1	5.0	1.7	2.5	4.6	1.2	21.9	24.5	33.3	27.4	22.2	23.0	20.8	23.3	25.6	18.6	41.7	36.8	34.3	97.8	173.7	41.1	108.8	76.5	32.1	30.7	33.2	25.5	238.3	43.1	77.6	384.7	63.9	55.5	23.3	67.0	220.2	83.7	122.4	35.7	191.4	88.0	47.7	96.9	48.5	67.6	940.0	69.9	68.6	70.9	80.2	75.4	36.1	76.0	42.1	82.0	75.7	41.1	77.6	91.4	34.9	59.0	210.7	244.1	43.6	64.4	130.5
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 92.1"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 685.3;Suprabasal keratinocytes: 589.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 5.2;intermediate monocyte: 7.4;myeloid DC: 4.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.4;monocytes: 7.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 32.8;hTERT-HME1: 20.3;OE19: 17.5;U-2197: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002926	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	29.2	8.5	2.7	23.8	3.9	14.4	23.7	1.8	3.5	39.1	28.9	5.6	5.5	10.2	17.8	18.6	34.9	22.0	32.4	18.6	2.4	2.2	4.8	5.1	35.6	4.4	2.7	2.2	18.6	2.3	2.7	2.8	41.0	6.2	11.3	29.6	11.7	11.9	6.5	13.6	92.1	39.4	16.0	3.3	21.8	22.2	11.2	2.0	1.9	7.8	81.1	30.7	16.8	24.1	0.0	4.4	0.4	7.4	0.1	0.0	1.3	5.7	2.3	0.2	0.0	6.0	15.5	2.2	2.0	10.6	2.7	3.2	0.8	7.3	0.0	0.3	2.6	9.4	4.2	2.6	1.5	1.0	0.0	1.1	0.0	4.0	0.1	9.0	0.0	0.0	2.0	32.8	5.5	20.3	0.6	0.2	0.1	0.2	0.0	1.5	3.7	0.0	0.7	1.8	17.5	11.5	0.1	0.6	0.1	0.8	1.6	0.1	0.1	1.6	4.8	6.0	4.8	0.7	2.5	1.2	1.6	0.0	49.8	0.8	0.0	0.0	0.0	1.6	1.0	2.8	0.0	5.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.1	2.9	0.4	0.0	1.3	2.7	3.9	1.8	3.5	2.4	2.2	2.7	2.2	6.2	2.0	11.9	47.4	12.3	228.3	387.3	0.4	56.5	17.8	18.7	29.6	1.8	7.9	33.0	1.7	21.1	201.9	242.7	430.0	0.0	34.8	55.7	240.7	170.1	55.2	3.9	80.6	0.0	118.8	142.4	148.1	123.4	133.2	214.3	195.7	12.6	685.3	1.7	32.1	447.5	57.0	1.2	1.8	38.8	108.2	4.1	15.1	589.1	90.3	5.3	253.4	169.8
ACTL7B	Tact1	ENSG00000148156	"Actin like 7B"	Q9Y614	9	108854589-108856967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	437	"testis: 43.6"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 1482.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021803, HPA024664"	Enhanced					NA	NA					"HPA021803: AB_1844551, HPA024664: AB_1844552"					"unprognostic (7.64e-2)"	"unprognostic (1.62e-1)"								"unprognostic (3.09e-1)"	"unprognostic (3.83e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1482.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	301.1	8.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	7.9	3.2	0.0	0.0	0.0	0.0	0.0
ACTL7A		ENSG00000187003	"Actin like 7A"	Q9Y615	9	108862266-108863759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	145	"testis: 81.7"	"Group enriched"	"Detected in some"	122	"Early spermatids: 1179.4;Late spermatids: 3544.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;NB-4: 1.0;U-2197: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021624	Enhanced					NA	NA					"HPA021624: AB_1844549"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1179.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3544.4	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	19.4	0.0	17.9	6.4	0.0	0.0	0.0	0.0	0.0
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108867517-108934116	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.7;Ciliated cells: 12.0;Collecting duct cells: 14.0;Exocrine glandular cells: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB021340: , HPA049677: AB_2680847, HPA050686: AB_2681216"	"prognostic unfavorable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	10.4	33.0	18.7	10.6	22.9	10.8	13.1	37.6	19.9	13.0	11.5	17.2	11.4	8.2	15.7	17.3	9.8	15.1	10.3	15.3	14.8	15.2	13.0	14.7	11.2	12.8	20.9	17.3	26.4	12.9	41.3	42.3	11.2	20.5	13.1	12.6	15.0	12.0	12.8	11.6	15.7	11.2	14.4	16.7	13.3	11.3	11.7	19.3	12.1	15.4	8.3	13.2	10.4	13.4	2.1	2.7	26.9	2.6	4.0	4.2	1.9	9.2	17.9	15.4	10.0	17.0	16.3	12.6	15.2	10.5	15.5	12.3	16.8	6.8	17.0	6.9	13.6	17.9	23.9	23.6	19.0	17.1	16.0	14.8	9.9	27.8	45.5	12.6	19.3	8.9	12.4	13.3	21.6	20.4	15.7	13.3	21.4	23.4	12.0	14.2	15.8	16.5	12.0	19.6	23.7	17.9	14.4	20.7	10.6	11.7	12.0	18.7	15.0	16.7	16.7	10.3	17.4	21.7	8.7	12.7	8.9	10.3	19.8	15.1	11.4	25.5	8.6	14.9	12.8	12.0	26.9	1.7	2.5	3.1	2.0	4.2	2.1	3.0	4.0	2.7	1.4	2.9	3.6	0.3	4.0	2.6	1.3	2.4	1.9	18.7	22.9	37.6	19.9	14.8	15.2	20.9	17.3	20.5	19.3	11.9	19.7	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.7	14.0	0.0	5.6	0.0	5.7	0.0	0.0	0.0	0.0	18.1	5.2	0.0	0.0	2.3	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	8.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
FAM206A	"C9orf6, CG-8, FLJ20457, Simiate"	ENSG00000119328	"Family with sequence similarity 206 member A"	Q9NX38	9	108934181-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035917, HPA035918"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Cytokinetic bridge"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	12.0	11.4	16.8	9.0	28.8	12.9	17.8	12.3	19.2	11.6	13.3	12.8	10.3	13.8	12.6	22.9	16.0	18.9	9.9	13.3	16.2	16.0	14.1	12.6	12.0	9.9	16.7	20.0	13.7	13.7	23.3	28.5	10.6	16.0	11.9	15.1	7.6	16.9	13.5	12.2	22.9	15.1	14.4	16.6	7.5	13.0	16.7	14.8	8.4	20.9	10.2	10.6	10.5	11.7	10.6	23.6	24.4	20.7	12.4	16.1	11.9	8.7	9.4	10.3	11.3	18.3	25.5	13.8	8.9	9.6	8.3	6.9	13.9	4.8	8.5	4.9	7.9	11.4	21.2	8.2	8.7	8.3	5.2	8.6	5.2	12.8	13.1	15.3	18.6	7.3	13.4	16.4	10.1	23.3	10.7	11.3	12.6	18.2	8.9	9.8	24.5	13.3	7.5	11.6	26.4	13.8	6.6	16.7	8.9	10.8	9.7	13.2	7.2	12.8	11.2	14.0	10.2	15.2	10.1	7.4	4.6	8.5	20.6	10.5	7.2	18.7	6.3	14.9	7.4	6.8	19.9	20.6	19.0	9.9	20.6	15.2	10.6	15.8	13.1	22.6	6.9	16.1	12.1	24.4	12.4	20.7	23.6	13.0	11.9	16.8	28.8	12.3	19.2	16.2	16.0	16.7	20.0	16.0	14.8	3.0	11.8	0.0	6.0	13.5	3.6	17.7	15.3	56.2	18.2	0.0	9.8	4.9	8.3	4.9	5.5	7.1	6.5	0.0	7.9	8.4	9.1	3.9	2.3	2.9	6.9	6.4	4.1	3.7	2.7	5.5	15.8	5.9	10.1	1.8	7.2	6.0	6.4	8.4	17.3	6.5	6.9	19.4	8.5	29.5	8.8	12.2	6.1	2.2	6.3	4.8
CTNNAL1	"alpha-CATU, CLLP"	ENSG00000119326	"Catenin alpha like 1"	Q9UBT7	9	108942569-109013529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 92.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;NK-cells: 5.8;T-cells: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (2.93e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.67e-1)"	9.9	92.9	5.5	8.0	4.4	10.3	16.5	3.5	8.5	9.1	11.8	1.6	18.0	3.8	11.1	13.6	13.8	9.2	9.4	38.1	4.4	3.8	16.0	15.4	20.9	5.8	5.1	4.7	44.1	10.6	8.3	7.9	14.1	15.1	10.5	5.7	17.2	6.4	17.1	16.2	7.5	6.2	24.9	7.1	9.3	13.1	17.7	2.4	8.0	53.7	6.1	4.4	15.9	12.0	1.4	0.2	4.8	0.3	5.8	8.6	3.0	33.4	11.8	13.2	10.7	9.1	24.1	23.9	44.7	20.1	44.4	29.0	36.8	52.8	10.3	14.0	22.6	34.6	25.2	17.2	39.6	54.5	14.4	10.9	5.4	12.3	24.8	12.6	13.1	1.3	18.6	2.8	23.4	32.4	37.5	21.5	8.6	12.6	10.5	20.2	3.4	9.0	9.5	14.9	31.1	25.3	18.0	35.1	9.1	46.1	7.3	10.3	7.0	14.2	1.4	10.2	13.4	10.6	5.0	24.0	17.7	25.8	15.8	25.0	8.1	7.7	9.6	24.8	10.1	19.7	0.0	0.3	1.3	0.9	0.0	3.0	1.4	1.3	2.4	0.2	0.3	2.1	0.6	4.8	5.8	0.0	0.1	8.6	3.0	5.5	4.4	3.5	8.5	4.4	3.8	5.1	4.7	15.1	2.4	17.9	37.0	11.5	67.2	97.7	6.9	105.5	15.3	76.3	36.4	27.9	27.5	183.1	111.0	70.2	50.4	118.9	3.8	46.7	91.2	85.9	56.1	64.4	4.7	18.7	21.1	31.8	20.2	112.3	5.4	14.5	50.9	14.7	52.3	8.2	16.7	75.9	141.6	11.5	42.5	13.5	14.8	12.9	40.5	93.9	10.4	21.0	72.5	18.7	18.5	18.6
TMEM245	"C9orf5, CG-2"	ENSG00000106771	"Transmembrane protein 245"	Q9H330	9	109015152-109119945	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023892	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023892: AB_1845828"	"unprognostic (1.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.46e-9)"	"unprognostic (6.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-2)"	16.5	35.5	14.4	7.2	18.1	4.0	24.2	15.7	20.6	14.0	19.2	14.7	22.0	7.7	18.4	17.3	14.6	18.7	15.3	25.2	12.6	14.9	29.0	16.2	20.5	12.3	14.5	14.8	29.0	20.3	43.2	14.9	17.5	13.7	16.4	10.7	22.1	14.5	22.3	29.8	9.2	16.8	23.1	13.6	10.4	17.2	12.2	14.3	12.3	52.1	8.9	7.5	20.8	11.2	3.5	3.5	6.3	3.3	5.4	9.0	2.7	13.7	18.4	13.6	4.6	32.0	18.4	30.0	19.9	15.4	21.5	17.0	24.6	27.7	12.5	20.4	15.1	20.9	21.8	17.2	12.8	25.5	16.1	7.4	15.4	15.4	14.5	14.0	11.7	12.2	19.6	13.1	20.9	19.4	23.2	17.9	13.8	10.3	13.8	24.4	9.1	15.5	5.4	15.1	18.6	16.6	8.9	27.0	7.7	22.9	13.5	7.5	7.4	13.1	13.2	13.1	21.1	17.5	6.6	19.6	16.8	12.6	15.6	22.6	9.2	23.8	4.0	23.3	6.3	24.3	6.3	2.6	2.2	4.0	1.8	4.9	2.7	6.8	5.6	2.5	3.5	9.0	6.2	1.0	5.4	3.3	3.5	6.5	2.7	14.4	18.1	15.7	20.6	12.6	14.9	14.5	14.8	13.7	14.3	107.2	79.6	16.9	16.5	22.3	43.1	117.8	63.7	32.1	31.8	82.0	100.1	40.7	3.3	19.7	5.9	48.2	31.1	93.5	27.0	14.5	19.9	23.7	30.1	82.0	15.7	60.4	30.0	48.5	21.0	5.4	38.0	15.7	21.9	10.0	34.9	49.9	24.5	34.3	48.1	28.4	30.3	45.3	36.0	28.7	40.4	24.8	12.6	17.3	34.3	19.9
FRRS1L	"C9orf4, CG-6"	ENSG00000260230	"Ferric chelate reductase 1 like"	Q9P0K9	9	109130293-109167295	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.0;ovary: 15.2"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 51.6;Horizontal cells: 92.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 3.8;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071086	Enhanced					NA	NA					"HPA071086: AB_2686342"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.21e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.02e-2)"	"unprognostic (5.78e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.38e-3)"	0.9	10.9	10.2	1.1	26.6	1.2	1.1	19.3	38.0	2.4	1.2	2.3	0.1	1.3	2.7	4.4	3.2	2.2	2.0	2.0	10.5	12.5	0.8	0.9	1.0	1.0	6.1	13.1	15.2	1.5	4.4	6.0	0.8	6.6	4.9	1.2	3.0	1.1	3.0	0.9	1.1	1.4	2.5	3.5	1.0	1.1	1.7	3.4	0.0	1.0	0.0	0.9	0.9	0.3	1.3	0.8	2.7	1.6	1.3	0.8	0.3	0.1	0.6	3.8	0.2	0.2	0.2	0.5	0.1	0.0	0.1	0.3	0.2	0.3	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.5	0.5	0.3	0.0	0.2	0.3	0.5	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.5	0.2	0.1	0.2	0.7	1.7	0.1	0.1	0.4	0.1	0.2	0.1	0.3	1.5	9.3	0.0	0.2	0.1	0.3	0.2	0.3	0.4	0.2	0.4	0.2	0.1	0.3	0.1	0.1	0.1	0.2	0.2	2.6	0.9	0.6	0.6	1.2	0.5	0.8	0.6	0.5	0.3	1.3	0.8	0.7	2.7	1.3	1.6	0.8	0.4	0.3	10.2	26.6	19.3	25.8	10.5	12.5	6.1	13.1	6.6	3.4	3.0	1.1	0.0	1.2	0.3	51.6	2.0	0.0	0.0	1.2	0.0	2.0	0.2	0.0	0.0	3.8	0.4	1.7	0.0	0.0	0.1	0.7	0.9	1.1	0.0	0.1	92.2	1.2	0.0	0.0	3.1	12.0	0.5	1.7	0.0	0.2	13.1	0.1	0.0	15.9	0.0	5.8	0.0	0.4	0.3	1.1	0.5	0.2	0.0	1.2	0.9
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.2	5.3	0.3	0.4	0.4	0.0	16.0	0.5	0.2	1.8	0.9	9.0	4.2	0.0	1.1	0.5	4.5	6.9	10.6	5.6	2.0	4.4	2.5	0.0	1.7	12.8	1.1	0.2	0.0	0.1	25.1	0.7	8.6	0.5	0.1	3.9	0.1	0.0	2.6	10.7	0.1	0.1	6.9	30.4	7.8	0.0	0.0	0.2	6.4	6.4	6.6	0.7	1.7	11.1	0.0	3.3	2.6	0.0	0.2	3.8	3.9	1.2	1.5	0.0	0.0	0.0	2.8	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3	6.0	3.2	0.8	4.6	10.2	8.3	14.9	22.9	16.0	5.7	7.0	0.0	3.3	0.0	3.2	8.7	0.7	67.5	0.0	18.0	1.6	2.2	9.9	0.0	107.1	0.5	36.5	49.7	4.3	1.6	1.5	12.4	0.2	1.7	0.0	52.8	1.8	12.8	37.4	2.5	0.6	1.0	0.0	0.4	1.4	14.8	21.0	1.6	0.0	34.5	5.7
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase, non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"OE19: 16.9;RPTEC TERT1: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA					"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	2.7	1.9	3.4	4.8	5.0	0.0	4.8	2.1	11.1	4.4	9.4	2.0	10.7	7.6	3.2	13.4	10.3	6.4	6.3	12.1	3.1	2.8	28.8	21.1	4.9	0.5	1.2	3.9	1.5	17.0	10.6	4.9	14.5	4.5	4.7	6.5	3.8	13.1	13.6	38.1	18.8	18.8	0.8	0.9	0.9	5.9	2.1	0.0	1.1	9.4	7.2	9.5	4.1	5.5	0.6	0.3	2.8	0.6	0.3	0.3	0.1	6.3	7.9	0.3	2.1	0.0	0.0	12.6	1.4	0.0	1.7	1.9	4.2	10.4	0.0	1.4	0.1	4.4	15.2	2.2	8.9	1.8	3.5	4.8	0.0	3.8	4.3	0.0	0.0	0.1	0.1	9.6	2.2	4.6	0.7	0.0	2.7	0.0	0.1	0.1	8.0	10.9	1.9	1.0	16.9	5.9	0.0	2.6	0.1	20.6	12.3	5.2	1.1	3.5	13.0	0.0	4.5	7.4	1.0	0.0	0.6	5.0	0.8	0.0	6.3	10.2	0.0	6.8	0.0	4.5	0.4	0.6	0.8	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.6	0.3	0.3	2.8	0.3	0.6	0.3	0.1	0.1	3.4	5.0	2.1	11.1	3.1	2.8	1.2	3.9	4.5	0.0	14.9	25.0	0.0	20.1	10.5	9.6	46.0	20.4	24.1	19.4	29.6	0.0	19.8	14.9	13.1	20.8	2.2	25.4	0.0	16.7	20.5	3.6	23.7	1.1	32.7	2.2	0.0	12.6	4.3	0.0	12.7	1.1	1.9	3.3	1.0	16.5	0.3	22.0	23.5	1.8	16.1	2.1	6.5	6.2	0.9	11.7	18.1	9.0	0.8	17.3	26.2
PALM2		ENSG00000243444	"Paralemmin 2"	Q8IXS6	9	109640788-109946703	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9;liver: 19.7"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 5.9;Fibroblasts: 5.4;Hepatocytes: 14.7;Intestinal endocrine cells: 7.9;Smooth muscle cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 5.9;RH-30: 20.8"	"Low region specificity"	"Detected in many"							"HPA074153, HPA076866"			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.74e-6)"	"unprognostic (8.39e-2)"	14.8	6.1	8.1	2.0	11.1	1.2	6.7	1.7	17.9	4.3	2.4	9.1	0.0	1.8	4.9	1.7	2.4	3.8	3.0	7.6	6.3	1.8	2.7	19.7	4.8	1.5	5.0	9.7	2.3	2.2	1.4	1.6	3.1	8.4	2.4	2.4	0.0	3.2	1.4	2.5	3.1	2.0	2.2	4.9	1.5	2.2	2.7	8.7	0.0	4.3	0.0	1.4	2.8	2.6	0.5	0.1	1.1	0.2	0.3	0.1	0.0	0.1	0.6	0.5	0.0	0.4	0.9	0.2	0.4	1.2	0.7	1.7	0.3	0.7	0.1	0.1	1.9	4.2	1.8	0.0	0.6	1.3	0.1	1.0	0.0	2.5	0.2	0.0	0.0	0.1	2.0	0.8	5.9	0.9	0.6	0.0	0.0	0.0	0.0	2.5	0.5	0.0	0.0	3.4	0.2	1.3	0.0	20.8	0.4	2.9	0.4	3.9	0.0	5.1	0.2	1.6	0.9	2.0	0.4	0.2	2.1	3.0	0.1	1.7	0.1	0.7	0.1	1.6	0.0	2.4	0.3	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.1	0.0	1.1	0.3	0.1	0.1	0.0	0.0	8.1	11.1	1.7	12.7	6.3	1.8	5.0	9.7	8.4	8.7	0.0	0.3	0.0	0.5	1.1	0.0	5.9	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.3	0.0	0.0	0.2	1.5	5.4	0.4	0.0	14.7	0.1	0.0	7.9	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	6.6	0.2	1.0	2.0	0.2	0.0	0.4	0.1
PALM2-AKAP2		ENSG00000157654	"PALM2-AKAP2 readthrough"		9	109780309-110172512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 41.0;heart muscle: 26.8"	"Group enriched"	"Detected in some"	14	"Alveolar cells type 1: 125.0;granulocytes: 32.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.7;hTEC/SVTERT24-B: 15.1;RH-30: 29.7;U-251 MG: 13.2;WM-115: 17.3"									"HPA058905, HPA074153, HPA076866"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: "	"unprognostic (7.12e-2)"	"unprognostic (1.64e-6)"	"unprognostic (7.90e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.36e-5)"	41.0	2.8	1.6	3.3	1.6	0.1	19.6	0.7	4.7	4.8	2.3	1.5	2.1	1.1	15.2	4.7	2.1	2.5	5.0	26.8	1.8	2.4	2.4	24.8	9.7	1.2	1.9	0.5	5.9	1.1	1.6	1.1	9.2	3.0	3.2	0.6	1.1	2.0	3.6	4.5	1.8	1.0	7.8	1.4	0.5	1.1	1.4	0.9	0.0	3.8	2.5	0.3	5.2	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	3.3	0.0	15.7	5.6	1.3	5.5	5.4	1.6	3.7	0.0	0.1	0.0	0.5	5.7	6.5	2.0	0.0	1.3	4.6	0.2	1.6	0.0	5.1	0.1	0.1	0.0	0.0	7.1	0.1	15.1	2.4	4.8	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	4.4	0.0	1.4	0.0	29.7	0.0	4.1	0.0	1.8	0.0	2.1	0.2	7.5	4.6	0.6	0.0	0.1	3.4	8.6	0.3	13.2	0.0	0.2	0.0	4.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.6	1.6	0.7	3.0	1.8	2.4	1.9	0.5	3.0	0.9	125.0	5.8	0.0	0.0	0.0	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0
AKAP2	"AKAP-KL, DKFZp564L0716, KIAA0920, MISP2, PRKA2"	ENSG00000241978	"A-kinase anchoring protein 2"	Q9Y2D5	9	110048598-110172512	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"Alveolar cells type 1: 181.7;granulocytes: 73.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.0;naive B-cell: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 54.2;hTERT-HME1: 58.7"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.77e-1)"	"unprognostic (1.41e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.87e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.30e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	59.5	5.9	6.0	22.7	6.6	3.9	55.1	3.3	5.9	17.6	18.9	3.9	8.0	6.0	19.9	10.3	15.7	13.2	26.4	42.7	6.9	7.4	13.9	10.5	45.8	13.3	8.1	1.4	14.1	5.3	3.5	4.7	46.9	9.4	14.7	8.1	9.8	15.7	14.1	13.7	8.7	11.3	26.2	6.0	30.0	11.9	7.3	3.6	25.3	22.3	10.9	18.6	26.9	34.3	11.5	2.4	2.0	0.1	2.0	3.7	1.2	3.9	1.4	22.3	0.0	17.7	17.9	5.4	21.6	27.0	20.7	18.1	27.2	3.0	18.6	6.2	24.0	27.5	4.6	1.9	19.7	37.5	13.7	1.7	1.8	3.8	1.9	16.3	2.4	54.2	20.5	4.8	31.5	58.7	11.3	31.3	2.9	0.0	15.9	40.0	0.0	12.2	6.2	7.5	1.7	12.1	1.1	5.1	5.0	12.6	0.3	3.8	0.3	0.2	1.8	2.3	17.4	0.1	4.4	49.3	18.3	12.5	28.7	16.6	11.0	16.8	10.8	15.2	10.4	8.1	2.0	0.0	1.1	1.0	0.1	0.2	11.0	1.2	1.4	1.1	11.5	0.8	0.8	0.0	2.0	0.0	2.4	3.7	1.2	6.0	6.6	3.3	5.9	6.9	7.4	8.1	1.4	9.4	3.6	181.7	6.4	3.4	0.1	0.2	0.0	0.4	0.0	1.4	4.5	0.0	0.0	0.5	0.0	0.8	0.0	2.8	0.0	0.0	0.2	0.9	0.9	0.0	73.2	0.8	0.6	0.0	0.0	3.7	0.0	0.0	0.6	0.4	0.0	1.0	0.0	0.0	0.2	0.0	1.8	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	16	"Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"OE19: 57.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.7	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	8.9	12.3	0.0	2.5	0.2	0.0	0.2	22.9	5.3	10.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	7.7	0.0	9.9	0.0	0.2	16.2	0.0	0.9	0.1	0.0	24.9	0.0	0.0	0.0	0.0	0.2	10.1	0.0	113.3	0.0	5.3	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	69.7	4.7
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Cell type enriched"	"Detected in all"	10	"monocytes: 27271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Cell line enhanced"	"Detected in all"		"OE19: 265.0"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	45.9	63.1	17.1	18.8	43.2	56.3	25.2	55.9	52.2	39.0	29.7	40.9	55.4	40.9	24.0	51.6	85.4	103.8	24.3	74.5	38.3	60.7	54.1	20.5	59.2	70.8	49.4	50.9	62.7	39.9	49.1	57.0	43.2	36.3	34.2	26.1	34.5	39.4	53.3	37.2	42.3	76.4	36.4	265.0	77.0	17.8	58.0	47.6	49.8	32.6	37.2	13.3	60.3	49.0	37.9	34.4	47.0	35.2	41.0	40.2	26.0	75.4	69.2	20.0	56.4	34.8	58.3	44.4	55.8	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0	363.3	237.5	189.1	832.3	1158.8	34.8	96.1	504.4	436.3	374.2	249.5	19.6	560.0	824.0	1017.1	20.9	327.5	1162.8	233.6	1150.3	840.4	409.8	774.5	261.1	685.2	516.6	27.0	534.8	206.2	278.9	11.1	373.3	793.2	723.7	27271.2	934.3	40.9	1608.6	1292.8	268.3	2636.4	24.8	142.3	563.4	10.6	70.3	1303.3	391.5	213.2	1478.0	1356.2
TXNDC8	"bA427L11.2, SPTRX-3, TRX6"	ENSG00000204193	"Thioredoxin domain containing 8"	Q6A555	9	110303521-110337884	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	17	"testis: 23.9"	"Group enriched"	"Detected in some"	151	"Early spermatids: 310.1;Late spermatids: 448.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;HeLa: 1.5;NTERA-2: 1.0;SK-BR-3: 1.4;THP-1: 5.8"					"Not detected"	"Not detected"									NA	NA							"unprognostic (1.50e-1)"				"unprognostic (1.13e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	310.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	448.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365251-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 141.1"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 33.2;Leydig cells: 38.9;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 51.6;ASC TERT1: 30.0;BJ hTERT+: 21.1;HHSteC: 18.9;HSkMC: 23.4"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	7	"cerebellum: 31.1"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	18.8	2.5	1.0	3.9	1.8	0.0	11.9	6.7	0.9	7.1	8.6	0.5	3.6	0.6	6.1	7.8	4.7	4.4	5.4	4.4	1.1	0.7	2.1	1.5	8.6	5.8	1.1	0.5	4.2	2.7	2.2	0.7	141.1	0.7	4.3	3.1	1.5	2.2	1.3	7.4	3.5	3.3	5.7	0.6	3.4	3.6	4.0	0.9	0.0	3.5	2.3	1.3	9.6	7.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	51.6	30.0	0.0	5.4	21.1	0.4	0.6	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.1	0.3	0.0	0.1	0.0	0.4	0.0	18.9	0.0	1.0	23.4	0.0	4.1	1.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.5	0.7	0.0	3.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.4	0.8	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	6.7	0.9	1.1	0.7	1.1	0.5	0.7	0.9	0.0	0.3	0.0	0.5	5.0	0.0	1.2	7.6	0.0	0.0	0.0	0.0	7.6	0.0	0.6	0.2	2.1	0.0	0.0	0.2	1.1	33.2	0.2	0.0	0.0	2.7	0.0	0.0	3.1	0.0	0.0	38.9	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.1	1.4	2.9	56.3	0.0	0.0	0.1
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 50.0"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 2.7;Late spermatids: 3.3;Leydig cells: 4.9;Peritubular cells: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"LHCN-M2: 19.8;RH-30: 20.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Not detected"	"Not detected"									NA	NA						"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	7.5	0.3	0.6	5.8	0.7	0.0	0.2	0.1	0.2	0.3	6.8	0.0	0.0	2.3	0.2	4.0	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0.0	0.2	0.6	0.3	1.9	5.3	0.0	0.4	0.0	50.0	0.3	5.0	3.0	0.3	0.2	2.6	5.9	0.0	0.0	0.3	1.4	3.9	3.6	2.9	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	20.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.4"	"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.5;eosinophil: 15.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.6;monocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7"	"Low region specificity"	"Detected in all"							HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	16.3	9.5	55.8	12.0	56.2	0.3	14.8	4.7	30.9	43.7	12.3	71.4	3.4	9.4	12.1	12.3	10.6	10.1	9.8	8.5	55.6	30.6	5.7	1.9	7.3	10.5	59.4	17.0	8.9	4.6	1.1	2.3	25.7	29.1	9.4	12.8	3.5	5.6	17.2	3.3	6.9	10.2	14.0	69.8	9.5	6.5	4.8	49.4	0.1	6.2	3.2	11.3	15.4	17.8	0.0	1.9	15.6	7.5	1.8	0.0	1.6	1.8	3.5	5.0	0.0	98.3	57.4	0.0	24.5	69.5	17.2	7.8	0.4	0.3	0.0	0.0	25.3	3.1	7.3	0.0	19.1	14.2	0.0	0.6	0.0	0.2	0.0	26.6	0.0	0.0	41.7	1.1	8.5	16.2	10.3	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.9	0.0	19.8	0.0	3.7	0.0	3.9	3.3	0.1	1.2	0.5	0.0	0.0	1.0	1.7	0.0	0.0	8.1	0.2	5.8	0.0	0.2	0.0	0.0	1.2	0.0	8.9	0.9	7.5	15.6	0.0	2.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	1.8	1.1	0.1	0.0	1.6	55.8	56.2	4.7	29.5	55.6	30.6	59.4	17.0	29.1	49.4	0.0	0.6	0.0	10.4	11.6	0.0	0.8	0.0	2.7	10.3	0.0	0.0	0.5	1.7	1.3	1.0	1.7	5.1	0.0	2.5	0.3	45.6	9.6	0.0	0.0	3.3	0.0	0.0	3.1	3.3	1.5	35.9	2.5	13.5	12.6	3.7	1.1	1.7	0.0	66.4	0.0	0.0	0.0	7.2	0.0	2.4	8.2	0.7	0.0	4.0	5.5
OR2K2	"HSHTPCRH06, HTPCRH06, OR2AR1P"	ENSG00000171133	"Olfactory receptor family 2 subfamily K member 2"	Q8NGT1	9	111327483-111330183	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.2;skeletal muscle: 1.6;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.7;Karpas-707: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024261	Uncertain					NA	NA					"HPA024261: AB_1854786"					"unprognostic (1.03e-1)"													0.0	0.2	0.3	0.0	0.4	0.4	0.4	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.9	0.8	0.0	0.0	0.0	0.1	1.8		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.2	1.6	0.7	0.0	0.2	3.2	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ECPAS	"ECM29, FLJ22036, KIAA0368"	ENSG00000136813	"Ecm29 proteasome adaptor and scaffold"	Q5VYK3	9	111360692-111484745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 92.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 53.6;Alveolar cells type 2: 52.8;Ciliated cells: 44.2;Club cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021646, HPA059795"	Uncertain		Approved	Nucleoplasm		Yes	No			Nucleoplasm		"HPA021646: AB_2670788, HPA059795: AB_2684127"	"unprognostic (1.64e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.05e-1)"	21.0	17.2	16.4	12.9	29.0	13.2	19.4	18.4	18.1	16.6	16.6	14.1	20.8	17.1	18.9	17.2	13.6	14.3	13.2	19.9	27.4	13.7	16.0	16.6	12.7	13.8	15.1	12.8	17.9	19.2	28.5	20.8	12.8	15.7	19.2	16.4	13.7	14.9	23.3	92.6	15.3	17.8	19.5	11.5	13.9	15.7	18.3	11.5	8.7	17.7	23.7	14.5	17.8	18.5	5.6	11.6	4.0	8.6	6.6	8.2	3.6	20.7	19.2	12.9	13.8	30.8	30.9	21.2	25.6	22.0	21.1	14.6	17.8	12.9	21.0	12.1	22.4	17.3	30.3	16.4	17.1	19.7	23.1	10.3	12.9	23.2	25.5	22.9	24.1	14.2	28.0	18.0	21.1	31.5	24.0	21.4	5.3	29.7	29.8	17.2	17.6	0.1	14.1	25.2	26.6	16.1	11.8	39.6	12.6	17.9	18.7	24.7	11.8	21.9	23.6	16.0	14.6	18.5	12.9	23.3	14.2	16.3	21.2	23.4	26.4	49.2	25.8	20.8	10.0	13.1	4.0	8.2	2.7	6.9	8.6	8.2	5.6	7.4	8.0	11.6	5.3	4.5	7.6	2.6	6.6	6.2	5.3	5.8	3.6	16.4	29.0	18.4	18.1	27.4	13.7	15.1	12.8	15.7	11.5	53.6	52.8	0.0	0.0	0.0	0.0	0.0	0.0	44.2	60.3	12.2	0.0	13.8	8.3	18.8	0.0	0.0	0.0	0.0	18.6	9.6	0.0	0.0	22.1	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	19.0	0.0	0.0	20.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3;pituitary gland: 40.4"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 44.0;Horizontal cells: 33.4;Muller glia cells: 21.7;Rod photoreceptor cells: 22.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli		NA	NA			Nucleoli		"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	3.2	10.1	13.9	2.1	30.5	7.7	5.6	35.9	36.3	6.1	4.0	8.6	2.9	2.0	10.0	11.9	2.4	7.0	4.9	4.7	18.1	7.3	5.1	2.5	3.9	3.4	9.5	23.0	12.6	4.3	13.6	40.4	1.8	24.4	7.2	2.4	5.9	3.2	7.7	2.3	3.5	2.9	5.5	9.8	4.8	3.9	11.8	10.3	0.0	12.5	0.0	3.1	4.7	4.8	2.5	1.0	4.6	1.0	2.1	6.5	1.5	0.3	3.2	3.2	4.8	0.4	0.6	1.0	0.4	1.6	3.2	3.0	0.4	1.5	0.5	0.5	1.3	2.4	0.9	1.5	1.7	1.9	0.2	1.9	1.7	4.5	2.6	0.9	0.6	0.4	1.2	0.6	1.7	0.9	2.4	2.9	2.1	1.3	0.9	0.7	3.0	0.2	0.8	11.8	1.5	1.1	0.3	4.9	0.4	1.2	1.3	6.9	3.3	1.2	0.6	0.8	3.0	1.9	0.4	0.5	1.0	1.6	1.5	2.2	0.7	1.9	0.4	1.1	0.5	0.7	4.6	1.0	0.6	4.8	0.5	2.7	1.5	3.3	2.3	0.3	2.5	5.9	6.5	3.4	2.1	0.7	1.0	1.6	1.5	13.9	30.5	35.9	36.3	18.1	7.3	9.5	23.0	24.4	10.3	0.0	7.5	0.0	4.4	0.7	44.0	2.9	0.0	1.4	6.8	7.0	19.6	0.9	5.0	0.8	17.5	1.8	0.2	0.0	1.8	0.5	3.1	3.3	0.0	2.1	0.3	33.4	2.9	0.6	0.0	6.7	4.4	1.0	1.7	0.0	0.0	21.7	0.9	0.0	9.6	0.0	22.6	6.5	2.3	7.5	2.7	1.3	0.6	0.0	0.1	3.0
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599855	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;liver: 113.8"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 377.0;Hepatocytes: 710.5;Proximal tubular cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"OE19: 135.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		940000			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	9.9	23.7	6.7	3.4	8.1	0.4	8.0	9.7	10.0	8.0	116.3	2.2	3.0	45.2	8.0	7.8	27.4	14.3	15.2	7.7	7.0	4.2	47.3	113.8	5.2	2.6	3.3	6.6	5.9	4.3	6.2	9.0	3.2	6.4	12.3	6.7	6.8	11.4	6.4	3.3	6.7	117.6	8.7	2.5	2.2	21.2	3.3	3.4	1.1	9.0	36.4	12.5	21.9	23.6	0.3	8.9	0.2	0.9	0.0	0.2	0.5	7.7	32.9	9.6	0.1	35.3	35.7	7.5	12.6	19.2	12.0	12.6	8.9	10.6	0.0	3.6	12.0	23.8	9.5	7.7	13.3	14.9	0.0	2.3	1.9	20.4	43.3	8.1	1.1	4.0	25.4	20.1	16.5	8.4	14.2	30.4	0.0	1.3	0.0	23.3	2.3	0.0	0.2	3.9	135.6	8.1	0.0	2.7	0.2	14.1	25.3	10.8	0.5	15.5	4.7	4.6	10.1	14.5	5.2	24.5	2.3	4.9	26.9	2.2	0.0	0.0	0.0	11.5	0.0	2.9	0.0	0.9	0.0	0.0	0.1	0.2	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	8.9	0.0	0.5	6.7	8.1	9.7	10.0	7.0	4.2	3.3	6.6	6.4	3.4	17.9	24.1	7.4	46.4	34.3	15.0	31.9	377.0	41.5	26.1	134.3	23.6	41.2	127.6	59.9	2.6	22.5	52.9	0.0	153.0	26.9	30.9	61.7	1.1	710.5	45.6	0.0	25.5	47.3	25.0	2.2	30.8	19.7	33.7	37.9	29.6	37.3	177.9	43.2	37.1	445.1	42.8	12.9	54.5	8.7	4.5	26.7	17.2	5.1	43.5	89.4
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631352-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 41.9"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	5.1	10.2	3.3	3.9	4.6	1.9	5.8	4.5	4.2	3.4	5.1	2.5	5.7	4.6	4.1	7.7	3.4	3.8	3.6	6.7	4.3	3.8	7.8	41.9	3.5	4.1	2.7	2.3	5.7	7.0	7.4	9.0	4.4	3.3	5.9	3.0	3.6	9.7	4.0	3.6	2.4	6.9	5.0	2.9	2.9	3.7	4.2	1.9	1.4	4.3	2.4	2.2	6.4	4.5	0.6	1.1	1.2	1.9	0.4	0.8	0.3	2.6	2.0	1.4	2.4	14.7	6.6	5.4	10.2	4.9	4.0	4.0	3.9	1.7	2.3	4.0	7.0	6.3	8.6	1.5	2.9	3.9	1.9	2.0	2.3	0.0	7.9	4.8	4.3	3.4	5.7	8.3	3.1	5.9	3.2	3.3	1.3	4.6	2.0	5.1	2.9	1.3	0.2	2.5	5.1	4.8	2.2	7.5	2.1	8.4	2.9	2.4	1.3	5.7	8.0	3.6	2.6	4.2	1.1	6.4	4.9	2.2	13.1	5.8	3.7	5.6	1.3	8.4	2.1	4.3	0.0	0.1	1.2	0.6	1.9	0.2	0.3	0.5	0.0	0.5	0.6	0.5	0.2	0.8	0.4	1.0	1.1	0.8	0.3	3.3	4.6	4.5	4.2	4.3	3.8	2.7	2.3	3.3	1.9	6.0	11.0	14.5	13.2	9.4	7.7	9.0	7.6	13.4	12.5	10.4	19.6	11.8	11.6	13.6	7.8	4.9	17.6	0.0	14.1	18.7	13.1	26.6	1.1	75.4	10.9	12.7	16.6	6.7	5.0	1.4	9.5	7.9	11.8	4.6	14.9	3.9	11.0	7.4	9.6	10.7	20.2	12.9	11.3	29.8	11.9	8.2	11.6	7.9	10.9	17.1
DNAJC25-GNG10		ENSG00000244115	"DNAJC25-GNG10 readthrough"		9	111631386-111670229	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 9.6;Ciliated cells: 14.7;Club cells: 13.6;granulocytes: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 36.2"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 36.2"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"													NA	NA																							14.5	13.5	17.1	12.7	13.0	12.5	10.3	8.3	11.5	8.4	9.2	5.1	10.2	5.6	8.7	13.2	6.1	8.4	6.0	11.7	10.9	13.4	13.5	46.9	8.0	7.6	12.2	4.8	10.1	12.2	9.8	15.3	12.7	6.4	12.2	5.4	6.8	16.4	7.3	7.0	2.9	12.0	9.0	7.7	9.7	7.1	7.8	4.2	3.3	7.9	4.9	4.8	11.6	8.2	0.8	2.5	36.2	3.3	0.7	1.9	1.8	10.6	4.9	6.6	10.1	17.4	18.4	8.9	13.3	12.7	8.7	7.9	6.5	9.5	1.0	6.2	12.9	19.0	9.5	8.5	12.3	17.7	2.5	5.0	1.9	6.6	4.7	11.7	5.1	5.5	12.1	12.9	6.9	21.0	15.2	13.5	5.4	4.6	4.2	17.5	5.7	3.9	5.1	7.8	19.7	8.2	3.2	28.0	0.7	18.8	6.7	7.7	6.8	10.8	4.8	13.3	10.4	11.5	6.8	10.5	10.7	9.0	24.5	12.4	4.5	4.2	2.0	15.7	11.6	7.1	1.4	3.3	4.3	0.7	3.0	1.4	0.6	1.1	0.9	2.5	0.8	1.3	0.7	36.2	0.7	2.6	1.7	1.9	1.8	17.1	13.0	8.3	9.4	10.9	13.4	12.2	4.8	6.4	4.2	11.9	9.6	0.0	0.1	0.0	0.0	0.0	0.0	14.7	13.6	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.1	5.8	0.2	0.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
GNG10		ENSG00000242616	"G protein subunit gamma 10"	P50151	9	111661335-111670246	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Paneth cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 75.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 75.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.62e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.91e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.42e-1)"	32.3	33.1	36.9	31.0	31.9	25.3	20.1	11.9	30.5	21.4	18.5	17.3	7.7	12.5	21.6	16.8	15.2	16.9	20.6	23.2	29.9	30.4	19.7	24.7	21.5	34.2	27.6	20.1	16.6	17.1	25.9	34.6	28.1	18.6	28.3	16.3	17.4	20.1	15.4	11.1	7.5	18.5	23.5	26.8	32.3	16.4	11.8	18.3	11.8	20.3	11.9	13.8	32.5	15.1	2.1	7.3	75.4	8.7	1.7	4.6	4.7	22.9	11.5	9.8	14.9	36.4	25.8	16.3	23.9	30.1	23.4	21.6	17.6	16.7	1.2	10.1	31.0	34.9	17.2	17.8	23.3	27.1	7.9	18.7	2.9	12.9	13.4	23.8	9.2	8.2	23.5	16.8	20.6	27.8	24.7	26.9	10.4	9.8	6.0	37.7	15.2	6.1	7.5	17.2	34.2	27.0	4.7	45.6	1.2	43.5	14.7	15.3	12.9	23.9	11.6	21.9	15.7	26.4	14.8	18.7	21.4	17.7	43.4	25.4	3.7	7.3	2.6	31.0	22.4	13.8	3.0	8.7	11.8	2.0	7.8	3.2	1.6	2.7	2.5	7.3	2.1	2.9	2.1	75.4	1.7	6.5	4.6	4.6	4.7	36.9	31.9	11.9	30.5	29.9	30.4	27.6	20.1	18.6	18.3	11.9	11.7	2.4	0.8	1.5	0.4	0.2	5.1	13.4	12.5	1.8	0.0	3.9	0.0	18.5	0.1	2.1	7.3	0.0	18.3	4.4	2.4	1.0	9.3	2.4	6.2	0.0	13.3	5.5	11.1	0.0	1.7	8.4	0.0	10.0	10.6	1.0	18.9	22.1	2.1	3.1	0.4	0.0	1.2	0.0	0.0	1.0	1.3	1.3	9.9	1.4
C9orf84	FLJ32779	ENSG00000165181	"Chromosome 9 open reading frame 84"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 33.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 46.5;Spermatocytes: 81.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 4.1"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA032108			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.1	2.9	0.1	0.5	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.0	0.3	0.6	0.2	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	1.1	33.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.2	0.2	4.1	0.0	0.1	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.8	1.1	0.4	0.0	0.0	0.3	0.0	0.0	22.4	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.1	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	0.0	0.0	0.1	0.0	0.6	1.2	0.0	1.4	1.2	0.0	2.0	0.0	13.3	0.0	46.5	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.6	0.0	11.5	2.8	0.0	0.0	0.0	0.0	0.2	0.9	0.0	3.5	0.0	0.3	6.5	0.0	81.0	5.5	0.0	0.0	0.0	0.0	0.7
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896766-111935369	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Urothelial cells: 446.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"plasmacytoid DC: 39.7"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 39.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA					"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	33.7	37.7	5.9	21.4	7.8	55.2	20.5	9.5	11.2	14.6	19.6	5.0	3.3	13.3	10.6	8.6	34.0	11.1	24.5	17.5	8.6	9.0	23.8	18.4	28.1	35.4	7.1	5.8	15.9	11.4	3.5	11.9	15.3	6.8	12.4	10.5	11.9	10.8	5.4	14.0	21.7	25.5	12.4	12.9	33.1	26.1	11.7	6.2	17.9	8.5	16.9	27.7	34.2	25.9	2.0	39.7	0.4	0.3	0.5	1.2	0.5	23.1	2.4	4.0	2.7	8.8	10.6	2.1	14.5	15.3	17.0	23.1	4.9	17.8	5.5	11.5	9.6	37.3	11.9	4.7	6.3	18.3	2.2	2.7	2.2	3.7	2.4	6.3	2.4	3.6	10.5	4.9	16.2	23.4	39.5	5.2	2.7	12.1	10.7	50.2	3.9	2.6	2.7	4.6	7.8	2.6	3.0	28.9	1.7	39.1	8.8	1.9	3.1	6.4	5.4	15.9	25.1	29.2	2.5	24.4	7.8	4.0	21.9	10.3	2.0	7.3	2.5	9.7	1.5	10.6	0.0	0.1	0.0	0.4	0.2	0.7	1.6	0.8	0.6	0.6	2.0	0.7	0.7	0.4	0.5	0.3	39.7	1.2	0.5	5.9	7.8	9.5	11.2	8.6	9.0	7.1	5.8	6.8	6.2	38.7	48.5	29.9	123.9	67.2	26.0	9.2	30.6	115.1	113.7	27.9	58.9	5.7	14.9	98.3	14.5	72.6	52.6	0.0	43.7	10.2	46.0	156.5	10.4	15.5	19.6	17.5	17.7	92.7	30.2	3.6	45.5	30.8	55.6	69.5	41.5	7.8	67.4	21.0	36.0	56.0	14.2	12.9	60.8	1.6	1.5	106.9	2.9	26.6	12.8	446.9
SUSD1	DKFZP761E1824	ENSG00000106868	"Sushi domain containing 1"	Q6UWL2	9	112040785-112175408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 24.1;monocytes: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 24.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 24.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7;HEL: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048554	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		530000	Nucleoplasm		"HPA048554: AB_2680439"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (3.63e-6)"	"unprognostic (2.14e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	9.6	13.9	9.1	9.7	13.9	14.1	8.4	3.1	15.3	7.6	10.2	2.7	11.6	8.6	5.7	9.8	4.8	6.7	7.6	11.2	6.1	16.4	15.5	4.4	11.5	15.7	8.3	8.2	3.3	8.1	9.4	8.2	23.3	7.4	5.8	11.4	8.1	10.7	12.8	2.9	3.6	9.9	9.3	5.1	14.5	12.2	5.8	3.5	9.6	5.6	1.4	6.6	13.1	4.6	0.2	24.9	5.8	2.7	1.7	1.6	1.1	1.3	8.5	6.1	0.0	4.5	3.0	19.5	5.4	7.3	7.7	9.9	16.9	11.4	0.1	6.1	9.5	0.5	3.9	2.1	1.0	5.8	22.7	1.8	25.7	6.2	11.4	5.4	6.7	8.3	3.7	0.8	4.3	0.1	5.3	17.9	3.8	13.9	1.1	4.8	1.6	0.9	4.1	2.0	21.0	1.3	5.7	1.4	0.0	1.8	4.5	2.1	5.2	3.0	0.6	0.0	3.5	1.0	7.3	13.6	0.1	2.9	0.8	0.0	0.3	0.3	0.5	5.3	2.6	1.6	3.5	1.4	5.8	1.6	1.6	0.5	0.1	0.4	1.1	1.0	0.2	0.2	1.2	0.5	1.7	2.7	24.9	0.1	1.1	9.1	13.9	3.1	15.3	6.1	16.4	8.3	8.2	7.4	3.5	0.0	4.5	1.5	1.2	0.5	0.0	1.9	2.5	6.7	5.7	12.2	0.0	7.4	0.0	5.6	1.7	2.3	4.7	0.0	6.2	8.8	4.0	1.8	5.7	0.0	14.2	0.0	4.1	10.4	24.1	1.2	0.0	10.8	0.0	18.0	4.5	0.0	8.8	3.5	1.8	1.7	1.6	0.0	3.8	0.3	0.3	0.6	7.2	4.9	5.6	7.3
PTBP3	"DKFZp781I1117, ROD1"	ENSG00000119314	"Polypyrimidine tract binding protein 3"	O95758	9	112217716-112333667	"Predicted intracellular proteins"	"Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048374			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048374: AB_2680376"	"unprognostic (6.12e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.38e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.39e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.10e-2)"	22.4	9.4	7.2	24.5	9.2	22.9	26.3	9.5	6.8	17.2	21.7	5.6	18.9	17.7	14.3	18.9	38.4	10.0	17.2	11.6	6.1	8.7	26.8	12.7	25.1	37.2	6.2	4.5	13.0	17.9	9.0	17.8	25.8	6.6	13.8	22.1	9.0	20.2	22.6	8.0	25.0	32.4	12.8	11.4	23.9	20.9	22.6	6.6	41.7	12.6	30.7	38.4	22.1	21.5	7.0	11.8	23.9	9.5	4.3	8.7	4.5	20.0	21.3	8.1	7.0	7.2	7.9	41.5	8.2	6.7	10.1	10.5	24.2	30.1	23.0	9.2	10.6	8.0	28.5	11.2	23.4	13.5	25.6	3.9	23.3	8.8	17.0	9.1	30.5	28.4	8.9	15.9	13.5	18.7	6.4	17.1	17.9	31.1	21.6	11.5	18.7	30.1	8.3	12.8	31.0	7.3	19.6	27.7	11.6	14.9	26.6	10.2	6.5	16.3	21.4	7.9	18.2	25.3	13.8	13.2	8.9	12.2	12.8	10.1	11.1	27.4	20.9	7.7	15.6	8.7	14.2	6.3	11.8	8.4	7.7	8.7	5.5	6.3	6.8	7.2	7.0	5.0	6.0	23.9	4.3	9.5	11.8	6.5	4.5	7.2	9.2	9.5	6.8	6.1	8.7	6.2	4.5	6.6	6.6	26.8	59.3	29.8	34.2	71.2	7.7	6.7	63.7	69.6	70.5	108.2	17.7	29.6	24.9	37.2	53.1	41.4	73.5	46.7	61.6	89.7	27.7	65.8	62.5	27.0	49.5	7.9	86.8	43.6	100.8	105.3	20.1	76.6	27.0	63.1	73.2	3.5	88.0	63.3	17.7	25.4	15.7	19.4	25.9	17.2	19.8	90.8	29.3	57.3	69.2	200.8
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.0	13.5	10.2	5.1	17.7	17.5	11.7	10.3	6.4	7.4	6.2	25.9	17.0	9.7	5.7	15.1	9.5	17.3	10.9	14.5	9.1	40.5	7.2	10.0	21.8	25.3	11.0	5.6	6.5	18.6	10.5	11.0	8.0	10.8	8.5	11.9	13.9	6.5	20.1	9.9	13.9	5.3	6.0	36.1	17.5	9.1	30.7	14.2	15.6	13.7	7.3	5.2	25.9	17.2	8.7	8.7	24.3	6.9	9.7	10.7	10.0	29.7	10.0	7.7	18.9	4.6	13.2	8.4	6.2	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5	92.3	61.8	13.9	14.4	11.7	9.4	160.9	12.7	48.2	43.3	14.0	5.9	21.7	54.7	13.9	135.8	13.9	29.7	0.0	16.4	25.3	13.4	15.9	30.0	98.6	31.2	6.4	14.3	19.6	18.9	127.6	25.3	23.6	8.5	56.9	28.3	22.3	14.4	24.6	44.2	86.7	14.6	45.3	30.3	11.8	16.2	14.2	26.5	7.5	34.3	26.2
KIAA1958	FLJ39294	ENSG00000165185	KIAA1958	Q8N8K9	9	112486847-112669397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020625	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA020625: AB_1852451"	"unprognostic (3.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.58e-1)"	2.6	14.7	8.6	2.8	14.4	8.7	6.3	21.2	11.7	10.4	3.0	10.8	5.6	3.7	7.0	3.1	3.6	6.3	3.1	2.8	7.8	5.2	11.7	6.9	7.8	2.9	14.0	6.2	19.9	10.8	4.1	8.0	1.9	11.3	3.5	3.4	5.5	5.5	8.0	2.7	4.0	3.9	6.5	10.6	3.2	8.8	11.0	16.5	4.7	5.0	0.4	2.9	3.8	4.8	2.1	2.4	2.6	2.8	2.4	2.7	1.5	2.9	4.2	17.3	5.0	1.2	0.3	8.3	2.2	0.7	2.7	3.0	7.7	2.0	9.5	2.6	7.2	1.8	2.6	12.7	1.2	3.8	2.9	5.1	3.7	5.7	5.4	0.7	5.6	4.7	0.5	1.0	3.5	1.7	2.4	2.1	9.0	8.6	2.4	0.8	3.4	8.7	3.2	9.5	6.9	2.0	7.1	9.9	2.7	3.6	4.1	8.9	9.4	3.7	3.9	2.2	10.0	3.5	5.7	0.4	0.9	5.2	0.6	2.7	4.5	8.1	5.7	1.2	3.9	0.7	1.4	2.8	0.2	2.1	0.9	0.9	0.3	0.8	1.6	0.9	2.1	2.0	2.7	2.6	2.4	0.8	2.4	0.4	1.5	8.6	14.4	21.2	11.7	7.8	5.2	14.0	6.2	11.3	16.5	3.0	13.4	0.0	3.6	4.1	19.3	3.6	2.5	2.7	9.1	1.8	13.7	1.0	6.6	2.5	3.4	0.8	3.6	0.0	5.9	0.9	1.7	5.6	0.0	6.8	0.8	6.4	4.6	0.6	3.5	1.5	6.1	4.1	1.7	0.0	4.4	11.6	3.3	4.3	4.9	9.8	11.0	6.5	2.1	1.1	4.7	4.1	0.7	1.0	5.2	3.5
INIP	"C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C"	ENSG00000148153	"INTS3 and NABP interacting protein"	Q9NRY2	9	112683926-112718236	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020382	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020382: AB_1845840"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.67e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.47e-3)"	"prognostic favorable (2.00e-8)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.26e-1)"	9.0	11.3	16.1	9.8	17.3	11.4	14.7	18.7	22.9	10.9	12.4	21.0	4.4	12.8	9.6	11.2	12.6	10.4	11.0	9.3	16.8	15.6	15.1	13.7	10.5	16.6	18.6	14.4	11.0	8.1	11.1	18.4	7.5	20.6	8.9	14.8	7.8	10.2	8.6	7.6	11.4	13.4	9.7	19.3	12.5	8.7	8.2	18.2	17.3	13.6	6.1	17.1	12.6	9.2	15.0	21.2	25.1	23.0	13.1	19.5	14.8	8.5	8.4	11.6	16.6	10.1	10.8	11.9	12.1	6.7	10.7	10.7	10.0	7.0	23.0	7.6	8.3	7.7	12.2	11.4	5.3	14.3	27.3	6.7	9.5	10.0	9.4	6.5	19.2	7.2	5.3	8.0	11.2	9.2	5.2	9.9	11.7	16.3	15.0	11.6	13.9	17.0	9.9	6.0	15.5	15.6	19.1	24.7	9.9	12.1	11.7	15.2	11.4	15.2	9.8	7.8	8.1	14.6	12.0	8.1	8.6	13.5	16.7	11.6	7.5	31.3	19.4	11.0	11.2	14.4	17.7	19.7	25.1	13.4	23.0	17.5	12.5	17.2	19.5	21.2	15.0	19.0	16.3	16.0	13.1	19.8	7.5	15.8	14.8	16.1	17.3	18.7	22.9	16.8	15.6	18.6	14.4	20.6	18.2	20.8	17.0	13.2	16.0	32.5	16.5	12.9	22.9	8.1	18.2	14.0	15.7	18.3	48.0	20.2	1.5	17.9	14.2	0.0	14.2	26.5	13.3	15.6	25.5	15.3	22.8	41.3	21.5	13.5	17.4	1.5	13.0	29.0	18.6	36.9	17.3	19.3	18.3	8.6	11.3	21.9	15.7	0.0	14.1	12.9	18.3	36.5	12.4	21.8	18.0	24.0
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750838-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 65.1;Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	4.9	4.4	12.2	7.7	12.6	8.3	7.7	18.1	18.5	10.9	11.1	25.6	3.6	7.9	6.4	4.1	5.3	3.8	5.4	3.4	14.2	12.0	23.7	5.2	23.4	8.8	14.8	12.8	6.9	5.2	6.9	6.3	5.1	14.7	4.1	11.7	4.9	7.1	4.3	2.6	5.7	8.9	7.5	20.3	7.4	4.7	12.7	11.8	2.3	3.1	2.6	8.7	5.4	4.6	0.7	4.2	1.5	5.1	0.8	1.7	1.6	6.0	3.8	6.6	5.2	8.3	7.6	5.5	5.2	10.9	4.4	4.2	13.5	1.4	10.1	4.4	13.4	7.9	7.2	7.9	3.1	6.9	3.2	3.7	3.1	3.4	5.4	6.0	3.1	5.6	6.2	4.3	6.8	5.1	11.2	3.8	2.6	4.8	5.8	5.9	4.2	2.0	3.6	7.2	9.8	4.0	4.3	15.4	2.6	8.6	10.6	9.8	3.1	6.8	9.4	13.0	7.0	7.0	5.6	4.2	6.6	7.0	19.3	4.4	15.1	13.9	4.8	8.5	2.9	12.8	0.0	5.1	1.5	0.8	2.0	1.7	0.0	0.8	1.0	4.2	0.7	0.7	0.6	0.7	0.8	2.1	0.7	1.6	1.6	12.2	12.6	18.1	18.5	14.2	12.0	14.8	12.8	14.7	11.8	6.0	65.1	0.0	1.9	7.2	5.7	3.8	5.1	1.4	9.1	5.2	9.8	0.4	5.0	2.1	5.3	3.0	12.4	46.7	2.8	1.6	5.7	3.1	6.9	5.9	11.9	7.9	4.6	12.3	19.7	6.3	5.2	12.5	20.3	1.0	9.7	2.6	3.4	17.3	7.4	33.2	2.7	0.0	1.4	5.5	10.5	9.7	0.3	3.8	8.6	5.4
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890913	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 35.7;Kupffer cells: 13.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 17.0;intermediate monocyte: 8.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 17.0"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.1;U-2197: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved					NA	NA					"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.2	0.1	0.1	0.5	0.1	0.0	1.0	1.1	0.5	17.7	0.1	0.0	21.1	0.0	3.6	10.4	1.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	17.1	1.9	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.8	0.0	0.1	0.4	9.9	0.1	22.3	0.2	0.6	0.2	1.0	0.1	1.5	0.0	31.8	0.1	0.0	0.3	5.4	0.7	0.0	3.8	0.2	17.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.2	0.1	0.2	0.0	0.0	1.1	0.0	1.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	6.5	0.1	0.0	4.1	0.1	0.1	1.1	0.5	0.1	0.3	0.1	0.2	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.4	2.5	1.4	2.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	13.2	1.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ZNF883		ENSG00000285447	"Zinc finger protein 883"	P0CG24	9	112997120-113050043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 32.4;Cone photoreceptor cells: 15.7;Distal tubular cells: 18.3;Horizontal cells: 15.9;Rod photoreceptor cells: 39.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;BJ: 1.2;BJ hTERT+ SV40 Large T+: 1.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;fHDF/TERT166: 3.6;RPTEC TERT1: 3.2;U-2 OS: 1.8"															NA	NA																							0.7	0.2		0.0		0.6	0.0		0.6	1.3	0.1			0.0	0.7	0.0	0.0	0.0	0.0	0.0			0.2	0.0	0.5	0.0			0.9	0.9	0.0		0.0		0.6	0.0		0.8	0.0	0.0	1.3	0.0	0.0		0.0	0.2	0.0			0.0		0.2	0.0		0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	1.2	3.5	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	1.8	0.7	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.6	0.3	32.4	10.5	0.0	0.0	0.0	3.5	15.7	0.0	18.3	5.8	1.7	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	15.9	1.2	4.3	0.8	2.1	0.3	0.2	0.0	0.0	0.1	13.5	0.2	0.0	4.6	2.3	39.3	0.0	1.0	3.0	9.7	0.5	0.0	0.0	0.6	0.9
ZFP37	ZNF906	ENSG00000136866	"ZFP37 zinc finger protein"	Q9Y6Q3	9	113038380-113056759	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049112	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			"Nucleoplasm, Vesicles"		"HPA049112: AB_2680637"	"unprognostic (3.18e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.54e-3)"	"prognostic favorable (1.96e-4)"	"unprognostic (7.84e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.22e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.07e-1)"	3.8	4.4	4.9	3.1	19.2	0.9	6.7	10.9	9.9	6.5	3.6	5.3	4.0	2.1	10.5	5.8	3.2	6.3	3.5	3.7	10.5	5.6	5.8	1.7	3.2	2.8	6.7	10.6	17.0	3.2	4.3	8.5	3.2	10.7	6.3	2.9	2.8	3.2	4.8	3.2	3.2	2.5	6.2	9.1	4.7	3.0	5.1	5.9	0.4	6.9	2.4	3.2	4.3	5.6	2.3	0.9	0.2	0.4	1.3	5.6	0.7	0.6	1.8	7.7	6.4	4.3	8.3	3.9	2.4	3.6	2.7	2.3	0.0	1.8	4.3	1.9	2.5	3.5	1.6	0.0	0.9	4.2	5.3	0.9	0.2	3.8	2.0	2.3	0.0	0.9	2.3	0.8	3.2	6.3	6.6	1.5	0.0	0.4	3.8	5.6	0.0	0.0	0.0	7.9	4.6	0.0	0.0	10.7	0.6	2.0	0.0	6.6	6.2	7.5	1.6	1.4	4.0	6.3	0.0	0.6	6.3	2.8	7.3	3.6	1.5	2.9	0.0	4.8	0.1	3.8	0.2	0.1	0.1	2.5	0.4	1.9	2.3	2.2	2.2	0.9	1.1	1.8	2.5	0.2	1.3	0.0	0.1	5.6	0.7	4.9	19.2	10.9	9.9	10.5	5.6	6.7	10.6	10.7	5.9	0.0	0.3	0.0	0.8	0.2	10.6	2.0	0.0	0.0	0.0	0.0	5.9	0.7	3.3	1.2	0.6	2.2	0.0	0.0	0.8	1.3	2.1	0.4	5.7	1.1	0.4	6.4	1.2	1.3	0.0	0.0	2.0	0.4	0.0	0.0	0.1	3.1	0.2	0.2	2.1	2.2	5.2	6.5	1.5	5.6	4.1	0.0	0.1	0.5	0.1	0.4
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.5	2.5	1.4	2.0	22.2	9.1	4.8	4.2	5.4	5.1	4.9	1.8	1.7	0.3	0.8	3.5	8.3	20.6	2.0	12.0	4.8	2.8	0.8	0.3	1.2	2.9	8.5	2.2	1.2	10.2	33.7	11.9	23.1	2.7	2.7	2.7	1.6	3.0	26.6	5.3	2.1	1.3	0.7	2.8	2.3	0.4	20.1	0.4	1.7	3.4	1.3	2.2	5.8	17.8	1.7	1.2	6.4	2.0	2.5	2.8	1.9	9.2	3.6	1.9	3.9	0.2	8.8	2.9	2.8	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2	8.9	8.6	18.0	5.3	33.0	6.9	0.4	2.5	10.7	5.7	1.8	33.4	80.2	3.3	10.7	2.3	6.7	17.4	0.0	6.6	5.8	13.3	7.9	0.0	18.7	55.9	6.4	3.4	17.2	82.1	2.0	14.7	93.6	0.0	89.2	3.2	8.2	13.8	7.0	8.9	17.4	9.1	19.4	8.9	30.6	5.1	33.5	36.0	8.3	3.5	4.2
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FK506 binding protein 15"	Q5T1M5	9	113161006-113221361	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 53.0;Kupffer cells: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	19.8	17.8	16.7	25.3	21.9	19.2	19.4	18.6	21.6	16.9	15.3	25.4	14.2	15.1	18.1	17.0	18.8	16.7	14.4	16.4	16.2	13.1	15.7	17.2	26.7	30.9	22.6	15.4	18.6	17.5	34.7	22.1	24.4	19.2	17.2	18.7	17.6	20.0	22.3	19.2	22.3	18.2	20.5	23.5	36.5	15.9	6.8	20.9	25.1	18.7	13.4	23.3	18.6	18.3	2.8	8.5	5.7	20.5	3.7	3.4	4.5	11.7	12.1	8.1	7.9	17.7	15.6	11.0	14.7	22.3	16.6	14.9	7.6	12.3	19.7	7.2	18.7	32.9	25.8	9.9	14.4	15.3	15.0	6.6	7.6	13.2	7.3	14.4	16.1	19.9	15.7	14.7	18.2	19.0	17.1	16.1	11.4	9.3	12.1	16.9	18.0	12.0	8.5	8.5	16.9	9.7	10.9	17.2	7.1	12.0	10.9	7.2	7.2	17.9	13.7	8.6	11.2	16.4	6.0	18.7	17.9	6.7	17.6	15.2	10.4	11.3	9.1	18.7	9.3	14.6	1.8	11.6	1.6	3.4	14.6	2.8	2.0	2.1	2.1	8.5	2.8	2.5	1.9	5.7	3.7	20.5	3.5	2.2	4.5	16.7	21.9	18.6	21.6	16.2	13.1	22.6	15.4	19.2	20.9	14.9	29.0	13.4	5.8	5.0	12.3	12.0	10.2	14.7	14.8	14.0	25.5	11.9	1.7	10.8	0.9	11.3	8.1	0.0	11.8	10.2	12.4	6.3	10.5	7.8	53.0	11.1	4.6	17.8	50.5	1.1	15.5	49.5	6.8	1.0	7.4	8.3	13.5	8.6	14.9	4.3	16.1	19.4	6.1	3.9	11.5	3.6	10.2	11.8	8.0	9.2
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221562-113264492	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.7;salivary gland: 57.9"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013810	Approved					NA	NA					"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	7.8	12.1	5.0	4.9	6.1	4.6	6.0	3.7	6.7	10.6	16.2	6.7	21.2	20.7	4.9	7.8	9.8	4.8	5.7	5.8	5.0	4.9	15.4	55.7	8.8	3.5	5.6	4.0	6.3	11.4	5.8	9.4	7.9	7.4	10.3	8.1	8.5	57.9	21.7	3.0	14.3	41.8	4.6	5.8	8.6	9.3	4.7	5.0	2.6	6.3	6.8	9.8	5.8	5.2	1.0	9.9	5.0	17.0	2.5	2.0	4.3	8.2	8.9	7.3	16.0	16.7	12.0	26.9	14.6	22.3	10.1	11.9	12.6	7.2	6.4	5.9	12.5	12.9	20.4	13.7	8.3	11.4	5.6	7.7	5.3	7.9	14.1	40.9	9.6	8.1	14.4	18.9	13.1	21.5	6.8	9.2	7.5	12.0	12.0	9.6	8.7	6.5	4.9	11.8	31.6	10.0	6.8	19.1	6.4	9.3	10.3	6.9	9.0	14.1	28.3	38.2	10.7	14.4	8.3	8.4	7.6	4.7	15.2	8.7	7.2	14.7	9.0	12.6	9.1	8.9	1.3	13.0	1.5	1.5	16.2	2.0	1.0	1.0	1.5	9.9	0.9	1.2	1.1	5.0	2.5	17.0	1.4	1.1	4.3	5.0	6.1	3.7	6.7	5.0	4.9	5.6	4.0	7.4	5.0	32.8	31.0	8.2	8.3	13.5	12.2	7.0	17.8	25.4	40.9	5.2	31.4	14.3	8.3	15.5	0.2	8.4	47.6	0.0	23.5	21.7	15.1	32.7	4.7	81.5	41.2	6.4	8.6	12.3	27.6	0.5	5.8	27.2	11.8	11.8	14.4	11.3	18.9	11.8	6.7	23.2	11.2	6.5	12.2	11.9	34.9	13.8	18.8	2.5	16.6	16.2
CDC26	"ANAPC12, APC12, C9orf17"	ENSG00000176386	"Cell division cycle 26"	Q8NHZ8	9	113255835-113275589	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044130	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044130: AB_10963690"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.79e-2)"	24.2	21.8	19.1	21.0	25.3	15.8	27.4	20.8	19.8	24.2	27.4	18.0	30.9	19.7	20.1	29.4	22.2	18.6	16.6	37.5	18.1	15.9	27.6	34.9	21.7	24.7	24.9	15.2	23.2	24.2	27.4	23.3	26.7	20.7	23.4	23.2	15.6	31.7	24.6	28.1	21.7	37.1	36.3	29.1	27.7	21.8	13.3	25.7	22.7	34.5	20.1	29.7	31.5	44.6	54.8	30.1	65.2	30.3	44.9	68.5	38.2	14.2	23.4	20.5	10.3	35.2	30.4	9.4	20.9	32.9	22.4	22.2	24.6	17.4	26.7	18.7	18.7	25.3	28.3	17.3	31.9	22.4	24.2	12.6	17.5	23.6	22.8	17.2	30.7	17.7	21.0	22.4	20.7	30.4	23.4	30.0	21.4	26.1	20.1	16.9	29.4	26.0	19.8	33.8	67.2	20.9	22.9	44.0	13.1	23.5	25.1	15.8	15.1	28.1	20.3	15.6	23.6	18.6	13.3	19.7	13.5	12.5	19.9	26.9	13.5	23.3	21.1	18.9	18.2	13.1	48.1	30.0	65.2	46.7	30.3	57.2	54.8	59.4	51.5	30.1	45.3	68.5	53.1	46.0	44.9	28.0	25.5	56.7	38.2	19.1	25.3	20.8	19.8	18.1	15.9	24.9	15.2	20.7	25.7	32.8	39.2	64.1	66.0	69.1	19.1	3.6	33.1	41.5	34.2	21.0	21.6	37.2	96.2	52.8	18.0	69.7	46.7	46.7	52.2	58.4	57.1	55.8	26.5	66.9	53.1	14.3	30.6	50.3	51.1	10.0	74.2	59.9	49.0	69.5	42.9	29.4	51.6	55.4	41.1	133.8	30.6	25.8	44.3	31.4	15.8	79.4	40.0	74.6	45.5	76.1
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275343-113292905	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	16.4	20.9	13.8	23.8	17.4	18.4	21.7	19.4	23.2	15.2	15.7	14.4	20.0	13.4	18.9	28.6	22.9	17.8	17.6	16.8	15.3	13.9	21.5	24.3	15.2	19.6	12.4	19.2	24.3	22.7	19.1	19.6	17.2	19.0	20.6	17.6	13.9	16.8	19.7	26.1	21.8	14.7	21.1	14.4	18.7	15.9	16.6	12.6	21.8	16.5	18.2	23.1	18.0	24.6	16.5	19.9	18.1	21.7	17.0	17.9	13.7	12.8	22.0	14.7	16.1	10.4	10.7	14.9	20.1	10.1	22.2	16.4	21.4	12.0	26.7	11.9	10.9	22.9	29.6	30.7	17.7	25.1	18.9	11.5	13.6	19.2	15.7	9.5	23.8	12.5	7.7	12.1	23.2	22.5	8.3	10.6	15.0	23.2	14.9	18.9	20.0	22.3	17.1	23.3	33.6	24.3	20.8	35.2	18.4	9.7	10.5	19.3	13.1	29.5	16.0	9.3	12.4	24.9	12.4	10.4	18.1	13.7	23.3	25.6	19.1	51.7	26.3	14.0	15.4	23.2	18.1	15.8	15.1	15.2	19.3	17.9	16.5	15.2	13.8	19.9	16.4	15.5	15.3	5.3	17.0	21.7	13.1	13.6	13.7	13.8	17.4	19.4	23.2	15.3	13.9	12.4	19.2	19.0	12.6	8.9	17.3	24.5	12.9	14.0	20.0	12.5	7.6	18.7	18.2	17.4	17.7	21.3	21.6	13.9	13.3	9.0	4.7	0.0	14.7	27.7	14.9	9.8	18.5	8.1	16.2	27.0	16.8	6.2	10.2	10.2	10.6	17.5	5.0	31.5	12.7	22.1	12.2	10.5	10.3	13.2	22.1	0.0	15.6	28.3	21.0	16.4	18.0	11.4	12.0	12.5
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 19.0;kidney: 9.5"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 7.6;Collecting duct cells: 5.2;Intestinal endocrine cells: 8.1;Proximal tubular cells: 18.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 20.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057675	Uncertain					NA	NA					"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.2			0.2	1.2	19.0	5.1	1.2	6.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.9	0.0		0.8	0.3		6.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	3.7	4.3			0.1		0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.0	0.6	0.3	7.6	0.0	0.0	5.2	0.0	0.0	1.7	0.3	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.2	2.1	0.0	0.4	18.3	2.7	0.0	0.1	3.4	1.1	0.0	0.0	0.0	1.5	0.8
WDR31	FLJ35921	ENSG00000148225	"WD repeat domain 31"	Q8NA23	9	113313222-113340298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 54.9;Ciliated cells: 34.8;Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019340, HPA019347"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA019340: AB_1858800, HPA019347: AB_2215267"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.78e-3)"	"prognostic favorable (1.85e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.90e-9)"	"unprognostic (9.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-3)"	"unprognostic (8.50e-2)"	2.2	6.8	4.1	1.0	8.2	1.5	4.7	1.7	5.5	3.2	2.4	4.0	8.8	1.5	4.5	3.3	2.4	6.3	2.3	8.9	3.3	4.1	5.6	3.1	2.3	0.9	3.5	2.7	3.7	3.0	16.6	11.2	1.0	4.0	3.4	2.2	5.8	10.2	7.5	1.3	2.5	1.1	2.2	3.6	0.8	2.1	7.3	1.7	3.8	7.1	1.4	0.8	3.0	2.0	1.6	0.9	4.4	1.0	2.3	1.4	0.8	5.5	4.2	1.5	3.0	5.1	5.9	1.4	1.4	2.7	1.4	1.7	0.7	3.6	2.1	1.0	2.1	4.1	3.7	1.2	2.7	2.7	3.3	0.3	1.7	2.2	0.7	5.8	0.9	0.3	3.1	3.6	5.8	5.2	4.0	1.1	3.3	4.5	1.9	1.5	3.8	2.4	1.4	0.9	5.3	5.3	2.1	1.3	2.6	3.7	1.2	3.6	2.7	6.7	1.2	3.2	1.2	8.8	0.9	0.6	2.0	2.2	5.0	1.5	4.0	3.8	0.5	3.0	1.4	1.9	4.4	1.0	1.0	0.9	0.6	0.8	0.9	1.0	0.8	0.8	1.6	1.4	1.3	3.4	2.3	0.7	0.9	0.7	0.8	4.1	8.2	1.7	5.5	3.3	4.1	3.5	2.7	4.0	1.7	6.0	8.0	0.0	4.6	4.7	4.5	54.9	5.1	34.8	12.5	1.8	27.5	0.3	5.0	1.4	23.9	1.5	0.3	0.0	0.2	0.2	1.7	3.4	4.7	2.6	0.7	6.4	0.0	0.6	1.2	21.5	1.7	2.0	0.0	0.0	1.5	7.2	1.2	0.0	1.4	4.8	40.9	0.0	2.3	22.7	8.7	3.8	0.2	0.0	2.3	2.4
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	18.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	3.8	11.6	0.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	2.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	9.4	0.1	0.0	0.0	27.0	0.3	0.0	0.4	31.4	0.0	0.4	0.0	14.1	1.8	3.9	6.2	0.0	0.0	13.6	0.0	0.8	13.7	1.9	0.0	0.0	0.0	0.0	0.0	4.4	5.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8	6.0	5.8	2.4	1.7	0.9	0.6	1.6	15.3	2.7	4.5	26.2	5.9	8.1	33.2	59.2	0.1	0.1	12.9	0.0	58.0	0.7	0.4	15.4	3.5	0.8	1.2	0.0	19.7	0.0	0.0	0.2	0.0	0.1	10.1	1.8	19.3	0.3	56.5	14.0	0.0	15.3	9.1	0.0	0.0	0.5	2.3	12.4	5.6	0.5	24.3	13.9
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 54.7"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 204.4;Paneth cells: 171.9;Proximal tubular cells: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	4.9	54.7	5.1	10.1	8.4	3.3	12.7	6.2	8.5	6.0	29.8	5.6	10.6	38.2	6.4	15.5	13.8	5.8	18.1	9.1	4.6	5.3	17.7	36.6	4.4	6.3	4.5	9.4	7.2	23.7	20.5	9.1	6.5	7.3	10.6	16.8	8.3	24.4	12.5	2.8	11.4	47.1	8.0	4.8	6.0	17.7	4.5	4.0	8.0	18.2	6.1	6.8	7.0	6.9	12.1	10.6	5.9	2.9	5.6	12.3	5.8	3.4	9.7	2.1	5.8	5.2	2.3	17.7	2.5	4.8	4.1	4.5	17.8	17.0	7.5	3.2	1.4	8.2	13.3	3.3	3.9	1.4	10.4	7.6	10.3	5.3	11.0	6.1	0.6	8.0	3.6	8.3	3.3	9.5	4.8	2.1	7.0	8.1	1.9	1.9	22.1	4.7	3.0	4.7	34.0	7.6	3.9	0.0	6.0	5.2	7.1	5.3	3.4	4.3	18.8	6.3	4.8	11.8	2.1	2.1	0.8	0.0	0.7	0.8	4.6	9.0	3.1	1.0	0.0	0.6	0.1	2.9	5.9	9.9	1.6	11.2	11.3	11.5	9.0	4.5	12.1	12.0	8.9	1.9	5.6	0.2	10.6	12.3	5.8	5.1	8.4	6.2	8.5	4.6	5.3	4.5	9.4	7.3	4.0	8.9	8.5	18.1	18.5	8.9	9.4	12.0	73.9	22.7	11.4	22.7	9.8	23.7	72.9	66.3	0.1	8.9	204.4	23.3	138.2	16.2	7.5	24.3	7.0	74.9	17.6	1.6	38.8	8.6	5.1	0.9	13.3	6.7	10.1	19.8	61.9	10.8	96.2	171.9	8.5	218.3	12.1	6.5	7.5	0.2	6.1	12.8	26.4	17.3	72.5	40.4
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386317-113401333	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.2"	"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced					NA	NA		44000000			"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (7.33e-5)"	"prognostic favorable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favorable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	19.9	70.3	24.1	6.4	26.3	27.3	13.7	14.0	24.8	8.3	10.5	28.3	8.8	11.6	7.5	11.5	14.6	6.8	13.0	23.3	24.6	20.8	29.9	84.2	8.4	5.9	37.5	20.6	12.3	18.8	24.1	7.2	10.2	27.9	14.5	10.2	9.8	37.2	15.1	10.6	15.6	10.7	8.9	40.1	5.9	18.1	5.4	28.6	4.7	10.9	6.6	7.5	9.0	8.0	7.6	12.1	19.1	13.1	5.5	9.7	7.6	3.3	5.8	4.6	6.4	32.2	22.1	29.3	9.1	15.3	6.0	7.7	8.1	7.0	4.7	5.6	12.9	4.6	12.4	3.3	6.3	3.5	11.7	4.2	9.3	7.3	10.6	7.3	8.5	8.0	18.7	4.7	5.5	2.4	23.9	11.8	7.9	3.5	7.0	9.9	24.5	9.8	8.4	2.3	24.4	11.6	7.7	8.0	8.1	9.4	7.1	4.2	4.0	11.6	14.1	8.3	8.7	14.8	9.8	12.8	5.4	4.1	10.6	5.1	10.5	9.8	3.7	15.1	7.9	5.8	7.2	11.5	19.1	9.7	13.1	5.4	5.9	8.4	5.4	12.1	7.6	8.1	8.9	5.6	5.5	12.7	4.9	8.5	7.6	24.1	26.3	14.0	24.8	24.6	20.8	37.5	20.6	27.9	28.6	14.9	14.1	10.2	9.3	6.3	12.5	50.8	17.8	10.7	9.1	14.0	25.5	36.1	11.6	14.5	4.7	12.8	25.6	70.0	23.3	18.1	9.4	7.0	13.9	55.7	15.4	4.8	8.7	12.9	16.7	6.9	10.9	10.2	11.8	5.4	13.8	5.8	15.3	28.8	13.8	42.7	14.9	6.5	9.9	6.2	7.5	8.0	9.5	6.9	16.9	6.8
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047945: AB_2680218"	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.9	19.9	14.0	21.0	8.0	7.2	12.3	21.3	10.9	24.2	19.1	18.4	14.5	58.1	13.3	12.4	14.7	27.4	27.3	23.4	22.4	11.0	16.5	30.1	20.7	18.8	8.6	62.4	18.2	8.1	16.2	21.0	27.0	8.8	16.7	29.6	41.9	32.5	16.7	40.6	42.8	33.6	18.1	34.3	36.1	43.9	58.5	32.6	10.5	15.3	30.5	17.6	31.0	19.6	16.7	8.9	29.3	28.1	13.7	17.9	24.3	22.7	36.4	17.0	55.5	78.3	16.4	36.9	21.4	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9	35.7	27.5	46.8	23.7	83.3	13.9	39.7	22.9	46.8	44.3	29.6	5.9	49.3	36.5	26.8	4.0	34.3	14.2	0.0	39.2	47.2	34.7	19.7	54.5	37.2	44.5	12.7	23.6	23.4	27.8	11.5	33.1	54.6	38.8	53.3	31.4	30.3	28.9	10.5	40.0	22.0	17.1	12.9	47.2	27.9	98.5	82.9	29.2	63.4	39.3	18.2
C9orf43	MGC17358	ENSG00000157653	"Chromosome 9 open reading frame 43"	Q8TAL5	9	113410054-113429684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	10	"testis: 39.4"	"Group enriched"	"Detected in some"	7	"Early spermatids: 78.7;Late spermatids: 167.1;Spermatocytes: 82.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA021310			Approved	Cytosol		NA	NA			Cytosol		"HPA021310: AB_1845825"	"unprognostic (2.91e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-1)"	0.5	1.6	1.5	0.4	2.4	1.8	1.3	2.1	2.3	0.5	0.4	1.6	0.2	0.4	0.4	1.6	0.5	0.9	0.6	0.4	1.4	0.8	1.0	1.7	0.5	0.6	0.8	1.9	1.0	3.5	1.3	3.8	0.5	1.6	0.7	0.5	1.0	0.9	0.7	0.4	0.8	0.5	0.3	1.8	0.6	0.6	39.4	1.0	0.6	1.0	0.0	0.6	0.5	0.5	1.5	1.3	2.3	1.5	1.0	2.1	0.8	1.2	1.2	0.6	1.9	1.5	0.8	0.9	0.6	1.1	1.7	1.3	1.3	1.0	3.3	1.1	0.3	3.8	2.4	0.7	1.7	0.7	2.7	0.5	2.9	2.1	0.6	1.3	0.5	0.4	1.8	2.6	2.2	2.6	1.1	1.5	3.9	1.7	3.1	0.9	2.4	1.4	0.8	0.9	1.5	3.9	0.8	0.7	1.9	1.8	0.6	3.1	0.7	3.0	1.4	1.7	1.4	4.1	0.3	0.2	2.6	0.6	1.7	2.6	2.0	3.6	5.0	1.4	1.1	0.9	0.0	0.7	0.0	1.5	1.5	0.0	1.5	0.8	2.1	0.8	0.8	1.4	2.1	2.3	1.0	0.3	1.3	0.1	0.8	1.5	2.4	2.1	2.3	1.4	0.8	0.8	1.9	1.6	1.0	0.0	0.0	0.8	0.5	0.6	1.7	0.0	0.0	10.7	2.3	0.0	0.0	0.4	1.7	0.3	78.7	0.3	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.3	167.1	2.0	0.6	0.0	1.0	0.0	2.3	1.1	0.0	1.4	0.7	2.6	0.0	0.0	82.6	16.0	0.0	0.0	0.0	0.0	0.5
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 149.4;Proximal tubular cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 53.6;HDLM-2: 86.1"	"Low region specificity"	"Detected in all"							HPA044234			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044234: "	"prognostic unfavorable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	25.2	17.8	7.6	10.7	18.3	4.7	34.0	4.2	13.8	9.8	13.0	27.9	5.1	9.9	11.4	8.0	11.3	8.4	25.0	52.2	9.7	10.1	31.9	20.1	24.9	12.5	18.4	8.5	7.2	17.5	6.3	8.1	18.9	18.1	14.5	9.6	12.9	5.6	6.6	24.6	7.0	10.8	17.9	16.8	16.2	12.3	14.8	17.1	4.0	13.2	10.7	8.3	18.3	8.1	1.4	3.8	10.6	4.1	22.4	15.0	7.8	0.9	3.5	8.7	8.0	2.7	4.0	0.6	8.8	53.6	7.2	6.1	8.6	3.2	3.7	6.5	7.1	7.2	2.3	0.1	3.4	4.2	86.1	0.0	0.3	2.9	5.2	5.5	0.0	1.2	7.2	3.6	19.9	2.9	16.0	27.0	0.2	0.0	3.7	13.0	3.9	0.2	0.4	2.2	6.0	2.9	0.2	4.3	0.6	14.8	1.7	6.8	0.9	0.8	6.9	5.2	4.4	4.7	0.8	13.0	24.2	2.6	1.1	16.5	1.8	0.3	0.5	27.9	0.8	11.1	3.4	3.5	2.1	15.0	4.1	10.1	1.4	3.5	12.1	3.8	1.2	1.4	6.6	10.6	22.4	3.1	0.1	2.0	7.8	7.6	18.3	4.2	13.8	9.7	10.1	18.4	8.5	18.1	17.1	14.9	11.5	1.9	9.8	10.6	0.6	39.3	61.1	6.7	6.8	21.0	5.9	4.1	69.6	58.9	34.8	43.8	18.6	0.0	27.0	3.4	35.7	4.0	48.3	27.3	12.9	149.4	0.0	71.8	13.6	11.9	4.4	7.1	52.3	7.2	7.0	2.7	26.2	14.2	13.1	130.2	6.1	6.5	49.5	6.6	1.5	9.9	2.5	20.3	9.0	11.6
ZNF618	"KIAA1952, NEDD10"	ENSG00000157657	"Zinc finger protein 618"	Q5T7W0	9	113876282-114056591	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 20.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023116, HPA061732"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023116: AB_10964204, HPA061732: AB_2684596"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.22e-7)"	"unprognostic (4.57e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.51e-2)"	5.2	7.5	5.0	8.1	5.2	3.4	6.1	19.2	5.0	9.3	3.6	5.4	4.0	3.3	11.5	7.3	3.5	8.4	12.1	3.1	4.3	3.8	13.3	8.2	5.2	3.0	2.8	3.3	15.0	13.3	15.8	11.6	3.2	4.8	5.9	2.5	14.5	6.0	4.8	3.1	3.4	2.6	6.9	2.7	5.4	6.4	5.6	2.4	5.6	10.9	2.6	3.0	4.3	6.6	1.3	4.3	4.0	0.9	2.8	0.9	0.9	4.4	13.6	20.4	8.9	4.9	5.8	1.0	2.9	4.8	5.9	5.2	0.1	3.2	2.4	2.8	5.0	1.6	0.1	10.2	5.0	2.3	0.0	4.0	0.0	1.0	0.0	3.7	2.6	4.6	5.6	2.0	6.2	1.4	5.4	14.8	0.3	0.0	0.0	2.6	7.2	0.1	3.3	10.1	0.3	3.0	18.8	11.9	0.0	6.3	4.9	6.3	15.0	8.3	5.3	5.4	6.1	0.4	5.3	12.0	7.9	6.3	4.4	3.5	0.0	0.0	0.0	0.6	4.0	5.5	4.0	0.9	0.6	0.9	0.5	0.3	0.0	0.1	0.8	3.4	1.3	0.7	0.5	0.0	2.8	0.7	4.3	0.0	0.9	5.0	5.2	19.2	5.0	4.3	3.8	2.8	3.3	4.8	2.4	3.0	10.4	0.8	4.7	1.8	14.0	2.4	28.1	2.7	4.5	10.4	3.9	0.2	6.6	11.5	5.1	3.0	0.0	0.0	7.0	0.2	5.8	2.0	20.7	7.8	3.6	55.6	2.4	12.3	3.3	3.3	14.1	6.0	0.0	18.0	1.4	9.1	9.6	1.9	14.5	8.4	1.1	25.8	11.3	0.1	13.2	3.1	0.2	2.2	2.3	1.6
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 9824.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	154	"Hep G2: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		71000000000	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	168.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	42.0	0.6	1.3	0.0	0.0	2035.7	0.0	1.2	1.8	0.0	0.0	3.3	105.1	19.2	0.0	0.4	256.9	25.3	0.3	0.1	0.4	0.0	9824.4	0.7	0.0	2.4	175.6	182.3	40.5	0.6	0.0	0.0	6.4	0.9	0.0	22.8	1.1	0.0	9.9	0.0	0.0	0.0	0.2	0.1	0.4	1.1	3.8	1.0	0.3
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.1;kidney: 51.5;pancreas: 42.1"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 101.9;Collecting duct cells: 85.5;Distal tubular cells: 68.0;Intestinal endocrine cells: 61.7;Proximal tubular cells: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5;OE19: 11.2;RPTEC TERT1: 30.9;SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA020192, HPA024127"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.4	0.0	0.8	0.8	1.2	0.0	9.1	0.8	0.6	3.3	5.8	0.4	3.3	11.8	4.7	18.0	0.5	3.8	33.1	0.4	0.4	0.2	51.5	9.8	1.0	0.4	0.4	0.5	1.1	42.1	0.0	0.6	1.3	0.4	2.4	1.7	0.8	1.8	4.2	0.4	0.4	7.3	0.4	0.4	0.4	5.5	1.5	0.4	1.0	11.6	0.4	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	3.6	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	11.2	0.4	0.0	0.0	0.0	30.9	0.1	4.5	0.1	0.0	0.6	0.0	0.1	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.8	0.6	0.4	0.2	0.4	0.5	0.4	0.4	0.0	4.1	0.8	0.8	0.0	0.0	0.4	101.9	0.0	0.0	85.5	0.0	0.1	68.0	28.9	5.4	0.0	7.1	0.0	10.4	6.4	0.2	2.2	0.0	7.4	0.3	0.0	61.7	0.0	0.0	9.5	0.6	0.0	0.0	1.8	22.5	0.0	8.1	20.9	0.0	57.8	0.0	0.0	0.0	1.5	4.5	0.0	0.5	0.0	23.4	0.1
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155560-114312511	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9;cervix, uterine: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 73.9;Extravillous trophoblasts: 60.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 56.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.2;Hep G2: 25.5"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	23	"cerebellum: 141.7"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	4.7	4.2	6.0	4.2	4.6	0.1	4.1	56.9	5.7	41.9	4.4	2.6	5.7	2.9	25.9	17.0	3.6	6.4	6.3	3.3	4.9	1.7	11.0	16.5	4.4	2.9	5.8	1.8	13.1	12.9	0.7	2.2	9.0	8.6	9.8	1.0	9.6	4.1	11.3	4.0	11.9	3.5	8.4	7.3	3.0	9.7	2.7	5.1	2.8	6.1	5.2	3.2	5.7	17.9	0.9	0.4	2.0	0.2	0.5	0.3	0.1	2.0	4.1	9.8	3.5	0.7	1.1	30.2	4.7	3.2	3.4	2.9	4.3	0.1	0.0	1.2	2.3	2.6	4.9	3.3	4.4	1.9	0.0	0.4	0.0	3.4	25.5	1.0	0.0	10.9	2.7	1.2	4.2	1.9	1.9	5.1	4.0	0.0	1.0	1.9	0.9	0.0	1.8	3.5	8.0	1.1	13.6	9.9	1.9	8.1	2.2	0.1	0.1	0.2	0.1	0.5	3.9	0.9	3.1	4.7	3.0	6.1	0.4	7.3	0.5	0.0	0.0	2.5	0.0	4.6	0.6	0.2	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.2	2.0	0.5	0.1	0.4	0.2	0.1	6.0	4.6	56.9	5.7	4.9	1.7	5.8	1.8	8.6	5.1	3.0	16.5	1.5	4.6	24.2	0.6	24.9	73.9	0.0	6.8	8.7	5.9	0.7	3.3	9.2	1.1	3.6	0.0	0.0	4.3	60.6	14.4	5.3	0.0	35.8	5.2	1.6	4.6	6.2	1.0	0.9	17.8	0.6	21.9	0.0	1.6	6.1	5.4	0.8	4.2	5.7	1.0	25.8	35.4	0.2	1.9	19.6	1.9	0.0	2.2	1.6
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 834.6"	"Cell type enriched"	"Detected in some"	35	"Hepatocytes: 50531.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"					"Cell type enriched"	"Detected in some"	45	"neutrophil: 53.4"	"Lineage enriched"	"Detected in many"	45	"granulocytes: 53.4"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 161.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	120000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	834.6	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	53.4	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	161.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	14.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.2	0.0	0.0	0.3											3.0	14.9	263.0	0.0	0.0	0.0	0.0	1452.2	0.0	1.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	794.3	4.5	0.1	0.0	31.6	0.0	50531.7	0.1	0.0	0.0	844.6	848.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333252	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 404.1"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 9578.7"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"					"Cell type enriched"	"Detected in single"	35	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 13.2"	"Cell line enriched"	"Detected in single"	237	"Hep G2: 136.6"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	61000000000	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	404.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	136.6	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.1											0.0	8.0	42.8	0.0	0.0	0.0	0.0	224.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	0.0	70.0	5.4	0.0	0.0	2.1	0.0	9578.7	0.0	0.0	0.0	141.2	136.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.2"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 137.4;T-cells: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 32.0;MOLT-4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favorable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.29e-4)"	7.2	2.8	4.6	41.8	4.9	17.5	6.1	2.0	4.5	13.9	7.3	5.9	2.4	5.7	13.4	4.5	3.3	11.4	12.9	2.8	4.9	3.8	3.9	5.6	11.2	30.4	4.9	3.3	9.9	3.4	0.8	3.6	2.8	4.9	5.3	4.7	7.1	10.2	4.2	1.6	2.5	18.4	8.8	3.6	43.1	7.3	3.9	4.8	71.2	4.0	4.5	42.9	6.1	6.4	7.2	8.8	16.6	6.1	11.9	16.6	6.4	1.4	1.5	1.8	1.3	12.8	1.5	8.0	1.6	1.9	1.5	1.2	2.7	1.6	17.5	1.6	1.4	2.8	3.4	1.2	0.4	0.5	32.0	0.7	1.8	0.7	1.8	15.4	16.9	19.2	2.6	2.8	1.3	1.4	2.2	2.7	15.8	1.7	21.2	0.6	2.5	30.4	22.0	6.9	3.4	1.8	18.9	0.3	4.0	14.6	0.8	0.9	1.7	0.4	1.4	4.7	2.4	4.0	9.3	4.4	0.8	1.7	0.3	1.4	4.4	4.9	14.8	1.0	8.6	0.7	8.0	6.1	9.6	16.6	4.6	13.1	6.5	8.9	14.1	4.1	7.2	7.9	10.6	16.6	11.9	4.1	8.8	7.0	6.4	4.6	4.9	2.0	4.5	4.9	3.8	4.9	3.3	4.9	4.8	11.9	28.1	43.3	5.9	4.6	25.8	3.1	0.0	29.4	12.5	22.7	139.4	7.7	0.0	3.4	16.1	6.3	6.7	0.0	7.0	5.7	8.0	6.2	31.3	8.5	16.0	4.8	12.2	13.5	41.0	20.2	13.6	31.2	5.0	26.2	19.5	6.5	5.0	10.5	6.3	0.9	137.4	0.0	10.8	0.6	0.7	3.0	2.9	94.4	12.9	7.5
WHRN	"CIP98, DFNB31, PDZD7B, USH2D"	ENSG00000095397	Whirlin	Q9P202	9	114402080-114505450	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 58.2"	"Cell type enriched"	"Detected in some"	4	"Ciliated cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0;memory CD8 T-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.3;Karpas-707: 47.6;U-266/70: 29.9;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.43e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.44e-1)"	3.3	58.2	11.7	4.1	24.5	3.2	4.9	7.6	18.1	8.3	5.4	31.7	2.9	8.3	17.8	8.4	4.7	9.5	4.1	3.6	12.0	9.1	4.0	2.2	3.7	4.5	26.0	7.6	12.6	9.8	10.2	19.3	3.2	20.0	7.8	2.9	13.0	10.9	6.9	1.3	7.3	8.0	9.5	14.4	17.8	6.5	23.6	29.8	11.0	5.7	1.5	2.4	4.0	7.2	0.3	0.0	0.2	0.0	0.7	2.0	0.1	0.6	1.0	1.6	6.0	0.6	0.2	3.2	0.4	0.9	0.6	0.4	0.1	0.3	0.0	1.2	0.4	7.9	3.6	0.3	0.6	0.1	16.3	2.7	0.0	11.5	1.3	0.2	0.0	0.4	0.5	1.9	2.2	0.2	4.4	0.0	0.8	3.3	47.6	0.6	6.0	0.0	0.2	2.1	0.0	9.9	0.8	0.0	12.5	1.6	0.3	7.4	0.5	3.5	4.2	12.5	1.9	4.0	0.1	1.0	2.1	1.2	2.3	2.9	29.9	30.7	0.2	0.8	0.0	1.2	0.0	0.0	0.0	0.3	0.0	2.0	0.1	0.5	2.0	0.0	0.3	0.0	0.6	0.2	0.7	0.0	0.0	1.0	0.1	11.7	24.5	7.6	18.1	12.0	9.1	26.0	7.6	20.0	29.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	14.7	2.3	0.0	0.0	2.5	0.0	1.6	0.0	0.0	0.0	0.0	1.8	1.9	0.0	0.0	2.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	18.2	17.6	36.2	8.8	30.1	21.8	33.6	28.5	22.6	23.6	17.0	23.6	22.0	17.7	24.9	20.3	44.1	41.4	27.0	21.5	19.9	14.0	18.6	17.0	22.3	34.2	42.1	37.8	31.5	27.9	57.9	18.9	23.6	24.8	22.3	28.7	32.5	37.6	32.2	39.6	36.4	23.9	42.8	52.2	33.2	35.4	23.2	28.3	48.4	31.4	27.3	34.9	38.4	67.2	101.2	36.5	54.4	44.9	29.7	19.3	15.3	30.0	31.9	50.7	99.4	30.9	24.8	22.7	26.4	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6	148.9	142.4	298.6	409.4	461.0	169.7	124.8	155.4	207.5	149.0	314.0	39.3	304.8	822.3	322.2	78.2	218.7	155.2	93.5	229.3	273.5	294.0	644.3	261.0	292.4	487.8	155.7	346.4	198.9	353.7	42.3	283.3	376.1	469.0	820.6	271.3	242.1	355.1	164.9	235.8	828.3	125.3	232.8	269.9	334.2	301.9	504.0	633.4	276.3	162.4	656.9
TMEM268	"C9orf91, DKFZp547P234, FLJ38045"	ENSG00000157693	"Transmembrane protein 268"	Q5VZI3	9	114611206-114646422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017199	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA017199: AB_1845845"	"unprognostic (8.57e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.47e-1)"	9.1	9.0	9.6	8.5	15.8	3.8	9.7	4.4	31.0	7.3	6.6	5.1	3.4	4.3	7.7	7.6	4.8	5.7	4.8	3.7	12.5	9.1	3.8	6.3	6.6	10.6	8.5	15.3	10.2	5.6	15.1	4.6	5.9	8.7	15.9	6.8	11.1	8.9	9.1	5.0	4.3	6.4	8.8	7.7	15.5	7.5	4.8	5.0	10.3	7.9	2.0	11.4	7.8	5.4	4.3	8.4	2.3	2.5	1.5	1.9	0.9	2.6	4.6	2.2	4.7	6.3	4.6	1.7	2.6	4.5	3.6	3.6	3.5	1.0	11.6	2.2	2.9	10.2	4.5	4.3	2.1	3.0	5.9	2.9	3.6	3.4	2.1	10.8	7.5	1.8	4.1	3.8	4.9	5.2	4.5	2.3	14.9	7.1	30.3	2.5	7.8	8.7	2.2	5.7	3.3	4.6	9.9	2.5	9.8	2.0	2.1	7.5	4.8	8.5	11.2	22.9	1.4	14.9	7.0	1.3	3.5	4.1	1.4	4.6	16.8	15.7	12.5	1.9	6.4	6.4	0.5	2.5	0.5	1.3	2.1	0.5	2.3	1.3	0.7	1.4	4.3	1.9	1.5	2.3	1.5	1.8	8.4	0.2	0.9	9.6	15.8	4.4	31.0	12.5	9.1	8.5	15.3	8.7	5.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	8.1	2.3	0.0	0.0	3.8	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	33.3	0.0	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0
TEX53		ENSG00000230054	"Testis expressed 53"		9	114656304-114662374	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	36	"testis: 36.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.4;Karpas-707: 6.1;T-47d: 1.6;U-266/70: 1.8"															NA	NA						"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.85e-2)"		"unprognostic (1.90e-2)"	"unprognostic (6.83e-2)"		"unprognostic (4.19e-2)"	"unprognostic (8.18e-4)"	"unprognostic (8.64e-6)"	"unprognostic (9.94e-2)"	"unprognostic (1.79e-1)"		"unprognostic (1.94e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	6.1	0.0	0.8	0.3	0.0	0.3	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.4	1.8	1.0	1.1	0.0	0.1	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX48		ENSG00000230601	"Testis expressed 48"	A0A1B0GUV7	9	114666434-114682066	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"testis: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.4"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 12.2"															NA	NA						"unprognostic (2.70e-1)"		"unprognostic (6.41e-2)"	"unprognostic (7.83e-2)"		"unprognostic (2.53e-1)"		"unprognostic (5.10e-2)"		"unprognostic (2.33e-2)"		"unprognostic (1.70e-1)"		"unprognostic (5.11e-2)"		"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	2.4	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.7	0.0	0.3	3.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	12.2	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.2	0.1	0.2	1.5	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	1.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"	NA	NA	1110000		"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.5	1.3	0.0	0.0	0.4	11.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.3	0.0	0.0	14.0	0.0	0.0	0.8	0.4	0.5	0.0	0.0	0.2	13.1	0.0	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.0	0.6	0.0	5.0	1.0	0.0	6.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1	11.9	8.9	0.0	4.4	0.5	0.1	0.5	0.0	0.0	1.2	7.0	0.0	0.5	0.0	4.0	0.2	0.0	6.9	0.0	1.8	0.1	0.8	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	9.0	1.8	0.2	1.1	0.0	0.4	9.6	0.1	0.0	1.0	0.0	0.0	0.5	0.2	0.0	3.9	5.1
TNFSF8	"CD153, CD30LG"	ENSG00000106952	"TNF superfamily member 8"	P32971	9	114893343-114930595	"Cancer-related genes, CD markers, Predicted membrane proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.6;lymphoid tissue: 48.1"	"Group enriched"	"Detected in some"	4	"B-cells: 4.4;Hofbauer cells: 3.2;Kupffer cells: 6.5;Macrophages: 4.4;T-cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Daudi: 34.1;SuSa: 16.1;U-698: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.82e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.58e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.82e-1)"	3.6	1.7	1.1	12.0	1.7	12.7	1.8	0.5	0.9	1.6	2.4	1.4	0.6	0.3	1.1	2.5	1.4	1.5	4.6	2.8	1.1	1.2	1.8	1.4	4.9	48.1	1.6	0.6	0.9	1.1	0.0	0.8	2.2	1.0	1.3	1.9	1.4	3.7	0.9	0.7	1.0	7.0	1.3	2.8	14.9	1.7	1.1	1.0	45.6	1.6	0.8	18.5	3.2	1.3	1.7	7.3	3.9	14.1	1.0	18.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	14.1	0.0	4.1	7.3	13.8	1.0	16.4	9.8	7.3	1.7	18.6	13.5	3.9	1.0	0.9	4.0	5.9	8.7	1.1	1.7	0.5	0.9	1.1	1.2	1.6	0.6	1.0	1.0	0.0	0.0	4.4	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	0.0	0.0	1.3	6.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.2	0.0	0.0
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019578-115118257	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 111.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 47.4;Basal glandular cells: 45.4;Smooth muscle cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 85.5;hTEC/SVTERT24-B: 69.9;U-138 MG: 58.8;U-251 MG: 51.6;U-87 MG: 78.4;WM-115: 134.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	NA	NA	560000000	760000000			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	20.6	2.5	1.4	50.9	11.4	0.5	12.6	0.4	6.4	19.4	63.6	18.6	24.1	5.3	42.4	23.9	18.5	12.0	16.9	13.6	3.4	2.8	16.4	2.6	21.0	66.3	4.3	3.3	10.6	1.8	0.6	3.3	3.2	14.7	13.0	9.3	0.0	8.5	10.8	10.8	10.3	21.2	111.4	5.7	26.9	31.3	5.4	6.8	4.7	5.5	15.4	16.1	20.4	6.6	0.3	0.3	1.9	0.3	0.2	0.3	0.1	2.5	0.6	0.7	0.1	4.2	1.1	0.0	22.0	85.5	46.6	23.0	0.5	6.0	0.0	3.4	31.0	0.7	9.2	0.0	1.3	28.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.6	0.1	69.9	32.5	4.8	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	7.2	0.1	9.4	0.0	49.4	0.0	42.4	0.0	0.0	0.6	9.2	0.0	2.2	16.9	0.0	0.1	0.0	58.8	9.7	10.1	51.6	1.6	0.0	0.0	78.4	0.0	134.1	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.2	1.9	0.2	0.0	0.2	0.0	0.1	1.4	11.4	0.4	3.9	3.4	2.8	4.3	3.3	14.7	6.8	11.9	47.4	0.0	45.4	10.8	0.0	1.1	0.0	1.4	14.8	1.8	0.0	0.7	0.0	19.5	15.8	5.4	0.0	0.0	4.1	0.2	24.2	6.4	2.3	0.0	1.0	0.0	0.0	3.7	0.6	12.7	3.1	2.6	5.0	0.0	0.0	0.5	3.4	0.0	0.4	0.1	0.2	0.0	91.7	0.4	0.2	4.0	0.8	0.7	0.0	5.1
DEC1	CTS9	ENSG00000173077	"Deleted in esophageal cancer 1"	Q9P2X7	9	115141818-115402644	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"stomach 1: 1.4;testis: 2.3"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 4.3;Intestinal endocrine cells: 1.7;Late spermatids: 8.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.3;HeLa: 4.7;SuSa: 1.5;WM-115: 1.8"															NA	NA						"unprognostic (9.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.78e-5)"	"unprognostic (1.75e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.18e-3)"	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.2			0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.1	0.0	0.4	0.4		0.0	0.0	0.0	1.0	0.0		0.1	0.0		0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	1.4	2.3			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Group enriched"	"Detected in many"	6	"Collecting duct cells: 157.1;Proximal tubular cells: 39.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.3;ASC TERT1: 14.8;HSkMC: 53.2;U-138 MG: 13.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.5	8.4	0.0	19.3	14.8	0.0	4.5	8.0	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.4	0.6	0.0	0.0	6.0	0.0	0.0	0.9	4.6	0.0	9.4	0.0	0.0	53.2	0.0	6.2	0.7	10.3	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	2.7	0.0	0.0	10.7	13.9	0.7	0.4	0.5	0.0	0.0	0.0	9.9	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5	0.0	1.0	0.0	0.2	2.6	5.0	2.2	0.0	0.0	2.3	157.1	11.8	0.3	8.3	5.8	14.3	0.7	0.0	0.0	0.8	7.4	16.4	0.6	1.1	0.0	0.4	0.0	0.0	5.5	0.0	12.7	13.3	0.3	1.7	0.0	0.0	2.3	0.5	0.0	8.1	39.6	2.7	0.0	8.2	1.7	0.4	1.0	11.7	0.0	0.0	0.1
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116425225-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Early spermatids: 119.3;Late spermatids: 157.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	4.1	11.9	13.0	3.3	14.9	4.4	5.3	17.2	25.5	5.6	4.6	20.0	5.5	4.6	3.8	5.3	3.2	9.6	3.4	18.6	13.5	16.3	5.5	5.2	3.0	3.0	15.4	19.4	4.0	7.4	5.6	10.7	2.6	16.1	29.2	4.2	6.7	6.1	13.6	7.7	3.5	5.2	3.6	11.3	3.1	4.1	16.7	16.9	1.9	2.4	0.9	2.4	3.6	3.0	2.3	1.3	2.5	0.7	7.8	10.3	1.3	2.5	7.8	3.1	4.7	5.2	4.8	10.4	3.8	1.5	1.7	1.9	5.4	3.0	5.8	4.5	2.5	6.3	0.9	7.6	0.4	2.1	3.1	2.0	2.2	3.7	11.1	2.0	1.4	4.2	6.5	0.7	5.2	0.4	3.7	1.2	6.9	2.7	4.3	5.2	2.6	2.7	1.1	9.1	6.9	4.7	3.3	18.4	1.7	5.3	8.3	4.3	24.9	4.6	1.5	3.2	10.5	10.4	0.9	2.4	4.0	6.5	3.9	3.3	6.3	3.6	5.5	7.1	1.4	16.9	2.5	0.6	0.6	3.9	0.4	4.8	2.0	4.2	3.2	0.3	2.3	4.0	3.3	2.4	7.8	0.7	1.3	10.3	1.3	13.0	14.9	17.2	23.2	13.5	16.3	15.4	19.4	16.1	16.9	6.0	6.2	0.0	3.6	1.1	2.1	19.3	2.5	17.4	7.9	1.8	9.8	0.4	3.3	0.7	119.3	0.7	0.7	0.0	1.0	0.3	3.6	12.1	5.8	1.8	2.5	9.5	12.1	0.6	0.0	157.4	2.6	0.3	0.0	0.0	0.9	3.3	0.7	2.6	5.3	5.7	4.7	0.0	3.8	5.1	13.0	0.5	0.2	2.5	1.7	2.0
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.5	15.0	8.9	9.8	18.1	13.0	6.7	12.2	13.4	13.9	11.7	10.0	7.2	6.8	5.4	18.7	10.4	14.0	10.8	13.7	12.7	5.9	5.2	3.6	9.7	6.1	9.4	2.4	12.0	11.2	12.4	13.1	7.8	15.4	9.0	7.6	5.0	5.8	16.3	8.4	6.4	0.0	8.1	15.8	9.1	7.6	24.0	4.4	5.7	15.3	8.9	4.5	9.6	6.7	6.9	9.4	18.5	2.4	11.1	13.0	10.4	9.5	9.1	9.5	2.5	10.6	10.8	1.6	12.7	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2	6.0	1.1	3.0	5.1	3.8	11.5	6.1	7.6	6.7	5.7	8.7	0.0	6.0	1.7	7.8	2.8	2.4	2.4	0.0	7.0	3.6	6.5	2.8	2.3	3.9	5.8	1.6	4.1	2.5	2.7	1.3	4.9	1.4	1.7	1.0	5.2	4.1	4.9	3.5	11.3	2.2	4.5	0.0	3.6	9.8	11.1	3.1	6.2	4.6	4.9	3.4
AL160272.2		ENSG00000285082			9	117704157-117877478	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.0"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 5.1"															NA	NA																							12.0	3.8	7.2	3.0	4.9	10.1	10.7	4.0	4.5	2.0	2.3	4.7	0.6	2.1	2.5	3.7	1.5	1.6	3.0	4.8	9.6		3.8	2.7	5.3	15.4	5.6	5.1	2.0	6.0	4.5	0.4	4.2	4.6	2.0	2.6	2.9	4.5	1.5	3.0	4.4	3.7	1.8	4.9	21.0	3.4	2.5	5.9	0.0	2.7	2.0	2.1	3.4	7.6	2.0	1.7	4.2	1.9	0.6	1.1	0.5	0.4	5.1	2.0	0.5	0.0	1.6	1.3	0.7	0.4	0.1	0.3	3.4	1.2	0.9	0.5	0.5	0.5	1.3	0.2	0.6	0.8	1.1	0.3	1.8	1.8	0.7	0.0	2.6	0.6	0.7	0.4	1.4	0.6	0.4	0.7	0.6	0.4	3.1	1.2	1.7	0.8	1.9	0.9	0.6	1.1	0.5	0.5	0.8	0.4	2.0	0.9	1.3	1.3	1.9	0.7	1.3	0.7	0.7	2.0	1.4	0.4	1.5	0.6	2.2	2.4	1.3	1.3	1.3	0.9	4.2	1.9	1.3	0.7	0.9	0.7	0.9	0.7	0.6	0.6	2.0	0.9	1.1	3.8	0.6	1.2	1.7	0.5	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724730	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.6;TIME: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	29.2	12.1	15.5	23.5	12.5	17.8	21.9	9.4	10.3	6.9	6.8	10.6	3.0	4.4	5.8	7.7	5.0	6.8	10.6	10.9	19.9	7.5	9.0	16.5	16.0	30.9	12.4	11.4	6.7	3.0	2.9	3.8	22.8	10.5	5.7	7.4	7.2	9.0	3.6	7.4	5.2	6.6	10.4	11.1	41.4	4.5	2.4	13.0	1.1	8.3	5.6	7.5	12.1	16.1	0.6	7.5	30.1	21.4	0.0	0.0	6.9	0.0	0.0	12.7	0.0	5.9	12.0	0.1	5.0	8.8	1.3	0.7	0.0	1.2	1.7	0.2	13.0	3.9	0.0	0.0	1.1	1.9	0.0	0.0	2.7	2.7	0.1	4.4	9.1	0.0	7.4	0.0	2.8	0.3	11.4	15.5	0.0	0.0	29.6	15.4	0.0	0.0	1.8	1.5	1.2	0.6	0.0	14.3	9.3	0.5	14.8	0.0	0.0	3.2	0.0	0.5	1.2	0.0	5.0	21.4	0.7	9.6	0.0	2.4	0.0	0.0	0.0	0.4	9.6	7.6	17.6	21.4	7.2	0.0	19.6	0.0	0.6	0.0	0.0	7.5	0.2	0.0	0.0	30.1	0.0	20.2	0.3	0.0	6.9	15.5	12.5	9.4	10.3	19.9	7.5	12.4	11.4	10.5	13.0	0.0	5.3	1.5	0.1	0.7	0.2	2.5	5.1	2.7	4.5	0.0	0.0	0.2	0.0	0.0	0.0	19.7	0.3	0.0	0.2	0.2	1.9	0.2	15.1	1.8	31.7	0.0	0.0	59.5	88.0	0.0	0.0	33.1	1.7	0.0	0.6	13.8	0.3	1.7	0.0	0.4	0.8	6.5	0.9	0.0	0.2	0.0	0.7	0.0	0.1	2.2
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369467	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.0"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 7.5;Cone photoreceptor cells: 23.6;Ito cells: 4.9;Proximal tubular cells: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 9.2;NTERA-2: 17.6;SCLC-21H: 7.8;SH-SY5Y: 3.4;SuSa: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"	NA	NA			Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	1.0	5.6	17.7	1.0	16.5	0.9	3.8	19.7	47.0	1.4	1.1	5.1	0.0	1.1	1.2	7.2	1.2	1.0	2.7	2.8	16.0	12.4	3.0	1.7	1.1	0.9	7.4	10.7	1.0	0.9	1.0	1.0	0.9	5.8	2.9	1.0	0.2	1.7	7.6	1.2	0.9	1.7	1.0	9.7	1.3	1.0	1.5	5.1	0.0	1.3	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	17.6	0.0	0.0	0.0	1.8	0.0	0.1	0.0	7.8	3.4	0.0	0.0	0.0	6.5	0.7	0.0	0.0	1.2	1.9	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	16.5	19.7	32.2	16.0	12.4	7.4	10.7	5.8	5.1	0.0	0.0	0.0	0.4	0.0	7.5	0.6	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	2.4	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	8.8	2.3	0.0	0.3	0.7	0.7	0.0	0.0	0.0	0.0	0.1
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.9	23.5	14.1	10.1	15.0	12.6	12.4	9.5	14.1	13.2	13.2	12.7	17.9	5.7	12.1	9.6	21.2	18.5	14.2	13.6	14.3	7.4	15.3	30.9	23.5	9.5	18.9	10.2	27.0	9.5	12.4	16.5	10.6	12.2	21.7	14.1	15.6	18.4	21.6	20.2	12.1	21.7	20.5	12.8	19.8	28.1	8.4	10.0	7.7	15.4	17.7	21.5	11.8	14.3	10.6	27.8	13.0	8.1	12.2	13.4	14.3	14.0	11.4	15.8	20.1	12.7	12.1	25.7	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7	26.8	36.1	14.1	10.3	6.3	24.3	48.4	15.3	41.5	20.5	1.8	15.7	9.3	6.6	10.8	27.1	10.3	5.9	23.3	12.4	10.0	11.9	11.1	16.2	18.8	9.3	17.5	8.1	6.7	10.0	25.6	20.4	12.9	11.8	13.6	10.2	23.9	9.9	5.9	21.9	3.6	28.0	32.3	13.2	57.4	36.8	5.9	6.1	13.8	6.7	7.3
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.7	10.7	9.4	2.9	13.1	8.1	3.0	2.8	2.4	0.7	1.0	0.6	1.6	10.1	4.2	2.6	3.4	11.8	13.5	4.8	2.0	8.2	3.9	1.4	20.1	4.4	5.6	4.0	8.7	3.8	14.8	4.6	3.7	26.3	6.6	5.5	3.2	4.8	7.8	7.8	7.9	1.4	0.4	6.0	2.9	6.0	10.5	4.3	19.3	8.9	9.3	7.9	3.3	2.7	7.9	1.6	8.1	4.1	7.7	2.8	1.6	10.4	4.2	8.8	10.3	3.3	4.0	4.8	16.1	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8	80.4	47.6	4.9	4.8	24.4	27.8	23.0	15.3	6.7	21.6	22.7	200.3	0.3	0.0	3.9	0.6	7.3	6.5	23.3	4.7	1.1	6.1	8.8	6.9	41.0	5.9	12.7	6.3	10.4	54.2	0.9	10.6	18.5	25.3	2.8	3.3	28.2	11.0	6.8	11.0	5.0	70.5	12.9	9.9	8.4	6.1	38.3	1.0	9.6	6.0	5.7
FBXW2	"FBW2, Fwd2, Md6"	ENSG00000119402	"F-box and WD repeat domain containing 2"	Q9UKT8	9	120751978-120793412	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067878	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067878: AB_2685913"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.88e-3)"	"prognostic favorable (1.38e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.83e-2)"	26.4	31.7	17.4	22.9	25.8	35.6	29.7	27.0	30.3	26.0	22.6	22.6	17.4	18.1	28.8	25.2	25.5	22.7	24.2	25.3	18.1	16.1	20.4	25.5	27.4	25.0	15.1	19.8	20.9	27.3	30.7	23.4	18.8	18.8	22.8	22.3	23.8	25.6	23.2	20.2	27.2	20.9	29.7	16.8	30.1	24.5	23.0	16.7	32.9	22.8	15.7	26.6	25.2	23.8	10.6	11.7	17.7	13.2	15.4	19.3	9.6	14.1	18.0	13.5	22.8	25.6	21.1	12.5	19.1	21.9	21.1	20.7	14.2	17.2	21.3	10.1	24.8	21.4	31.3	19.4	19.0	26.4	28.5	8.4	13.8	30.4	20.6	14.5	30.7	19.1	15.3	23.8	23.3	25.0	19.9	24.7	22.2	18.3	23.3	18.3	22.7	22.0	9.2	20.1	24.2	17.2	17.0	21.6	21.3	14.6	16.1	10.8	16.4	26.8	19.9	13.8	16.7	32.5	8.9	18.3	18.1	14.5	29.1	23.5	16.9	33.9	18.6	19.2	13.7	18.5	13.3	12.6	17.7	19.3	12.0	14.7	10.6	14.1	18.1	11.7	6.9	11.7	15.8	13.4	15.4	13.2	10.3	13.4	9.6	17.4	25.8	27.0	30.3	18.1	16.1	15.1	19.8	18.8	16.7	23.8	49.9	14.5	22.8	20.1	19.5	19.1	17.8	17.4	29.6	10.4	11.8	15.7	18.3	22.8	36.2	31.5	18.9	0.0	29.7	24.2	25.1	28.8	15.1	28.7	22.4	31.8	26.6	34.4	30.8	127.2	24.5	23.2	45.5	33.3	21.9	14.7	25.6	22.9	33.6	21.1	23.1	6.5	25.0	40.3	58.2	28.0	14.9	30.5	21.3	22.6
B3GNT10		ENSG00000214654	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10 (putative)"	A8MXE2	9	120792403-120799918	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 1.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"													NA	NA						"unprognostic (4.59e-3)"	"unprognostic (2.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-7)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.73e-1)"	1.8	1.0	0.9	2.3	3.8	6.5	3.1	0.8	2.6	1.7	2.4	6.3	3.5	1.9	3.1	4.3	1.5	2.6	2.5	1.8	1.4		3.9	1.4	1.3	3.6	3.5	1.5	3.8	5.5	4.3	3.9	1.7	3.3	2.7	3.1	4.1	6.7	2.3	1.9	1.4	3.4	1.5	1.5	2.4	3.2	8.3	3.2	3.6	4.2	0.9	4.2	2.4	1.5	2.8	2.0	3.6	3.1	3.6	4.9	2.3	3.0	3.8	4.3	2.8	3.6	2.8	5.2	2.9	3.1	4.9	3.0	1.2	4.7	5.8	2.6	1.5	5.8	8.1	7.4	5.9	5.7	7.0	2.2	3.3	2.6	1.9	6.1	3.9	1.5	3.0	3.1	3.7	8.8	1.1	0.9	6.8	10.1	8.1	3.1	4.3	2.9	0.9	6.1	6.5	3.7	3.0	8.0	8.8	2.8	3.0	6.1	4.7	5.4	2.6	5.6	2.7	10.5	0.8	1.4	2.5	2.2	5.2	2.9	9.7	14.5	5.6	5.2	2.2	5.0	1.0	1.8	3.6	3.5	1.7	3.6	2.7	3.3	3.9	2.0	2.8	4.9	2.7	1.3	3.6	3.1	1.5	3.6	2.3											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	3.5	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842984	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		12000000	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	14.1	20.1	10.2	12.2	16.2	14.7	32.5	20.7	21.8	14.6	12.9	10.2	12.3	10.3	14.8	14.1	17.3	13.8	10.6	12.7	11.7	12.3	11.5	21.0	34.8	23.6	9.8	14.1	16.7	32.2	13.3	11.7	10.5	14.5	16.1	12.5	8.8	15.1	15.7	10.0	16.7	11.2	24.5	9.9	12.3	14.4	11.3	8.1	13.0	12.6	9.2	15.5	14.9	13.5	17.5	14.4	15.2	17.9	14.2	25.2	14.2	13.1	17.1	8.3	15.4	18.6	18.5	9.8	19.5	15.3	18.5	16.9	15.2	8.7	13.4	8.9	19.8	14.6	19.7	0.0	19.2	21.6	12.2	1.9	11.2	23.8	8.4	14.0	3.9	4.2	15.5	12.5	17.9	19.2	9.2	10.7	14.7	41.0	9.0	17.2	16.3	11.9	8.1	12.3	32.1	12.2	11.0	18.1	10.6	17.0	11.6	11.4	7.3	23.6	20.1	9.3	6.5	24.0	9.5	16.5	0.0	10.0	7.7	17.2	5.4	5.4	14.7	11.4	12.9	16.3	15.2	14.9	12.3	17.1	16.5	18.6	17.5	19.9	20.5	14.4	13.2	19.4	15.1	8.1	14.2	17.9	10.5	25.2	14.2	10.2	16.2	20.7	21.8	11.7	12.3	9.8	14.1	14.5	8.1	8.9	14.2	12.8	9.5	11.0	14.0	7.5	12.7	6.7	21.6	8.7	11.8	10.1	10.0	10.8	5.2	10.9	9.5	0.0	11.6	9.5	13.9	12.5	13.9	22.2	10.6	4.8	7.5	16.0	13.9	3.2	12.0	10.6	13.5	7.2	14.3	9.5	13.9	10.8	15.2	12.9	10.4	6.5	15.1	21.1	20.0	11.8	9.2	17.5	9.3	8.4
PHF19	"DKFZP727G051, MTF2L1, PCL3, TDRD19B"	ENSG00000119403	"PHD finger protein 19"	Q5T6S3	9	120855652-120894896	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 30.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 86.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (2.78e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (2.74e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.01e-2)"	7.6	7.9	10.3	18.2	21.0	30.0	9.6	10.8	9.9	11.7	10.8	9.3	4.0	4.4	11.7	9.5	14.3	11.7	11.0	8.7	10.9	7.7	5.0	2.9	9.0	23.5	17.0	5.6	14.7	2.5	3.5	15.4	7.8	9.1	11.4	11.1	10.4	4.5	11.6	4.9	6.5	9.6	17.2	10.5	14.0	10.0	5.2	17.0	24.3	5.1	18.6	27.3	11.2	23.0	2.1	5.6	0.9	30.1	1.6	12.1	3.7	8.7	31.2	7.1	15.1	5.5	11.4	1.1	9.5	13.4	44.8	32.4	17.6	20.6	18.2	6.1	13.0	14.2	21.0	19.9	20.4	20.8	18.7	7.6	18.6	41.7	11.2	3.0	28.2	9.2	6.4	3.4	19.3	20.6	12.0	28.8	18.5	51.1	52.4	23.5	21.8	18.7	26.9	7.1	27.3	50.0	14.5	7.6	51.1	13.4	3.0	21.2	9.8	19.1	0.3	9.6	6.3	18.1	11.9	10.7	9.9	11.8	9.4	21.2	26.6	86.9	30.6	6.2	17.1	27.2	0.3	5.6	0.7	2.3	22.0	1.8	2.1	5.2	1.9	5.6	1.3	2.5	2.0	0.9	1.6	30.1	1.9	12.1	3.7	10.3	21.0	10.8	9.9	10.9	7.7	17.0	5.6	9.1	17.0	0.0	9.3	5.2	8.0	8.2	4.3	4.5	2.5	0.0	10.3	0.0	9.8	0.6	1.7	2.4	1.5	8.4	2.0	0.0	1.8	2.2	12.3	5.1	25.4	1.1	24.2	0.0	1.2	4.9	16.3	2.2	7.2	20.2	15.1	2.8	4.1	14.5	2.4	2.9	14.5	1.1	22.2	0.0	14.6	5.6	14.2	5.9	1.1	17.5	10.0	4.7
TRAF1	EBI6	ENSG00000056558	"TNF receptor associated factor 1"	Q13077	9	120902393-120929173	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"monocytes: 550.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;T-cells: 11.1"	"Group enriched"	"Detected in many"	6	"HDLM-2: 35.9;WM-115: 45.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001852, CAB009593"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009593: , HPA001852: AB_1080344"	"unprognostic (1.45e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (2.19e-5)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.42e-5)"	"unprognostic (1.85e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.64e-1)"	"unprognostic (9.87e-3)"	5.4	8.6	9.5	21.6	20.5	8.7	5.7	4.7	13.7	5.3	6.5	17.5	9.2	4.3	6.6	7.4	5.2	6.7	8.6	7.5	11.4	5.5	7.8	4.9	7.4	33.1	14.8	11.2	10.9	3.9	5.3	11.0	3.6	12.5	10.0	5.0	9.4	10.3	7.2	2.4	8.2	8.9	7.8	7.6	15.5	6.6	3.1	19.1	3.5	7.9	2.2	24.0	9.0	10.0	0.2	2.8	0.0	0.4	1.4	11.1	2.0	1.2	0.8	0.1	0.0	1.5	3.7	0.0	0.3	2.0	0.6	1.1	0.1	0.7	2.4	0.4	0.4	6.0	0.5	0.2	0.1	0.7	35.9	0.0	0.2	0.8	0.1	1.1	0.1	2.8	1.8	1.9	2.3	1.7	0.7	0.3	0.7	0.0	4.9	0.3	0.1	0.0	1.0	0.4	0.5	0.1	0.6	0.6	4.9	0.2	0.1	0.4	0.0	0.3	0.1	0.1	1.1	0.3	0.4	0.3	0.5	0.3	2.0	6.4	3.8	1.3	1.2	1.2	0.2	45.4	0.0	0.3	0.0	3.6	0.4	6.4	0.2	8.8	7.4	0.4	0.2	2.7	4.0	0.0	1.4	0.3	2.8	11.1	2.0	9.5	20.5	4.7	13.7	11.4	5.5	14.8	11.2	12.5	19.1	6.0	0.0	6.7	4.1	8.7	0.3	2.3	2.5	0.0	6.8	3.5	17.7	0.0	1.7	24.7	0.5	2.7	0.5	0.0	1.6	0.0	2.8	2.0	36.8	1.8	2.8	0.0	1.7	0.6	3.4	0.6	1.7	14.8	6.8	550.0	0.5	1.0	9.9	0.0	1.8	0.7	6.6	0.0	5.1	1.4	0.5	9.2	0.0	25.9	0.6	1.7
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050276	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"liver: 259.9"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 458.7"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 20.5;Hep G2: 21.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	46000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.5	4.7	8.3	6.1	7.1	0.2	2.5	2.6	0.7	1.5	0.6	2.0	3.0	0.1	1.3	2.8	8.1	0.2	0.2	1.1	0.6	0.0	1.2	1.0	21.6	1.1	0.7	0.5	3.1	0.4	1.5	2.7	1.3	0.7	1.2	0.5	2.8	1.6	4.0	0.3	0.1	1.2	5.0	8.0	1.8	2.1	0.3	1.3	0.6	1.2	4.9	1.1	0.0	2.0	3.4	1.6	2.7	0.9	2.1	0.1	5.5	2.4	1.7	1.2	1.2	1.6	2.8	5.0	0.0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3	6.0	25.8	2.2	1.0	0.9	4.5	0.6	38.2	5.3	12.5	1.8	0.0	0.1	1.7	0.1	1.3	0.5	0.0	0.0	0.4	0.0	0.8	0.7	0.0	458.7	1.5	6.4	0.0	8.0	12.9	1.7	2.8	3.1	0.0	1.8	0.4	3.9	1.1	0.0	8.5	7.8	2.5	0.0	1.2	1.8	2.3	1.1	0.0	0.7	0.9	0.1
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 156.6;Spermatocytes: 334.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 35.4"	"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol		NA	NA			Centrosome	Cytosol	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.4	3.6	10.2	7.3	1.5	2.3	1.8	3.8	2.8	3.0	2.6	2.1	6.0	25.1	1.5	2.7	5.4	11.5	3.4	2.3	4.9	15.1	2.6	13.1	6.7	2.5	2.1	35.4	15.9	1.4	1.7	3.1	7.6	1.3	6.5	10.4	8.4	14.3	2.9	3.5	13.9	12.1	3.5	7.0	3.0	13.1	15.4	7.2	1.4	2.5	3.8	5.8	12.9	2.3	2.9	1.8	4.9	17.0	4.8	3.2	5.5	4.9	7.0	10.0	10.9	17.0	2.6	14.6	7.2	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8	26.8	26.2	35.1	12.7	3.0	28.2	7.0	5.1	156.6	48.9	3.5	35.3	1.5	3.3	3.8	56.2	14.4	2.1	0.0	5.2	2.1	5.9	3.8	49.9	2.0	22.5	28.6	8.1	12.3	34.6	27.0	12.7	37.9	8.5	22.6	7.3	7.0	5.3	3.5	11.3	1.1	64.1	38.8	5.1	334.4	72.6	5.0	0.7	29.8	5.2	4.7
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178137-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		9900000	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	28.4	29.2	35.7	29.7	37.3	41.4	37.2	36.5	50.2	29.9	30.3	31.4	38.2	28.5	27.9	26.1	50.1	25.6	25.5	24.3	33.3	34.1	37.0	58.7	57.5	38.0	44.5	34.8	27.5	22.7	38.6	25.2	30.7	35.0	29.5	31.5	20.0	29.2	55.5	28.2	42.4	27.4	24.7	43.0	28.1	31.3	23.5	41.4	23.9	32.4	25.8	34.3	27.7	32.3	19.0	23.3	24.0	30.9	19.2	21.5	15.7	21.6	22.1	28.1	23.5	32.8	35.9	22.2	30.9	24.8	23.9	19.1	17.4	23.6	20.8	18.1	29.5	20.8	41.4	20.0	23.0	27.1	17.9	13.2	22.5	30.7	17.7	22.7	24.0	27.0	22.8	41.6	24.5	27.0	26.5	33.8	19.5	17.0	19.1	35.7	20.5	23.2	19.3	16.7	42.6	25.0	18.5	30.5	24.3	26.3	31.2	24.9	14.6	36.7	32.6	21.0	20.8	34.3	19.0	31.2	25.6	18.8	31.6	21.5	17.2	32.4	21.2	24.1	21.1	33.5	23.4	21.9	24.0	18.0	30.9	17.9	19.0	16.9	19.5	23.3	17.0	20.4	20.2	23.7	19.2	30.2	14.3	21.5	15.7	35.7	37.3	36.5	50.2	33.3	34.1	44.5	34.8	35.0	41.4	148.9	86.3	53.6	73.4	140.4	91.2	33.9	71.4	87.0	89.9	59.3	35.3	75.8	72.9	69.8	30.5	73.0	67.3	0.0	56.3	68.7	55.1	66.3	74.1	102.0	79.3	89.0	57.9	59.5	87.7	24.1	48.1	78.2	104.6	89.2	51.7	90.0	61.8	46.0	53.0	77.8	55.5	58.2	60.8	83.2	110.1	177.0	97.1	57.5	49.0	92.9
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 1444.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 171.2;HaCaT: 68.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	510000000000	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	187.8	23.1	14.1	23.7	21.4	26.6	186.2	7.3	20.0	81.9	69.6	53.7	48.0	22.3	88.1	64.7	99.6	57.8	59.6	235.1	17.6	11.9	14.8	3.9	30.6	12.9	42.8	16.5	40.8	20.4	7.4	25.7	17.5	33.4	74.0	29.0	83.0	44.8	63.2	48.1	55.6	32.7	154.8	33.4	12.4	45.0	32.5	29.9	5.6	67.7	46.4	20.9	113.5	109.0	2.2	43.3	133.9	15.2	24.4	0.4	11.8	6.0	8.2	6.0	17.3	171.2	56.3	3.9	20.0	44.1	4.8	9.8	8.3	17.9	0.4	5.4	26.3	7.4	68.0	0.4	13.7	2.8	1.1	1.1	4.8	7.6	18.8	4.7	1.1	23.4	21.0	13.1	8.0	5.1	13.1	17.4	0.8	1.4	0.6	21.5	10.7	0.0	35.1	2.0	11.0	6.4	1.1	2.0	0.5	22.7	9.2	0.9	1.5	9.0	9.8	26.2	12.7	38.6	21.3	31.6	14.0	4.9	1.3	1.9	0.2	0.2	0.4	15.5	2.3	38.5	30.2	15.2	133.9	0.2	10.2	0.1	2.2	0.1	0.1	43.3	0.6	0.0	0.0	37.0	24.4	2.6	28.7	0.4	11.8	14.1	21.4	7.3	20.0	17.6	11.9	42.8	16.5	33.4	29.9	137.0	60.9	14.2	278.6	303.1	7.0	213.2	89.2	178.0	84.2	115.1	72.6	38.7	89.5	187.0	7.8	643.0	116.7	0.0	181.3	83.9	1444.1	71.1	102.6	18.7	489.5	1.6	60.6	248.6	117.0	8.4	545.1	370.4	509.5	819.7	545.7	186.0	216.7	466.4	631.5	19.2	78.1	601.5	596.4	7.0	11.7	261.3	70.3	27.7	39.3	112.7
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.9;HHSteC: 57.5;hTCEpi: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.5	9.8	0.8	4.5	105.9	30.4	0.0	26.3	26.2	7.4	11.7	1.3	1.9	12.0	6.5	32.8	4.4	2.6	5.5	24.4	13.2	7.3	2.3	27.9	21.7	3.8	57.5	10.3	5.9	50.4	86.5	11.6	15.4	2.1	26.5	3.7	6.0	16.1	16.1	7.9	0.3	7.9	12.0	0.6	3.1	1.4	0.0	26.1	5.8	0.3	1.0	0.1	22.0	19.5	11.3	8.2	6.7	8.5	33.6	17.2	5.4	17.1	2.4	6.8	7.5	0.7	6.6	10.4	9.2	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3	148.9	81.9	21.1	213.5	93.8	3.6	29.1	119.8	124.5	113.7	33.2	5.9	85.6	3.3	48.0	2.7	299.7	8.4	373.8	19.1	46.5	164.1	41.4	34.7	315.8	77.6	3.2	0.0	270.1	169.6	5.7	61.5	72.7	84.4	33.3	0.2	8.0	31.1	14.4	96.9	74.2	4.6	135.8	215.9	21.4	6.8	104.1	144.5	93.2	0.1	170.5
DAB2IP	"AF9Q34, AIP1, DIP1/2, KIAA1743"	ENSG00000136848	"DAB2 interacting protein"	Q5VWQ8	9	121567057-121785530	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Cell cycle, Growth regulation, Immunity, Inflammatory response, Innate immunity, Stress response, Unfolded protein response"	"Developmental protein, GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 81.4"	"Cell type enriched"	"Detected in single"	16	"MAIT T-cell: 2.8"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 34.2;HDLM-2: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (4.00e-15)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.81e-2)"	13.0	8.1	17.4	6.9	18.1	0.2	12.2	81.4	24.5	11.2	15.8	6.0	23.0	12.7	15.9	9.0	14.1	12.2	10.4	17.6	13.6	8.5	12.1	4.7	13.1	2.4	7.6	13.6	11.4	8.8	8.9	6.0	9.8	8.4	9.9	10.5	6.0	26.4	21.3	29.5	9.8	14.2	15.5	5.5	10.2	12.1	12.8	6.6	1.8	8.0	8.9	4.2	12.6	10.7	0.0	0.0	0.0	0.0	0.1	2.8	0.0	5.6	6.7	7.4	6.5	1.6	0.8	9.7	4.6	12.0	4.4	2.2	4.8	6.1	0.0	7.3	4.7	6.2	34.2	6.9	19.3	1.1	25.1	3.9	0.1	9.3	9.7	1.8	1.1	0.0	0.6	13.8	1.5	3.0	3.6	6.6	0.4	0.1	0.1	1.1	7.4	5.3	1.5	7.9	20.9	2.6	2.5	5.1	11.2	4.5	11.2	7.6	13.8	3.0	18.0	9.9	4.5	21.4	0.9	5.8	5.4	6.2	1.0	4.5	0.1	0.1	0.3	0.6	0.2	5.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	17.4	18.1	81.4	24.5	13.6	8.5	7.6	13.6	8.4	6.6	41.7	9.4	2.0	14.7	4.4	17.9	19.2	30.6	1.4	9.1	10.4	0.0	4.8	8.3	32.4	5.1	19.6	18.4	0.0	27.7	8.5	9.9	17.4	0.0	9.0	1.0	14.3	5.8	12.9	0.0	5.8	11.8	0.8	13.5	1.0	17.4	42.0	31.4	5.8	9.2	6.8	2.4	6.5	16.5	3.9	10.0	2.5	22.2	1.7	20.8	15.3
TTLL11	"bA244O19.1, C9orf20"	ENSG00000175764	"Tubulin tyrosine ligase like 11"	Q8NHH1	9	121821928-122093606	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 35.5"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 21.0;Late spermatids: 19.2;Spermatocytes: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021828	Approved				"Intracellular and membrane"	NA	NA					"HPA021828: AB_2670841"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.61e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.53e-2)"	4.9	5.8	8.5	3.3	14.4	1.6	4.6	15.7	17.2	5.3	8.3	35.5	4.1	3.4	6.2	4.0	9.0	6.5	4.4	6.4	10.9	6.8	3.8	6.7	4.8	2.9	15.6	10.5	5.7	6.2	7.7	5.2	5.5	17.3	5.9	5.3	2.7	6.0	7.0	26.6	5.0	3.6	11.7	19.9	3.8	4.6	13.4	16.1	1.3	4.5	3.7	3.2	6.4	4.2	2.0	1.5	0.0	1.0	1.7	0.5	0.2	2.7	1.4	4.6	6.2	6.5	7.9	1.8	5.2	6.4	9.1	5.2	4.2	1.6	6.1	1.6	10.7	3.0	6.7	7.9	6.2	5.6	4.2	6.5	3.0	6.1	4.2	7.5	5.2	3.5	5.6	9.0	3.6	5.8	3.4	3.2	5.4	9.0	6.2	3.2	4.2	3.7	4.2	2.4	9.3	9.7	3.8	8.0	9.5	4.7	2.2	9.7	4.0	3.1	5.9	3.8	2.6	4.7	4.6	3.6	4.3	0.8	7.7	6.9	6.9	8.6	2.6	4.0	5.9	1.2	0.0	1.0	0.0	0.0	0.5	0.1	2.0	0.2	0.0	0.4	0.4	0.2	0.5	0.0	1.7	0.7	1.5	0.1	0.2	8.5	14.4	15.7	17.2	10.9	6.8	15.6	10.5	17.3	16.1	0.0	1.0	2.2	0.8	2.3	2.6	1.5	2.5	2.7	0.0	1.8	9.8	1.2	1.7	1.8	21.0	0.6	0.5	0.0	1.6	0.6	1.4	0.8	1.1	1.7	1.4	6.4	1.2	0.0	0.3	19.2	3.4	0.0	3.3	0.0	1.3	1.5	1.7	0.0	2.8	1.3	2.6	0.0	3.3	10.7	2.3	3.6	0.8	1.0	0.9	0.8
NDUFA8	"MGC793, PGIV"	ENSG00000119421	"NADH:ubiquinone oxidoreductase subunit A8"	P51970	9	122144058-122159819	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 105.4"	"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 528.1;Distal tubular cells: 520.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041510, HPA041600"	Enhanced		Supported	Mitochondria		NA	NA		14000	Mitochondria		"HPA041510: AB_10794379, HPA041600: AB_10796778"	"unprognostic (2.90e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (4.17e-6)"	"unprognostic (1.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.62e-2)"	15.4	20.0	35.9	9.5	40.5	7.3	16.5	18.8	36.8	14.2	23.4	12.4	19.6	19.4	12.6	26.9	17.0	18.9	16.9	105.4	32.3	27.5	29.0	23.6	10.9	11.2	31.3	30.3	11.3	16.8	21.8	15.3	14.1	22.4	17.9	26.6	14.6	25.1	19.7	68.3	11.1	17.4	22.0	19.1	10.9	18.0	25.1	16.8	10.0	18.5	30.9	15.8	15.6	15.3	29.7	39.7	22.2	34.3	25.5	30.8	24.3	17.9	33.3	22.1	29.1	23.9	22.0	27.4	21.0	24.9	28.8	24.3	42.2	17.9	26.3	20.8	24.5	52.6	45.3	41.8	45.3	28.4	25.8	28.9	20.7	55.9	36.4	25.8	36.5	21.4	24.0	44.3	28.8	18.5	26.5	41.2	29.5	31.5	19.8	32.8	45.7	22.6	23.8	20.2	81.0	64.2	18.2	34.9	38.3	41.4	25.0	38.3	15.1	32.9	39.1	26.0	23.6	41.4	17.6	26.7	16.0	16.1	30.0	23.4	22.4	36.1	26.0	33.3	23.7	26.4	5.1	29.4	22.2	29.1	34.3	27.8	29.7	27.0	28.4	38.1	29.3	29.0	30.5	4.8	25.5	28.8	39.7	30.8	24.3	35.9	40.5	18.8	36.8	32.3	27.5	31.3	30.3	22.4	16.8	26.8	30.2	50.6	59.9	42.8	43.3	528.1	56.0	69.6	48.9	78.5	27.5	106.7	520.6	91.1	282.6	89.5	102.7	46.7	88.4	95.7	43.5	75.0	19.7	93.1	108.4	42.9	74.3	58.3	41.0	68.2	52.3	46.0	89.4	88.4	92.7	52.1	87.8	87.7	70.7	161.2	38.8	25.8	56.7	227.6	125.0	49.7	105.8	45.0	118.7	71.0
MORN5	"C9orf113, C9orf18, FLJ46909"	ENSG00000185681	"MORN repeat containing 5"	Q5VZ52	9	122159908-122200088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 56.9;testis: 52.1"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 386.8;Early spermatids: 358.0;Late spermatids: 462.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;HHSteC: 3.2;JURKAT: 1.4;NB-4: 5.0;RPTEC TERT1: 1.3;U-87 MG: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.24e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.12e-1)"			"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	0.2	0.2	2.8	0.5	4.1	0.1	0.3	0.3	2.1	1.8	10.7	4.5	2.1	0.6	2.9	5.3	1.3	56.9	2.2	0.2	3.1	3.4	0.8	0.1	5.4	0.2	1.1	2.7	4.1	0.4	1.8	3.8	0.2	9.2	0.6	3.1	0.7	0.9	2.2	0.1	0.1	1.2	8.8	0.9	0.1	2.1	52.1	1.3	0.0	0.2	0.0	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	5.0	0.0	1.1	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	4.1	0.3	2.1	3.1	3.4	1.1	2.7	9.2	1.3	0.0	2.2	0.0	0.1	0.0	0.9	0.0	0.0	386.8	28.4	3.5	2.0	0.0	0.0	0.1	358.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	1.6	0.0	0.0	0.0	462.5	6.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.9	2.2	4.7	0.0	0.0	68.8	4.5	0.0	0.0	0.0	0.0	0.0
LHX6	LHX6.1	ENSG00000106852	"LIM homeobox 6"	Q9UPM6	9	122202577-122229626	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.4"	"Group enriched"	"Detected in some"	9	"Early spermatids: 64.4;Late spermatids: 142.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 11.7;K-562: 8.5;NB-4: 16.1;PC-3: 11.1;U-87 MG: 8.9"	"Group enriched"	"Detected in many"	5	"amygdala: 11.3;basal ganglia: 16.2;cerebral cortex: 8.5;hippocampal formation: 9.5;hypothalamus: 10.7"	"Group enriched"	"Detected in many"	7	"amygdala: 13.1;basal ganglia: 12.2;cerebral cortex: 13.3;hippocampal formation: 13.4;hypothalamus: 4.9"	"HPA047854, HPA058319"	Approved		Uncertain	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoli fibrillar center"	"Plasma membrane"	"HPA047854: AB_2680183, HPA058319: "	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.72e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.14e-2)"	"unprognostic (5.64e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	14.4	1.2	7.3	4.2	11.5	0.5	10.6	0.4	17.4	3.6	3.0	0.9	0.9	2.6	3.8	2.5	4.1	2.6	6.1	6.4	12.3	3.5	1.9	0.9	5.2	2.2	2.0	12.4	2.1	1.1	2.3	0.3	6.0	1.1	2.4	3.2	1.4	2.3	2.3	4.3	2.5	3.1	7.4	1.5	0.6	2.3	7.8	2.2	0.0	3.2	4.6	2.5	5.3	7.3	0.0	0.0	0.0	0.1	0.0	0.5	0.1	2.4	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	11.7	3.0	0.0	2.6	0.0	1.0	0.0	1.3	3.3	0.0	0.0	1.9	0.1	0.8	0.5	0.0	2.2	0.6	0.0	0.8	0.0	0.2	0.0	4.3	0.6	8.5	0.0	0.0	2.4	0.0	16.1	2.6	0.4	11.1	0.0	5.6	0.0	2.0	0.0	1.7	0.4	3.0	0.9	3.0	0.5	2.5	0.0	0.7	0.8	1.2	0.0	0.2	0.3	0.1	0.2	8.9	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	7.3	11.5	0.4	17.4	12.3	3.5	2.0	12.4	1.1	2.2	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	64.4	11.9	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	142.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	2.3	6.9	0.3	0.0	0.0	0.0	0.1
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.2	12.4	15.4	7.3	13.3	10.9	9.1	8.5	7.0	5.8	10.2	5.8	8.6	10.1	13.7	13.1	13.8	11.5	10.4	5.9	7.6	10.2	5.9	14.0	15.1	10.5	13.1	15.7	9.6	19.6	9.2	13.1	8.3	10.4	8.0	13.6	6.3	7.8	9.3	6.5	19.8	10.2	7.0	17.4	13.8	12.7	6.6	17.6	9.3	10.0	14.1	15.0	6.9	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.7	21.5	8.5	14.1	9.4	10.2	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0	29.8	10.9	16.7	9.8	19.3	11.8	46.6	7.6	17.4	13.6	24.4	2.0	28.1	23.2	20.9	61.1	24.8	12.3	0.0	14.0	35.6	16.0	18.9	17.3	13.7	24.5	3.2	18.9	13.5	21.4	54.6	12.4	16.2	18.6	10.0	16.7	15.8	18.5	13.9	15.9	18.9	11.6	19.4	23.1	10.1	19.4	22.6	47.6	17.3	13.6	14.1
MRRF	RRF	ENSG00000148187	"Mitochondrial ribosome recycling factor"	Q96E11	9	122264603-122331343	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 205.6;Late spermatids: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047177, HPA049987"	Supported		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA047177: AB_2679970, HPA049987: AB_2680984"	"unprognostic (8.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (2.14e-8)"	"unprognostic (3.89e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.02e-2)"	"unprognostic (8.88e-3)"	20.1	17.0	10.1	12.6	14.8	13.4	21.0	15.0	14.5	13.0	26.3	14.0	20.3	25.3	23.3	17.8	21.6	10.4	9.9	18.8	10.5	11.2	23.3	21.7	12.5	14.8	17.1	11.7	12.1	17.6	24.3	20.1	12.7	15.9	14.3	31.6	14.8	15.8	14.7	31.1	19.1	19.4	15.7	15.4	15.7	13.5	17.1	15.1	10.6	16.1	23.3	20.9	15.2	14.3	10.3	19.6	3.8	18.7	13.7	11.6	7.1	13.1	17.7	10.1	16.9	14.5	13.3	19.3	13.1	16.8	17.7	10.4	21.1	15.8	28.6	6.6	10.4	14.1	38.6	28.9	30.6	14.5	9.5	11.8	9.7	21.7	11.5	9.6	27.2	13.0	12.4	20.9	15.8	28.4	9.0	19.7	11.5	16.5	11.0	17.7	20.9	13.5	8.9	11.8	32.9	17.9	10.2	19.3	30.3	30.1	13.4	12.0	7.9	14.1	22.9	10.4	10.1	24.7	7.0	10.5	7.8	11.9	20.2	16.0	7.6	18.4	12.9	14.8	16.3	8.9	2.7	11.5	3.8	9.3	18.7	10.0	10.3	9.4	8.7	19.6	9.2	9.8	11.6	1.4	13.7	18.7	8.4	10.4	7.1	10.1	14.8	15.0	14.5	10.5	11.2	17.1	11.7	15.9	15.1	3.0	7.8	16.1	18.7	13.7	10.7	17.9	22.9	18.7	12.5	14.0	11.8	24.2	29.9	32.2	205.6	19.9	25.2	0.0	25.7	44.0	10.8	12.9	24.3	16.3	27.3	4.8	7.5	11.6	10.5	142.3	8.9	17.2	13.5	22.6	21.2	6.1	23.3	21.0	7.1	29.2	23.1	19.4	12.2	33.2	15.7	19.6	31.0	10.2	32.9	16.3
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 205.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		25000000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.8	22.8	0.0	27.9	38.1	0.2	0.2	0.0	0.0	1.0	1.3	4.7	0.0	1.7	0.1	2.5	0.2	0.0	0.0	17.5	0.1	0.0	8.3	1.2	74.3	11.6	0.3	1.4	0.0	0.0	10.3	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.3	2.0	3.6	0.0	0.1	0.1	0.1	2.3	0.0	0.1	0.0	2.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.6	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1	0.0	10.0	0.9	2.4	8.9	0.0	1.1	0.0	1.4	2.3	40.1	0.0	0.1	0.0	0.5	0.0	6.0	0.0	0.0	0.4	0.2	4.7	1.9	205.3	0.0	25.3	0.0	1.7	36.8	10.7	0.0	1.4	22.9	3.3	4.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.3	0.3	0.7	0.5	0.6
OR1J1	hg32	ENSG00000136834	"Olfactory receptor family 1 subfamily J member 1"	Q8NGS3	9	122476958-122477926	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;JURKAT: 3.0;MCF7: 1.1;PC-3: 1.3;REH: 1.4;RT4: 1.3;U-266/70: 1.1"	"Not detected"	"Not detected"													NA	NA							"unprognostic (5.33e-2)"				"unprognostic (2.86e-2)"		"unprognostic (3.08e-2)"		"unprognostic (9.41e-2)"				"unprognostic (3.03e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.10e-1)"	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.6	0.4			0.0	0.4	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.2	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.3	0.0		1.2	0.3	0.0	0.5	0.6	0.3	0.0	0.4	0.2	1.4			0.3		0.1	0.5	0.2	0.3	0.1	1.1	0.1	0.0	0.3	0.0	0.1	0.7	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	1.2	0.0	0.7	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	1.3	0.6	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1J2	"OR1J3, OR1J5, OST044"	ENSG00000197233	"Olfactory receptor family 1 subfamily J member 2"	Q8NGS2	9	122510802-122511743	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.3;testis: 1.2;urinary bladder: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HSkMC: 1.3"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1			0.0	0.4	1.3	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.2			0.0		0.0	1.7	0.0	0.5	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1J4	"HSHTPCRX01, HTPCRX01"	ENSG00000239590	"Olfactory receptor family 1 subfamily J member 4"	Q8NGS1	9	122519141-122520082	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.4;BJ hTERT+: 3.1;fHDF/TERT166: 2.6;HMC-1: 1.3;JURKAT: 1.6;U-266/70: 1.2"	"Not detected"	"Not detected"													NA	NA											"unprognostic (7.83e-2)"		"unprognostic (2.53e-1)"		"unprognostic (4.13e-2)"				"unprognostic (1.82e-1)"			"unprognostic (4.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2			0.0	0.3	2.0	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.4		0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.6	0.2	0.8			0.0		0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	1.4	3.1	0.0	0.0	0.0	0.4	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1N1	"OR1-26, OR1N3"	ENSG00000171505	"Olfactory receptor family 1 subfamily N member 1"	Q8NGS0	9	122526358-122527296	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 1.2;testis: 1.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"endometrial cancer: 0.8;ovarian cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.2;U-266/70: 1.3"															NA	NA															"unprognostic (3.63e-2)"								0.2	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.2	1.2	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.3		0.3	0.0	0.0	0.0	0.0		0.2	0.2		0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1N2		ENSG00000171501	"Olfactory receptor family 1 subfamily N member 2"	Q8NGR9	9	122553112-122554214	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"	33	"Cardiomyocytes: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RT4: 1.1"	"Not detected"	"Not detected"							HPA060968			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA060968: "																		0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
OR1L8		ENSG00000171496	"Olfactory receptor family 1 subfamily L member 8"	Q8NGR8	9	122567117-122583384	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"RT4: 10.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (9.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.68e-1)"		"unprognostic (4.94e-3)"		"unprognostic (1.36e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-4)"	"unprognostic (9.82e-3)"	"unprognostic (3.33e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.06e-1)"	0.9	0.1	0.3	0.0	0.6	0.1	1.0	0.3	0.7	0.8	0.4			0.1	1.4	0.7	0.2	0.9	0.8	0.9	0.7	0.9	0.7	0.6	0.8	0.5	0.5		0.4	0.1	0.0	0.6	0.5		0.6	0.2		0.8	0.4	0.7	0.6	0.3	0.4	0.9	3.7	0.3	2.0			0.7		0.2	1.1	0.5	0.6	0.2	1.6	0.2	1.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	10.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.4	0.2	0.0	0.1	0.1	0.2	0.2	0.0	0.6	1.2	0.8	0.6	1.1	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1Q1	"HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106"	ENSG00000165202	"Olfactory receptor family 1 subfamily Q member 1"	Q15612	9	122614738-122615682	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"epididymis: 4.4;urinary bladder: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;JURKAT: 1.7;Karpas-707: 1.6"	"Not detected"	"Not detected"							HPA044828	Uncertain					NA	NA					"HPA044828: AB_10960565"										"unprognostic (5.41e-2)"				"unprognostic (2.00e-1)"			"unprognostic (1.98e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.2			0.0	0.7	4.4	0.2	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.4	0.2		0.2	0.2		0.3	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	0.3			0.0		0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.2	0.2	1.0	3.2	0.0	0.0	0.0	1.4	0.0	0.2	2.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	0.0	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1B1	OR9-B	ENSG00000280094	"Olfactory receptor family 1 subfamily B member 1 (gene/pseudogene)"	Q8NGR6	9	122628579-122629573	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RT4: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.2	0.0		0.0		1.2	0.7		0.6	0.0	0.0			0.0	0.5	0.0	0.3	0.0	0.1	0.0			0.0	0.1	0.0	0.3			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	4.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1L1	"OR1L2, OR9-C"	ENSG00000173679	"Olfactory receptor family 1 subfamily L member 1"	Q8NH94	9	122661566-122662648	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"urinary bladder: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"RT4: 2.0"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4			0.0		0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1L3	OR9-D	ENSG00000171481	"Olfactory receptor family 1 subfamily L member 3"	Q8NH93	9	122675036-122676153	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									HPA058878	Uncertain					NA	NA					"HPA058878: AB_2683843"																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0			0.0	0.1	1.3	0.7	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1L4	"OR1L5, OR9-E"	ENSG00000136939	"Olfactory receptor family 1 subfamily L member 4"	Q8NGR5	9	122723990-122724925	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"breast: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"JURKAT: 1.2"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0			0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1L6	OR1L7	ENSG00000171459	"Olfactory receptor family 1 subfamily L member 6"	Q8NGR2	9	122742303-122750783	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1			0.0		0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5C1	"hRPK-465_F_21, OR5C2P, OR9-F"	ENSG00000148215	"Olfactory receptor family 5 subfamily C member 1"	Q8NGR4	9	122788933-122789895	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.0"	"Not detected"	"Not detected"													NA	NA																			"unprognostic (2.73e-1)"				1.0	0.2	0.3	0.2	1.3	0.2	2.8	0.4	0.8	0.5	0.2	0.3	0.0	0.2	0.2	0.4	0.2	0.5	0.6	6.1	1.2	0.2	0.8	0.5	0.3	0.5	0.1	0.4	0.4	0.3	0.2	0.4	1.0	0.1	1.0	0.2	0.0	1.5	0.2	2.4	0.8	0.3	0.2	0.9	0.6	0.2	1.0	0.1	0.0	1.2	0.7	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.7	1.2	0.2	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDCL	"DKFZp564M1863, PhLP"	ENSG00000136940	"Phosducin like"	Q13371	9	122798389-122828631	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021571, HPA021647, CAB026473"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115"	"unprognostic (3.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-1)"	20.7	14.8	17.5	14.1	21.0	23.8	23.0	20.5	21.9	19.6	15.1	23.7	11.4	13.2	21.5	12.8	18.4	15.9	14.9	14.6	18.4	17.3	13.7	10.1	19.7	17.5	20.2	17.1	15.5	13.0	17.5	13.7	20.6	22.2	17.1	15.9	13.9	21.7	14.7	8.1	15.4	14.7	17.2	22.8	18.4	15.5	12.1	18.8	19.1	17.3	13.3	17.6	15.8	16.4	12.6	14.7	20.6	16.3	16.2	25.3	10.8	9.6	13.3	23.1	8.5	21.0	14.2	12.8	13.5	14.3	12.5	12.9	8.8	12.8	16.1	11.1	16.2	13.8	18.9	14.2	13.3	14.0	15.7	7.2	16.6	17.8	14.7	10.8	14.0	32.9	12.1	9.7	12.3	6.2	11.8	25.7	10.3	16.6	9.5	14.1	14.8	14.9	12.6	16.9	16.6	10.5	15.7	21.9	11.9	15.2	0.0	18.5	16.5	18.3	10.4	8.1	15.8	15.7	9.7	28.0	11.7	13.9	17.0	13.0	7.3	14.6	17.2	10.0	11.3	11.1	20.6	11.9	19.6	13.9	10.4	15.0	11.4	16.7	12.8	12.3	12.6	17.5	15.2	9.8	16.2	16.3	14.7	25.3	10.8	17.5	21.0	20.5	21.9	18.4	17.3	20.2	17.1	22.2	18.8	8.9	8.6	12.8	13.9	21.5	41.4	3.6	10.2	18.7	4.5	19.2	21.6	24.0	8.3	18.4	4.7	30.5	7.9	0.0	15.8	22.8	25.4	15.3	56.5	6.6	22.4	38.1	12.1	26.4	23.7	2.1	21.3	16.0	18.6	41.5	17.7	34.4	14.0	15.9	15.9	11.8	34.6	19.4	22.7	12.0	17.2	20.3	26.7	20.8	12.1	14.0
OR1K1	"hg99, MNAB"	ENSG00000165204	"Olfactory receptor family 1 subfamily K member 1"	Q8NGR3	9	122800123-122801073	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.1;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																			"unprognostic (3.77e-1)"				0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.3	0.0			0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.1		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.6	0.0	0.0	0.6	0.8	0.0	0.1	0.2	0.0	1.5			0.1		0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905341	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA042863: AB_2678204, HPA062144: AB_2732677"	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	16.4	10.7	25.4	14.1	28.8	30.6	14.1	18.7	27.6	17.1	13.0	10.5	14.4	11.0	14.6	9.7	16.5	12.2	12.6	15.7	18.1	11.2	15.0	14.8	16.2	19.2	12.3	25.3	14.7	9.7	19.0	16.2	16.3	12.6	11.5	13.1	9.4	13.2	13.9	16.1	13.8	13.0	16.3	14.4	15.2	12.8	12.8	13.2	18.9	15.0	11.5	18.8	14.1	13.7	8.6	9.6	12.4	10.4	4.9	8.9	3.7	10.0	14.7	19.5	10.5	10.4	12.4	10.9	12.8	14.1	15.2	13.3	17.7	10.7	16.8	10.5	17.1	17.8	23.6	20.9	15.1	16.7	7.7	8.3	9.6	26.4	11.7	13.7	11.4	15.4	11.9	14.7	14.8	21.0	12.6	20.8	14.6	13.5	12.4	19.2	13.5	11.1	8.0	9.7	13.6	13.6	11.2	32.3	10.8	14.8	8.0	23.0	16.0	22.8	14.1	11.6	14.1	16.9	9.6	20.6	11.7	9.9	15.9	22.9	8.7	14.1	18.4	13.4	10.1	13.2	12.4	6.6	8.5	8.9	10.4	7.3	6.5	7.3	8.9	5.8	8.6	7.0	6.8	11.8	4.9	9.3	9.6	7.1	3.7	25.4	28.8	18.7	27.6	18.1	11.2	12.3	25.3	12.6	13.2	38.7	32.8	12.8	10.7	9.7	18.4	31.3	12.7	12.0	11.4	8.7	35.3	12.6	3.3	10.7	4.0	26.6	12.3	0.0	10.0	12.7	13.4	18.1	16.2	12.4	8.5	27.0	22.3	31.9	20.4	6.4	12.4	15.0	13.5	15.4	22.4	15.8	18.0	3.5	17.0	11.0	17.8	19.4	15.6	25.0	12.6	12.9	19.2	30.2	13.2	22.7
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	11.9	10.4	10.7	11.8	12.2	5.2	12.9	17.7	13.2	13.7	9.4	9.0	10.7	10.4	12.6	8.2	11.6	9.4	7.3	9.7	10.2	9.4	11.0	9.2	12.4	26.2	15.6	10.3	13.8	10.0	11.6	14.0	14.1	10.5	10.2	9.0	6.3	9.9	11.4	14.0	10.0	15.0	10.0	13.2	14.0	9.7	9.5	14.4	22.7	13.8	10.1	16.0	11.1	9.3	2.1	2.3	11.8	3.9	3.8	4.0	2.4	4.1	4.8	7.9	7.2	8.4	8.1	8.0	7.0	8.6	7.0	6.3	5.0	5.3	6.6	4.4	6.3	6.3	19.0	8.2	8.6	8.8	9.3	6.5	7.0	10.4	4.6	8.3	9.2	12.7	6.6	13.1	6.4	10.7	8.7	6.4	8.4	7.3	8.2	10.1	7.7	9.3	6.2	9.9	12.3	8.3	5.0	21.7	9.2	7.4	6.8	10.0	12.9	10.8	10.6	6.6	8.7	13.3	6.1	6.5	7.7	6.0	7.8	8.0	14.4	17.2	1.8	9.0	6.3	7.8	11.8	2.3	3.3	2.0	2.5	2.7	2.1	2.8	1.9	2.3	1.7	4.0	3.5	3.0	3.8	3.9	1.3	2.9	2.4	10.7	12.2	17.7	12.1	10.2	9.4	15.6	10.3	10.5	14.4	6.0	2.2	0.0	2.7	1.9	7.3	2.8	7.6	4.0	9.1	1.8	9.8	1.7	0.0	2.1	7.6	2.9	2.6	0.0	2.1	1.0	2.5	3.2	7.0	2.4	2.1	6.4	2.9	7.4	9.2	3.2	2.8	5.4	1.7	1.8	4.2	7.4	2.6	3.4	7.4	3.3	9.1	6.5	2.5	5.2	3.0	2.4	1.6	5.1	3.3	2.7
ZBTB26	ZNF481	ENSG00000171448	"Zinc finger and BTB domain containing 26"	Q9HCK0	9	122915566-122931500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 26.3;Late spermatids: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021444	Uncertain					NA	NA					"HPA021444: AB_1858948"	"unprognostic (5.39e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.26e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.81e-2)"	5.3	5.1	7.1	7.3	10.8	7.6	10.3	14.8	11.1	10.8	10.6	7.5	6.2	6.1	13.0	8.1	6.4	9.3	6.0	5.6	8.2	6.2	6.8	4.5	6.9	8.6	6.8	6.7	15.6	8.1	13.6	12.5	8.7	8.4	10.4	8.2	7.0	8.1	10.2	8.9	5.8	9.2	12.9	8.5	10.4	7.6	14.8	11.1	7.0	12.0	1.7	8.4	10.1	16.5	2.7	3.0	3.7	5.0	3.1	2.0	1.3	3.4	3.6	14.0	6.6	4.2	8.1	5.5	4.0	4.4	4.6	4.4	7.1	5.8	6.9	3.9	3.9	10.8	13.2	6.1	3.0	7.0	7.0	4.8	8.8	11.6	5.2	5.3	7.9	9.0	5.8	8.9	3.9	5.3	8.8	5.1	11.0	8.2	11.1	4.6	6.1	8.1	6.1	5.4	11.6	4.8	7.3	13.0	8.0	5.0	4.7	10.9	9.3	7.3	4.0	5.0	7.1	9.9	2.9	4.6	6.6	6.4	5.5	3.5	8.4	13.2	7.6	4.1	3.3	7.1	3.7	2.1	2.3	1.0	5.0	2.0	1.0	2.0	1.5	3.0	2.7	2.0	2.0	1.8	3.1	1.8	1.4	0.9	1.3	7.1	10.8	14.8	11.1	8.2	6.2	6.8	6.7	8.4	11.1	3.0	0.6	1.4	1.8	0.2	4.0	2.0	2.5	4.0	2.3	1.8	0.0	2.1	5.0	1.2	26.3	2.3	1.3	0.0	0.5	0.7	1.9	1.9	4.6	1.7	1.2	3.2	5.8	4.3	4.0	43.5	2.0	1.3	0.0	1.0	1.8	2.6	0.8	2.9	5.6	1.1	2.5	6.5	2.5	9.5	5.2	0.4	1.7	2.2	2.3	1.4
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041651, HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA041651: AB_10794673, HPA064860: AB_2685372, HPA072273: AB_2686504"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	16.9	12.6	24.2	12.5	31.0	5.1	17.1	16.9	36.3	18.8	27.6	19.5	16.4	9.5	23.6	20.9	25.5	18.2	15.2	20.0	22.4	20.8	16.2	9.0	15.0	14.0	23.9	25.0	19.6	12.6	29.1	17.7	18.5	23.9	24.1	18.6	19.4	18.1	25.4	23.7	17.3	12.8	25.6	23.0	13.5	17.8	16.4	17.5	11.4	31.2	8.6	16.2	22.9	16.4	4.1	3.9	6.1	5.5	2.1	4.5	1.4	8.9	12.0	19.0	15.7	22.0	18.0	11.7	9.4	17.0	14.6	13.7	13.9	8.8	12.4	7.5	14.6	19.5	30.5	12.1	11.8	15.8	11.5	7.3	9.7	19.4	10.5	18.9	7.8	8.4	17.3	18.1	12.5	14.2	21.1	16.5	12.4	8.3	9.5	17.5	19.9	10.2	6.2	7.0	25.8	9.3	16.9	34.7	10.5	12.2	10.0	10.7	8.3	16.8	15.2	8.6	14.9	28.9	4.3	12.6	12.4	7.4	13.6	9.4	9.3	15.1	13.0	11.7	4.0	10.8	6.1	3.6	4.3	2.6	5.5	2.0	3.0	2.7	2.3	2.8	4.1	4.5	2.9	5.6	2.1	2.4	3.9	3.1	1.4	24.2	31.0	16.9	36.3	22.4	20.8	23.9	25.0	23.9	17.5	23.8	43.2	18.2	20.2	16.0	47.9	39.5	10.2	33.5	34.2	10.4	47.1	17.8	3.3	9.1	11.8	24.1	12.7	0.0	12.8	7.4	18.2	30.8	13.9	13.7	13.6	54.0	16.3	27.0	26.4	10.7	37.7	15.9	13.5	18.0	17.1	36.5	10.0	10.5	48.4	9.0	35.9	84.1	32.0	71.1	34.5	15.2	34.8	8.7	14.4	15.5
GPR21		ENSG00000188394	"G protein-coupled receptor 21"	Q99679	9	123034527-123035696	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HBEC3-KT: 8.4"	"Low region specificity"	"Detected in many"							HPA041651	Uncertain					NA	NA					"HPA041651: AB_10794673"													"unprognostic (9.22e-3)"			"unprognostic (1.46e-1)"		3.6	0.0	1.1	1.7	2.2	0.2	1.1	0.1	4.6	2.1	0.4			0.0	2.7	1.0	1.9	0.9	0.8	0.5	0.7	0.4	0.3	0.0	0.5	1.9	0.3		1.4	0.0	0.2	0.0	1.5		0.1	0.6		0.1	0.7	0.4	0.6	0.3	1.7	0.4	0.9	0.5	0.0			1.0		0.9	1.3	2.0	0.9	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STRBP	"FLJ11307, ILF3L, SPNR"	ENSG00000165209	"Spermatid perinuclear RNA binding protein"	Q96SI9	9	123109500-123268576	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 104.4;Spermatocytes: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 49.7;U-698: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020651	Approved					NA	NA					"HPA020651: AB_1857616"	"unprognostic (1.92e-2)"	"unprognostic (3.56e-2)"	"unprognostic (4.47e-2)"	"unprognostic (4.07e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.18e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (1.70e-10)"	"unprognostic (3.25e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-1)"	3.9	6.1	13.0	19.2	17.0	11.2	11.1	16.8	30.9	8.5	15.1	4.6	8.5	13.7	6.1	16.8	19.4	13.7	6.2	6.4	13.7	11.9	10.5	7.5	5.9	24.4	9.6	15.5	4.6	13.1	34.7	19.9	5.0	11.8	8.5	16.0	6.5	15.3	7.0	6.4	5.6	13.3	5.3	8.7	10.7	9.7	31.9	11.1	19.9	15.7	5.0	30.9	7.7	7.9	9.6	6.9	3.6	0.7	2.3	2.3	0.9	7.6	6.8	9.6	5.4	1.0	0.5	14.0	1.5	0.6	3.3	2.4	7.2	9.2	49.7	4.3	1.7	15.1	6.4	10.9	3.7	4.5	7.2	6.2	8.7	7.0	7.7	2.4	20.0	3.1	0.3	5.1	0.7	3.2	1.1	3.5	16.0	22.5	23.2	0.9	12.1	19.1	9.2	13.2	19.4	5.5	30.9	8.1	16.1	7.3	6.0	15.9	5.2	8.3	9.2	7.2	13.1	12.0	14.6	1.5	0.4	5.0	5.2	6.1	28.2	28.3	45.3	2.1	8.0	3.6	3.6	0.6	1.4	1.7	0.3	1.6	9.6	1.7	1.8	0.6	9.3	2.3	1.8	1.6	2.3	0.7	6.9	1.3	0.9	13.0	17.0	16.8	30.9	13.7	11.9	9.6	15.5	11.8	11.1	17.9	20.8	60.4	17.9	7.9	35.2	24.5	20.4	104.4	31.8	15.7	82.5	15.3	14.9	18.0	63.6	8.2	27.7	0.0	16.6	8.5	3.5	23.7	11.5	13.4	8.2	15.9	31.2	8.6	2.7	23.2	4.9	8.1	16.9	9.0	24.3	42.7	15.8	20.1	4.6	15.9	58.3	0.0	7.2	144.3	38.7	9.2	10.8	14.6	27.1	30.2
CRB2	"FLJ16786, FLJ38464"	ENSG00000148204	"Crumbs 2, cell polarity complex component"	Q5IJ48	9	123356170-123380324	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Gastrulation	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 30.9;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 97.1"	"Group enriched"	"Detected in some"	7	"glioma: 9.4;ovarian cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"AF22: 27.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043674	Approved	Supported			"Intracellular and membrane"	NA	NA		240000			"HPA043674: AB_10962974"	"unprognostic (1.38e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.56e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.38e-1)"	1.3	0.6	6.8	1.9	8.7	1.3	1.0	3.0	16.2	0.5	2.4	21.5	0.0	0.9	2.4	0.9	0.7	3.4	0.5	0.6	9.7	3.7	5.7	0.5	0.6	2.4	7.3	17.4	0.9	0.5	0.5	1.3	0.7	7.4	0.6	1.7	5.1	0.6	0.6	0.5	1.0	1.0	1.3	9.5	1.8	1.1	1.1	7.7	0.0	0.6	0.0	2.3	0.7	0.2	0.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.1	27.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.0	0.0	3.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.8	8.7	3.0	8.2	9.7	3.7	7.3	17.4	7.4	7.7	0.0	0.0	0.0	0.0	0.2	30.9	2.2	0.0	0.0	0.0	1.8	111.9	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	2.3	0.0	1.1	0.0	0.2	3.2	2.9	0.0	0.0	6.2	1.7	0.0	0.0	0.0	2.8	4.9	0.0	0.0	0.0	0.0	97.1	0.0	0.4	0.1	0.1	0.5	0.2	0.0	3.1	0.1
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	11.4	12.2	17.4	13.9	19.8	32.5	10.0	18.6	21.2	10.9	14.8	12.8	10.3	15.8	13.3	9.0	11.3	13.0	10.5	10.3	15.9	12.8	16.4	14.5	9.4	11.6	11.8	14.9	12.0	8.9	20.1	19.0	23.9	13.9	11.0	14.1	14.5	8.5	11.8	11.0	9.3	17.2	14.4	10.1	20.2	9.9	12.1	13.2	10.6	15.5	5.6	9.5	10.6	17.4	1.5	8.4	11.2	15.2	0.5	1.3	3.2	14.8	8.8	7.9	14.9	5.4	8.5	36.8	14.4	21.8	12.3	10.7	12.0	6.6	11.9	3.0	11.6	16.3	8.4	6.7	10.5	12.0	5.0	5.1	5.6	21.3	8.8	7.2	6.7	3.8	7.8	9.5	10.2	17.5	4.3	10.9	11.6	15.4	9.2	9.9	8.5	8.0	9.7	15.7	17.2	13.4	12.5	7.7	10.1	6.1	5.3	16.8	13.7	11.6	7.7	9.0	5.4	10.5	17.0	5.1	13.3	5.1	15.5	7.5	14.0	10.9	8.2	11.2	13.4	8.8	11.2	15.2	2.8	1.3	10.1	0.7	1.1	0.9	0.6	8.4	1.5	0.6	0.7	9.3	0.5	8.2	1.3	0.4	3.2	17.4	19.8	18.6	21.2	15.9	12.8	11.8	14.9	13.9	13.2	0.0	1.0	7.3	2.3	4.5	15.9	7.7	7.6	1.4	1.2	15.7	15.7	8.6	5.0	4.0	28.4	10.1	17.6	0.0	4.4	27.4	5.2	4.7	4.6	12.1	14.5	30.2	11.5	7.4	15.9	67.9	13.6	10.8	3.3	2.8	6.6	13.5	5.2	10.7	10.6	11.5	12.3	0.0	5.2	3.4	1.1	2.5	7.3	3.8	6.7	3.1
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.7;retina: 17.0"	"Cell type enriched"	"Detected in some"	9	"Muller glia cells: 245.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Group enriched"	"Detected in many"	6	"amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2"	"Group enriched"	"Detected in many"	5	"amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7"	"Group enriched"	"Detected in many"	6	"amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5"	HPA000838		Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.9	1.0	30.7	1.1	20.5	0.9	1.1	0.0	44.7	0.8	0.9	4.7	0.0	1.0	0.8	0.8	0.8	0.8	1.0	0.8	23.6	2.4	0.8	6.1	0.9	1.1	1.5	16.1	1.1	0.8	0.8	4.6	5.1	0.0	0.8	1.1	17.0	1.1	0.8	0.8	2.2	0.9	0.8	0.2	0.9	0.9	4.0	4.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	4.9	0.1	15.7	0.0	0.2	1.6	0.4	0.2	1.2	0.1	4.9	0.0	0.1	2.1	0.9	12.3	0.1	15.7	0.0	0.6	0.0	3.4	0.0	10.9	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	7.8	0.0	0.1	19.5	0.0	4.6	4.2	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	0.0	0.1	5.6	2.0	0.0	10.2	0.4	2.9	0.7	0.2	3.2	0.0	0.6	2.2	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	30.7	20.5	0.0	26.6	23.6	2.4	1.5	16.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.0	7.9	0.0	6.7	0.0	16.0	0.0	0.0	0.0	0.0	0.0	245.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.6	0.0	0.1	0.0	0.0	0.0
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7.0	17.1	16.6	12.9	51.9	17.0	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13.0	11.3	19.0	5.8	12.9	4.0	6.3	1.9	22.0	17.7	10.1	21.9	11.5	29.0	18.8	8.3	3.8	7.6	7.4	12.3	11.9	4.6	22.5	29.4	14.8	9.4	15.1	14.6	12.2	11.6	14.0	9.1	15.1	18.1	33.4	1.4	6.1	27.3	9.9	10.0	5.4	24.9	10.4	20.4	26.9	4.5	62.6	39.1	4.4	13.8	14.3	38.4	15.9	4.3	4.4	0.4	26.0	7.8	0.2	4.9	3.0	39.4	11.2	9.6	8.9	4.6	15.6	2.7	5.3	1.8	3.0	5.8	13.3	12.6	12.7	18.4	31.0	10.7	10.8	7.3	6.4	2.0	2.5	5.2	13.4	10.2	14.1	10.2	18.8	29.0	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9.0	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9	8.9	6.6	9.8	11.0	2.2	0.7	2.5	17.8	1.4	4.5	3.5	0.0	33.9	1.7	35.3	14.7	5.5	12.9	23.3	20.0	103.8	9.9	17.8	21.9	33.3	99.7	0.0	5.8	4.3	10.7	12.3	4.6	30.4	6.8	90.2	15.5	28.1	24.3	15.2	3.5	29.9	1.8	0.0	5.3	1.2	10.6	1.0	30.2	0.0	18.6	8.9
PSMB7		ENSG00000136930	"Proteasome subunit beta 7"	Q99436	9	124353466-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2700000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	36.9	56.9	51.0	32.8	55.1	53.4	41.9	33.7	52.7	26.6	33.3	34.0	27.9	32.5	33.6	52.1	41.9	32.6	29.2	59.6	44.5	41.3	53.7	87.1	27.0	33.6	43.6	46.9	32.7	67.1	38.5	24.1	53.2	47.3	28.8	37.1	31.1	48.2	26.9	76.7	48.7	32.2	31.4	39.9	28.6	33.1	50.3	36.5	48.2	32.7	67.7	39.5	32.3	30.8	53.4	67.9	45.2	62.7	53.6	66.2	69.0	52.6	64.4	44.1	53.3	31.2	37.2	63.6	51.3	70.8	74.4	51.4	84.6	51.6	60.1	41.5	48.0	73.5	75.4	54.9	54.3	68.4	57.8	47.4	37.7	102.4	70.2	70.5	74.7	37.6	44.5	48.0	77.5	77.7	57.5	62.4	54.6	76.8	42.8	57.4	91.7	53.5	50.2	65.2	80.2	92.2	47.4	65.8	70.2	52.6	34.5	52.1	42.3	48.8	62.5	76.0	45.2	72.1	32.9	49.4	48.2	38.9	61.4	76.8	46.5	130.1	60.7	80.6	46.1	67.6	40.4	61.7	45.2	41.8	62.7	45.0	53.4	48.1	46.1	67.9	47.5	46.3	44.9	27.3	53.6	58.4	57.8	66.2	69.0	51.0	55.1	33.7	52.7	44.5	41.3	43.6	46.9	47.3	36.5	71.5	73.0	111.6	140.8	172.4	37.7	121.6	112.1	101.7	62.6	66.3	21.6	382.0	280.2	281.6	279.3	121.5	147.6	46.7	340.4	299.5	140.7	127.9	102.7	222.4	205.6	31.8	135.5	87.8	123.1	322.3	128.9	128.4	189.0	172.3	121.7	86.0	308.8	129.0	117.8	341.8	43.4	84.1	126.0	246.2	184.2	191.3	408.7	106.6	146.6	177.4
ADGRD2	"GPR144, PGR24"	ENSG00000180264	"Adhesion G protein-coupled receptor D2"	Q7Z7M1	9	124451425-124478589	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8"	"Group enriched"	"Detected in some"	18	"Early spermatids: 27.1;Late spermatids: 64.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 1.5"					"Group enriched"	"Detected in some"	4	"hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7"							NA	NA						"unprognostic (7.39e-4)"	"unprognostic (1.34e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.01e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.23e-6)"		"unprognostic (1.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.63e-2)"		"unprognostic (2.25e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	0.0	0.6	0.1	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	7.2	0.0		0.3	0.0		0.0	5.8	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.9
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507430	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.7;lymphoid tissue: 50.8"	"Group enriched"	"Detected in some"	10	"Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 39.1;Hep G2: 25.3;K-562: 9.3"	"Region enriched"	"Detected in single"	20	"hypothalamus: 6.1"	"Not detected"	"Not detected"			HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.2	47.7	0.2	0.2	0.5	0.0	0.2	0.2	0.4	0.2	0.2	1.3	0.2	0.0	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	13.1	0.2	0.0	5.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.8	0.0	9.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	25.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.3	0.8	0.1	0.1	47.8	0.1	0.4	0.3	0.5	11.0	1.2	2.1	0.4	0.0	1.6	1.1	0.6	0.5	0.7	0.5	2.0	1.7	1.8	10.7	0.0	1.0	3.1	0.0	0.6	0.5	0.7	0.1	0.1	0.5	14.1	0.3	0.2	0.2	0.0	1.3	17.0	0.5	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	9.8	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.3	1.9	0.3	1.0	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8	0.0	7.7	0.0	15.1	33.2	2.8	1.4	10.2	4.0	4.5	5.2	27.5	30.8	1.7	7.9	43.0	2.7	13.2	0.0	3.1	112.0	3.0	14.2	1.1	5.5	7.1	1.6	4.6	1.3	1.8	22.4	1.1	4.6	8.5	5.4	6.7	8.0	2.3	7.0	1.8	1.9	10.5	0.0	2.1	68.9	111.8	34.8	25.6	0.0	13.0	11.9
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.1	58.3	0.0	0.8	2.9	1.2	1.2	0.0	0.7	0.0	1.5	0.0	12.1	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.7	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.5	13.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.0	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.5	10.6	1.4	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.6	0.3	22.8	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6	0.0	2.2	0.0	3.7	10.6	0.5	12.1	0.0	1.4	0.0	0.0	2.0	0.2	0.0	0.1	0.6	14.2	0.0	0.0	0.6	0.2	13.1	1.0	0.0	0.0	0.1	0.0	0.0	3.1	2.4	1.2	2.6	0.5	10.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	3.9	12.9	28.8	0.2	0.7	7.3	0.0	0.0	0.0	1.6
WDR38		ENSG00000136918	"WD repeat domain 38"	Q5JTN6	9	124853417-124857890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"fallopian tube: 51.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 83.0;Early spermatids: 23.2;Late spermatids: 80.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HDLM-2: 3.0;HeLa: 2.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA056607			Approved	Vesicles		NA	NA			Vesicles		"HPA056607: AB_2683188"	"unprognostic (5.66e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.29e-3)"	"unprognostic (7.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.01e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.42e-2)"	0.2	0.2	2.0	0.2	3.1	0.2	0.2	0.2	0.5	2.9	0.2	10.6	0.0	0.2	0.7	11.9	0.2	51.4	0.2	0.3	2.8	3.3	0.2	0.2	10.8	0.2	0.3	0.4	6.0	0.2	0.2	1.0	0.2	8.8	0.2	0.2	0.0	0.2	0.3	0.3	0.3	0.2	0.3	0.7	0.2	0.2	7.0	1.3	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.3	0.5	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.4	2.5	0.1	0.1	0.3	1.1	0.1	0.2	0.0	0.0	3.0	0.3	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.7	0.1	0.3	0.6	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.7	0.0	0.2	1.3	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.1	0.2	0.5	2.8	3.3	0.3	0.4	8.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.0	9.1	0.0	0.0	0.0	0.0	0.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	80.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0
RPL35	L35	ENSG00000136942	"Ribosomal protein L35"	P42766	9	124857880-124861981	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA006047	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA006047: AB_1856443"	"unprognostic (1.16e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.58e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	91.6	70.1	81.9	116.6	59.2	178.1	156.1	49.2	55.6	109.3	118.5	45.8	86.8	63.0	95.1	98.9	158.5	98.4	89.9	97.0	60.2	55.0	77.5	140.3	89.1	228.4	65.9	48.1	189.1	492.3	25.7	67.0	71.8	45.8	118.3	56.6	63.9	150.9	98.5	247.1	142.7	75.6	131.5	60.8	113.4	78.2	60.5	46.0	113.3	128.4	154.6	130.1	125.5	176.4	201.4	172.2	31.1	82.2	105.1	165.8	281.7	92.1	144.0	81.7	112.1	89.4	189.6	112.2	72.8	117.7	151.9	103.7	237.6	91.4	138.3	75.8	81.0	90.8	178.8	94.8	159.3	55.8	84.6	164.0	55.9	195.6	153.5	159.7	124.3	74.8	174.5	249.4	89.8	159.9	83.9	111.5	132.0	119.8	175.6	113.8	299.6	146.3	285.2	153.2	277.3	177.6	125.0	126.1	307.8	130.3	109.5	110.7	89.9	66.1	156.8	147.5	42.4	159.3	205.3	57.1	67.8	71.7	117.5	147.7	99.1	230.7	206.2	95.2	131.0	113.8	28.5	82.2	31.1	116.6	72.1	155.1	201.4	156.5	133.8	121.0	189.4	165.8	143.9	10.8	105.1	58.8	172.2	122.6	281.7	81.9	59.2	49.2	55.6	60.2	55.0	65.9	48.1	45.8	46.0	592.6	1127.4	4054.2	3642.8	4892.3	209.9	654.8	1602.5	592.9	1178.4	1076.5	80.5	2511.2	2289.6	1953.2	1188.8	2070.4	1494.7	1448.3	5315.3	3981.0	2376.0	2324.3	1249.1	2646.1	2485.0	103.3	1248.3	1951.4	2954.3	3494.2	2571.6	3157.2	2675.7	2877.4	2738.3	357.7	3375.0	1946.4	1208.2	2550.5	284.6	976.6	2381.7	761.7	853.4	6349.1	2061.3	2553.9	3546.1	3372.3
ARPC5L	"ARC16-2, MGC3038"	ENSG00000136950	"Actin related protein 2/3 complex subunit 5 like"	Q9BPX5	9	124862130-124877733	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 443.6;Late spermatids: 782.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022013	Approved					NA	NA		120000			"HPA022013: AB_1845045"	"unprognostic (2.10e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.48e-2)"	"unprognostic (9.37e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.58e-1)"	15.8	23.1	33.8	20.8	33.8	30.8	15.7	20.7	43.0	12.3	19.6	8.8	19.9	18.2	10.8	17.4	35.4	12.0	18.3	26.0	30.7	23.0	15.9	24.8	19.0	28.6	22.8	34.6	6.6	17.3	13.0	18.9	18.7	23.4	14.1	19.5	8.7	15.5	14.7	40.9	26.9	14.8	13.2	13.6	24.1	22.8	29.8	13.7	10.4	14.1	28.8	33.1	15.8	17.5	22.5	19.0	6.9	5.5	28.8	28.9	8.3	19.2	10.4	9.0	10.4	7.6	11.1	22.0	20.2	11.2	15.6	10.9	21.4	16.9	17.7	12.2	12.2	11.4	28.6	14.0	17.8	14.8	19.5	10.9	9.3	24.3	12.5	12.2	20.3	11.9	8.5	21.4	13.8	15.1	9.6	17.7	10.9	24.8	48.9	16.2	28.2	11.6	19.5	21.1	30.6	26.6	18.7	15.6	50.9	15.0	13.7	13.2	10.7	13.5	17.4	16.4	10.3	24.6	20.2	19.5	13.1	15.2	19.2	27.8	32.6	90.7	23.3	15.5	15.6	12.3	2.8	5.5	6.9	27.4	4.6	26.8	22.5	16.5	28.9	9.5	19.4	12.2	19.4	3.2	28.8	5.2	19.0	18.3	8.3	33.8	33.8	20.7	43.0	30.7	23.0	22.8	34.6	23.4	13.7	53.6	53.1	95.3	108.2	314.6	24.9	76.7	73.9	52.2	52.4	64.6	2.0	130.7	111.0	118.3	443.6	70.0	79.9	0.0	144.4	131.2	64.1	120.2	36.9	70.6	82.2	23.8	63.1	65.1	28.3	782.4	38.3	52.4	86.0	60.5	58.1	57.3	191.3	59.6	45.6	76.3	19.9	25.8	51.4	136.5	122.0	365.9	178.7	165.1	74.0	249.7
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878357-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 60.9;Spermatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	13.2	16.2	11.2	13.6	16.0	7.7	12.1	11.0	15.3	11.8	15.1	22.0	16.9	15.0	19.3	9.6	15.2	12.3	11.5	14.9	13.6	9.1	11.8	16.0	12.0	11.5	17.3	13.2	13.6	15.8	16.8	15.1	14.2	16.6	13.1	14.5	19.3	13.4	13.4	20.0	16.4	14.7	21.4	16.9	13.7	13.5	30.0	15.7	8.7	12.5	11.2	12.9	18.2	12.5	5.5	6.7	11.5	5.2	4.1	6.9	1.8	6.3	11.5	7.0	7.3	12.2	10.7	8.9	10.5	11.4	11.3	8.3	7.6	7.6	4.3	5.3	11.8	8.7	16.8	5.6	9.0	8.3	6.2	5.5	4.6	14.8	10.0	14.0	5.4	10.9	7.3	6.6	10.9	13.3	8.2	10.1	5.5	7.3	7.4	8.0	13.4	3.8	6.3	2.5	15.3	10.7	2.4	10.1	9.3	5.8	8.8	4.0	7.6	12.8	10.5	6.9	6.4	20.0	3.8	11.5	10.5	5.9	13.4	9.7	9.4	14.4	5.0	13.3	5.7	11.0	10.4	5.2	6.1	6.4	5.0	5.2	4.6	4.0	6.9	4.7	5.5	4.2	3.9	11.5	4.1	3.9	6.7	3.7	1.8	11.2	16.0	11.0	15.3	13.6	9.1	17.3	13.2	16.6	15.7	6.0	11.8	3.7	4.0	1.8	15.5	17.5	7.6	25.4	13.6	5.2	60.9	5.7	3.3	8.4	9.4	7.4	8.5	0.0	7.7	4.0	3.9	4.3	15.1	11.9	5.7	17.5	5.2	11.1	7.8	7.7	5.5	5.5	8.5	9.0	10.3	11.8	7.4	0.0	8.5	5.1	36.7	6.5	6.3	43.3	19.6	3.8	7.2	5.3	8.0	3.5
SCAI	"C9orf126, FLJ36664, NET40"	ENSG00000173611	"Suppressor of cancer cell invasion"	Q8N9R8	9	124942608-125143506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 65.5;Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020632	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA020632: AB_1845804"	"unprognostic (1.93e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.75e-2)"	"unprognostic (4.54e-3)"	"unprognostic (5.69e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-3)"	4.5	6.5	9.5	6.4	14.3	6.8	5.4	9.5	19.1	5.0	4.5	3.5	3.1	3.3	5.9	4.6	4.1	6.1	3.7	3.7	7.1	7.9	4.4	3.8	8.5	7.2	4.6	12.0	7.6	4.6	5.7	4.6	2.7	4.8	5.5	5.0	12.4	3.7	3.3	4.2	6.6	4.0	4.0	4.0	5.0	4.4	5.2	5.1	34.4	5.3	2.1	6.2	4.2	4.5	2.9	3.1	1.5	1.7	2.5	2.6	1.3	3.7	2.9	3.9	3.7	2.2	5.3	6.5	2.3	4.9	2.5	3.6	3.7	3.6	6.7	1.8	2.3	3.0	6.3	5.0	2.6	5.2	4.7	1.8	4.4	5.3	3.2	3.0	4.7	3.4	2.0	2.3	3.9	2.6	4.3	3.6	12.2	6.2	7.9	3.8	4.0	14.9	3.2	3.8	7.2	3.2	9.4	6.2	5.8	1.7	5.1	4.0	2.5	5.5	3.1	2.9	4.4	7.6	2.1	3.7	2.3	4.3	3.8	4.0	4.4	8.3	6.4	2.8	3.8	3.4	0.8	1.2	0.2	1.1	1.7	1.2	2.0	1.9	1.3	0.8	2.9	2.6	1.8	1.5	2.5	0.6	3.1	2.6	1.3	9.5	14.3	9.5	17.0	7.1	7.9	4.6	12.0	4.8	5.1	65.5	23.3	13.0	7.7	2.5	39.5	3.9	17.8	9.4	12.5	17.4	188.5	5.6	1.7	3.0	9.2	6.8	5.0	0.0	1.8	4.3	5.4	6.4	4.7	7.6	3.5	15.9	12.6	13.5	5.6	4.1	8.9	3.2	3.3	1.8	7.1	32.7	2.2	6.6	5.6	1.9	114.6	0.0	3.8	27.2	20.4	3.8	2.2	8.7	8.6	3.7
PPP6C	PP6	ENSG00000119414	"Protein phosphatase 6 catalytic subunit"	O00743	9	125146573-125189939	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050940	Uncertain					NA	NA					"HPA050940: AB_2681283"	"unprognostic (6.45e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.50e-6)"	"unprognostic (1.54e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	21.7	20.1	20.1	15.7	24.5	24.8	21.2	20.8	26.2	17.0	19.1	25.9	15.1	13.9	15.6	17.2	21.2	14.0	12.9	15.3	19.8	16.6	22.8	17.8	16.3	21.5	20.1	16.1	17.5	27.7	21.3	17.3	17.6	17.8	14.5	21.8	16.8	26.9	14.6	50.5	19.3	17.3	16.3	22.6	19.4	16.5	22.8	23.7	34.1	22.2	20.5	24.0	13.8	15.6	17.3	14.8	32.2	19.5	13.9	23.3	13.8	14.1	10.3	18.8	17.8	20.2	16.9	19.0	15.0	16.3	22.2	18.6	16.5	15.0	20.4	11.7	20.1	18.9	28.9	25.4	16.3	25.8	18.2	12.3	16.7	16.2	14.6	16.6	29.1	23.2	13.9	22.4	18.2	17.4	17.1	20.7	23.4	19.5	23.7	23.9	21.0	27.4	18.4	17.5	39.6	19.2	22.4	28.5	27.2	18.8	14.3	19.5	19.3	26.8	21.6	17.4	16.7	33.4	18.4	20.0	13.7	13.1	26.5	19.9	26.2	47.2	27.0	18.4	19.1	22.2	27.2	13.2	21.4	14.7	17.4	18.0	17.3	18.9	16.6	14.8	13.3	18.9	17.5	32.2	13.9	19.5	10.7	23.3	13.8	20.1	24.5	20.8	26.2	19.8	16.6	20.1	16.1	17.8	23.7	38.7	27.8	41.7	45.6	68.7	15.2	30.8	35.7	21.4	23.9	26.2	7.9	40.2	48.0	40.6	102.7	41.4	34.6	23.3	47.6	45.3	30.1	41.0	43.9	36.1	46.7	14.3	46.0	46.6	52.3	56.7	27.6	48.9	42.2	46.9	41.6	28.7	41.6	38.6	33.9	54.9	12.9	51.8	44.8	93.3	43.0	76.5	72.9	49.0	37.9	48.2
RABEPK	"bA65N13.1, RAB9P40"	ENSG00000136933	"Rab9 effector protein with kelch motifs"	Q7Z6M1	9	125200542-125234158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023920, HPA067106"	Supported		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023920: AB_1856023, HPA067106: "	"unprognostic (8.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.69e-1)"	11.9	11.7	14.9	11.5	21.6	8.6	13.7	9.3	21.3	11.0	11.4	12.4	9.0	9.9	18.7	15.3	12.9	13.7	10.6	11.6	13.8	15.1	9.8	49.6	8.6	13.9	16.5	17.7	11.5	10.9	7.7	13.6	10.2	15.0	10.1	13.1	9.5	13.0	12.0	17.4	12.4	8.5	14.3	13.0	8.1	9.0	11.1	12.6	11.6	9.2	10.0	11.4	10.2	10.0	15.9	14.6	19.0	13.5	13.8	28.5	16.0	9.3	22.9	8.7	16.0	14.0	17.1	16.6	13.3	13.1	16.0	12.7	28.1	9.7	29.0	11.7	18.0	15.6	25.8	22.2	16.7	15.5	16.2	18.6	12.4	21.4	41.5	12.7	24.0	9.0	12.5	20.4	23.0	24.4	9.5	16.7	18.1	27.9	8.1	15.0	26.6	16.7	16.4	18.0	38.3	21.2	24.4	16.7	31.8	12.6	7.5	21.0	10.3	13.7	9.1	15.4	9.0	19.1	10.5	14.1	10.5	10.8	25.1	22.9	11.0	24.2	19.6	13.9	15.9	16.1	16.5	13.5	14.9	17.2	10.8	15.9	15.9	25.0	16.8	14.6	13.4	28.5	20.6	19.0	13.8	11.1	14.0	25.3	16.0	14.9	21.6	9.3	21.3	13.8	15.1	16.5	17.7	15.0	12.6	0.0	9.9	9.3	12.6	12.9	11.2	8.1	7.6	6.7	4.5	5.2	7.9	28.7	21.6	12.3	59.9	10.5	7.7	0.0	11.5	25.3	19.1	8.8	4.7	48.8	18.9	12.7	2.4	10.4	8.2	12.6	15.0	8.7	8.5	47.7	10.6	9.2	9.0	0.0	17.7	16.8	16.3	0.0	13.9	7.7	13.0	11.3	10.6	8.7	15.6	11.6
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal glandular cells: 1106.3;Syncytiotrophoblasts: 1110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.0	31.7	41.8	37.9	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.1	41.1	40.0	46.7	103.4	45.5	28.3	57.2	51.3	23.8	14.3	24.6	30.1	67.1	200.5	33.5	46.6	27.0	112.4	38.2	167.8	50.6	74.0	8.7	18.2	57.5	34.6	26.3	14.7	23.7	35.8	87.0	24.2	14.0	32.3	66.6	46.2	23.5	16.4	29.2	40.7	43.7	65.3	51.1	45.0	24.5	49.6	29.1	28.3	29.7	29.7	60.2	57.4	34.8	70.6	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5	172.7	228.8	134.1	1106.3	260.1	93.3	493.6	73.9	190.1	253.6	106.4	331.8	423.2	38.1	330.8	34.2	189.6	316.5	46.7	227.7	576.5	389.6	402.8	329.8	324.2	392.1	60.4	487.5	159.0	114.8	42.9	162.3	280.8	172.1	141.5	125.9	124.7	293.4	101.7	164.1	109.1	122.6	116.4	222.8	360.8	228.7	206.6	1110.2	140.9	109.4	772.3
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA029386: AB_10599604, HPA029387: AB_10600311"	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	17.6	16.2	16.0	14.9	18.6	26.6	16.9	25.7	21.3	17.5	16.1	20.9	18.0	10.8	19.1	14.0	24.3	16.0	13.7	15.4	15.5	14.1	17.6	14.5	20.5	15.1	21.1	15.6	18.9	14.1	30.3	20.2	23.3	20.1	14.7	13.2	16.4	15.9	17.2	31.6	23.5	14.6	17.4	15.3	17.3	14.6	32.1	20.2	18.6	24.8	12.2	19.9	16.2	17.7	10.4	14.8	19.2	17.8	13.6	14.8	10.0	11.6	12.2	11.5	10.7	14.0	15.3	16.8	13.1	15.0	15.2	12.8	19.3	8.4	15.6	7.1	16.4	15.2	23.8	23.9	13.7	16.2	14.3	14.3	17.7	29.9	9.5	16.5	21.0	30.0	10.9	13.4	18.0	14.6	9.9	18.0	12.6	34.4	8.7	12.6	17.1	15.7	9.2	11.7	21.1	13.9	13.8	25.2	15.1	8.7	12.0	15.4	10.3	19.1	17.7	10.4	12.1	21.7	11.0	18.9	10.8	7.9	19.1	13.9	11.1	21.0	16.1	13.2	12.0	13.8	18.6	15.0	18.0	13.7	15.6	13.4	10.2	14.2	14.8	14.8	10.4	14.2	14.7	19.2	13.6	17.8	5.6	10.9	10.0	16.0	18.6	25.7	21.3	15.5	14.1	21.1	15.6	20.1	20.2	101.3	47.6	9.5	14.1	28.3	29.0	55.7	15.3	50.9	35.2	26.2	49.1	33.2	8.3	14.4	33.5	20.2	12.1	23.3	16.7	19.4	21.6	17.0	15.1	13.9	23.4	33.4	12.1	23.4	25.4	10.0	21.3	27.3	16.9	16.2	16.0	21.3	17.3	14.0	22.6	13.4	38.0	19.4	22.1	63.7	35.1	32.2	56.1	19.1	16.1	22.1
MAPKAP1	"MGC2745, MIP1, SIN1"	ENSG00000119487	"Mitogen-activated protein kinase associated protein 1"	Q9BPZ7	9	125437393-125707234	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029091, HPA029092"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029091: AB_10599732, HPA029092: AB_10601568"	"unprognostic (6.65e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.27e-2)"	27.2	33.9	35.0	24.4	41.4	20.4	22.6	20.3	30.4	27.0	30.1	21.0	20.6	20.1	26.4	25.6	30.3	20.5	21.3	44.9	29.5	24.9	37.5	37.5	20.1	21.3	28.3	20.4	29.1	24.8	29.8	24.1	31.3	27.1	21.7	26.7	22.8	29.7	26.2	60.7	18.2	23.3	33.2	28.5	27.0	25.1	24.9	22.1	24.1	32.7	23.2	24.7	27.2	25.7	7.6	7.1	18.8	6.1	5.4	7.5	2.5	23.7	27.0	18.2	19.3	25.2	24.1	30.4	30.1	30.9	23.4	16.5	27.3	26.8	24.4	18.5	42.0	25.7	33.2	28.2	35.4	31.9	27.6	11.5	17.5	32.6	25.8	28.4	31.3	20.5	23.6	32.7	33.4	35.1	26.2	34.5	24.1	27.8	19.3	49.6	49.6	23.1	12.6	29.0	56.1	33.9	19.6	43.2	32.4	25.7	17.3	22.2	21.8	30.2	28.5	18.9	25.9	33.0	18.4	22.2	33.3	22.0	39.9	50.0	24.2	59.4	24.9	47.5	14.5	35.9	3.6	6.1	5.3	4.6	5.8	6.2	7.5	5.0	5.0	4.8	7.6	4.4	7.5	18.8	5.4	5.2	7.1	5.4	2.5	35.0	41.4	20.3	30.4	29.5	24.9	28.3	20.4	27.1	22.1	11.9	14.2	27.4	23.3	14.1	24.1	59.7	30.6	14.7	36.4	14.0	39.3	28.8	46.4	43.0	56.5	22.7	24.3	23.3	57.0	40.4	18.6	34.5	17.3	28.8	47.0	30.2	9.2	14.1	24.3	91.3	17.5	38.5	21.9	66.7	20.1	28.1	47.7	20.1	16.6	60.6	25.2	6.5	23.4	54.5	81.3	16.9	42.6	24.5	23.4	26.9
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.7"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 16.1"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 16.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.5"	"Region enhanced"	"Detected in all"		"olfactory region: 205.0"	"Region enriched"	"Detected in all"	4	"olfactory region: 287.4"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	8.0	25.0	4.4	16.2	11.6	3.0	10.4	6.6	3.4	16.6	18.9	3.7	6.5	3.1	10.7	10.9	9.1	5.9	22.8	16.1	2.9	6.3	3.4	7.6	9.4	6.1	9.5	3.4	35.0	12.9	86.7	6.8	3.1	13.0	18.8	6.1	7.1	10.5	12.3	3.6	8.2	6.0	21.2	17.6	5.5	10.0	5.1	6.2	6.8	14.7	5.5	3.8	13.3	12.0	1.8	16.1	2.9	1.8	3.8	2.1	1.0	4.7	4.6	20.8	19.2	5.8	9.5	3.7	12.4	7.1	8.7	6.2	5.9	9.4	4.7	1.5	9.9	8.9	3.6	11.7	5.0	17.2	5.0	8.3	4.0	3.5	2.3	7.4	4.4	7.3	4.8	5.7	6.8	4.4	19.2	9.7	3.2	0.2	4.5	17.9	2.5	4.1	2.1	15.3	5.7	3.1	7.7	31.0	0.6	6.6	2.8	11.2	19.4	8.6	1.6	3.8	8.2	7.1	36.5	11.7	17.6	4.8	10.3	23.2	3.2	5.0	4.9	8.4	6.2	9.0	2.9	1.8	2.3	0.9	1.6	1.2	1.4	1.2	1.0	2.1	1.8	2.1	1.0	1.7	3.8	1.3	16.1	1.8	1.0	4.4	11.6	6.6	3.4	2.9	6.3	9.5	3.4	13.0	6.2	8.9	14.7	3.2	9.5	20.1	6.8	52.9	2.5	9.4	13.6	12.2	35.3	0.3	6.6	9.5	11.1	10.8	0.9	0.0	2.2	0.8	11.1	16.7	16.1	9.6	14.6	39.7	11.1	11.1	29.5	8.8	18.4	15.9	6.8	9.0	6.2	8.0	2.8	15.9	10.6	1.5	38.9	0.0	12.0	12.2	7.9	23.1	0.3	7.2	2.3	7.6
MVB12B	"C9orf28, FAM125B, FLJ00001"	ENSG00000196814	"Multivesicular body subunit 12B"	Q9H7P6	9	126326849-126507041	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"AF22: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043683, HPA049383"			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA043683: AB_2678616, HPA049383: AB_2680737"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.82e-2)"	"unprognostic (9.59e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.12e-3)"	5.6	5.5	15.2	4.3	21.2	10.7	5.0	7.3	22.9	6.3	6.1	52.0	2.4	3.7	5.9	3.3	4.3	10.2	3.9	4.6	22.8	15.3	3.4	4.0	17.7	5.9	31.1	9.8	6.6	3.3	8.8	5.3	14.8	28.2	5.9	6.4	5.8	3.1	9.0	21.4	3.3	4.2	6.6	62.2	10.3	4.0	5.4	28.8	4.8	5.7	1.5	2.6	6.9	3.2	0.4	2.0	0.2	1.5	0.1	5.7	1.4	2.9	4.0	21.9	12.0	0.7	0.2	13.0	2.4	2.0	4.4	0.8	3.4	0.1	0.0	1.5	2.3	6.5	1.3	6.7	1.1	2.7	4.8	4.2	1.0	0.7	14.9	1.8	1.9	0.9	1.7	2.2	0.9	0.0	3.7	3.4	15.9	0.0	0.0	3.2	2.3	3.1	6.1	4.8	0.5	5.5	4.6	12.0	0.0	0.2	12.0	5.5	10.1	4.0	2.9	2.5	9.6	2.9	11.7	4.9	5.0	3.7	2.8	5.0	0.0	0.0	1.2	1.4	8.7	2.6	0.0	1.5	0.2	3.1	0.4	5.7	0.2	1.4	5.0	2.0	0.4	0.3	2.2	0.1	0.1	0.4	0.1	0.0	1.4	15.2	21.2	7.3	15.9	22.8	15.3	31.1	9.8	28.2	28.8	6.0	5.3	0.0	2.8	3.2	8.8	3.1	5.1	9.4	1.2	1.8	3.9	10.2	0.0	1.1	0.5	4.8	1.3	0.0	1.2	1.8	3.8	1.2	6.9	5.0	1.4	9.5	2.4	1.3	18.0	1.7	2.6	4.0	0.0	1.8	2.1	8.8	0.9	5.9	6.0	0.0	5.5	0.0	1.8	1.4	3.3	2.3	2.9	4.4	2.3	1.4
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126614443-126701032	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5;salivary gland: 35.3"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.4;Early spermatids: 1.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 17.2;OE19: 10.9;T-47d: 10.6"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.9"	HPA073716			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073716: AB_2686630"	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	1.3	0.1	0.0	0.1	0.0	0.1	7.5	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	1.9	0.1	0.2	1.4	0.0	0.1	0.0	0.6	0.0	0.1	0.8	0.0	0.6	0.0	2.9	0.1	0.0	16.5	35.3	0.0	0.4	1.5	0.2	0.0	2.4	0.0	0.1	3.1	0.0	0.0	0.9	0.1	0.0	0.2	0.1	0.6	0.4	1.2	0.3	0.9	0.5	0.0	2.4	1.1	0.4	3.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	0.5	0.0	2.8	1.2	3.8	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.5	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	17.2	0.0	0.0	0.0	10.9	0.2	0.0	3.2	0.0	0.0	0.3	0.0	1.5	0.3	0.1	0.4	0.1	10.6	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.5	0.4	1.2	0.9	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favorable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	6.6	6.2	7.8	4.9	12.1	51.7	6.6	10.6	13.6	5.8	5.6	9.5	3.0	5.6	6.6	5.2	10.3	5.3	5.9	9.5	7.9	5.7	5.1	9.0	9.3	6.0	8.6	7.1	7.1	5.9	9.6	9.3	8.2	8.1	5.1	6.6	7.5	7.4	4.4	34.7	14.6	6.7	6.0	8.5	5.7	7.4	15.7	9.3	5.3	6.2	7.1	10.1	5.5	7.0	6.1	5.2	10.6	6.3	9.0	10.7	4.3	4.6	3.6	6.5	6.0	5.6	7.9	6.8	6.6	6.1	4.9	4.4	8.7	3.2	6.5	3.1	6.2	9.9	13.5	5.8	6.1	6.1	6.1	3.8	4.5	10.6	3.7	7.5	6.2	8.5	9.6	15.5	7.9	19.9	4.7	3.7	5.4	7.7	15.1	7.2	5.0	5.4	4.0	5.9	5.0	6.2	4.7	21.1	5.2	5.4	5.4	5.8	5.4	6.7	6.4	5.8	6.2	5.9	4.0	3.5	5.9	5.7	6.6	5.3	16.2	11.5	2.5	7.4	5.3	4.8	10.6	6.3	5.3	10.7	6.3	10.2	6.1	5.8	6.2	5.2	5.1	6.4	7.3	3.5	9.0	4.8	2.8	8.2	4.3	7.8	12.1	10.6	13.6	7.9	5.7	8.6	7.1	8.1	9.3	32.8	40.1	29.9	62.2	75.4	37.7	33.5	22.9	20.1	46.6	26.2	102.1	15.5	1.7	27.3	73.1	17.3	40.0	0.0	16.1	10.4	25.7	47.1	30.1	22.9	13.6	25.4	10.9	17.2	14.6	30.4	16.4	26.4	23.6	11.8	16.6	33.0	31.3	14.2	13.4	5.8	56.4	12.9	25.9	42.1	61.8	102.6	43.5	20.1	18.1	123.4
ZBTB34	"KIAA1993, MGC24652, ZNF918"	ENSG00000177125	"Zinc finger and BTB domain containing 34"	Q8NCN2	9	126860665-126885878	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023893	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023893: AB_2219180"	"unprognostic (2.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-3)"	"unprognostic (6.59e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.01e-2)"	9.4	5.0	9.7	7.1	12.0	21.8	6.7	15.6	13.2	5.8	6.1	9.0	4.7	5.2	9.4	5.8	6.0	6.4	6.9	5.3	10.0	5.2	6.1	5.4	9.8	8.9	12.2	6.5	6.7	6.3	7.9	7.0	11.4	11.5	5.9	5.3	8.9	7.3	5.8	6.1	7.5	6.8	5.6	10.2	10.6	6.6	5.2	10.3	8.9	7.2	2.2	7.7	6.4	10.8	0.7	1.0	4.5	1.0	1.2	0.8	0.4	2.5	3.4	10.2	4.2	8.0	8.0	14.1	3.1	4.6	3.7	4.1	8.2	4.8	4.9	3.4	3.3	3.4	7.9	12.2	3.1	3.7	5.1	5.1	5.6	9.1	4.3	5.6	7.6	9.3	7.0	5.0	4.3	5.0	4.8	4.9	8.7	11.8	3.9	3.5	3.6	4.9	6.4	8.8	4.9	2.6	9.3	11.7	5.0	4.8	3.8	3.2	11.0	4.1	3.7	5.6	9.6	3.6	11.5	5.1	3.4	6.3	4.8	3.4	7.0	8.1	4.2	3.1	6.4	3.2	2.3	1.0	3.0	0.8	0.4	0.8	0.6	0.3	0.3	0.8	0.7	0.8	0.4	4.5	1.2	0.6	1.0	0.1	0.4	9.7	12.0	15.6	13.2	10.0	5.2	12.2	6.5	11.5	10.3	3.0	5.8	0.0	2.3	4.7	6.2	2.0	0.0	1.4	3.4	1.8	5.9	3.3	1.7	2.3	6.3	4.5	3.3	0.0	1.4	2.4	4.9	3.8	0.0	3.4	6.5	7.9	1.7	4.9	11.3	15.3	6.4	6.9	5.0	1.8	3.8	1.9	2.6	4.8	0.7	1.9	11.9	0.0	4.2	4.2	2.5	7.2	2.7	1.5	2.3	4.6
RALGPS1	"KIAA0351, RALGEF2, RALGPS1A"	ENSG00000136828	"Ral GEF with PH domain and SH3 binding motif 1"	Q5JS13	9	126914774-127223166	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.49e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.47e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.02e-3)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.20e-11)"	"unprognostic (4.79e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.24e-3)"	2.9	3.7	13.7	4.6	18.6	3.0	6.8	31.8	22.7	4.4	10.4	20.4	3.4	28.9	4.9	9.7	6.3	8.6	6.4	12.3	14.1	13.5	10.0	2.2	6.1	4.1	16.3	14.6	3.6	10.2	18.1	14.8	4.0	19.6	7.0	12.9	9.8	12.0	8.7	8.2	9.0	26.8	7.1	18.5	4.3	17.4	21.8	17.7	6.8	13.6	2.3	6.2	8.4	4.5	4.8	1.9	2.5	0.4	2.3	0.9	0.2	2.5	2.3	6.1	6.0	1.2	0.9	6.6	0.8	0.8	1.3	1.8	6.3	4.3	4.4	0.6	1.0	7.8	8.9	1.8	1.0	0.8	1.7	3.7	0.3	2.9	1.1	0.9	0.7	4.8	0.5	3.7	0.7	0.8	1.0	2.1	9.9	0.6	4.4	0.3	4.7	0.7	0.7	1.7	24.6	2.0	2.8	1.5	8.2	2.6	6.4	5.6	8.5	2.5	8.1	1.8	4.5	7.2	0.5	1.0	0.5	1.9	1.2	0.9	7.9	7.7	2.2	2.4	0.7	0.9	0.2	0.4	2.0	0.4	0.1	0.6	4.8	0.9	0.6	0.1	2.3	0.2	0.4	2.5	2.3	0.3	1.9	0.4	0.2	13.7	18.6	31.8	22.7	14.1	13.5	16.3	14.6	19.6	17.7	6.0	2.6	3.7	3.1	2.4	34.5	9.1	20.4	6.7	12.5	10.4	98.2	6.9	5.0	4.5	22.6	1.4	22.3	0.0	5.8	0.8	2.7	5.6	0.0	1.7	2.2	42.9	7.5	3.1	2.1	30.4	1.4	2.2	1.7	2.8	16.5	12.3	7.2	17.0	3.5	2.7	122.9	6.5	2.1	29.8	10.7	4.1	3.3	5.0	16.4	7.1
ANGPTL2	"ARP2, HARP"	ENSG00000136859	"Angiopoietin like 2"	Q9UKU9	9	127087332-127122883	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 66.4;Leydig cells: 19.2;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.4;ASC TERT1: 28.2;BJ hTERT+: 58.2;HSkMC: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040933, HPA041299"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	2510000	770000	"Golgi apparatus"		"HPA040933: AB_10795530, HPA041299: AB_10794552"	"unprognostic (5.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.07e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.15e-2)"	56.6	4.9	3.3	13.5	4.7	0.0	29.0	8.2	16.5	34.9	26.8	19.5	4.4	6.2	29.9	19.8	12.6	13.1	34.9	28.4	4.6	3.4	4.3	6.1	8.3	3.8	9.3	2.9	38.4	2.2	1.6	1.5	8.7	9.6	22.9	7.8	3.4	7.1	12.1	41.9	11.4	10.0	37.4	6.3	26.6	12.7	8.7	8.5	1.7	6.4	27.0	6.4	38.7	20.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.9	0.0	41.4	28.2	2.5	2.1	58.2	2.6	2.4	0.0	0.0	0.0	1.9	5.8	0.5	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	8.9	0.0	0.0	28.4	0.0	5.3	0.0	8.3	7.5	0.6	0.0	0.0	1.8	0.0	0.0	1.1	5.2	0.0	0.2	4.3	7.6	0.4	0.6	0.0	2.5	2.8	0.0	0.0	0.0	1.0	0.0	0.0	2.3	9.6	1.2	13.6	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.7	8.2	9.0	4.6	3.4	9.3	2.9	9.6	8.5	8.9	3.7	0.0	6.6	12.7	14.5	12.9	0.0	2.7	0.0	0.0	2.0	0.8	0.0	0.2	0.7	11.7	0.0	0.0	0.0	0.7	66.4	1.3	0.0	0.0	1.2	0.0	0.0	2.5	0.0	1.3	19.2	0.3	6.8	0.0	0.0	1.6	1.0	0.0	6.0	1.4	0.3	0.0	25.2	0.2	0.0	9.7	2.2	0.0	0.0	0.6
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 7.8;RPMI-8226: 5.6;SH-SY5Y: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	4.2	8.4	11.4	2.5	13.5	0.4	6.4	33.3	19.6	9.1	3.6	12.9	3.8	3.0	10.6	6.6	7.0	8.5	5.8	16.3	7.5	9.6	3.4	3.0	3.8	2.0	7.8	10.7	6.6	3.5	15.7	3.1	2.3	12.9	9.0	3.1	4.3	7.0	6.4	2.2	4.3	2.7	10.1	7.2	2.4	2.9	4.0	9.4	0.0	8.6	1.5	2.1	7.9	4.8	0.5	3.8	0.0	0.5	0.0	1.3	0.2	0.8	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.5	0.3	1.7	1.8	0.6	0.0	1.6	0.1	0.6	0.9	3.2	0.0	0.3	0.0	1.3	0.0	2.7	1.8	0.8	0.7	0.3	0.1	2.5	0.0	0.0	2.3	1.2	2.8	1.3	1.0	0.1	0.9	0.0	0.6	0.7	7.8	2.6	0.1	1.9	5.6	3.0	3.9	2.0	6.1	1.3	4.4	0.5	1.0	1.5	0.0	0.0	0.3	1.8	0.0	0.6	3.9	3.7	1.9	0.8	0.9	0.8	0.0	0.5	0.0	1.2	0.1	0.3	0.2	0.1	1.3	0.5	0.5	0.8	0.0	0.0	0.0	0.0	3.8	0.6	0.2	11.4	13.5	33.3	19.6	7.5	9.6	7.8	10.7	12.9	9.4	0.0	0.0	0.0	1.8	2.4	11.8	6.2	5.1	0.0	3.4	3.5	0.0	0.5	1.7	0.3	1.4	1.0	0.5	0.0	0.6	0.1	3.7	3.3	0.0	1.8	0.7	1.6	1.2	1.3	1.8	0.4	6.9	0.6	1.7	0.0	0.9	5.7	0.6	0.9	3.2	1.1	0.9	0.0	1.7	1.4	3.9	1.8	0.2	0.0	0.8	0.8
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 119.6;Late spermatids: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 33.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 46.6;Hep G2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	10.9	24.5	11.4	13.3	11.3	3.5	10.4	15.0	15.2	9.0	19.8	11.7	37.0	17.7	9.5	17.4	8.7	6.0	9.4	9.8	10.4	9.3	8.7	25.7	8.1	7.3	12.5	10.2	6.7	12.1	5.7	5.5	13.2	8.7	18.5	6.5	12.5	9.4	28.3	22.6	11.6	17.0	44.1	10.3	11.3	13.1	30.6	9.3	1.2	9.1	6.9	4.3	42.4	9.1	2.4	33.8	6.9	5.6	1.2	6.3	2.0	1.8	7.2	3.2	7.2	0.0	0.0	10.2	2.8	1.9	4.5	2.7	46.6	1.7	2.8	6.4	1.5	7.2	9.7	3.9	4.5	1.1	2.6	6.2	0.4	5.7	27.5	4.2	0.0	3.0	0.1	4.2	0.4	1.8	2.2	3.5	3.9	2.9	6.3	1.8	13.1	0.0	0.0	5.2	10.2	11.3	1.0	4.5	7.8	4.2	19.3	5.4	3.7	6.7	11.5	2.5	4.3	7.4	1.6	3.0	0.0	4.7	0.3	6.2	19.5	18.2	4.2	3.1	0.0	3.4	0.0	3.0	6.9	4.9	5.6	3.5	2.3	1.6	3.3	4.6	2.4	0.3	1.2	0.2	1.2	5.1	33.8	6.3	2.0	11.4	11.3	15.0	15.2	10.4	9.3	12.5	10.2	8.7	9.3	8.9	9.6	5.4	6.1	9.8	11.1	6.1	7.6	5.3	4.5	5.2	9.8	66.2	13.3	12.0	119.6	7.4	15.1	23.3	14.7	10.8	11.6	11.0	6.9	23.6	59.6	6.4	11.6	12.9	12.4	229.4	10.0	8.2	25.3	8.2	13.3	14.9	15.9	21.5	11.0	12.2	7.7	12.9	8.1	38.0	10.9	9.3	56.3	6.9	15.6	5.5
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 5.1;Spermatocytes: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	9.9	11.0	7.6	6.7	7.8	6.7	8.1	18.3	8.5	9.2	9.6	10.3	6.9	5.6	12.9	10.4	7.0	9.4	5.6	6.8	6.8	5.3	6.8	9.5	6.8	8.3	7.5	5.2	9.1	9.5	13.2	11.8	8.1	8.4	11.2	8.2	10.7	12.2	8.3	13.2	8.7	7.7	8.3	6.1	10.2	8.8	21.1	8.6	12.8	8.5	4.8	10.5	13.3	9.9	8.5	7.5	7.4	6.0	9.4	11.8	4.9	2.3	4.6	6.2	3.6	6.9	4.1	17.2	5.7	6.9	6.8	7.9	4.9	2.1	4.9	2.3	4.2	9.1	7.1	4.6	6.9	5.4	4.9	3.0	3.4	7.4	5.4	8.1	8.0	5.4	4.1	7.8	8.4	6.9	4.4	7.1	5.7	5.7	7.4	6.4	5.0	6.2	3.0	4.9	5.7	5.9	5.2	8.5	7.0	2.9	3.3	7.0	4.7	10.8	5.6	3.2	5.5	7.4	4.6	4.9	4.4	4.0	4.3	4.4	9.9	21.2	6.3	5.6	2.5	7.2	3.3	4.9	7.4	9.3	6.0	10.6	7.4	6.4	11.8	7.0	8.5	8.4	9.1	6.5	9.4	4.0	7.5	7.9	4.9	7.6	7.8	18.3	8.5	6.8	5.3	7.5	5.2	8.4	8.6	0.0	0.3	0.0	1.0	1.3	0.8	1.6	5.1	0.0	2.3	0.0	0.0	1.8	1.7	1.7	2.1	0.7	0.6	0.0	0.5	0.6	1.1	0.5	0.0	1.0	1.7	1.6	0.0	1.3	0.6	3.7	0.6	0.9	0.0	0.0	0.6	1.3	0.4	0.0	1.8	0.7	1.4	0.0	1.2	5.1	1.3	0.9	2.2	0.8	0.9	0.7
RPL12	L12	ENSG00000197958	"Ribosomal protein L12"	P30050	9	127447674-127451405	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003403	Approved		Approved	"Golgi apparatus"		NA	NA		520000	"Golgi apparatus"		"HPA003403: AB_1856432"	"unprognostic (5.89e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (4.98e-2)"	"unprognostic (3.05e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.80e-2)"	68.0	44.4	34.5	55.7	38.5	81.6	103.5	23.4	35.9	80.3	56.3	26.3	48.3	35.0	54.4	82.8	71.4	79.4	59.0	40.1	28.9	22.1	54.2	68.9	48.6	108.3	29.2	26.8	118.6	174.8	16.1	34.3	40.0	28.7	57.2	49.7	34.1	88.8	68.4	116.2	88.3	54.0	63.7	38.8	82.7	52.3	35.6	38.7	63.9	58.4	102.4	82.0	83.6	77.0	173.9	97.8	17.7	60.5	76.2	152.2	157.1	64.9	60.1	66.5	133.3	128.1	287.8	102.5	58.3	159.1	104.9	82.4	129.4	68.0	124.4	79.4	99.1	52.7	78.7	84.0	135.7	72.1	62.6	77.2	72.8	81.8	117.2	272.5	111.2	78.7	312.4	271.5	73.5	280.2	209.2	141.6	78.0	98.1	106.3	130.3	224.0	104.7	171.9	97.2	193.6	112.6	89.6	127.7	134.5	154.0	65.8	58.7	85.5	43.8	147.8	180.9	82.0	121.3	154.4	79.2	39.6	70.8	67.8	114.6	55.4	67.9	127.1	41.1	106.7	60.1	17.7	58.0	16.5	67.8	60.5	125.9	173.9	127.1	92.4	97.8	171.9	152.2	126.5	7.5	76.2	58.0	89.5	109.6	157.1	34.5	38.5	23.4	35.9	28.9	22.1	29.2	26.8	28.7	38.7	646.2	1503.7	5061.0	4045.1	5372.0	160.0	370.4	2430.6	770.9	1642.4	1207.3	80.5	2922.1	3451.8	1765.9	255.9	2512.6	1491.9	1168.1	6162.0	4789.2	2566.4	3026.3	1780.6	2248.3	2994.4	90.6	2015.9	2955.6	5097.2	446.3	5005.1	4147.9	3416.3	2961.2	3509.9	262.9	3860.9	2195.4	2246.6	3878.9	223.2	970.2	2259.3	323.0	463.1	6086.7	3114.7	2449.3	4507.2	4205.0
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.8	5.3	10.2	9.0	8.9	8.4	5.4	6.8	8.4	6.2	10.1	5.6	9.9	5.6	7.5	4.3	19.1	6.5	11.4	3.3	10.4	4.9	5.4	11.4	8.8	7.2	5.9	11.4	5.1	9.4	5.7	11.0	10.8	9.0	8.2	4.7	10.3	3.7	14.6	4.1	5.1	5.0	13.4	8.9	6.7	4.8	15.4	9.1	5.0	9.8	8.1	3.5	12.1	7.1	5.3	24.9	3.2	10.5	5.6	5.7	7.0	3.7	11.4	8.5	1.6	9.3	5.5	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9	8.9	4.6	2.7	2.8	1.0	5.6	18.3	5.1	6.7	10.3	0.0	5.9	4.1	5.0	5.4	0.6	3.6	5.6	0.0	1.2	1.7	2.4	3.6	9.2	5.9	5.4	11.1	1.2	4.3	6.6	0.2	2.6	4.5	3.3	10.8	5.2	5.7	4.2	4.3	4.9	5.0	4.8	0.0	4.1	4.6	3.0	2.4	5.8	5.0	4.9	3.0
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.6	30.4	24.0	44.1	41.0	24.4	15.1	8.0	24.5	0.0	17.5	49.8	30.1	37.0	4.4	32.6	8.1	4.2	4.7	3.8	37.5	8.3	30.8	0.1	10.8	33.2	20.5	40.1	14.1	44.9	36.6	1.4	7.1	0.2	46.1	26.1	0.2	6.2	5.3	38.1	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	36.0	25.7	15.6	7.6	16.9	1.2	47.3	25.1	10.9	31.5	36.4	0.4	0.8	0.0	70.6	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2	65.5	43.5	0.0	30.8	28.7	0.4	4.2	38.2	10.7	36.4	36.6	0.0	59.0	3.3	72.5	1.0	28.6	94.2	0.0	92.9	33.5	19.8	56.7	28.9	1.0	21.5	0.0	21.4	28.8	11.8	1.8	29.7	23.3	21.9	2.8	41.6	12.6	107.3	42.4	47.4	1.5	1.5	12.9	32.0	0.3	1.1	32.6	101.1	2.2	37.3	104.7
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.1	8.6	8.3	9.3	18.8	16.2	7.5	14.5	7.4	8.7	7.7	0.4	4.9	4.0	8.1	9.4	24.3	1.5	7.2	8.9	10.7	9.3	4.9	5.5	23.4	1.5	9.5	0.5	4.8	12.2	5.0	22.8	11.1	14.0	10.3	13.9	5.5	6.3	14.6	7.6	3.9	1.7	7.1	6.7	11.9	2.3	3.9	9.8	7.2	0.2	47.7	23.2	24.4	12.1	41.2	7.7	1.8	1.7	15.4	9.9	5.0	19.5	5.4	13.6	22.3	5.5	19.5	5.9	9.1	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3	23.8	57.7	0.8	7.5	10.3	111.5	13.2	0.0	17.4	12.5	3.5	147.3	2.1	6.6	12.0	1.6	21.6	0.0	0.0	7.4	4.6	12.7	9.7	4.7	0.4	3.7	79.4	43.8	20.9	2.7	1.5	19.0	3.2	10.1	1.0	8.8	24.1	5.7	0.0	41.8	8.6	147.7	12.9	12.3	17.7	6.8	6.6	20.5	0.9	0.6	5.5
PTRH1	"C9orf115, PTH1"	ENSG00000187024	"Peptidyl-tRNA hydrolase 1 homolog"	Q86Y79	9	127690348-127724873	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021223	Uncertain					NA	NA					"HPA021223: AB_1845798"	"unprognostic (6.58e-2)"	"unprognostic (7.01e-3)"	"unprognostic (3.46e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.58e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.74e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-2)"	14.9	15.0	12.5	8.3	11.9	7.1	9.1	3.9	13.7	9.4	7.8	10.7	12.9	7.7	7.8	16.1	7.8	9.9	12.6	13.1	10.7	9.4	14.5	19.3	7.5	14.7	11.6	8.5	6.2	24.7	8.8	11.0	7.2	8.9	9.9	4.0	8.3	9.3	9.9	13.0	15.1	5.8	6.4	6.2	9.4	12.4	16.1	6.2	7.1	18.8	9.1	5.7	9.4	5.6	8.7	11.4	5.6	14.4	10.5	29.4	12.8	15.9	7.1	1.6	4.4	2.3	3.0	12.5	10.6	2.9	4.1	2.2	3.7	6.0	6.0	14.3	4.4	5.5	17.6	1.3	7.7	1.2	8.7	2.4	2.6	8.9	7.1	6.9	3.9	7.2	2.5	8.0	4.9	5.1	2.2	8.1	8.4	6.8	4.8	4.6	14.7	7.0	5.8	2.2	14.6	32.3	6.1	3.5	13.6	7.4	3.5	7.1	6.5	11.4	13.7	8.0	1.5	12.3	2.5	9.6	5.9	8.2	20.9	6.6	14.4	7.7	3.9	7.9	3.0	7.1	2.5	13.2	5.6	29.3	14.4	29.3	8.7	15.1	29.4	11.4	7.2	11.1	25.5	1.7	10.5	7.5	10.4	14.2	12.8	12.5	11.9	3.9	13.7	10.7	9.4	11.6	8.5	8.9	6.2	3.0	7.8	12.4	33.6	15.0	22.3	0.3	25.5	46.8	6.8	45.4	43.2	11.0	56.3	56.3	53.7	19.7	8.1	0.0	29.3	19.6	18.8	39.9	17.3	25.2	41.1	15.9	28.9	19.0	9.1	11.4	20.4	13.7	15.1	17.2	19.3	20.7	39.4	10.4	88.4	101.3	60.3	0.0	21.5	27.4	7.9	18.4	15.7	20.3	16.6	30.8
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 348.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.3	0.9	1.2	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	2.3	4.6	0.0	0.0	0.0	3.4	1.1	0.9	7.6	2.3	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.5	0.0	2.8	3.1	0.7	0.0	6.6	1.3	0.5	0.9	1.7	4.9	2.0	0.9	1.5	0.0	0.4	6.4	1.1	1.9	3.6	0.7	0.2	3.2	0.3	1.7	1.9	1.5	5.0	0.8	1.0	2.6	1.2	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5	8.9	10.9	0.0	0.2	0.0	0.6	0.0	0.0	348.0	51.2	0.0	0.0	0.0	1.7	0.3	44.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.3	0.2	0.2	0.0	0.0	0.0	0.3	61.4	0.3	0.4	0.0	0.0	0.6	0.8	0.0	0.0	0.7	0.3	0.2	0.0	0.0	11.4	1.1	0.0	0.0	0.0	0.2	0.1
TTC16	FLJ32780	ENSG00000167094	"Tetratricopeptide repeat domain 16"	Q8NEE8	9	127716066-127731600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 30.8"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 54.9;Early spermatids: 91.4;Late spermatids: 218.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"gdT-cell: 3.9;MAIT T-cell: 2.4;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	40	"T-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.1;MOLT-4: 1.7;REH: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.87e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.54e-3)"	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.2	1.3	0.0	10.4	0.1	0.0	0.3	0.3	0.2	0.0	2.1	0.4	0.0	0.2	1.3	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.9	0.0	2.4	0.0	1.3	2.8	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.5	0.0	0.6	0.3	0.3	0.0	0.2	0.6	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	54.9	9.1	0.0	0.0	0.0	0.0	0.0	91.4	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	218.9	1.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	3.5	0.2	0.4	0.0	0.0	23.2	1.5	0.0	0.0	0.5	0.0	0.0
TOR2A	"FLJ14771, TORP1"	ENSG00000160404	"Torsin family 2 member A"	"Q5JU69, Q8N2E6"	9	127731524-127735317	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071229	Approved				"Secreted to blood"	NA	NA					"HPA071229: AB_2732175"	"unprognostic (1.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.82e-2)"	7.3	10.1	6.2	11.8	6.2	33.3	10.9	11.3	9.1	7.2	13.5	6.1	8.2	16.4	6.3	10.1	9.9	7.9	11.8	5.8	5.8	5.6	10.2	16.2	12.8	22.8	4.9	7.3	7.9	18.3	3.2	8.3	15.0	5.1	7.1	8.4	6.1	9.7	10.2	2.8	8.3	20.9	4.5	4.0	18.9	12.6	16.9	5.6	18.6	8.0	6.8	10.9	7.2	6.3	6.2	26.3	34.5	28.8	10.0	13.1	13.4	4.0	6.2	5.4	6.6	2.7	2.6	7.1	3.1	3.5	4.4	3.5	4.2	6.9	7.5	4.3	2.4	3.4	12.9	1.7	3.5	1.2	11.9	6.1	2.9	5.5	5.1	4.4	5.9	15.4	4.2	6.5	4.1	2.2	2.2	6.3	8.9	8.6	20.6	2.6	22.9	7.5	18.5	4.8	12.9	5.8	12.9	2.5	16.2	4.6	3.8	11.7	4.7	2.6	9.1	2.6	3.1	20.3	11.5	3.9	2.8	3.4	5.1	3.2	13.3	11.4	3.0	3.6	9.6	2.8	8.8	25.3	34.5	13.1	28.8	10.2	4.8	7.6	12.6	26.3	6.2	5.8	10.2	17.1	10.0	26.6	6.1	11.6	13.4	6.2	6.2	11.3	9.1	5.8	5.6	4.9	7.3	5.1	5.6	3.0	6.1	19.7	3.6	1.3	12.3	0.6	12.7	4.0	3.4	3.5	0.0	32.4	1.7	16.6	51.5	3.5	22.2	46.7	24.4	32.1	2.9	4.9	5.7	6.4	49.3	7.9	21.9	14.7	28.1	6.2	10.6	16.9	3.3	16.2	20.3	12.8	13.5	21.0	10.6	7.3	12.1	0.0	3.1	30.4	7.5	1.3	43.4	15.0	18.5	4.0
SH2D3C	NSP3	ENSG00000095370	"SH2 domain containing 3C"	Q8N5H7	9	127738317-127778741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 40.9;Ito cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 23.9;HUVEC TERT2: 26.2;REH: 25.6;RPMI-8226: 19.6;TIME: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047586	Enhanced					NA	NA					"HPA047586: AB_2680093"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.47e-4)"	"unprognostic (5.23e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (3.75e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.28e-2)"	21.0	6.0	7.3	14.1	8.2	9.8	14.4	12.3	17.9	7.5	3.9	3.6	2.2	4.5	11.0	2.8	6.0	7.9	8.7	15.6	5.8	6.7	8.4	3.7	31.3	21.8	5.0	7.4	5.7	3.2	3.2	4.8	15.0	5.6	6.4	2.2	8.4	6.0	3.9	12.2	4.6	8.9	7.3	4.1	31.4	4.8	3.5	3.0	15.9	14.5	7.7	12.0	8.7	6.2	11.5	21.3	29.7	39.8	11.4	12.4	10.1	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.4	0.0	0.5	0.3	0.0	0.0	0.0	6.5	0.1	3.2	0.0	0.0	0.1	2.3	23.9	0.1	0.1	0.1	0.0	0.0	26.2	5.4	0.1	9.3	0.0	0.0	2.1	7.1	0.3	0.0	0.0	25.6	0.4	19.6	0.0	0.0	6.4	1.9	0.1	0.0	0.0	0.6	0.0	4.1	21.6	0.0	0.5	0.0	0.0	9.1	8.9	8.8	0.1	2.0	0.0	11.4	10.2	12.7	12.4	32.6	10.0	10.0	7.2	11.5	11.5	11.5	6.5	6.8	29.7	11.4	39.8	21.3	7.5	10.1	7.3	8.2	12.3	17.9	5.8	6.7	5.0	7.4	5.6	3.0	3.0	7.2	9.4	0.2	1.1	2.6	6.9	0.0	1.4	1.2	0.0	0.0	0.3	0.0	0.3	14.0	40.9	0.0	0.0	0.0	0.1	1.0	0.1	10.5	0.5	5.2	3.2	4.1	41.1	8.2	12.3	1.1	6.7	1.7	3.6	0.0	3.4	0.1	0.0	0.7	0.0	2.2	6.5	1.4	0.5	1.3	0.4	0.6	13.8	0.0	0.1
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	9.0	16.4	10.3	11.3	11.7	9.2	13.5	9.3	13.7	9.7	8.8	12.2	10.2	15.9	10.9	10.5	13.4	18.3	6.8	15.2	3.7	14.2	8.1	14.8	17.8	10.0	17.1	14.3	23.8	16.1	18.6	10.3	11.6	12.6	20.0	14.2	12.8	21.3	8.7	23.8	15.6	21.6	22.8	13.7	17.6	45.2	8.8	22.7	14.1	10.1	10.2	12.2	14.0	14.8	8.3	8.4	18.6	13.6	22.9	11.7	13.2	10.0	9.0	38.9	29.9	14.2	10.9	9.8	10.6	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1	11.9	14.3	20.4	20.9	21.4	13.1	12.9	15.3	18.7	7.9	10.4	2.0	18.7	13.3	26.6	3.2	26.7	12.9	0.0	32.7	18.8	16.4	18.5	24.3	23.6	20.6	23.8	18.5	31.9	17.0	4.3	18.1	18.9	15.1	64.9	11.8	16.2	30.5	11.8	29.4	12.7	7.5	0.0	22.7	7.5	24.0	19.3	42.9	23.5	13.1	23.1
FPGS		ENSG00000136877	"Folylpolyglutamate synthase"	Q05932	9	127794597-127814327	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050488	Approved				"Intracellular and membrane"	NA	NA					"HPA050488: AB_2681143"	"unprognostic (6.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	18.2	25.0	6.0	17.4	7.1	14.8	18.9	7.9	6.9	13.9	16.6	9.2	16.6	9.3	16.8	19.2	12.2	17.1	20.0	19.2	6.1	5.9	12.5	44.0	14.9	25.6	8.1	6.6	41.3	24.0	6.6	8.9	6.7	7.7	12.8	6.3	9.9	12.3	18.9	30.4	7.9	10.3	12.6	5.4	17.6	12.4	10.1	7.7	13.6	11.1	15.2	16.0	14.7	9.2	15.5	19.9	1.0	11.8	20.4	21.1	10.2	13.6	9.5	5.4	11.7	8.5	9.3	16.9	10.9	12.9	13.9	10.6	9.8	22.3	17.0	14.2	14.7	9.3	25.8	6.7	14.8	4.5	18.5	8.8	13.2	11.9	12.0	20.3	24.3	11.3	13.0	8.5	13.2	17.7	11.7	16.5	16.0	14.8	11.0	14.2	17.3	21.1	18.1	15.8	15.0	29.1	44.0	9.1	29.5	20.0	11.0	8.2	14.0	31.3	15.3	2.1	2.3	9.2	10.3	24.9	7.2	10.3	20.9	21.6	12.3	5.2	13.6	15.7	11.3	10.5	0.1	7.8	1.0	21.1	11.8	18.9	12.2	12.6	18.2	15.6	15.5	10.4	13.7	0.4	20.4	11.6	19.9	13.1	10.2	6.0	7.1	7.9	6.9	6.1	5.9	8.1	6.6	7.7	7.7	20.8	29.1	20.1	17.5	9.3	5.4	18.0	33.1	6.7	19.4	8.7	13.7	13.4	10.0	43.0	3.1	16.3	13.6	0.0	46.4	18.3	16.9	18.0	30.1	61.4	27.0	4.8	22.0	16.5	12.7	2.1	17.5	18.2	8.5	71.3	10.9	6.3	54.2	10.5	6.7	15.9	6.5	12.9	16.5	6.5	16.6	7.8	12.4	22.3	22.2	28.6
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815012-127854756	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Endothelial cells: 336.5;Ito cells: 724.3;Leydig cells: 451.1;Peritubular cells: 1336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 36.6;HUVEC TERT2: 68.4;TIME: 139.4;U-138 MG: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		260000000	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	40.3	19.3	6.4	26.6	10.5	5.5	52.7	3.9	8.6	26.3	14.0	7.6	18.5	11.2	27.0	25.2	17.2	23.2	28.3	105.4	8.0	5.0	40.8	26.8	66.7	44.1	10.6	7.0	66.4	9.6	8.6	12.5	60.2	10.1	23.1	6.4	35.5	9.9	51.7	24.1	10.1	14.5	23.1	8.7	52.4	11.6	37.2	7.7	6.7	35.4	19.3	11.0	20.3	44.8	1.1	6.4	0.3	17.7	4.6	2.3	4.6	0.1	0.1	1.0	0.0	17.2	11.8	30.3	19.9	14.3	10.6	6.2	0.0	0.1	0.1	9.7	36.6	8.0	0.3	0.0	3.2	3.5	0.0	0.0	5.6	11.3	0.6	13.3	2.6	0.0	20.1	0.7	13.8	5.0	0.1	68.4	0.1	0.0	0.1	12.4	0.1	0.0	0.2	0.2	0.0	0.5	8.8	1.7	0.1	0.0	0.0	0.1	0.2	10.5	9.2	2.7	0.7	1.8	4.0	139.4	34.9	1.9	22.7	0.0	0.7	0.1	0.1	9.4	7.0	11.4	0.0	12.2	0.3	1.3	17.7	0.4	0.4	2.1	2.3	6.4	1.1	1.3	2.0	0.3	4.6	13.0	2.4	0.8	4.6	6.4	10.5	3.9	8.6	8.0	5.0	10.6	7.0	10.1	7.7	3.0	23.1	25.1	2.3	10.6	2.5	16.5	22.9	8.1	3.4	3.5	3.9	24.4	0.0	8.3	7.0	336.5	0.0	23.3	1.0	249.8	36.6	1.4	15.0	5.1	119.5	0.0	2.4	724.3	66.8	29.3	451.1	50.7	23.6	46.9	1.1	3.1	2.0	0.0	1336.5	0.0	4.1	71.1	20.8	3.7	4.9	7.3	314.8	5.7	0.2	1.1
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell type enhanced"	"Detected in all"	11	"Late spermatids: 823.7;Peritubular cells: 363.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		NA	NA		32000000	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.0	6.5	8.3	11.4	20.3	41.3	7.6	10.5	10.6	18.7	11.4	4.8	9.6	0.4	11.5	21.6	12.4	21.7	0.0	11.7	7.5	2.4	7.2	2.2	18.7	8.4	11.4	0.0	0.2	31.4	22.8	13.9	10.1	10.3	25.0	0.2	8.9	0.6	21.2	14.4	0.0	0.3	3.0	37.8	20.2	0.4	8.4	3.3	12.5	1.1	13.6	8.4	27.7	16.0	8.0	4.5	12.8	9.0	20.6	13.1	5.3	46.1	10.0	1.0	0.1	0.0	16.4	0.0	9.1	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1	38.7	148.9	3.7	16.6	23.5	48.5	42.8	30.6	46.8	19.4	7.0	15.7	6.3	14.9	97.5	229.8	49.4	94.1	93.5	54.8	37.4	51.2	15.5	1.1	69.2	46.3	46.1	102.2	47.9	3.2	823.7	209.7	11.0	79.2	2.8	66.4	290.8	46.6	58.8	363.1	6.3	55.1	25.8	50.9	14.4	15.6	24.8	11.3	7.5	73.1	20.9
ST6GALNAC6	"SIAT7F, ST6GALNACVI"	ENSG00000160408	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6"	Q969X2	9	127885321-127905408	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 94.1;Mucus-secreting cells: 109.4;Paneth cells: 153.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"NK-cells: 12.7;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.7"									HPA018890	Approved				"Intracellular and membrane"	NA	NA					"HPA018890: AB_1857531"	"unprognostic (2.27e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.24e-3)"	"unprognostic (3.31e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.67e-2)"	39.3	12.9	45.1	9.7	40.8	7.7	59.6	23.4	37.4	17.2	44.5	8.7	18.6	5.5	14.8	27.3	21.0	31.1	17.8	22.8	38.2	17.0	13.2	18.1	23.5	13.7	18.3	28.3	39.4	19.1	12.7	7.8	10.8	13.6	12.8	72.9	9.6	14.5	22.0	18.9	9.8	9.8	21.9	9.6	18.7	12.1	6.9	15.9	2.3	9.6	9.1	11.2	16.7	29.2	3.3	1.1	2.7	2.8	12.7	16.0	6.5	3.6	3.3	6.5	11.7	52.7	28.5	2.5	9.3	21.4	13.6	11.2	5.5	3.1	3.7	4.1	21.2	9.4	6.2	8.4	6.9	6.3	17.7	4.7	3.9	5.4	5.6	13.8	1.1	6.4	28.9	8.5	9.9	4.4	19.2	13.5	3.7	3.6	4.6	17.5	3.1	2.3	6.1	2.8	3.5	5.9	7.3	8.1	4.5	10.9	0.7	4.1	6.1	6.4	2.6	2.4	4.7	3.1	7.8	8.1	8.1	4.9	8.9	5.1	5.6	3.4	6.9	7.6	1.3	2.8	2.7	0.7	0.1	16.0	1.1	11.7	3.3	10.3	11.5	1.0	2.6	6.5	8.4	0.4	12.7	2.8	1.1	15.3	6.5	45.1	40.8	23.4	37.4	38.2	17.0	18.3	28.3	13.6	15.9	3.0	7.0	15.2	14.5	20.6	18.2	7.0	7.6	4.0	2.3	0.0	5.9	3.2	0.0	0.4	1.7	22.5	94.1	23.3	0.3	6.5	34.0	11.5	6.9	24.2	10.8	23.8	37.0	35.0	6.9	4.7	61.5	5.8	23.6	2.8	109.4	31.6	0.4	153.1	57.3	0.0	6.4	84.1	72.1	1.0	4.3	23.5	3.0	29.8	56.2	15.7
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.5;RPMI-8226: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA009042: AB_1079963"	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.2	5.5	1.4	7.0	9.9	7.6	1.0	5.6	6.2	5.7	3.3	3.1	5.9	20.5	8.5	7.0	8.1	7.9	2.9	5.9	0.9	35.5	2.4	6.5	17.6	11.6	12.1	0.5	6.8	9.2	6.3	5.1	4.6	4.6	15.2	3.9	4.6	13.7	2.7	1.5	1.2	0.7	1.6	10.5	13.6	6.2	3.7	50.3	5.8	0.1	12.0	2.7	8.1	17.6	1.0	0.5	3.6	4.2	10.8	4.7	5.4	14.6	8.7	22.4	11.5	6.4	9.4	2.9	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7	8.9	24.5	43.4	11.9	1.9	2.4	10.3	10.2	5.3	4.5	1.8	0.0	0.9	1.7	14.0	0.1	10.8	19.6	23.3	12.5	14.4	11.9	2.0	8.1	1.5	22.1	0.0	65.1	4.9	11.4	0.0	16.1	8.5	6.8	12.6	13.1	14.1	11.9	6.5	40.3	17.3	1.7	12.9	8.9	0.2	1.3	2.8	3.8	10.2	16.4	10.0
PIP5KL1	"bA203J24.5, MGC46424"	ENSG00000167103	"Phosphatidylinositol-4-phosphate 5-kinase like 1"	Q5T9C9	9	127920879-127930797	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 9.4;Ciliated cells: 9.4;Early spermatids: 20.0;Late spermatids: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 1.2;MAIT T-cell: 1.0;memory B-cell: 1.0;myeloid DC: 1.0;naive B-cell: 2.4;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Karpas-707: 29.6;RPMI-8226: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA056240	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA056240: AB_2683075"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.51e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.95e-8)"	"unprognostic (1.87e-1)"	"unprognostic (7.21e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.59e-1)"	0.6	0.7	3.1	0.6	1.0	1.4	2.5	2.4	5.3	2.1	0.6	1.9	0.6	0.5	1.3	0.6	3.7	1.8	1.2	0.6	2.1	2.9	1.3	0.6	2.9	0.6	1.4	2.6	0.7	1.3	6.5	4.8	1.6	8.3	3.3	0.2	1.0	8.7	4.1	0.6	4.7	0.6	1.0	1.5	0.6	2.4	2.5	1.2	0.6	2.9	0.6	0.6	1.2	4.0	2.4	1.3	0.0	1.2	0.0	1.0	0.3	0.0	0.5	0.4	0.5	0.5	1.3	2.8	0.6	0.5	0.1	0.1	0.2	3.6	0.3	1.1	2.4	1.1	1.1	0.0	2.6	0.1	0.3	1.7	0.0	0.8	0.0	0.9	0.0	0.1	1.4	1.7	0.3	0.0	0.9	0.0	2.4	0.0	29.6	0.0	2.5	0.0	1.0	0.2	1.1	0.4	0.2	0.0	19.3	0.0	0.0	1.0	1.8	0.1	0.7	0.0	0.3	1.1	1.4	0.3	0.3	1.0	0.6	0.1	2.6	1.7	0.7	5.3	0.4	0.3	0.0	0.0	0.0	0.0	1.2	1.0	1.0	0.1	0.0	1.0	2.4	0.2	0.1	0.0	0.0	0.1	1.3	0.0	0.3	3.1	1.0	2.4	5.3	2.1	2.9	1.4	2.6	8.3	1.2	0.0	9.4	0.5	3.7	1.9	0.2	0.5	0.0	9.4	1.2	5.2	0.0	0.7	1.7	1.2	20.0	0.6	0.0	0.0	1.3	3.8	0.8	1.9	0.0	0.0	0.3	4.8	0.0	0.6	0.3	14.7	0.9	0.0	0.0	0.0	0.2	1.7	1.2	0.0	0.4	0.0	0.7	0.0	0.8	1.1	0.9	1.0	2.6	0.0	0.2	1.8
DPM2	"MGC111193, MGC21559"	ENSG00000136908	"Dolichyl-phosphate mannosyltransferase subunit 2, regulatory"	O94777	9	127935099-127938484	"Disease related genes, Predicted membrane proteins"			"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064623	Approved					NA	NA					"HPA064623: AB_2685303"	"unprognostic (8.30e-3)"	"unprognostic (1.07e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (2.20e-4)"	"unprognostic (3.67e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.71e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	9.6	13.6	15.2	6.9	18.0	8.5	12.3	8.4	19.4	14.3	11.3	9.7	14.7	10.4	8.0	18.7	12.2	19.8	12.9	6.8	15.4	12.1	16.9	17.9	11.1	9.5	14.4	11.5	10.3	27.2	15.6	10.9	16.0	11.3	10.3	8.9	14.3	21.0	13.4	5.1	9.7	8.9	10.8	9.4	9.4	31.9	13.6	8.4	7.9	22.1	11.9	13.9	7.4	7.9	25.2	25.0	15.4	20.6	17.7	22.5	14.7	6.6	14.3	4.9	4.5	13.4	8.8	5.3	9.0	7.7	7.3	4.7	7.9	9.5	4.5	5.1	15.6	13.1	8.2	4.8	15.2	3.9	10.2	11.5	5.4	15.4	8.4	17.1	9.9	7.3	9.8	11.0	12.2	16.9	7.0	10.5	12.2	11.2	6.3	10.8	29.2	3.7	11.3	7.5	30.9	10.8	3.4	5.8	28.0	13.3	5.7	3.5	11.2	9.0	9.2	6.3	4.4	12.3	7.8	5.8	4.1	4.4	4.9	7.5	14.5	18.6	2.9	16.8	5.7	6.5	11.6	17.4	15.4	22.5	20.6	19.5	25.2	16.7	21.0	20.0	23.3	13.8	17.2	7.3	17.7	16.6	25.0	14.0	14.7	15.2	18.0	8.4	19.4	15.4	12.1	14.4	11.5	11.3	8.4	26.8	31.5	25.3	30.5	24.0	23.8	11.1	40.8	25.4	30.7	38.4	15.7	72.6	38.1	50.5	5.6	29.0	35.6	163.5	51.4	89.2	38.5	52.1	28.8	27.0	72.2	36.5	31.2	35.0	23.0	9.4	24.5	25.5	30.4	60.5	41.7	24.6	49.5	34.5	19.1	39.2	18.6	6.5	28.8	14.9	20.7	30.2	54.3	30.5	40.4	32.7
FAM102A	"bA203J24.7, C9orf132, Eeig1, SYM-3A"	ENSG00000167106	"Family with sequence similarity 102 member A"	Q5T9C2	9	127940579-127980513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036030			Approved	Cytosol		NA	NA			Cytosol		"HPA036030: AB_10670675"	"unprognostic (3.27e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.28e-3)"	"unprognostic (6.98e-2)"	5.3	18.3	28.2	19.9	39.1	7.6	12.1	10.5	31.8	22.4	35.8	65.9	8.7	33.3	15.7	12.6	27.4	29.8	28.5	6.7	29.4	17.3	15.1	23.9	8.5	34.4	41.5	22.9	19.7	21.6	12.9	22.9	5.7	28.0	10.6	11.2	12.5	19.1	13.5	1.9	18.7	39.3	16.7	39.0	12.9	61.8	15.4	53.0	32.0	12.1	13.7	26.3	17.8	18.6	4.7	0.1	2.2	0.1	0.5	11.8	3.0	10.1	22.5	4.8	3.8	10.2	12.3	18.3	3.9	10.9	2.7	1.6	12.9	18.1	11.6	2.6	7.5	5.7	11.2	2.5	2.0	1.0	5.5	2.5	3.4	5.7	11.5	6.4	1.6	26.9	5.0	10.4	7.5	3.2	5.3	3.6	7.1	2.8	14.6	3.0	26.2	6.7	3.6	5.8	20.0	10.9	3.5	3.5	4.2	7.6	17.5	7.5	3.7	6.5	14.7	9.3	5.4	27.6	2.2	3.8	4.2	4.5	22.1	5.9	19.8	26.9	8.0	18.1	2.2	9.9	0.6	0.1	2.2	1.9	0.0	6.1	4.7	9.4	5.6	0.1	1.2	9.1	6.0	0.1	0.5	0.0	0.0	11.8	3.0	28.2	39.1	10.5	31.8	29.4	17.3	41.5	22.9	28.0	53.0	6.0	7.0	18.2	26.3	19.5	14.0	10.9	45.9	13.4	6.8	61.1	9.8	5.0	6.6	45.0	4.6	5.8	107.7	0.0	86.2	4.9	13.2	53.6	18.4	40.9	2.9	25.4	26.9	69.3	7.9	4.3	31.7	2.3	21.9	4.6	34.2	62.4	54.3	31.6	40.7	10.5	15.5	0.0	7.8	5.9	9.3	41.9	4.5	20.3	20.4	65.9
NAIF1	"bA379C10.2, C9orf90, DKFZp762G199"	ENSG00000171169	"Nuclear apoptosis inducing factor 1"	Q69YI7	9	128061233-128068206	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054898, HPA064931"			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054898: AB_2682633, HPA064931: AB_2732725"	"unprognostic (7.09e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.60e-1)"	"unprognostic (6.15e-2)"	"unprognostic (9.41e-2)"	"prognostic favorable (1.02e-5)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.92e-2)"	7.1	7.2	4.5	5.1	4.5	11.3	10.3	5.6	5.5	6.0	4.5	2.4	10.9	6.0	6.3	5.1	7.1	5.4	6.6	7.4	5.5	3.4	5.2	8.3	9.3	8.3	3.8	4.2	5.4	7.3	3.4	4.5	7.3	5.3	6.0	3.7	5.5	6.5	9.5	7.1	5.5	6.2	5.2	4.8	9.0	5.5	15.6	2.9	12.5	6.2	6.1	7.8	5.5	16.3	3.4	2.2	4.5	3.0	1.6	3.4	1.5	4.8	4.2	2.7	6.9	2.5	2.3	6.1	3.7	2.2	3.2	2.6	3.3	3.9	5.9	3.3	2.3	4.5	3.6	2.8	2.8	2.6	18.0	3.7	4.4	5.0	1.9	4.2	6.0	12.4	2.1	3.4	2.4	4.0	2.5	2.9	6.7	10.3	3.8	2.9	5.6	5.8	7.3	2.9	6.6	7.2	5.6	4.3	5.3	2.4	3.0	3.9	4.5	3.6	5.1	3.8	2.0	3.9	6.0	1.9	3.8	11.9	3.1	4.2	6.2	12.9	3.9	3.6	3.9	5.0	0.0	2.2	3.3	1.7	2.0	1.4	1.1	3.4	2.5	2.2	3.4	2.6	2.2	4.5	1.6	3.0	1.7	0.9	1.5	4.5	4.5	5.6	5.5	5.5	3.4	3.8	4.2	5.3	2.9	0.0	4.0	8.8	4.0	4.2	3.3	3.9	5.1	0.0	2.3	5.2	0.0	5.0	3.3	3.1	5.9	4.7	5.1	0.0	5.8	5.0	3.3	3.0	8.1	2.4	4.8	9.5	5.2	5.5	4.7	9.2	5.8	4.4	0.0	4.6	2.5	4.1	3.4	4.0	2.8	3.4	5.0	0.0	3.3	10.8	7.6	3.3	3.9	7.2	3.1	2.0
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	29.2	15.8	7.3	8.1	12.8	5.5	10.6	8.8	20.0	14.4	7.2	6.3	20.0	7.9	14.6	8.2	22.7	17.5	31.6	5.6	7.6	9.0	9.5	48.4	12.4	6.7	7.5	8.0	13.6	52.6	12.1	19.0	7.6	15.0	8.5	5.5	13.6	7.6	63.5	31.3	9.5	10.0	17.3	8.7	7.8	10.5	7.3	5.3	5.4	10.8	20.2	9.7	8.6	9.6	2.9	4.6	3.8	8.4	1.5	7.6	3.9	5.7	6.1	8.6	12.4	6.5	5.6	5.7	12.0	11.2	10.1	6.7	10.9	6.1	7.5	3.7	5.5	5.6	10.3	6.8	3.9	3.8	8.7	5.6	4.3	12.2	6.5	10.4	5.0	10.0	7.2	3.8	9.9	7.3	3.3	6.8	12.6	15.6	16.2	6.3	13.9	8.7	5.1	8.7	18.7	9.5	8.7	7.4	15.7	3.9	6.0	21.4	9.2	12.6	8.1	16.7	3.5	8.9	2.9	4.3	11.5	6.8	8.6	11.8	14.2	24.8	8.0	7.8	2.7	9.4	3.8	2.3	1.2	4.8	7.3	2.4	1.7	5.3	4.8	4.6	2.9	4.5	7.6	0.4	1.5	8.4	1.5	3.9	3.9	7.3	12.8	8.8	20.0	7.6	9.0	7.5	8.0	15.0	5.3	20.8	41.7	5.2	37.8	23.2	18.1	2.0	33.1	21.4	9.1	19.2	119.8	8.5	10.0	10.3	0.3	33.7	36.7	23.3	10.0	10.4	16.9	26.9	8.1	58.9	8.4	17.5	49.5	19.0	13.3	0.6	8.6	18.9	20.3	18.0	17.3	12.8	10.0	28.1	7.8	8.6	65.5	19.4	63.4	4.1	8.6	37.6	19.2	8.7	15.3	47.7
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	9.3	17.0	16.5	9.2	17.8	4.4	7.4	15.3	24.1	7.1	14.8	9.9	7.6	17.7	8.1	9.0	12.6	8.4	10.0	36.4	17.4	14.0	13.2	13.0	5.8	10.2	14.2	11.6	9.2	18.3	11.7	14.3	10.7	10.5	8.0	7.0	13.2	16.2	12.0	73.5	9.3	13.2	5.9	7.0	9.5	14.3	5.8	9.8	9.3	10.5	16.2	13.3	8.5	7.3	5.2	8.2	1.2	6.3	3.7	6.5	2.9	12.7	35.8	4.0	14.8	3.6	3.7	12.2	9.8	5.5	12.4	6.6	26.7	20.0	11.3	15.7	3.9	9.7	33.2	5.8	12.1	1.7	8.1	15.6	5.8	27.1	24.9	11.1	11.7	11.6	5.0	8.8	10.0	6.9	3.8	8.5	12.0	12.8	7.0	4.1	39.5	14.0	22.4	12.8	15.4	29.0	10.6	7.9	28.8	8.4	9.6	20.0	12.0	14.2	22.6	9.5	2.0	20.2	6.3	11.1	12.8	15.8	17.2	17.8	16.2	7.9	11.0	9.7	9.1	11.8	1.2	6.0	1.0	5.6	6.3	6.5	5.2	3.7	5.9	6.7	4.5	4.3	5.1	1.1	3.7	2.8	8.2	4.2	2.9	16.5	17.8	15.3	24.1	17.4	14.0	14.2	11.6	10.5	9.8	14.9	5.4	25.3	29.8	20.4	34.7	606.9	35.7	0.0	6.8	22.7	19.6	69.1	124.3	64.1	1.9	21.1	88.3	0.0	44.8	49.4	20.3	34.0	14.9	33.3	50.6	35.0	43.4	15.4	22.9	3.2	28.4	33.8	54.0	154.1	52.3	18.2	52.2	51.8	20.5	79.0	38.1	19.4	28.3	2.3	56.6	21.5	55.7	21.7	83.1	40.8
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Cell type enhanced"	"Detected in many"	16	"Ductal cells: 4866.3;Exocrine glandular cells: 1633.7;Pancreatic endocrine cells: 4295.8;Urothelial cells: 1384.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 277.6;EFO-21: 113.7"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.7	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	277.6	0.0	113.7	0.0	0.2	18.1	0.0	0.5	0.0	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	5.1	0.0	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1	0.0	17.3	2.4	352.2	0.2	0.0	0.2	932.5	180.7	184.2	130.9	0.0	0.3	0.0	4866.3	1.9	0.1	78.8	23.3	1633.7	0.3	0.2	349.2	13.8	18.3	0.5	0.0	55.6	2.5	0.6	10.5	3.1	0.6	0.0	103.6	135.4	0.0	4295.8	131.2	0.0	0.7	0.0	0.0	3.1	0.0	0.2	0.0	0.2	0.7	262.6	1384.7
C9orf16	"EST00098, FLJ12823, MGC4639"	ENSG00000171159	"Chromosome 9 open reading frame 16"	Q9BUW7	9	128160260-128163928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 98.6"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 689.6;Urothelial cells: 732.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA020725	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA020725: AB_1845816"	"unprognostic (8.85e-2)"	"prognostic favorable (7.60e-4)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (6.42e-3)"	"unprognostic (3.98e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (8.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.09e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.00e-3)"	"unprognostic (2.48e-2)"	19.6	83.4	70.6	13.9	34.4	38.7	13.1	16.9	59.7	16.3	17.0	12.1	13.3	16.9	12.3	10.3	16.8	16.9	18.7	22.7	98.6	20.3	16.0	12.2	13.5	23.9	27.4	22.1	14.2	35.0	4.2	14.7	9.5	19.1	15.6	6.9	16.1	27.0	25.4	14.0	31.4	15.4	15.1	12.1	24.3	20.1	12.1	9.1	33.2	13.3	13.7	16.6	31.0	16.4	52.3	43.6	58.3	37.1	45.5	73.7	42.0	9.2	12.4	6.4	39.4	4.8	10.9	16.5	8.8	7.4	7.4	5.9	6.1	24.4	10.4	18.2	3.7	1.5	26.2	1.9	7.1	0.3	19.7	15.9	7.3	14.8	12.3	8.7	8.0	18.9	8.2	10.6	3.8	1.9	5.7	10.5	29.5	19.4	20.8	3.9	54.3	27.2	35.2	15.4	19.0	23.5	25.9	4.2	43.3	9.3	8.0	17.7	26.3	15.8	14.1	18.4	1.7	15.8	7.5	12.5	7.6	18.4	9.6	7.5	20.4	14.8	15.6	21.5	11.3	7.6	53.4	37.1	58.3	50.1	30.4	54.0	50.7	58.0	48.8	40.7	52.3	46.6	47.1	42.3	45.5	25.6	43.6	73.7	42.0	70.6	34.4	16.9	59.7	98.6	20.3	27.4	22.1	19.1	9.1	6.0	3.7	150.4	291.1	175.2	71.1	28.3	124.9	13.4	20.5	336.8	13.7	81.7	261.9	196.7	136.2	148.4	198.7	23.3	311.7	68.6	88.9	227.8	162.3	95.5	224.6	17.5	391.5	115.4	207.4	689.6	71.1	196.6	212.6	198.4	171.2	31.1	204.1	127.0	78.1	126.0	32.1	71.1	160.2	36.3	46.0	204.0	50.5	263.3	158.6	732.8
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128166064-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	31.9	24.3	33.6	23.8	36.0	36.7	36.7	39.4	40.4	31.5	35.7	28.0	21.3	26.8	33.6	20.9	30.3	33.5	26.7	25.5	30.5	19.9	19.7	12.1	22.2	24.8	29.4	27.5	56.3	41.7	23.1	21.1	21.9	23.4	30.1	21.8	23.3	31.3	28.8	51.4	49.6	26.1	40.0	27.3	22.5	28.9	35.4	37.0	30.3	22.8	24.2	27.0	35.2	39.3	6.7	4.6	4.9	5.8	8.1	8.3	3.2	23.0	27.9	23.9	22.5	24.7	29.9	23.4	18.2	27.4	33.5	19.0	25.5	20.3	27.1	15.5	30.7	27.9	33.6	18.4	19.6	18.3	24.6	21.0	25.9	35.0	16.4	28.5	24.0	30.9	28.9	35.1	36.7	31.3	24.4	22.6	17.4	62.6	23.5	20.1	53.9	31.4	24.4	20.7	31.2	28.7	26.7	25.2	27.9	15.1	15.9	29.8	23.1	40.5	28.7	24.0	11.1	29.9	31.3	23.9	35.8	25.5	40.6	34.1	27.3	30.8	26.2	25.3	16.1	38.3	4.6	4.3	4.9	5.0	5.8	4.5	5.7	6.1	6.4	4.6	6.7	6.1	5.5	0.7	8.1	4.3	4.6	8.3	3.2	33.6	36.0	39.4	40.4	30.5	19.9	29.4	27.5	23.4	37.0	3.0	11.7	14.1	19.6	20.6	21.1	8.7	12.7	5.3	9.1	17.4	27.5	19.0	11.6	22.6	63.0	13.4	23.6	0.0	38.7	23.5	21.6	14.9	9.2	4.7	19.4	15.9	21.9	14.7	16.7	60.3	32.2	14.9	18.6	20.8	17.7	17.7	26.4	14.0	29.4	14.6	23.8	12.9	20.8	24.4	24.7	21.8	17.4	17.9	25.5	13.3
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Group enriched"	"Detected in many"	10	"Bipolar cells: 113.1;Cone photoreceptor cells: 84.4;Horizontal cells: 47.7;Rod photoreceptor cells: 70.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 49.8;U-87 MG: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm		NA	NA		440000	Nucleoplasm		"CAB005920: , HPA049910: AB_2680948, HPA061801: AB_2797266"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.3	49.8	4.5	1.1	1.4	15.2	0.2	3.1	7.5	6.3	2.6	0.6	1.0	0.0	4.3	6.5	0.2	6.0	0.7	0.3	3.5	0.0	4.8	3.1	7.1	0.2	1.0	0.4	2.2	4.0	0.1	4.9	0.0	6.1	0.0	2.9	1.1	0.2	0.0	1.4	0.2	1.0	4.8	0.8	9.1	5.9	0.1	1.5	0.9	0.0	6.5	10.9	10.6	0.3	0.4	0.6	0.1	4.3	0.2	0.2	14.4	14.5	6.3	0.4	0.1	0.3	19.0	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8	0.0	0.0	0.0	1.6	7.0	113.1	2.0	7.6	1.4	1.2	0.0	84.4	0.2	1.7	0.7	0.5	1.5	0.6	0.0	0.7	0.2	3.9	0.7	1.1	0.5	8.0	47.7	0.0	0.0	0.8	0.4	2.6	1.9	3.3	1.0	0.1	8.1	1.0	2.9	1.4	3.4	70.6	0.0	4.1	0.3	1.3	6.6	0.7	0.7	0.6	0.5
GOLGA2	"GM130, golgin-95"	ENSG00000167110	"Golgin A2"	Q08379	9	128255829-128275995	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB015421, HPA021178, HPA021230, HPA021799"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841"	"unprognostic (2.88e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (3.70e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (9.77e-5)"	"unprognostic (3.92e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.27e-2)"	23.3	21.2	21.2	15.4	27.0	15.5	23.4	23.0	30.5	37.7	20.0	23.4	35.0	15.3	30.7	32.6	34.7	23.6	22.1	32.2	18.9	21.4	23.9	30.5	22.5	11.5	16.9	20.5	30.7	47.1	54.2	66.6	34.8	26.3	29.6	23.5	27.6	31.3	38.2	27.6	33.0	23.5	30.4	33.3	15.4	24.5	16.1	18.6	11.3	26.8	27.4	27.9	28.9	30.9	5.3	8.8	21.1	5.0	5.0	4.6	1.8	14.5	14.6	15.6	16.3	39.5	45.3	14.5	29.3	37.8	23.5	21.3	17.6	13.3	6.9	11.1	44.3	25.1	28.6	8.8	13.7	22.2	10.0	8.5	7.4	34.3	14.2	26.3	11.3	22.7	28.9	22.0	23.6	24.5	37.2	18.7	16.1	23.9	17.2	22.7	30.2	9.4	9.6	4.8	26.2	26.3	9.8	17.6	11.8	18.8	12.2	9.0	10.6	18.3	15.4	12.9	16.5	36.2	9.3	26.1	31.7	16.6	20.5	15.1	13.2	14.6	8.7	27.9	5.8	20.5	15.7	4.7	7.9	4.6	3.5	2.9	3.9	3.0	2.4	1.8	5.3	3.2	4.3	21.1	5.0	5.0	8.8	2.3	1.8	21.2	27.0	23.0	30.5	18.9	21.4	16.9	20.5	26.3	18.6	41.7	66.3	18.6	24.6	28.2	66.7	75.3	43.3	80.3	56.9	40.1	39.3	32.7	36.5	38.5	26.9	31.3	51.3	0.0	52.8	30.4	48.0	41.2	63.6	61.8	25.1	23.8	44.3	51.5	22.5	4.0	63.3	20.0	23.6	15.4	66.4	27.5	47.6	38.6	60.8	25.6	48.8	12.9	33.0	42.2	27.1	39.6	85.6	23.5	30.2	32.2
SWI5	"bA395P17.9, C9orf119, SAE3"	ENSG00000175854	"SWI5 homologous recombination repair protein"	Q1ZZU3	9	128275379-128288990	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 892.4;Late spermatids: 836.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA052032	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA052032: AB_2681702"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.58e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.38e-2)"	10.2	11.7	14.7	11.8	15.9	6.0	17.9	18.0	13.2	18.2	9.0	12.3	48.0	9.9	13.0	44.8	13.5	20.4	12.7	14.8	12.5	13.2	14.2	18.0	12.5	8.7	16.7	11.0	19.6	13.2	26.5	23.8	10.7	13.6	14.6	8.1	14.1	15.2	50.7	14.1	10.3	9.5	12.8	13.7	7.7	9.2	57.1	16.2	8.9	27.8	12.5	10.5	12.4	17.1	12.6	14.2	28.1	9.6	13.4	15.3	10.0	9.5	17.1	10.2	11.8	27.6	25.3	11.5	16.9	22.5	22.0	14.9	21.9	11.3	9.1	22.6	27.5	13.6	16.1	16.2	22.5	15.0	13.7	12.1	6.9	32.8	17.1	35.6	4.4	6.5	21.2	10.8	36.6	19.8	19.5	21.0	33.6	16.3	14.8	22.4	39.0	9.6	6.4	6.9	22.2	35.7	9.0	14.0	14.5	14.7	5.0	11.7	6.5	21.0	13.5	20.0	11.8	22.4	4.8	13.0	16.0	13.3	30.9	14.2	15.7	23.5	12.1	21.8	6.9	17.2	28.1	9.6	16.4	10.2	5.7	12.0	12.6	10.1	10.2	9.8	12.5	12.2	15.3	6.4	13.4	5.6	14.2	10.0	10.0	14.7	15.9	18.0	13.2	12.5	13.2	16.7	11.0	13.6	16.2	6.0	19.5	14.5	34.6	21.8	13.1	30.0	30.6	14.7	18.2	34.9	11.8	55.7	56.3	21.8	892.4	21.5	27.0	0.0	33.5	35.4	41.0	29.6	9.2	68.6	29.0	1.6	24.5	27.6	19.7	836.9	40.0	17.2	35.4	27.1	23.4	24.7	25.7	20.1	29.7	53.2	17.7	32.3	26.4	56.3	38.7	19.2	97.8	18.3	20.5	27.5
TRUB2	CLONE24922	ENSG00000167112	"TruB pseudouridine synthase family member 2"	O95900	9	128305161-128322742	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021211	Uncertain					NA	NA					"HPA021211: AB_1858375"	"unprognostic (2.40e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.81e-3)"	"prognostic favorable (5.57e-10)"	"unprognostic (8.74e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	8.3	18.2	18.9	8.8	19.4	9.4	12.1	11.5	27.4	9.2	11.2	18.3	7.9	12.5	7.6	8.2	12.8	10.8	7.3	18.9	18.1	18.1	16.2	26.0	6.3	10.3	20.3	13.7	10.3	17.0	13.5	12.7	7.7	21.6	9.4	10.9	9.8	13.2	9.4	14.0	13.4	10.7	8.4	15.3	7.4	9.3	7.0	12.3	7.1	13.2	10.9	12.1	10.0	7.1	8.9	7.5	3.8	5.1	8.1	8.6	5.1	5.1	11.9	5.6	7.5	8.9	6.6	5.9	5.8	6.8	9.4	7.8	8.9	6.9	11.5	5.0	7.7	9.3	14.2	12.3	9.8	6.3	5.6	8.3	5.5	10.9	8.1	6.9	10.0	7.5	8.4	11.1	9.2	8.7	5.9	9.6	10.3	20.6	5.2	7.4	15.2	13.1	11.4	7.7	17.7	15.3	10.4	9.0	16.4	8.6	4.7	11.8	8.7	10.9	11.9	7.4	4.5	15.7	6.9	6.5	7.9	6.2	9.2	6.9	6.2	12.7	9.4	8.1	7.8	8.5	3.8	5.1	1.5	7.4	5.1	8.3	8.9	7.0	8.3	7.5	7.8	8.2	8.6	2.7	8.1	2.7	5.4	8.2	5.1	18.9	19.4	11.5	27.4	18.1	18.1	20.3	13.7	21.6	12.3	23.8	9.3	15.6	12.0	8.5	20.9	42.9	22.9	13.4	18.2	33.2	15.7	44.2	54.7	30.8	10.7	14.6	21.2	23.3	30.6	37.0	13.3	11.4	8.1	45.0	27.7	3.2	18.3	13.5	8.8	11.5	19.2	13.1	11.8	23.4	24.9	14.1	25.6	21.2	17.0	59.6	15.0	0.0	11.3	13.0	15.5	9.3	23.5	15.2	33.7	9.1
COQ4	CGI-92	ENSG00000167113	"Coenzyme Q4"	Q9Y3A0	9	128322536-128334072	"Disease related genes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021406, HPA042945"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA021406: AB_2670691, HPA042945: AB_10961047"	"unprognostic (9.15e-2)"	"prognostic favorable (2.97e-5)"	"unprognostic (2.29e-1)"	"prognostic favorable (4.93e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (5.76e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.14e-3)"	15.5	29.4	22.6	21.4	29.9	12.2	25.4	20.7	33.8	19.8	23.0	15.7	34.8	53.8	14.8	30.5	32.8	37.7	24.0	23.9	22.6	21.7	31.8	33.4	28.9	28.6	18.9	31.4	18.1	43.8	24.7	30.7	13.1	27.7	22.2	18.0	15.2	32.9	50.7	29.6	31.6	37.3	20.1	25.7	15.9	23.1	17.5	14.3	13.6	34.5	25.0	16.7	18.5	17.9	18.3	28.2	8.0	15.5	14.1	21.1	13.2	11.1	16.8	10.2	11.1	7.5	10.6	18.4	9.8	6.4	12.9	9.2	14.3	14.0	15.0	8.8	7.5	9.4	31.9	8.7	11.7	4.8	7.2	17.3	5.5	36.3	16.0	12.3	15.6	8.4	12.3	13.7	10.7	11.7	7.5	10.1	12.8	36.4	10.2	8.1	30.9	19.0	12.0	11.3	22.6	19.8	18.6	14.1	28.5	15.8	11.0	19.0	13.6	19.2	22.9	11.9	4.8	29.5	5.3	13.9	12.3	11.5	17.8	13.1	17.5	14.4	12.3	15.6	7.6	8.5	7.8	14.2	8.0	21.1	15.5	19.1	18.3	19.2	20.9	17.7	16.0	15.5	18.9	1.8	14.1	15.2	28.2	15.2	13.2	22.6	29.9	20.7	33.8	22.6	21.7	18.9	31.4	27.7	14.3	20.8	25.3	41.0	43.1	25.5	29.2	33.9	33.1	141.8	30.7	54.1	25.5	75.4	121.0	46.8	11.0	23.3	99.8	23.3	55.3	39.9	29.9	34.1	36.8	66.0	44.1	28.6	30.5	26.4	24.0	19.1	27.9	22.1	38.8	27.1	55.4	23.8	40.3	56.2	29.0	133.2	46.9	25.8	26.7	41.4	31.6	43.7	39.5	30.2	71.7	40.9
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.1	7.3	14.4	10.1	9.6	7.0	9.3	12.1	35.2	12.4	10.0	3.1	9.6	19.1	5.7	17.7	12.5	8.5	10.5	9.2	6.3	13.7	10.4	8.3	4.5	11.4	13.0	13.5	6.7	9.2	25.2	12.4	10.1	4.6	23.2	32.0	15.2	10.1	17.8	17.2	15.5	17.9	9.8	14.5	26.7	9.5	5.4	13.3	4.0	16.7	12.1	11.8	13.2	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9	0.0	1.4	3.0	1.2	2.5	9.3	2.8	7.6	1.4	0.0	8.7	11.8	4.9	1.7	12.4	2.2	3.3	75.1	0.0	13.8	5.7	3.8	2.4	9.2	15.5	9.9	7.9	12.6	4.9	7.1	3.6	1.1	2.9	1.7	12.6	14.0	4.8	20.8	31.7	3.9	8.1	6.2	6.5	2.7	8.8	6.9	5.4	4.3	1.7	12.4	2.6
URM1	"C9orf74, MGC2668"	ENSG00000167118	"Ubiquitin related modifier 1"	Q9BTM9	9	128371319-128392016	"Predicted intracellular proteins"	"tRNA processing, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053645, HPA065160"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA053645: AB_2682215, HPA065160: AB_2685423"	"unprognostic (7.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.04e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.43e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.17e-2)"	27.2	28.9	25.4	22.4	25.5	31.3	23.2	19.4	40.9	23.4	26.3	36.0	19.7	30.9	25.0	24.4	26.5	26.9	22.9	32.3	25.0	21.4	25.5	39.1	20.8	28.5	29.2	22.9	23.4	53.2	21.2	19.6	28.6	32.0	23.7	25.2	22.2	29.2	23.9	34.9	24.4	36.6	26.4	31.8	30.6	25.6	19.2	21.4	34.9	28.0	29.7	28.8	23.0	20.5	12.4	16.7	10.2	17.7	11.3	15.5	11.5	9.0	17.7	16.0	10.8	16.3	16.1	14.5	8.3	14.7	21.4	14.7	14.0	14.5	18.1	7.0	18.9	14.1	30.3	20.3	18.8	10.8	12.8	14.0	15.3	21.3	16.4	15.9	18.5	15.4	20.8	16.8	16.7	14.4	15.5	25.9	21.0	20.6	12.9	15.2	20.3	26.3	27.3	20.0	36.6	21.2	21.6	20.7	22.8	17.3	8.1	14.4	19.0	15.8	26.8	20.3	10.0	25.7	15.4	14.6	15.8	15.0	15.7	14.4	12.4	22.9	18.6	16.5	16.1	19.5	5.6	14.3	10.2	15.5	17.7	13.1	12.3	13.5	14.2	16.7	12.4	13.5	14.4	3.7	11.3	16.1	12.4	14.9	11.5	25.4	25.5	19.4	40.9	25.0	21.4	29.2	22.9	32.0	21.4	14.9	23.2	41.0	28.6	20.1	18.6	19.3	15.3	14.7	10.3	26.2	13.7	74.6	59.7	60.6	1.9	40.5	64.5	0.0	97.1	67.0	38.6	29.5	36.9	19.5	72.0	9.5	21.4	36.2	33.2	2.7	28.7	35.3	50.6	87.4	43.2	22.6	72.9	43.2	29.4	39.9	14.1	19.4	24.2	21.3	25.3	20.8	60.0	45.0	55.7	26.7
CERCAM	"CEECAM1, CerCAM, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.1"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	12.7	5.1	40.0	7.2	65.5	1.6	9.0	10.0	62.1	19.1	6.9	61.2	5.0	4.8	11.4	10.9	8.2	6.0	17.3	8.8	72.8	34.7	4.9	1.8	5.3	2.3	59.5	28.1	14.1	18.8	15.8	21.6	27.4	31.4	11.1	5.2	3.5	13.2	13.6	4.3	8.9	6.0	27.7	78.1	3.3	5.4	5.2	62.1	0.0	6.7	2.4	2.7	15.1	6.6	0.3	2.0	0.3	1.6	1.1	5.3	2.2	9.5	6.1	6.9	7.3	55.6	59.3	5.9	30.9	29.2	8.1	6.1	2.2	0.4	0.0	12.7	50.4	6.9	6.5	3.0	4.1	3.1	2.4	4.9	0.5	5.6	3.3	17.0	1.1	17.3	32.8	2.2	8.8	2.1	33.5	9.1	0.6	2.8	7.6	10.5	18.1	0.4	11.7	0.4	0.4	4.7	0.9	4.8	1.3	3.8	3.6	1.0	1.9	6.9	8.4	3.5	2.3	6.8	2.3	10.1	21.6	5.9	29.6	4.7	8.9	6.9	0.1	20.4	3.4	4.2	0.3	1.1	0.1	3.8	1.6	0.3	0.3	0.3	4.7	1.5	0.1	0.1	5.3	0.3	1.1	0.1	2.0	0.0	2.2	40.0	65.5	10.0	24.5	72.8	34.7	59.5	28.1	31.4	62.1	6.0	13.0	0.0	6.2	7.9	1.1	3.2	0.0	6.7	21.6	10.4	0.0	14.3	0.0	10.7	2.0	7.1	0.0	0.0	2.9	48.9	70.1	3.9	8.1	0.0	5.9	6.4	0.0	18.4	0.6	1.5	22.5	4.7	38.8	1.0	0.0	0.1	6.9	0.0	24.8	0.5	0.7	6.5	15.6	1.0	19.0	3.6	16.4	2.5	0.0	2.0
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 101.1"	"Group enriched"	"Detected in all"	22	"Early spermatids: 1694.9;Late spermatids: 5811.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Centrosome		NA	NA			Centrosome		"HPA001874: AB_1079522, HPA048841: AB_2680536"	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	6.2	4.8	5.6	9.9	6.7	10.2	7.0	14.3	7.7	7.1	5.7	6.7	5.4	4.0	9.7	6.4	5.2	8.8	5.7	5.7	6.3	5.1	4.7	6.7	5.8	8.9	6.2	4.1	6.4	5.1	7.6	18.2	6.0	7.5	6.6	6.0	5.4	5.3	8.3	3.7	7.2	5.3	8.0	5.2	7.3	5.7	101.1	7.1	18.4	5.5	3.7	9.6	6.4	6.4	8.3	8.8	16.0	16.3	11.0	14.6	9.1	14.7	17.9	29.9	34.0	11.9	14.3	24.1	24.9	11.7	20.7	10.9	17.6	10.9	26.5	9.4	20.2	16.1	38.8	21.8	14.8	21.1	17.5	10.1	23.5	27.2	14.7	6.9	25.4	29.8	11.8	9.4	22.0	15.6	12.9	18.0	20.3	27.7	14.9	19.5	45.2	26.9	31.1	11.6	30.3	12.9	24.7	28.8	20.5	10.8	11.5	18.0	15.4	23.3	22.3	8.1	14.1	20.8	18.5	17.1	25.9	16.0	29.7	24.1	28.0	40.3	19.1	11.8	23.2	22.4	16.0	8.9	9.8	12.4	13.4	14.6	8.3	10.9	12.9	8.8	8.2	7.9	10.0	3.1	11.0	16.3	8.4	8.0	9.1	5.6	6.7	14.3	7.7	6.3	5.1	6.2	4.1	7.5	7.1	6.0	5.0	9.0	13.5	14.8	8.2	8.9	10.2	46.8	9.1	7.0	9.8	10.4	10.0	9.2	1694.9	15.1	3.2	46.7	7.8	14.2	11.0	11.6	18.5	9.6	10.8	7.9	3.5	8.0	10.2	5811.6	39.4	10.0	10.1	9.0	8.2	6.5	7.1	2.9	31.8	5.9	8.2	12.9	13.9	171.1	48.6	11.5	27.8	12.5	6.6	11.8
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.1	9.9	10.1	13.3	11.0	9.4	15.5	11.0	13.7	7.6	22.0	8.9	12.3	14.9	38.3	17.3	15.7	13.4	20.9	11.3	11.3	22.5	12.7	11.2	18.2	14.9	7.1	15.3	17.5	18.8	8.6	8.7	20.7	16.1	19.5	17.7	25.2	17.9	12.9	8.5	29.2	17.7	18.3	24.6	29.1	10.4	9.7	11.9	8.9	26.8	16.3	9.6	8.5	30.0	12.9	6.3	16.5	11.0	19.2	15.2	19.6	47.1	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8	8.9	7.0	10.2	6.2	5.8	6.6	10.9	0.0	9.4	4.5	7.0	7.9	14.2	5.0	9.6	55.3	3.1	11.4	0.0	5.4	9.5	5.1	4.8	9.2	10.5	13.4	9.5	5.2	3.7	12.6	44.8	9.5	9.9	3.3	20.8	13.4	8.4	7.6	5.8	6.0	11.1	8.2	12.9	5.1	45.3	28.1	5.9	11.1	11.5	13.9	4.3
SPTAN1		ENSG00000197694	"Spectrin alpha, non-erythrocytic 1"	Q13813	9	128552558-128633662	"Disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 263.0;Cone photoreceptor cells: 292.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004581, HPA007927"	Enhanced		Approved	Vesicles,Microtubules		NA	NA		270000	"Vesicles, Microtubules"		"CAB004581: AB_671135, HPA007927: AB_1857435"	"unprognostic (1.46e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.84e-12)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.19e-3)"	27.8	18.0	46.4	21.3	54.0	14.7	18.0	80.9	74.7	21.1	22.3	33.3	17.0	14.5	27.5	20.5	22.2	33.1	19.4	37.2	42.6	46.2	19.5	13.8	32.1	20.6	41.8	59.8	32.4	14.2	47.2	18.2	33.1	75.1	20.2	22.0	26.9	16.7	29.3	12.7	40.1	17.9	35.1	31.8	24.2	18.2	26.1	29.9	18.0	22.2	11.4	21.7	19.6	27.5	5.5	2.5	3.2	1.2	5.7	12.8	4.2	23.8	26.4	17.4	19.2	25.5	28.9	14.3	20.5	17.2	23.0	17.4	37.5	17.0	20.9	18.3	30.9	16.2	43.9	18.5	20.5	14.3	11.7	10.9	3.5	71.6	21.0	14.4	15.4	11.8	13.8	16.6	38.6	13.1	19.5	30.8	19.9	1.9	24.7	22.5	16.5	29.7	6.5	22.2	28.1	16.5	20.1	20.9	13.2	18.7	20.5	13.5	21.2	67.1	9.3	9.7	22.3	16.1	4.4	52.6	16.0	23.8	23.1	15.8	15.1	17.8	11.8	19.5	7.1	15.0	2.5	1.2	3.2	8.9	1.1	12.2	5.5	11.2	8.2	1.9	5.3	7.0	7.2	1.3	5.7	0.9	2.5	12.8	4.2	46.4	54.0	80.9	74.1	42.6	46.2	41.8	59.8	75.1	29.9	65.5	28.0	29.7	27.3	33.2	263.0	64.5	71.4	26.8	15.9	96.0	292.6	22.3	6.6	59.2	14.0	81.5	108.9	0.0	51.0	14.3	55.4	41.9	11.5	31.0	25.3	117.6	54.6	74.9	26.2	29.1	78.9	22.5	33.7	22.6	49.0	93.5	75.3	73.0	89.1	15.8	152.1	25.8	39.7	29.2	41.3	39.6	15.2	38.9	54.5	43.6
WDR34	"bA216B9.3, DIC5, FAP133, MGC20486"	ENSG00000119333	"WD repeat domain 34"	Q96EX3	9	128633661-128656787	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 19.1;naive B-cell: 25.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 25.3"	"Cell line enhanced"	"Detected in all"		"MCF7: 89.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040764, HPA041091"	Approved		Approved	Cytosol		NA	Yes			Cytosol		"HPA040764: AB_10795625, HPA041091: AB_10796237"	"unprognostic (1.45e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.01e-5)"	"unprognostic (2.27e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (8.79e-4)"	"unprognostic (6.04e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-1)"	6.3	23.0	8.2	16.9	9.0	23.4	21.3	4.2	12.3	12.6	13.6	7.4	24.1	17.3	11.4	19.9	17.3	24.4	24.2	13.6	8.0	9.1	23.6	16.0	14.4	9.1	5.6	8.0	13.1	23.9	14.8	18.2	15.1	14.2	14.5	8.3	11.2	21.6	24.1	7.3	12.3	14.3	9.2	6.2	11.6	16.1	51.0	7.1	42.1	33.1	17.8	13.7	8.6	11.2	25.3	5.6	0.9	2.5	2.0	2.8	1.9	23.2	42.1	11.4	16.6	2.5	3.7	33.5	10.3	6.8	14.1	9.0	20.7	42.3	8.8	7.1	6.2	13.3	38.9	9.9	10.7	3.5	20.0	8.9	5.6	29.9	10.5	3.1	8.8	9.0	1.7	5.4	14.1	4.0	5.2	9.6	24.2	17.3	7.4	7.4	89.2	31.9	22.6	14.0	19.7	26.2	34.5	14.4	28.8	8.8	7.7	27.5	22.3	31.2	28.7	7.5	3.1	49.2	8.6	6.2	17.2	25.6	20.6	19.2	8.6	21.0	8.2	15.4	8.8	15.6	0.9	0.5	0.2	0.8	0.8	1.2	19.1	1.5	2.1	1.4	25.3	0.6	0.9	0.4	2.0	2.5	5.6	2.8	1.9	8.2	9.0	4.2	12.3	8.0	9.1	5.6	8.0	14.2	7.1	44.7	36.9	20.1	22.9	11.9	2.1	18.2	53.5	68.3	44.3	33.2	0.0	49.8	69.6	49.2	78.8	9.8	97.6	23.3	49.4	74.8	25.8	19.9	14.9	50.3	18.9	3.2	54.1	14.1	3.8	159.5	19.0	5.3	21.9	2.8	42.2	17.0	36.8	31.3	18.7	64.3	11.3	12.9	11.7	106.6	71.8	10.2	31.2	7.2	46.6	15.9
SET	"2PP2A, IPP2A2, PHAPII"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	47.2	49.7	66.5	59.3	65.8	71.8	56.5	64.2	61.2	54.4	51.3	55.3	45.6	40.1	64.8	33.1	71.6	51.6	48.9	81.6	63.6	57.3	51.7	57.8	51.2	91.1	65.4	56.1	76.5	61.3	55.0	38.7	65.4	47.3	59.2	56.4	36.3	52.1	46.9	76.3	53.6	45.7	59.0	73.5	62.8	46.8	34.8	58.6	152.9	69.1	46.2	92.7	74.4	84.1	72.2	66.4	43.2	56.5	78.8	77.9	69.7	51.4	58.8	84.6	66.9	25.2	39.6	78.0	42.5	47.1	61.5	42.4	80.7	63.2	133.1	36.0	43.7	48.1	96.5	124.9	63.9	70.3	60.7	53.2	76.6	91.4	65.6	56.5	139.7	50.2	33.0	50.1	52.3	105.0	49.5	57.5	71.6	148.6	54.0	50.3	86.8	117.0	51.6	141.2	78.7	62.6	107.0	105.1	107.8	47.4	58.1	86.2	54.1	93.6	62.9	50.8	62.8	78.4	43.6	55.0	72.7	54.5	44.8	70.3	42.5	122.1	158.5	34.6	74.5	69.2	34.5	53.9	43.2	58.9	56.5	72.1	72.2	67.9	62.8	52.7	66.3	65.8	77.9	35.4	78.8	45.6	66.4	52.3	69.7	66.5	65.8	64.2	61.2	63.6	57.3	65.4	56.1	47.3	58.6	113.2	124.3	265.7	328.1	598.4	174.9	190.6	209.0	89.7	129.7	186.7	41.2	273.8	330.0	223.2	30.8	200.0	100.9	93.5	188.0	401.9	250.8	373.4	128.3	164.3	210.2	117.6	245.8	160.2	212.7	25.3	151.8	217.3	310.4	235.4	230.5	205.1	229.0	108.7	163.0	257.3	97.8	129.4	279.5	127.7	287.7	613.8	263.1	219.3	275.8	519.4
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	"Protein kinase N3"	Q6P5Z2	9	128702523-128720918	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 13.4;Extravillous trophoblasts: 5.1;Ito cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 33.4;REH: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA045390: AB_2679308, HPA058305: AB_2683674"	"unprognostic (4.36e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.18e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.36e-1)"	11.4	1.8	1.5	6.8	3.8	3.7	10.5	10.1	3.9	4.3	5.8	3.7	4.8	7.7	9.7	2.2	7.1	5.3	10.9	7.3	2.3	1.7	5.0	6.4	8.9	9.1	3.9	1.2	4.0	4.2	3.3	1.4	5.6	4.5	4.2	1.6	4.1	12.9	3.7	7.4	6.7	5.4	4.9	4.4	7.8	7.4	4.3	1.7	9.3	8.1	6.1	5.9	4.4	5.0	0.4	1.0	2.3	0.7	1.0	1.8	0.3	1.4	6.9	5.6	8.5	0.0	0.1	13.9	4.3	1.3	6.3	6.5	0.0	5.0	0.0	4.2	2.3	1.3	9.3	6.8	1.0	1.4	4.3	12.8	8.2	33.4	9.7	1.0	1.0	1.5	0.3	0.3	3.4	0.9	1.3	12.4	2.5	18.6	0.9	1.1	12.8	1.2	4.4	5.2	6.3	2.0	20.3	10.6	1.8	2.6	0.8	0.9	4.2	3.2	1.7	3.2	3.2	6.1	6.6	10.7	0.0	5.3	9.9	3.2	3.1	1.3	2.7	0.8	1.0	3.9	0.0	0.1	1.4	0.9	0.7	1.8	0.2	0.6	0.8	1.0	0.4	0.8	0.1	2.3	1.0	0.2	0.2	1.0	0.3	1.5	3.8	10.1	3.9	2.3	1.7	3.9	1.2	4.5	1.7	0.0	1.3	0.0	1.4	0.9	0.0	1.5	0.0	0.0	2.3	0.0	0.0	1.2	0.0	1.6	0.3	13.4	1.1	0.0	2.3	5.1	0.9	0.9	0.0	0.2	1.5	0.0	0.0	6.2	0.3	0.4	1.4	0.2	0.0	1.8	1.0	0.5	2.6	0.8	0.7	0.3	0.2	0.0	0.8	1.0	3.4	0.9	1.1	1.0	1.4	1.6
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type containing 12"	Q96GR4	9	128720869-128724127	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 77.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 54.8"	"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	7.3	10.9	3.9	15.3	4.5	21.8	11.2	2.5	6.5	7.5	21.2	6.8	19.3	16.2	5.9	8.3	27.2	6.9	21.5	9.2	3.5	3.1	20.6	23.6	14.2	28.0	3.8	3.8	5.0	40.5	4.3	5.0	24.7	4.8	11.1	8.4	7.7	26.3	13.3	7.5	16.8	33.0	5.4	5.8	14.9	18.7	9.2	2.7	23.6	10.3	16.4	24.4	10.1	11.7	22.2	50.6	77.4	28.7	17.4	26.1	18.8	14.2	39.0	1.6	8.4	5.1	3.5	16.4	9.2	8.2	10.1	6.8	31.9	16.5	9.9	8.6	6.9	17.6	37.7	3.5	18.2	1.0	18.2	9.4	5.2	29.7	14.0	10.4	8.7	24.2	5.6	12.6	8.2	3.1	4.8	7.4	18.8	5.2	25.3	1.9	54.8	11.9	17.5	7.2	31.7	32.3	5.4	5.9	28.5	7.7	13.4	11.6	8.4	12.5	17.3	4.9	2.7	26.7	9.3	7.4	0.0	10.5	7.1	12.3	16.4	28.9	4.4	16.8	10.1	11.1	39.2	26.5	77.4	23.5	24.7	20.3	20.3	21.8	22.5	21.0	22.2	22.7	20.6	56.8	17.4	28.7	50.6	26.1	18.8	3.9	4.5	2.5	6.5	3.5	3.1	3.8	3.8	4.8	2.7	14.9	8.1	54.1	42.0	14.3	0.9	9.6	79.0	4.0	11.4	43.6	0.0	147.4	11.6	94.7	58.6	14.7	157.1	70.0	176.4	191.0	11.1	49.6	18.4	48.9	121.4	0.0	49.2	28.3	52.9	22.4	8.9	39.8	40.5	159.7	93.7	14.5	109.4	171.9	6.7	32.7	1.7	6.5	9.5	23.1	17.5	24.6	112.1	48.4	94.2	52.6
ZER1	"C9orf60, Hzyg, ZYG, ZYG11BL"	ENSG00000160445	"Zyg-11 related cell cycle regulator"	Q7Z7L7	9	128729786-128772414	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048464			Approved	Cytosol		NA	NA			Cytosol		"HPA048464: AB_2756306"	"unprognostic (1.37e-1)"	"prognostic favorable (1.18e-6)"	"unprognostic (9.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.65e-1)"	"unprognostic (4.90e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (5.15e-11)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.14e-1)"	15.4	17.1	36.0	9.7	32.0	12.0	12.5	28.0	45.3	15.9	18.2	19.7	11.3	27.4	16.7	12.3	23.8	21.9	14.4	29.9	27.0	28.5	15.7	11.1	16.5	10.4	19.9	34.2	22.1	22.0	24.1	18.2	13.1	29.1	20.6	11.0	14.7	21.9	22.2	40.3	17.4	25.3	14.0	13.5	12.5	14.1	25.8	18.8	16.9	19.0	8.5	9.3	17.9	12.6	5.0	5.7	15.8	5.8	5.5	7.7	4.9	8.8	9.8	6.5	8.9	19.5	13.5	18.0	8.5	14.8	11.9	9.7	8.8	10.1	5.5	9.7	14.9	8.9	19.5	7.1	12.7	5.0	10.9	9.4	3.8	17.4	6.4	15.3	5.5	10.6	16.8	19.2	12.0	8.5	16.2	10.1	11.1	6.8	12.1	8.1	33.7	10.4	6.2	6.5	12.4	12.7	9.5	8.7	20.8	8.9	12.0	12.7	9.6	14.4	18.5	9.8	7.9	27.0	6.6	11.3	9.8	4.4	12.5	5.1	15.2	14.1	4.3	14.5	3.3	7.1	10.9	3.7	10.0	5.6	5.6	7.7	3.8	5.8	7.2	3.9	5.0	6.5	5.9	15.8	5.5	5.8	5.7	5.3	4.9	36.0	32.0	28.0	45.3	27.0	28.5	19.9	34.2	29.1	18.8	11.9	15.6	2.4	3.3	2.5	19.4	19.8	5.1	10.7	2.3	5.2	13.7	3.9	1.7	4.4	4.2	5.8	24.2	0.0	8.2	2.1	4.9	6.4	10.3	6.8	5.1	20.6	6.9	8.6	6.6	1.3	10.3	3.2	8.5	10.8	14.0	10.3	6.5	21.0	9.9	9.9	12.2	12.9	4.2	10.2	3.1	5.1	7.1	3.3	8.9	2.3
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787204-128810432	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"monocytes: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No			Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	12.5	17.4	23.0	8.3	20.8	12.1	10.1	12.0	24.7	9.8	10.7	17.3	8.4	11.7	13.3	14.2	8.4	14.7	10.9	13.4	17.8	18.5	26.0	8.9	10.5	11.0	13.9	12.7	19.3	11.3	30.2	9.7	9.5	14.9	11.6	8.2	12.5	16.9	14.3	16.6	11.6	13.0	12.6	8.7	12.0	11.2	8.1	13.3	8.6	14.1	7.6	11.2	11.2	8.5	5.0	9.0	15.7	2.8	3.4	5.6	3.4	6.3	15.2	16.0	16.0	20.8	10.1	15.6	15.2	13.1	15.8	10.3	16.5	8.5	10.6	10.6	18.0	15.8	17.2	9.7	12.1	9.4	8.4	11.1	11.4	17.8	15.1	12.9	17.1	23.3	14.1	14.4	13.7	8.3	14.1	20.3	11.4	17.5	7.2	18.8	13.6	10.3	10.2	15.2	17.6	23.0	11.7	14.8	24.1	11.6	8.3	16.2	11.3	21.2	13.6	8.9	16.3	14.5	16.1	16.0	19.9	12.5	16.1	12.3	9.3	11.9	10.5	14.5	10.3	14.2	15.7	2.7	4.6	4.9	2.8	4.9	5.0	3.8	4.7	3.1	4.0	3.3	5.6	2.2	3.4	2.1	9.0	2.8	3.4	23.0	20.8	12.0	24.7	17.8	18.5	13.9	12.7	14.9	13.3	3.0	7.0	4.2	2.6	2.1	8.3	8.9	0.0	4.0	3.4	15.7	9.8	4.3	8.3	5.6	1.3	9.5	7.8	0.0	8.6	4.1	5.7	2.8	8.1	11.6	14.2	6.4	5.2	16.0	8.6	2.3	8.6	4.1	0.0	87.4	6.1	6.7	6.8	7.0	7.1	24.8	5.8	6.5	3.5	5.1	9.3	2.8	2.1	5.0	6.0	2.0
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818474-128822677	"Plasma proteins, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 91.2"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"	NA	NA					"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favorable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	5.8	6.4	8.6	3.2	9.1	3.9	8.1	8.1	15.0	4.4	8.4	5.3	8.8	10.3	3.1	2.6	5.7	7.7	4.3	19.9	8.0	8.3	9.9	18.5	3.8	5.7	7.2	7.2	3.5	8.4	8.0	4.8	3.9	6.0	6.9	5.5	4.8	5.9	7.0	91.2	5.2	7.6	3.4	4.1	3.4	7.6	6.1	6.5	5.2	8.1	18.1	3.7	4.3	7.1	3.9	6.9	1.5	3.8	2.3	3.1	1.3	6.7	7.3	1.9	10.1	5.1	4.3	8.7	6.5	3.4	6.2	4.3	4.4	5.4	2.2	5.9	4.2	3.8	19.0	6.1	5.7	1.1	4.2	10.9	3.8	7.1	7.8	2.3	11.6	14.5	4.5	7.0	3.7	2.5	3.7	4.7	7.4	11.8	3.4	3.8	9.8	9.0	24.0	4.8	11.7	27.5	10.9	2.2	22.6	9.2	2.4	16.8	16.8	14.5	13.3	3.3	1.3	12.8	5.8	4.7	4.3	2.6	6.1	4.8	11.0	1.5	4.1	8.7	8.4	4.4	0.0	2.3	1.5	2.8	3.8	2.5	3.2	2.8	1.3	3.6	3.9	2.7	3.1	0.0	2.3	1.7	6.9	1.1	1.3	8.6	9.1	8.1	15.0	8.0	8.3	7.2	7.2	6.0	6.5	8.9	5.6	7.4	19.5	7.8	12.7	0.6	22.9	57.6	14.8	22.7	3.9	26.8	86.2	4.1	68.9	6.3	48.0	0.0	6.7	25.6	14.1	19.2	1.1	66.2	17.1	11.1	13.8	7.4	15.1	101.7	17.3	7.0	10.1	2.8	22.6	31.6	6.8	21.6	17.7	68.6	11.9	6.5	10.3	83.7	5.7	12.7	8.5	8.7	25.5	25.2
SPOUT1	"C9orf114, CENP-32, HSPC109"	ENSG00000198917	"SPOUT domain containing methyltransferase 1"	Q5T280	9	128819651-128829821	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 29.4;Extravillous trophoblasts: 18.6;Hofbauer cells: 18.6;monocytes: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076946	Approved					NA	NA					"HPA076946: "	"unprognostic (1.85e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.70e-2)"	14.8	14.1	23.3	18.6	35.0	16.8	12.8	20.6	27.9	11.9	11.3	14.6	19.6	15.9	14.5	12.7	18.4	13.6	12.8	15.2	19.5	14.3	15.7	28.8	11.8	23.7	24.8	12.3	19.6	25.1	13.1	15.3	13.6	21.5	22.3	8.2	10.6	22.2	16.3	20.3	25.0	14.0	16.0	20.9	21.7	15.3	9.4	27.7	15.5	16.6	9.6	18.4	14.6	17.5	13.7	11.8	4.1	8.6	16.5	18.7	11.5	6.0	14.3	11.6	16.8	7.0	6.7	20.4	6.8	3.9	12.0	6.7	19.5	10.8	12.3	7.2	6.7	12.3	25.2	10.5	10.4	4.0	11.6	11.2	9.8	21.9	15.9	7.1	14.2	17.8	6.9	8.6	8.5	8.7	5.4	8.7	18.1	19.4	10.7	6.6	37.9	17.5	28.8	15.1	27.9	18.0	19.3	11.3	21.1	7.8	11.1	13.6	13.4	12.6	18.1	8.4	6.9	18.0	15.8	9.2	17.1	7.8	11.5	16.6	12.3	20.4	12.7	10.8	12.4	13.7	4.1	8.6	4.0	18.4	8.3	18.7	13.7	14.9	16.6	9.8	13.7	14.9	14.8	2.6	16.5	6.8	11.8	13.2	11.5	23.3	35.0	20.6	27.9	19.5	14.3	24.8	12.3	21.5	27.7	3.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	14.8	8.7	0.0	29.4	10.0	13.8	0.0	0.0	0.0	0.0	15.3	18.6	0.0	0.0	12.8	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	27.1	0.0	0.0	13.2	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 5.3;Cytotrophoblasts: 3.4;Distal tubular cells: 3.3;Proximal tubular cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		21000	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	4.4	5.2	12.2	5.1	18.9	3.9	7.0	17.8	17.6	4.7	3.8	14.2	5.5	4.1	5.5	5.4	4.6	8.5	4.8	13.5	12.1	9.3	8.1	12.0	4.1	7.3	18.4	12.1	7.1	5.0	8.9	8.1	4.5	12.2	8.9	2.7	5.8	7.0	8.4	17.0	12.2	4.8	5.8	10.2	5.8	4.0	6.9	17.2	3.7	7.5	2.8	7.4	8.1	8.1	12.1	7.6	3.5	5.1	4.6	9.6	4.9	3.8	8.7	8.0	7.9	7.2	9.1	4.1	5.2	6.1	5.2	7.8	4.8	7.1	7.3	2.6	3.9	6.5	12.4	11.8	10.2	6.7	8.2	8.2	4.8	21.2	8.7	6.5	4.6	2.0	4.0	6.5	6.8	6.5	17.5	9.1	18.5	7.3	6.4	6.8	2.5	10.6	3.1	14.0	15.0	6.8	12.7	6.9	13.7	7.1	1.6	8.5	7.3	8.4	2.1	4.8	10.3	5.1	1.7	6.0	3.9	6.8	5.9	4.6	11.9	10.1	9.1	7.5	7.2	3.1	0.1	3.1	3.3	7.8	2.2	6.2	12.1	8.1	8.1	7.6	5.8	8.6	9.6	3.5	4.6	5.1	4.8	8.7	4.9	12.2	18.9	17.8	17.6	12.1	9.3	18.4	12.1	12.2	17.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	3.4	3.3	1.5	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882112-128918039	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 147.0;Glandular cells: 170.8;Urothelial cells: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 50.6"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favorable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	25.8	10.6	24.3	14.2	26.8	13.4	17.8	28.5	50.4	13.8	14.0	18.5	10.9	9.0	18.8	7.4	37.9	12.4	21.1	14.5	22.6	21.0	11.6	16.4	20.3	7.7	27.2	19.5	11.4	19.0	21.3	7.4	21.8	21.1	18.4	8.2	12.1	16.2	24.8	8.0	16.0	9.5	25.8	13.0	10.5	16.7	9.2	22.6	8.4	13.5	12.0	14.3	20.9	18.7	2.5	2.8	3.2	1.9	6.1	7.4	1.7	10.5	16.6	10.1	8.6	23.7	9.2	12.7	12.2	8.1	7.6	5.4	7.3	22.7	3.8	13.8	13.2	9.5	50.6	6.2	27.0	3.6	3.9	5.0	3.4	10.7	8.8	16.1	4.1	6.4	7.1	19.2	13.4	16.1	15.4	26.2	5.4	7.6	3.9	9.9	9.1	4.6	3.9	30.0	17.7	18.1	6.4	11.6	6.2	11.9	5.3	6.0	12.6	13.6	8.5	4.8	7.9	6.2	3.1	45.8	22.3	9.6	9.4	17.7	4.5	10.6	4.7	12.3	3.1	12.8	1.2	1.4	3.2	7.4	1.9	3.4	2.5	3.7	4.7	1.8	2.0	3.7	3.6	2.6	6.1	0.5	2.8	6.1	1.7	24.3	26.8	28.5	32.6	22.6	21.0	27.2	19.5	21.1	22.6	14.9	14.1	6.0	147.0	93.9	11.9	28.4	15.3	9.4	34.2	7.0	5.9	10.4	0.0	22.5	5.2	46.3	20.4	46.7	18.3	15.3	18.4	170.8	5.8	12.4	5.3	23.8	15.4	51.0	7.6	2.2	21.3	7.4	25.3	2.8	15.4	42.9	51.7	13.9	41.8	7.3	9.7	64.7	30.8	3.3	5.1	126.8	17.4	10.9	8.8	292.5
PHYHD1	MGC16638	ENSG00000175287	"Phytanoyl-CoA dioxygenase domain containing 1"	Q5SRE7	9	128920895-128942041	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 101.2;Muller glia cells: 104.5;Proximal tubular cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;ASC TERT1: 15.3;BEWO: 23.4;HSkMC: 13.1;RPTEC TERT1: 35.3"					"Low region specificity"	"Detected in many"			HPA012115			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA012115: AB_1859448"	"unprognostic (1.18e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.38e-10)"	"unprognostic (1.10e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.83e-3)"	14.4	11.4	20.3	3.9	15.7	5.9	20.0	8.5	14.0	31.1	8.3	16.3	31.9	2.3	14.2	29.7	16.3	18.5	12.7	14.9	18.4	13.6	25.0	35.9	14.4	5.6	16.9	11.2	24.3	29.9	12.4	6.3	7.3	16.4	16.9	3.2	29.4	29.4	30.2	17.5	25.4	4.3	13.7	25.8	5.5	11.9	9.0	17.7	3.1	30.2	6.6	8.1	9.9	9.8	3.5	13.9	1.1	0.7	2.6	2.5	0.6	0.1	0.2	0.1	0.4	21.4	15.3	23.4	1.6	0.0	1.5	2.7	0.8	0.2	0.3	0.2	1.3	0.1	0.3	0.1	0.1	1.4	0.2	2.4	0.0	3.1	7.7	7.0	0.3	0.3	13.1	0.5	0.2	0.1	0.0	0.1	0.1	0.2	0.5	10.9	0.5	0.2	1.0	7.6	0.1	0.2	9.0	4.3	0.2	35.3	0.3	0.5	0.2	0.2	0.1	0.1	5.4	2.1	0.7	0.5	0.3	1.0	0.3	0.2	0.2	0.4	8.9	0.2	0.2	0.3	1.1	0.6	0.5	1.6	0.7	0.6	3.5	0.8	0.7	1.8	1.2	2.3	2.5	1.1	2.6	0.6	13.9	0.4	0.6	20.3	15.7	8.5	14.0	18.4	13.6	16.9	11.2	16.4	17.7	29.8	26.4	3.6	47.1	19.6	7.5	18.2	10.2	14.7	40.9	31.4	27.5	46.7	101.2	7.6	0.3	4.3	0.0	0.0	13.8	24.1	20.5	15.1	0.0	70.6	8.7	3.2	1.2	38.1	2.2	1.3	63.6	2.5	11.8	0.0	2.6	104.5	17.8	0.0	62.2	114.6	61.9	51.8	14.1	0.9	2.8	21.2	25.9	2.5	1.1	26.5
AL672142.1		ENSG00000251184			9	128941478-128957021	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"skeletal muscle: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;BJ: 4.4;HL-60: 4.0;RH-30: 4.5;U-138 MG: 3.5;U-698: 3.5"															NA	NA																							0.2	0.3	0.7	0.0	1.1	0.0	0.2	1.2	0.6	1.4	0.1			0.0	1.3	1.6	0.0	0.5	0.0	0.3	0.1	0.3	0.3	0.3	0.3	0.5	0.7		0.4	0.0	0.0	0.0	0.3		0.0	0.0		0.0	0.0	5.3	0.0	0.0	0.4	0.7	0.0	0.8	0.3			0.2		0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	1.1	3.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.7	0.0	1.1	0.0	0.0	1.4	0.7	1.6	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.7	4.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	2.5	0.0	1.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: AB_2732751, HPA068706: AB_2732118"	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.3	6.8	10.1	20.2	10.7	9.3	10.8	17.5	13.3	9.9	15.1	8.2	2.8	5.7	15.6	18.8	36.7	9.3	13.5	6.9	4.7	8.1	3.5	13.3	10.9	20.5	3.8	6.3	14.8	12.5	14.3	7.9	7.8	12.9	4.1	8.6	4.6	14.3	25.4	3.1	3.2	8.8	14.8	12.0	3.2	9.0	11.2	11.9	7.8	6.3	7.0	14.3	11.8	6.3	6.7	20.6	5.1	10.7	12.0	4.3	15.1	8.8	4.4	10.8	2.9	11.3	3.5	9.1	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0	6.0	2.6	1.5	3.2	1.5	9.0	3.0	7.6	6.7	3.4	7.0	7.9	21.7	0.0	14.1	10.7	8.3	6.2	0.0	12.3	14.0	5.6	3.1	1.1	8.3	11.4	4.8	1.2	17.2	6.9	2.8	11.2	2.7	3.3	1.8	3.8	11.2	10.4	5.8	5.6	7.2	6.5	0.0	4.1	24.0	14.9	1.1	15.2	1.9	5.5	1.7
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.9	21.0	17.4	23.7	13.2	13.1	15.6	15.4	12.2	28.3	18.9	25.3	8.8	19.2	5.8	16.9	18.3	32.6	39.0	19.1	21.2	15.4	18.8	17.1	39.2	19.9	8.4	29.2	17.3	9.1	9.0	29.7	15.2	8.3	16.2	25.0	37.5	13.7	19.9	27.8	24.9	11.9	23.3	21.1	20.2	22.9	37.7	19.6	8.7	12.4	24.5	11.8	39.9	15.2	5.9	13.4	16.7	10.8	13.1	23.5	16.7	23.6	27.5	11.7	21.6	26.0	13.7	18.7	17.3	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3	0.0	13.0	7.5	5.2	5.8	14.9	2.7	7.6	4.0	2.3	5.2	43.2	6.4	1.7	5.5	10.1	6.8	3.2	0.0	5.6	5.9	6.9	7.5	5.8	3.8	7.4	19.1	8.7	12.9	4.9	3.1	8.9	7.2	1.7	4.6	6.7	7.5	7.5	0.0	11.0	1.9	25.0	25.8	4.2	41.6	37.7	9.8	7.2	7.0	6.0	7.2
SH3GLB2	KIAA1848	ENSG00000148341	"SH3 domain containing GRB2 like, endophilin B2"	Q9NR46	9	129007036-129028303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cytotrophoblasts: 90.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021438, HPA024734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021438: AB_1856820, HPA024734: AB_1856821"	"unprognostic (2.59e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.88e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-3)"	"prognostic favorable (4.28e-4)"	9.3	18.8	36.9	11.7	27.0	30.4	16.6	31.3	47.2	15.8	16.4	33.0	43.7	25.7	14.4	14.2	29.5	21.0	13.6	14.8	34.2	24.4	15.8	6.6	14.9	13.6	28.8	37.9	20.0	35.9	29.1	26.8	45.2	26.3	21.3	10.1	13.4	30.0	33.8	19.4	46.6	20.4	16.6	30.9	14.9	25.8	7.8	24.1	16.9	16.4	15.0	15.8	27.8	18.1	7.7	7.6	6.6	4.6	5.0	4.9	2.8	13.4	11.4	5.6	7.6	3.4	4.3	16.8	4.7	10.7	9.4	8.6	7.1	23.3	14.2	3.7	8.3	7.2	33.2	1.7	10.2	2.7	9.1	7.7	3.6	18.2	6.2	7.1	3.2	8.7	3.1	11.7	4.8	4.3	10.3	7.8	18.8	4.8	19.0	4.7	33.1	18.2	8.5	5.0	22.8	8.0	37.1	10.6	63.5	10.4	16.3	17.7	14.3	6.8	17.8	7.3	4.9	25.5	4.8	7.1	4.4	7.5	11.1	10.3	18.5	9.0	9.0	10.1	4.0	2.3	4.4	3.3	6.6	4.1	1.6	4.9	7.7	4.7	3.8	2.7	3.8	3.4	3.0	2.7	5.0	4.6	7.6	3.9	2.8	36.9	27.0	31.3	47.2	34.2	24.4	28.8	37.9	26.3	24.1	14.9	30.8	10.4	24.5	18.4	20.3	9.0	12.7	5.3	19.4	45.4	7.9	90.7	13.3	12.2	8.2	11.3	41.2	23.3	22.8	15.3	16.4	24.4	5.8	7.8	17.9	44.5	24.3	11.6	11.6	14.9	17.5	9.8	13.5	4.6	31.4	26.6	19.7	49.9	19.1	6.2	15.6	12.9	16.5	6.1	6.6	46.9	125.1	10.4	29.9	48.9
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 9.0;Club cells: 5.7;Collecting duct cells: 7.0;monocytes: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	10.1	14.3	7.7	11.5	10.2	17.3	6.8	17.6	16.0	5.6	17.2	8.9	14.6	23.7	7.6	8.7	11.5	7.1	13.3	24.4	7.9	11.6	7.6	7.4	5.2	7.5	9.0	10.9	8.4	6.8	7.5	8.5	3.1	9.4	9.3	5.5	8.7	11.1	12.3	13.0	9.8	21.6	9.0	7.6	7.1	9.9	7.0	7.2	8.0	9.6	5.3	10.8	10.0	9.8	2.8	3.9	8.5	3.1	1.2	6.5	2.2	4.0	8.3	2.6	13.0	7.1	3.7	5.8	7.3	5.5	8.4	5.3	7.2	8.5	6.1	3.3	5.6	7.3	19.3	3.5	5.4	1.3	5.6	5.1	4.4	16.2	5.3	7.9	5.0	10.1	5.2	4.3	7.6	3.9	2.7	5.8	5.8	6.4	2.6	4.5	10.6	5.0	10.3	6.0	9.7	12.1	10.3	7.6	10.1	4.4	7.8	8.2	5.8	8.1	12.9	4.5	1.6	9.3	5.4	5.7	5.5	6.3	9.1	5.5	3.5	5.1	5.7	7.8	4.0	6.4	8.5	2.6	2.4	3.0	3.1	6.5	2.3	2.2	3.9	2.9	2.8	2.2	1.3	4.8	1.2	1.7	3.9	1.9	2.2	7.7	10.2	17.6	16.0	7.9	11.6	9.0	10.9	9.4	7.2	3.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	7.0	0.0	2.5	1.7	4.7	0.0	0.0	0.0	0.0	4.0	1.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	6.4	0.0	0.0	4.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081100-129090438	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	6.4	12.8	10.0	6.8	10.6	7.7	6.8	11.7	19.3	8.3	17.1	17.7	8.6	28.6	6.0	7.4	18.8	6.6	9.2	4.1	10.1	10.7	9.4	21.8	6.7	6.6	13.2	10.6	7.7	10.5	10.4	6.9	11.6	12.5	10.0	14.2	6.1	10.3	5.8	5.2	10.3	27.7	6.3	15.2	8.5	11.8	12.2	11.0	9.4	6.3	8.5	9.1	7.8	8.0	8.8	12.5	9.8	8.3	7.9	21.7	7.2	4.1	16.0	15.7	14.4	5.3	4.5	18.2	10.3	6.0	19.6	11.0	20.6	13.9	8.1	9.1	6.4	15.0	30.3	16.1	8.6	8.3	9.4	9.9	10.6	10.8	15.7	9.4	11.0	13.2	4.9	12.1	12.8	10.2	4.5	8.7	15.1	17.5	8.1	5.5	21.0	12.5	11.4	13.5	30.9	13.0	14.8	12.7	14.5	7.1	6.7	18.0	11.8	13.0	11.8	4.3	9.6	21.7	7.3	7.1	16.9	8.1	15.9	13.9	10.1	19.4	12.3	7.5	2.2	11.1	4.4	6.8	9.8	8.9	8.1	21.7	8.8	10.9	10.8	8.5	6.0	11.1	10.5	1.4	7.9	8.3	12.5	10.1	7.2	10.0	10.6	11.7	19.3	10.1	10.7	13.2	10.6	12.5	11.0	6.0	4.6	3.7	2.9	2.1	3.2	1.6	5.1	0.0	2.3	1.8	5.9	16.9	1.7	5.9	0.5	2.4	26.6	0.0	8.4	11.4	3.3	2.7	5.7	17.0	6.5	3.2	3.5	6.2	3.8	0.4	2.0	2.3	5.0	4.6	9.0	9.1	5.4	13.3	3.9	3.8	3.4	0.0	3.1	4.5	8.7	3.4	13.7	3.8	12.2	3.4
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094810-129111189	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6;testis: 71.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 149.6;Late spermatids: 410.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		13000	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	11.6	13.4	8.4	4.6	9.2	5.9	10.7	7.5	15.9	8.3	15.4	8.6	6.2	24.3	6.5	9.5	9.4	5.4	10.0	17.3	7.7	7.9	12.9	50.0	4.2	3.1	8.3	9.1	7.3	33.1	16.8	3.2	7.9	9.3	10.5	4.4	8.1	14.7	7.9	98.6	7.0	22.8	8.3	5.2	4.6	8.1	71.7	4.4	2.4	8.0	20.2	4.4	9.3	6.8	2.6	11.3	6.0	11.3	6.0	10.0	8.1	0.1	18.3	6.4	13.1	12.0	16.1	9.3	7.8	8.7	9.5	6.0	3.8	7.4	0.7	4.7	13.1	12.7	3.3	1.7	2.8	3.4	11.8	0.4	3.6	9.2	14.7	17.1	0.1	14.0	14.7	0.0	8.0	0.2	12.1	12.4	3.5	1.6	3.8	9.7	3.6	0.3	8.1	1.5	19.8	8.2	9.1	12.3	6.0	9.2	0.3	2.1	6.6	0.0	4.1	2.7	2.1	26.6	4.0	11.1	14.3	1.0	17.9	7.7	13.0	11.0	0.0	16.9	2.2	9.1	2.5	11.3	6.0	5.0	7.4	10.0	2.4	6.9	6.6	11.3	2.6	4.3	4.7	2.9	6.0	7.3	5.3	6.4	8.1	8.4	9.2	7.5	15.9	7.7	7.9	8.3	9.1	9.3	4.4	6.0	3.0	5.4	4.5	2.9	1.4	52.0	20.4	1.4	3.4	3.5	2.0	38.4	14.9	16.6	149.6	12.6	94.4	0.0	19.6	46.4	21.8	14.9	6.9	58.6	18.0	1.6	14.9	14.1	8.1	410.0	20.4	8.8	5.0	9.0	16.9	13.4	12.1	38.6	23.0	41.0	1.4	6.5	14.6	94.3	6.9	4.0	42.1	10.7	22.1	9.9
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.3	43.2	26.6	49.3	18.0	22.1	26.6	25.5	28.9	35.0	24.5	23.1	30.1	25.4	19.3	43.2	39.8	39.7	27.8	31.4	30.2	45.0	15.2	15.7	45.7	21.9	53.6	27.0	34.1	26.5	31.0	25.6	24.4	53.1	35.6	26.6	23.2	28.2	29.4	63.2	24.6	16.7	41.9	66.2	43.0	24.6	24.6	46.6	36.7	30.6	28.9	20.4	51.6	53.3	31.9	26.4	56.5	11.8	26.1	29.1	26.3	30.0	35.9	25.8	65.9	22.9	35.8	17.7	40.1	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	50.6	0.0	42.8	46.4	58.5	0.0	0.0	0.0	0.0	54.1	37.3	0.0	0.0	8.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	37.9	0.0	0.0	49.9	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0
IER5L	bA247A12.2	ENSG00000188483	"Immediate early response 5 like"	Q5T953	9	129175552-129178262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 15.5;SiHa: 21.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021327			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021327: AB_2121674"	"unprognostic (2.46e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.90e-3)"	"unprognostic (8.49e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (6.91e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.29e-1)"	12.6	11.3	6.0	6.4	9.0	3.3	31.3	2.1	15.3	29.6	8.2	3.5	14.9	5.0	17.4	10.8	13.0	11.0	14.3	14.9	6.4	5.0	14.8	15.0	9.4	8.1	5.5	3.9	35.0	5.4	3.2	8.0	9.8	7.9	15.2	3.7	6.1	8.1	30.1	8.4	8.0	5.3	10.5	11.8	5.7	11.1	6.2	4.1	1.2	9.4	4.9	3.8	20.7	25.5	0.0	0.3	2.1	1.1	0.4	0.8	0.2	5.2	15.5	4.4	8.4	3.3	5.2	13.4	7.9	0.7	1.2	1.2	0.8	8.7	0.1	3.2	1.8	3.6	11.5	0.2	0.9	0.2	0.7	1.1	0.0	3.3	1.4	2.5	0.1	0.1	5.7	1.2	0.9	0.1	7.0	0.5	0.1	0.4	2.8	0.2	13.5	0.1	0.6	0.4	1.3	8.2	0.7	0.3	2.2	4.7	0.7	2.0	2.6	21.8	7.1	8.9	1.9	2.2	1.4	3.2	7.6	4.5	5.1	11.2	1.5	1.0	0.1	9.6	1.5	3.3	0.0	1.1	0.0	0.3	0.6	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	2.1	0.4	0.2	0.1	0.0	0.2	6.0	9.0	2.1	9.0	6.4	5.0	5.5	3.9	7.9	4.1	14.9	1.7	2.9	5.9	6.1	6.0	1.4	20.4	2.7	4.5	45.4	0.0	3.5	8.3	10.6	0.7	11.1	16.9	0.0	22.8	5.4	12.9	12.2	0.0	9.7	25.2	3.2	10.3	29.4	15.4	1.1	10.0	9.2	13.5	3.6	14.6	14.0	18.0	9.3	6.7	14.3	2.7	25.8	20.8	0.0	1.7	4.0	6.8	1.0	8.4	6.7
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636131	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 302.3;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	10.2	25.7	11.9	11.5	13.1	13.8	10.0	13.2	15.3	8.9	10.7	9.0	14.4	11.7	8.8	13.6	10.2	7.8	16.6	31.8	11.5	11.5	11.7	16.8	8.9	11.5	15.7	11.3	8.8	19.5	9.4	10.8	12.1	13.8	10.2	7.4	9.4	13.0	11.4	54.6	10.7	10.2	13.6	10.3	13.1	10.5	56.2	10.7	10.8	12.3	22.1	9.8	12.3	14.5	27.1	28.4	20.3	34.2	14.8	26.6	19.4	16.7	34.8	14.4	24.4	9.2	13.7	15.5	31.9	18.9	32.3	28.0	28.5	22.0	21.6	16.4	22.7	23.3	32.7	30.2	28.1	20.4	16.6	16.2	9.0	31.3	28.7	29.5	18.1	13.7	14.6	14.3	33.8	16.9	10.4	17.6	19.3	33.0	16.2	16.8	55.4	20.4	24.5	18.8	31.2	30.4	19.4	17.0	43.2	13.0	9.6	29.3	15.3	15.7	29.5	21.8	9.6	24.5	9.5	11.9	38.9	19.7	36.0	33.4	12.8	15.2	32.8	17.7	18.8	22.2	15.1	27.3	20.3	25.2	28.7	24.8	23.4	25.5	26.6	26.4	27.1	26.4	22.0	7.6	14.8	34.2	28.4	23.4	19.4	11.9	13.1	13.2	15.3	11.5	11.5	15.7	11.3	13.8	10.7	3.0	11.5	55.2	60.7	88.7	16.0	2.8	20.4	10.7	18.2	21.0	21.6	61.3	82.9	57.5	302.3	31.5	59.1	0.0	48.7	71.0	52.7	55.2	30.0	42.9	59.3	39.7	19.4	20.3	27.3	570.1	32.5	46.3	52.3	28.9	25.6	18.8	57.3	24.6	23.3	72.8	22.1	25.8	84.4	60.3	47.2	86.8	113.4	40.1	37.2	65.8
C9orf50	FLJ35803	ENSG00000179058	"Chromosome 9 open reading frame 50"	Q5SZB4	9	129612225-129620776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 9.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 60.3;Late spermatids: 168.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 2.9;MCF7: 4.4"									HPA026743	Enhanced					NA	NA					"HPA026743: AB_1845829"	"unprognostic (2.23e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.28e-2)"	0.0	0.4	1.5	0.1	1.2	0.2	0.0	0.9	2.5	0.2	0.2			0.0	0.2	0.0	0.0	1.5	1.5	0.0	1.0	1.4	0.4	0.0	0.1	0.1	1.1		0.0	0.0	0.1	0.5	0.2		0.1	0.0		0.8	1.5	0.0	0.0	0.0	0.4	0.8	0.3	0.1	9.4			0.5		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.7	0.3	1.9	0.2	0.8	0.0	0.5	1.7	1.2	0.5	0.0	0.6	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.1	0.0	0.0	1.4	0.3	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.6	4.4	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.2	0.1	1.6	0.4	0.2	0.0	0.1	0.4	0.0	0.0	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.3	0.1	0.3	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.2	60.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	168.5	0.9	0.0	0.0	0.0	0.0	7.0	0.2	0.0	1.8	0.5	0.2	0.0	0.5	1.2	2.2	0.0	0.0	0.0	0.0	0.1
ASB6		ENSG00000148331	"Ankyrin repeat and SOCS box containing 6"	Q9NWX5	9	129634604-129642169	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004341	Approved					NA	NA					"HPA004341: AB_1845070"	"unprognostic (1.60e-2)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.00e-2)"	9.7	15.2	12.9	10.8	18.3	30.8	17.8	17.9	27.7	9.9	8.4	12.6	4.9	10.0	10.6	8.6	13.5	14.3	8.9	10.3	13.5	10.9	12.2	8.3	9.4	14.3	11.1	13.8	10.4	14.6	13.2	12.1	12.5	14.8	10.0	7.2	13.5	14.4	13.0	7.7	18.7	9.9	10.2	10.0	15.0	12.9	11.7	10.5	13.7	12.0	7.3	11.5	9.8	11.7	9.0	9.6	9.1	8.5	14.3	14.9	9.6	6.9	11.5	8.4	19.1	9.2	9.1	14.0	13.4	9.1	14.1	8.6	12.9	10.3	6.3	7.9	16.8	19.1	19.2	11.2	13.4	5.8	12.2	17.7	5.7	22.7	6.0	13.6	12.6	11.3	12.1	9.5	17.4	8.2	8.0	11.0	16.8	12.3	9.3	9.6	17.5	13.2	10.1	14.6	13.7	26.8	12.4	9.3	12.4	12.2	6.6	17.6	21.9	13.2	17.0	10.8	6.7	14.4	7.8	11.8	19.9	10.8	23.6	13.6	12.7	13.3	10.1	15.8	9.3	13.1	8.5	8.5	9.1	14.9	8.5	13.5	9.0	10.2	14.3	9.6	8.0	12.7	10.7	4.8	14.3	8.4	8.9	11.4	9.6	12.9	18.3	17.9	27.7	13.5	10.9	11.1	13.8	14.8	10.5	0.0	5.6	5.2	3.9	19.6	6.1	10.1	7.6	2.7	0.0	8.7	5.9	11.1	18.3	12.8	1.5	7.1	10.2	0.0	9.3	8.9	8.6	5.5	2.3	2.6	7.5	9.5	6.9	8.0	3.7	2.1	8.1	6.7	3.3	5.4	6.6	6.3	9.9	9.5	7.4	5.6	6.1	12.9	5.2	7.2	9.4	17.7	11.9	7.9	6.9	4.9
PRRX2	"PMX2, PRX2"	ENSG00000167157	"Paired related homeobox 2"	Q99811	9	129665641-129722674	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 24.4;Early spermatids: 53.9;Fibroblasts: 25.4;Smooth muscle cells: 37.7;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.1;BJ: 17.1;BJ hTERT+: 12.2;fHDF/TERT166: 24.6;U-2197: 20.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006607, HPA026808"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA006607: AB_2667623, HPA026808: AB_10603228"	"unprognostic (4.02e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.47e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-10)"	"unprognostic (6.66e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.47e-3)"	8.4	2.1	0.4	2.5	0.4	0.2	7.3	0.2	0.6	15.6	2.4	0.5	3.5	0.7	4.6	5.4	5.3	2.1	2.3	8.6	0.4	0.2	0.6	0.4	2.8	1.8	0.3	0.1	3.2	2.2	0.3	2.8	2.6	1.7	15.1	0.7	12.8	4.6	5.2	6.6	15.8	1.1	10.2	1.2	0.4	1.6	6.7	0.0	0.6	7.9	9.3	6.5	10.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	2.1	8.1	0.0	17.1	12.2	2.2	2.5	0.0	0.0	0.0	6.2	24.6	0.9	0.2	0.5	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	2.6	1.2	3.8	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.8	0.0	0.0	0.9	1.6	0.3	0.0	0.0	5.1	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.4	0.2	0.3	0.1	1.7	0.0	0.0	0.0	0.0	1.2	24.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	53.9	0.1	0.0	0.0	0.0	0.3	25.4	2.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	2.6	0.0	8.5	0.0	0.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	37.7	3.2	6.8	26.0	0.3	0.0	0.0	5.0
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803153-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	14.2	14.4	9.7	13.8	12.2	14.0	18.4	23.6	11.9	11.3	22.5	10.5	11.6	12.3	14.0	8.2	13.5	10.5	15.0	13.3	11.7	11.5	11.8	35.3	13.0	10.8	9.4	9.0	10.8	21.1	13.3	13.6	20.0	10.6	12.9	25.8	10.8	12.8	13.7	13.5	13.0	18.1	14.2	8.9	12.4	14.9	19.5	8.3	16.8	16.4	10.0	11.9	14.9	18.0	4.6	6.2	17.2	14.6	7.3	12.3	8.4	5.3	12.3	5.1	13.7	25.9	19.4	12.0	19.2	12.5	13.2	13.1	10.1	12.2	3.8	12.2	18.8	20.6	21.8	5.6	7.9	13.6	13.9	5.9	3.3	10.4	7.1	11.1	6.3	14.9	11.0	13.9	18.8	9.3	9.8	11.7	10.1	11.5	8.9	12.3	14.9	8.6	9.9	10.8	25.1	9.7	3.5	9.0	11.5	10.1	5.6	7.1	8.3	12.4	14.3	7.6	9.7	20.6	6.2	10.7	25.0	11.9	29.7	16.4	6.5	24.2	3.2	13.7	8.2	16.9	6.3	11.5	17.2	12.2	14.6	12.3	3.9	9.5	10.5	6.2	4.6	7.1	7.1	14.2	7.3	8.5	3.8	9.1	8.4	9.7	12.2	23.6	11.9	11.7	11.5	9.4	9.0	10.6	8.3	8.9	3.7	4.5	5.2	5.8	2.5	5.1	5.1	5.3	1.2	5.2	3.9	9.7	0.0	8.8	9.2	6.7	8.0	0.0	12.2	15.2	8.5	9.2	4.6	13.5	10.8	6.4	18.4	11.6	4.3	10.9	4.0	7.6	3.3	12.6	15.5	4.8	10.0	3.5	5.3	3.0	2.5	19.4	9.5	10.3	7.0	4.6	12.7	10.0	10.7	10.1
TOR1A	"DQ2, DYT1"	ENSG00000136827	"Torsin family 1 member A"	O14656	9	129812944-129824134	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012473, HPA051195"	Approved		Supported	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Vesicles"		"CAB012473: AB_2240792, HPA051195: AB_2681382"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-1)"	19.8	26.8	17.8	21.9	19.3	28.0	37.5	19.9	28.4	18.8	19.0	15.5	17.8	15.2	22.5	19.6	15.0	17.4	22.7	18.0	18.4	19.7	20.9	47.1	19.3	34.4	16.1	14.3	20.4	18.8	15.2	15.9	28.9	15.6	20.8	21.3	14.9	18.9	24.7	15.8	17.8	21.0	24.0	15.9	23.1	18.1	11.7	11.3	32.8	22.6	11.9	18.2	21.0	16.1	17.3	24.1	53.3	28.8	24.9	24.0	27.2	13.3	20.1	14.9	17.1	22.6	22.0	19.8	31.3	38.8	28.0	24.1	13.0	19.7	16.5	18.5	40.4	19.2	31.6	14.2	20.7	23.1	26.1	13.6	14.7	21.1	12.9	28.6	32.4	27.4	29.8	21.1	26.4	19.2	25.8	30.0	26.7	26.1	13.3	30.7	33.5	23.1	31.5	22.3	15.7	23.0	12.1	23.5	16.7	22.9	17.2	11.2	19.9	32.4	12.7	17.1	17.5	25.4	25.5	26.5	27.8	15.9	20.6	23.9	15.3	33.8	15.1	20.6	18.8	22.2	30.0	28.8	53.3	24.0	26.4	20.1	17.3	20.6	21.6	24.1	12.9	17.7	18.3	28.2	24.9	21.3	22.1	22.4	27.2	17.8	19.3	19.9	28.4	18.4	19.7	16.1	14.3	15.6	11.3	8.9	10.2	22.0	14.3	15.7	10.7	7.8	20.4	13.4	19.4	14.0	2.0	42.7	13.3	38.6	0.4	17.7	12.1	0.0	43.7	54.7	23.7	18.0	21.9	21.2	41.6	20.6	18.5	14.1	12.3	1.0	11.8	30.3	13.5	56.9	17.9	18.9	34.7	21.5	14.5	14.0	7.9	32.3	13.4	5.9	9.1	16.2	44.6	26.7	15.3	16.9
C9orf78	"HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	23.9	29.0	42.7	24.5	44.0	73.8	28.0	37.0	34.5	24.0	24.7	27.6	25.5	21.8	24.1	28.9	26.2	21.5	24.8	28.7	40.3	39.6	44.8	41.7	21.8	35.7	39.5	30.8	31.1	26.3	20.9	26.6	24.5	29.3	27.5	27.6	18.0	26.7	26.4	45.8	27.8	25.9	28.9	38.7	28.1	22.5	32.3	32.8	42.0	33.6	23.5	34.0	32.4	31.3	28.5	22.9	57.6	43.6	37.8	52.8	34.4	9.3	9.3	10.0	15.6	17.9	12.1	12.4	13.6	11.0	12.2	8.9	9.7	9.9	14.6	11.0	15.5	19.2	20.1	13.7	11.6	10.2	14.3	9.8	23.3	16.6	10.2	11.9	33.8	24.1	11.0	20.6	14.9	12.7	12.3	11.1	62.7	58.3	17.9	14.8	22.4	43.3	43.5	14.8	38.1	22.3	12.5	15.4	30.9	12.2	6.4	8.3	15.8	20.5	19.1	16.3	9.9	16.7	23.9	12.5	18.2	13.8	17.8	17.1	8.0	23.2	23.8	15.1	27.5	14.9	36.4	23.3	57.6	44.4	35.3	43.9	28.5	46.4	48.0	19.2	28.1	52.8	48.2	18.0	37.8	43.6	22.9	48.9	34.4	42.7	44.0	37.0	34.5	40.3	39.6	39.5	30.8	29.3	32.8	83.4	75.8	65.1	59.9	69.4	38.3	50.4	61.1	103.1	105.8	54.1	35.3	62.3	106.1	56.0	34.8	56.1	58.8	186.9	78.2	64.8	51.4	57.1	128.5	71.9	59.9	30.2	81.0	35.6	56.4	11.6	54.7	75.9	69.2	90.2	53.5	48.4	55.0	38.6	57.3	121.7	34.8	77.6	67.6	82.1	101.3	74.3	56.5	139.4	52.1	49.2
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.3;K-562: 25.9;MOLT-4: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	2.5	2.5	4.4	6.0	5.8	5.0	6.3	4.1	3.5	3.2	2.2	2.1	2.8	3.5	3.6	4.0	3.6	6.5	2.6	3.0	1.3	19.0	3.5	6.5	6.8	1.4	4.1	6.1	4.8	4.4	4.4	4.2	3.1	5.6	3.4	42.3	25.9	4.4	1.9	6.8	23.8	14.5	3.5	5.4	6.0	4.0	5.0	5.9	2.5	2.8	1.0	4.9	4.8	6.2	3.9	2.7	6.4	8.5	5.0	3.5	1.6	4.7	2.7	4.3	6.3	2.4	7.0	8.0	3.3	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8	8.9	8.6	3.2	2.3	2.5	7.9	5.9	2.5	4.0	2.3	1.8	3.9	5.1	3.3	2.2	1.1	2.4	4.0	0.0	3.4	2.1	3.8	3.0	1.1	5.6	3.0	9.5	8.1	7.4	2.1	2.8	5.8	3.1	3.3	3.6	4.6	5.8	2.3	3.7	4.6	2.2	5.9	0.0	6.2	12.2	4.4	1.8	5.1	11.3	5.1	1.4
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 605.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6;JURKAT: 45.5;MOLT-4: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	11.5	6.5	20.7	30.5	27.3	20.0	10.1	56.0	21.3	16.9	42.5	30.1	12.2	8.5	23.6	10.2	23.0	15.6	15.9	8.7	22.3	18.6	7.8	10.4	14.1	39.8	25.1	14.5	13.4	5.5	6.2	8.6	9.2	22.8	20.8	17.4	11.4	7.7	26.7	12.2	13.4	15.7	64.7	29.9	32.1	15.3	9.1	27.3	52.1	15.7	5.7	40.4	34.6	12.4	13.5	8.2	12.3	6.9	6.5	13.4	4.9	13.1	6.1	11.3	13.1	6.9	8.6	9.5	7.5	6.4	5.7	4.8	6.3	5.1	25.8	6.6	14.0	6.7	6.6	10.5	6.8	5.7	42.6	3.1	7.1	7.4	4.2	11.9	19.1	24.5	6.2	3.0	10.5	6.4	8.3	8.3	45.5	1.6	0.3	5.2	10.5	42.8	18.8	8.8	1.7	10.4	9.9	9.1	7.4	7.1	7.2	1.8	5.7	13.7	13.8	5.2	11.3	9.6	8.8	10.0	5.4	6.8	9.8	4.6	5.3	19.5	1.2	6.5	13.2	8.0	12.3	6.0	10.5	13.4	6.6	11.7	13.5	12.2	12.7	6.8	9.0	11.3	10.9	11.4	6.5	6.9	8.2	12.3	4.9	20.7	27.3	56.0	21.3	22.3	18.6	25.1	14.5	22.8	27.3	32.8	31.8	93.1	17.5	29.5	17.2	13.2	7.6	44.2	37.5	21.0	49.1	14.3	16.6	18.3	1.3	38.0	14.7	0.0	15.0	20.9	49.4	46.8	77.5	14.7	40.2	27.0	17.4	46.1	165.2	3.6	43.1	119.6	72.6	605.1	8.3	55.6	16.4	17.3	48.4	11.3	28.0	58.2	45.6	12.6	39.8	35.9	53.4	178.7	14.4	26.8
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	21.0	21.6	24.2	16.6	26.8	12.5	23.7	28.1	28.0	25.0	24.0	35.9	20.5	13.3	24.0	19.1	22.5	26.2	20.9	20.6	22.3	26.6	24.4	22.9	23.0	17.4	29.5	23.1	21.8	26.6	34.4	21.6	40.7	29.9	28.4	26.3	29.3	23.0	24.4	20.5	25.6	15.4	26.7	28.8	17.2	18.9	23.9	22.9	17.3	40.0	15.4	19.7	19.4	17.3	2.0	3.4	6.3	6.3	1.4	2.4	2.3	12.7	18.7	17.9	14.1	19.2	20.4	17.9	20.4	23.0	17.3	17.3	17.9	17.4	7.1	15.1	22.5	20.3	32.2	13.7	12.6	14.9	11.0	9.2	7.5	23.0	10.2	18.6	15.6	11.0	17.0	19.7	17.2	17.4	19.7	15.9	8.6	10.6	7.1	14.8	15.7	8.3	6.3	12.0	26.0	14.2	7.9	26.3	11.2	14.5	17.8	6.3	13.8	26.7	19.0	14.4	16.3	33.3	8.2	18.7	22.0	11.8	17.9	15.4	4.5	15.0	6.8	19.6	7.5	20.7	2.8	5.7	3.4	1.5	6.1	2.1	1.8	1.6	1.7	3.4	2.0	1.0	2.4	6.3	1.4	6.3	2.1	1.5	2.3	24.2	26.8	28.1	27.6	22.3	26.6	29.5	23.1	29.9	22.9	23.8	17.1	3.9	4.2	5.7	15.8	20.6	25.5	13.4	12.5	15.7	37.3	11.3	0.0	11.0	5.3	9.0	11.9	0.0	15.2	14.5	12.6	12.8	5.8	11.5	13.2	17.5	9.2	24.5	18.1	4.9	17.5	8.3	13.5	13.6	17.2	12.0	17.7	10.5	18.0	6.1	15.2	0.0	8.9	11.7	9.5	9.5	22.3	6.5	13.2	7.3
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172578-130237304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.65e-1)"	5.8	12.6	76.8	7.9	56.6	4.6	2.8	18.6	66.2	7.7	20.1	6.4	5.0	3.6	12.6	4.1	24.9	13.5	8.7	4.6	74.3	25.7	8.7	1.6	2.5	1.6	20.6	28.1	4.6	3.5	1.5	2.7	1.6	17.7	14.9	6.8	4.2	5.3	41.6	0.9	10.0	4.3	34.3	6.8	1.1	5.1	2.2	7.1	0.0	20.1	0.7	2.7	16.4	4.6	0.0	0.0	0.0	0.0	0.0	1.2	0.1	7.8	16.0	8.3	16.6	5.2	11.7	4.0	20.3	9.4	15.6	10.4	7.6	4.0	0.0	7.4	25.6	18.3	14.2	13.5	17.8	7.0	23.2	4.1	0.0	10.6	8.1	8.0	0.7	9.8	13.6	9.1	17.6	11.2	13.9	14.7	3.1	5.7	0.1	22.5	22.6	1.4	7.8	12.7	4.2	6.7	0.0	26.3	5.4	15.2	5.0	22.0	20.7	12.5	6.0	12.0	6.6	11.1	5.0	11.5	30.3	24.7	24.3	26.0	0.0	0.0	0.0	35.4	2.2	32.6	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	76.8	56.6	18.6	59.9	74.3	25.7	20.6	28.1	17.7	7.1	0.0	0.0	0.0	8.5	8.7	2.7	3.6	0.0	5.3	7.9	10.4	3.9	0.0	5.0	6.6	0.3	0.0	0.0	0.0	2.5	1.5	7.1	4.5	3.5	0.0	3.6	106.5	1.2	1.3	0.0	0.0	1.1	2.3	5.0	17.2	0.5	18.7	4.9	0.0	1.4	12.4	3.1	0.0	20.2	0.0	0.9	6.0	0.5	0.0	0.0	2.6
HMCN2	"DKFZp434P0216, FLJ23816"	ENSG00000148357	"Hemicentin 2"	Q8NDA2	9	130265882-130434123	"Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 15.6;Enterocytes: 21.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.2;RH-30: 19.2;SCLC-21H: 2.8;SH-SY5Y: 4.5;U-138 MG: 3.2;U-87 MG: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053903, HPA070647"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		7700000	Vesicles		"HPA053903: AB_2682301, HPA070647: AB_2686290"	"unprognostic (1.61e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (8.63e-2)"	7.4	1.7	0.2	10.2	0.2	0.1	3.8	0.1	0.4	18.3	25.0	0.0	1.0	5.9	21.9	25.1	4.9	5.1	5.0	8.7	0.4	0.4	1.4	0.4	2.7	2.3	0.0	0.0	8.9	0.8	0.2	0.1	0.3	0.8	5.1	2.3	0.1	1.7	3.4	24.3	2.8	11.2	20.8	0.5	0.3	2.3	6.3	0.0	1.8	2.6	10.9	1.5	12.1	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	19.2	0.1	0.0	0.1	2.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.4	0.4	0.0	0.0	0.8	0.0	3.0	6.9	0.5	0.2	0.8	0.5	3.6	0.0	6.7	6.8	0.0	0.0	0.0	1.7	0.0	15.6	1.3	21.5	0.0	0.0	0.1	2.4	0.7	7.0	1.1	0.3	1.6	0.0	0.6	0.3	8.0	0.0	0.9	1.7	0.0	1.9	0.0	0.1	7.0	0.0	1.1	0.6	0.0	3.8	0.2	0.7	0.5	0.2	0.0	2.9	3.3
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.7	1.1	1.3	2.2	8.9	22.7	4.3	14.0	87.4	2.8	8.5	5.0	3.3	0.0	9.5	28.9	0.8	82.8	5.8	0.5	1.9	2.0	2.6	0.0	1.8	12.8	31.0	1.7	0.1	15.0	80.5	4.5	8.1	0.0	0.1	37.6	0.4	52.2	2.8	58.1	0.6	24.5	1.8	60.2	2.6	0.1	1.5	134.1	7.6	5.8	33.8	0.5	50.0	52.7	3.9	5.4	36.2	100.4	0.0	1.1	7.0	0.2	1.2	8.7	8.3	2.9	22.0	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2	23.8	25.8	33.7	45.3	62.6	0.0	5.0	94.3	20.1	50.0	45.4	0.0	159.6	112.7	79.7	0.8	23.2	457.5	0.0	98.3	5.0	15.7	85.0	5.7	809.9	12.7	0.0	11.5	35.0	18.0	2.7	28.7	2.6	3.3	2.8	129.1	4.8	73.5	143.8	117.4	889.6	0.3	0.0	10.8	1.1	2.0	15.3	120.5	12.5	77.1	385.2
FUBP3	FBP3	ENSG00000107164	"Far upstream element binding protein 3"	Q96I24	9	130578965-130638352	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047658, HPA058392"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		6200	Nucleoplasm	Cytosol	"HPA047658: AB_2680114, HPA058392: AB_2683703"	"unprognostic (1.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (3.12e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.23e-2)"	26.6	24.1	24.3	18.5	24.3	10.5	21.8	23.9	30.3	22.8	24.0	37.7	22.9	19.9	32.7	20.7	24.2	22.1	25.4	24.3	24.6	20.0	22.4	37.6	19.9	18.7	27.4	22.8	25.2	27.7	36.6	23.8	33.8	23.9	26.1	20.4	21.9	26.1	25.3	15.2	22.0	20.5	26.9	30.0	20.2	22.0	30.0	27.5	26.4	39.9	18.1	20.1	23.2	22.9	4.5	5.6	2.1	4.5	7.3	6.9	3.0	20.8	19.2	28.1	23.1	20.3	23.1	35.6	29.9	26.8	24.2	18.8	27.7	19.3	20.2	15.8	28.3	21.4	36.4	23.6	25.4	28.8	22.3	20.2	22.4	30.6	20.3	27.8	33.6	25.3	22.3	20.5	25.4	24.0	20.3	19.7	16.9	35.5	12.6	25.0	28.0	25.9	17.1	36.1	32.9	24.6	23.2	35.0	27.1	21.2	22.1	18.7	30.9	31.8	23.6	19.5	22.1	32.4	25.6	25.0	43.9	20.9	29.5	34.6	11.6	19.1	26.3	24.5	14.6	31.2	0.0	3.7	2.1	4.7	4.5	6.9	4.5	5.1	5.6	5.6	3.3	5.9	5.1	1.0	7.3	3.5	4.9	4.0	3.0	24.3	24.3	23.9	23.7	24.6	20.0	27.4	22.8	23.9	27.5	17.9	19.4	18.0	17.5	29.8	22.5	16.5	25.5	21.4	12.5	15.7	13.7	24.3	24.9	18.3	3.2	20.4	13.2	0.0	16.5	25.4	24.2	24.1	7.0	48.6	22.9	30.2	20.8	30.1	22.9	7.2	19.0	17.2	35.4	16.2	18.9	52.7	20.0	17.3	26.2	29.5	27.4	12.9	30.9	14.3	10.4	35.8	38.3	15.4	15.5	22.6
PRDM12		ENSG00000130711	"PR/SET domain 12"	Q9H4Q4	9	130664594-130682981	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"brain: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"RH-30: 19.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 11.2"	"Group enriched"	"Detected in some"	33	"basal ganglia: 6.1;hypothalamus: 2.0"	HPA043143	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043143: AB_10806379"	"unprognostic (3.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.81e-4)"	"unprognostic (7.90e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.01e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.30e-4)"	"unprognostic (1.40e-1)"	0.1	0.7	1.0	0.3	1.5	0.0	0.1	1.1	2.2	0.0	0.1			0.3	0.0	0.9	0.0	0.0	0.0	0.0	1.0	3.7	0.0	0.2	0.0	0.0	0.5		0.0	0.8	0.1	0.2	0.0		0.0	0.3		0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.7			0.0		0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.3	0.2	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.9	0.0	0.8	0.0	0.1	0.1	0.0	19.4	0.5	0.0	0.0	0.9	0.3	0.4	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021756: AB_2670809, HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.6	27.9	16.7	14.8	6.0	6.8	12.2	20.5	9.9	20.5	15.9	22.5	11.9	27.2	11.2	11.0	22.6	25.0	26.7	20.4	22.8	16.1	13.0	21.7	27.4	15.6	11.4	32.7	14.4	8.7	7.7	28.8	33.7	7.5	14.5	18.3	23.6	11.8	14.2	24.2	23.0	9.1	20.7	37.4	18.1	18.2	30.7	29.6	9.6	12.7	10.3	11.5	23.9	18.3	10.8	12.2	19.0	11.8	8.9	20.3	15.8	18.0	28.9	6.1	23.8	41.2	14.5	19.1	15.8	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6	6.0	18.6	18.5	10.3	9.4	12.8	7.4	2.5	9.4	5.7	3.5	5.9	14.1	5.0	10.0	1.0	6.8	3.6	0.0	9.8	17.2	9.3	5.7	12.7	8.6	11.5	4.8	1.2	7.4	3.8	0.2	7.8	8.0	6.8	4.6	6.4	10.4	7.3	0.0	7.4	8.7	12.5	6.5	10.8	4.2	13.5	7.3	7.0	10.2	10.5	7.1
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	20.1	11.6	12.4	15.0	18.1	10.7	22.0	6.7	16.0	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18.0	10.8	14.2	17.0	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5.0	2.4	2.6	1.6	7.2	16.1	17.2	20.8	25.3	30.9	6.3	12.7	19.9	14.9	12.6	12.6	9.4	11.9	7.3	16.8	15.3	14.0	8.7	11.7	11.0	7.4	5.4	7.8	27.4	10.7	17.3	11.9	10.9	22.5	12.9	26.6	16.5	20.8	20.6	15.4	43.5	9.5	18.1	13.7	15.1	9.8	19.1	11.3	11.9	17.5	22.3	12.8	15.1	8.5	16.1	20.1	21.3	8.3	10.2	10.5	16.2	11.0	23.6	57.2	14.8	21.8	19.9	2.9	6.8	15.9	23.5	9.9	18.1	0.2	2.1	1.1	2.0	1.2	2.6	3.1	2.0	1.9	2.0	1.4	1.9	1.7	0.2	2.4	5.0	3.1	0.9	1.6	12.4	18.1	6.7	16.0	10.3	8.4	24.1	9.4	17.1	21.2	8.9	9.9	4.2	6.4	8.1	6.2	5.8	12.7	5.3	5.7	14.0	11.8	11.3	1.7	12.6	3.1	14.3	15.4	0.0	9.5	3.5	27.8	8.1	2.3	13.4	13.7	9.5	21.2	20.3	13.7	7.4	25.9	6.5	5.0	3.6	15.7	15.7	14.3	20.3	24.1	8.4	9.7	19.4	21.0	11.9	13.6	5.9	12.7	7.9	19.1	6.4
QRFP	"26RFa, P518"	ENSG00000188710	"Pyroglutamylated RFamide peptide"	P83859	9	130892702-130896812	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	20	"Alveolar cells type 1: 3.0"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	10	"classical monocyte: 1.8;intermediate monocyte: 3.3;non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 7.5"	"Region enriched"	"Detected in single"	18	"hypothalamus: 1.0"	"Low region specificity"	"Detected in all"			HPA043377	Uncertain				"Secreted in other tissues"	NA	NA					"HPA043377: AB_10959754"	"unprognostic (1.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-3)"	"unprognostic (4.14e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.04e-3)"	0.9	0.3	0.0	0.9	0.1	0.6	0.3	0.0	0.4	1.4	3.7			0.7	1.1	0.0	4.2	0.8	1.1	0.5	0.1	0.2	0.4	0.0	0.5	0.4	0.0		1.0	4.9	0.0	1.8	0.4		3.2	0.2		0.3	0.0	0.4	0.7	1.3	0.0	0.2	0.2	1.7	1.8			1.1		0.0	3.0	1.0	0.0	0.0	0.0	3.3	0.0	0.2	0.5	1.3	0.7	0.5	3.3	0.0	0.0	1.7	1.3	0.0	0.0	0.0	2.1	0.8	0.5	0.5	0.0	2.1	0.5	0.0	0.0	0.0	0.2	0.4	0.1	1.8	1.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	2.7	0.0	0.0	4.4	0.5	3.0	2.9	0.4	0.4	3.1	1.9	1.3	0.0	1.1	1.1	1.4	1.1	0.4	1.3	1.0	1.8	1.0	0.4	7.5	1.9	3.0	3.5	0.3	1.2	1.5	1.3	0.9	3.8	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5											3.0	0.6	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.2	2.3	0.8	0.0	0.0	0.0	0.0	5.0	5.9	0.3	0.8	0.0	2.5	0.0	1.8	0.2	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	0.2	0.0	0.1	2.7	0.0	9.4	0.0	0.0	0.6	0.0	0.0	21.2	0.0	2.2	1.5	15.0	0.5	0.0	4.4	0.3	16.5	0.0	0.1	0.0	0.7	0.0	0.5	0.7	1.3	8.2	0.0	0.9	11.3	0.1	9.2	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	7.7	0.0	0.3	14.5	0.1	4.7	0.0	27.4	0.4	1.8	0.7	0.0	0.0	0.9	3.2	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	12.2	0.8	16.7	3.5	3.2	0.0	0.1	0.0	0.3	1.1	15.1	0.0	3.3	0.0	4.7	1.7
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009082-131094473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.8;testis: 32.5"	"Group enriched"	"Detected in some"	5	"Leydig cells: 109.6;Peritubular cells: 342.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;EFO-21: 20.5;Hep G2: 7.4;SiHa: 7.6;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022814	Enhanced				"Secreted to extracellular matrix"	NA	NA		240000			"HPA022814: AB_2670960"	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.3	9.5	1.0	0.9	2.0	0.6	1.6	0.8	3.0	23.5	1.3	2.4	2.2	1.0	6.0	5.1	1.2	1.2	9.1	0.9	1.4	1.0	8.8	3.7	15.6	0.6	1.7	2.1	1.3	3.3	0.9	8.8	50.8	3.6	7.0	0.7	7.5	1.8	4.9	0.7	6.2	0.6	10.7	1.9	17.0	1.0	32.5	0.8	0.0	1.1	2.4	0.5	13.8	12.4	0.7	0.2	1.7	0.3	0.3	0.8	0.1	0.0	0.7	5.2	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.5	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.8	7.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.5	0.1	7.6	0.0	3.3	0.6	0.0	0.6	0.0	0.0	6.4	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	1.2	0.3	0.3	0.2	0.0	0.2	0.7	0.5	0.1	0.2	0.4	0.8	0.5	1.7	0.3	0.1	0.2	0.5	0.1	1.0	2.0	0.8	3.0	1.4	1.0	1.7	2.1	3.6	0.8	0.0	0.0	0.0	0.0	6.1	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.8	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.6	36.3	0.0	0.0	0.0	1.3	0.0	0.0	3.7	0.0	3.4	109.6	0.0	10.1	0.0	0.0	0.0	0.1	0.0	342.3	0.0	0.0	45.3	6.6	0.6	3.2	3.9	0.8	0.0	0.0	0.0
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 128.9;lymphoid tissue: 92.1"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 338.5;Distal tubular cells: 245.4;Extravillous trophoblasts: 271.1;Proximal tubular cells: 142.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"AF22: 35.3;MCF7: 23.2;NTERA-2: 26.5;RPTEC TERT1: 76.2;SuSa: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced					NA	NA					"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	20.5	3.1	31.4	3.3	35.4	2.2	17.4	7.7	24.9	7.6	3.6	42.9	42.1	1.9	5.5	6.1	28.2	6.3	5.1	10.4	36.9	22.4	128.9	1.9	7.0	2.0	45.3	12.4	2.9	3.4	13.2	5.5	12.4	27.3	3.4	4.0	5.9	15.2	39.4	7.4	7.4	2.6	6.1	59.9	92.1	2.8	4.2	25.4	0.0	45.0	7.7	5.2	5.8	6.9	0.1	0.0	0.0	0.0	1.8	0.4	0.2	0.1	0.5	35.3	6.1	0.0	0.0	14.7	0.0	0.0	0.0	0.0	6.3	2.7	0.0	16.0	0.0	0.7	3.3	5.2	0.3	0.2	0.0	6.8	3.5	1.8	12.5	0.0	0.0	1.8	0.3	1.6	0.1	0.1	0.1	1.6	9.6	2.3	0.0	0.0	23.2	2.1	0.4	26.5	2.1	2.4	0.0	0.4	9.7	76.2	2.0	13.4	2.2	1.8	15.0	4.9	21.9	14.2	0.2	0.2	0.9	2.6	0.1	7.2	0.1	0.1	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	31.4	35.4	7.7	24.9	36.9	22.4	45.3	12.4	27.3	25.4	0.0	0.0	0.0	1.8	3.7	0.0	3.9	0.0	0.0	2.3	338.5	0.0	2.9	245.4	1.6	1.1	17.3	0.0	0.0	0.7	271.1	15.3	4.2	0.0	0.0	6.2	0.0	3.5	17.8	0.3	1.7	34.8	0.8	64.1	0.0	1.9	14.5	4.7	0.0	55.5	142.6	0.0	0.0	4.1	0.3	2.3	2.0	17.6	0.0	1.1	1.4
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Cell line enhanced"	"Detected in all"		"K-562: 73.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA		100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: AB_2680521"	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.8	9.8	8.4	5.0	6.8	6.6	8.8	6.1	6.3	8.0	6.5	8.0	5.0	11.1	4.9	8.4	8.3	15.7	11.3	8.0	7.8	8.0	5.5	6.9	14.0	15.6	6.0	10.8	7.5	7.1	7.4	10.2	8.3	5.1	8.1	7.4	73.0	6.4	8.2	12.8	14.2	16.4	9.1	9.9	8.6	5.0	10.6	11.1	9.2	6.3	7.1	7.4	10.2	9.4	5.3	6.3	12.4	27.0	7.0	14.1	7.9	9.2	9.9	5.6	10.9	10.8	6.9	6.5	8.5	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3	17.9	19.9	15.2	9.5	7.7	29.6	24.0	15.3	16.0	15.9	22.7	43.2	10.9	8.3	9.1	225.7	14.6	13.6	0.0	13.1	9.3	11.4	11.4	8.1	11.9	75.5	15.9	19.5	18.4	255.0	282.5	21.6	77.0	10.1	15.4	14.3	14.8	12.0	5.8	19.1	6.7	31.6	6.5	8.1	90.1	44.5	9.5	9.2	11.8	16.3	9.3
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.6	0.8	0.2	18.5	0.2	0.1	0.2	0.1	0.1	0.1	7.7	0.1	0.1	0.3	0.0	7.4	0.1	0.0	1.9	0.6	17.4	0.2	0.1	0.3	17.2	0.8	0.2	0.4	0.0	0.0	0.2	10.3	5.0	6.1	2.2	0.2	2.6	0.7	27.2	1.2	0.1	0.3	1.8	1.1	10.7	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.4	0.6	24.3	0.3	1.1	1.2	0.6	0.0	1.6	0.8	4.4	0.1	16.3	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4	0.0	1.0	24.3	0.0	0.8	57.8	12.8	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	73.4	3.1	0.0	0.0	0.0	28.2	1.3	0.0	1.1	0.0	22.1	0.0	0.0	3.7	14.3	101.2	4.6	10.1	1.7	5.4	0.0	0.8	0.2	0.0	3.2	0.0	1.7	0.0	0.5	1.2	0.4	0.6	1.1	14.4	0.0	0.1
PLPP7	"C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3"	ENSG00000160539	"Phospholipid phosphatase 7 (inactive)"	Q8NBV4	9	131289459-131359022	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.0;skeletal muscle: 107.3"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070252	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			Vesicles	Nucleoplasm	"HPA070252: AB_2686242"	"unprognostic (2.19e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.71e-1)"	"unprognostic (8.78e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.72e-3)"	3.6	3.7	3.3	1.7	4.6	1.2	2.8	7.7	8.2	2.3	3.2	4.6	0.0	1.5	2.5	3.1	2.5	2.0	2.3	29.0	3.6	3.9	1.9	1.1	1.5	1.3	3.7	4.2	3.9	1.8	1.1	1.7	1.4	3.7	2.6	1.3	2.0	1.6	2.6	107.3	1.3	1.6	2.9	3.2	1.7	1.4	2.2	3.2	0.0	1.2	22.6	1.2	2.1	1.6	1.3	4.6	0.0	5.2	2.3	0.5	1.9	0.0	0.0	2.2	11.0	11.6	8.8	2.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.3	4.4	2.5	0.0	0.2	0.0	0.1	0.0	1.9	0.0	0.1	3.5	2.9	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	11.3	8.7	0.0	0.1	0.0	0.3	0.3	2.7	0.1	0.1	0.8	0.5	0.0	0.0	0.4	0.0	1.9	0.0	1.7	0.0	5.2	0.0	0.0	3.3	0.0	1.0	0.0	0.0	4.6	1.3	0.4	0.5	0.0	2.3	2.8	2.0	0.0	1.9	3.3	4.6	7.7	8.2	3.6	3.9	3.7	4.2	3.7	3.2	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	1.8	2.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.5	7.9	0.0	1.8	0.8	1.3	4.6	0.4	0.0	0.0	0.0	2.3	0.4	0.0	3.5	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRRC2B	"BAT2L, BAT2L1, KIAA0515, LQFBS-1, MGC10526"	ENSG00000130723	"Proline rich coiled-coil 2B"	Q5JSZ5	9	131373636-131500197	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021022, HPA064301"	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA021022: AB_1852324, HPA064301: AB_2685237"	"unprognostic (4.78e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.42e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-2)"	27.4	29.1	43.3	30.3	44.1	30.3	22.1	54.6	56.3	29.4	26.3	32.7	27.3	18.9	33.8	19.7	35.7	36.1	27.5	28.0	39.0	34.1	24.7	18.1	22.5	31.8	26.8	36.8	51.4	30.2	42.0	35.5	23.6	28.9	28.2	15.1	31.8	23.0	29.9	29.4	42.4	23.0	27.2	21.4	27.4	22.2	21.9	26.9	28.1	29.9	18.3	28.1	26.0	29.5	10.3	6.9	4.1	4.5	5.8	7.4	3.0	17.8	34.6	37.0	25.6	28.3	29.2	37.0	18.1	17.7	21.1	17.5	32.4	15.2	30.9	21.4	20.7	24.0	43.0	36.9	15.4	16.0	31.7	19.9	19.2	60.9	14.2	19.1	25.5	25.5	28.6	20.4	22.8	26.6	21.2	24.4	12.4	34.8	23.1	18.9	37.4	21.3	16.5	26.9	17.9	14.2	41.3	37.7	29.7	15.3	28.0	50.0	31.4	43.8	26.7	18.2	24.5	54.1	15.8	35.2	47.4	22.0	20.9	23.6	10.2	25.4	41.5	16.6	13.8	23.4	4.1	4.5	2.7	7.4	1.9	5.5	5.5	4.4	6.6	2.3	10.3	7.2	6.3	3.2	5.8	1.1	6.9	3.6	3.0	43.3	44.1	54.6	54.7	39.0	34.1	26.8	36.8	28.9	26.9	26.8	34.8	28.7	29.5	37.2	106.8	8.4	40.8	36.1	40.9	54.1	72.6	26.9	1.7	29.1	7.3	39.4	18.8	0.0	26.2	28.6	31.7	42.9	26.6	34.7	23.4	138.2	59.8	41.7	40.8	7.8	55.5	20.7	27.0	32.5	26.8	32.1	30.4	14.4	50.2	17.4	66.0	25.8	34.8	7.7	14.5	37.1	19.5	37.3	30.7	40.7
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502902-131523806	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.7;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	9.5	12.3	21.6	10.6	18.8	10.2	10.2	34.2	22.4	10.0	12.1	16.9	14.6	11.2	15.0	14.6	8.8	14.6	13.0	15.2	25.8	17.9	13.8	12.8	10.6	13.2	15.0	16.5	17.2	16.9	17.1	18.0	12.9	15.2	16.0	11.6	13.3	19.5	17.1	28.2	16.6	11.9	12.1	13.4	12.3	10.7	49.9	13.4	8.7	11.6	5.5	11.0	7.8	9.5	2.8	5.1	3.4	3.8	3.8	10.8	4.9	6.7	10.8	9.9	16.6	12.7	10.3	17.8	7.8	9.7	12.5	8.6	11.4	9.5	2.1	9.5	18.0	5.7	15.3	12.1	8.5	6.6	11.1	17.2	3.9	25.5	7.9	15.0	10.0	8.7	7.2	7.7	8.3	2.8	14.8	10.8	13.8	6.8	11.5	12.5	18.0	9.4	22.9	5.7	5.6	13.6	10.9	9.3	16.1	11.0	2.0	11.2	9.9	13.3	15.5	7.8	6.7	22.7	10.1	11.7	9.9	2.1	17.9	6.6	7.2	6.2	3.5	5.9	18.8	8.1	0.0	3.8	3.4	7.4	3.6	10.8	2.8	7.2	7.4	5.1	2.7	6.7	5.5	0.5	3.8	3.3	3.1	7.6	4.9	21.6	18.8	34.2	22.4	25.8	17.9	15.0	16.5	15.2	13.4	8.9	20.2	7.3	4.8	3.9	11.9	8.5	10.2	4.0	6.8	12.2	7.9	18.5	1.7	9.9	49.7	7.1	12.3	0.0	5.8	10.1	7.1	5.3	2.3	9.7	9.1	20.6	7.5	6.7	5.3	24.3	8.1	5.7	5.0	10.0	8.2	14.1	7.3	3.5	9.6	9.0	16.9	6.5	6.0	57.0	7.9	2.6	14.6	6.9	8.0	2.0
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
PRRT1B	IFITMD8	ENSG00000283526	"Proline rich transmembrane protein 1B"		9	131545514-131558620	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.0;lung: 16.0;pancreas: 7.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A549: 16.0;BEWO: 10.7;MCF7: 4.2;T-47d: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA																							0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.5	4.7	0.0	0.0	0.3	0.6	1.0	0.0	9.0	3.9	0.0	0.0		1.3	6.1	16.0	0.0	0.0	0.0	1.7	7.6	1.7	0.0	0.1	0.1	3.4	2.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 123.9;monocytes: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	16.2	10.8	18.4	21.5	28.0	19.7	18.5	21.8	19.5	9.6	11.5	13.7	6.0	10.1	11.1	6.9	10.3	11.4	10.2	21.5	17.4	16.0	9.4	9.7	16.9	21.7	13.1	10.2	7.4	24.1	9.0	7.3	28.5	13.5	9.0	10.3	16.8	8.5	10.0	83.3	9.2	13.7	13.2	13.0	16.7	12.0	6.8	11.6	12.4	9.9	8.8	25.9	11.3	12.0	9.2	2.9	5.3	3.9	2.0	6.5	2.3	10.6	12.4	12.6	12.7	12.9	14.0	48.4	9.2	18.9	10.7	7.7	15.4	7.0	19.3	11.6	18.5	23.0	19.5	14.4	12.8	5.4	44.7	5.9	5.6	20.8	8.1	10.9	23.3	26.1	10.6	23.6	14.0	16.7	10.8	19.3	22.5	15.1	38.3	13.8	11.1	16.4	8.3	12.7	10.6	11.3	16.4	29.4	26.8	4.9	12.9	10.7	10.7	13.4	12.8	13.4	13.2	12.2	19.7	20.3	28.8	12.1	18.2	14.0	12.9	11.2	38.1	13.7	10.0	6.9	5.3	2.0	2.6	6.5	3.8	3.7	9.2	4.2	4.2	2.4	5.3	1.1	2.9	2.3	2.0	3.9	2.9	3.0	2.3	18.4	28.0	21.8	18.5	17.4	16.0	13.1	10.2	13.5	11.6	6.0	17.3	13.3	8.3	16.7	18.8	12.5	22.9	20.1	14.8	5.2	13.7	16.3	5.0	6.8	2.1	30.2	16.8	0.0	15.9	28.3	7.6	9.5	19.7	11.3	25.1	123.9	11.6	22.1	24.1	1.5	8.1	48.3	30.4	83.8	12.0	19.1	15.1	14.4	11.3	7.0	13.2	6.5	7.2	4.4	10.7	9.9	43.3	23.5	10.2	10.2
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131860107-132079908	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	11.1	12.1	18.0	9.5	18.1	15.5	11.5	14.0	21.4	10.9	11.7	19.5	10.1	7.8	18.6	23.5	15.5	13.9	9.5	17.5	17.5	11.2	10.4	7.5	10.9	13.5	18.6	19.1	12.7	7.9	10.6	17.8	12.7	17.4	12.7	10.7	16.0	17.7	14.4	15.2	15.7	8.6	16.3	16.1	11.7	10.2	14.7	14.0	17.9	13.2	9.6	15.8	12.3	10.5	12.9	19.8	13.4	18.6	18.0	19.7	11.8	16.1	15.9	18.4	14.6	13.2	12.2	15.5	16.8	22.4	33.8	26.5	23.8	13.1	16.0	11.4	17.5	22.6	29.4	25.4	23.9	22.2	17.2	15.0	12.0	16.7	14.1	19.8	21.5	15.2	13.4	16.5	26.6	27.3	10.7	17.6	23.5	17.5	13.4	24.6	25.7	23.1	12.5	18.7	15.9	27.1	20.4	26.0	19.6	13.6	9.0	34.4	13.9	21.7	11.2	11.2	12.3	17.8	10.1	14.7	34.4	15.1	25.4	25.3	5.4	16.6	28.4	19.1	15.0	23.4	3.5	12.2	13.4	18.9	18.6	15.3	11.6	14.8	18.5	19.2	12.9	12.7	15.5	4.8	18.0	16.0	19.8	19.7	11.8	18.0	18.1	14.0	21.4	17.5	11.2	18.6	19.1	17.4	14.0	14.9	8.5	3.0	11.2	5.4	24.5	5.9	5.1	6.7	10.3	12.2	17.7	28.2	11.6	13.9	12.9	10.6	2.1	0.0	14.5	17.3	8.9	5.1	10.4	4.9	15.2	20.6	5.1	5.5	3.7	5.4	13.3	8.8	6.8	11.8	4.2	23.3	12.9	0.0	15.9	6.0	17.8	6.5	8.3	20.7	22.2	4.4	45.8	10.2	4.7	10.7
NTNG2	"KIAA1857, Lmnt2, NTNG1"	ENSG00000196358	"Netrin G2"	Q96CW9	9	132161676-132244534	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.9;brain: 32.0"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 56.2;Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 109.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;HMC-1: 12.2;NB-4: 27.6;U-937: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065089, HPA071290"	Approved		Approved	"Plasma membrane,Cytokinetic bridge,Midbody ring"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Cytokinetic bridge, Midbody ring"	"HPA065089: AB_2732730, HPA071290: AB_2686381"	"unprognostic (5.01e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.62e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (9.30e-12)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	1.2	1.4	11.9	1.6	10.9	38.9	0.6	4.4	32.0	1.0	0.8	11.5	0.2	1.8	0.7	0.9	0.8	0.7	1.4	4.6	11.4	3.1	0.8	0.8	2.0	1.9	4.4	7.4	0.6	1.8	11.9	1.0	1.1	11.7	7.4	0.7	10.7	1.3	1.8	0.9	0.8	1.1	0.8	5.3	2.8	1.2	1.8	2.8	0.0	0.7	0.0	1.0	1.1	0.9	0.1	0.1	4.0	0.2	0.0	0.4	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.7	4.8	12.2	0.0	0.0	0.2	0.0	1.0	0.0	1.0	0.0	0.0	0.3	0.1	0.2	27.6	1.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	3.4	3.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.6	2.2	2.6	0.1	0.1	0.0	0.0	1.0	7.2	0.8	0.6	0.2	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.0	0.0	0.1	0.1	0.1	0.0	11.9	10.9	4.4	32.0	11.4	3.1	4.4	7.4	11.7	2.8	0.0	1.1	0.0	0.5	0.2	56.2	2.8	0.0	0.0	1.2	0.0	161.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	1.5	1.4	1.1	0.0	0.6	1.6	0.0	1.3	0.3	1.0	0.6	0.1	1.7	0.0	0.0	15.3	0.2	0.0	1.1	0.0	109.1	6.5	0.6	0.2	0.0	0.3	0.1	0.0	0.0	0.3
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354985	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA024105: AB_2671437, HPA057269: AB_2683389"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	20.3	12.3	13.0	23.5	15.0	14.0	16.1	16.7	14.8	14.7	16.0	11.2	14.5	9.9	18.3	15.2	13.2	17.5	12.3	13.8	13.0	8.3	12.5	15.8	18.5	23.5	19.8	12.6	15.8	11.0	24.0	24.6	13.4	16.9	13.8	12.6	8.6	16.2	16.1	18.4	15.2	19.4	16.9	20.6	25.7	13.2	34.5	18.1	26.3	31.6	10.8	24.0	18.8	16.3	8.0	5.5	16.9	5.0	5.3	6.5	2.3	9.1	12.3	14.2	15.3	18.3	22.3	8.5	12.2	13.7	9.9	9.3	12.9	10.5	15.6	6.0	22.7	24.4	18.8	14.2	10.5	10.9	14.8	6.1	16.3	13.8	11.2	17.2	25.0	19.9	15.6	16.6	16.9	15.1	12.2	15.9	11.1	18.9	12.6	11.4	13.2	15.4	9.6	15.2	15.5	9.6	14.7	20.6	10.4	11.0	12.0	8.9	13.6	20.1	8.9	11.1	19.7	12.3	12.9	18.1	20.8	9.0	13.9	11.6	7.7	13.0	24.2	9.5	10.0	11.1	7.7	4.9	4.8	6.1	4.5	6.5	6.2	4.6	4.6	3.6	8.0	5.0	4.3	16.9	5.3	5.0	5.5	3.4	2.3	13.0	15.0	16.7	14.8	13.0	8.3	19.8	12.6	16.9	18.1	56.6	43.7	27.4	25.9	26.9	29.3	49.2	20.4	54.9	56.9	19.2	27.5	11.5	3.3	17.7	5.9	43.4	27.4	0.0	12.7	8.9	28.8	33.6	55.6	30.4	24.7	63.5	13.9	58.3	69.1	10.9	28.4	39.3	11.8	16.2	27.3	24.6	20.3	19.8	33.9	18.0	28.0	12.9	22.7	47.4	38.0	29.4	7.9	39.9	17.1	38.1
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA054837: AB_2682621"	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	10.3	6.6	9.9	12.6	14.6	18.0	12.5	15.0	13.4	10.3	12.1	8.5	13.8	6.2	11.9	12.1	8.5	9.6	6.8	16.6	9.8	8.5	8.3	6.2	8.9	12.2	10.4	11.3	11.8	8.7	8.7	15.4	8.3	14.1	13.4	8.8	6.8	9.0	10.1	18.0	9.3	8.6	9.5	13.5	9.7	8.7	11.6	12.7	15.1	16.9	7.0	12.3	13.4	11.5	12.3	10.2	19.4	6.3	7.3	9.1	3.0	7.4	7.1	10.1	9.2	5.7	7.3	9.2	8.4	6.5	9.8	7.2	7.3	8.3	12.3	7.1	6.2	11.2	18.0	11.2	6.5	10.6	7.9	7.8	5.6	10.7	5.5	5.6	15.0	9.2	4.4	7.7	8.5	6.3	7.8	8.4	20.4	11.2	10.8	7.6	11.2	34.6	9.1	18.6	13.3	11.0	22.1	14.0	14.6	7.8	6.1	9.0	15.4	11.8	9.0	6.0	10.1	11.0	8.0	8.0	16.1	9.9	13.5	9.8	5.1	14.4	15.0	9.1	12.3	15.3	11.3	5.4	10.3	6.5	5.2	8.3	11.2	8.2	7.4	3.3	12.3	9.1	6.9	19.4	7.3	6.3	10.2	8.4	3.0	9.9	14.6	15.0	13.4	9.8	8.5	10.4	11.3	14.1	12.7	23.8	16.3	52.5	19.7	8.8	26.4	37.0	20.4	24.1	13.6	17.4	56.9	21.3	16.6	23.7	13.3	29.0	11.8	46.7	18.3	18.6	14.6	18.1	22.0	7.3	16.3	28.6	11.6	25.8	18.6	5.6	21.9	22.5	1.7	22.6	13.5	19.1	21.2	20.3	24.4	12.9	53.5	25.8	18.4	48.9	61.5	7.4	21.1	34.9	16.6	19.5
CFAP77	"C9orf171, FLJ46082"	ENSG00000188523	"Cilia and flagella associated protein 77"	Q6ZQR2	9	132410043-132573317	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 30.9;testis: 22.0"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 66.9;Early spermatids: 92.0;Late spermatids: 37.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.8;SH-SY5Y: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021329, HPA024647, HPA061069"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657"	"unprognostic (7.28e-4)"	"unprognostic (5.68e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.74e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	0.2	0.2	1.6	0.2	4.5	0.2	0.2	1.6	0.3	1.6	0.2	8.4	0.0	0.2	0.7	8.8	0.2	30.9	0.2	4.2	2.5	2.5	0.2	0.2	5.5	0.2	0.1	0.0	9.7	0.3	0.2	1.7	0.2	8.9	0.2	0.2	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	22.0	1.6	0.0	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.4	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.8	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	1.8	6.6	0.0	0.0	0.0	0.5	0.3	0.0	0.6	1.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.5	1.6	0.1	2.5	2.5	0.1	0.0	8.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	5.7	0.0	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.5	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.4	0.0	0.0	10.7	2.3	0.0	0.1	0.0	0.0	0.0
BARHL1		ENSG00000125492	"BarH like homeobox 1"	Q9BZE3	9	132582185-132590266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	44	"brain: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"cerebellum: 23.8;pons and medulla: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	105	"SCLC-21H: 19.8"	"Group enriched"	"Detected in some"	5	"cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 16.3"	HPA004809	Enhanced					NA	NA					"HPA004809: AB_1078266"					"unprognostic (2.29e-1)"					"unprognostic (6.42e-2)"	"unprognostic (8.07e-2)"			"unprognostic (9.31e-2)"				0.3	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.0	40.1	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.5	2.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	6.8	6.9	8.2	15.3	11.2	6.0	12.3	18.4	8.5	7.5	6.6	9.4	12.6	5.0	8.9	8.8	9.8	8.8	7.5	5.4	6.3	6.3	8.4	9.2	12.0	15.1	9.1	5.7	16.9	17.3	10.0	8.8	5.8	9.8	9.2	8.0	7.4	12.7	12.6	12.9	14.0	7.2	12.7	12.9	8.7	6.8	15.2	8.3	6.8	22.7	10.8	13.8	7.2	12.6	5.0	4.5	1.9	2.7	3.1	6.9	3.0	7.0	13.2	6.4	8.8	7.9	7.1	12.6	7.6	7.5	12.0	9.2	14.6	14.6	17.7	6.9	7.1	12.5	19.8	20.2	8.9	9.7	10.8	7.5	9.6	11.7	7.6	9.5	17.0	7.8	6.3	12.2	12.3	17.3	4.6	7.8	13.2	17.6	6.9	9.9	15.2	11.8	9.3	15.9	21.0	13.5	12.5	11.4	20.3	10.9	6.8	11.6	8.3	13.9	12.4	10.5	7.8	25.9	5.0	6.6	20.4	9.2	11.5	11.7	3.4	10.7	13.8	7.3	10.8	15.3	0.0	1.9	1.9	5.7	2.7	4.7	4.2	5.5	4.4	4.5	5.0	6.9	5.1	0.3	3.1	1.9	2.8	3.6	3.0	8.2	11.2	18.4	8.5	6.3	6.3	9.1	5.7	9.8	8.3	6.0	5.9	3.4	3.1	4.9	3.4	3.1	0.0	6.7	15.9	7.0	3.9	4.6	1.7	4.1	2.1	3.9	0.7	0.0	4.6	5.8	2.6	4.1	1.1	3.2	4.6	1.6	23.6	3.1	2.4	2.4	16.7	2.8	1.7	4.6	3.7	1.5	4.7	0.0	12.4	4.3	3.1	0.0	2.1	11.2	15.7	5.5	2.5	4.1	5.7	2.6
GTF3C4	"KAT12, TFIIIC90"	ENSG00000125484	"General transcription factor IIIC subunit 4"	Q9UKN8	9	132670035-132694955	"Enzymes, Predicted intracellular proteins"	Transcription	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069369			Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA069369: AB_2686130"	"unprognostic (7.02e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	6.9	8.5	12.3	6.6	11.6	7.8	11.6	23.8	13.9	10.8	8.0	7.0	5.6	5.3	10.2	9.3	11.4	9.5	7.4	7.8	8.7	8.1	8.7	7.4	8.9	10.9	9.4	11.6	15.0	8.4	16.6	10.1	9.7	8.9	8.9	7.7	7.6	11.3	8.4	11.6	14.5	6.6	8.6	5.6	6.3	8.1	16.9	6.4	11.6	13.3	5.3	9.3	8.8	7.9	2.3	2.1	1.5	1.5	2.1	3.1	0.9	8.5	12.2	15.5	13.3	7.7	9.1	11.2	8.2	10.9	11.7	8.6	14.9	6.4	13.3	5.6	10.7	10.9	19.8	23.7	13.5	13.0	8.0	9.8	11.2	17.6	6.3	7.6	16.5	7.1	7.0	10.3	12.0	15.7	7.1	10.0	8.9	18.2	6.8	8.4	14.0	10.1	7.7	19.7	13.0	11.9	10.0	18.9	11.7	8.6	7.2	21.6	14.6	14.8	15.0	9.1	10.1	20.9	6.8	10.4	19.4	10.9	8.8	12.3	2.8	6.4	14.8	8.2	10.4	11.9	0.1	1.5	1.2	2.5	1.3	2.0	2.3	2.2	3.1	1.2	2.2	2.3	2.4	1.5	2.1	1.2	2.1	2.0	0.9	12.3	11.6	23.8	13.9	8.7	8.1	9.4	11.6	8.9	6.4	17.9	8.6	7.8	6.7	27.2	15.0	11.2	2.5	18.7	6.8	3.5	13.7	6.2	6.6	7.2	4.8	9.0	3.5	0.0	5.4	6.0	11.5	9.1	1.1	7.8	5.4	19.1	12.6	7.4	7.3	2.1	17.5	4.6	3.3	2.8	7.4	11.3	5.8	7.0	18.0	5.6	16.9	0.0	7.6	15.1	12.6	35.0	5.4	6.1	8.0	4.6
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.8;fallopian tube: 17.7;testis: 15.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 81.9;Late spermatids: 93.2;monocytes: 85.6;Spermatocytes: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.9"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 5.3;RPTEC TERT1: 6.2;T-47d: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced					NA	NA					"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.5	0.7	1.3	0.5	2.2	0.0	0.5	1.6	1.3	1.6	0.5	0.5	0.5	0.0	1.1	12.8	0.5	17.7	0.7	0.5	1.3	2.0	1.4	0.5	1.1	0.5	1.2	0.5	0.9	0.5	2.5	1.7	1.5	2.3	0.5	0.0	0.9	1.0	1.8	0.5	1.1	0.5	0.5	1.7	0.5	0.3	15.6	0.5	0.5	3.1	0.5	0.5	0.5	0.5	0.1	0.0	0.0	0.0	3.9	0.5	0.0	2.0	1.0	0.6	3.1	0.4	0.8	0.6	0.3	0.2	0.2	0.0	0.4	2.2	0.0	0.7	0.3	0.8	0.5	0.3	0.0	0.1	0.1	0.7	0.0	0.2	0.0	1.3	0.0	0.0	1.9	0.9	0.3	0.6	0.6	0.2	1.8	0.1	0.0	0.5	5.3	1.5	0.4	0.2	0.9	0.6	0.0	0.0	0.0	6.2	0.0	1.1	1.2	2.6	0.0	0.4	0.6	4.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.3	2.2	1.6	1.0	1.3	2.0	1.2	0.5	2.3	0.5	3.0	1.7	0.0	0.5	0.5	0.2	0.8	0.0	10.7	2.3	3.5	0.0	0.4	0.0	1.9	81.9	0.5	0.0	0.0	0.5	0.4	0.7	0.5	0.0	0.0	1.5	0.0	0.0	0.0	0.3	93.2	5.8	0.8	1.7	85.6	0.7	0.6	1.0	0.0	3.9	4.4	1.7	0.0	0.5	23.3	5.7	1.4	0.3	0.0	0.6	0.5
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"epididymis: 55.8;fallopian tube: 29.1;testis: 53.8"	"Cell type enriched"	"Detected in some"	4	"Ciliated cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"JURKAT: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	2.7	6.0	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7.0	7.0	8.9	7.0	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3.0	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8.0	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3.0	2.9	3.8	6.0	3.0	5.6	3.3	7.8	3.5	1.6	1.9	2.1	3.2	2.7	4.6	5.9	3.9	1.2	2.3	1.7	1.9	0.5	6.1	0.5	2.9	5.7	3.7	2.8	1.3	3.6	1.6	2.3	2.6	0.5	1.5	0.7	6.7	1.4	0.2	6.7	7.7	4.3	4.8	7.3	2.0	32.5	0.5	1.7	4.7	4.2	4.9	5.6	0.7	3.7	2.0	2.3	0.7	1.4	7.1	0.7	0.9	3.2	5.3	0.9	4.2	2.5	7.0	0.5	1.9	3.8	2.6	3.6	0.5	0.7	1.1	1.7	7.0	0.5	1.8	5.6	2.2	3.6	2.2	2.0	2.5	6.0	2.4	1.3	3.0	4.7	2.9	2.6	3.1	7.8	3.3	1.0	3.5	1.6	7.8	8.4	4.3	9.3	7.0	8.9	7.2	7.3	6.9	5.1	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	116.4	9.1	22.7	0.0	14.2	28.2	6.2	0.0	0.0	0.0	0.0	6.2	10.9	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.4	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 99.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	10.4	13.6	15.8	8.8	26.8	13.6	11.4	32.1	28.3	12.7	10.8	22.6	7.9	9.1	14.6	12.3	10.9	12.4	9.7	17.6	13.0	12.1	13.1	9.4	11.6	10.2	12.5	15.1	21.2	12.1	15.9	19.5	15.8	21.1	11.8	12.6	13.1	11.6	10.4	20.0	13.8	11.2	14.2	12.4	13.7	10.6	36.2	14.9	10.5	16.2	8.6	14.2	10.9	11.1	2.8	3.1	4.8	7.0	4.9	7.1	2.6	6.2	7.4	10.1	8.3	10.4	9.9	19.0	8.4	13.6	8.8	8.7	12.5	7.3	14.6	3.7	16.0	13.4	16.2	11.9	8.5	9.0	7.0	6.3	4.6	14.7	10.2	12.4	6.8	6.3	10.7	6.4	11.2	13.8	8.8	10.1	13.0	8.1	8.0	10.0	11.5	6.1	5.8	13.9	9.2	6.2	7.4	19.1	8.2	3.9	8.2	5.1	7.8	9.8	6.1	4.8	12.5	11.1	4.0	10.4	14.4	8.7	8.6	5.7	4.5	10.0	14.2	8.2	4.0	6.4	4.1	4.4	4.8	6.5	7.0	7.1	1.9	3.6	5.7	3.1	2.8	5.9	5.3	1.7	4.9	3.2	1.8	5.7	2.6	15.8	26.8	32.1	28.3	13.0	12.1	12.5	15.1	21.1	14.9	20.8	25.6	10.8	4.8	6.6	26.0	26.6	7.6	21.4	12.5	10.4	35.3	12.8	11.6	9.5	39.6	8.7	6.3	0.0	6.2	19.5	9.1	6.5	8.1	5.0	7.8	23.8	16.1	12.3	8.7	99.6	14.4	7.4	11.8	8.2	7.9	10.4	10.9	8.4	10.6	7.5	25.2	19.4	8.0	18.9	17.8	7.5	17.6	7.1	9.9	6.5
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 71.0;bone marrow: 29.2"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 70.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"basophil: 31.2;eosinophil: 71.0"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 71.0"	"Group enriched"	"Detected in some"	5	"HEL: 55.6;HMC-1: 36.0;K-562: 17.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.2	0.0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0.0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0.0	0.1	0.0	0.1	0.2	0.0	0.1	1.2	0.0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1.0	0.2	3.3	0.3	4.0	0.0	1.0	0.2	0.0	0.5	0.4	0.2	0.0	0.3	71.0	2.7	0.1	0.1	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	7.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	55.6	0.1	0.0	0.0	0.0	36.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	31.2	0.0	71.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.1	2.7	0.1	0.0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	70.0	0.0	0.1	0.0	0.5	13.9	0.0	0.1	0.0	1.2	0.0	0.8	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.3	0.1
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	21.2	24.6	20.1	18.2	30.4	33.3	21.8	38.7	30.6	21.9	25.0	39.6	20.6	24.7	23.1	21.9	28.0	25.7	16.2	24.5	20.8	17.3	20.9	25.1	18.8	23.1	31.9	19.9	41.3	24.6	24.4	26.0	24.9	22.7	24.0	18.5	21.3	26.4	20.1	36.7	31.2	23.6	20.6	23.0	23.9	20.4	24.2	30.8	43.5	22.1	29.3	29.2	19.5	22.5	11.2	12.0	28.4	13.2	13.8	17.0	11.5	11.7	22.0	19.2	17.9	10.5	9.1	25.6	11.5	13.0	22.2	15.7	23.1	19.6	19.8	10.9	12.7	17.9	28.8	22.9	20.8	12.6	20.1	19.0	22.6	25.2	21.3	16.1	18.4	48.7	12.8	13.9	23.3	16.2	10.9	19.5	65.7	29.2	19.5	11.5	39.3	29.4	25.6	24.9	27.4	22.1	31.2	19.2	25.0	14.6	13.8	23.0	17.0	19.0	21.1	12.1	12.2	27.0	26.3	11.9	26.7	20.7	16.4	19.0	7.5	15.2	21.5	13.3	13.6	18.0	28.4	11.0	14.9	11.8	13.2	17.0	11.2	12.2	15.3	12.0	10.8	14.0	12.4	6.6	13.8	10.7	11.6	13.4	11.5	20.1	30.4	38.7	30.6	20.8	17.3	31.9	19.9	22.7	30.8	8.9	14.7	20.4	14.8	11.0	14.4	27.1	7.6	10.7	13.6	15.7	7.9	34.8	24.9	20.8	3.0	14.3	26.2	23.3	26.2	32.0	16.6	10.9	16.1	15.3	19.8	14.3	13.8	20.9	15.5	3.6	16.1	10.8	15.1	16.2	14.6	20.6	22.9	23.0	20.1	10.2	17.1	45.3	15.6	17.2	28.4	14.4	34.8	19.1	21.2	15.3
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
RALGDS	"RalGEF, RGDS, RGF"	ENSG00000160271	"Ral guanine nucleotide dissociation stimulator"	Q12967	9	133097720-133149334	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 88.7;Urothelial cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 16.7;MAIT T-cell: 6.6;memory CD4 T-cell: 7.6;memory CD8 T-cell: 12.0;naive CD8 T-cell: 6.5;NK-cell: 5.7;T-reg: 13.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 5.7;T-cells: 16.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 53.1;SH-SY5Y: 33.7"									"HPA025961, CAB032582"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB032582: AB_2238105, HPA025961: AB_2671795"	"unprognostic (1.01e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.35e-2)"	"unprognostic (7.92e-3)"	"unprognostic (8.20e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.91e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.03e-2)"	"unprognostic (9.54e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	18.9	19.8	28.2	14.5	43.2	26.3	16.8	33.1	38.1	14.8	11.1	43.6	12.8	13.0	10.3	10.4	28.7	18.8	23.9	18.7	30.4	23.0	6.3	5.7	19.9	18.8	45.6	19.2	26.6	17.4	11.5	31.8	8.2	38.0	11.8	8.0	8.0	21.6	16.7	13.1	24.8	15.3	10.6	44.3	13.4	13.3	3.8	48.0	5.5	12.2	14.5	13.6	17.1	12.7	1.1	0.5	1.3	0.4	5.7	16.7	3.5	2.6	3.8	8.1	10.0	3.1	4.5	6.8	3.1	4.7	3.2	2.1	3.3	5.7	3.9	2.9	5.3	4.9	12.4	8.2	5.7	1.1	53.1	5.8	3.4	7.6	4.7	4.0	5.3	6.2	5.3	8.1	1.7	3.6	8.8	6.6	7.8	6.6	24.8	2.9	8.5	7.6	5.1	5.5	11.7	10.0	7.8	1.9	6.6	3.9	4.5	25.6	33.7	3.7	5.5	4.9	3.3	5.7	5.6	3.5	3.6	3.8	2.7	2.1	1.1	3.0	4.7	3.2	6.1	4.0	1.3	0.4	0.5	16.7	0.2	6.6	1.1	7.6	12.0	0.5	0.3	1.7	6.5	0.2	5.7	0.1	0.5	13.1	3.5	28.2	43.2	33.1	38.1	30.4	23.0	45.6	19.2	38.0	48.0	29.8	13.7	6.9	42.4	49.2	12.3	5.9	12.7	12.0	17.0	8.7	11.8	3.6	3.3	9.9	0.4	26.3	24.7	0.0	5.8	3.4	9.1	38.3	15.1	3.0	11.6	58.8	35.5	37.4	8.3	1.5	12.4	18.0	21.9	1.8	13.4	20.5	10.0	13.5	8.5	2.2	8.5	0.0	11.2	2.3	3.8	88.7	4.9	23.0	15.8	86.8
AL162417.1		ENSG00000285245			9	133098121-133163914	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.8;HUVEC TERT2: 2.1;K-562: 1.5;REH: 2.4;TIME: 2.3;U-937: 1.5"									HPA025961	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025961: AB_2671795"																		2.4	1.8	2.0	5.1	1.5	3.4	6.0	2.6	2.4	1.6	1.5	1.8	1.0	3.2	2.0	1.5	1.9	0.9	2.0	2.0	2.1		1.2	0.9	2.9	8.2	1.2	0.9	6.5	4.6	0.8	0.9	7.9	2.9	2.7	1.1	6.5	2.2	2.6	1.3	1.3	1.0	3.7	2.2	3.0	1.4	0.9	1.5	0.0	2.6	0.4	4.1	2.0	3.0	0.0	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.6	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	2.1	0.1	1.5	0.5	0.0	0.0	0.6	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163945	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"granulocytes: 11.5;Hofbauer cells: 19.5;Kupffer cells: 23.4;Macrophages: 13.6;monocytes: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 30.7;HMC-1: 28.7;HUVEC TERT2: 11.9;NB-4: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA					"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	10.2	12.9	6.7	13.7	5.7	10.3	15.5	8.1	7.8	5.8	5.6	6.3	4.7	4.1	8.5	5.7	6.7	7.8	9.0	7.2	7.0	4.6	7.7	2.0	11.2	20.4	6.7	4.3	15.8	4.4	5.6	5.6	19.7	8.8	8.4	3.9	16.7	6.3	8.2	2.9	4.2	7.3	8.2	7.2	11.2	21.7	4.3	5.7	1.7	8.1	3.2	11.5	8.3	9.0	3.4	3.2	5.2	11.2	0.9	0.5	2.5	0.0	0.8	0.8	0.0	0.5	0.6	0.2	2.3	1.8	1.3	0.0	0.0	0.4	0.6	7.8	2.3	0.9	8.6	5.1	0.5	0.0	0.0	0.2	30.7	0.5	0.0	6.3	1.1	28.7	2.7	0.8	0.3	0.0	5.4	11.9	0.4	8.9	0.1	0.4	0.1	0.1	13.8	2.5	0.2	0.2	2.2	0.2	0.8	0.8	0.1	0.2	0.9	0.0	1.2	0.0	1.0	0.0	6.8	7.4	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.1	4.9	0.4	4.7	11.2	5.2	0.2	7.7	0.5	1.7	0.4	0.0	3.2	3.4	0.1	0.1	2.0	0.9	6.4	2.3	0.2	2.5	6.7	5.7	8.1	7.8	7.0	4.6	6.7	4.3	8.8	5.7	0.0	1.7	0.9	2.6	0.7	0.1	2.0	0.0	0.0	1.2	1.8	0.0	2.0	0.0	3.6	0.0	1.1	0.0	0.0	0.5	0.8	3.7	1.2	11.5	0.0	19.5	0.0	0.0	0.6	23.4	0.0	6.9	13.6	0.0	11.8	0.0	2.4	1.2	10.4	1.8	1.4	0.3	0.0	3.5	0.0	0.1	1.0	3.0	1.0	1.2	1.0
OBP2B	"hOBPIIb, LCN14"	ENSG00000171102	"Odorant binding protein 2B"	Q9NPH6	9	133205277-133209250	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 3.6;skin 1: 3.0;testis: 12.1"	"Cell type enhanced"	"Detected in some"	13	"Late spermatids: 1.4;Leydig cells: 1.1;Melanocytes: 1.7"	"Group enriched"	"Detected in many"	8	"breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 2.4"														"Secreted in other tissues"	NA	NA						"unprognostic (1.40e-1)"		"unprognostic (5.70e-2)"	"unprognostic (9.45e-3)"	"unprognostic (6.65e-2)"					"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.03e-2)"	"unprognostic (6.82e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0			0.0	1.2	2.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	12.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ABO	"A3GALNT, A3GALT1"	ENSG00000175164	"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase"		9	133250401-133275219	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 28.2"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	8	"B-cells: 2.2;granulocytes: 3.0"	"Group enriched"	"Detected in some"	6	"K-562: 20.4;RT4: 8.0"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA						"unprognostic (2.78e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.30e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.04e-2)"	1.6	1.0	0.1	5.8	0.1	0.3	0.4	0.0	0.6	1.0	15.0	0.0	2.3	1.7	1.6	0.8	3.0	0.3	7.6	0.3	0.0		10.7	0.3	3.6	0.3	0.0	0.0	3.2	2.6	0.3	0.0	0.3	0.2	1.5	2.4	1.0	2.2	0.3	1.4	0.3	28.2	0.6	0.0	0.3	0.3	2.0	0.0	0.0	10.1	4.2	5.8	1.0	1.4	2.2	0.1	3.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.2											29.8	22.2	0.5	3.6	0.0	0.0	2.8	17.8	56.2	27.3	45.4	0.0	0.7	0.0	3.7	3.3	6.8	68.1	0.0	0.3	0.2	0.8	6.5	0.0	0.0	0.2	0.0	24.6	3.1	0.6	6.7	14.1	0.3	0.0	1.0	54.8	0.0	8.2	49.5	6.3	19.5	0.1	6.5	0.6	0.5	1.5	0.0	0.6	0.0	61.3	15.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.4	5.0	7.4	3.1	2.9	8.3	6.5	3.9	5.8	3.7	10.1	7.1	11.9	5.1	3.6	4.3	12.5	6.4	6.9	2.2	7.9	7.2	8.2	7.4	6.0	5.6	13.8	7.1	4.1	6.1	6.1	5.7	5.3	3.0	11.7	17.8	6.5	5.2	10.7	11.2	11.4	14.5	16.8	11.7	11.8	6.9	12.1	5.1	4.0	10.5	8.9	6.4	10.5	5.7	3.2	9.2	7.8	6.2	13.4	7.1	6.7	8.9	4.8	6.8	15.5	5.0	9.5	7.8	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8	41.7	23.5	25.1	10.6	21.1	24.6	26.3	30.6	17.4	35.2	21.0	5.9	26.9	18.3	29.0	1.1	20.3	37.7	0.0	16.8	19.1	14.3	11.8	24.3	29.2	18.5	20.6	32.3	12.9	11.1	2.4	25.6	14.2	6.8	21.6	37.2	16.4	23.6	28.1	26.2	11.9	20.1	0.0	17.0	18.9	21.0	24.1	15.9	16.6	47.0	10.5
MED22	"Med24, SRB6, SURF5"	ENSG00000148297	"Mediator complex subunit 22"	Q15528	9	133338323-133348131	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020391, HPA063694"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020391: AB_1857668, HPA063694: AB_2685093"	"unprognostic (2.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.56e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (4.99e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.46e-4)"	"unprognostic (3.99e-1)"	"prognostic favorable (3.76e-11)"	"unprognostic (9.25e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.62e-1)"	12.6	14.4	15.2	15.9	16.5	11.9	11.3	19.6	26.0	19.0	16.6	15.5	12.6	14.3	18.4	12.6	13.4	16.2	14.3	15.4	13.7	14.3	14.0	10.6	13.8	15.6	14.5	16.2	19.7	15.0	19.3	13.0	16.2	15.7	18.1	8.7	14.6	14.7	21.7	14.5	14.9	14.4	20.4	15.4	16.9	12.2	8.3	12.7	11.4	20.4	7.5	13.4	14.5	12.3	4.6	4.8	6.3	4.9	1.6	2.9	2.4	7.0	8.3	13.0	9.3	2.9	4.9	15.2	8.6	6.0	10.7	7.2	18.1	6.6	14.2	5.1	6.1	9.4	14.0	9.7	8.3	4.4	11.1	5.6	7.5	18.1	5.0	4.9	9.6	7.8	3.8	6.6	9.6	6.4	5.0	5.2	8.3	10.9	6.9	5.1	9.7	13.6	8.1	18.2	8.8	10.0	18.7	10.5	13.0	4.4	5.2	10.6	8.6	10.0	12.7	7.5	5.6	14.4	3.4	6.8	14.0	9.8	9.5	11.2	4.7	6.3	13.7	8.0	7.5	11.5	2.2	3.9	6.3	2.0	3.7	2.6	3.4	2.4	2.6	3.0	4.6	2.9	2.2	6.0	1.6	4.9	4.8	2.0	2.4	15.2	16.5	19.6	26.0	13.7	14.3	14.5	16.2	15.7	12.7	20.8	13.2	5.1	9.2	7.3	12.8	7.5	10.2	0.0	2.3	15.7	0.0	5.2	3.3	5.2	1.7	7.2	7.4	0.0	4.5	4.4	10.1	7.1	7.0	5.0	6.7	12.7	6.4	5.5	6.9	1.6	10.9	7.5	1.7	1.0	6.7	8.4	6.1	0.0	15.6	4.9	10.9	25.8	21.5	7.1	10.4	5.6	4.6	5.0	5.6	3.6
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348214-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles		NA	NA		160000	Nucleoli	Vesicles	"HPA046794: AB_2732534"	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	58.8	72.8	34.9	64.0	39.6	78.6	96.3	33.1	43.2	70.1	66.6	27.6	66.9	38.9	137.4	81.5	96.0	94.8	74.4	48.2	29.5	25.7	51.0	59.3	48.1	159.6	32.7	45.2	164.9	193.1	29.1	50.6	42.4	34.1	90.1	67.6	47.3	204.8	70.0	85.2	91.9	48.6	91.0	35.5	68.1	61.4	78.2	24.0	80.5	77.9	70.1	93.2	75.1	109.7	79.7	56.4	12.1	35.8	50.2	80.4	94.0	44.6	68.0	77.7	77.3	136.7	227.0	74.2	56.3	115.3	101.6	56.7	103.3	58.9	140.1	34.8	98.1	54.9	109.5	114.8	135.3	82.0	59.4	65.0	49.3	101.1	100.4	90.7	116.6	58.4	228.3	202.5	73.4	127.5	165.7	128.9	98.9	94.2	73.9	116.6	151.6	90.4	122.1	84.4	200.3	67.1	79.6	97.5	178.2	130.8	57.2	73.0	64.5	46.1	118.7	71.9	67.4	129.4	123.6	70.3	67.1	48.3	60.3	66.7	28.9	57.5	86.1	52.4	81.5	52.1	12.1	35.8	7.7	52.2	33.6	77.3	79.7	71.2	64.3	56.4	71.8	80.4	73.5	5.5	50.2	29.3	56.1	54.6	94.0	34.9	39.6	33.1	43.2	29.5	25.7	32.7	45.2	34.1	24.0	482.4	687.0	2813.3	3757.7	2882.1	278.7	355.9	1538.8	477.8	915.6	567.0	135.5	3181.9	1798.9	1584.8	1644.9	1944.8	1276.3	864.3	3823.0	4356.2	1751.6	3047.6	827.3	1030.7	2186.7	123.9	1445.6	1391.5	1793.3	3226.4	3459.6	1682.6	1434.0	2247.1	2534.7	429.4	2742.5	1749.9	1813.9	2011.8	362.0	950.7	1790.0	984.2	735.4	3479.5	2766.0	1939.0	3532.0	4275.0
SURF1		ENSG00000148290	"SURF1, cytochrome c oxidase assembly factor"	Q15526	9	133351755-133356676	"Disease related genes, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033946	Uncertain					NA	NA					"CAB033946: AB_2302648"	"unprognostic (1.87e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (6.92e-9)"	"unprognostic (3.91e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.98e-1)"	12.8	18.2	23.7	10.0	24.2	11.5	17.2	14.2	19.5	11.8	19.9	15.0	18.0	15.0	11.3	32.6	17.7	17.5	13.5	20.7	18.7	15.3	22.9	38.1	13.4	15.2	19.3	24.6	13.3	54.4	18.8	13.4	15.2	12.4	16.0	17.3	13.5	23.1	18.8	25.1	12.7	18.4	20.0	13.8	12.9	19.6	16.6	10.3	14.9	17.4	11.6	16.7	15.5	12.7	16.3	11.6	18.9	9.7	5.0	12.4	4.5	4.3	10.1	7.8	11.1	19.3	10.8	17.0	5.3	13.0	9.0	7.9	13.6	15.3	5.9	7.8	8.4	13.2	13.0	9.5	12.8	7.3	10.8	6.2	6.0	14.4	10.6	22.9	9.5	6.4	12.8	22.7	6.3	15.4	11.1	7.0	15.6	6.1	12.4	9.9	19.3	11.9	9.9	8.8	39.9	10.4	8.3	11.7	18.5	14.9	9.4	7.7	21.5	12.2	16.2	13.7	11.2	23.6	7.3	5.7	11.2	7.0	7.6	5.3	15.4	22.9	7.4	10.6	4.7	11.3	8.4	9.7	18.9	5.9	6.4	7.2	16.3	9.0	8.1	8.8	12.2	12.4	7.1	10.0	5.0	5.6	11.6	11.6	4.5	23.7	24.2	14.2	19.5	18.7	15.3	19.3	24.6	12.4	10.3	26.8	23.5	73.1	40.1	41.3	22.7	74.2	63.7	18.7	15.9	64.6	5.9	77.6	116.0	77.4	39.8	42.2	163.4	46.7	88.2	72.1	47.6	59.1	23.0	138.6	89.3	27.0	51.6	45.4	86.1	95.7	48.3	71.0	65.8	108.2	49.2	45.0	71.6	87.7	45.3	160.1	18.5	32.3	59.7	70.6	99.6	42.9	67.4	53.8	67.8	45.3
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356552-133361169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.1"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 358.5;Late spermatids: 675.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	8.3	9.2	15.8	9.0	13.2	8.2	10.7	13.1	14.5	5.7	8.8	7.4	10.8	13.2	6.4	12.0	11.0	10.7	11.2	8.9	13.4	11.0	14.3	12.0	6.5	12.1	13.1	8.7	9.0	17.5	7.1	11.3	5.9	10.3	7.7	5.7	7.7	14.2	8.8	11.5	14.8	11.4	6.9	9.4	8.6	9.3	50.1	6.6	10.6	10.1	14.9	9.8	6.5	8.3	17.5	15.6	13.1	16.2	13.2	26.9	14.1	7.2	12.5	5.3	6.5	3.8	3.0	11.1	3.7	3.3	5.9	3.1	17.1	6.0	7.2	5.4	2.4	5.1	19.9	8.3	9.0	2.7	6.9	11.5	5.7	14.3	6.3	7.7	9.3	4.3	3.6	10.7	8.4	12.4	2.1	2.7	8.9	9.0	5.0	4.0	43.6	9.6	6.2	16.6	17.4	24.2	10.7	7.9	16.9	5.0	8.3	19.7	9.9	8.2	13.8	11.0	3.4	14.7	4.4	5.1	9.0	9.1	9.2	13.1	6.2	12.3	7.8	5.7	5.6	9.0	13.1	16.2	12.0	17.8	16.2	23.1	15.6	21.9	20.2	13.8	17.5	20.8	19.7	7.1	13.2	11.6	15.6	26.9	14.1	15.8	13.2	13.1	14.5	13.4	11.0	13.1	8.7	10.3	6.6	11.9	7.8	21.6	25.7	74.8	17.9	12.4	45.9	48.2	17.0	21.0	2.0	33.0	89.5	56.4	358.5	19.4	48.7	0.0	70.1	21.0	22.4	21.1	9.2	21.5	25.8	12.7	35.1	20.3	25.9	675.3	24.2	22.4	40.5	27.9	17.1	13.2	50.2	28.1	23.0	64.0	18.9	64.7	32.0	140.5	86.5	77.0	21.4	26.1	23.8	17.8
SURF4	"ERV29, FLJ22993, MGC102753"	ENSG00000148248	"Surfeit 4"	O15260	9	133361449-133376166	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 272.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064613	Approved					NA	NA		470000			"HPA064613: AB_2685299"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.47e-5)"	"prognostic unfavorable (8.11e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.29e-3)"	31.1	33.7	11.4	19.0	15.3	29.1	34.4	9.9	23.4	24.0	36.9	19.3	29.5	40.4	26.6	27.2	24.6	23.5	32.4	24.4	10.9	11.0	28.6	120.0	27.1	26.7	12.6	12.1	27.2	60.3	16.8	29.4	48.7	13.2	22.3	20.0	18.9	65.6	30.8	18.0	19.2	61.5	22.5	13.5	19.8	26.2	26.5	11.5	21.3	35.5	21.0	23.2	20.2	20.6	7.7	18.9	18.8	19.0	13.7	29.7	28.0	14.5	24.3	16.8	23.1	35.6	37.3	32.8	45.3	45.5	32.9	32.6	36.4	21.5	10.2	17.6	63.9	31.9	38.5	19.3	23.9	25.4	21.3	11.2	17.9	23.1	38.6	41.4	30.6	24.3	39.8	22.2	28.2	31.4	26.5	30.2	16.0	21.3	28.3	41.9	32.6	14.6	28.4	18.4	40.5	23.3	10.1	23.2	38.6	25.9	14.2	13.8	16.9	34.0	25.8	23.4	16.7	27.3	18.9	31.7	46.9	16.7	35.4	29.5	14.6	20.4	11.6	43.5	16.6	35.0	18.8	19.0	16.6	27.0	15.7	29.7	7.7	19.2	24.7	16.3	6.3	11.8	18.2	13.8	13.7	14.0	18.9	22.3	28.0	11.4	15.3	9.9	23.4	10.9	11.0	12.6	12.1	13.2	11.5	41.7	40.8	25.7	53.2	54.0	19.6	33.9	20.4	8.1	25.0	33.2	37.3	139.2	16.6	91.6	24.8	37.0	108.9	23.3	102.3	209.4	84.5	89.9	24.3	194.5	78.7	31.8	72.2	60.8	48.4	14.2	63.3	37.8	38.8	50.5	87.5	56.5	101.3	60.4	49.8	44.4	23.7	77.6	66.9	54.4	43.9	54.5	272.0	74.0	55.4	60.0
STKLD1	"C9orf96, MGC43306, SGK071"	ENSG00000198870	"Serine/threonine kinase like domain containing 1"	Q8NE28	9	133376367-133406096	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 16.2"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 27.3;Late spermatids: 39.6;Spermatocytes: 15.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA029902	Uncertain					NA	NA					"HPA029902: AB_10603554"	"unprognostic (6.65e-2)"	"unprognostic (9.43e-3)"	"unprognostic (7.54e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.05e-2)"	"unprognostic (2.94e-4)"	"unprognostic (1.92e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.52e-2)"	0.4	0.4	0.4	0.2	1.4	0.5	0.4	0.7	2.2	0.4	0.3	2.2	1.3	0.5	0.9	2.1	0.3	0.6	0.5	0.3	0.8	0.3	0.3	0.4	0.3	0.8	0.5	1.3	0.8	0.4	0.1	0.3	0.5	1.5	0.5	0.1	0.8	0.6	0.4	0.6	0.8	0.5	0.3	0.5	0.4	0.4	16.2	0.7	0.0	0.3	0.0	0.3	0.3	0.3	0.6	0.4	0.0	0.2	0.2	0.6	0.0	0.0	0.6	0.4	0.7	0.5	0.5	1.1	0.2	0.0	0.1	0.2	0.9	0.3	0.3	0.2	0.0	0.6	0.6	0.1	0.0	0.0	0.4	0.8	0.7	0.9	0.5	0.3	0.5	0.4	0.4	0.1	0.0	0.1	0.4	0.0	1.5	0.8	1.0	0.0	0.2	0.6	0.8	0.3	0.6	1.0	0.3	0.3	0.8	0.1	0.1	1.0	1.0	0.3	0.9	2.2	0.3	1.3	0.3	0.6	1.0	0.6	0.9	0.1	2.2	2.2	0.6	0.4	0.4	0.3	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.4	0.2	0.1	0.6	0.6	0.2	0.0	0.2	0.1	0.4	0.0	0.0	0.4	1.4	0.7	2.2	0.8	0.3	0.5	1.3	1.5	0.7	0.0	0.0	0.0	1.1	0.0	3.3	1.2	2.5	0.0	1.2	0.0	2.0	3.6	8.3	0.4	27.3	0.5	0.0	0.0	1.0	0.6	0.3	0.7	0.0	1.0	0.8	1.6	0.0	0.0	0.3	39.6	2.0	0.0	0.0	0.0	0.3	1.2	0.3	0.0	1.8	1.7	2.3	0.0	0.2	15.1	3.4	0.0	2.7	0.0	0.7	0.6
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA047006: AB_2679900"	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	9.9	13.7	16.9	15.1	18.4	10.9	14.5	21.6	18.3	12.7	11.9	11.9	13.2	13.8	14.5	10.7	15.5	13.5	11.2	14.6	13.8	11.8	12.0	19.3	9.7	18.3	18.0	13.2	22.2	21.4	13.3	14.6	14.1	15.4	13.7	10.1	8.8	14.9	13.1	36.4	15.1	13.5	11.9	16.1	16.9	13.0	18.7	18.4	15.0	15.2	9.1	16.3	12.5	21.3	5.5	3.6	3.3	2.5	7.2	5.2	1.8	5.7	13.5	6.3	9.3	6.6	6.9	11.3	10.0	5.7	10.6	7.0	16.0	7.5	18.9	6.8	5.4	8.6	15.8	13.2	10.5	6.1	12.2	12.3	10.2	14.3	12.5	8.3	23.3	10.0	6.4	8.9	11.1	15.3	8.1	7.7	10.2	22.4	8.3	6.7	16.6	16.3	14.0	12.8	20.9	19.4	11.6	10.4	18.7	6.7	5.5	18.2	9.9	10.6	12.4	11.4	6.6	15.2	9.4	6.7	19.4	10.1	9.2	12.1	5.5	6.7	12.9	7.2	13.5	11.5	0.7	2.5	3.3	3.9	2.5	4.3	4.7	4.0	4.0	2.0	5.5	5.1	5.2	0.1	7.2	2.0	3.6	3.4	1.8	16.9	18.4	21.6	18.3	13.8	11.8	18.0	13.2	15.4	18.4	20.8	16.7	29.8	15.4	22.1	25.1	8.3	20.4	10.7	5.7	24.4	21.6	30.4	16.6	26.8	36.5	13.7	23.1	0.0	24.7	31.4	12.1	12.4	17.3	25.5	18.7	15.9	12.7	14.1	16.4	56.5	26.7	12.6	6.8	50.5	19.2	14.2	26.4	17.5	22.6	14.7	29.5	19.4	11.7	39.0	65.9	24.1	26.3	27.7	26.9	11.2
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"SuSa: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	38000000	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.3	3.3	4.6	2.7	2.4	1.2	1.1	0.9	0.4	0.6	0.5	3.6	0.4	1.5	0.8	1.1	0.6	0.3	0.6	0.1	1.9	3.0	0.4	1.3	0.7	1.9	0.1	1.1	6.4	1.6	0.5	1.2	2.2	0.3	2.3	0.1	1.4	0.5	5.5	0.1	1.5	3.5	1.9	2.0	0.4	0.4	1.6	1.5	1.4	2.1	6.8	2.3	1.3	1.8	7.1	5.8	0.6	0.8	2.4	1.4	1.6	0.0	2.5	0.6	0.5	2.0	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4	0.0	1.3	0.0	0.1	0.2	1.4	3.6	7.6	0.0	3.4	0.0	0.0	0.1	1.7	0.6	20.6	0.3	1.0	0.0	0.3	0.2	0.8	0.4	0.0	1.5	0.2	3.2	1.2	8.0	0.0	10.2	0.9	0.0	0.0	0.0	1.3	1.9	0.3	1.4	1.4	0.7	1.7	0.0	0.4	4.7	3.8	0.4	0.1	0.0	0.6	0.3
CACFD1	"C9orf7, D9S2135, flower"	ENSG00000160325	"Calcium channel flower domain containing 1"	Q9UGQ2	9	133459965-133470848	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015280			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015280: AB_1845833"	"unprognostic (3.15e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.83e-8)"	"unprognostic (5.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.99e-3)"	2.8	7.0	7.2	7.4	6.9	3.5	11.4	8.5	9.4	5.7	14.0	9.4	5.9	18.9	6.7	16.9	8.4	7.3	15.8	9.1	6.5	5.5	19.1	33.7	9.8	8.6	12.3	6.7	7.7	16.6	10.6	12.6	5.3	8.4	8.3	8.3	6.9	9.9	10.3	5.2	3.3	17.9	6.3	8.7	5.0	22.1	13.7	8.6	4.4	13.7	3.7	3.8	8.7	12.6	4.2	1.3	7.6	1.4	2.7	1.0	1.1	0.8	3.7	8.1	5.0	1.7	0.8	5.1	2.5	3.4	2.3	0.8	8.1	6.7	1.0	8.1	3.4	3.9	1.6	2.5	2.0	0.1	1.4	3.0	0.6	5.3	5.6	4.3	0.0	1.0	1.8	5.5	1.8	1.3	6.6	3.0	1.9	1.4	2.7	2.6	9.4	1.0	1.4	4.9	8.2	3.1	2.1	2.1	7.1	4.7	3.6	10.2	11.4	3.2	13.8	2.0	3.3	15.9	1.8	1.4	5.5	5.2	1.5	0.3	4.6	5.5	3.0	2.1	0.6	1.9	3.7	1.4	7.6	0.8	1.1	0.6	3.5	0.7	1.0	1.3	4.2	0.4	0.7	0.2	2.7	0.9	0.5	0.5	1.1	7.2	6.9	8.5	9.4	6.5	5.5	12.3	6.7	8.4	8.6	17.9	15.8	1.4	4.6	2.5	4.4	7.0	28.1	1.4	6.8	19.2	11.8	1.9	3.3	17.8	10.8	2.3	46.4	0.0	28.6	3.0	5.1	9.4	4.6	38.0	2.9	3.2	27.9	6.2	5.6	6.2	7.5	1.8	5.0	4.6	36.5	6.0	22.8	42.1	7.1	14.4	9.7	0.0	4.2	12.5	6.5	1.4	2.4	1.8	12.8	5.5
SLC2A6	"GLUT6, GLUT9, HSA011372"	ENSG00000160326	"Solute carrier family 2 member 6"	Q9UGQ3	9	133471095-133479137	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.7;brain: 17.3"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 49.1;granulocytes: 45.2;monocytes: 68.5;Rod photoreceptor cells: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 27.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.7;HMC-1: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042272, CAB046014"	Uncertain					NA	NA					"CAB046014: AB_2270444, HPA042272: AB_2677924"	"unprognostic (2.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.71e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.36e-2)"	"unprognostic (6.28e-3)"	3.8	3.1	7.2	12.7	8.3	10.5	2.1	8.1	16.3	1.4	2.5	4.3	0.0	3.3	2.3	3.1	1.8	1.4	3.6	3.0	9.1	12.1	2.3	2.7	7.4	10.8	12.4	9.1	1.7	3.2	1.1	1.8	2.5	17.3	1.6	2.1	2.9	2.2	2.2	2.1	1.9	4.9	3.3	7.3	10.6	4.0	2.2	2.4	1.7	1.6	0.0	7.1	4.9	1.1	4.0	7.0	15.6	27.7	0.4	0.6	3.1	2.5	4.7	1.7	5.1	1.0	1.5	1.3	2.6	4.5	2.7	2.7	2.3	3.7	2.1	6.6	2.6	12.6	4.1	1.1	3.2	0.6	15.7	0.8	2.6	3.5	2.7	3.4	0.0	37.0	2.1	0.5	4.0	0.5	0.2	2.7	2.5	0.4	2.2	1.9	6.1	1.5	2.7	2.5	1.2	5.6	1.0	2.8	11.7	3.8	7.5	2.0	2.7	3.9	2.1	1.3	1.0	8.0	1.1	6.9	6.5	2.5	6.8	2.1	1.1	0.8	3.0	1.6	0.6	1.4	15.6	7.2	0.7	0.6	14.6	0.4	4.0	0.1	0.4	6.4	3.9	0.2	0.5	0.4	0.4	27.7	7.0	0.1	3.1	7.2	8.3	8.1	16.3	9.1	12.1	12.4	9.1	17.3	2.4	3.0	5.5	19.9	1.3	0.3	24.3	2.0	5.1	2.7	0.0	3.5	49.1	0.3	0.0	32.4	6.3	4.7	1.8	0.0	7.9	0.5	1.9	1.1	45.2	0.0	4.6	22.3	3.5	2.5	19.2	1.3	0.9	31.5	3.3	68.5	1.5	3.9	16.6	31.7	0.0	0.0	45.6	32.3	7.2	2.2	6.6	0.4	0.2	3.8	1.2	0.5
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Myogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"HSkMC: 18.4;RH-30: 8.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA051846, HPA055785"	Uncertain					NA	NA					"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.6	0.2	0.5	0.0	3.3	0.2	0.0	0.7	2.6	0.0	0.0	0.8	0.0	0.0	0.0	3.1	0.6	0.1	0.0	0.3	1.0	0.4	1.7	0.2	0.3	0.0	0.9	2.1	0.0	0.0	0.0	0.1	2.0	1.6	0.6	0.0	0.0	0.2	0.0	8.0	0.2	0.0	0.0	0.4	0.1	0.0	1.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	0.7	2.6	1.0	0.4	0.9	2.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.4;heart muscle: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		67000000	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.6	30.4	5.5	1.8	5.4	0.7	0.9	6.4	9.3	1.6	1.6	8.8	0.9	2.4	1.9	4.9	1.8	1.8	11.0	36.4	4.7	4.0	15.1	24.8	11.3	6.8	5.7	4.9	6.9	7.9	1.4	8.6	2.6	9.9	4.3	1.1	4.5	5.4	3.8	5.5	0.9	2.6	1.8	5.1	3.5	2.3	3.2	6.8	0.0	6.5	1.3	1.3	2.2	6.0	0.3	0.2	1.0	0.2	0.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.4	0.0	0.9	0.6	8.2	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.8	0.4	0.0	0.2	0.0	0.3	5.5	5.4	6.4	9.3	4.7	4.0	5.7	4.9	9.9	6.8	0.0	0.3	0.0	0.1	0.1	1.8	2.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.3	0.0	1.6	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.9	0.2	0.0	5.1	8.0	0.0	0.7	4.4	0.2	0.0	0.0	0.0	0.2	0.2	0.0	2.8	0.6	0.3	6.5	1.6	0.0	0.2	0.3	0.0	0.0	0.7	0.1
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133578415-133586197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 15.1"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"SH-SY5Y: 40.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067336	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: AB_2685825"	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	8.2	10.0	0.0	2.7	0.0	0.0	3.2	41.7	0.0	0.4			0.0	0.0	0.3	0.0	0.0	0.4	1.2	6.1	3.9	0.1	2.7	0.0	1.3	3.3		0.0	0.1	0.0	0.0	0.6		0.0	0.4		0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.8	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 94.3"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.9	11.1	0.0	0.3	1.5	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.2	1.4	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.7	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.3	0.1	8.3	0.0	0.2	7.0	1.9	13.5	1.4	1.7	1.0	0.1	0.9	11.6	23.4	0.0	0.1	1.0	9.3	0.0	0.3	2.3	0.5	1.5	0.1	0.0	2.1	2.0	0.2	0.0	0.1	0.0	0.8	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8	0.0	3.4	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	1.0	0.2	1.1	94.3	0.1	0.0	1.2	2.5	2.4	0.2	4.4	0.2	0.0	0.0	0.0	2.1	0.2	0.0	2.8	14.7	0.2	0.0	1.0	0.1	0.9	0.1	0.0	2.9	0.0	0.1
VAV2		ENSG00000160293	"Vav guanine nucleotide exchange factor 2"	P52735	9	133761894-133992604	"Plasma proteins, Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 34.9;Hepatocytes: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.4"	"Group enriched"	"Detected in many"	36	"B-cells: 6.4;dendritic cells: 2.0;monocytes: 3.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003224	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003224: AB_1080554"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.16e-2)"	"prognostic favorable (7.39e-7)"	"unprognostic (8.64e-3)"	"unprognostic (3.00e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (3.97e-2)"	6.3	19.2	6.8	13.3	5.6	1.9	8.1	2.8	7.3	7.7	16.6	5.8	9.3	15.5	9.8	9.2	5.4	9.5	21.3	5.7	5.4	6.9	16.0	30.3	17.2	12.5	7.7	5.5	6.1	44.1	8.8	6.5	9.6	9.6	7.8	7.3	9.4	12.1	11.0	1.7	4.6	28.1	7.6	4.7	13.8	7.0	3.5	4.0	3.1	11.6	3.9	13.3	8.6	17.3	6.4	2.0	0.0	3.6	0.0	0.1	0.7	4.8	8.6	13.5	5.4	3.7	6.3	34.9	9.8	5.4	8.3	5.0	13.0	7.6	1.4	8.0	9.7	10.7	29.0	12.7	21.1	4.3	8.2	2.9	1.6	10.8	14.5	13.9	3.9	0.6	6.2	13.6	7.3	10.4	5.5	9.2	2.9	2.8	2.4	5.7	24.7	0.3	2.0	6.6	21.2	8.2	13.2	11.4	4.7	18.8	8.8	15.0	10.2	25.7	17.2	3.5	9.1	10.4	5.7	7.4	11.8	6.6	11.6	13.4	0.1	0.1	2.7	7.8	3.5	7.2	0.0	1.4	0.0	0.1	3.6	0.0	6.4	0.0	0.1	2.0	4.5	0.0	0.0	0.0	0.0	2.4	1.2	0.0	0.7	6.8	5.6	2.8	7.3	5.4	6.9	7.7	5.5	9.6	4.0	0.0	4.8	11.3	2.4	4.5	1.0	3.2	30.6	1.4	7.9	34.9	0.0	0.6	3.3	8.1	2.6	4.2	29.3	0.0	10.8	14.7	5.4	4.7	0.0	35.0	5.2	0.0	27.1	9.8	4.5	5.8	6.6	5.5	1.7	10.8	6.3	5.3	18.4	11.4	5.6	11.7	1.4	12.9	8.5	0.1	1.9	2.4	0.8	0.0	11.6	2.0
BRD3OS	"bA374P20.3, FLJ35348, LINC00094, NCRNA00094"	ENSG00000235106	"BRD3 opposite strand"		9	134025439-134034666	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 11.9;Ciliated cells: 38.8;Collecting duct cells: 15.7;Distal tubular cells: 16.6;Proximal tubular cells: 11.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (7.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.97e-1)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.95e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.31e-4)"	4.1	5.9	9.2	2.8	9.2	0.6	7.7	3.4	14.7	6.1	2.0	4.0	4.2	1.5	6.1	7.7	3.7	15.3	6.0	4.6	8.0		6.3	1.4	4.1	5.3	1.9	10.8	11.2	4.8	9.9	7.8	2.8	8.0	5.2	2.0	4.7	4.3	8.8	0.7	2.2	1.4	5.5	6.0	3.0	2.7	5.7	3.4	3.5	9.5	0.9	4.6	4.3	3.1	12.7	3.8	2.0	6.7	8.7	11.6	5.1	6.5	10.4	8.7	15.6	13.0	17.7	3.8	7.6	10.7	13.2	6.8	7.6	5.7	3.8	5.7	15.6	15.5	9.7	9.1	9.9	7.2	5.9	4.7	2.8	16.2	3.0	8.2	6.0	5.6	11.2	14.7	13.5	5.8	22.7	8.7	11.8	3.2	6.0	9.8	9.3	11.5	2.8	11.9	8.6	9.4	5.1	8.1	7.6	12.9	3.0	21.3	10.6	10.7	5.4	3.7	5.4	17.1	5.8	9.1	13.4	10.3	16.0	8.9	2.3	4.4	1.8	15.9	5.8	6.2	0.8	2.8	0.1	10.3	2.8	9.3	11.1	11.1	10.0	2.8	12.7	11.6	9.1	2.0	8.7	6.7	3.8	4.3	5.1											11.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	38.8	9.1	15.7	0.0	2.0	16.6	9.6	0.0	0.0	0.0	0.0	6.9	6.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.8	0.0	0.0	6.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
BRD3	"KIAA0043, ORFX, RING3L"	ENSG00000169925	"Bromodomain containing 3"	Q15059	9	134030305-134068535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051830	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA051830: AB_2681627"	"unprognostic (3.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.00e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.42e-1)"	16.3	15.7	18.0	12.0	20.0	12.3	14.2	21.8	21.8	21.0	20.3	26.7	17.3	13.8	21.7	17.4	14.6	17.7	12.6	17.1	19.9	14.8	11.3	14.5	14.6	11.9	15.8	15.8	19.1	18.7	21.8	15.8	15.7	15.6	19.9	10.3	16.6	16.5	22.5	29.2	19.6	12.9	16.3	17.8	20.1	14.8	17.8	18.2	35.4	18.7	9.2	10.3	17.9	14.1	7.3	16.6	14.6	12.9	15.4	11.9	7.8	4.1	12.6	16.1	12.5	8.9	7.3	14.7	4.2	4.8	4.7	4.8	10.5	6.9	1.6	4.5	3.8	5.3	14.4	14.9	5.8	3.7	9.8	8.3	9.0	14.3	11.8	8.0	11.7	8.1	7.8	7.2	5.4	6.2	7.7	7.7	15.1	8.1	4.7	4.8	13.9	21.7	15.8	21.4	10.8	9.8	16.1	23.2	7.8	6.6	4.4	23.6	21.8	18.9	7.2	5.0	10.1	10.3	19.6	9.8	11.6	6.5	7.5	3.7	2.5	2.7	1.4	5.8	8.1	7.6	5.9	12.9	14.5	11.9	9.8	10.0	7.1	9.6	10.6	12.5	7.3	9.1	9.7	14.6	15.4	7.9	16.6	4.4	7.8	18.0	20.0	21.8	21.8	19.9	14.8	15.8	15.8	15.6	18.2	29.8	21.6	14.1	17.5	28.7	54.2	17.9	25.5	24.1	29.6	22.7	35.3	22.4	16.6	37.3	34.3	26.7	15.2	93.5	21.3	17.8	30.4	33.1	16.1	25.1	15.9	54.0	51.9	27.0	25.1	14.1	52.9	20.6	21.9	19.0	24.6	41.9	25.2	21.0	63.3	13.0	54.0	58.2	32.6	13.7	61.1	31.1	27.3	25.8	30.3	14.7
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047182			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047182: AB_2679971"	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	14.0	14.3	18.5	18.5	18.1	17.2	27.8	23.1	19.4	14.8	14.3	11.5	13.2	17.5	18.5	12.4	21.0	15.6	13.6	12.4	12.3	10.8	11.8	20.8	13.0	16.0	14.4	15.4	19.1	21.4	16.2	17.6	14.7	12.7	13.3	14.3	10.2	16.9	19.6	32.9	20.5	16.9	13.9	10.0	13.7	15.4	41.6	14.2	19.6	14.3	18.5	17.4	15.2	22.9	7.1	11.3	1.8	10.5	5.3	8.5	7.0	15.3	18.9	18.1	20.6	9.9	11.0	28.7	15.6	10.4	21.4	14.7	22.0	12.7	24.6	10.0	12.7	18.8	38.5	24.5	16.0	17.5	16.4	16.7	14.1	29.6	17.7	10.6	31.6	14.9	10.5	15.2	15.9	19.7	8.8	14.1	24.6	26.3	13.8	14.8	41.1	27.0	26.0	23.0	35.1	23.9	29.6	36.8	23.2	10.5	15.1	30.4	15.8	23.5	18.5	10.4	12.6	25.4	27.9	12.2	22.0	20.2	20.1	25.1	7.2	13.8	26.6	12.7	21.6	17.6	1.0	10.5	1.8	8.1	6.6	8.0	5.4	8.1	8.2	11.3	7.1	8.5	6.4	0.9	5.3	5.4	9.4	7.1	7.0	18.5	18.1	23.1	19.4	12.3	10.8	14.4	15.4	12.7	14.2	8.9	7.5	7.5	12.0	10.5	7.9	8.0	12.7	0.0	3.4	5.2	21.6	21.3	8.3	14.6	127.2	6.3	12.9	0.0	17.9	35.3	10.3	12.8	9.2	17.8	16.7	7.9	6.3	6.2	7.0	22.2	10.6	8.9	5.0	7.2	11.4	6.3	14.6	8.6	11.0	8.4	7.1	6.5	10.1	32.9	42.2	14.3	14.9	8.5	18.3	14.1
RXRA	NR2B1	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 186.8;Kupffer cells: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.9;non-classical monocyte: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.9;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HaCaT: 27.4;RT4: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (2.68e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.65e-3)"	"prognostic favorable (7.02e-4)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	18.5	10.1	9.9	10.4	6.7	19.6	36.8	4.6	9.8	11.0	9.3	4.9	8.1	14.0	10.1	6.1	24.2	9.3	12.9	14.2	9.0	3.7	11.7	49.3	12.8	10.4	6.0	7.0	11.7	20.6	8.0	10.7	9.6	9.4	9.7	2.0	9.5	9.3	9.7	45.8	19.0	15.2	10.6	9.5	11.5	8.8	5.9	8.1	1.5	13.6	18.3	5.9	16.0	23.7	0.1	1.7	14.9	12.3	1.3	1.1	1.8	5.6	15.8	2.0	5.0	3.6	3.3	24.3	3.0	3.5	4.4	2.5	8.8	8.8	0.0	8.3	4.4	3.8	27.4	0.7	10.7	0.2	8.0	2.0	0.0	19.3	13.3	4.6	6.6	2.4	5.4	4.6	5.5	2.6	0.6	3.7	0.9	10.9	0.5	1.0	15.1	0.5	1.4	3.8	4.1	5.5	2.9	7.5	10.9	0.2	24.4	4.5	2.0	9.6	9.2	2.4	0.1	12.8	9.0	4.8	5.4	6.5	5.7	2.7	0.7	0.0	0.1	4.1	6.7	3.5	1.1	5.2	2.8	1.1	9.3	0.0	0.1	0.7	0.7	1.7	0.0	0.2	0.9	14.9	1.3	12.3	0.1	0.9	1.8	9.9	6.7	4.6	9.8	9.0	3.7	6.0	7.0	9.4	8.1	29.8	22.2	2.2	14.1	30.7	3.8	30.8	79.0	8.1	21.6	8.7	23.6	24.3	1.7	11.9	4.5	17.5	46.7	23.3	12.2	27.0	17.3	15.8	1.1	186.8	29.1	31.8	9.2	72.4	115.8	14.1	30.0	27.5	11.8	5.4	24.8	42.2	14.1	34.5	19.8	16.2	21.2	19.4	17.9	0.7	12.3	40.9	20.0	13.1	23.9	26.0
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641774-134844843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 110.7"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 127.8;Leydig cells: 56.7;Peritubular cells: 36.4;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;fHDF/TERT166: 67.3;HeLa: 48.1;HHSteC: 45.8;SiHa: 47.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		12000000	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	11.5	4.2	1.5	13.7	1.4	0.0	9.5	3.0	1.2	110.7	20.9	1.4	11.8	3.6	42.1	24.1	12.3	20.5	31.8	12.2	1.8	0.9	4.3	3.4	13.4	7.8	3.0	1.3	19.5	3.7	3.7	2.6	53.8	2.2	23.3	4.7	9.1	5.1	9.9	5.0	6.9	8.7	26.7	1.5	6.5	12.5	9.5	1.1	2.7	4.1	10.1	4.0	21.8	22.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	2.1	3.4	32.6	35.1	1.3	72.5	14.6	12.4	13.3	0.0	0.0	0.0	16.1	67.3	6.6	0.9	0.0	0.0	3.5	0.0	0.1	0.0	48.1	0.0	45.8	0.0	0.4	34.4	0.0	11.9	0.9	0.0	14.7	0.0	0.0	0.2	6.5	0.6	0.0	0.1	1.2	0.0	1.4	2.5	8.4	0.3	0.0	0.0	0.9	0.4	47.8	0.3	0.0	30.7	0.1	0.0	25.1	26.0	10.8	31.9	15.1	0.0	0.0	0.0	20.6	0.0	4.4	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	3.0	1.2	1.8	0.9	3.0	1.3	2.2	1.1	0.0	2.6	0.0	3.4	12.9	0.3	5.6	0.0	0.0	0.0	1.8	2.0	4.0	1.7	1.3	5.2	6.8	0.0	0.0	0.0	10.7	127.8	0.4	0.0	0.0	8.0	0.0	0.0	32.5	0.3	11.4	56.7	0.5	6.8	0.0	0.0	6.9	1.9	0.0	36.4	0.1	0.6	51.8	23.2	0.5	0.6	6.8	8.7	0.0	0.0	0.3
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880812-134887520	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 77.4"	"Cell type enriched"	"Detected in some"	16	"Ito cells: 1725.4"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.0;intermediate monocyte: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2"														"Secreted to blood"	NA	NA	8100000000	1800000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		2.0	11.4	0.2	0.2	0.2	0.0	4.0	0.2	0.3	0.2	0.3	0.3	0.5	0.0	0.3	0.6	0.2	0.0	0.2	0.5	0.2	0.0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0.0	0.2	1.4	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0.0	3.3	1.3	6.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.9	0.0	0.0	6.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.3	0.0	2.5	0.0	0.0	7.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	1725.4	106.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134905890-134917963	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 318.5;bone marrow: 135.4"	"Cell type enriched"	"Detected in many"	9	"Kupffer cells: 627.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 318.5;intermediate monocyte: 218.1"	"Lineage enhanced"	"Detected in many"		"monocytes: 318.5"	"Group enriched"	"Detected in some"	7	"NB-4: 15.7;U-937: 23.4"									"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	NA	NA	1060000000	63000000			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	6.6	0.9	0.6	35.2	0.7	135.4	2.2	0.4	1.0	1.8	2.0	0.4	0.0	0.1	1.6	7.8	1.0	3.6	2.9	7.6	0.5	0.6	2.3	4.6	24.9	23.5	2.3	0.1	3.5	1.6	0.0	0.7	9.2	0.9	1.6	1.0	3.0	1.7	0.3	2.7	0.7	1.3	8.1	1.2	47.3	2.2	1.0	0.5	6.8	1.6	1.1	3.6	8.5	1.6	0.8	93.9	53.7	318.5	0.4	0.6	273.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.7	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.2	0.0	23.4	0.0	1.2	318.5	3.0	0.5	218.1	0.6	0.8	0.2	0.3	93.9	0.2	0.3	0.3	53.7	0.4	99.0	2.5	0.3	273.0	0.6	0.7	0.4	1.0	0.5	0.6	2.3	0.1	0.9	0.5	6.0	27.5	10.5	0.2	1.6	0.0	2.4	0.0	1.4	9.1	1.8	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.1	0.2	11.6	1.3	71.4	0.0	0.0	3.1	627.5	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.5	0.0	0.1
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.6	3.2	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	13.1	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.5	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	21.5	0.1	0.0	28.6	20.3	0.0	0.0	0.0	12.0	0.0	0.0	41.3	5.5	34.2	0.1	2.1	2.2	53.0	0.0	0.0	2.0	4.6	23.1	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8	0.0	9.3	0.0	2.8	8.7	20.7	5.8	7.6	0.0	3.4	0.0	41.2	0.0	0.0	7.4	5.8	26.1	0.0	0.0	2.3	0.0	8.2	6.1	2.3	0.5	0.3	36.5	2.4	74.3	4.5	8.9	41.1	2.8	20.3	0.0	1.7	32.6	3.6	2.9	27.6	0.0	12.0	0.0	11.7	0.6	3.4	5.5	0.0	0.0	5.5	0.9
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavorable (3.98e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favorable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.2	6.2	13.8	3.0	10.1	1.0	8.4	3.0	18.2	6.0	6.4	6.9	12.4	7.9	5.0	6.4	5.1	9.0	8.1	11.3	13.2	10.2	8.1	6.6	8.9	2.1	8.3	9.6	7.5	12.5	22.9	11.9	5.4	9.1	7.4	4.4	8.9	13.3	10.8	6.9	4.0	8.0	8.1	5.7	4.7	11.4	6.1	7.3	1.1	8.2	2.8	4.5	7.4	3.7	0.6	1.7	3.0	1.3	2.6	0.6	0.4	6.7	10.2	5.5	5.6	2.3	2.0	0.0	3.7	5.1	5.1	3.4	9.9	11.8	0.0	7.1	3.6	13.0	25.3	5.0	4.8	1.7	0.3	5.6	0.1	15.4	7.3	5.5	3.3	12.6	1.4	9.0	2.5	6.3	5.6	3.2	0.0	6.7	0.0	2.9	15.4	0.1	1.0	8.0	13.9	14.1	0.0	9.6	11.2	4.9	9.1	8.4	12.4	6.6	9.3	6.9	4.5	7.1	3.0	3.8	1.9	8.6	9.1	4.2	5.2	12.3	0.2	4.0	0.6	4.8	0.0	1.3	3.0	0.4	0.4	0.0	0.6	0.2	0.0	1.7	0.4	0.0	0.0	0.3	2.6	0.6	0.3	0.6	0.4	13.8	10.1	3.0	18.2	13.2	10.2	8.3	9.6	9.1	7.3	3.0	4.8	0.0	2.0	1.9	10.1	7.3	17.8	2.7	2.3	7.0	7.9	0.4	5.0	5.2	0.2	2.3	5.2	0.0	2.9	0.7	2.3	4.1	2.3	4.9	4.8	1.6	6.3	4.3	2.4	0.0	1.1	1.1	3.3	0.0	9.7	7.2	6.1	7.0	1.8	3.9	7.7	0.0	1.7	0.3	3.6	1.5	0.2	0.0	6.5	2.3
C9orf116	"MGC29761, PIERCE1, RbEST47"	ENSG00000160345	"Chromosome 9 open reading frame 116"	Q5BN46	9	135495181-135501734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 63.3;testis: 47.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 473.8;Early spermatids: 387.4;Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.6;T-47d: 23.4;U-2197: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021439, HPA065287"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021439: AB_1845799, HPA065287: AB_2732732"	"unprognostic (9.02e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (3.53e-5)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.23e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-1)"	1.5	7.2	8.0	1.0	9.2	1.0	2.2	1.5	6.2	4.1	1.1	6.2	8.2	1.1	3.3	22.1	1.0	63.3	2.7	1.5	9.6	9.3	7.8	1.5	9.8	0.9	4.9	4.9	9.3	4.5	3.3	7.6	1.5	19.9	2.0	1.3	1.7	2.0	5.0	1.4	1.2	1.0	1.3	2.6	1.0	1.8	47.8	2.6	0.1	6.7	0.2	1.2	2.2	0.3	1.7	0.9	0.1	2.6	1.8	4.2	1.1	5.9	10.3	4.5	7.1	2.0	4.3	0.9	4.0	2.9	4.9	3.3	3.9	6.0	1.0	5.4	2.7	2.7	4.1	5.0	2.2	4.2	0.3	4.6	0.0	11.4	11.9	5.6	0.8	2.8	3.0	1.7	2.4	0.8	4.0	2.3	4.8	5.5	0.8	2.3	22.6	3.0	1.0	9.6	9.3	12.1	4.7	2.2	3.7	11.6	4.3	4.4	4.7	5.7	2.4	0.6	2.2	23.4	1.0	1.1	2.8	3.7	24.2	1.5	2.7	6.6	0.9	8.4	0.3	0.8	0.1	2.6	0.0	1.9	1.6	4.2	0.7	1.3	1.4	0.9	1.7	2.4	1.8	0.0	1.8	0.4	0.4	1.6	1.1	8.0	9.2	1.5	6.2	9.6	9.3	4.9	4.9	19.9	2.6	8.9	5.6	0.0	2.5	0.8	4.6	1.4	7.6	473.8	29.6	14.0	13.7	9.7	10.0	23.1	387.4	1.5	0.7	0.0	7.0	1.8	2.7	2.3	1.1	1.6	3.1	3.2	1.2	0.6	1.9	493.5	7.5	1.9	0.0	3.6	1.0	6.5	9.2	1.4	7.1	40.0	15.4	0.0	1.0	87.1	20.2	0.3	3.8	0.0	1.7	1.4
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA029487: , HPA057261: AB_2683385"	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	18.5	31.7	15.6	14.8	18.4	17.7	32.1	17.9	28.9	15.2	19.6	12.6	31.3	20.9	19.7	15.7	20.7	33.3	20.6	43.6	15.0	15.5	24.5	48.6	17.8	32.7	15.4	15.1	25.6	37.1	21.7	15.5	16.5	14.1	18.3	16.2	15.0	25.7	29.3	43.0	19.7	16.0	22.0	12.8	18.4	20.6	12.3	10.6	18.5	22.5	28.4	18.2	18.5	15.7	20.6	16.2	7.3	15.8	14.5	22.3	13.7	16.4	27.3	10.0	13.6	11.4	12.8	17.3	12.1	11.0	20.5	15.3	41.0	15.6	20.9	16.6	11.1	21.8	37.3	25.1	28.3	8.0	12.8	39.4	10.3	27.6	27.4	20.0	20.9	12.7	17.1	22.1	22.3	16.0	13.2	19.1	21.0	34.0	15.4	11.9	50.6	20.4	36.5	22.9	30.5	44.1	22.4	16.4	43.9	17.0	14.0	30.3	16.0	16.4	31.6	17.4	7.0	26.2	16.6	11.8	15.1	16.9	25.9	21.7	17.0	33.3	23.1	15.5	19.1	13.8	4.8	15.8	7.3	18.0	14.9	20.4	20.6	18.1	19.2	16.2	20.3	19.7	19.6	1.3	14.5	12.2	13.9	22.3	13.7	15.6	18.4	17.9	28.9	15.0	15.5	15.4	15.1	14.1	10.6	11.9	16.0	41.4	32.0	39.8	20.6	28.6	30.6	12.0	28.4	12.2	5.9	59.6	61.3	46.7	11.0	25.6	22.5	0.0	33.5	47.9	22.6	23.0	8.1	40.9	37.4	23.8	20.8	19.0	15.9	24.2	22.5	14.8	18.6	40.5	34.8	16.9	37.7	28.1	21.5	65.5	14.5	32.3	24.7	7.2	19.4	40.0	31.2	29.7	51.6	29.8
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526532	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"tongue: 204.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-2 OS: 1.0;U-87 MG: 2.0"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		20000000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	16.8	3.3	0.0	0.7	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.4	15.8	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	204.2	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OBP2A	"hOBPIIa, LCN13, OBP"	ENSG00000122136	"Odorant binding protein 2A"	Q9NY56	9	135546139-135549969	"Predicted secreted proteins"	"Olfaction, Sensory transduction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 23.7;testis: 13.3"	"Group enriched"	"Detected in some"	6	"Late spermatids: 1.0;Leydig cells: 1.4;Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"U-266/70: 2.8;U-266/84: 10.6"									HPA055955	Uncertain				"Secreted in other tissues"	NA	NA					"HPA055955: AB_2682985"	"unprognostic (2.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.20e-1)"		"unprognostic (2.75e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.23e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-11)"	"unprognostic (5.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.84e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	23.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	1.2	0.4	0.1	0.4	0.0	0.1	0.1	0.1	0.1	2.9	0.1	0.1	0.1	0.2	0.0	13.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3"	"Group enriched"	"Detected in some"	20	"Club cells: 7.9;Ductal cells: 4.2"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 22.0"									"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"	NA	NA					"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavorable (0.00e+0)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.3	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	1.3	0.1	0.0	176.9	0.2	79.9	0.1	0.1	5.0	0.0	0.1	0.1	0.3	0.1	0.3	0.4	0.0	0.1	0.0	0.8	0.1	0.0	0.2	105.3	0.0	1.1	0.0	0.0	0.2	13.9	0.1	1.1	0.1	0.0	0.1	0.2	2.0	0.5	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.3	1.3	5.8	0.9	0.8	0.8	0.3	0.1	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.6	2.3	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.2	3.1	0.5	0.0	0.3	0.0	0.7	0.5	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.5	0.2	0.1	0.2	22.0	0.7	0.4	0.2	0.0	0.1	1.1	0.3	0.1	1.0	2.1	0.2	0.3	0.4	0.5	5.8	0.9	0.6	0.6	0.5	0.5	0.6	0.8	0.6	0.3	1.3	0.7	0.8	4.0	0.8	0.8	1.3	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL354761.1		ENSG00000236543			9	135604345-135618952	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	52	"skin 1: 20.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	16	"BEWO: 13.4"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.3		0.0		0.0	0.0		0.0	0.4	0.0	20.8	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLT6D1	GLTDC1	ENSG00000204007	"Glycosyltransferase 6 domain containing 1"	Q7Z4J2	9	135623656-135639540	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	28	"testis: 10.3"	"Group enriched"	"Detected in some"	22	"Early spermatids: 13.2;Late spermatids: 4.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023424	Uncertain				"Intracellular and membrane"	NA	NA					"HPA023424: AB_1849729"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA060941: AB_2732654"					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135699528	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 21.1;testis: 21.5"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 82.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CACO-2: 14.8;U-266/84: 22.8"									HPA059439			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.2	0.1	4.4	0.2	3.2	0.1	0.2	1.7	21.1	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.1	0.2	0.2	9.4	1.4	0.2	0.2	0.2	0.2	2.0	0.2	0.3	0.2	0.3	1.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.2	21.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.2	1.7	21.1	9.4	1.4	2.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	8.0	82.1	0.0	0.0	0.0	0.0	0.0
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;skeletal muscle: 19.5"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 4.5"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059880	Uncertain					NA	NA					"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	1.4	0.8	7.3	1.0	12.4	1.0	0.7	29.7	29.3	0.7	0.9	0.2	0.0	1.0	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12.0	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0.0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0.0	0.8	0.0	0.7	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.6	0.0	0.0	1.9	4.2	0.0	0.0	6.3	1.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12.0	6.1	3.1	0.0	0.0	0.0	0.0	0.0	0.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.7	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0
CAMSAP1	"DKFZp434F195, FLJ31228"	ENSG00000130559	"Calmodulin regulated spectrin associated protein 1"	Q5T5Y3	9	135808487-135907228	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Cone photoreceptor cells: 320.0;Rod photoreceptor cells: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020527, HPA024161"	Approved		Supported	"Mitotic spindle,Cytosol"		Yes	No			"Mitotic spindle, Cytosol"		"HPA020527: , HPA024161: AB_1845967"	"unprognostic (3.18e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	"prognostic favorable (3.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-3)"	8.0	8.6	12.4	6.5	15.7	10.5	8.3	23.9	21.7	7.6	6.3	14.3	7.2	4.1	9.5	6.9	22.0	9.8	6.5	9.2	11.2	10.8	5.2	4.8	8.2	6.6	10.4	9.9	13.5	9.5	8.9	9.4	6.5	12.2	8.0	4.7	24.2	7.3	8.6	32.7	10.4	4.3	8.6	10.3	6.2	6.2	20.8	9.2	10.0	5.7	14.4	11.4	7.6	10.0	2.4	1.1	3.8	1.6	1.0	2.1	1.2	9.3	13.7	22.7	16.0	5.3	4.6	11.1	7.5	6.3	8.2	6.3	12.0	8.2	4.3	10.9	9.5	10.6	19.1	11.9	8.2	6.3	14.6	6.6	6.2	15.4	6.0	8.1	10.8	9.4	6.2	10.4	10.5	14.5	7.9	9.2	9.6	12.8	9.4	10.7	16.6	10.0	6.7	13.0	11.2	10.0	19.7	18.9	10.5	8.3	11.5	24.8	24.4	9.7	7.1	10.5	7.8	9.9	9.0	11.3	15.7	12.4	11.5	12.8	4.7	8.8	11.8	10.2	7.4	9.0	3.8	1.5	0.3	1.1	1.6	2.1	2.4	1.8	1.7	0.9	0.5	1.3	1.9	0.5	1.0	1.3	1.1	1.4	1.2	12.4	15.7	23.9	21.5	11.2	10.8	10.4	9.9	12.2	9.2	6.0	3.8	6.0	12.6	20.1	32.5	12.2	5.1	16.0	15.9	3.5	320.0	10.0	0.0	10.2	8.6	7.9	3.0	23.3	7.6	3.1	5.4	12.1	5.8	7.3	9.4	15.9	12.1	4.9	9.2	13.6	5.5	8.9	11.8	10.0	3.8	16.5	12.6	3.5	5.6	3.8	218.3	12.9	9.0	16.3	32.4	27.7	4.7	3.2	3.8	24.1
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell type enhanced"	"Detected in all"	6	"Erythroid cells: 233.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 60.5;K-562: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		54000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favorable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	9.1	10.7	7.6	11.0	5.8	6.7	14.3	8.0	6.9	10.0	8.1	14.8	11.7	11.1	7.8	6.6	11.9	31.3	10.6	9.3	4.5	60.5	10.0	9.2	19.2	8.3	6.0	12.0	8.8	6.3	12.2	6.3	6.2	6.7	8.3	10.5	76.7	9.0	7.9	18.9	9.7	12.3	18.0	21.6	18.2	11.1	14.3	14.6	7.1	5.9	11.8	13.0	11.6	10.5	8.1	7.1	8.9	13.0	6.7	5.7	8.6	6.8	9.9	5.3	9.8	13.2	10.5	10.9	7.7	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8	14.9	7.7	13.7	32.8	36.1	36.5	74.9	12.7	91.0	14.8	26.2	29.5	121.1	79.6	15.6	80.0	25.3	39.3	233.6	20.0	20.6	17.0	18.9	6.9	26.7	64.5	12.7	16.1	16.0	27.7	144.8	18.1	30.0	33.7	43.3	32.5	43.1	17.5	46.5	21.2	21.9	35.3	19.4	19.8	43.5	52.7	56.7	50.6	10.1	47.7	37.6
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095285	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 71.6;Late spermatids: 228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA047924: AB_2680212, HPA052962: AB_2681998"	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (8.28e-5)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	15.3	9.0	27.4	10.9	26.3	2.7	12.8	16.3	37.3	10.0	15.5	14.5	11.7	8.3	11.4	6.9	11.6	10.1	16.6	16.8	20.7	16.7	8.0	15.2	8.3	7.6	30.3	6.4	10.3	10.0	6.2	3.8	3.9	15.2	12.7	5.5	10.2	9.9	23.8	12.6	5.8	9.5	31.7	33.4	7.8	8.2	7.8	11.0	0.0	5.8	4.7	3.1	21.8	4.6	0.0	2.4	5.7	4.5	0.5	1.7	1.4	3.1	17.3	1.9	26.3	8.5	4.8	2.4	7.7	5.2	2.5	0.8	7.3	5.7	0.0	9.3	12.2	4.0	12.4	4.2	4.2	0.8	9.6	3.8	2.1	16.6	9.1	8.7	0.0	4.0	8.0	3.9	2.3	2.3	10.3	6.9	0.0	6.5	0.0	4.8	10.6	0.0	6.0	5.9	5.0	10.8	0.0	2.0	5.2	10.3	3.6	0.7	0.8	10.9	9.2	9.5	9.2	9.3	19.8	11.4	6.7	7.6	5.6	5.3	0.0	0.0	0.1	8.9	0.7	13.4	2.8	4.5	1.5	1.7	3.6	0.7	0.0	0.6	1.5	2.4	0.0	0.5	0.6	5.7	0.5	3.4	0.3	0.4	1.4	27.4	26.3	16.3	17.7	20.7	16.7	30.3	6.4	15.2	11.0	11.9	5.3	1.5	4.0	4.0	2.1	25.0	10.2	1.4	4.5	5.2	0.0	0.6	0.0	10.1	71.6	13.0	6.8	0.0	11.7	1.6	6.4	8.7	2.3	31.1	6.9	3.2	2.4	17.8	38.6	228.0	16.7	10.8	5.0	5.4	4.1	16.7	15.4	8.6	18.0	12.6	1.8	25.8	18.9	1.8	4.5	4.4	0.3	2.9	4.5	7.0
TMEM250	"bA83N9.1, C9orf69"	ENSG00000238227	"Transmembrane protein 250"	H0YL14	9	136114581-136118863	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 14.0;Cytotrophoblasts: 14.7;Extravillous trophoblasts: 18.7;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.9;Proximal tubular cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA066070	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066070: AB_2685608"	"unprognostic (2.79e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.64e-1)"	16.4	11.4	16.1	15.0	19.4	5.5	25.3	13.8	28.4	12.4	19.3	9.2	8.2	22.5	12.2	10.9	22.2	14.2	13.8	10.7	17.1	9.5	13.0	17.6	15.2	15.2	9.4	14.2	15.9	12.7	9.4	10.1	15.2	9.8	13.4	11.4	7.4	18.3	13.0	33.9	26.8	18.9	14.1	7.7	14.0	17.3	12.8	10.0	15.4	11.2	12.9	12.0	13.2	11.8	3.0	4.6	5.3	6.3	4.7	9.9	3.0	11.0	21.0	8.2	12.2	11.7	10.7	25.7	13.3	9.6	8.1	5.8	11.9	16.2	8.2	15.7	14.2	12.9	28.4	5.8	9.4	2.5	35.3	11.1	6.9	21.9	8.3	16.3	12.5	9.0	9.6	18.1	8.7	9.2	10.4	12.8	8.2	15.5	8.7	7.0	25.5	15.2	10.1	18.2	19.4	23.0	6.2	11.4	13.5	8.8	8.1	14.2	10.8	14.4	10.0	11.4	5.1	9.1	18.9	14.4	14.2	6.3	18.5	14.7	5.1	4.9	4.9	14.2	9.0	13.3	4.9	4.6	2.7	9.9	6.2	7.4	3.0	7.6	8.3	4.6	2.4	3.7	6.9	5.3	4.7	6.3	3.0	3.8	3.0	16.1	19.4	13.8	28.4	17.1	9.5	9.4	14.2	9.8	10.0	6.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	14.0	0.0	14.7	3.3	10.6	0.0	0.0	0.0	0.0	9.1	18.7	0.0	0.0	2.3	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.4	0.0	0.0	13.9	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0
LHX3		ENSG00000107187	"LIM homeobox 3"	Q9UBR4	9	136196250-136205128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 33.4"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;U-266/70: 5.2;U-698: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (4.17e-2)"			"unprognostic (4.72e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.57e-1)"							"unprognostic (3.31e-2)"	"unprognostic (6.18e-2)"			0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.2	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	13.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245841	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		5700000	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.2	8.0	8.4	15.9	14.1	16.0	7.3	30.3	10.6	5.8	5.8	9.4	8.9	6.0	8.1	13.2	5.6	8.1	5.5	7.0	7.6	7.1	7.0	9.2	6.5	19.1	11.0	6.7	9.4	21.7	12.1	29.2	5.8	9.6	6.1	6.7	7.9	6.5	4.9	5.1	12.4	10.3	8.1	7.1	14.6	7.6	11.7	10.1	8.3	12.1	6.0	16.7	5.4	6.4	3.4	0.8	1.6	0.3	0.4	0.8	0.2	7.0	17.1	14.2	18.8	8.0	9.8	17.9	8.9	10.0	17.5	16.1	12.7	15.3	10.8	14.8	12.0	32.2	22.8	16.8	12.9	14.2	15.9	8.4	5.8	28.3	14.0	11.4	17.2	8.9	7.8	13.2	17.3	21.1	7.7	12.8	11.4	14.0	29.3	9.2	11.9	6.3	11.5	16.8	21.2	10.9	11.8	18.5	17.7	6.0	6.3	15.2	11.5	14.1	11.2	7.5	9.7	8.0	10.1	7.3	21.3	15.4	17.4	20.3	10.4	13.8	23.8	14.2	9.1	19.8	1.6	0.3	0.7	0.5	0.0	0.8	1.9	0.6	0.2	0.1	3.4	0.2	0.4	0.1	0.4	0.0	0.8	0.3	0.2	8.4	14.1	30.3	10.6	7.6	7.1	11.0	6.7	9.6	10.1	8.9	6.4	6.9	2.5	5.0	16.1	3.1	0.0	8.1	5.7	5.2	17.7	1.2	1.7	3.3	4.9	7.0	1.1	0.0	3.4	2.5	4.7	4.8	1.1	3.4	2.0	4.8	15.6	2.5	4.8	4.7	5.5	2.7	0.0	1.0	4.9	2.8	3.5	0.0	6.7	1.9	8.2	6.5	5.7	16.8	26.4	10.0	0.8	3.1	3.4	3.3
CCDC187	MGC50722	ENSG00000260220	"Coiled-coil domain containing 187"	A0A096LP49	9	136249971-136306901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"fallopian tube: 10.2;testis: 35.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 100.2;Late spermatids: 351.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"					"Cell type enriched"	"Detected in single"	5	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Group enriched"	"Detected in some"	7	"RPMI-8226: 14.8;SCLC-21H: 4.6"															NA	NA						"unprognostic (1.11e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-2)"		"unprognostic (6.18e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.93e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	10.2	0.0	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	35.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	14.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	41.5	6.8	1.8	0.0	0.0	0.0	0.0	100.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	351.2	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	2.1	1.2	0.0	0.0	0.0	0.0	0.0
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 32.2;Cone photoreceptor cells: 21.6;Muller glia cells: 33.2;Rod photoreceptor cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	7.8	10.2	15.2	5.6	8.3	5.6	4.2	38.6	23.0	10.5	5.3	12.8	4.8	4.7	13.4	10.1	2.6	7.1	8.3	25.5	8.8	11.6	5.5	1.8	13.8	3.2	8.8	14.2	16.4	28.1	4.4	6.6	8.8	10.5	12.7	2.2	20.4	7.7	8.6	2.8	12.0	4.6	9.0	9.1	8.0	6.1	12.0	9.9	2.8	3.9	3.7	2.0	5.0	8.2	0.4	0.7	0.0	2.0	0.0	2.1	0.3	1.7	2.8	6.7	11.7	3.9	6.7	5.6	19.3	8.1	5.5	3.0	5.6	1.8	0.0	8.2	11.7	4.6	1.3	1.0	4.0	1.2	15.2	11.4	2.2	9.1	1.0	16.5	0.1	2.8	10.9	2.7	5.0	2.9	6.8	5.5	2.7	5.8	0.1	3.6	6.3	1.0	2.1	7.1	0.6	10.2	36.1	12.1	5.6	1.5	1.3	16.4	20.4	3.6	0.4	6.0	2.7	8.1	3.8	8.9	10.2	8.1	11.8	3.9	3.5	0.1	0.0	6.1	0.0	9.6	0.0	0.3	0.0	0.7	2.0	0.8	0.0	1.2	0.1	0.7	0.4	0.5	0.3	0.0	0.0	0.0	0.0	2.1	0.3	15.2	8.3	38.6	18.8	8.8	11.6	8.8	14.2	10.5	9.9	3.0	3.5	0.0	2.1	3.8	32.2	9.7	0.0	0.0	0.0	0.0	21.6	0.4	10.0	2.6	0.5	3.6	0.0	0.0	1.6	0.7	8.4	3.9	5.7	0.0	1.0	9.5	1.7	5.5	0.8	1.1	9.8	1.8	8.5	0.0	0.0	33.2	5.9	0.0	8.9	0.0	40.9	0.0	4.7	0.0	1.7	2.9	0.2	0.0	0.0	2.4
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363789	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 7.4;Collecting duct cells: 5.2;Spermatogonia: 4.8;Suprabasal keratinocytes: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.2;MCF7: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.6	11.3	13.8	13.0	11.9	13.4	10.4	8.1	13.9	9.7	8.9	9.2	4.0	12.8	10.0	6.2	13.4	7.4	7.1	29.9	11.2	9.1	13.7	14.0	8.0	14.9	11.4	3.5	13.6	25.3	5.0	6.5	7.1	8.5	11.2	2.8	6.2	9.2	7.0	29.6	7.0	7.2	9.9	8.0	13.7	8.3	6.3	6.8	11.6	11.2	7.4	8.9	8.0	9.2	8.6	4.2	8.0	3.1	0.9	6.9	1.2	4.1	7.6	2.6	7.7	1.3	2.8	6.8	6.9	3.8	5.6	2.5	9.1	4.5	9.9	25.3	5.0	4.1	9.2	1.6	4.0	0.6	40.2	10.0	3.5	3.8	3.8	5.2	8.0	6.7	3.5	4.1	4.1	2.5	1.4	2.9	4.3	5.7	7.1	3.6	31.6	9.4	13.1	11.5	6.1	20.1	28.7	3.8	11.4	6.8	4.4	11.7	16.9	7.0	6.5	6.2	1.1	8.1	7.3	6.4	9.4	8.5	6.5	10.5	6.2	8.9	8.7	6.9	3.9	8.6	8.0	1.8	0.3	3.8	3.1	4.8	8.6	5.3	5.6	2.4	5.7	5.4	4.5	1.4	0.9	1.7	4.2	6.9	1.2	13.8	11.9	8.1	11.7	11.2	9.1	11.4	3.5	8.5	6.8	0.0	0.0	1.7	0.9	7.4	0.4	0.8	0.0	0.0	1.2	5.2	0.0	0.8	1.7	0.4	0.1	0.5	0.8	0.0	1.0	0.8	1.0	0.5	0.0	0.9	0.9	0.0	0.0	0.6	0.3	0.0	1.1	1.0	1.7	0.0	1.1	0.5	0.5	0.0	1.1	2.4	0.4	0.0	3.3	0.9	4.8	8.0	0.9	0.0	1.1	1.0
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;bone marrow: 19.4;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 19.6;Horizontal cells: 14.3;Kupffer cells: 14.8;Macrophages: 18.4;monocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 24.5;non-classical monocyte: 20.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.8;HMC-1: 33.2;NB-4: 24.1;THP-1: 29.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced					NA	NA					"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.7	2.4	3.6	8.8	10.4	19.4	2.2	2.7	6.4	2.1	1.9	5.5	0.3	2.7	1.4	1.9	1.7	3.3	4.2	1.7	4.0	2.4	2.0	2.3	4.8	6.6	8.1	2.0	1.6	1.0	0.6	1.5	2.3	5.0	2.7	1.0	1.5	2.9	2.2	0.8	4.8	3.8	2.0	4.8	15.9	1.7	0.8	6.9	0.9	0.8	1.5	4.6	2.5	1.8	0.0	11.3	4.6	24.5	0.3	0.4	5.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	5.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	9.8	0.1	3.2	2.4	6.1	33.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	24.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.2	7.4	0.0	7.9	0.0	0.0	2.3	29.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	7.3	0.1	2.3	14.6	4.6	0.0	24.5	0.4	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.1	0.3	20.5	0.1	0.3	5.1	3.6	10.4	2.7	6.4	4.0	2.4	8.1	2.0	5.0	6.9	0.0	5.8	0.0	0.6	1.5	0.0	1.7	0.0	0.0	6.8	3.5	0.0	0.3	1.7	0.1	0.7	0.3	0.0	0.0	0.0	0.3	2.0	0.1	10.4	0.0	19.6	14.3	0.0	1.3	14.8	4.6	0.3	18.4	1.7	11.8	0.0	5.7	0.0	0.0	0.0	0.2	1.0	0.0	1.2	0.9	1.3	1.5	0.3	1.3	0.0	0.3
SNAPC4	"FLJ13451, PTFalpha, SNAP190"	ENSG00000165684	"Small nuclear RNA activating complex polypeptide 4"	Q5SXM2	9	136375577-136400168	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046627, HPA073243"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA046627: AB_10961152, HPA073243: AB_2686585"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"prognostic favorable (4.52e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.41e-2)"	6.8	5.8	7.6	9.5	15.4	12.7	7.6	20.1	19.4	8.0	6.6	10.9	8.7	9.5	9.9	10.1	6.6	14.5	9.2	6.3	10.1	8.0	8.6	11.5	8.0	10.8	7.7	10.1	11.2	17.8	13.4	13.3	6.7	10.4	9.1	7.2	11.8	10.8	8.5	7.2	13.5	7.8	8.0	8.2	11.7	8.1	20.0	10.2	11.2	10.0	5.7	10.2	9.4	7.1	3.4	1.7	3.7	1.6	2.3	2.6	0.6	6.1	7.2	7.4	10.3	4.8	9.4	13.7	8.0	5.4	8.5	6.8	16.5	5.7	9.5	5.8	6.3	5.9	20.0	9.0	10.4	5.1	13.3	14.1	6.4	18.3	7.8	4.3	13.5	7.7	7.4	8.7	7.3	7.0	7.4	7.5	7.9	13.1	7.1	5.9	13.8	7.8	15.2	15.4	9.8	9.5	12.8	7.5	13.5	4.9	11.2	21.5	15.0	8.1	13.4	4.3	6.7	13.7	7.9	10.6	8.8	8.0	15.7	11.4	4.4	5.1	7.7	6.1	6.3	5.1	0.0	1.6	1.3	2.6	1.3	1.2	2.0	1.1	1.1	0.6	3.4	0.9	0.7	3.7	2.3	0.5	1.7	0.9	0.6	7.6	15.4	20.1	19.4	10.1	8.0	7.7	10.1	10.4	10.2	6.0	7.0	2.9	1.9	4.7	7.5	3.2	2.5	17.4	3.4	3.5	2.0	2.4	0.0	5.9	2.6	3.6	3.6	23.3	3.8	1.7	2.7	2.2	1.1	6.4	2.8	3.2	5.1	5.5	1.6	1.5	4.6	2.8	0.0	1.0	5.2	4.8	5.3	6.0	4.6	4.2	11.5	0.0	2.3	8.6	8.8	5.9	1.1	3.2	5.6	2.8
SDCCAG3	NY-CO-3	ENSG00000165689	"Serologically defined colon cancer antigen 3"	Q96C92	9	136401922-136410609	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 32.3;Horizontal cells: 31.8;Late spermatids: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029303	Approved					NA	NA					"HPA029303: AB_10602222"	"unprognostic (8.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.35e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.23e-2)"	17.0	12.7	8.2	18.7	9.9	10.5	17.9	14.9	12.8	12.8	17.2	13.6	17.3	16.2	13.2	13.0	14.7	12.6	18.2	17.9	10.4	8.1	15.9	40.6	11.9	21.3	12.8	10.9	14.0	22.9	8.2	10.2	12.5	11.9	12.8	10.6	10.5	15.9	10.7	20.2	16.6	15.2	18.0	8.6	20.3	14.8	22.9	10.7	18.0	15.7	10.0	16.8	15.1	16.9	5.3	2.3	2.2	1.5	2.1	4.9	1.3	13.2	16.7	10.9	22.5	10.8	10.2	22.1	12.7	7.5	13.1	8.4	21.2	10.3	11.3	10.6	9.8	16.3	33.1	20.4	14.7	7.8	21.7	13.8	9.8	28.4	14.5	15.0	15.5	11.2	9.4	21.3	12.6	26.7	6.9	10.1	17.4	22.6	8.4	12.0	24.6	6.5	16.4	38.3	35.0	17.5	12.6	11.9	44.7	10.8	11.0	21.7	17.8	13.5	21.7	20.5	8.8	31.5	17.5	10.7	20.1	12.0	25.9	24.6	6.5	12.0	16.5	17.1	19.5	19.8	0.0	1.5	2.2	1.6	0.6	4.9	5.3	2.6	2.2	0.8	2.9	2.8	3.4	1.1	2.1	1.4	2.3	2.6	1.3	8.2	9.9	14.9	12.8	10.4	8.1	12.8	10.9	11.9	10.7	3.0	8.5	10.9	7.8	13.2	13.1	0.0	0.0	2.7	5.7	0.0	9.8	3.9	0.0	0.0	32.3	8.3	5.4	0.0	0.0	4.8	6.8	9.7	1.1	23.1	15.3	31.8	3.5	6.7	10.1	37.2	7.2	4.1	6.8	0.0	11.2	10.3	0.0	0.0	3.9	0.0	10.4	0.0	5.2	10.7	11.1	10.9	2.4	5.0	11.9	9.3
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439823	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus, Focal adhesion sites"	Nucleoplasm	"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	14.3	11.2	14.9	15.3	10.4	8.9	19.2	19.9	19.1	10.5	10.7	11.5	11.1	10.3	13.1	10.1	8.4	17.2	9.4	11.9	12.6	12.0	10.2	9.0	10.1	13.5	8.4	12.3	14.7	11.6	11.4	12.3	9.8	13.2	9.9	5.2	11.0	14.4	12.9	11.6	18.2	10.7	10.7	6.6	19.4	8.6	15.2	10.3	8.5	12.5	6.2	10.7	8.8	19.3	2.6	1.0	1.9	0.5	0.0	2.4	0.6	6.2	7.2	8.5	8.4	4.3	5.6	10.5	7.5	4.4	5.8	3.7	7.4	4.4	7.8	7.7	6.3	8.3	17.5	3.7	5.1	2.2	24.3	14.7	5.2	12.4	4.9	7.3	6.1	8.5	6.0	4.8	6.4	5.7	6.9	5.6	10.0	8.8	7.2	4.9	10.3	7.8	13.4	5.5	3.9	12.0	14.3	6.5	5.8	5.2	6.1	8.9	8.0	7.2	6.8	5.2	6.1	10.9	9.1	8.0	17.9	6.7	7.2	13.0	7.8	6.3	3.3	9.2	5.4	6.5	0.0	0.5	1.9	2.0	0.0	1.3	2.6	2.3	1.5	0.5	1.7	0.8	1.6	0.4	0.0	0.3	1.0	2.4	0.6	14.9	10.4	19.9	19.1	12.6	12.0	8.4	12.3	13.2	10.3	3.0	5.8	2.9	1.5	4.8	7.1	4.1	7.6	6.7	3.4	3.5	2.0	2.0	1.7	4.5	0.3	5.8	2.8	0.0	4.8	2.0	3.9	2.0	9.2	3.0	2.6	14.3	5.8	2.5	3.8	0.7	6.9	3.5	5.0	4.6	2.9	8.5	5.3	0.0	5.3	2.2	11.4	0.0	4.8	9.8	7.8	4.3	0.7	4.3	4.3	1.6
SEC16A	"KIAA0310, p250, Sec16L"	ENSG00000148396	"SEC16 homolog A, endoplasmic reticulum export factor"	O15027	9	136440096-136483759	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005684	Supported		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA005684: AB_1079189"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.41e-1)"	9.7	11.2	13.4	10.6	16.4	21.5	10.1	36.8	21.0	11.4	9.4	9.2	10.7	10.0	11.7	8.9	10.9	10.4	9.0	8.7	13.3	5.4	10.0	23.8	11.6	10.5	12.3	11.5	10.7	20.2	11.9	26.3	7.6	13.2	13.2	7.2	10.4	16.3	9.7	14.3	13.4	11.3	7.3	6.7	13.4	19.1	46.7	12.9	19.6	15.8	5.7	8.1	10.0	8.4	5.9	6.1	4.7	7.2	3.3	7.1	4.5	10.7	24.0	12.1	19.9	12.9	13.3	14.3	13.4	11.7	10.0	7.7	17.2	9.2	10.8	9.5	16.2	12.3	29.8	13.4	19.2	5.5	22.8	8.7	11.0	22.3	13.7	12.5	18.7	19.6	14.3	13.9	13.9	16.4	8.1	13.6	14.5	13.7	15.0	10.5	46.6	12.5	10.1	10.6	32.4	17.0	18.0	15.0	18.3	10.2	14.5	17.1	11.4	17.3	26.3	8.2	6.1	26.9	14.7	19.5	16.2	12.2	13.0	10.3	7.2	10.9	14.0	12.6	8.5	16.1	3.9	5.9	2.8	6.3	7.1	6.5	5.9	6.4	7.1	3.6	3.8	4.2	6.7	4.7	3.3	7.2	6.1	4.5	4.5	13.4	16.4	36.8	21.0	13.3	5.4	12.3	11.5	13.2	12.9	23.8	39.0	11.5	13.2	22.0	19.1	10.8	12.7	28.1	20.5	12.2	23.6	6.9	6.6	12.7	3.8	15.2	20.6	0.0	14.2	9.5	15.3	23.5	23.1	50.5	14.4	31.8	39.1	18.4	21.3	3.6	12.0	16.3	13.5	12.6	57.7	12.5	18.6	8.6	15.6	8.6	16.0	12.9	12.7	23.8	12.8	23.5	12.6	13.8	17.8	20.7
NOTCH1	TAN1	ENSG00000148400	"Notch 1"	P46531	9	136494433-136545786	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 41.3;Ito cells: 68.2;Muller glia cells: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 25.0;HMC-1: 21.7;hTCEpi: 24.0;MOLT-4: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		8100000	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	20.0	4.0	10.0	14.5	10.4	14.6	12.8	3.8	18.8	12.8	14.2	19.9	8.2	9.8	11.2	5.1	13.3	9.6	13.1	9.6	10.7	5.8	9.4	7.2	17.4	13.7	11.6	7.5	9.2	17.8	3.7	5.6	8.5	9.3	12.1	5.7	10.4	14.2	11.8	8.2	32.3	10.8	7.7	6.6	20.7	8.6	4.1	9.9	34.8	9.4	10.2	10.9	12.3	22.2	0.6	1.1	8.8	1.0	2.7	1.3	0.9	4.4	7.5	6.2	3.1	0.2	0.5	7.8	2.2	0.6	1.3	0.4	1.1	0.5	6.1	4.7	1.7	1.6	25.0	2.0	10.3	0.2	13.8	1.1	3.4	3.0	0.4	3.4	3.6	21.7	0.4	24.0	1.8	3.8	1.5	8.0	2.7	1.5	1.1	0.9	8.1	38.1	5.8	5.2	3.2	3.4	7.9	5.0	11.2	0.9	3.8	0.0	0.4	3.3	3.5	1.4	1.9	2.1	5.8	11.8	3.3	4.8	3.2	2.4	1.3	1.1	2.4	2.2	2.5	16.9	0.7	1.0	2.8	1.3	0.4	0.8	0.4	0.6	1.0	0.6	0.6	0.4	1.1	8.8	2.7	0.4	1.1	0.4	0.9	10.0	10.4	3.8	11.7	10.7	5.8	11.6	7.5	9.3	9.9	8.9	28.2	13.8	10.6	22.0	0.3	7.3	7.6	0.0	6.8	1.8	2.0	0.7	0.0	4.8	0.3	41.3	4.9	0.0	3.4	1.8	4.8	6.6	34.6	6.8	8.0	1.6	2.4	68.2	10.5	0.0	1.1	17.1	6.8	1.0	11.0	50.6	2.2	7.0	0.7	4.1	1.7	6.5	11.5	0.2	3.2	26.1	0.9	12.9	24.7	14.1
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 112.4"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 251.2;Hofbauer cells: 218.0;Ito cells: 521.1;Spermatogonia: 179.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 2.6;eosinophil: 4.2;intermediate monocyte: 7.7;non-classical monocyte: 6.2;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 7.1;granulocytes: 4.2;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.9;HUVEC TERT2: 70.6;RPMI-8226: 27.7;TIME: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA050716: AB_2732562"	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	54.8	11.2	17.7	9.0	23.7	8.7	34.2	8.5	23.6	19.7	10.3	7.2	17.4	9.3	28.9	19.7	9.5	14.6	17.5	31.0	18.0	12.7	24.3	10.6	46.9	12.0	21.5	8.1	7.5	9.7	5.7	10.5	112.4	27.5	13.7	3.5	19.9	21.3	16.1	29.3	14.1	9.9	10.9	10.4	41.1	7.4	11.4	17.6	0.2	20.7	16.2	4.9	10.7	55.3	0.1	7.1	4.2	7.7	0.2	0.3	3.4	0.0	9.6	3.1	11.2	0.2	0.2	7.2	2.7	0.5	1.6	0.5	3.3	9.0	0.0	39.9	0.9	2.5	1.3	0.8	1.7	0.0	15.9	3.0	5.9	0.7	0.2	2.5	0.0	8.7	0.3	0.7	0.8	0.0	0.5	70.6	0.4	21.3	0.0	0.5	17.2	0.1	0.1	4.5	13.3	0.5	18.9	1.2	27.7	1.0	0.2	2.0	6.7	1.3	1.2	2.5	0.9	3.3	9.1	65.9	0.4	8.2	0.9	0.5	0.0	0.0	0.1	0.0	0.0	8.1	0.0	2.6	4.2	0.1	7.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	1.1	0.2	6.2	7.1	0.0	3.4	17.7	23.7	8.5	23.6	18.0	12.7	21.5	8.1	27.5	17.6	0.0	40.6	8.9	4.8	10.5	1.1	15.4	5.1	0.0	2.3	3.5	0.0	2.9	6.6	21.4	2.1	251.2	1.7	0.0	1.6	13.3	17.6	15.2	19.7	15.3	218.0	3.2	1.2	521.1	30.4	6.8	8.1	8.2	18.6	0.0	2.8	1.3	8.5	1.1	5.6	16.8	1.6	12.9	13.3	3.6	179.3	8.3	5.0	2.5	0.0	3.1
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 930.5;Paneth cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.7	20.8	2.4	11.5	17.9	5.6	10.5	9.8	7.8	6.7	5.1	23.6	29.2	4.9	22.1	5.6	10.9	40.1	3.5	6.1	0.7	50.5	15.9	7.2	8.6	5.1	12.3	7.5	17.6	5.3	8.5	5.7	3.0	5.8	3.5	6.6	8.7	0.8	2.8	26.6	0.5	23.5	6.3	27.2	37.8	11.1	8.9	26.9	7.9	9.3	5.5	8.9	12.7	13.4	16.1	2.0	8.5	29.8	6.8	8.9	9.2	2.9	6.2	1.2	0.1	3.1	0.1	16.3	8.9	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9	14.9	59.7	17.6	50.1	40.2	2.1	34.7	68.8	10.7	18.2	69.8	0.0	6.7	46.4	135.1	138.9	26.4	930.5	0.0	193.7	28.9	36.3	80.5	13.8	203.0	114.8	38.1	34.3	22.1	50.6	271.0	24.7	62.8	129.9	36.9	126.5	13.3	140.9	350.7	19.1	33.5	3.6	45.3	29.6	1.1	36.6	71.0	5.7	20.3	115.8	138.0
FAM69B	"C9orf136, MGC20262"	ENSG00000165716	"Family with sequence similarity 69 member B"	Q5VUD6	9	136712570-136724050	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 15.8;Horizontal cells: 25.4;Ito cells: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"naive B-cell: 7.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	34	"B-cells: 7.3;dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 28.7;HEK 293: 25.7;HUVEC TERT2: 31.9;REH: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054443			Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		No	No			"Nuclear bodies"	"Nucleoplasm, Vesicles"	"HPA054443: AB_2682489"	"unprognostic (2.78e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.10e-2)"	"prognostic favorable (9.48e-5)"	"unprognostic (2.77e-1)"	"unprognostic (6.67e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-1)"	8.0	3.8	12.3	3.6	14.2	8.2	5.6	19.8	21.4	6.1	4.6	4.9	2.3	4.7	9.6	5.0	4.7	11.0	5.9	18.8	12.3	14.6	6.6	5.5	11.0	4.5	12.4	15.9	5.4	11.9	7.9	11.4	24.5	14.2	6.5	1.3	17.5	11.2	4.5	9.9	13.0	4.4	4.1	5.3	7.9	3.5	7.5	3.2	1.6	7.6	4.1	2.1	3.2	3.1	7.3	1.9	0.0	0.1	0.0	0.0	0.7	0.5	3.4	9.6	9.4	0.0	0.0	8.6	0.3	0.0	0.4	0.4	9.7	1.6	0.8	28.7	0.0	3.1	2.9	4.9	0.1	0.0	1.3	25.7	5.4	0.4	0.3	0.1	0.8	2.9	0.1	0.0	0.1	0.0	1.4	31.9	6.9	6.4	0.9	0.0	4.2	3.7	8.6	14.8	2.1	2.1	20.5	0.2	9.6	0.5	1.0	16.4	17.7	0.4	1.9	7.1	3.1	5.3	5.0	16.3	0.8	7.1	1.3	0.6	5.7	0.5	2.5	0.6	0.8	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	12.3	14.2	19.8	21.4	12.3	14.6	12.4	15.9	14.2	3.2	0.0	5.3	1.4	1.3	0.9	10.5	4.4	0.0	0.0	1.2	0.0	9.8	0.5	3.3	0.6	1.2	15.8	0.0	0.0	0.0	5.3	2.1	1.3	1.1	3.9	0.4	25.4	0.0	20.3	0.6	3.7	4.4	0.2	11.8	0.0	0.0	9.7	0.2	0.0	2.5	1.1	8.3	0.0	0.8	1.2	5.5	0.3	0.2	0.0	0.0	0.0
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"memory B-cell: 5.5;naive B-cell: 6.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;Hep G2: 1.3;REH: 2.1;RPMI-8226: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055919	Approved				"Secreted in male reproductive system"	NA	NA					"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	2.8	0.0	0.5	1.4	0.5	0.2	2.2	0.5	1.0	6.2	0.9	0.7	3.2	0.2	7.2	21.8	0.8	7.8	1.2	4.5	0.5	0.0	0.5	0.5	0.5	0.8	0.5	0.5	1.8	1.5	0.0	0.5	0.5	0.5	2.1	0.6	0.5	1.2	0.8	0.6	0.2	2.0	2.5	0.5	1.4	1.5	2.1	0.5	0.5	4.3	0.5	0.9	2.1	2.6	6.2	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.7	0.6	0.0	0.0	2.1	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	6.2	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.5	0.5	0.5	1.0	0.5	0.0	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN6		ENSG00000267206	"Lipocalin 6"	P62502	9	136744011-136748528	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	19	"epididymis: 261.0"	"Cell type enhanced"	"Detected in some"	21	"Endothelial cells: 16.9;Ito cells: 3.7;Leydig cells: 5.2;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in some"	10	"thyroid cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 4.7;REH: 14.9"														"Secreted in male reproductive system"	NA	NA						"unprognostic (4.05e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.83e-4)"	"unprognostic (3.41e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-1)"	4.5	0.5	0.4	1.3	0.6	1.1	4.4	0.4	0.6	5.1	1.6	0.4	13.9	0.5	10.1	261.0	1.5	6.5	1.8	8.3	0.4	0.0	0.8	0.5	1.1	0.6	0.6	0.5	2.6	1.0	0.6	0.3	0.5	0.6	3.4	0.6	0.6	2.0	1.2	1.5	0.5	3.1	1.4	0.7	1.0	3.1	3.2	0.4	0.3	2.2	0.4	0.5	2.9	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	14.9	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.4	0.6	0.4	0.0	0.6	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.2	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"epididymis: 72.1"	"Cell type enriched"	"Detected in single"	8	"B-cells: 2.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 5.3"	"Group enriched"	"Detected in some"	57	"memory B-cell: 5.3;naive B-cell: 9.3"	"Lineage enriched"	"Detected in single"	72	"B-cells: 9.3"	"Cell line enriched"	"Detected in some"	6	"REH: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA									"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"		0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.7	0.1	0.0	0.0	2.5	0.0	0.2	72.1	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.5	0.0	0.0	0.9	0.0	0.6	0.0	0.0	1.9	0.0	0.2	0.0	0.0	9.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	7.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	5.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell type enriched"	"Detected in some"	54	"Intestinal endocrine cells: 377.4"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.7"					"Low region specificity"	"Detected in all"			HPA060584	Enhanced				"Secreted in other tissues"	NA	NA					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	377.4	0.0	0.8	1.7	0.0	0.0	1.7	0.0	0.7	0.0	0.0	7.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791355-136793257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.4;T-47d: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	10.0	15.5	15.7	23.4	15.3	15.5	22.9	11.6	28.3	17.2	54.4	21.0	22.4	21.9	9.4	31.1	35.5	22.6	27.9	22.8	15.2	12.2	38.5	43.4	14.4	23.0	19.9	19.3	13.8	46.3	20.6	23.1	31.7	22.0	49.0	51.4	12.5	32.5	27.5	13.5	22.0	25.6	10.5	19.1	14.1	23.3	16.5	13.8	16.3	28.6	26.0	15.2	16.4	16.3	11.1	42.7	9.0	19.4	12.4	11.3	12.2	15.0	11.0	9.8	6.1	12.4	10.0	21.2	8.5	13.4	10.6	8.5	14.5	13.7	14.5	13.3	9.2	9.6	22.6	4.2	25.0	3.4	10.5	7.6	8.1	6.1	16.1	18.1	8.4	10.1	9.6	42.9	8.1	23.0	12.1	15.7	19.3	8.0	7.8	13.8	30.8	11.5	6.5	4.7	64.4	12.4	9.6	10.3	42.7	24.0	8.5	16.5	7.4	9.2	35.1	9.6	8.8	62.6	8.2	10.7	7.6	6.0	13.8	5.5	5.1	7.9	7.7	11.4	12.2	10.8	6.5	13.8	9.0	11.3	19.4	10.2	8.7	7.9	8.1	11.2	11.1	10.9	10.0	3.3	12.4	16.0	42.7	7.5	12.2	15.7	15.3	11.6	28.3	15.2	12.2	19.9	19.3	22.0	13.8	53.6	66.5	48.0	79.9	36.1	13.8	38.7	140.1	40.2	47.8	111.7	7.9	153.9	530.6	139.6	35.4	42.8	541.1	0.0	69.3	125.8	30.6	159.7	40.5	149.9	127.7	4.8	198.8	60.2	56.6	92.7	34.8	37.5	81.0	99.2	409.6	43.5	87.4	627.8	28.0	354.2	22.0	45.3	28.3	48.3	42.6	54.8	229.4	48.4	378.9	92.2
CCDC183	"bA216L13.7, KIAA1984, MGC15438"	ENSG00000213213	"Coiled-coil domain containing 183"	Q5T5S1	9	136796350-136807741	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 26.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 186.3;Late spermatids: 116.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 4.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.1;HL-60: 1.4;HSkMC: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043812	Uncertain					NA	NA					"HPA043812: AB_10961860"	"unprognostic (2.91e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.89e-5)"	"unprognostic (3.45e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.16e-3)"	"unprognostic (4.32e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.20e-2)"	"unprognostic (5.15e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.6	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.2	3.4	0.4	0.0	4.0	2.3	1.8	0.0	2.0	1.7	0.9	186.3	0.2	2.6	0.0	0.6	0.8	1.5	3.7	0.0	0.5	0.4	4.8	7.5	1.3	1.5	116.1	2.6	0.7	3.3	1.0	5.9	2.9	1.2	20.1	3.5	0.7	4.4	6.5	0.9	3.2	0.8	0.1	5.8	1.3	4.9	0.8
RABL6	"bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1"	ENSG00000196642	"RAB, member RAS oncogene family like 6"	Q3YEC7	9	136807943-136841187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044037	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA044037: AB_10966437"	"unprognostic (3.10e-3)"	"unprognostic (8.52e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.00e-4)"	"unprognostic (9.23e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (5.23e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (9.14e-4)"	"unprognostic (4.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.15e-1)"	20.8	17.7	31.0	21.6	42.8	32.9	17.9	43.6	41.4	12.5	25.1	18.0	14.8	29.4	13.7	14.6	17.9	12.8	22.2	29.4	28.2	22.2	17.1	7.3	17.2	18.5	22.7	21.6	13.9	39.6	17.4	23.3	16.0	16.7	24.3	16.6	13.1	24.8	16.9	98.6	21.5	29.4	15.6	20.6	20.0	24.5	16.5	17.2	20.9	13.9	22.6	13.9	13.8	19.9	4.7	4.1	2.9	5.7	6.1	5.2	1.4	19.2	25.6	18.4	21.5	7.5	8.5	48.4	17.5	11.3	17.0	12.5	28.5	20.5	27.3	11.0	13.6	17.9	42.3	20.4	15.5	5.8	28.4	26.3	16.7	32.0	33.3	13.6	30.9	21.5	9.4	16.0	10.5	11.7	10.4	17.7	23.6	36.3	13.4	11.6	38.5	33.0	21.4	34.4	23.7	22.1	43.3	22.0	26.6	11.2	17.2	60.6	25.1	30.9	36.3	21.6	10.2	31.2	31.2	21.3	22.1	19.2	23.2	28.3	11.5	13.1	22.2	18.5	15.1	20.6	1.2	4.8	2.9	3.7	5.7	3.8	4.5	3.9	3.6	3.3	4.7	3.2	4.1	2.3	6.1	2.0	4.1	5.2	1.4	31.0	42.8	43.6	41.4	28.2	22.2	22.7	21.6	16.7	17.2	26.8	48.3	8.9	15.4	16.0	37.2	29.1	0.0	8.1	7.9	24.4	19.6	20.7	26.6	28.0	10.1	16.9	100.2	0.0	49.7	27.9	22.0	31.8	15.0	0.0	27.4	36.5	49.8	0.0	0.0	10.9	18.1	26.0	38.8	26.2	55.1	18.1	55.1	51.0	25.1	38.5	38.3	0.0	17.3	15.4	26.4	16.9	23.7	12.9	57.2	21.6
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;testis: 15.0"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 5.2;Ductal cells: 1.4;granulocytes: 1.1;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.7"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	1.1	1.9	4.6	1.3	6.3	1.4	1.1	22.7	7.9	1.1	4.0	1.1	1.1	3.3	1.2	1.1	1.1	0.3	1.1	1.2	4.4	3.1	1.1	1.1	1.1	1.1	2.1	1.1	1.1	7.6	1.1	5.2	1.1	1.1	2.6	1.1	1.1	2.0	2.2	3.9	1.5	4.3	1.1	1.3	3.6	2.3	15.0	1.1	1.1	1.1	1.1	1.1	2.6	1.1	0.2	3.9	0.1	1.6	0.2	1.9	0.8	3.7	3.0	0.4	1.1	0.5	0.4	4.9	3.0	0.5	0.4	0.2	1.0	2.0	2.3	2.6	0.8	1.0	4.2	0.4	1.1	0.0	5.8	2.2	0.6	5.6	0.9	1.7	1.3	4.2	0.9	1.5	0.5	0.3	2.5	0.2	1.1	3.5	1.5	0.7	4.1	0.4	4.5	1.2	3.1	3.9	2.8	0.9	7.3	0.9	0.7	7.4	2.6	1.9	7.6	4.0	0.6	6.0	2.8	3.1	5.0	3.5	1.7	1.8	6.6	4.5	0.8	8.8	4.6	1.2	0.0	1.6	0.1	1.9	1.0	0.4	0.2	0.5	0.9	1.5	0.0	0.2	0.9	0.1	0.2	1.5	3.9	0.1	0.8	4.6	6.3	22.7	6.8	4.4	3.1	2.1	1.1	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		430000	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	15.8	26.4	31.5	12.1	28.0	11.7	15.3	14.7	27.2	19.2	15.7	18.5	13.7	14.7	11.2	21.7	13.7	21.1	14.2	59.1	22.7	19.3	18.4	12.6	12.1	12.7	27.0	21.0	13.7	46.5	15.6	21.2	14.7	20.8	20.2	11.6	14.1	30.5	22.6	86.0	9.2	16.3	16.9	24.3	10.3	13.4	13.8	18.6	7.5	20.7	19.8	10.4	12.0	9.8	24.9	48.8	3.3	35.4	20.0	24.3	32.1	7.1	52.0	29.7	18.9	19.2	34.9	43.7	16.6	21.2	20.3	18.1	18.9	16.3	15.2	20.2	20.5	24.3	18.9	6.4	37.5	6.4	13.6	13.2	4.8	34.2	41.5	23.9	9.5	19.5	43.5	30.9	11.6	14.0	18.4	26.6	11.9	11.5	14.1	31.4	40.6	13.8	20.0	23.5	47.6	22.4	11.5	13.0	25.1	32.1	11.9	14.6	13.8	17.9	21.0	8.6	14.8	15.9	26.4	21.6	42.5	13.2	11.7	15.3	9.4	9.1	9.3	24.0	6.9	25.4	2.9	35.4	3.3	24.3	34.2	20.9	24.9	21.1	21.9	37.5	16.5	15.0	21.3	1.7	20.0	24.0	48.8	22.9	32.1	31.5	28.0	14.7	27.2	22.7	19.3	27.0	21.0	20.8	18.6	89.3	132.7	80.4	156.2	133.5	37.9	336.8	191.1	136.5	125.1	205.9	21.6	300.5	633.3	164.3	214.6	110.1	411.5	70.0	220.3	372.9	227.8	244.3	120.2	179.9	249.5	63.5	254.7	94.5	103.8	640.4	189.8	148.3	317.2	367.9	241.4	126.9	202.0	354.2	210.0	509.4	53.8	84.1	248.0	93.6	149.9	141.4	220.8	93.5	262.8	160.3
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.6	2.6	1.5	2.9	0.6	0.1	18.9	2.7	0.3	0.3	0.6	2.0	1.6	1.4	0.6	0.7	0.8	2.2	0.3	1.3	0.0	2.1	0.9	0.8	5.3	2.3	1.2	0.2	4.9	0.8	1.7	1.4	0.6	1.4	0.6	2.5	2.7	1.2	0.2	4.2	1.0	3.7	1.4	1.1	0.7	1.6	0.4	2.5	0.9	1.4	1.7	2.1	0.6	1.3	1.1	1.0	4.4	0.9	0.8	7.6	4.8	1.5	0.4	3.1	1.6	0.4	1.7	2.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2	0.0	4.3	0.0	0.8	0.7	5.4	6.2	12.7	2.7	0.0	1.8	0.0	2.2	1.7	0.8	1.7	1.4	19.8	0.0	4.4	2.8	2.6	1.3	0.0	16.6	2.4	15.9	0.0	2.5	2.4	1.9	1.7	2.2	0.0	1.0	19.5	2.6	0.9	12.5	1.4	2.1	7.4	0.0	1.4	1.2	2.2	0.4	1.9	1.3	10.3	0.7
EDF1	"CFAP280, EDF-1"	ENSG00000107223	"Endothelial differentiation related factor 1"	O60869	9	136862119-136866286	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Activator, Calmodulin-binding, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035642	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		140000	"Nucleoplasm, Cytosol"		"HPA035642: AB_10611959"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.65e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	49.5	68.5	77.7	58.3	67.3	55.6	71.0	68.2	75.2	51.6	68.7	35.1	75.3	106.6	55.0	60.9	68.4	57.3	66.7	83.2	66.5	61.8	65.4	107.5	47.2	75.3	64.9	64.2	72.1	273.4	44.5	64.4	47.7	62.3	64.1	46.5	38.2	123.3	96.5	175.4	69.4	102.3	64.3	71.9	48.8	61.9	49.5	44.8	43.6	64.5	75.1	51.5	51.9	57.7	78.2	116.5	58.0	70.5	68.6	83.6	85.4	63.7	85.8	47.8	48.5	47.7	50.3	94.1	73.7	49.9	59.8	46.7	69.4	44.7	56.1	68.7	64.1	53.3	77.2	37.2	56.4	22.0	60.6	45.3	39.0	108.0	94.3	94.9	66.4	53.4	49.7	72.6	46.8	54.6	55.8	57.4	50.9	56.4	72.7	51.1	139.7	59.2	105.8	50.4	99.2	73.6	52.1	69.8	113.2	79.3	68.2	61.3	58.9	76.9	108.4	74.5	33.0	104.7	93.4	69.5	65.4	49.4	70.7	68.5	42.0	70.1	47.2	85.4	40.0	59.8	45.7	70.5	58.0	69.9	59.9	77.2	78.2	74.8	72.1	70.8	71.9	66.9	68.8	28.2	68.6	48.9	116.5	83.6	85.4	77.7	67.3	68.2	75.2	66.5	61.8	64.9	64.2	62.3	44.8	211.4	257.9	360.4	480.4	463.8	134.8	270.5	479.0	235.5	258.2	298.4	37.3	561.0	978.2	614.3	98.1	432.9	1611.3	163.5	1109.8	593.2	450.9	513.8	287.2	695.8	501.5	89.0	425.8	343.1	356.1	224.5	538.4	426.7	499.4	906.3	749.8	223.0	954.5	1406.3	401.0	993.5	116.5	271.7	418.6	236.6	258.3	542.3	942.8	422.7	608.2	611.5
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	7.3	6.6	8.7	20.3	10.4	15.9	8.6	16.0	10.0	7.3	8.7	7.4	7.3	11.1	12.3	6.9	12.3	9.0	8.3	8.3	7.5	6.5	8.5	12.3	11.5	19.7	11.2	8.3	6.8	13.9	5.9	8.8	12.1	8.1	10.2	6.2	7.5	13.0	10.1	6.4	13.0	10.4	10.6	8.2	13.8	10.7	13.7	6.4	16.4	14.7	5.2	15.9	8.4	37.5	12.6	11.5	6.7	8.3	10.1	17.4	6.2	10.6	32.9	8.9	7.9	2.5	4.0	17.5	8.8	4.9	12.9	8.8	20.3	19.4	13.3	11.5	5.5	17.5	28.2	12.2	14.4	5.3	20.2	9.9	10.0	29.8	12.6	3.7	9.9	10.4	3.0	4.4	10.5	6.0	4.9	6.1	12.4	16.9	15.2	5.7	15.5	15.9	14.2	14.5	24.5	14.8	15.1	13.7	18.1	7.9	8.4	14.6	6.8	11.0	25.9	10.0	10.4	18.6	11.6	6.8	16.9	10.9	11.0	14.8	6.4	10.3	13.3	6.0	8.1	12.4	1.3	3.7	6.7	10.4	4.2	14.6	12.6	11.1	13.0	4.9	10.0	9.1	10.9	3.3	10.1	8.3	11.5	17.4	6.2	8.7	10.4	16.0	10.0	7.5	6.5	11.2	8.3	8.1	6.4	0.0	8.3	13.4	12.1	10.5	6.8	6.3	12.7	0.0	3.4	5.2	0.0	16.7	3.3	18.9	2.5	8.2	15.4	0.0	11.0	25.5	7.4	11.2	10.3	4.0	11.7	17.5	10.9	4.3	2.4	2.7	3.1	7.3	13.5	55.1	9.2	4.2	16.3	5.8	7.4	5.0	10.0	19.4	12.7	9.2	22.0	11.2	14.9	13.8	12.4	9.1
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944696	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 460.8;Late spermatids: 1531.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favorable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	17.6	13.9	13.3	12.4	14.4	14.7	11.8	11.2	24.3	9.8	17.0	9.6	12.7	23.7	11.1	11.8	19.5	8.5	15.9	30.7	15.3	9.6	13.4	31.0	9.0	10.8	11.8	10.9	8.4	25.9	8.8	10.5	12.8	12.0	13.7	7.5	9.3	25.7	16.1	68.2	11.5	23.4	18.2	6.5	12.7	16.4	67.8	9.6	16.2	12.8	17.3	16.0	14.4	11.6	16.3	38.7	33.0	28.4	20.1	41.2	26.0	15.1	26.3	6.0	14.7	14.7	9.6	35.8	15.9	10.9	11.1	6.1	17.5	19.8	10.4	18.4	16.2	8.7	20.0	5.4	13.8	1.8	13.9	18.3	9.0	35.9	18.0	16.3	13.1	23.3	11.0	12.4	10.1	8.4	8.9	11.3	8.1	17.5	17.2	8.3	40.1	10.2	15.7	11.1	18.4	28.8	11.5	9.2	18.9	9.6	15.5	12.7	12.8	19.6	21.2	21.1	2.4	24.4	20.7	21.9	16.6	15.0	30.9	13.7	14.4	17.1	6.9	22.6	11.7	12.5	19.6	24.8	33.0	41.2	28.4	31.3	16.3	31.3	34.5	23.3	12.9	14.0	23.2	13.1	20.1	21.9	38.7	36.3	26.0	13.3	14.4	11.2	24.3	15.3	9.6	11.8	10.9	12.0	9.6	17.9	47.9	36.0	34.0	25.4	26.7	73.4	48.4	13.4	19.4	22.7	15.7	58.4	63.0	97.4	460.8	47.6	329.2	0.0	129.2	114.9	40.1	69.0	28.8	95.6	79.2	57.2	64.6	41.1	51.5	1531.1	47.8	44.4	65.8	159.7	119.4	39.5	113.5	143.8	66.8	98.2	31.7	58.2	56.1	189.9	37.9	31.5	84.8	55.4	85.6	54.2
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945246-136946974	"Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 165.8"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 942.4"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.5;T-cells: 3.4"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 61.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA046269	Approved				"Secreted to blood"	NA	NA		1500000000			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.2	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	6.0	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.5	0.0	0.1	0.0	3.4	0.3	0.1	0.9	0.1	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	1.1	0.6	1.1	0.7	0.0	0.2	1.0	0.0	0.1	0.0	1.1	0.1	0.4	1.7	4.6	0.0	0.1	61.0	0.0	0.2	0.2	0.0	0.2	0.2	0.4	0.1	0.6	0.2	0.8	0.1	0.5	0.0	0.1	0.2	0.1	0.2	0.9	0.2	0.5	0.2	0.2	0.2	1.7	0.3	0.1	1.5	0.4	0.7	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.2	0.5	0.2	0.0	0.1	0.0	3.4	0.0	0.4	0.0	0.7	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.3	48.4	0.0	0.0	0.0	2.0	0.3	0.0	0.2	0.8	0.4	38.4	0.0	0.7	0.8	0.2	0.1	9.2	942.4	0.2	0.0	1.7	22.7	24.1	0.9	0.0	0.0	0.0	0.0	0.7	0.8	0.6	3.5	0.7	1.4	0.5	0.0	0.0	0.7	0.7	0.4	2.9	3.8	1.7	0.1
LCN12	MGC48935	ENSG00000184925	"Lipocalin 12"	Q6JVE5	9	136949551-136955497	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 131.5"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 47.1;Distal tubular cells: 16.6;Intestinal endocrine cells: 15.7;Muller glia cells: 26.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	21	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.8;BEWO: 1.4;Daudi: 1.0;EFO-21: 1.7;HEL: 1.5;SH-SY5Y: 1.1"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA						"unprognostic (7.27e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.33e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.06e-1)"	"unprognostic (5.00e-2)"	"unprognostic (7.91e-4)"	0.3	0.4	0.9	0.3	1.8	0.3	0.3	0.2	0.9	0.9	0.3	0.4	24.4	0.4	0.5	131.5	0.3	2.4	0.3	0.3	0.8	0.8	2.3	1.2	0.3	0.3	1.0	0.7	0.6	0.7	0.3	1.9	0.3	1.2	0.3	0.3	1.6	0.3	10.9	0.3	0.3	0.4	0.3	0.9	0.6	0.4	1.1	0.9	0.0	8.6	0.0	0.3	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.9	1.8	0.2	0.9	0.8	0.8	1.0	0.7	1.2	0.9	0.0	2.1	0.5	0.3	0.0	0.2	6.9	0.0	1.4	2.3	47.1	2.0	0.1	16.6	1.0	0.6	0.0	2.9	0.0	1.1	0.0	0.2	0.9	0.0	10.2	0.2	0.0	15.7	0.0	0.3	0.8	13.8	0.0	0.0	0.0	2.6	26.1	0.7	0.0	10.3	5.9	0.9	0.0	0.0	1.4	0.2	0.0	0.2	0.0	4.7	0.2
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 35232.9;Peritubular cells: 61248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"	"Group enriched"	"Detected in some"	6	"HHSteC: 106.3;HSkMC: 51.8"									"HPA004938, CAB009916"	Approved				"Secreted to blood"	NA	NA		4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	106.3	0.0	0.2	51.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.1	13.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2	0.0	1.1	0.0	3.5	62.5	41.8	283.2	0.0	0.0	0.0	130.9	49.1	12.3	58.0	0.3	163.9	98.7	0.0	0.0	0.0	31.2	935.4	19.2	1.1	1.6	48.0	20.6	0.0	51.5	2.8	458.6	35232.9	41.1	199.1	1.8	0.0	4317.3	1.2	0.0	61248.9	0.6	110.6	161.7	44.3	116.5	105.1	70.0	29.6	37.4	0.0	14.4
LCNL1	FLJ45224	ENSG00000214402	"Lipocalin like 1"	Q6ZST4	9	136981904-136986410	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.1;seminal vesicle: 3.7;testis: 2.5"	"Group enriched"	"Detected in some"	30	"Leydig cells: 49.5;Muller glia cells: 41.0;Peritubular cells: 119.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;fHDF/TERT166: 1.4;HSkMC: 1.0;TIME: 1.3"															NA	NA						"unprognostic (1.39e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.08e-3)"	"unprognostic (5.14e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.03e-5)"	"unprognostic (6.46e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.34e-9)"	"unprognostic (4.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	0.1	0.0	2.2	0.0	1.8	0.0	0.1	0.4	1.9	1.0	0.1			0.0	0.3	1.6	0.0	0.4	0.2	0.5	2.0	1.3	0.3	0.0	0.2	0.7	3.1		0.0	0.0	0.0	0.0	0.5		1.0	0.0		0.0	3.7	1.0	0.0	0.2	0.1	2.6	0.3	0.1	2.5			0.0		0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0											0.0	0.0	0.0	0.0	0.1	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	49.5	0.0	0.0	0.0	0.0	41.0	0.0	0.0	119.9	0.0	1.4	0.0	0.4	0.3	0.7	0.0	0.1	0.0	0.0	0.0
PAXX	"C9orf142, XLS"	ENSG00000148362	"PAXX, non-homologous end joining factor"	Q9BUH6	9	136992418-136993984	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 112.4;Distal tubular cells: 111.0;Extravillous trophoblasts: 180.6;Syncytiotrophoblasts: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045268	Uncertain		Supported	Nucleoplasm		NA	NA		77000	Nucleoplasm		"HPA045268: AB_10963079"	"unprognostic (1.85e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.97e-3)"	14.0	10.2	20.7	17.2	18.4	28.0	15.6	14.7	25.4	11.9	17.8	16.4	10.3	22.0	10.6	12.9	14.1	11.8	14.3	12.4	19.4	16.9	14.2	18.2	12.9	24.2	20.7	12.5	10.1	25.9	9.4	17.1	17.1	16.0	16.0	4.9	9.9	24.8	15.7	15.8	19.5	18.1	7.1	25.3	27.8	28.0	6.4	14.7	34.5	16.4	11.5	15.0	11.5	10.3	8.3	56.3	4.1	12.6	19.1	36.2	13.5	10.2	11.5	1.8	7.0	3.3	3.0	27.5	7.9	4.8	5.3	2.9	5.0	7.5	9.3	13.9	2.0	2.0	16.4	0.6	5.9	0.4	23.7	16.4	7.2	5.9	4.2	5.0	10.3	16.1	2.2	5.6	1.8	2.3	0.9	4.8	17.0	10.7	2.7	1.1	22.6	10.8	16.8	11.1	11.9	35.3	14.1	3.8	26.2	3.5	5.3	8.8	11.0	6.8	16.9	9.0	0.3	20.2	8.7	6.3	2.5	7.8	12.0	9.3	5.1	4.5	6.2	4.5	11.8	9.4	4.1	10.8	4.1	36.2	12.6	31.1	8.3	20.2	31.2	11.0	7.8	11.2	25.6	3.7	19.1	6.4	56.3	15.1	13.5	20.7	18.4	14.7	25.4	19.4	16.9	20.7	12.5	16.0	14.7	14.9	25.1	0.0	0.0	0.0	0.0	0.0	0.0	21.4	13.6	38.4	0.0	112.4	111.0	40.3	0.0	0.0	0.0	0.0	37.7	180.6	0.0	0.0	11.6	0.0	69.5	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	61.3	0.0	0.0	33.7	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	74.1	0.0	0.0	0.0
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994635-136996803	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.5;esophagus: 74.1;placenta: 103.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 778.7;Extravillous trophoblasts: 921.9;Syncytiotrophoblasts: 1705.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 163.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 163.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 68.1;MCF7: 31.0;SK-BR-3: 13.0;T-47d: 29.6;TIME: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	1.9	0.2	0.1	1.6	0.2	1.2	1.1	0.0	0.5	17.6	0.5	0.1	0.0	0.2	1.3	6.8	74.1	0.6	0.8	1.8	0.2	0.1	0.4	0.2	27.3	1.4	0.2	0.2	0.4	0.2	0.1	0.5	103.5	0.8	1.0	0.1	1.3	8.2	0.6	0.2	25.0	0.8	0.3	0.6	2.2	2.9	0.6	0.0	15.7	55.5	53.4	43.1	0.8	28.1	0.2	163.5	0.6	0.1	17.1	15.8	10.2	5.5	0.0	0.0	0.0	0.1	0.3	68.1	0.5	0.2	0.1	0.0	0.3	2.7	0.0	4.5	4.8	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	11.7	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.3	13.0	0.0	0.0	29.6	0.0	23.5	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	15.8	0.1	6.9	0.1	2.2	9.6	0.6	0.2	0.5	8.6	0.6	17.1	0.1	163.5	0.7	10.2	0.1	0.2	0.0	0.5	0.2	0.1	0.2	0.2	0.8	0.0	199.5	37.7	10.4	3.5	3.4	0.0	1.6	0.0	1.4	30.7	1.8	0.0	778.7	8.3	2.3	0.7	5.8	6.5	0.0	5.8	921.9	16.8	2.3	1.1	0.8	81.9	0.0	4.7	4.3	1.0	5.3	116.2	0.2	10.1	3.6	3.8	0.0	49.2	9.9	39.3	0.3	0.0	0.0	1.7	0.0	0.2	16.9	1705.4	70.8	2.9	18.2
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007227-137028922	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 84.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 35.0;Intestinal endocrine cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 35.2"	"Low region specificity"	"Detected in all"							HPA042886	Approved					NA	NA					"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	7.8	6.1	20.0	3.9	42.4	5.7	2.6	16.7	54.2	4.0	4.5	84.3	0.9	3.2	2.8	4.7	3.5	6.3	5.7	7.1	32.2	17.6	4.8	3.8	4.1	4.1	57.5	21.9	2.5	8.6	8.1	7.8	3.3	31.1	5.2	2.5	3.8	8.0	5.1	5.7	6.3	4.1	2.7	70.5	8.3	6.1	3.0	47.7	0.2	9.5	0.1	2.2	3.3	1.8	0.4	2.7	0.4	0.3	1.2	2.2	1.1	4.4	4.8	2.4	9.7	6.1	6.5	4.2	4.9	2.0	2.2	0.8	1.4	5.4	0.2	14.1	5.3	2.2	7.5	1.5	3.6	0.4	3.3	3.1	0.4	13.9	1.7	3.0	7.0	7.7	2.7	3.3	1.6	0.4	8.3	1.2	1.4	1.1	0.8	2.7	13.3	0.0	15.0	1.2	5.6	4.9	6.8	2.4	6.5	1.5	1.0	9.3	10.7	5.3	10.4	3.8	0.1	35.2	9.1	6.3	6.1	3.3	8.6	2.0	0.1	0.1	0.0	10.3	1.3	3.0	0.0	0.3	0.0	2.2	0.2	1.3	0.4	0.2	0.7	0.3	0.2	0.0	0.9	0.4	1.2	0.0	2.7	1.0	1.1	20.0	42.4	16.7	30.7	32.2	17.6	57.5	21.9	31.1	47.7	0.0	0.0	0.5	1.3	3.0	9.5	4.0	17.8	0.0	0.0	1.8	13.7	1.0	1.7	2.9	0.6	3.4	10.3	0.0	1.3	1.0	4.3	2.6	0.0	6.7	1.2	35.0	33.4	7.4	2.4	1.1	20.4	1.1	5.0	0.0	5.7	10.8	2.3	6.8	22.3	1.1	7.2	0.0	3.8	0.5	4.5	2.4	0.7	14.1	8.9	0.9
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137033010	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 40.4;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 40.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"NB-4: 14.4;THP-1: 18.5;U-937: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042780			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.4	0.1	0.2	2.5	0.2	5.9	0.2	3.2	0.3	0.2	0.2	0.2	0.2	0.0	1.4	0.2	0.4	0.5	4.4	0.2	0.3	0.3	0.2	0.2	1.5	6.2	1.7	0.2	0.2	0.2	0.0	0.4	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.6	0.2	0.4	10.5	0.3	0.2	0.2	0.2	0.3	0.2	4.6	0.5	0.2	4.2	40.4	18.3	1.5	22.1	16.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.4	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.3	1.5	0.3	2.1	0.3	10.5	4.2	10.3	5.7	4.4	1.2	0.2	0.8	18.3	22.1	0.0	40.4	16.3	3.4	0.2	0.2	3.2	0.3	0.3	0.3	1.7	0.2	0.9	0.2	0.0	0.0	3.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	7.0	0.0	0.0	2.9	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.7	0.2	0.0
NPDC1	"CAB-, CAB1, DKFZp586J0523"	ENSG00000107281	"Neural proliferation, differentiation and control 1"	Q9NQX5	9	137039470-137046203	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 329.4;Intestinal endocrine cells: 270.4;Ito cells: 337.0;Mucus-secreting cells: 535.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4"	"Lineage enriched"	"Detected in many"	7	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008189	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		180000	Nucleoplasm	Cytosol	"HPA008189: AB_1854584"	"unprognostic (6.94e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.84e-2)"	35.4	21.7	33.1	11.9	35.5	4.1	21.6	59.7	65.6	27.8	27.1	18.4	23.8	22.2	26.7	10.8	11.6	25.4	32.3	20.4	34.5	35.3	12.7	5.9	18.9	11.5	25.1	49.0	12.0	28.6	17.2	47.7	20.1	29.5	73.1	13.3	10.6	58.0	35.5	19.0	17.7	23.0	16.4	30.3	32.4	59.6	10.4	14.5	0.8	11.5	8.6	7.2	12.8	20.2	0.1	2.0	0.5	0.4	0.1	13.6	2.6	9.4	11.4	2.8	18.4	6.6	6.8	0.7	20.4	6.4	4.6	1.8	4.6	5.2	9.4	15.5	7.8	1.4	35.7	2.4	5.5	0.5	7.6	11.6	3.8	29.2	3.3	9.5	3.3	0.0	4.7	8.6	2.5	5.0	12.0	11.8	3.8	0.2	0.2	0.9	35.9	0.2	0.3	6.1	30.0	19.0	5.6	0.0	36.0	7.8	6.1	22.7	15.7	5.4	18.2	12.2	1.1	39.3	4.7	20.3	3.4	6.2	24.3	6.2	0.0	0.1	0.3	5.0	0.3	2.9	0.0	0.4	0.5	8.4	0.0	10.7	0.1	13.2	13.6	0.7	0.0	0.3	2.3	0.0	0.1	0.0	2.0	10.4	2.6	33.1	35.5	59.7	65.6	34.5	35.3	25.1	49.0	29.5	14.5	0.0	10.6	4.2	65.4	20.9	88.5	13.4	79.0	2.7	4.5	27.9	15.7	1.0	0.0	43.0	1.0	147.8	41.7	23.3	59.4	1.0	34.3	329.4	0.0	0.8	17.1	58.8	270.4	337.0	25.4	2.5	149.3	6.8	28.7	2.8	535.1	32.8	34.0	79.7	136.9	0.3	54.6	38.8	34.0	2.9	19.1	20.7	1.5	7.7	84.8	89.4
ENTPD2	"CD39L1, NTPDase-2"	ENSG00000054179	"Ectonucleoside triphosphate diphosphohydrolase 2"	Q9Y5L3	9	137048098-137054045	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Group enriched"	"Detected in many"	4	"Leydig cells: 178.1;Peritubular cells: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 2.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.9;hTCEpi: 8.8;MCF7: 11.0;OE19: 17.7;SK-BR-3: 14.8;T-47d: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017676	Approved					NA	NA					"HPA017676: AB_1848179"	"unprognostic (1.64e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.71e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (3.51e-6)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.51e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.12e-3)"	1.7	1.6	18.8	1.5	10.1	0.6	7.0	4.0	10.4	9.8	9.1	21.9	1.7	17.6	2.8	4.4	3.3	9.4	10.7	2.7	22.6	9.6	4.5	1.0	1.0	0.5	6.1	12.8	0.8	2.6	1.2	3.1	3.9	11.9	11.2	5.8	2.5	6.2	2.9	3.0	9.3	11.1	1.9	7.5	0.5	9.5	6.8	11.7	0.0	0.7	2.6	1.0	0.9	3.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.9	0.0	0.0	3.4	0.3	2.5	0.0	0.0	0.1	0.0	0.4	15.9	0.0	0.0	0.2	0.0	8.8	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	17.7	2.4	0.0	0.7	1.6	1.9	0.4	2.4	0.0	0.2	14.8	0.0	0.1	16.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.8	10.1	4.0	9.8	22.6	9.6	6.1	12.8	11.9	11.7	0.0	0.0	0.0	1.1	1.4	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.3	0.0	6.1	1.1	0.7	31.6	0.0	3.9	0.9	1.7	5.9	0.0	0.9	0.2	0.0	24.2	0.6	0.0	2.1	178.1	0.0	5.0	1.0	8.1	7.2	4.5	31.7	90.9	8.4	0.0	0.0	0.4	1.2	4.3	1.3	0.8	0.0	12.8	1.0
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062124-137070588	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes			Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	1.0	0.4	11.5	10.5	7.0	3.3	2.6	1.4	14.4	2.5	6.2	10.1	0.0	7.6	1.0	0.4	7.8	0.8	5.4	0.4	9.6	7.5	1.2	0.4	2.7	4.7	8.0	3.8	0.3	0.8	0.3	0.4	1.8	5.4	5.4	3.5	0.0	7.3	0.4	0.4	5.4	7.7	1.0	7.0	2.7	4.6	1.5	2.7	9.2	0.6	3.5	10.0	1.0	1.9	0.5	0.8	0.5	1.7	0.0	0.4	0.4	16.0	8.7	3.4	10.2	0.1	0.2	18.5	2.6	1.8	2.8	1.3	16.4	7.4	16.8	8.6	1.3	2.6	22.8	10.8	3.0	0.6	11.5	12.4	7.3	9.6	18.3	0.0	8.3	12.7	0.0	0.5	1.0	1.8	0.7	4.6	8.6	10.1	7.6	0.8	37.7	2.4	22.4	6.4	37.2	19.8	25.6	13.1	18.6	3.5	4.6	17.9	10.6	10.2	28.6	3.9	0.8	23.1	15.8	2.9	2.6	8.8	7.7	13.0	2.6	7.6	8.1	6.0	9.9	8.1	0.2	1.7	0.0	0.0	0.5	0.4	0.5	0.3	0.0	0.8	0.2	0.1	0.0	0.5	0.0	0.8	0.2	0.3	0.4	11.5	7.0	1.4	6.1	9.6	7.5	8.0	3.8	5.4	2.7	0.0	0.0	0.0	0.6	3.8	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.7	1.7	0.3	0.0	0.0	0.4	0.0	0.0	2.7	0.6	2.1	0.0	0.0	2.5	0.0	0.0	0.6	3.0	0.0	0.0	1.8	0.0	0.0	6.4	0.6	0.3	4.9	0.0	0.0	0.5	0.0	0.3	0.0	1.2	2.4	0.5	1.0	4.5	0.5
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077501-137084539	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 18.6;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	10.5	14.7	13.6	9.8	20.6	5.0	16.3	3.4	17.5	13.0	8.8	22.1	8.6	10.0	7.3	9.7	5.9	5.8	9.4	11.3	14.7	8.1	12.5	3.1	11.6	12.2	24.9	9.3	3.9	10.5	8.5	14.7	10.9	14.2	12.8	6.7	14.1	15.2	10.9	2.5	9.0	9.4	6.6	13.5	20.3	10.8	3.5	29.1	1.4	13.3	4.9	10.3	11.4	13.9	2.1	1.8	0.6	3.7	0.3	3.0	1.2	0.4	2.8	0.0	7.5	13.0	6.1	2.2	3.8	10.1	10.8	7.6	5.4	1.2	1.7	2.3	3.9	19.7	5.8	14.1	0.9	2.2	4.6	1.2	3.7	4.2	5.2	29.0	0.0	15.3	4.4	1.0	6.1	5.1	5.1	8.4	3.5	1.1	8.6	7.2	6.2	0.3	3.7	1.2	13.2	4.0	5.9	0.1	5.2	4.3	0.5	4.5	2.8	0.9	21.2	8.6	1.9	11.4	10.2	6.6	19.6	4.2	13.6	1.8	9.5	13.5	3.6	17.0	4.0	5.5	0.4	3.7	0.1	0.8	2.0	3.0	2.1	0.4	1.3	1.8	1.0	1.0	1.3	0.6	0.3	0.0	1.1	1.7	1.2	13.6	20.6	3.4	17.5	14.7	8.1	24.9	9.3	14.2	29.1	0.0	5.9	2.9	0.5	5.5	4.8	3.5	7.6	0.0	1.2	0.0	2.0	0.3	10.0	1.3	0.1	2.1	0.2	0.0	0.8	4.6	4.4	1.9	4.6	0.2	18.6	19.1	1.7	7.4	12.7	0.0	2.3	8.1	8.5	5.4	1.7	6.5	0.9	1.9	3.5	3.1	4.7	0.0	3.4	0.5	1.5	3.9	1.1	2.6	2.3	0.1
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086927-137109187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051516	Approved		Uncertain	Vesicles		NA	NA		540000	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	20.4	25.4	19.7	13.5	23.7	9.8	18.6	21.6	36.1	24.3	21.6	24.5	20.6	19.8	22.7	28.1	23.1	28.9	25.9	19.5	20.5	21.5	24.3	32.7	20.4	19.9	18.6	25.2	24.2	32.6	23.6	25.1	30.8	18.0	21.2	12.0	22.0	32.7	23.1	12.2	25.4	17.8	18.5	16.4	22.2	21.8	30.3	18.2	19.9	25.1	12.7	19.3	21.0	16.0	13.0	23.0	16.3	24.4	18.0	21.9	18.5	7.2	17.1	6.0	16.9	22.5	19.4	19.8	12.4	26.2	16.5	14.7	8.4	22.9	6.6	41.5	20.6	23.3	25.1	3.6	12.0	3.0	9.1	6.0	2.9	15.4	9.6	21.3	5.1	11.4	22.9	22.7	9.6	8.1	22.1	10.9	8.9	8.0	10.9	11.7	14.7	5.4	12.1	8.0	21.4	17.3	3.1	10.0	20.9	13.2	3.6	6.9	6.2	18.3	19.4	12.6	3.2	21.6	10.9	15.3	24.5	9.1	18.0	14.4	4.4	3.6	4.4	29.4	6.5	21.0	7.9	20.1	16.3	21.9	21.8	20.5	13.0	17.3	20.6	23.0	11.0	17.0	17.0	5.9	18.0	24.4	16.1	21.5	18.5	19.7	23.7	21.6	36.1	20.5	21.5	18.6	25.2	18.0	18.2	17.9	33.0	15.9	12.9	10.3	17.8	9.3	15.3	16.0	7.9	24.4	15.7	44.1	6.6	27.3	4.5	16.8	31.6	0.0	27.7	61.8	26.8	11.6	20.7	17.9	29.2	28.6	29.2	17.8	16.4	4.3	19.5	16.3	21.9	33.3	26.3	17.7	26.2	24.6	20.5	13.0	18.2	12.9	16.0	15.6	26.2	14.2	38.0	24.5	21.3	6.8
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 751.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.2;THP-1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.9	11.0	0.9	0.9	13.6	10.9	1.4	10.5	17.2	7.0	4.6	10.4	5.7	13.7	11.5	6.9	0.3	15.0	8.0	2.1	0.3	13.4	0.5	6.3	15.2	0.3	30.5	16.9	35.2	13.4	8.3	3.0	6.3	10.2	9.1	17.0	13.8	10.7	4.6	19.2	8.5	16.2	3.7	25.2	10.8	12.5	0.1	57.2	11.1	7.7	17.6	12.2	12.1	31.9	29.7	0.2	11.4	54.9	11.0	17.9	6.1	11.3	7.2	13.2	7.5	3.7	21.4	10.3	8.0	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8	50.6	79.4	78.5	85.1	59.5	68.6	52.7	58.6	42.8	46.6	50.6	33.4	44.8	31.5	93.8	230.4	57.3	44.4	23.3	59.4	85.7	82.6	106.0	74.8	62.7	275.2	114.4	84.6	55.3	148.6	751.7	143.8	125.9	158.6	165.1	27.0	123.1	65.3	48.9	159.1	69.0	73.5	51.8	56.5	57.7	46.0	56.8	43.0	127.1	37.4	74.0
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137138390-137168762	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"brain: 97.5"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 5.6;Cardiomyocytes: 2.4;monocytes: 3.6;Rod photoreceptor cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.6;REH: 3.1;RPMI-8226: 4.3;SCLC-21H: 10.0;SH-SY5Y: 6.9;T-47d: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA					"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	1.7	2.0	23.6	2.0	47.5	1.7	1.8	28.1	97.5	1.8	2.0	3.2	0.0	2.2	1.7	1.8	1.7	1.7	1.7	1.7	29.1	26.4	1.8	1.7	1.8	1.8	15.4	37.9	1.7	1.8	1.8	0.0	1.7	22.0	2.2	1.8	0.7	2.5	1.8	1.7	1.8	2.2	1.8	4.7	1.8	1.8	1.9	6.3	0.0	1.7	0.0	1.8	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.1	0.0	0.2	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	2.6	0.0	3.1	0.0	4.3	0.0	0.0	10.0	6.9	0.1	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	23.6	47.5	28.1	87.9	29.1	26.4	15.4	37.9	22.0	6.3	0.0	0.0	0.0	0.4	0.0	5.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	1.6	1.7	0.0	0.0	0.4	0.0	0.0	0.0	3.6	1.7	1.6	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.3
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 173.1"	"Cell type enriched"	"Detected in some"	9	"Mucus-secreting cells: 513.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	408	"plasmacytoid DC: 40.8"	"Lineage enriched"	"Detected in single"	408	"dendritic cells: 40.8"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.0	1.3	0.0	0.0	2.1	0.7	0.1	0.3	6.8	0.0	11.2	1.2	0.3	0.1	0.7	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.4	0.4	0.0	173.1	20.0	0.0	1.3	4.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	10.3	4.6	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.3	8.7	0.0	52.8	0.0	0.0	0.4	0.1	0.2	2.6	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	13.9	0.0	0.4	0.0	0.1	45.8	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.6	0.0	0.0	54.0	1.0	513.0	0.0	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	16.2	3.3
AL929554.1		ENSG00000261793			9	137168854-137171984	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"salivary gland: 31.6;testis: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	33	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 6.5"	"Group enriched"	"Detected in some"	5	"REH: 10.1;RPMI-8226: 16.7;SK-BR-3: 11.2;T-47d: 6.5"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.0	31.6	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.2	0.1	0.2	0.0	10.1	0.0	16.7	0.0	1.3	0.4	0.1	0.0	11.2	0.0	0.0	6.5	0.5	0.0	0.0	0.4	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM210		ENSG00000185863	"Transmembrane protein 210"	A6NLX4	9	137170858-137172409	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.7"	"Group enriched"	"Detected in some"	58	"Early spermatids: 718.1;Late spermatids: 1521.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.1;granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA066907	Enhanced					NA	NA					"HPA066907: AB_2685747"	"unprognostic (5.17e-2)"		"unprognostic (5.04e-2)"	"unprognostic (2.87e-5)"						"unprognostic (4.18e-2)"		"unprognostic (3.63e-2)"		"unprognostic (3.14e-2)"	"unprognostic (8.00e-2)"			0.1	0.0	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.1	4.0	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	18.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.6	4.1	1.4	0.3	0.5	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.7	0.1	15.8	0.0	0.0	0.1	0.1	0.0	2.1	0.1	0.1	1.5	0.0	0.0	0.1	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.2	0.0	1.4	0.3	0.1	0.2	0.2	0.3	0.1	0.2	0.2	0.2	0.6	0.3	0.3	1.2	0.5	0.2	4.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	718.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1521.3	11.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.0	0.0	0.0	19.4	0.1	8.8	3.5	0.1	0.0	0.0	0.0	0.2
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188549	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.6	15.5	13.3	15.3	17.9	19.0	14.1	21.8	26.9	12.2	11.8	28.5	17.7	17.1	15.1	12.3	13.6	13.8	16.4	14.1	12.5	10.2	12.3	19.1	13.1	19.1	22.4	14.5	15.4	23.7	10.6	12.6	11.0	16.2	15.2	5.0	15.5	25.7	14.5	20.0	25.0	16.2	9.4	13.3	19.3	16.2	31.6	13.4	14.0	14.4	11.7	15.2	13.2	11.7	1.4	2.3	0.6	3.2	1.1	2.4	3.3	10.2	22.8	5.5	9.1	6.7	4.0	17.4	9.2	5.9	8.8	6.8	13.7	10.7	11.1	10.9	6.1	8.2	21.2	6.6	7.1	1.3	14.1	11.3	6.6	26.6	12.4	7.9	10.1	11.6	8.0	5.7	5.9	3.2	4.4	10.7	10.3	9.7	13.7	4.1	28.9	12.1	14.3	11.2	13.7	17.4	14.5	13.6	20.6	6.8	9.1	7.3	11.0	14.0	19.1	5.8	2.8	20.3	13.9	11.2	13.1	10.4	15.5	8.3	6.7	9.8	12.0	10.5	7.0	9.4	0.3	2.3	0.4	2.4	2.4	1.4	1.4	1.2	1.9	1.9	1.4	1.4	1.5	0.6	1.1	3.2	2.3	1.2	3.3	13.3	17.9	21.8	26.9	12.5	10.2	22.4	14.5	16.2	13.4	0.0	0.3	6.5	7.4	8.2	4.7	3.1	7.6	0.0	1.2	10.4	3.9	22.6	11.6	9.4	31.6	5.7	18.6	0.0	9.4	9.5	8.5	6.4	11.5	10.4	13.6	1.6	9.8	12.3	9.5	40.9	10.3	6.6	13.5	16.2	14.6	3.5	6.9	7.0	8.9	13.4	4.3	0.0	9.9	30.0	24.3	8.3	20.5	10.2	11.3	6.3
SSNA1	"N14, NA14"	ENSG00000176101	"SS nuclear autoantigen 1"	O43805	9	137188647-137190370	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (6.70e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-2)"	"prognostic favorable (8.94e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.66e-1)"	19.5	19.1	21.3	22.5	21.7	30.2	21.0	21.7	26.1	16.8	23.4	21.3	18.1	24.3	16.6	16.2	30.0	23.4	21.9	32.0	22.4	17.0	27.5	28.8	18.6	27.5	22.0	24.3	15.2	39.2	8.5	11.7	21.8	21.5	20.5	11.3	15.4	35.2	17.8	40.4	26.9	24.6	21.3	23.7	21.6	24.9	53.3	19.9	30.1	26.2	28.5	20.6	20.0	17.9	45.9	59.2	60.2	53.9	39.0	53.4	34.1	19.3	42.7	14.1	22.1	13.7	12.2	14.5	18.7	16.3	25.0	13.9	21.0	27.5	18.8	23.2	15.4	22.0	32.4	16.9	25.3	3.8	35.1	11.6	15.4	32.3	21.9	18.8	25.9	16.5	12.3	22.1	16.6	14.6	11.9	22.4	29.4	16.2	36.5	16.9	57.1	34.3	26.2	22.0	41.9	20.1	22.6	19.1	55.3	21.1	17.1	24.9	13.9	14.3	40.0	20.3	5.8	42.8	30.6	15.8	24.4	14.1	36.7	23.7	9.0	33.1	18.4	27.0	25.6	20.1	39.1	39.4	60.2	42.1	53.9	38.2	45.9	39.6	42.4	35.7	45.1	37.0	37.2	34.1	39.0	49.6	59.2	53.4	34.1	21.3	21.7	21.7	26.1	22.4	17.0	22.0	24.3	21.5	19.9	38.7	36.9	90.1	61.3	56.6	37.5	40.6	81.5	34.8	30.7	59.3	15.7	121.8	96.2	129.9	51.7	59.4	174.0	70.0	202.7	144.6	60.4	65.8	57.5	70.0	137.6	38.1	74.6	46.1	69.1	41.8	55.8	83.0	113.1	242.5	83.2	61.9	171.3	115.8	47.7	155.0	31.2	32.3	50.9	312.1	121.9	73.4	92.9	99.1	97.2	56.9
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.8;pancreas: 45.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 109.1;Mucus-secreting cells: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 27.8;T-47d: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.9"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favorable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favorable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.2	3.8	8.5	5.0	16.8	3.2	3.3	26.1	17.9	3.4	18.5	32.8	2.3	23.6	2.8	1.8	8.2	4.2	4.8	3.6	11.2	7.0	12.1	10.0	5.8	3.0	25.3	7.1	4.7	45.3	2.8	2.7	4.3	11.0	4.4	8.1	13.1	8.7	4.8	5.0	8.0	29.0	2.4	11.9	3.7	10.8	4.7	21.7	0.2	2.5	2.3	3.5	3.8	2.7	1.2	2.3	0.2	2.9	2.9	2.2	0.6	4.5	5.2	1.7	7.9	2.5	2.6	14.1	3.2	2.0	3.3	1.8	17.4	5.6	8.4	4.8	1.6	4.3	14.0	3.6	1.8	0.4	5.3	5.1	3.9	7.8	11.4	3.7	6.0	5.1	2.2	3.5	2.9	2.0	2.1	2.0	3.8	7.1	3.0	0.9	27.8	3.9	13.0	6.3	25.0	6.8	11.8	4.2	12.7	7.3	9.6	11.5	4.2	4.9	23.2	5.7	1.4	26.9	9.5	2.3	6.0	2.8	9.4	6.8	2.5	4.8	4.3	4.3	5.4	3.3	0.0	2.9	0.2	1.3	2.6	0.4	1.1	1.3	1.8	2.1	1.2	0.6	1.2	0.0	2.9	1.5	2.3	2.2	0.6	8.5	16.8	26.1	17.9	11.2	7.0	25.3	7.1	11.0	21.7	17.9	5.6	2.7	1.1	1.5	15.5	7.3	12.7	1.4	1.2	15.7	5.9	4.7	6.6	7.1	2.3	1.9	109.1	23.3	38.5	1.1	1.6	2.8	1.1	14.4	3.1	11.1	8.6	4.3	3.2	3.8	3.1	2.1	5.0	1.8	43.9	10.9	16.4	23.2	4.2	16.6	5.9	6.5	1.7	1.0	5.5	2.5	1.6	0.0	21.2	1.7
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205638	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	15.3	21.1	20.6	13.5	22.4	7.6	19.2	18.2	34.1	16.8	20.0	19.0	17.6	18.5	20.0	23.5	19.2	20.2	20.0	31.4	19.7	18.2	23.7	35.5	15.6	20.5	20.0	17.0	24.8	17.4	20.9	16.9	16.5	19.1	17.1	15.8	19.7	22.3	20.0	33.2	26.2	22.8	18.8	14.5	20.0	18.0	17.5	16.3	21.4	25.2	15.6	18.4	15.9	16.9	9.9	6.5	6.4	5.8	9.2	12.7	3.5	17.0	18.2	17.2	28.4	25.7	20.1	20.7	22.4	21.8	26.2	19.7	14.9	15.5	17.8	21.8	19.4	25.2	33.7	21.2	22.3	15.3	32.1	20.4	12.3	21.6	16.9	21.5	28.3	12.7	19.1	35.7	17.0	22.7	17.5	16.7	23.5	28.6	20.9	20.2	29.6	22.4	24.6	28.6	33.0	29.6	24.5	24.1	35.4	21.9	12.5	22.9	22.4	17.9	22.9	17.6	12.4	32.3	23.1	14.8	27.0	14.4	30.0	25.0	11.3	35.2	22.4	20.8	21.1	22.1	6.4	5.3	5.3	7.4	5.8	9.2	9.9	8.5	9.2	6.1	7.1	12.7	8.7	2.8	9.2	5.0	6.5	5.2	3.5	20.6	22.4	18.2	34.1	19.7	18.2	20.0	17.0	19.1	16.3	8.9	5.0	14.4	20.3	15.7	35.3	10.8	25.5	1.4	6.8	29.6	3.9	26.3	44.7	45.2	2.9	15.8	14.2	0.0	36.9	22.8	18.1	25.7	5.7	36.1	25.5	30.2	15.6	13.5	20.2	6.8	20.4	13.2	23.6	66.7	14.0	43.3	31.8	7.0	19.4	46.8	19.4	12.9	13.0	16.7	11.5	23.8	16.2	14.0	18.9	16.2
NDOR1	"bA350O14.9, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	9.6	11.4	10.6	18.4	17.4	29.2	10.0	15.0	16.2	9.4	10.4	18.7	7.4	19.1	11.4	10.5	11.2	11.0	10.4	7.4	11.6	7.7	12.1	9.4	11.6	20.5	18.6	8.6	10.2	14.7	9.7	12.2	9.2	13.5	13.0	6.8	12.5	17.3	16.1	6.5	18.5	16.5	8.7	14.2	19.9	13.9	22.2	14.2	20.6	14.4	4.9	15.8	9.7	9.4	2.7	3.7	6.6	4.8	1.6	4.0	3.0	7.2	10.9	7.5	11.4	3.2	3.2	22.5	10.6	4.9	10.4	7.2	10.9	8.6	10.1	8.4	4.1	8.3	27.1	5.4	7.5	2.1	13.0	8.4	9.0	26.2	5.8	5.3	10.1	19.3	4.3	5.3	11.6	4.3	2.8	4.8	13.7	14.5	10.8	3.7	13.0	10.4	17.9	11.9	6.7	13.6	19.2	8.8	14.4	3.3	6.3	9.4	9.3	8.8	8.9	5.5	3.4	14.4	11.7	6.2	19.1	12.5	22.0	11.8	6.7	13.2	10.5	8.3	9.2	10.8	1.7	4.4	6.3	3.2	4.8	2.7	1.3	2.8	2.7	3.7	2.7	1.6	1.4	6.6	1.6	3.8	2.4	4.0	3.0	10.6	17.4	15.0	16.2	11.6	7.7	18.6	8.6	13.5	14.2	0.0	1.6	0.8	0.6	0.5	0.2	1.1	0.0	0.0	2.3	3.5	0.0	4.2	1.7	0.9	0.6	1.5	2.2	0.0	1.0	2.8	0.6	0.5	1.1	0.6	2.3	0.0	2.4	1.8	3.7	0.8	0.6	1.6	1.7	4.6	1.4	0.1	1.5	0.8	0.4	1.1	1.0	0.0	0.8	1.9	1.1	0.3	3.1	0.0	1.7	0.7
BX255925.3		ENSG00000284976			9	137217452-137219361	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"esophagus: 30.6;pancreas: 25.2"	"Cell type enhanced"	"Detected in some"	15	"Exocrine glandular cells: 21.2;Pancreatic endocrine cells: 23.6;Proximal tubular cells: 6.2"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"													NA	NA																							0.6	3.0	0.4	1.6	0.3	5.0	1.2	0.3	0.8	3.8	7.1	0.3	0.8	5.3	0.6	3.5	30.6	1.1	12.4	2.1	0.3		1.7	1.2	1.5	2.3	0.3	0.3	0.5	25.2	0.7	0.3	1.5	0.3	3.1	0.5	0.3	14.6	1.4	1.1	6.2	8.9	0.9	0.3	1.9	7.0	15.0	0.3	0.3	0.5	15.0	15.1	1.0	0.3	1.8	4.9	3.7	2.3	2.0	2.9	5.6	5.5	9.1	5.4	7.0	2.5	2.5	21.2	6.5	3.5	6.8	4.9	8.4	6.4	8.1	4.6	2.3	5.1	20.2	3.4	4.7	1.5	8.9	9.5	4.7	21.5	7.5	4.2	6.9	15.8	3.3	4.4	7.7	2.1	1.8	3.1	7.9	11.5	6.9	2.3	15.5	6.1	20.0	9.3	12.6	31.6	15.5	7.3	9.4	2.9	5.5	7.0	8.0	5.8	7.1	5.0	2.0	18.3	10.9	3.7	10.5	12.0	16.9	8.0	5.5	9.3	7.0	6.0	8.0	7.8	0.0	1.9	3.7	1.8	2.3	2.9	1.5	1.4	1.1	1.2	1.8	0.8	0.8	3.3	2.0	1.2	4.9	1.4	5.6											6.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	3.5	0.0	0.0	5.0	5.3	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	23.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF208	DKFZP761H1710	ENSG00000212864	"Ring finger protein 208"	Q9H0X6	9	137220247-137221581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 21.6;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 12.4;MCF7: 29.7;REH: 23.9;RPMI-8226: 13.2;T-47d: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021256, HPA021429"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021256: AB_1844331, HPA021429: AB_2180654"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.12e-8)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.40e-2)"	3.7	7.1	17.3	1.2	13.3	0.7	4.3	10.1	27.4	1.9	1.7	1.5	1.2	2.0	1.7	2.7	4.6	3.4	1.2	6.2	18.1	10.8	3.7	8.1	1.8	3.4	9.4	4.6	1.5	8.8	5.7	3.0	1.2	3.5	4.0	0.6	1.8	11.4	5.5	13.2	6.6	2.4	1.2	3.3	1.8	3.4	3.1	2.1	1.2	2.1	3.2	1.2	2.1	1.3	0.6	0.0	0.8	0.7	0.0	1.2	0.8	0.8	1.5	1.1	1.8	0.7	0.1	3.2	0.4	0.6	0.7	0.7	4.5	2.8	0.4	2.3	0.5	0.1	2.3	2.5	0.1	0.1	1.1	0.9	3.1	5.2	12.4	2.4	0.6	1.1	0.5	0.8	0.7	0.3	2.8	0.7	4.6	4.4	0.2	0.3	29.7	1.6	1.4	1.3	2.9	3.3	23.9	0.2	13.2	0.8	0.1	3.0	10.6	0.3	0.9	0.6	0.6	10.7	2.3	0.3	0.5	0.7	1.1	0.0	0.4	0.4	0.1	1.4	0.2	0.6	0.0	0.4	0.2	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.8	17.3	13.3	10.1	27.4	18.1	10.8	9.4	4.6	3.5	2.1	6.0	2.1	1.5	1.1	0.3	8.2	8.2	5.1	4.0	0.0	7.0	11.8	0.2	21.6	3.9	0.5	1.4	4.0	0.0	1.9	0.2	0.9	1.6	0.0	6.8	1.1	15.9	7.5	1.3	0.3	0.5	1.1	0.0	1.7	1.8	3.9	5.5	3.5	4.2	3.2	8.8	3.2	0.0	0.9	1.7	2.2	1.6	0.2	0.8	3.3	0.7
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"		9	137224635-137226311	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"esophagus: 33.4"	"Cell type enriched"	"Detected in some"	6	"Pancreatic endocrine cells: 33.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"		Yes	No			"Nuclear speckles"	"Vesicles, Midbody"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.7	0.4	1.0	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1.0	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0.0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3.0	0.9	0.3	0.1	10.0	1.2	1.0	2.1	0.0	0.1	2.8	0.3	0.3	0.4	0.2	0.7	12.7	0.7	0.8	0.2	0.4	14.1	0.3	3.2	0.0	1.3	1.0	0.2	12.5	6.6	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.7	0.1	1.0	0.4	2.2	0.8	19.6	0.4	0.7	0.5	2.0	1.5	1.5	1.3	1.7	0.5	0.7	0.3	1.0	2.1	1.8	0.5	0.7	4.0	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.8	0.6	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3.0	0.4	0.2	0.1	1.0	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	4.5	5.2	0.0	0.4	0.0	1.1	0.5	0.0	0.4	0.0	5.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	33.8	0.0	0.4	0.5	0.5	0.0	0.2	1.9	0.3	0.0	0.0	0.0	0.2	1.1
RNF224		ENSG00000233198	"Ring finger protein 224"	P0DH78	9	137227271-137229638	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"esophagus: 4.8;pituitary gland: 7.7"	"Cell type enhanced"	"Detected in single"	20	"Proximal tubular cells: 1.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;HeLa: 5.3;MCF7: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.45e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.01e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	0.0	0.6	0.5	0.1	0.7	0.3	0.0	0.2	0.9	0.3	0.0			1.0	0.4	0.1	4.8	2.0	1.0	0.3	0.5	0.5	2.8	0.0	1.1	0.4	0.1		0.0	1.5	0.2	7.7	0.0		0.9	0.0		4.6	0.0	0.1	1.5	1.6	0.0	0.1	0.4	1.2	1.2			1.0		0.1	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.7	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	7.4	0.2	0.3	0.0	0.4	3.5	0.0	0.1	0.0	2.5	0.6	0.0	5.3	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.6	0.0	12.9	0.1	0.2	0.6	0.9	1.7	0.8	0.3	0.3	0.1	0.8	0.0	1.7	0.7	2.8	0.1	1.0	2.8	0.3	0.2	0.3	0.2	1.6	0.0	0.9	0.2	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236554	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.4;kidney: 14.8"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 20.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023776	Enhanced					NA	NA					"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0.0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	1.6	0.2	0.2	0.2	0.0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.7	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	6.0	0.4	0.2	0.0	0.1	3.0	0.0	0.0	0.0	3.7	0.2	0.0	4.0	2.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.7	0.0	9.7	0.1	0.1	0.6	1.1	1.2	1.3	0.5	0.0	0.0	0.5	0.0	1.5	0.6	1.4	0.3	0.7	3.4	0.1	0.4	0.5	0.4	1.9	0.1	1.1	0.5	0.4	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241213-137243707	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 207.7"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 1754.5;Late spermatids: 2132.3;Spermatocytes: 1761.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	Yes			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.36e-6)"	"unprognostic (1.69e-1)"	31.1	22.1	33.0	22.1	32.7	87.5	24.4	22.3	67.2	23.0	44.0	35.9	25.2	33.4	22.7	52.7	65.7	122.5	32.1	66.4	35.2	55.5	46.6	49.7	28.4	21.0	33.8	46.6	33.7	33.0	13.4	25.3	31.9	48.4	29.8	27.3	40.9	41.8	31.8	37.1	55.9	38.9	28.4	21.5	21.0	30.5	207.7	12.2	61.1	40.1	56.7	40.1	21.8	25.7	17.2	18.3	37.0	14.6	11.2	21.7	14.4	59.3	89.0	38.1	27.4	19.2	20.3	53.1	55.8	47.0	77.2	53.4	94.0	73.1	36.4	42.7	54.1	75.3	113.0	47.1	89.8	29.4	25.9	39.8	26.4	70.9	73.8	12.1	31.0	29.4	13.0	25.5	58.9	16.2	19.2	55.1	26.1	36.8	21.0	63.6	163.2	28.1	42.3	40.2	105.3	155.3	35.8	72.7	33.7	58.0	55.6	26.7	28.7	73.9	42.6	14.8	22.6	61.3	33.8	42.7	55.2	61.5	62.5	73.3	8.1	22.5	40.2	45.0	24.3	47.8	37.0	14.1	20.5	21.4	14.6	20.6	17.2	16.7	18.2	17.5	14.1	10.7	14.3	28.6	11.2	14.6	18.3	21.7	14.4	33.0	32.7	22.3	67.2	35.2	55.5	33.8	46.6	48.4	12.2	205.4	139.7	150.7	842.9	289.7	457.2	82.3	132.5	1026.5	175.1	136.1	282.7	235.6	187.3	348.8	1754.5	152.3	547.1	490.6	391.5	458.3	161.8	365.4	188.9	114.3	228.8	230.4	375.8	129.5	67.2	2132.3	235.3	111.2	131.6	359.7	292.5	271.2	343.5	375.2	143.9	259.6	647.3	109.9	245.2	1761.9	564.6	260.1	268.5	97.8	359.3	575.4
FAM166A		ENSG00000188163	"Family with sequence similarity 166 member A"	Q6J272	9	137243584-137247770	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"testis: 54.2"	"Group enriched"	"Detected in some"	96	"Early spermatids: 561.7;Late spermatids: 950.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"T-47d: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023307	Enhanced					NA	NA					"HPA023307: AB_1848930"	"unprognostic (2.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.67e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.18e-3)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.1	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	54.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.4	0.5	1.2	0.8	0.0	0.7	0.0	0.5	0.0	0.0	0.5	2.0	0.6	0.1	0.0	0.3	1.0	0.0	0.0	0.0	1.1	0.7	0.5	1.2	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.2	0.9	0.0	0.3	0.3	1.9	0.3	0.3	0.1	0.6	0.1	0.8	0.8	0.8	0.3	1.0	0.8	0.4	3.2	0.9	0.7	0.8	1.0	0.3	0.1	0.8	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.4	0.3	0.0	0.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	561.7	0.0	0.0	0.0	0.0	0.1	0.2	0.1	3.5	0.8	0.1	0.0	0.0	0.6	0.3	950.4	5.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.5	0.0	0.0	7.9	3.0	0.3	0.2	0.0	0.0	0.1
STPG3	"C9orf173, FLJ40246"	ENSG00000197768	"Sperm-tail PG-rich repeat containing 3"	Q8N7X2	9	137251261-137253483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 55.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.3;RPMI-8226: 3.0;SK-BR-3: 3.0;T-47d: 4.6;U-266/70: 2.9"									HPA044352			Uncertain	Vesicles		NA	NA			Vesicles		"HPA044352: AB_10965328"	"unprognostic (1.20e-1)"	"unprognostic (5.32e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.72e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.95e-2)"	0.8	0.4	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.3	0.2	0.2	0.2	4.4	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	1.7	0.2	0.2	0.2	0.2	0.2	1.4	0.0	1.1	0.2	0.2	0.2	0.0	0.2	1.5	0.2	0.2	0.5	3.2	0.2	0.2	0.2	0.5	55.3	0.2	0.2	1.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.6	2.0	1.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	7.3	0.0	0.1	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.5	1.3	1.1	0.0	1.7	0.0	0.2	0.0	0.5	0.4	0.0	0.0	3.0	0.0	0.0	0.9	0.6	0.4	3.0	0.0	0.6	4.6	0.0	0.0	0.8	1.4	0.2	0.0	2.9	1.5	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NELFB	"COBRA1, KIAA1182, NELF-B"	ENSG00000188986	"Negative elongation factor complex member B"	Q8WX92	9	137255173-137273546	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020259	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020259: AB_1847072"	"unprognostic (2.56e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (7.74e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (6.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-2)"	21.9	16.5	28.2	20.1	27.8	21.2	17.1	20.2	41.6	19.2	20.6	20.6	17.0	23.7	19.6	10.6	24.7	21.8	17.9	28.8	25.8	21.8	20.1	17.9	19.9	25.8	23.0	27.6	27.3	33.7	14.8	14.6	19.4	24.0	20.6	12.6	19.2	29.6	18.4	29.3	29.0	24.9	26.9	17.3	22.6	22.6	19.1	21.1	17.7	21.5	13.0	23.1	20.7	34.2	6.8	8.3	9.2	6.1	7.1	8.0	3.6	18.4	32.1	16.2	21.1	14.3	10.6	23.4	15.4	11.9	20.1	14.3	33.4	22.3	26.7	23.0	16.1	21.9	35.7	17.0	19.0	6.2	25.6	21.3	17.2	39.5	26.4	14.5	25.2	21.1	12.4	19.5	18.4	10.7	11.5	18.5	17.2	29.3	23.1	11.7	44.9	18.4	32.3	25.1	33.2	31.8	30.3	29.6	43.1	11.1	17.7	24.0	21.4	21.5	23.5	14.4	9.2	31.5	28.7	23.0	28.9	21.2	44.3	24.4	11.7	20.5	22.1	22.7	18.2	25.3	2.3	6.1	9.2	8.0	4.8	5.4	6.4	6.8	6.0	5.2	6.8	6.3	6.6	3.2	7.1	4.4	8.3	7.2	3.6	28.2	27.8	20.2	41.6	25.8	21.8	23.0	27.6	24.0	21.1	6.0	19.9	13.0	10.8	13.3	19.3	11.8	15.3	4.0	15.9	22.7	17.7	19.9	11.6	24.1	3.1	14.1	26.2	0.0	33.2	23.2	13.5	16.6	18.4	17.9	22.7	41.3	27.1	22.7	9.5	4.0	21.6	16.4	6.8	50.5	33.3	24.7	26.8	17.3	19.4	12.4	13.9	38.8	13.7	11.9	24.7	12.2	13.0	13.1	29.0	11.3
TOR4A	"C9orf167, FLJ20245"	ENSG00000198113	"Torsin family 4 member A"	Q9NXH8	9	137277749-137282641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Undifferentiated cells: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 22.9;TIME: 20.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044913	Enhanced		Approved	Nucleoplasm		NA	NA		1500000	Nucleoplasm		"HPA044913: AB_10965030"	"unprognostic (1.95e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.99e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.56e-1)"	8.7	3.0	1.6	9.1	3.1	3.2	3.8	0.6	1.7	6.0	12.9	2.8	7.6	12.5	5.0	4.7	8.4	4.6	23.2	12.4	1.5	1.3	8.0	6.6	14.8	7.5	2.8	1.1	9.4	4.0	0.4	2.1	4.9	2.3	3.4	5.8	5.5	1.8	9.7	1.8	2.0	14.5	1.9	2.4	19.4	15.6	1.9	2.0	2.9	5.0	1.4	13.3	4.5	3.9	0.9	1.6	3.7	3.5	0.7	0.7	0.9	8.0	10.6	0.0	0.3	0.1	0.8	0.8	13.4	9.2	6.2	3.3	1.3	15.3	0.8	18.9	4.7	0.4	16.7	0.0	4.4	2.1	0.6	0.7	8.8	7.3	7.1	13.4	3.8	22.9	0.5	4.7	1.2	2.4	7.1	8.4	0.0	13.2	1.0	1.0	0.8	0.0	10.6	1.3	8.7	11.9	2.1	2.9	5.4	7.4	0.0	0.4	0.1	9.7	0.1	0.2	0.3	0.8	11.9	20.5	0.3	7.4	1.4	2.2	0.1	0.5	5.1	2.3	3.5	3.0	1.6	2.3	3.7	0.5	2.1	0.6	0.7	0.4	0.1	1.6	0.9	0.0	0.1	1.4	0.7	3.5	0.2	0.7	0.9	1.6	3.1	0.6	1.7	1.5	1.3	2.8	1.1	2.3	2.0	0.0	5.1	3.9	2.1	2.4	0.0	5.6	25.5	1.4	2.3	12.2	0.0	0.1	0.0	9.4	0.1	3.8	20.6	0.0	1.9	0.1	0.9	1.4	10.3	0.8	12.7	0.0	6.9	26.4	25.2	0.0	2.3	8.2	0.0	11.8	23.9	0.8	14.0	24.9	3.9	0.4	0.5	19.4	3.1	0.0	0.9	2.0	0.0	2.2	28.7	10.8
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137300482-137302251	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 41.7"	"Group enriched"	"Detected in many"	7	"Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	7.9	1.6	6.5	8.4	7.8	1.7	13.8	3.9	11.7	5.6	41.7	6.1	1.1	17.1	5.2	1.9	17.4	3.2	26.0	7.1	5.0	6.5	3.2	2.9	7.0	1.8	6.0	3.0	5.6	14.2	3.1	7.1	8.9	7.4	11.8	22.8	5.6	1.9	2.8	4.4	19.7	15.7	4.5	3.2	7.7	8.7	6.0	3.4	2.3	4.2	14.0	14.4	7.6	10.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.5	3.5	4.2	0.0	0.0	1.6	0.1	0.1	0.0	0.0	2.8	1.4	0.0	6.4	0.0	0.1	23.4	6.4	0.2	0.1	0.2	11.8	0.7	1.0	2.6	0.4	0.9	2.3	0.0	1.1	0.0	0.2	0.0	5.3	0.1	6.9	0.1	0.0	7.7	0.1	2.7	17.2	11.5	3.5	4.6	0.7	8.4	0.6	0.2	2.4	4.4	0.7	1.2	0.0	0.7	11.9	1.9	17.1	0.0	0.0	0.1	1.0	0.1	0.1	1.4	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	6.5	7.8	3.9	6.8	5.0	6.5	6.0	3.0	7.4	3.4	0.0	0.0	0.5	2.8	86.2	0.3	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.7	6.0	10.7	0.0	1.0	0.0	0.6	6.0	0.0	0.0	0.4	0.0	9.8	5.5	0.8	2.9	0.0	0.0	16.9	0.0	15.3	9.4	0.6	31.1	0.4	0.0	2.5	6.5	23.4	0.0	0.8	333.1	0.0	0.0	19.6	5.5
EXD3	"FLJ20433, LOC54932, mut-7"	ENSG00000187609	"Exonuclease 3'-5' domain containing 3"	Q8N9H8	9	137306896-137423262	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"granulocytes: 63.2;Late spermatids: 57.2;Paneth cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.6"					"Low region specificity"	"Detected in all"			HPA047395	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"HPA047395: AB_10962864"	"unprognostic (2.91e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.75e-3)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.05e-2)"	9.7	10.9	8.0	10.1	11.1	8.4	10.4	11.9	12.4	11.2	15.5	16.5	14.9	22.8	10.2	17.5	11.1	11.5	14.1	10.5	8.7	7.9	11.8	7.3	12.3	8.0	9.5	11.2	11.1	13.3	8.3	13.8	8.3	11.0	14.0	8.9	13.9	17.5	11.4	15.9	17.4	20.6	15.8	7.4	16.3	14.3	5.1	9.1	1.7	11.4	6.8	7.8	10.0	10.8	4.0	5.3	10.8	6.0	5.3	8.5	3.6	5.7	4.9	2.4	6.8	2.0	3.0	5.7	2.9	3.3	2.5	3.9	3.3	12.4	2.5	7.9	2.1	6.3	10.7	0.7	3.1	0.8	5.8	5.9	2.0	8.7	5.1	6.2	1.4	21.6	3.4	4.3	2.2	1.9	7.3	8.6	0.0	4.7	4.6	2.1	15.4	0.1	4.9	2.8	12.6	3.4	4.4	2.0	17.2	5.1	3.3	3.3	6.0	2.8	6.0	2.7	2.9	9.7	6.4	10.7	3.5	3.4	5.5	4.3	6.1	2.7	2.1	6.7	4.5	6.6	10.8	5.0	10.6	3.5	6.0	4.0	3.9	6.0	3.3	5.3	4.0	4.8	3.7	1.2	5.3	5.8	3.4	8.5	3.6	8.0	11.1	11.9	12.4	8.7	7.9	9.5	11.2	11.0	9.1	0.0	4.6	0.5	9.4	5.3	13.3	4.5	5.1	5.3	6.8	7.0	13.7	8.3	8.3	6.2	13.5	11.3	39.9	0.0	9.8	2.8	5.3	8.7	63.2	5.5	7.6	20.6	7.0	16.5	4.9	57.2	5.5	5.1	3.3	2.8	22.2	8.6	6.3	178.5	7.4	10.3	10.3	12.9	7.1	2.8	9.4	7.9	3.3	6.9	28.5	7.4
NOXA1	"FLJ25475, NY-CO-31, SDCCAG31"	ENSG00000188747	"NADPH oxidase activator 1"	Q86UR1	9	137423350-137434406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 34.1;Paneth cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.6;EFO-21: 9.8;MCF7: 16.2;T-47d: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044781	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA044781: AB_10960532"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.97e-3)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.97e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-2)"	5.1	7.1	8.5	13.9	13.0	3.8	5.9	9.9	11.8	8.9	16.0	7.5	14.5	23.2	8.4	15.7	11.9	8.2	19.7	3.8	7.5	9.7	11.0	9.2	8.6	4.7	5.1	10.1	9.0	17.4	10.4	13.4	2.1	5.2	8.4	5.2	10.0	25.2	11.3	11.6	21.8	22.6	3.9	4.2	7.8	21.1	3.4	4.0	2.5	10.8	8.1	11.3	5.9	6.5	0.4	1.7	0.1	5.5	1.6	1.0	0.4	1.6	4.2	0.1	3.3	0.4	0.0	2.2	0.3	0.5	0.1	0.2	0.7	10.6	0.0	9.8	0.1	0.6	7.1	0.1	0.2	0.0	4.5	3.6	0.0	2.5	1.5	1.0	0.1	2.1	0.3	2.3	0.0	0.1	1.9	0.2	0.0	0.6	0.7	0.0	16.2	0.0	0.9	0.2	4.3	1.4	0.1	0.0	6.2	2.8	3.6	0.9	0.3	0.2	1.7	1.7	0.2	15.9	1.4	1.1	0.2	2.3	2.4	0.3	0.7	0.0	0.0	0.3	0.6	0.5	0.0	1.2	0.1	0.1	1.8	0.5	0.4	0.1	0.0	1.7	0.2	0.4	1.0	0.0	1.6	5.5	0.0	0.0	0.4	8.5	13.0	9.9	11.8	7.5	9.7	5.1	10.1	5.2	4.0	0.0	4.8	0.8	6.7	3.1	8.6	1.0	10.2	4.0	4.5	12.2	7.9	0.2	6.6	6.1	0.0	1.5	34.1	23.3	9.7	0.4	1.0	5.5	2.3	5.7	4.7	3.2	6.4	1.3	3.3	0.0	1.1	5.0	8.5	2.8	19.0	9.6	6.6	28.1	0.7	15.9	7.8	6.5	2.0	4.3	3.6	3.6	0.2	3.2	19.7	5.8
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Group enriched"	"Detected in some"	6	"Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	1.6	0.0	0.2	0.1	3.0	0.4	0.0	0.0	8.8	1.4	0.0	0.3	0.9	0.2	0.0	0.1	0.7	4.8	0.2	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.7	0.0	0.0	19.2	0.0	0.0	0.0	0.8	0.0	0.0	107.0	0.0	6.8	0.1	0.0	1.0	0.0	8.2	0.1	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	160.6	0.0	0.5	49.1	0.0	4.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	12.7	0.6
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447573-137459334	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 96.4"	"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.1;non-classical monocyte: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favorable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	8.8	8.8	61.7	6.9	34.4	6.1	5.3	6.4	67.3	6.0	8.1	18.2	2.1	16.9	8.6	6.6	6.6	7.2	5.7	5.0	96.4	21.8	15.3	6.2	5.2	6.9	20.4	30.2	5.0	14.7	10.8	13.7	4.2	12.1	9.0	6.3	5.4	11.5	8.7	4.0	9.7	13.7	8.2	9.6	6.8	9.6	7.8	15.0	2.4	5.1	1.3	5.8	6.4	3.8	0.2	6.0	3.1	12.1	0.0	1.5	1.4	7.7	6.3	11.1	16.6	26.2	12.4	9.6	7.5	9.9	7.1	5.5	16.7	4.6	9.6	10.1	11.0	16.0	23.6	16.4	10.0	4.3	12.6	17.6	7.5	14.8	22.1	14.2	5.1	17.2	14.1	19.2	8.3	19.5	16.2	7.5	0.2	17.2	1.6	9.6	17.9	0.2	22.1	14.2	31.2	16.9	4.6	17.7	21.5	4.9	3.9	46.9	38.2	17.9	10.0	11.2	4.8	7.1	10.6	19.0	12.7	10.4	30.7	12.6	3.4	5.2	14.7	7.2	6.8	11.6	1.5	2.0	3.1	1.5	12.1	0.2	0.2	0.5	0.9	6.0	0.1	0.6	0.7	0.3	0.0	10.5	0.2	0.7	1.4	61.7	34.4	6.4	62.9	96.4	21.8	20.4	30.2	12.1	15.0	0.0	4.6	5.1	6.4	12.0	7.2	4.4	15.3	1.4	0.0	10.4	7.9	0.3	5.0	7.8	6.1	9.9	41.2	0.0	18.2	1.0	8.2	16.2	2.3	18.3	5.6	27.0	18.4	11.6	8.9	11.4	22.2	5.9	15.1	4.6	15.7	10.4	18.9	17.5	67.1	26.7	13.1	12.9	13.0	2.5	5.3	12.8	1.3	5.7	11.5	13.9
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459953-137550534	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 16.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;T-reg: 3.5"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;T-cells: 3.5"	"Cell line enriched"	"Detected in some"	23	"HMC-1: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.3	5.6	10.6	2.8	11.0	2.8	6.3	17.0	11.4	6.4	4.5	6.7	3.8	3.1	7.6	2.1	2.2	5.8	4.7	4.8	8.4	2.6	2.3	7.4	4.1	5.4	9.7	9.7	9.7	17.7	3.3	7.1	1.1	6.6	14.7	2.1	5.4	18.7	4.8	19.1	15.4	4.8	7.2	6.7	5.4	9.6	1.8	11.6	0.4	7.6	4.2	2.8	7.8	3.7	3.6	0.7	0.0	0.4	0.0	3.5	0.5	0.0	0.5	0.1	0.2	0.4	0.3	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.8	0.4	0.4	0.4	0.1	0.3	0.2	43.9	0.6	0.1	0.1	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.8	0.1	0.8	0.0	0.6	0.5	1.0	0.7	1.3	0.0	0.2	0.8	0.2	0.0	0.3	0.1	0.1	1.9	0.6	0.3	0.0	0.1	0.2	0.0	0.4	0.1	0.1	0.6	0.4	0.0	0.0	0.4	0.0	0.8	0.3	0.0	0.8	0.5	0.4	0.7	3.6	1.2	0.9	0.0	0.0	0.1	0.4	3.5	0.5	10.6	11.0	17.0	11.4	8.4	2.6	9.7	9.7	6.6	11.6	8.9	5.1	3.7	1.0	1.3	2.5	3.2	2.5	1.4	3.4	1.8	5.9	0.1	0.0	0.4	0.3	0.7	3.5	0.0	0.0	0.2	1.0	3.5	6.9	6.7	2.1	4.8	16.6	2.5	2.5	0.2	4.0	0.9	0.0	1.8	7.4	3.5	0.8	5.8	1.8	0.8	9.1	0.0	0.9	1.6	1.4	2.9	0.0	0.0	1.8	0.7
MRPL41	"BMRP, MRP-L27, MRPL27, PIG3, RPML27"	ENSG00000182154	"Mitochondrial ribosomal protein L41"	Q8IXM3	9	137551199-137552555	"Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 55.8;skeletal muscle: 60.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 826.6;Distal tubular cells: 824.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 49.0;PC-3: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024550, HPA027160"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024550: AB_1854112, HPA027160: AB_1854113"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.32e-2)"	15.3	8.0	12.8	3.5	14.4	3.1	2.8	4.1	10.7	2.4	8.3			7.1	2.3	1.0	1.7	2.1	1.5	16.4	10.3	7.7	6.8	10.7	2.6	3.3	8.5		4.2	6.3	1.8	2.9	1.6		9.5	2.2		10.8	3.8	60.6	5.3	6.2	1.5	4.0	6.2	10.5	2.1			2.0		1.5	2.7	2.1	38.3	55.8	43.7	42.5	21.8	42.2	42.8	10.0	17.0	2.9	6.8	4.3	3.6	13.2	12.9	3.3	5.9	4.8	11.8	5.7	7.4	16.9	3.1	8.9	21.4	3.8	6.1	0.6	10.8	21.1	6.8	9.3	18.4	9.9	11.0	31.4	7.1	8.4	5.3	1.9	2.6	5.4	6.5	14.8	3.2	3.1	49.0	3.7	35.8	10.9	12.8	48.0	4.6	4.9	10.3	5.0	6.7	9.4	10.2	8.5	15.8	20.9	1.7	15.0	10.0	10.6	10.3	14.3	18.5	16.7	9.6	13.3	13.1	11.9	10.9	7.8	43.7	42.5	31.5	31.2	34.1	29.5	38.3	33.8	35.9	34.6	28.5	32.2	30.2	5.1	21.8	31.1	55.8	42.2	42.8											26.8	28.1	87.8	111.7	124.4	47.8	826.6	188.5	41.5	37.5	249.5	9.8	105.5	824.0	135.5	238.0	93.7	424.6	0.0	166.2	127.5	105.3	182.0	54.1	733.3	213.4	27.0	257.8	98.2	123.7	565.6	112.8	114.0	212.6	190.2	235.6	66.7	187.8	270.0	98.3	497.0	34.2	109.9	97.6	90.9	72.6	145.2	68.8	110.7	282.5	152.7
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554904-137578935	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.7	12.1	14.0	16.4	8.2	10.7	15.9	17.8	13.3	12.7	21.5	14.3	5.9	14.2	17.8	9.4	18.2	10.3	12.6	14.0	7.6	11.1	11.0	10.4	13.0	19.1	11.5	17.3	20.8	14.1	14.9	10.5	12.8	15.6	11.9	10.8	16.1	15.4	9.6	13.5	12.2	14.6	9.0	16.0	11.8	10.1	18.6	11.2	13.8	5.8	13.9	10.9	11.7	10.8	14.2	15.6	9.2	9.3	13.5	8.8	7.1	7.5	12.2	10.9	8.8	6.7	14.1	7.1	6.9	12.0	10.2	14.9	7.1	14.0	12.8	7.4	8.9	17.1	14.1	12.1	9.6	11.2	16.5	5.9	10.1	5.4	10.0	13.2	12.7	6.9	10.8	8.0	15.2	9.8	15.9	11.1	11.8	7.5	8.3	20.2	10.0	14.4	14.0	25.8	15.9	17.9	6.4	11.4	9.9	6.7	13.9	12.6	10.9	9.3	7.9	7.7	13.4	13.1	7.5	9.5	7.7	10.9	13.6	6.2	11.9	15.6	4.9	9.1	8.9	15.6	8.9	9.7	10.9	9.2	11.6	10.8	13.5	12.7	10.4	9.5	11.5	11.7	2.3	9.3	6.4	14.2	9.3	8.8	12.1	16.4	15.9	17.8	14.0	7.6	19.1	11.5	12.8	18.6	6.0	14.0	13.7	10.0	14.8	19.0	12.6	5.1	9.4	7.9	1.8	47.1	18.3	3.3	8.7	1.3	11.7	5.1	0.0	8.1	11.4	11.8	10.7	10.4	5.8	10.5	15.9	6.4	8.6	5.7	4.5	15.3	6.9	8.5	10.8	10.6	17.1	10.1	8.0	14.9	4.2	57.2	19.4	13.0	20.5	25.6	16.6	10.2	16.2	13.9	9.1
ZMYND19	MIZIP	ENSG00000165724	"Zinc finger MYND-type containing 19"	Q96E35	9	137582079-137590490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"Cone photoreceptor cells: 229.7;Rod photoreceptor cells: 694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020642, HPA050761"	Supported		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020642: AB_1859078, HPA050761: AB_2681228"	"unprognostic (2.30e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.72e-1)"	9.5	11.6	11.9	10.3	14.2	9.1	15.5	13.1	20.6	8.5	9.2	7.3	12.3	10.1	8.1	7.5	16.5	8.4	8.4	9.5	12.7	11.0	8.1	12.8	9.3	12.3	9.7	13.0	10.7	26.2	8.0	11.5	9.9	10.2	10.8	6.9	7.9	14.2	9.0	13.7	19.1	8.0	11.7	7.4	9.8	14.4	41.8	9.6	9.2	8.2	9.0	10.6	8.5	10.1	1.9	2.6	0.8	4.7	0.4	3.3	0.4	10.5	16.7	15.9	17.2	8.6	8.4	16.1	14.5	9.8	16.0	12.3	19.7	10.8	19.1	16.8	9.6	15.4	26.8	19.4	14.6	5.1	12.3	18.8	9.9	31.0	15.3	13.5	21.2	13.0	6.6	22.5	14.5	14.3	7.1	8.4	15.2	23.9	8.4	9.6	35.5	24.6	32.4	23.1	31.8	23.4	27.0	14.1	29.3	9.7	9.0	23.1	15.1	14.0	30.2	12.6	7.4	20.3	33.1	7.9	19.8	15.0	29.3	23.4	8.2	19.4	20.5	12.2	16.5	13.5	0.0	0.9	0.8	1.4	4.7	3.3	1.9	1.0	0.7	0.9	1.0	1.6	1.3	0.0	0.4	0.5	2.6	2.7	0.4	11.9	14.2	13.1	20.6	12.7	11.0	9.7	13.0	10.2	9.6	8.9	7.4	3.0	3.9	15.5	19.8	6.0	5.1	1.4	2.3	1.8	229.7	4.1	0.0	3.3	2.8	3.1	2.6	0.0	3.1	5.8	5.1	7.9	1.1	6.7	3.9	11.1	2.4	2.5	2.7	3.2	2.6	2.5	5.0	1.8	7.5	22.1	3.7	3.5	2.8	2.2	694.3	0.0	5.3	28.8	28.5	19.9	3.8	2.2	5.2	6.5
ARRDC1	MGC40555	ENSG00000197070	"Arrestin domain containing 1"	Q8N5I2	9	137605654-137615360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.1;T-47d: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044345	Uncertain					NA	NA					"HPA044345: AB_10965181"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.03e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (8.01e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.52e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (5.01e-3)"	"unprognostic (1.51e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.11e-3)"	8.4	8.9	5.3	16.9	7.0	22.1	10.7	4.2	8.0	11.1	21.4	6.0	23.2	24.2	6.9	12.5	22.4	8.5	20.6	7.1	6.0	4.8	13.9	14.6	19.6	19.3	5.9	7.6	4.7	30.4	6.9	12.0	15.9	7.9	16.0	6.4	9.3	22.1	26.7	9.1	15.2	28.4	6.2	4.7	21.5	30.7	6.9	4.5	16.6	14.4	11.6	21.2	11.4	12.6	9.9	32.1	52.7	33.9	6.6	12.4	13.4	12.2	7.6	0.6	2.4	1.2	1.3	12.6	3.1	2.6	1.6	1.3	6.1	15.5	3.1	8.7	2.1	3.2	24.3	0.8	9.8	0.2	2.5	4.9	2.0	5.7	5.6	3.0	3.6	5.0	0.5	14.9	1.5	6.4	2.2	2.4	4.4	4.1	1.6	0.7	60.1	4.0	21.1	1.2	12.7	10.7	4.8	1.1	12.9	6.0	8.5	3.1	2.3	2.2	24.4	3.2	0.8	26.3	7.5	6.5	0.6	1.4	6.7	2.7	3.6	2.4	2.5	2.3	7.6	1.0	23.3	26.9	52.7	10.2	33.9	7.5	6.5	9.2	9.1	32.1	9.9	8.3	8.1	24.2	6.6	29.7	12.2	12.4	13.4	5.3	7.0	4.2	8.0	6.0	4.8	5.9	7.6	7.9	4.5	17.9	21.1	28.2	54.0	15.0	7.1	3.9	48.4	20.1	15.9	55.8	58.9	74.0	31.5	45.5	9.4	19.2	66.9	0.0	40.4	33.4	11.3	50.9	18.4	20.4	42.4	3.2	16.7	23.4	50.2	9.6	10.0	28.8	6.8	52.3	41.2	9.1	53.1	71.9	9.9	21.6	45.2	0.0	9.5	21.6	14.5	18.6	61.3	43.3	41.2	56.2
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060022, HPA074729"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA060022: AB_2684190, HPA074729: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.1	22.4	25.1	23.3	10.7	11.1	21.1	14.8	9.4	10.8	8.9	14.6	14.0	34.3	14.4	11.2	13.1	24.1	15.0	16.2	8.6	19.2	10.6	14.5	22.4	9.3	9.3	22.0	17.4	9.9	11.4	13.1	12.8	8.0	17.8	13.0	21.7	11.9	7.7	25.8	25.8	10.9	24.5	17.7	14.9	33.2	21.6	19.8	9.1	20.6	22.3	18.1	28.1	19.8	6.4	18.8	22.2	17.8	16.7	12.8	13.3	19.6	14.0	7.6	21.1	28.3	9.5	11.8	13.8	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5	17.9	16.3	36.9	20.3	15.5	38.3	24.3	17.8	21.4	22.7	21.0	49.1	18.6	3.3	20.9	68.8	24.8	19.8	0.0	18.3	18.0	18.4	25.8	17.4	28.8	17.0	47.7	27.0	17.8	23.4	119.3	33.1	16.5	11.8	23.4	20.2	23.1	20.1	25.9	35.3	11.9	48.0	12.9	15.3	58.1	54.9	17.7	22.2	23.3	20.5	22.0
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 21.2"	"Low region specificity"	"Detected in all"							"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	4.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4	0.0	0.0	0.0	0.0	0.0	5.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.0	0.0	2.4	0.0	0.0	0.4	0.0	1.5	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.0	0.0
